data_2k7h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k7h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 89.0 m-85 -125.06 143.04 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.0 m -126.13 125.29 42.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.9 m-85 -121.72 139.1 54.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -112.9 133.56 54.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD2' ' CE ' ' A' ' 136' ' ' LYS . 49.1 t0 -132.3 165.0 25.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.84 157.9 16.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 27.2 mt -124.28 135.93 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 23.6 m120 -142.14 130.93 22.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.23 135.17 9.18 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.912 . . . . 0.0 109.481 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.49 -6.27 18.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.653 2.236 . . . . 0.0 111.794 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.489 HG23 ' CD2' ' A' ' 150' ' ' LEU . 2.7 p -87.16 150.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.33 136.84 60.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.07 -32.32 28.16 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.19 64.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -75.37 -38.63 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 39.6 tp -69.49 -39.65 77.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.9 t80 -64.68 -46.89 80.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 24' ' ' THR . 5.7 tptm -63.29 -46.16 88.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.12 -17.91 61.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 44.6 tp -80.05 -50.17 10.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.815 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 -45.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -71.09 -50.46 33.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 4.3 t70 -95.03 17.09 14.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -54.55 -52.84 60.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 44.8 t0 -66.32 -26.07 67.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 59.0 m-20 -88.04 -26.61 22.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 109.449 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG13 ' CG2' ' A' ' 146' ' ' ILE . 75.3 t -82.27 -40.15 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.8 mt -49.47 -48.68 74.86 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.31 -34.61 20.77 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.355 2.036 . . . . 0.0 111.839 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 48.4 mttt -79.96 -40.43 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.063 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.96 88.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.268 -0.895 . . . . 0.0 108.878 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 40.5 tp -83.54 102.54 12.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 108.967 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.41 -35.6 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.3 p -97.73 29.5 3.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.982 . . . . 0.0 109.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 39' ' ' SER . 17.2 t80 -54.69 119.83 5.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -84.89 -55.66 3.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.618 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.592 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 60.6 p -175.1 168.23 3.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.63 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 7.2 p -144.08 142.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 40' ' ' VAL . 65.2 mt-10 -149.89 155.64 40.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 85.4 m-20 -96.57 121.97 38.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.4 m -79.97 -27.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 26.0 mt-10 -163.17 152.02 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 51' ' ' THR . . . 90.4 157.69 33.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.97 9.44 43.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.566 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.62 -6.93 36.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.36 -160.46 22.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HA ' HG21 ' A' ' 70' ' ' ILE . 49.1 Cg_endo -70.0 129.04 16.67 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.691 2.261 . . . . 0.0 111.714 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 89.88 2.31 75.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.453 HG22 ' HA3' ' A' ' 45' ' ' GLY . 14.3 m -75.05 152.46 38.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -1.148 . . . . 0.0 109.604 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 8.3 mm -114.05 124.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.072 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 96.8 mttt -118.78 143.65 46.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 15.6 tttp -115.95 128.49 55.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 49.2 mt -117.95 143.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 28.2 m -120.54 133.22 55.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.36 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CZ ' ' CB ' ' A' ' 64' ' ' LYS . 33.5 p90 -134.47 154.26 51.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.97 123.46 40.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.301 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -136.63 126.85 26.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.616 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 56.89 35.53 26.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.68 9.98 53.29 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -109.04 133.88 52.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -79.2 119.4 22.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 57' ' ' PHE . 24.3 mttt -123.64 165.6 16.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.509 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 32.7 p90 -146.01 159.87 42.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 35.7 m -134.82 143.37 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 109.728 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 8.5 mt -112.42 131.86 55.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 0.0 109.105 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -127.79 141.25 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.611 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 28.3 tttt -121.32 150.94 40.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.267 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 37.9 mt -112.59 133.95 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 94.2 mt-10 -92.02 -32.69 15.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.6 p -176.97 147.2 0.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 73' ' ' ILE . 63.2 mt -113.85 138.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -133.36 76.12 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.45 -37.72 84.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.17 -47.31 68.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -95.57 11.96 31.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 48.45 51.21 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.56 148.72 20.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 19.4 p90 -151.05 167.76 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 109.215 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 37.4 m -126.88 138.57 53.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.454 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.581 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 15.5 p90 -152.53 155.43 37.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.0 p -146.83 156.16 42.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.04 133.37 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.406 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.423 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.9 t -123.77 0.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.018 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.446 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -167.34 157.18 29.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.35 173.52 21.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.94 -13.01 29.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.89 16.84 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 85' ' ' VAL . 1.2 tt -120.97 103.82 42.35 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 46.2 Cg_endo -68.38 151.19 76.25 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.739 2.293 . . . . 0.0 111.866 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 47.7 m-20 -79.36 -32.55 43.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.6 p -79.6 -0.97 35.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.756 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 119' ' ' TYR . . . -127.38 126.85 43.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.379 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 46.4 mt-10 -58.85 -54.11 50.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 85.9 mttt -160.82 163.63 31.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.467 HG22 ' CE2' ' A' ' 99' ' ' PHE . 30.5 mt -122.99 132.98 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 2.2 m -108.87 144.53 36.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.642 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.2 m-85 -126.52 120.86 30.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 0.0 109.8 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 59.2 t0 -119.9 102.4 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.15 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.534 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.9 t -119.06 140.58 49.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.128 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 61.6 tttt -119.36 163.72 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 109.122 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -133.45 123.46 25.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.63 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.67 143.03 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 109.315 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.37 58.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.528 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -126.6 162.65 20.72 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.82 -13.38 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.694 2.263 . . . . 0.0 111.776 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.57 -23.29 65.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.88 18.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.02 -140.06 3.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 87.0 p -110.08 145.92 36.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.6 41.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.83 171.19 35.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -105.53 142.45 35.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -1.189 . . . . 0.0 109.377 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 60.9 tp -115.55 136.89 52.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.585 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 30.4 m -127.8 125.57 40.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.35 131.95 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.52 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -113.39 122.16 46.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 40.1 t80 -110.76 119.99 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.553 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -103.45 145.33 30.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 26.2 p -120.62 151.69 39.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 28.0 mttt -49.78 -43.42 48.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 177.24 -111.64 0.34 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.45 -44.13 89.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.74 134.47 36.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.574 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.6 132.1 7.97 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.58 139.52 37.55 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.679 2.253 . . . . 0.0 111.783 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -64.15 177.48 0.81 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.315 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.02 -42.29 89.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.62 -47.11 86.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.6 -40.41 79.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 79.7 mt -61.92 -37.33 84.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -59.97 -49.48 77.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.265 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.3 m -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.02 -41.87 98.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' CE ' ' OD2' ' A' ' 7' ' ' ASP . 49.6 tttp -70.28 -40.39 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -1.109 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.19 64.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.424 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -65.25 -46.21 81.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.78 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 70.5 m-20 -50.81 -29.77 12.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.77 76.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.872 . . . . 0.0 109.239 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.2 mt -76.01 -43.86 42.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -56.03 -54.68 41.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 77.4 mttt -50.46 -40.49 50.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.71 -48.81 80.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.237 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.539 ' CG2' HG13 ' A' ' 29' ' ' VAL . 34.0 mt -68.81 -44.48 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -62.34 -45.06 94.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.325 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.08 70.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 39.5 t80 -67.14 -46.0 75.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 13' ' ' VAL . 9.5 mp -61.22 -43.49 98.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.6 mt -69.38 -36.17 76.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.26 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -127.07 84.05 64.46 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.68 -19.24 36.77 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.645 2.23 . . . . 0.0 111.725 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.79 -12.26 60.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 157' ' ' ASN . 41.7 t80 -77.52 125.87 30.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.569 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 7.3 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.499 HG23 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.452 ' CE1' ' HD2' ' A' ' 127' ' ' PRO . 97.1 m-85 -80.05 118.73 22.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 28.8 m -111.17 116.53 31.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.3 m-85 -108.91 163.67 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.688 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 46.0 mt-10 -130.34 132.47 45.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.253 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -132.91 166.23 22.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.27 140.99 36.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.15 136.69 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.307 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -151.76 138.99 19.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -153.07 144.7 16.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HG2' HD13 ' A' ' 151' ' ' LEU . 49.4 Cg_endo -70.25 -5.02 15.54 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.699 2.266 . . . . 0.0 111.794 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.48 ' CG1' ' OE1' ' A' ' 147' ' ' GLU . 7.1 p -92.88 151.62 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.14 79.19 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.3 Cg_endo -68.07 -30.61 31.73 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.71 2.273 . . . . 0.0 111.85 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.0 61.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 157' ' ' ASN . 58.6 m -76.7 -38.89 53.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.495 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 150' ' ' LEU . 33.3 tp -68.13 -39.36 82.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 85.2 t80 -66.04 -44.59 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 0.0 109.785 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HE3' ' CG2' ' A' ' 24' ' ' THR . 43.1 tptt -63.83 -46.76 83.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 109.681 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 156' ' ' TYR . . . -72.56 -17.67 61.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.544 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 51.1 tp -79.52 -49.05 12.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.39 -48.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 1.9 m -64.99 -49.43 70.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.9 m-20 -97.27 12.19 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -48.66 -53.56 18.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.338 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 73.7 m-20 -66.92 -23.56 65.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.927 . . . . 0.0 109.543 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 92.0 m-20 -87.23 -26.76 23.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 25' ' ' ASP . 85.7 t -81.55 -35.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.651 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 12.4 mt -53.68 -48.59 92.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.25 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.9 Cg_endo -67.23 -19.73 50.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.524 2.149 . . . . 0.0 112.251 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 35.4 mttm -104.12 -45.82 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 109.347 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.8 91.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.578 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 55.0 tp -79.63 107.13 12.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 108.878 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.46 -44.73 85.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -92.14 29.75 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.828 -1.17 . . . . 0.0 110.344 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 54.4 t80 -58.38 123.75 17.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.02 -1.05 . . . . 0.0 109.363 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.36 -52.4 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.588 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -177.49 170.37 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.493 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.73 135.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -135.18 134.97 40.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.13 137.8 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.1 m -99.96 -36.83 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.433 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 43' ' ' VAL . 55.9 mt-10 -158.7 146.25 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.65 155.18 20.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -109.38 29.72 7.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -1.142 . . . . 0.0 109.583 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.78 -21.98 38.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.48 -162.42 5.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.4 160.55 49.14 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.66 2.24 . . . . 0.0 111.749 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 63.16 12.12 42.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -76.36 153.69 35.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.0 109.521 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.526 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 9.4 mm -117.39 126.94 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -119.88 144.51 47.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.706 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.7 tttt -115.29 128.97 56.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 67.8 mt -117.41 145.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.3 m -124.43 125.15 43.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 109.298 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 48.0 p90 -133.66 158.21 43.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 58' ' ' LEU . 4.2 mm? -99.22 150.14 22.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.482 ' OE1' ' CE ' ' A' ' 64' ' ' LYS . 57.7 tt0 -152.97 129.81 10.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.566 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 48.13 23.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.38 29.4 36.73 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' GLU . 96.9 mt-10 -123.71 155.39 37.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.8 m -97.86 112.26 24.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 62.3 mttt -124.67 158.63 32.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 30.0 p90 -142.76 157.6 44.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 33.3 m -132.76 142.8 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.131 -0.98 . . . . 0.0 109.608 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.525 ' HB2' ' N ' ' A' ' 86' ' ' GLY . 10.5 mt -110.29 125.42 53.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -116.01 133.86 55.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 64.0 tttt -120.59 146.06 46.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.195 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 66.1 mt -113.31 138.28 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.551 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.1 -42.61 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -161.58 142.75 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 109.499 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 73' ' ' ILE . 68.3 mt -109.88 140.71 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.48 77.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.398 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.6 mt-10 -57.29 -38.17 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.443 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.05 -47.73 64.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -95.01 12.67 27.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.1 mt 47.72 31.54 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.408 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.94 152.79 19.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.511 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.5 p90 -150.24 169.65 20.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -1.124 . . . . 0.0 109.26 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -125.97 139.28 53.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 25.9 p90 -154.29 160.76 41.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.7 p -146.19 156.48 43.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -86.36 132.15 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG12 ' HE2' ' A' ' 96' ' ' LYS . 4.1 t -117.67 -5.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.781 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -171.96 162.71 34.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 122.54 160.43 10.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.05 -15.16 20.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -1.079 . . . . 0.0 109.296 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.93 -6.03 56.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.338 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tt -79.98 110.19 15.13 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 109.356 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.21 146.42 63.52 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.747 2.298 . . . . 0.0 111.695 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.451 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 62.5 m-20 -78.89 -32.65 45.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.9 p -79.86 -5.44 55.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.727 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . . . -122.75 136.92 55.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.058 -1.026 . . . . 0.0 109.624 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 81.1 mt-10 -70.63 -51.31 28.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 31.7 mttt -161.21 163.55 31.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' SER . 60.3 mt -124.01 133.1 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' A' ' 118' ' ' LYS . 6.1 m -109.52 125.52 52.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.0 m-85 -108.79 122.87 48.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 56.7 t0 -120.42 102.63 8.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.933 . . . . 0.0 109.252 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.441 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 17.1 m -119.44 139.57 51.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.909 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 103' ' ' LEU . 31.6 ttpt -120.58 156.87 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 62.3 mt -129.54 127.5 40.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 27.5 m -139.61 142.97 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.33 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.25 170.63 22.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.13 -8.94 24.84 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.684 2.256 . . . . 0.0 111.853 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -67.9 -24.94 65.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.32 44.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.98 -143.32 4.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 85.3 p -106.1 144.74 32.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.47 147.12 30.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.41 -165.52 32.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.11 145.14 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -117.69 132.37 56.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.465 ' N ' HD22 ' A' ' 115' ' ' LEU . 20.1 m -122.11 128.69 51.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.269 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' THR . 49.2 t -107.7 131.35 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' CG ' HG23 ' A' ' 2' ' ' VAL . 31.8 tttm -112.66 121.41 44.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.84 . . . . 0.0 109.225 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t80 -116.48 114.32 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.544 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' HG2' HG11 ' A' ' 2' ' ' VAL . 82.7 mt-10 -101.12 138.05 38.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.092 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.9 p -116.42 164.32 14.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.451 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 41.3 mttt -55.22 -43.05 74.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.47 -106.88 0.21 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 86.1 m-20 -63.32 -42.84 99.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 109.449 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -44.63 130.47 6.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 4.9 mt-10 -134.91 133.17 20.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.4 Cg_endo -70.44 158.13 56.99 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.613 2.209 . . . . 0.0 111.742 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.7 OUTLIER -90.93 164.99 13.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.95 -40.66 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.41 -46.63 89.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 64.7 mm-40 -58.11 -45.61 86.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.55 -38.31 80.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -61.27 -48.55 80.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.35 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.4 m -58.83 -38.54 78.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.324 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -46.0 95.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' CD ' HG21 ' A' ' 117' ' ' VAL . 4.8 mtmt -64.94 -38.82 92.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.0 62.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.49 -45.99 84.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.359 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.3 -55.35 10.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -54.06 -35.72 62.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.39 -46.96 82.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 142' ' ' LEU . 2.8 tm? -71.19 -33.57 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.202 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -56.07 -52.75 63.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.953 . . . . 0.0 109.125 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -51.76 -39.84 59.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.156 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.03 -38.71 73.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.305 -0.872 . . . . 0.0 109.053 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.476 HD11 ' CG1' ' A' ' 29' ' ' VAL . 7.6 mm -71.68 -44.35 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.234 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 30.6 tp10 -67.69 -41.63 83.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.86 -34.28 74.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.95 -46.68 64.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 18' ' ' LEU . 6.7 mp -63.26 -43.77 97.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD12 ' HG3' ' A' ' 147' ' ' GLU . 82.0 mt -68.05 -33.48 74.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.71 -17.82 61.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -129.56 95.07 30.72 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.6 -16.58 34.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.699 2.266 . . . . 0.0 111.72 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -73.43 -20.73 60.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.55 ' CZ ' ' HB1' ' A' ' 21' ' ' ALA . 70.8 t80 -79.89 129.92 34.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.427 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.4 m-85 -124.28 146.5 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.6 m -128.31 135.0 49.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 71.5 m-85 -126.39 160.0 31.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 71.7 mt-10 -135.93 129.26 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -133.26 165.13 25.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 8' ' ' GLU . 68.5 mm-40 -104.68 151.83 23.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 47.4 mt -121.53 134.91 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 25.7 m120 -144.72 131.34 19.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.549 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 2.0 p -148.02 144.54 19.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.0 Cg_endo -71.48 1.38 5.63 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.415 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CG1' ' OG ' ' A' ' 11' ' ' SER . 2.4 p -97.89 152.78 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.55 137.9 61.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HB3' ' HA ' ' A' ' 111' ' ' SER . 47.1 Cg_endo -67.98 -35.16 21.2 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.744 2.296 . . . . 0.0 111.826 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.89 68.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.29 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 157' ' ' ASN . 68.1 m -78.55 -35.25 46.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 150' ' ' LEU . 14.5 tp -70.62 -40.59 73.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.481 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.51 -49.78 67.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' THR . 7.3 tptm -59.77 -46.26 89.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.562 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -70.54 -18.63 62.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 13.4 mt -80.13 -46.16 16.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 109.749 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.52 -45.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.17 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 16.4 m -74.78 -50.05 18.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.334 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 4.6 t70 -92.12 9.18 34.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.0 109.819 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -51.05 -52.45 43.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' A' ' 30' ' ' ILE . 93.8 m-20 -65.19 -29.48 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.379 -0.826 . . . . 0.0 109.748 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 85.7 m-20 -84.41 -26.36 28.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG11 ' CG2' ' A' ' 146' ' ' ILE . 45.0 t -80.77 -37.14 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.628 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.4 mt -50.04 -49.48 74.76 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.37 -25.23 36.2 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.357 2.038 . . . . 0.0 111.97 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 59.6 mmtt -91.94 -33.31 14.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.149 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.65 -43.05 60.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -0.868 . . . . 0.0 109.046 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.61 106.6 18.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.016 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.26 -33.26 69.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.944 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 m -98.2 29.55 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 0.0 109.882 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 56.3 t80 -58.35 126.48 27.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -92.08 -52.04 4.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.611 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 54.3 p -177.66 170.85 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 109.722 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' CG2' ' CD1' ' A' ' 55' ' ' ILE . 5.6 p -142.33 140.32 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.308 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -145.93 153.79 41.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 7.1 m-20 -87.23 140.67 29.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 2.7 t -91.17 -39.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.644 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 87.9 mt-10 -161.03 149.21 15.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' HA3' HG22 ' A' ' 51' ' ' THR . . . 96.16 167.36 34.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -98.14 8.14 45.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.91 -6.37 35.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.79 17.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.69 130.7 19.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.658 2.239 . . . . 0.0 111.758 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.5 3.49 69.04 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 52' ' ' ILE . 91.7 m -77.76 155.19 31.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -1.178 . . . . 0.0 109.571 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.51 ' N ' HG23 ' A' ' 51' ' ' THR . 21.1 mm -118.79 128.31 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.942 . . . . 0.0 109.308 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.7 mttp -122.52 147.72 46.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 36.3 tttm -116.98 129.3 55.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.491 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 14.8 mm -116.28 146.21 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.528 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.5 m -130.71 121.59 25.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.903 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 47.6 p90 -129.1 160.8 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 62' ' ' GLU . 4.2 mm? -96.25 148.56 22.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -150.37 127.74 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.36 22.71 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.45 10.86 72.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 58' ' ' LEU . 93.1 mt-10 -108.35 159.12 16.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -1.11 . . . . 0.0 109.453 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 58' ' ' LEU . 31.6 m -104.93 115.47 30.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -121.22 164.68 16.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.49 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 45.6 p90 -143.75 156.47 44.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.516 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 27.1 m -135.85 144.7 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.557 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mt -109.87 126.79 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.219 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -118.5 134.84 54.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 17.8 tttm -116.05 147.21 41.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 50' ' ' GLY . 12.2 mm -106.83 126.54 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.32 -42.88 12.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 p -168.04 148.46 4.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.01 135.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.12 75.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.352 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.25 -36.67 78.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -48.74 72.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 49.3 m-20 -90.63 13.01 17.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.481 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 7.7 mt 47.53 49.27 16.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.472 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -148.73 153.9 25.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.3 p90 -150.38 169.47 21.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -1.124 . . . . 0.0 109.133 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.7 m -131.09 140.75 50.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 24.1 p90 -155.76 162.6 40.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.578 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 51.9 p -146.36 156.53 43.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.51 133.32 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 19.4 t -106.87 -7.93 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.471 ' N ' HD12 ' A' ' 90' ' ' LEU . . . 171.27 -179.06 43.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.75 166.02 27.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.84 -20.75 2.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -1.116 . . . . 0.0 109.379 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.92 -15.73 56.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 86' ' ' GLY . 0.7 OUTLIER -90.65 106.96 17.15 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.307 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.5 Cg_endo -69.58 146.26 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.728 2.285 . . . . 0.0 111.901 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.45 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 79.3 m-20 -77.47 -30.97 53.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 p -79.95 1.18 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.849 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.565 ' HB1' ' CZ ' ' A' ' 119' ' ' TYR . . . -127.56 126.32 41.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' OE1' ' OE2' ' A' ' 120' ' ' GLU . 92.8 mt-10 -58.15 -42.4 85.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -178.54 157.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.359 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.481 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 63.8 mt -119.67 135.56 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.532 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 34.6 m -109.62 128.2 55.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 94.2 m-85 -111.27 124.65 52.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -120.09 105.0 10.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.482 ' CB ' HD11 ' A' ' 115' ' ' LEU . 8.5 t -114.5 141.0 48.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.445 ' O ' HD21 ' A' ' 103' ' ' LEU . 74.1 tttt -127.7 146.86 50.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.86 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 46.5 mt -122.68 127.6 49.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.799 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 35.8 m -138.86 143.43 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.454 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -62.65 139.77 58.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.52 165.3 22.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.01 22.51 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.647 2.231 . . . . 0.0 111.831 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.16 -28.14 69.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.79 10.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.35 -134.44 2.08 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 100.0 p -108.42 143.16 37.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -1.129 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.94 141.97 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.57 -168.54 35.45 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' A' ' 6' ' ' GLU . 69.2 tttt -125.83 140.72 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -1.121 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.482 HD11 ' CB ' ' A' ' 101' ' ' SER . 25.0 tp -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 5' ' ' PHE . 59.1 m -126.83 127.1 44.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.494 HG13 ' CE1' ' A' ' 99' ' ' PHE . 58.6 t -111.81 132.7 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.8 ttpt -111.72 125.31 53.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CZ ' ' HB1' ' A' ' 94' ' ' ALA . 55.6 t80 -113.0 118.75 35.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 87.0 tt0 -103.44 146.78 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.399 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.483 HG23 ' CD ' ' A' ' 127' ' ' PRO . 11.8 p -119.77 157.19 29.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.397 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.2 mttt -45.9 -37.71 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.66 -96.4 0.16 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.18 -32.15 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -1.148 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.51 137.77 57.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -145.59 110.44 4.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.54 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 47.9 Cg_endo -69.77 144.48 54.1 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.728 2.285 . . . . 0.0 111.772 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.418 ' OD1' ' HG3' ' A' ' 131' ' ' GLU . 48.4 p30 -70.49 172.87 7.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.71 -35.1 78.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.47 -44.3 89.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.418 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 94.4 mt-10 -66.84 -39.99 87.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 95.7 mt -63.77 -42.93 97.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.46 -44.72 90.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.268 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.3 m -57.53 -38.66 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.04 97.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -62.98 -38.61 91.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HA ' ' OD2' ' A' ' 140' ' ' ASP . . . -51.71 -32.04 28.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.444 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -75.86 -36.65 59.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.22 -55.29 8.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.877 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 4.2 p30 -62.11 -26.03 68.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.499 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -58.76 -50.98 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.895 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.24 -38.16 76.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.883 . . . . 0.0 109.292 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.02 -54.95 38.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.128 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -51.54 -33.74 33.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.85 -53.72 53.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.247 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.518 ' CG2' HG11 ' A' ' 29' ' ' VAL . 45.0 mt -67.37 -53.55 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -50.48 -51.0 51.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.46 70.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.9 t80 -66.5 -39.72 88.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.394 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 18' ' ' LEU . 13.0 mt -61.21 -43.12 99.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.466 HD21 ' HG2' ' A' ' 12' ' ' PRO . 83.3 mt -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.37 61.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.595 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 93.85 46.59 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.81 -21.46 33.2 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.683 2.255 . . . . 0.0 111.759 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -75.42 -17.88 60.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 57.5 t80 -78.74 118.67 21.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 17' ' ' THR . 75.6 m-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.487 ' CG1' ' HE3' ' A' ' 118' ' ' LYS . 88.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.42 146.88 49.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -130.62 130.46 44.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 132' ' ' LEU . 88.0 m-85 -129.28 160.92 31.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -127.9 130.11 47.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -126.22 164.71 20.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -94.51 160.47 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 61.4 mt -128.12 142.38 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.36 132.11 42.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -152.42 112.67 2.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.25 -2.22 10.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.581 2.187 . . . . 0.0 111.726 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 68.0 t -95.2 154.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 132.39 26.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.0 Cg_endo -67.93 -29.64 34.15 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.745 2.296 . . . . 0.0 111.939 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.88 -34.05 62.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -77.31 -37.4 52.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.548 ' CD1' ' HB ' ' A' ' 13' ' ' VAL . 9.0 mt -69.24 -40.25 78.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.54 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 68.6 t80 -65.88 -45.54 81.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.3 OUTLIER -64.48 -47.6 78.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -70.34 -20.84 62.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.333 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 7.2 tt -80.13 -45.49 18.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 HG22 HD23 ' A' ' 22' ' ' LEU . 24.8 t -98.36 -54.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 20.7 m -63.69 -49.5 72.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.577 ' OD2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 m-20 -95.61 13.59 25.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.074 -1.017 . . . . 0.0 109.938 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -53.3 -52.87 57.71 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.193 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 63.9 t0 -67.61 -23.02 65.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.97 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 7.6 m120 -90.94 -27.42 18.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.9 p -83.51 -35.07 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.7 mt -56.63 -46.47 99.83 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.4 Cg_endo -66.72 -22.18 50.42 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.456 2.104 . . . . 0.0 112.42 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -108.47 -26.0 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.115 -0.991 . . . . 0.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -63.49 -28.61 70.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.969 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 42.2 tp -101.02 117.52 35.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.032 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.77 -44.07 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.532 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 57.9 m -93.02 28.17 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.891 -1.131 . . . . 0.0 110.072 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CE1' HG21 ' A' ' 30' ' ' ILE . 46.6 t80 -58.83 131.61 51.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.0 tttp -93.03 -51.08 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.933 . . . . 0.0 110.103 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.464 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 67.0 p -179.91 173.77 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 109.938 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 9.7 p -135.69 128.35 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.205 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 70.0 mm-40 -130.0 144.03 51.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.27 125.64 30.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 50.0 t -82.69 -44.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.562 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.41 ' O ' ' CG2' ' A' ' 51' ' ' THR . 81.7 tt0 -158.49 145.59 17.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.4 168.21 28.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.84 5.68 50.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -1.152 . . . . 0.0 109.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.28 -8.45 28.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -156.76 12.35 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.02 135.68 30.44 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.701 2.267 . . . . 0.0 111.774 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.25 1.5 84.06 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 44' ' ' GLU . 91.5 m -80.02 127.68 32.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 109.481 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.515 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 20.6 mm -93.29 134.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -125.77 150.75 47.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HE2' ' CG ' ' A' ' 65' ' ' PHE . 22.5 tttt -115.33 126.45 54.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.537 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 56.4 mt -111.77 141.01 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -125.39 123.41 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 41.1 p90 -128.71 166.84 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.27 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.0 mm? -99.35 151.39 21.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.501 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -154.13 119.0 4.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.927 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.12 31.78 7.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.26 -7.09 65.15 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' OE2' ' HE2' ' A' ' 64' ' ' LYS . 72.8 tt0 -91.25 144.51 25.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -1.145 . . . . 0.0 109.419 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.7 m -95.79 120.15 35.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 12.7 mmtt -125.69 169.81 12.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 5.0 p90 -147.93 161.39 41.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 21.8 m -137.94 147.18 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.558 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 3.9 mp -115.3 134.3 55.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -128.67 141.99 51.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 66.4 tttt -120.82 147.68 45.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.356 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.7 mt -108.61 132.2 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 92.9 mt-10 -87.6 -38.8 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.425 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 p -176.78 150.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.448 HG23 HG11 ' A' ' 23' ' ' VAL . 71.3 mt -116.03 137.16 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -131.46 79.43 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -61.86 -37.76 85.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.55 63.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 56.5 m-20 -90.58 13.32 16.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 9.8 mt 47.31 47.63 16.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.89 152.95 24.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CE1' HD21 ' A' ' 22' ' ' LEU . 17.3 p90 -151.12 169.35 22.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 109.14 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 22.7 t -137.76 142.03 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.9 p90 -154.64 160.7 41.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.349 -0.845 . . . . 0.0 109.533 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.4 p -145.55 156.49 43.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 90' ' ' LEU . 73.4 t -89.67 133.09 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.359 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -115.04 -1.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.863 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.52 168.09 39.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.32 166.28 18.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.0 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -1.148 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -81.35 -10.54 59.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.486 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -88.27 107.78 18.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.3 Cg_endo -69.43 148.29 66.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.647 2.231 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -79.37 -33.41 42.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -81.31 0.26 37.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -130.43 139.45 50.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 122' ' ' LYS . 89.7 mt-10 -67.03 -54.73 18.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 109.508 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 51.2 pttt -171.91 163.54 6.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 56.2 mt -118.98 135.75 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.5 m -110.15 122.6 48.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.221 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 92.4 m-85 -104.04 125.17 50.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.841 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 48.7 t0 -120.34 102.22 8.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.46 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 27.0 m -115.13 141.43 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.0 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 50.3 tttt -123.24 153.8 39.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 108.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 40.4 mt -129.88 126.45 37.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.94 143.26 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -70.4 148.3 48.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.48 168.07 24.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 -6.0 17.52 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.71 2.273 . . . . 0.0 111.701 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -63.81 -27.3 69.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.7 18.32 25.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.51 -139.09 3.42 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 31.0 t -117.0 145.99 43.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.682 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.11 166.13 25.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.885 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 169.2 169.43 32.55 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -109.51 144.93 37.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -1.164 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HG ' ' OG ' ' A' ' 101' ' ' SER . 1.2 tt -114.98 136.19 53.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.575 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 25.3 m -127.16 126.13 42.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.4 HG12 ' CE1' ' A' ' 99' ' ' PHE . 48.0 t -111.24 130.5 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.651 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.487 ' HE3' ' CG1' ' A' ' 2' ' ' VAL . 63.9 tttt -112.6 122.08 46.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 109.152 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.571 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 22.8 t80 -112.1 118.41 35.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 109.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.442 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 88.8 mt-10 -101.24 145.52 28.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.208 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 15.7 p -124.09 171.28 9.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HD3' ' HG3' ' A' ' 95' ' ' GLU . 41.9 mmtt -79.8 1.52 26.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.28 -88.46 0.46 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -57.79 -37.45 73.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.89 137.66 58.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 110.69 3.78 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.432 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' ' CD1' ' A' ' 119' ' ' TYR . 50.4 Cg_endo -70.28 147.22 59.04 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.732 2.288 . . . . 0.0 111.835 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.8 OUTLIER -84.61 163.51 19.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.448 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.61 -40.12 78.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.66 -45.56 91.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -59.36 -42.88 92.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 5' ' ' PHE . 90.9 mt -58.16 -35.32 71.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -65.39 -44.12 88.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.6 m -57.79 -39.6 77.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.29 98.8 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -63.3 -39.2 93.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -1.155 . . . . 0.0 109.448 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.16 -33.1 38.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.95 -43.24 93.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.99 -50.66 67.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.336 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 84.4 m-20 -51.57 -33.67 33.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.36 97.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.269 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 2.9 tm? -79.18 -36.45 40.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.12 -51.84 68.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 80.6 mttt -51.78 -39.87 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 0.0 109.212 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.32 81.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.143 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.09 -45.06 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.372 -0.83 . . . . 0.0 109.191 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 94.2 mt-10 -71.19 -37.82 72.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.83 79.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.162 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -71.33 -52.33 19.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 8.1 mp -60.97 -36.69 80.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.52 -31.69 68.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.46 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.71 -2.1 51.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -127.94 75.42 78.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.71 -14.17 35.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.673 2.249 . . . . 0.0 111.782 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -76.23 -26.1 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.577 ' CZ ' ' OD2' ' A' ' 25' ' ' ASP . 81.6 t80 -79.88 125.58 29.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.433 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 3' ' ' PHE . 97.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' OE1' ' A' ' 126' ' ' GLU . 97.6 m-85 -124.61 147.13 48.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.49 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -127.6 120.69 28.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.586 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 91.8 m-85 -123.16 133.66 54.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -101.9 132.69 47.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 53.3 t0 -127.74 160.58 31.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.47 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 90.4 mt-10 -92.09 160.2 15.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 77.0 mt -117.67 143.8 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -138.03 112.26 8.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 51.1 m -149.33 126.78 5.58 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.68 -35.96 9.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 18' ' ' LEU . 6.4 p -55.21 149.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.525 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -61.58 134.33 93.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.599 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HB3' ' HB3' ' A' ' 111' ' ' SER . 47.6 Cg_endo -68.67 -24.23 35.42 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.785 2.323 . . . . 0.0 111.826 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -44.16 49.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.667 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.8 m -76.27 -42.83 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.157 -0.965 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 16.1 tp -65.12 -38.35 90.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 109.639 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.516 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 83.7 t80 -66.17 -43.86 85.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.7 tptt -64.51 -46.74 81.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.689 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.26 -16.84 60.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 61.0 tp -77.02 -51.03 11.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.5 -48.25 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -61.59 -48.77 79.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 109.778 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' VAL . 65.3 m-20 -101.54 15.26 29.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.32 -52.68 12.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' HD13 ' A' ' 30' ' ' ILE . 86.3 m-20 -67.45 -23.16 65.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.541 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 m120 -88.53 -27.75 21.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.87 . . . . 0.0 109.317 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.0 p -82.76 -37.2 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.651 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.4 mt -49.74 -48.9 76.02 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.869 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.2 Cg_endo -68.48 -33.45 22.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.396 2.064 . . . . 0.0 111.87 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -82.33 -52.91 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.136 -0.978 . . . . 0.0 109.133 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.06 -38.07 62.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 108.974 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.571 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 26.8 tp -84.39 105.42 15.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.77 -39.33 77.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.079 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.6 p -95.61 28.28 3.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 109.862 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -56.44 125.7 23.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HB2' HD12 ' A' ' 58' ' ' LEU . 51.7 tptt -92.83 -52.69 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 m -170.34 162.92 8.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.717 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' SER . 96.3 t -143.03 142.42 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 86.1 mt-10 -150.97 161.86 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 109.54 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -88.51 135.4 33.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 109.446 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 28.5 t -83.27 -42.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 55.6 mm-40 -159.57 147.25 17.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.72 -154.09 21.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -140.66 13.21 2.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.13 31.04 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.87 -162.66 25.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.71 134.94 27.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.731 2.287 . . . . 0.0 111.866 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.98 0.25 90.19 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 52' ' ' ILE . 89.5 m -70.2 151.57 45.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.63 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.51 ' N ' HG22 ' A' ' 51' ' ' THR . 37.8 mm -115.65 124.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -117.91 143.39 46.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.002 . . . . 0.0 109.763 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 12.6 tttm -123.5 136.3 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.223 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.527 ' CD1' HG21 ' A' ' 30' ' ' ILE . 71.9 mt -128.92 146.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.804 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 30.3 m -120.14 121.99 40.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.279 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.571 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 51.4 p90 -122.32 162.27 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.546 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -101.07 149.98 23.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.27 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -164.89 131.29 2.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 53.85 28.81 8.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.05 67.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -107.74 129.0 55.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -1.207 . . . . 0.0 109.401 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -80.12 124.44 28.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 73.9 mttt -124.21 169.91 11.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.551 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 37.7 p90 -142.5 154.58 44.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.477 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 29.7 m -130.53 139.19 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.56 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -108.67 126.96 53.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -125.89 140.4 52.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.588 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 36.4 tttm -121.39 148.95 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.32 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 50' ' ' GLY . 57.7 mt -108.6 132.09 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' OE2' HG23 ' A' ' 98' ' ' THR . 97.2 mt-10 -88.29 -36.43 16.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 109.355 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -175.16 150.27 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.73 136.38 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -132.81 78.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 45.9 mt-10 -57.23 -39.41 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.5 -46.99 57.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.925 . . . . 0.0 109.421 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.481 ' HB3' ' NZ ' ' A' ' 102' ' ' LYS . 47.2 m-20 -93.77 13.68 21.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.281 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 7.6 mt 47.03 35.87 3.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.98 154.22 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.9 p90 -150.71 169.72 20.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 109.068 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 72.5 m -129.72 139.51 51.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.674 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.9 p90 -153.27 158.7 42.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -148.04 157.71 43.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.08 125.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.285 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.48 2.47 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.56 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -164.59 154.33 25.09 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 113.9 159.14 13.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -13.42 32.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.115 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.45 9.33 7.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.596 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.59 122.41 42.0 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.371 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 51.1 Cg_endo -70.5 145.2 52.22 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.691 2.261 . . . . 0.0 111.826 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -79.76 -32.28 40.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -80.18 -2.77 46.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 119' ' ' TYR . . . -125.0 117.98 25.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.967 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -49.94 -43.64 50.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -176.85 161.46 2.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.56 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 69.6 mt -122.65 134.04 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 50.8 m -107.89 129.81 55.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.8 m-85 -113.78 123.6 50.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.9 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -123.0 101.57 7.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.017 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.44 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 4.3 m -113.31 145.89 40.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.035 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 77' ' ' ASN . 19.4 tttt -123.27 158.39 31.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 77.0 mt -138.93 129.91 26.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.006 . . . . 0.0 110.139 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -142.83 169.68 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 0.0 108.979 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.526 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.32 137.47 39.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 109.516 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.89 161.09 19.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.62 -0.45 6.82 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.689 2.26 . . . . 0.0 111.74 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.93 -23.43 41.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.31 12.52 33.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.96 -146.43 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.45 145.89 24.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.661 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -146.78 143.13 28.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.363 -0.835 . . . . 0.0 109.197 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.16 -161.12 26.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.532 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 2.1 tt -116.73 136.78 52.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.7 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.447 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.0 m -123.27 127.72 48.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 99' ' ' PHE . 98.5 t -112.28 129.06 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 87.3 tttt -114.45 120.77 41.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.323 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.572 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 39.4 t80 -112.45 119.24 37.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 92.9 mt-10 -99.77 146.47 26.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 66.2 p -123.8 160.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -52.74 -43.55 65.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.17 -82.14 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 18.1 p30 -76.78 -15.38 59.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.6 138.04 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' OE1' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -134.92 111.25 11.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.561 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 50.3 Cg_endo -70.89 140.35 38.24 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.729 2.286 . . . . 0.0 111.795 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.92 156.6 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -53.37 -34.78 58.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -59.05 -45.99 89.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 68.8 mm-40 -60.32 -41.5 93.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.586 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 54.2 mt -60.88 -38.64 86.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.377 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -71.44 -37.53 71.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 58.8 m -58.72 -42.16 88.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.26 -32.03 71.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -68.99 -40.44 78.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.327 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.17 -37.02 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' O ' HD21 ' A' ' 142' ' ' LEU . 26.3 mttp -66.65 -42.95 85.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.306 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.79 -50.2 67.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.839 . . . . 0.0 109.285 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -56.37 -33.25 65.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.339 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.25 -54.46 40.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.34 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.7 mm? -76.34 -32.3 58.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -63.15 -50.79 69.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.381 -0.825 . . . . 0.0 109.259 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -62.4 -34.5 76.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.92 -44.38 82.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.484 HG12 HG22 ' A' ' 29' ' ' VAL . 26.6 mt -67.59 -46.59 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.341 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 38.3 mt-10 -64.65 -40.38 95.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.855 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.38 71.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -69.29 -43.24 74.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.887 . . . . 0.0 109.351 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' A' ' 18' ' ' LEU . 8.1 mp -70.56 -35.81 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.92 -37.28 64.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.616 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.63 -15.21 61.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -131.49 91.06 35.63 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -16.42 33.95 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.719 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -78.29 -9.63 59.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.72 142.09 15.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.538 HG12 ' CG ' ' A' ' 118' ' ' LYS . 91.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 59.9 m-85 -79.85 126.63 31.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.719 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.3 m -123.16 116.45 23.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 90.9 m-85 -103.8 167.09 10.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -140.81 130.92 24.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -139.87 165.37 27.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.31 140.92 37.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 70.3 mt -106.62 141.54 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.559 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -142.9 128.88 19.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 14.8 m -152.77 134.63 8.64 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 -0.78 7.76 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 111.679 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.4 p -92.51 149.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.494 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' GLY . . . -61.73 133.79 93.71 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.685 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 47.0 Cg_endo -68.34 -26.84 34.84 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.759 2.306 . . . . 0.0 111.695 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.67 -39.28 57.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.442 ' CG2' ' OXT' ' A' ' 157' ' ' ASN . 15.6 m -75.52 -43.49 48.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.537 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 3.8 tp -70.81 -39.81 72.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.1 t80 -66.83 -41.69 87.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 24' ' ' THR . 30.7 tptt -66.34 -46.3 77.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.8 -24.49 59.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.203 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 16.3 tp -66.44 -49.62 66.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.19 -46.21 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.545 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -67.66 -48.35 66.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.651 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.4 m-20 -94.2 6.36 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 29' ' ' VAL . . . -45.89 -52.57 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' HA ' HD11 ' A' ' 30' ' ' ILE . 19.6 t70 -67.06 -26.27 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.747 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.3 m-20 -87.12 -27.04 23.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.125 -0.985 . . . . 0.0 109.73 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.3 p -81.94 -35.54 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.619 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.1 mt -52.58 -47.49 93.69 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.324 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.2 Cg_endo -67.07 -17.39 50.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.352 2.035 . . . . 0.0 112.057 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 19.5 mttm -107.5 -35.78 6.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.471 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.44 -41.74 88.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 109.175 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 45.7 tp -86.69 109.05 18.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -57.51 -43.45 84.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.29 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -91.23 29.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 66.1 t80 -60.73 127.18 30.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.117 -0.99 . . . . 0.0 109.502 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 58' ' ' LEU . 41.3 mtmt -96.38 -49.85 5.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 109.551 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -178.15 170.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -138.81 141.81 38.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.412 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 34.4 t30 -77.63 129.67 35.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.445 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.425 ' CG2' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -79.85 -41.3 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.526 ' HG2' ' N ' ' A' ' 45' ' ' GLY . 81.8 tt0 -167.46 157.53 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.498 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.526 ' N ' ' HG2' ' A' ' 44' ' ' GLU . . . 97.42 173.31 33.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.09 3.9 22.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -1.164 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.04 -9.13 25.15 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.62 -160.77 26.44 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.15 125.41 11.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.616 2.211 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 100.29 0.06 55.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 52' ' ' ILE . 62.6 m -75.67 152.54 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 51' ' ' THR . 27.3 mm -115.78 125.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.854 . . . . 0.0 109.186 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 87.4 mttt -118.7 143.92 46.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.897 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HE2' ' CG ' ' A' ' 65' ' ' PHE . 22.2 tttt -115.54 128.48 56.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 66.2 mt -115.03 133.37 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -112.78 124.97 53.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.555 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 53.2 p90 -134.38 161.19 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.473 ' CD2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -101.73 135.94 42.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.368 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -137.51 128.43 27.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.586 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 50.77 22.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.546 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.02 59.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -117.06 140.67 49.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -1.089 . . . . 0.0 109.52 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.6 m -81.22 111.69 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -128.03 164.65 21.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 67' ' ' LEU . 10.8 p90 -149.66 165.6 31.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.527 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 25.8 m -137.13 146.28 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 65' ' ' PHE . 4.5 mp -115.32 134.57 55.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -131.19 144.32 51.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 31.9 tttt -125.42 150.21 47.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLY . 63.1 mt -106.48 133.07 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.8 pt-20 -107.53 -29.83 8.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.788 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 22.7 t -158.96 139.79 12.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.052 -1.03 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.39 131.57 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.078 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -131.99 81.73 1.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.284 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.1 -34.78 75.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.49 81.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -89.59 12.12 17.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' C ' ' CE2' ' A' ' 19' ' ' TYR . 4.8 mt 50.03 28.96 3.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.42 149.31 17.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 20.7 p90 -150.98 169.06 22.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.133 . . . . 0.0 109.04 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.464 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 42.3 m -135.84 141.4 44.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 26.6 p90 -154.28 160.47 41.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.341 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -142.46 155.59 45.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.9 132.87 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.46 0.47 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.26 171.3 42.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.66 171.35 24.59 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.72 -17.03 31.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.21 59.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.93 106.0 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.26 148.35 61.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.706 2.271 . . . . 0.0 111.781 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.444 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 80.6 m-20 -79.36 -32.95 43.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.82 . . . . 0.0 109.561 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 p -80.27 3.77 19.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.717 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -131.21 131.94 44.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.072 -1.018 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 89.6 mt-10 -59.73 -43.64 94.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 12.3 pttp -179.11 163.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 62.0 mt -122.68 133.39 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 28.7 m -105.88 136.8 44.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.299 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.548 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.5 m-85 -116.49 122.12 43.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 20.9 t70 -118.79 102.25 8.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -116.04 138.4 51.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.784 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 54.5 tttm -131.49 141.02 49.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.119 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.0 mm? -123.67 129.13 50.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 0.0 109.608 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 1.6 m -89.06 146.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HA ' ' CG ' ' A' ' 15' ' ' PRO . . . -78.4 103.71 8.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.634 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.67 137.47 19.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.47 -16.84 34.63 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.728 2.285 . . . . 0.0 111.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.5 -2.97 50.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . 104.26 -29.93 11.1 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.38 171.42 8.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 53.0 p -126.4 137.48 53.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.07 139.56 26.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -168.78 -157.09 11.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -131.69 144.54 51.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 1.3 tt -119.13 128.19 54.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 24.6 m -116.73 129.97 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.349 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 136' ' ' LYS . 58.3 t -112.26 128.12 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.538 ' CG ' HG12 ' A' ' 2' ' ' VAL . 18.5 tttt -115.81 119.62 36.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 40.4 t80 -110.0 118.67 37.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.141 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.498 ' HA ' HG13 ' A' ' 2' ' ' VAL . 78.4 tt0 -102.14 146.32 28.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.1 p -117.78 167.15 11.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 40.7 mttt -55.41 -32.63 62.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.67 -102.15 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -59.34 -19.82 49.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.44 132.71 48.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -133.49 107.89 12.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.468 ' CD ' HG22 ' A' ' 121' ' ' THR . 49.7 Cg_endo -70.2 146.91 58.83 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.655 2.237 . . . . 0.0 111.776 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -60.3 161.23 7.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.579 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -65.83 -36.45 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.45 -42.5 98.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.21 -40.0 80.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 85.8 mt -64.86 -39.28 93.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -68.13 -46.28 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.42 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.6 m -57.82 -36.51 72.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.08 99.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 117' ' ' VAL . 21.5 tttm -64.63 -37.81 88.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.515 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.64 -28.19 53.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -63.59 -45.62 89.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.06 90.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 80.8 m-20 -53.98 -33.74 57.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.71 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.509 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 3.3 tm? -77.79 -45.15 25.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -55.01 -53.14 59.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 45.3 mttm -54.85 -37.87 66.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . -56.37 -53.51 56.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.451 HD11 ' CD1' ' A' ' 22' ' ' LEU . 29.7 mt -68.02 -42.97 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -61.32 -44.64 96.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.98 71.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 26.7 t80 -68.44 -42.5 78.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 18' ' ' LEU . 6.9 mp -67.33 -41.85 84.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.65 -35.0 79.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.419 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.74 -13.41 59.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.84 86.8 57.03 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -20.17 33.47 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 111.788 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -75.85 -15.82 60.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 66.0 t80 -59.04 141.65 53.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.442 ' OXT' ' CG2' ' A' ' 17' ' ' THR . 98.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.537 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.447 HG11 ' HG2' ' A' ' 120' ' ' GLU . 92.7 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.18 145.03 48.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -125.2 131.74 53.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.867 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 132' ' ' LEU . 75.6 m-85 -126.71 156.18 41.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -128.01 132.62 49.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.23 165.13 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -99.56 152.06 20.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.444 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 69.0 mt -120.05 136.78 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 96.0 m-20 -139.13 134.25 32.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.5 126.44 4.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' OE2' ' A' ' 147' ' ' GLU . 49.6 Cg_endo -70.22 -5.02 15.52 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.728 2.285 . . . . 0.0 111.81 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.478 ' O ' ' OG ' ' A' ' 111' ' ' SER . 2.3 p -89.81 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 126.37 65.83 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.4 Cg_endo -68.23 -24.06 38.33 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.762 2.308 . . . . 0.0 111.834 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.46 64.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.48 ' CG2' ' C ' ' A' ' 157' ' ' ASN . 89.7 m -76.91 -36.22 56.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.567 HD21 ' CZ ' ' A' ' 143' ' ' PHE . 18.5 tp -70.24 -39.6 74.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.49 -44.22 87.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' THR . 22.4 tptm -66.15 -46.33 77.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.02 -20.59 60.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.375 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.541 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 42.3 tp -73.56 -49.1 28.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.655 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.96 -47.47 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.748 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.4 m -65.78 -46.94 76.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' VAL . 7.6 m-20 -98.51 9.35 43.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.822 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.31 -53.23 11.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.414 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HA ' HD11 ' A' ' 30' ' ' ILE . 54.5 t0 -68.41 -24.78 64.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.717 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.9 m120 -87.23 -26.78 23.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.59 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 30' ' ' ILE . 9.0 p -82.66 -36.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.66 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.5 mt -51.29 -47.99 86.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.3 Cg_endo -68.43 -21.63 40.3 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.352 2.035 . . . . 0.0 111.923 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 40.6 mttm -96.27 -35.15 11.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.293 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.38 -39.47 74.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 37' ' ' PHE . 15.9 tp -88.73 106.66 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.32 -29.8 66.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -104.54 27.93 7.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 109.95 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 39' ' ' SER . 20.2 t80 -56.74 127.84 33.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.153 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -92.31 -52.37 4.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -178.28 171.3 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 0.0 109.838 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' CD1' ' A' ' 55' ' ' ILE . 5.9 p -142.62 140.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 109.227 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 85.2 mt-10 -151.33 143.74 24.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 70.0 m-20 -84.09 127.38 33.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -83.82 -29.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 94.9 mt-10 -156.72 142.43 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 104.33 162.59 24.49 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -102.9 3.29 36.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 109.53 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.42 -14.9 13.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.7 -161.11 6.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.75 148.42 58.61 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.653 2.235 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 9.39 84.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.477 HG21 ' N ' ' A' ' 52' ' ' ILE . 25.0 m -79.98 157.24 26.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 109.545 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 15.6 mm -116.94 124.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.5 mttm -116.78 143.02 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HE2' ' CG ' ' A' ' 65' ' ' PHE . 20.3 tttm -117.42 129.29 55.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.316 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.553 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 11.9 mm -115.12 144.52 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 m -126.22 126.03 43.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.592 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CB ' HD23 ' A' ' 34' ' ' LEU . 30.8 p90 -129.78 175.22 9.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 4.3 mm? -110.04 147.42 33.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 109.543 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -156.58 123.03 5.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 54.34 33.01 17.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.06 4.72 63.68 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -102.37 138.17 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.389 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.5 m -86.38 119.99 27.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -125.44 167.92 14.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.599 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.3 p90 -147.71 161.73 40.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 28.7 m -134.64 143.78 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.321 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.599 HD13 ' CE1' ' A' ' 65' ' ' PHE . 5.4 mp -112.57 131.57 55.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -126.27 139.66 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.525 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 tttt -118.03 146.72 43.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -108.72 130.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.9 mt-10 -88.94 -33.33 17.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.4 m -177.49 157.65 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.16 132.99 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -129.48 78.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.2 mt-10 -64.84 -30.08 71.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -48.98 79.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.377 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 54.5 m-20 -89.86 14.25 12.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 16.2 mt 47.18 52.58 11.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.486 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -153.75 156.56 26.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.4 p90 -150.9 169.85 20.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.0 109.018 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 70.1 m -130.11 139.33 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.89 158.42 40.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 94.8 p -146.35 156.48 43.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.491 ' CG1' HD23 ' A' ' 90' ' ' LEU . 93.0 t -86.11 132.87 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.954 . . . . 0.0 109.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 4.8 t -109.48 -2.73 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.8 42.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.9 175.56 24.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.06 65.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -1.182 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.13 -11.92 59.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.491 HD23 ' CG1' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -99.68 108.73 52.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.343 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.8 Cg_endo -69.88 152.91 68.86 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.69 2.26 . . . . 0.0 111.935 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 83.7 m-20 -79.43 -30.12 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.421 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 15.8 p -79.99 7.1 9.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.566 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -132.15 131.29 42.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.489 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 91.9 mt-10 -61.08 -44.05 97.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 3.8 pttm 179.74 159.21 0.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.942 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' SER . 70.3 mt -118.38 135.7 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.676 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.9 m -107.41 138.76 43.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 76.6 m-85 -119.76 120.25 35.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.25 113.95 23.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.093 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.512 ' OG ' ' CD1' ' A' ' 115' ' ' LEU . 2.6 m -128.13 136.38 51.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 47.6 tttt -132.78 124.5 28.19 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 53.2 mt -108.57 132.9 53.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.062 -1.023 . . . . 0.0 110.266 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.8 143.05 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.06 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.34 141.17 51.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.47 166.03 22.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.4 -4.94 15.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.622 2.215 . . . . 0.0 111.792 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.98 -27.36 66.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.82 23.42 11.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.43 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -149.96 -131.1 1.87 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 68.9 m -118.73 143.98 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.3 166.06 25.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.274 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 164.86 -177.6 40.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 28.2 ttpt -123.24 143.25 50.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -1.089 . . . . 0.0 109.396 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.512 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 30.2 tp -116.5 135.3 53.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -124.25 125.93 45.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.94 132.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.6 tttt -116.43 116.04 26.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.474 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 33.3 t80 -105.9 122.09 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' HG2' HG11 ' A' ' 2' ' ' VAL . 90.9 mt-10 -105.63 141.44 37.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 16.6 p -118.29 164.61 14.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -0.978 . . . . 0.0 109.552 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 92.7 mttt -56.99 -40.06 75.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.45 -92.22 0.11 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -37.2 83.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -1.175 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.43 135.58 39.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.29 109.83 15.09 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 51.3 Cg_endo -70.24 124.29 10.75 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.675 2.25 . . . . 0.0 111.875 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.471 ' O ' HD22 ' A' ' 132' ' ' LEU . 1.7 m-20 -60.04 161.05 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.42 -36.15 80.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -56.03 -31.43 63.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.03 -34.95 61.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.271 -0.893 . . . . 0.0 108.729 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.61 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -61.53 -39.29 90.51 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -60.22 -48.31 82.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.5 m -57.22 -36.75 71.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.3 99.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -60.37 -37.1 79.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -1.091 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.448 ' O ' ' HB1' ' A' ' 141' ' ' ALA . . . -55.72 -30.43 61.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.252 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -66.0 -44.86 83.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.21 -55.41 10.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.9 -34.92 63.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 137' ' ' ALA . . . -57.49 -38.97 75.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.276 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 146' ' ' ILE . 29.8 mt -74.94 -44.0 50.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.567 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 73.9 t80 -61.62 -55.78 26.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.166 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -49.49 -46.73 48.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.303 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.94 77.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.153 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.3 mt -67.11 -44.11 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.251 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 12' ' ' PRO . 80.0 tt0 -60.46 -44.91 95.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . -60.52 -31.11 70.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 21.6 t80 -66.79 -38.88 87.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.85 . . . . 0.0 109.303 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 18' ' ' LEU . 7.5 mp -72.86 -40.85 65.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.18 -37.78 78.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 148' ' ' ALA . . . -74.51 -15.84 60.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -126.7 90.25 50.17 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.1 -18.91 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.61 2.207 . . . . 0.0 111.793 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -74.12 -12.68 60.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 63.8 t80 -80.01 125.48 29.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.48 ' C ' ' CG2' ' A' ' 17' ' ' THR . 8.5 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.412 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' HE2' ' A' ' 118' ' ' LYS . 89.4 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.316 0.579 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.61 149.53 42.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.7 m -129.81 128.84 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 0.0 109.428 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.81 163.34 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -135.59 133.81 38.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.411 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.29 166.09 25.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.15 151.17 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 9' ' ' ILE . 65.1 mt -114.36 128.22 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -128.95 127.61 42.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -153.43 132.92 7.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -19.0 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.677 2.251 . . . . 0.0 111.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 18' ' ' LEU . 2.2 p -70.39 153.1 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.545 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 139.77 97.73 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.22 -26.78 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.81 2.34 . . . . 0.0 111.91 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.52 -39.24 53.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -79.76 -41.85 25.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.77 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 13' ' ' VAL . 3.9 tp -67.15 -38.5 85.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.401 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 79.0 t80 -70.63 -36.4 73.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' THR . 43.9 tptt -67.17 -47.21 71.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 109.781 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' CA ' ' HB2' ' A' ' 25' ' ' ASP . . . -72.27 -40.13 67.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 146' ' ' ILE . 64.5 tp -53.33 -45.66 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -97.3 -53.63 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.974 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.531 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.1 m -66.38 -50.09 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -92.44 19.66 6.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -60.46 -51.61 68.71 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.155 -0.966 . . . . 0.0 109.143 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.6 m-20 -66.69 -31.24 71.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.648 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 75.2 m-20 -83.23 -29.57 28.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' ASP . 77.4 t -78.64 -34.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 12.0 mt -51.33 -51.71 66.17 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.929 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.9 Cg_endo -68.39 -34.87 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.552 2.168 . . . . 0.0 111.888 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.561 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 50.9 mttm -79.95 -40.75 27.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.089 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 145' ' ' ALA . . . -65.88 -38.08 87.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.874 . . . . 0.0 108.909 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 41.0 tp -87.16 106.0 17.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 108.968 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.11 -28.18 67.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -105.38 27.49 8.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.966 -1.084 . . . . 0.0 109.879 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 44.6 t80 -53.24 125.43 17.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -90.9 -56.22 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.806 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.57 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 28.8 p -174.27 166.56 4.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.681 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' C ' ' HG3' ' A' ' 41' ' ' GLU . 2.9 p -144.79 143.48 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.9 mt-10 -147.17 152.1 37.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.559 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -79.55 131.08 35.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 13.8 t -83.65 -44.38 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.315 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 80.8 mt-10 -159.38 146.87 17.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 95.59 -175.68 33.11 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -110.73 6.17 21.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 109.74 -3.7 30.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.63 -156.35 13.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.24 138.76 37.03 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.741 2.294 . . . . 0.0 111.811 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.46 -4.04 75.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.472 HG23 ' HA3' ' A' ' 45' ' ' GLY . 26.1 m -69.18 155.01 41.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 109.566 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' N ' HG21 ' A' ' 51' ' ' THR . 20.4 mm -119.33 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.19 147.35 46.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.846 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 22.4 tttt -116.89 127.35 54.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.22 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 66' ' ' VAL . 63.7 mt -115.25 145.35 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -0.999 . . . . 0.0 109.848 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.438 ' N ' HG21 ' A' ' 55' ' ' ILE . 24.0 m -128.1 123.0 33.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.201 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 64' ' ' LYS . 23.8 p90 -125.53 174.27 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.637 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.63 138.25 49.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' OE1' ' HE3' ' A' ' 64' ' ' LYS . 75.8 tt0 -148.49 127.76 12.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 53.12 34.62 17.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.77 66.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -107.3 134.14 50.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 m -82.73 116.16 21.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 23.0 mttm -116.74 164.21 14.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.532 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 18.5 p90 -145.87 157.75 43.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.522 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.7 p -141.2 149.68 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.898 . . . . 0.0 109.618 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.534 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 48.2 mt -112.6 130.98 55.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.241 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -122.55 136.88 55.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 42.3 tttm -119.08 145.18 46.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.5 mt -105.87 127.05 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 93.6 mt-10 -82.46 -53.45 5.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -162.73 137.59 6.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.78 133.73 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.91 . . . . 0.0 109.338 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -129.18 76.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.559 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 86.8 mt-10 -54.61 -37.61 65.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.19 57.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 78' ' ' LEU . 64.6 m-20 -90.67 17.0 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.377 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 11.6 mt 43.57 46.24 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.576 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.49 158.9 27.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.5 p90 -152.02 170.04 20.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -1.217 . . . . 0.0 109.131 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 4.7 m -126.3 138.84 53.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -156.06 160.67 40.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.458 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 54.8 p -150.41 158.22 43.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.483 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 89' ' ' ALA . 14.5 p -97.41 135.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 109.086 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' HD22 ' A' ' 90' ' ' LEU . 1.1 m -130.16 3.87 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.527 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -156.19 146.26 13.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.01 -174.29 16.79 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.17 62.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -80.85 1.49 30.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -112.9 83.52 6.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.328 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -68.9 163.43 37.48 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.897 2.398 . . . . 0.0 111.998 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 70.1 m-20 -80.12 -32.71 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.912 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 33.9 p -79.55 -11.99 59.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 110.026 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.585 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -119.95 127.75 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -62.51 -50.79 70.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -177.33 156.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.41 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 70.3 mt -113.42 137.55 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 1.4 m -107.42 138.2 44.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.848 . . . . 0.0 109.135 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.2 m-85 -118.56 120.58 37.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.881 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -117.2 106.39 13.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -115.59 136.13 53.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.773 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 20.3 tttt -132.96 131.26 40.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.833 . . . . 0.0 109.123 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 1.7 mm? -118.18 127.44 53.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.364 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 105' ' ' ALA . 2.0 m -120.48 172.58 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -80.25 127.14 32.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.206 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.99 155.54 17.93 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 -1.95 8.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.578 2.185 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -74.11 -15.55 61.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 7.15 63.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.56 -138.08 4.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' A' ' 103' ' ' LEU . 2.7 t -122.25 140.65 52.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -1.113 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.42 147.81 31.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.207 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -174.08 -143.63 4.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.05 138.95 32.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.353 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' A' ' 116' ' ' THR . 3.9 tt -115.31 136.4 53.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.497 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 14.5 m -125.5 126.89 45.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.35 136.16 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.331 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' HE2' ' CG1' ' A' ' 2' ' ' VAL . 26.6 tttt -116.07 121.02 40.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.574 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 30.3 t80 -103.58 126.56 50.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 2' ' ' VAL . 82.9 mt-10 -109.73 130.94 55.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.5 p -107.4 156.73 18.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 73.5 mmtt -60.13 -37.0 78.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.82 -103.84 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.35 -35.52 72.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -1.187 . . . . 0.0 109.468 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.9 136.98 33.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -149.34 107.66 3.36 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.2 Cg_endo -70.04 151.55 67.52 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.734 2.289 . . . . 0.0 111.699 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -83.22 178.73 7.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 92.9 mt-30 -67.89 -35.35 78.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.59 -48.53 80.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -61.14 -39.14 88.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.38 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.64 -35.79 81.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 26.2 mttt -64.22 -48.53 75.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.8 m -56.22 -33.24 65.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.343 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.22 -43.13 99.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HG2' ' OD1' ' A' ' 140' ' ' ASP . 23.9 tttp -67.14 -39.58 86.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -1.149 . . . . 0.0 109.497 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -31.22 64.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.29 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -77.3 -40.7 43.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.05 -26.41 53.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.825 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.422 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 96.9 m-20 -60.78 -41.64 95.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -44.95 82.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 23.0 mt -54.71 -46.19 74.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -61.61 -50.26 73.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 148' ' ' ALA . 88.6 mttt -63.22 -33.56 75.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . . . -56.7 -52.46 64.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.471 HG12 HG13 ' A' ' 29' ' ' VAL . 11.7 mt -68.47 -51.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.479 ' HG3' HG12 ' A' ' 13' ' ' VAL . 81.4 tt0 -59.21 -45.22 91.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.697 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 144' ' ' LYS . . . -59.63 -31.39 69.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.519 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.566 ' CZ ' ' CE1' ' A' ' 153' ' ' HIS . 34.4 t80 -69.3 -41.14 77.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 7.8 mp -66.43 -46.3 76.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.636 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.39 -33.79 74.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.96 -11.9 57.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.566 ' CE1' ' CZ ' ' A' ' 149' ' ' TYR . 74.4 m80 -122.06 90.16 48.72 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.26 -21.57 30.95 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.673 2.249 . . . . 0.0 111.767 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -70.87 -17.88 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.436 ' CD2' ' CG2' ' A' ' 17' ' ' THR . 42.3 t80 -67.31 158.8 30.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 17' ' ' THR . 74.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 97.6 m-85 -81.51 126.87 32.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 117.88 27.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.309 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.566 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 97.8 m-85 -110.25 164.23 12.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.624 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 88.2 mt-10 -134.05 134.24 42.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -137.09 165.0 27.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -104.13 158.59 16.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 42.3 mt -129.14 137.37 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.71 137.0 34.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.9 OUTLIER -152.58 138.68 11.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.09 0.74 6.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.665 2.243 . . . . 0.0 111.96 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 14' ' ' ALA . 69.4 t -98.17 155.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.559 ' O ' ' CD1' ' A' ' 18' ' ' LEU . . . -64.21 127.64 92.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.511 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' N ' ' OG ' ' A' ' 111' ' ' SER . 44.4 Cg_endo -66.84 -25.51 45.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.801 2.334 . . . . 0.0 111.904 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.928 . . . . 0.0 109.036 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 157' ' ' ASN . 76.5 m -72.7 -38.86 67.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.182 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 14' ' ' ALA . 2.4 mp -70.29 -38.63 75.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 72.5 t80 -63.92 -50.27 69.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 24' ' ' THR . 12.2 tptt -65.05 -46.38 81.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.749 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -71.63 -28.33 63.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 44.4 tp -67.01 -47.36 71.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.857 . . . . 0.0 109.67 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -97.96 -51.7 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.492 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 2.1 m -62.62 -45.64 91.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.7 m-20 -98.44 6.14 47.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.08 -1.012 . . . . 0.0 109.767 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -45.96 -53.27 10.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.6 m-20 -67.54 -23.3 65.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.772 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.432 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 90.9 m-20 -89.84 -25.79 20.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG11 ' N ' ' A' ' 30' ' ' ILE . 7.9 p -83.39 -35.98 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 109.545 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.676 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.3 mt -55.36 -47.07 99.44 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 110.211 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.6 Cg_endo -68.08 -35.97 18.46 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.307 2.004 . . . . 0.0 112.193 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 32.3 mttm -87.91 -29.28 20.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.421 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -69.42 -34.77 74.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.257 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 54.5 tp -96.18 113.31 24.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.32 -40.92 92.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.663 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -93.71 26.8 2.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.811 -1.181 . . . . 0.0 110.117 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 57.2 t80 -59.91 134.11 56.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.124 -0.985 . . . . 0.0 109.409 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 39' ' ' SER . 33.6 tttm -95.28 -49.12 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.312 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 68.9 p -178.59 172.13 1.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 40' ' ' VAL . 6.0 p -135.91 129.97 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.274 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -135.53 145.47 47.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 109.613 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.97 128.08 34.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 13.9 t -85.17 -41.0 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.673 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 96.5 mt-10 -158.58 145.44 17.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.601 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 159.04 30.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -94.59 5.36 52.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.93 -9.28 23.28 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.03 -158.66 13.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HA ' HG21 ' A' ' 70' ' ' ILE . 49.5 Cg_endo -70.05 131.16 20.26 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.644 2.23 . . . . 0.0 111.687 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 93.23 0.44 67.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.521 HG23 ' N ' ' A' ' 52' ' ' ILE . 90.3 m -76.01 154.78 35.5 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.307 -1.114 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 51' ' ' THR . 71.2 mt -129.89 138.32 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -126.67 152.39 46.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.6 tttm -112.87 125.74 54.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.425 -0.797 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 83.9 mt -113.88 142.95 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.2 m -131.36 119.54 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.56 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 39.0 p90 -124.5 171.55 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.348 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 145.85 31.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 62' ' ' GLU . 84.9 tt0 -141.84 123.74 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 49.66 27.73 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.66 71.38 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' GLU . 99.6 mt-10 -106.47 157.58 17.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -1.085 . . . . 0.0 109.421 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.456 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.2 m -104.94 112.55 25.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.413 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' HG21 ' A' ' 56' ' ' THR . 56.0 mttm -120.35 162.95 18.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -145.66 158.96 43.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 22.4 m -138.31 147.05 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.546 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 12.8 mt -116.63 137.82 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.065 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.72 141.82 50.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.752 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HG3' HG12 ' A' ' 52' ' ' ILE . 19.4 tttm -117.77 146.41 43.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.87 . . . . 0.0 109.121 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.0 mt -104.75 126.57 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -88.18 -40.19 13.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 t -173.74 150.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.58 132.67 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -127.03 85.51 2.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' OH ' ' A' ' 19' ' ' TYR . 97.0 mt-10 -64.24 -31.69 72.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.85 84.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -89.3 14.86 10.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.539 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 19.4 mt 47.52 51.86 13.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.27 27.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 28.7 p90 -150.96 168.4 24.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 108.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -126.67 138.64 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 19.4 p90 -152.49 155.82 38.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.382 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 97' ' ' ILE . 12.9 t -144.85 156.06 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 84' ' ' VAL . 10.0 p -98.52 128.35 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 ' HE3' ' A' ' 96' ' ' LYS . 1.5 t -127.49 4.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.729 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.546 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -158.46 148.48 17.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 128.0 152.29 7.8 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.38 47.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.275 -1.132 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' HB2' ' NZ ' ' A' ' 138' ' ' LYS . . . -79.89 -7.92 59.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.81 116.28 59.89 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.553 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 47.3 Cg_endo -68.48 146.6 68.7 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.767 2.311 . . . . 0.0 111.911 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 66.2 m-20 -78.84 -29.57 44.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.632 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.454 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 29.4 p -79.82 -7.49 58.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 119' ' ' TYR . . . -118.27 123.57 45.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.339 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 86.3 mt-10 -62.28 -52.18 64.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.703 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.4 mtpm? -159.1 161.65 36.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 109.721 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.473 HG23 ' CE2' ' A' ' 99' ' ' PHE . 62.8 mt -125.4 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CE ' ' A' ' 118' ' ' LYS . 8.9 m -109.83 137.58 47.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.8 m-85 -120.23 121.29 38.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 58.5 t0 -117.02 110.51 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.204 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -123.25 136.64 54.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.538 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 75.8 tttt -130.72 127.43 38.78 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.6 mm? -107.62 130.19 54.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.057 -1.027 . . . . 0.0 110.152 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -138.03 143.02 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.03 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 139.52 57.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.104 -0.998 . . . . 0.0 109.718 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.43 22.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.78 -9.71 26.76 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.774 2.316 . . . . 0.0 111.825 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.49 -31.95 68.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.84 27.93 6.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -157.94 -125.16 0.82 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 13' ' ' VAL . 73.9 m -118.54 144.91 45.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 9' ' ' ILE . . . -143.58 162.49 35.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.763 . . . . 0.0 108.991 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 171.63 176.15 40.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -112.08 141.22 46.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.439 -1.036 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 29.0 tp -116.33 131.62 56.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.519 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 26.0 m -130.0 122.11 27.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -0.926 . . . . 0.0 109.144 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.67 135.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.557 ' CG ' HG22 ' A' ' 2' ' ' VAL . 7.0 ttpt -115.0 116.71 28.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.15 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 36.6 t80 -107.73 120.92 43.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.672 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.441 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 98.2 mt-10 -106.32 133.52 50.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.518 ' CG2' ' HD3' ' A' ' 127' ' ' PRO . 17.4 p -109.92 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.4 mttt -54.85 -42.31 71.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.56 -92.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ALA . 82.1 m-20 -69.2 -35.8 76.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -45.03 133.79 6.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -126.24 121.13 23.78 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.563 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 49.3 Cg_endo -69.96 149.85 66.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.717 2.278 . . . . 0.0 111.743 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.7 m-20 -92.16 155.31 18.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -50.42 -38.33 42.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.24 -48.54 81.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.33 -42.08 90.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 5' ' ' PHE . 74.3 mt -60.15 -34.52 73.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.46 -46.47 82.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.259 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.5 m -57.4 -36.97 71.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.13 -47.36 91.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 140' ' ' ASP . 11.0 mtmm -57.09 -36.6 70.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -1.146 . . . . 0.0 109.391 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 140' ' ' ASP . . . -58.23 -33.49 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 89' ' ' ALA . 69.5 tttt -74.34 -43.14 57.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -69.76 -49.06 56.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 7.5 p30 -68.43 -22.56 64.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -56.86 -48.69 77.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 146' ' ' ILE . 12.7 tp -56.39 -35.52 67.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -74.33 -53.23 10.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 109.14 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -52.73 -37.92 59.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 -49.56 56.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 29' ' ' VAL . 51.7 mt -63.07 -55.33 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 150' ' ' LEU . 80.3 tt0 -45.55 -50.31 13.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.18 -37.82 72.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 41.1 t80 -68.44 -38.13 80.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.547 ' CD1' ' HG ' ' A' ' 18' ' ' LEU . 45.8 mt -59.16 -38.31 79.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mt -75.04 -27.68 60.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.61 61.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -128.5 91.88 42.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.27 -18.06 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.737 2.291 . . . . 0.0 111.747 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -77.26 -17.69 58.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.528 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 76.8 t80 -67.77 120.09 13.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.498 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.2 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 60.0 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -132.07 122.54 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.624 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 79.2 m -110.67 144.24 39.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.509 ' N ' HG22 ' A' ' 4' ' ' THR . 89.4 m-85 -132.7 132.62 42.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.0 mt-10 -106.14 133.74 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -137.15 164.98 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.385 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.87 157.61 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.4 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 9' ' ' ILE . 14.6 mt -125.65 134.42 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 109.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 97.9 m-20 -140.68 132.87 28.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 147' ' ' GLU . 27.3 m -152.78 138.63 11.81 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.52 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.26 -0.45 7.34 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.602 2.201 . . . . 0.0 111.714 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 HG13 ' CD2' ' A' ' 18' ' ' LEU . 98.1 t -94.73 153.49 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' N ' HG12 ' A' ' 13' ' ' VAL . . . -63.6 139.31 97.59 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 46.7 Cg_endo -68.01 -25.77 37.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.734 2.289 . . . . 0.0 111.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.36 -37.6 60.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 150' ' ' LEU . 60.3 m -75.01 -39.39 61.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 150' ' ' LEU . 20.0 mt -68.69 -39.11 80.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 78.0 t80 -64.54 -50.03 68.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.585 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.5 tptm -63.4 -46.43 86.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -73.18 -24.51 60.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 18.4 tp -75.37 -48.83 21.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.686 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.75 -49.89 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -65.82 -48.83 70.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.957 . . . . 0.0 110.145 -179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 29' ' ' VAL . 6.3 t70 -91.01 14.67 13.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.723 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -56.09 -52.16 65.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.263 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 22.1 t70 -66.1 -25.89 67.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.946 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.0 m120 -90.92 -26.06 19.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.601 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.0 p -83.87 -39.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 109.575 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.7 mt -52.88 -45.46 97.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.63 -21.84 45.04 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.394 2.063 . . . . 0.0 112.242 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' ALA . 41.8 mttm -108.98 -51.77 2.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 109.585 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -42.28 -33.19 0.59 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 44.8 tp -92.52 112.62 24.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.067 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.4 -47.16 82.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.526 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.9 m -88.38 29.36 0.98 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.915 -1.116 . . . . 0.0 110.173 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 67.2 t80 -61.89 130.54 46.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.505 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' A' ' 58' ' ' LEU . 3.6 mtpm? -102.42 -48.58 4.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.639 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 37' ' ' PHE . 54.8 p -172.51 164.89 5.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 41' ' ' GLU . 3.9 p -143.3 141.81 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 109.326 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' N ' HG21 ' A' ' 40' ' ' VAL . 82.4 mt-10 -144.08 148.36 35.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.61 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -80.64 132.07 35.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 19.0 t -79.99 -42.12 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 71.2 mt-10 -161.74 149.33 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.72 -168.85 36.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -132.12 35.08 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -1.92 76.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.425 ' O ' ' OG1' ' A' ' 51' ' ' THR . . . -76.73 -168.31 28.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.74 139.88 41.4 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.691 2.261 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 77.14 2.96 80.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 52' ' ' ILE . 85.9 m -69.23 150.44 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.58 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.509 ' N ' HG21 ' A' ' 51' ' ' THR . 25.1 mm -114.62 123.44 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -118.06 143.83 46.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.856 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 86.8 tttt -116.35 128.25 55.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 109.081 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 58.7 mt -114.28 140.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.1 m -119.42 120.74 37.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.216 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 40.5 p90 -131.5 176.02 8.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.405 ' CD2' ' HD2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -116.98 131.2 57.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -137.12 130.96 31.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 55.14 20.83 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.92 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.32 20.55 64.28 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -118.28 141.61 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.6 m -80.9 111.79 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 70.7 mttt -121.89 163.06 19.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 36.0 p90 -144.27 158.11 43.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.385 -0.822 . . . . 0.0 109.226 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 34.1 m -133.55 142.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 109.705 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 10.7 mt -111.23 130.55 55.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 109.003 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -126.23 139.83 53.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.146 -0.971 . . . . 0.0 109.71 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -122.52 150.81 42.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.238 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.7 mt -111.46 133.05 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 94.0 mt-10 -89.42 -33.57 16.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.243 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -172.82 155.39 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.54 131.86 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.327 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.56 81.51 2.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 78.3 mt-10 -59.18 -36.84 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.29 -41.31 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.634 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 6.4 m-20 -101.1 14.01 33.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.546 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.75 25.98 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.318 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.24 150.73 17.79 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.89 169.16 22.95 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -1.208 . . . . 0.0 109.166 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -130.96 139.01 49.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.98 . . . . 0.0 109.375 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 14.1 p90 -151.87 154.79 36.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 79.9 p -144.41 155.8 43.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.355 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.8 131.16 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.244 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -124.14 2.04 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.605 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -163.77 153.38 23.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 117.07 172.13 16.03 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.21 -13.05 62.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -1.099 . . . . 0.0 109.46 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.04 59.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 4.8 tt -100.2 107.22 46.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 47.9 Cg_endo -69.43 149.86 69.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.68 2.253 . . . . 0.0 111.912 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 83.6 m-20 -76.76 -28.71 55.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -79.86 6.6 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.7 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -133.7 142.52 48.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.596 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 122' ' ' LYS . 77.4 mt-10 -69.14 -54.6 14.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 16.1 pttm -175.64 159.71 2.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.347 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 83' ' ' SER . 55.4 mt -118.18 136.2 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.509 ' CG2' ' OE2' ' A' ' 71' ' ' GLU . 7.9 m -112.12 117.85 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.126 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 89.0 m-85 -96.28 125.41 40.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.826 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 116' ' ' THR . 89.9 m-20 -117.74 129.3 55.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 109.206 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.8 t -146.63 136.81 23.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 103' ' ' LEU . 28.3 tttt -117.2 159.1 23.17 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 33.6 mt -133.42 123.77 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.877 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.66 142.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.24 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.35 57.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.46 166.93 23.25 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.5 -0.05 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.646 2.231 . . . . 0.0 111.821 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -69.37 -28.34 66.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.11 26.78 8.14 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -156.14 -127.16 1.01 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 99.5 p -121.77 142.8 49.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -1.134 . . . . 0.0 109.746 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.57 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 162.95 168.64 25.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -105.29 147.66 27.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.137 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 49.6 tp -115.01 136.56 52.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 100' ' ' ASP . 24.6 m -138.78 119.31 13.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.043 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.652 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 2.7 p -112.33 138.68 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 110.142 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 31.9 tttt -114.29 120.08 39.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 37.4 t80 -102.72 126.82 49.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 96' ' ' LYS . 82.0 mt-10 -111.41 126.65 55.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.353 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 34.2 p -99.91 165.91 11.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 20.4 mmtp -71.01 -36.34 72.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.19 -100.0 0.16 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -65.08 -28.57 69.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.92 137.07 58.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -147.18 112.51 4.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.44 141.33 42.2 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.715 2.277 . . . . 0.0 111.7 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -69.78 168.65 14.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.89 . . . . 0.0 109.55 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.34 -39.64 87.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.882 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.85 -43.86 97.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.27 -39.34 82.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.457 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 25.0 mt -64.65 -36.82 85.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.63 -49.5 76.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 85.5 m -57.45 -32.45 66.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.89 -47.98 86.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . 27.9 ttpp -65.27 -38.32 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -1.133 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 140' ' ' ASP . . . -54.41 -28.4 43.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -76.21 -38.18 56.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.453 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.13 -55.08 8.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 3.9 p30 -63.43 -25.05 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -61.22 -53.44 56.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 109.319 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.445 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 19.0 mt -59.53 -35.21 73.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.15 -52.69 62.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -53.12 -38.42 62.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 142' ' ' LEU . . . -58.39 -39.63 80.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.361 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 29' ' ' VAL . 16.9 mm -62.73 -43.62 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.391 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.464 ' OE2' ' OG ' ' A' ' 11' ' ' SER . 90.6 mt-10 -64.28 -37.27 86.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . -60.52 -37.53 81.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -70.53 -52.5 21.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 18' ' ' LEU . 9.3 mp -63.77 -36.52 84.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.7 tp -76.1 -36.44 58.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 148' ' ' ALA . . . -72.21 -20.43 61.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -134.38 98.58 13.76 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -11.42 30.22 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 111.788 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.72 -26.66 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.45 ' CE2' ' HB1' ' A' ' 21' ' ' ALA . 62.5 t80 -64.43 138.79 58.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.428 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 2.3 p-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.498 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.547 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 88.4 m-85 -80.83 120.57 24.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 19.8 m -109.94 117.09 32.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 132' ' ' LEU . 97.0 m-85 -114.61 142.11 46.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.406 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 81.4 tt0 -109.3 133.34 53.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.265 -0.897 . . . . 0.0 109.63 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -130.01 164.41 24.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.58 153.59 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 54.1 mt -119.23 144.2 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 22.7 m120 -142.45 128.88 20.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.434 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -152.64 138.23 11.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.503 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.39 -12.82 32.36 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.702 2.268 . . . . 0.0 111.785 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 150' ' ' LEU . 1.6 p -81.49 152.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 141.69 95.88 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.92 -28.51 35.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.735 2.29 . . . . 0.0 111.747 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.96 -41.39 59.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.3 m -76.21 -37.43 57.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.347 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 150' ' ' LEU . 11.9 tp -69.15 -39.93 78.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 79.5 t80 -64.89 -44.81 88.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 24' ' ' THR . 12.8 tptm -65.18 -46.72 79.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.733 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -73.1 -17.77 61.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 19.5 tp -79.18 -48.25 14.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.91 -52.22 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 4.3 m -63.39 -49.37 74.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.943 . . . . 0.0 110.208 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m-20 -95.34 8.08 44.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.61 -53.22 11.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 109.292 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HA ' HD12 ' A' ' 30' ' ' ILE . 56.7 t0 -65.07 -24.89 67.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 95.3 m-20 -87.16 -26.81 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' A' ' 25' ' ' ASP . 98.2 t -82.66 -35.53 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 mt -50.98 -47.84 86.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 110.327 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.8 Cg_endo -67.53 -28.08 38.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.44 2.093 . . . . 0.0 112.183 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -90.73 -45.41 8.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.4 mp -76.04 102.22 5.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -54.89 -46.25 74.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.871 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 88.4 p -91.51 30.1 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -57.23 122.56 12.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.07 -53.56 4.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.675 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 34.9 p -174.9 167.89 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.752 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 39' ' ' SER . 99.6 t -143.92 143.91 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.148 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 73.8 mt-10 -155.0 158.4 39.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 73.2 m-20 -96.65 124.9 40.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 6.8 m -82.01 -27.9 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 56.9 mm-40 -161.33 151.26 17.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.87 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA3' HG22 ' A' ' 51' ' ' THR . . . 105.09 168.61 24.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -121.68 27.43 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -1.197 . . . . 0.0 109.62 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.97 -19.05 56.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' O ' ' OG1' ' A' ' 51' ' ' THR . . . -76.38 -169.18 28.72 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.95 140.97 43.26 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 111.71 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 88.64 5.64 74.44 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 52' ' ' ILE . 59.6 m -75.12 150.78 38.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -1.153 . . . . 0.0 109.759 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 51' ' ' THR . 17.2 mm -112.5 123.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 108.994 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.4 mttm -119.76 144.67 47.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.853 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 2.2 ttmt -120.41 133.78 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.133 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 74.8 mt -123.91 143.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 36.0 m -124.63 122.26 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 43.1 p90 -127.24 165.84 18.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 1.2 mp -100.23 143.29 30.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.4 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -156.19 131.81 9.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 56.41 28.39 13.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.69 0.49 63.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 49.2 tp10 -107.24 138.95 42.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -1.186 . . . . 0.0 109.537 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.4 m -86.03 124.94 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 34.0 mttp -128.63 172.47 11.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 6.5 p90 -147.31 161.32 41.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.516 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.408 ' C ' HD11 ' A' ' 67' ' ' LEU . 32.6 m -135.53 145.05 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.43 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 4.4 mp -114.49 133.02 56.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.923 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -132.04 145.32 51.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 16.1 tttm -124.5 146.55 48.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 7.0 mm -101.58 131.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.3 pt-20 -103.5 -32.68 9.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.995 . . . . 0.0 109.828 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 35.9 t -165.78 138.43 4.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.909 -1.119 . . . . 0.0 109.955 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.35 136.25 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 91.4 m-20 -130.69 83.18 2.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.43 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.4 mt-10 -63.67 -34.58 78.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.05 67.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.286 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -87.26 12.59 11.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.485 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 8.7 mt 48.02 37.25 7.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.474 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -132.64 151.96 20.13 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -151.63 166.44 31.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.065 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.543 ' HB3' ' CG ' ' A' ' 71' ' ' GLU . 29.0 t -137.37 143.17 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.2 p90 -153.05 160.62 42.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.339 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 97' ' ' ILE . 15.2 t -139.12 153.8 48.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 67' ' ' LEU . 14.4 p -85.1 133.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 69' ' ' LYS . 10.0 t -109.97 -4.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.49 43.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.05 164.27 15.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.59 -14.25 12.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -1.126 . . . . 0.0 109.452 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.89 -12.08 58.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.64 115.34 60.23 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.978 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.08 147.56 61.11 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.677 2.252 . . . . 0.0 111.829 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.508 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 90.6 m-20 -79.57 -31.93 41.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.615 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 p -83.79 3.74 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.715 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -132.43 143.23 49.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 109.624 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' OE2' ' HG2' ' A' ' 122' ' ' LYS . 62.6 mm-40 -69.27 -51.57 36.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.421 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -171.28 163.09 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.548 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.453 ' O ' ' OG ' ' A' ' 83' ' ' SER . 69.4 mt -120.56 137.21 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -108.21 126.8 53.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.2 m-85 -108.3 125.81 52.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 115' ' ' LEU . 25.6 t0 -120.11 102.81 8.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.188 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 9' ' ' ILE . 34.1 t -111.95 142.15 44.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.473 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 19.3 tttm -127.1 146.71 50.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 108.896 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.5 mm? -125.69 129.75 50.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.855 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 m -143.91 167.31 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 109.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -74.92 133.94 41.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.22 163.21 16.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.75 -3.96 13.06 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.628 2.219 . . . . 0.0 111.689 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.15 -23.84 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.87 24.98 10.07 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.71 -138.44 2.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -99.13 145.14 27.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -147.79 140.62 24.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.113 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -175.84 -170.58 38.8 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mttt -127.11 139.36 53.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -1.119 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 3.0 tt -114.31 137.73 51.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 m -114.3 133.4 55.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.178 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 4' ' ' THR . 96.2 t -109.26 127.72 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.55 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' CG ' HG21 ' A' ' 2' ' ' VAL . 37.5 tttp -115.09 122.24 45.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.592 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 42.8 t80 -117.59 115.32 24.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.61 140.36 37.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 17.5 p -106.49 165.77 11.03 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.612 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 75.1 mttt -73.85 -34.01 64.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.48 -145.91 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.14 -13.04 61.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.197 . . . . 0.0 109.468 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.69 130.16 24.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.07 131.49 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.592 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.7 Cg_endo -70.06 157.5 59.59 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.771 2.314 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 1.5 m-20 -86.94 175.15 8.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -71.13 -41.51 70.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -57.63 -47.13 83.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 69.4 mm-40 -58.03 -41.07 82.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.556 HD12 ' CE2' ' A' ' 5' ' ' PHE . 89.7 mt -62.55 -44.95 95.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -61.27 -46.41 90.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.335 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -58.99 -40.75 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.01 97.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -66.92 -39.84 87.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.338 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.85 80.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 109.284 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 39.8 mttm -60.78 -52.89 63.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.37 -56.07 6.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 52.0 t0 -50.04 -26.73 4.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.652 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 138' ' ' LYS . . . -55.15 -44.64 75.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 146' ' ' ILE . 1.3 tp -59.0 -45.53 90.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.199 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -68.6 -34.82 76.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.38 -0.825 . . . . 0.0 109.358 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 85.6 mttt -64.04 -44.85 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.16 68.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.917 . . . . 0.0 109.312 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 71.0 mt -58.6 -54.32 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -46.07 -53.74 9.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.85 69.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.877 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -65.7 -32.77 74.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.306 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 17.1 mt -70.28 -44.33 68.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.372 -0.83 . . . . 0.0 109.529 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.11 -34.5 78.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.62 61.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -130.1 83.23 63.94 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.48 -19.34 37.58 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.682 2.255 . . . . 0.0 111.726 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -93.92 16.36 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -60.75 135.61 57.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.551 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.0 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.268 0.556 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' VAL . 97.5 m-85 -126.42 135.77 51.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.9 m -116.89 130.49 56.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -128.78 158.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -133.15 139.76 47.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.461 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -142.33 165.71 26.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -108.29 150.15 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 52.9 mt -115.02 142.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.399 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 40.5 m-20 -134.69 129.43 34.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 m -151.9 129.16 5.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.68 0.15 6.78 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.753 2.302 . . . . 0.0 111.693 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG12 HD12 ' A' ' 150' ' ' LEU . 46.8 t -93.09 152.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.643 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 134.42 91.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.19 -29.57 32.58 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.74 2.293 . . . . 0.0 111.935 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.11 -37.24 61.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.523 HG23 ' CB ' ' A' ' 157' ' ' ASN . 39.7 m -80.13 -40.4 27.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 150' ' ' LEU . 3.8 tp -68.38 -38.29 81.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 84.4 t80 -71.2 -36.61 71.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.923 . . . . 0.0 109.773 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 24' ' ' THR . 48.6 tptt -68.92 -47.24 66.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.842 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' CA ' ' HB2' ' A' ' 25' ' ' ASP . . . -75.9 -37.19 59.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.485 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 22.7 tp -52.87 -47.18 68.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.7 t -97.48 -53.34 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 110.077 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.544 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -63.64 -47.17 82.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.162 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 29' ' ' VAL . 15.2 m-20 -95.62 17.64 14.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -66.34 -47.27 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 49.2 t0 -69.27 -29.08 66.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.94 . . . . 0.0 109.936 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -91.08 -31.61 16.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.963 . . . . 0.0 109.705 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 77.6 t -80.4 -42.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 42.0 mt -49.49 -51.86 54.91 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.381 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.7 Cg_endo -68.83 -46.69 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.532 2.154 . . . . 0.0 112.638 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -79.92 -44.68 19.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.0 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -48.13 -36.03 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.53 ' CD2' ' HB3' ' A' ' 36' ' ' SER . 14.5 tp -142.65 133.55 25.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.74 -26.73 50.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.145 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.53 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 3.0 t -54.01 -36.82 63.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CD1' ' CG2' ' A' ' 30' ' ' ILE . 62.8 t80 -52.74 135.74 34.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.428 -0.795 . . . . 0.0 109.124 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HE3' ' CG2' ' A' ' 63' ' ' THR . 9.9 mttm -90.17 -54.82 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.487 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 1.7 t -178.9 172.34 1.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 55' ' ' ILE . 10.9 p -139.07 134.75 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.776 . . . . 0.0 109.268 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -142.45 148.31 37.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 81.7 m-20 -92.18 119.39 31.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.6 m -80.13 -31.18 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.924 . . . . 0.0 109.456 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 51' ' ' THR . 79.4 tt0 -157.09 143.71 18.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.436 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.77 164.79 32.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -100.57 6.51 44.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 109.71 -8.67 32.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.25 -158.79 14.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 129.92 18.03 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.618 2.212 . . . . 0.0 111.718 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.36 3.66 69.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 52' ' ' ILE . 8.3 m -80.04 158.16 26.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -1.135 . . . . 0.0 109.697 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.538 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 13.9 mm -124.12 133.32 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 45.4 mtmt -129.02 153.96 47.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 78.9 tttt -111.89 121.92 46.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.281 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CG1' ' A' ' 66' ' ' VAL . 5.5 mm -106.35 138.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 43.2 m -131.65 120.25 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -134.23 175.01 9.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.15 139.23 38.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 83.1 tt0 -148.94 130.63 15.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 52.8 37.45 24.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.26 8.84 52.59 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.08 126.03 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.521 ' CG2' ' HE3' ' A' ' 38' ' ' LYS . 79.1 m -72.34 119.21 16.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HD2' ' OE1' ' A' ' 59' ' ' GLU . 64.7 mttm -119.6 167.29 12.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 23.1 p90 -144.68 156.63 44.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.368 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 3.1 p -143.43 152.01 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.781 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.3 mt -110.72 127.62 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' HG12 ' A' ' 66' ' ' VAL . 39.3 m80 -114.64 131.04 56.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.784 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 20.4 tttt -113.13 134.02 54.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 108.983 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 50' ' ' GLY . 46.5 mt -97.94 127.73 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 93.5 mt-10 -89.63 -33.25 16.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.224 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 81' ' ' SER . 65.3 p -174.86 154.75 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.88 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.68 84.34 2.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.333 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.39 -40.2 81.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.55 60.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.509 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 93.1 m-20 -94.39 14.63 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.9 mt 44.35 27.62 0.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.68 157.98 18.19 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 31.7 p90 -150.84 170.07 20.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 109.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 72' ' ' SER . 3.0 p -120.3 137.63 54.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 99' ' ' PHE . 19.7 p90 -152.91 156.67 39.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 77.3 p -148.02 158.19 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.605 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 90' ' ' LEU . 39.7 t -91.95 130.1 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 67' ' ' LEU . 4.2 m -118.92 -0.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.148 -0.97 . . . . 0.0 110.0 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -173.02 163.1 34.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.48 169.4 14.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.4 62.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -1.128 . . . . 0.0 109.305 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.14 -14.67 58.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 91' ' ' PRO . 6.5 tt -84.2 114.45 54.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.371 -0.83 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.0 Cg_endo -69.8 143.56 51.03 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.657 2.238 . . . . 0.0 111.757 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 73.9 m-20 -74.88 -28.47 60.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.5 p -79.87 2.62 22.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.961 . . . . 0.0 109.689 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -127.27 132.94 50.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 109.548 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.68 -43.97 87.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -176.28 159.0 1.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 83' ' ' SER . 76.2 mt -122.97 133.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 59.0 m -102.07 145.89 28.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 82' ' ' TYR . 96.3 m-85 -127.49 119.34 25.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.47 106.83 13.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 0.0 109.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.446 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 6.3 m -120.85 137.73 54.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 77' ' ' ASN . 33.6 tttt -116.04 159.83 21.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.083 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 24.1 mt -135.67 122.43 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 109.641 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 112' ' ' ALA . 27.7 m -140.27 143.96 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.15 150.26 46.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.81 175.19 21.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.07 -0.24 6.88 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.673 2.248 . . . . 0.0 111.842 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -74.34 -24.74 59.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.99 17.44 35.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.08 -132.88 2.62 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 t -117.28 140.55 49.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 104' ' ' VAL . . . -144.75 148.3 33.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.388 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.33 -167.24 35.36 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -122.36 145.21 48.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -1.119 . . . . 0.0 109.463 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 116' ' ' THR . 2.0 tt -120.31 125.72 48.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.392 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.487 ' N ' HD23 ' A' ' 115' ' ' LEU . 19.2 m -121.42 129.88 53.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 99' ' ' PHE . 81.6 t -121.2 121.39 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.9 ttpt -99.23 130.43 45.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 15.3 t80 -112.4 120.0 40.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.8 138.01 40.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.323 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 29.6 p -120.02 150.48 40.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.518 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.8 mttm -52.55 -36.26 55.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.15 -93.16 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.43 -36.67 78.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 109.422 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.66 134.91 35.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -134.58 111.11 11.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.8 Cg_endo -70.09 126.47 13.13 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.751 2.301 . . . . 0.0 111.781 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -72.14 161.12 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.329 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.91 -34.18 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -56.44 -31.44 63.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.127 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.1 -35.9 48.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.0 108.758 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.6 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -58.63 -35.17 72.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -71.19 -38.83 72.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.235 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.2 m -59.39 -42.26 91.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.15 -37.64 91.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -68.44 -40.36 81.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.247 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.51 66.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.832 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -62.54 -47.44 83.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.29 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.45 -46.34 90.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.14 -32.45 55.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.878 . . . . 0.0 109.466 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.47 86.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.8 mm? -78.59 -36.01 44.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -59.21 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -57.11 -37.1 71.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 -50.35 72.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.304 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.531 ' N ' HD13 ' A' ' 146' ' ' ILE . 4.6 mm -54.31 -46.13 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -66.05 -53.05 43.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -70.84 -45.55 64.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 13' ' ' VAL . 5.2 mt -55.09 -38.6 68.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.2 -28.31 48.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.29 66.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -135.44 93.95 15.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -12.04 31.52 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.697 2.264 . . . . 0.0 111.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -79.03 -16.18 57.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.432 ' CE2' ' OD2' ' A' ' 25' ' ' ASP . 51.1 t80 -74.6 107.53 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.523 ' CB ' HG23 ' A' ' 17' ' ' THR . 71.0 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.531 HG23 ' CE ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CZ ' ' HG3' ' A' ' 126' ' ' GLU . 94.3 m-85 -80.66 119.17 22.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 25.2 m -110.72 116.45 31.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.561 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -109.68 165.3 11.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 60.8 mt-10 -131.15 135.59 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.96 165.86 26.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 0.0 109.519 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -110.01 148.95 30.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.49 147.55 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -148.01 133.72 18.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.55 138.28 11.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -12.14 31.5 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.646 2.231 . . . . 0.0 111.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 88.0 t -86.05 153.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -57.27 137.82 80.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' CA ' ' HB2' ' A' ' 111' ' ' SER . 45.8 Cg_endo -67.86 -30.2 33.76 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.926 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.61 -33.23 62.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -77.09 -36.94 55.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.564 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 1.8 mt -71.07 -40.43 71.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 69.0 t80 -65.46 -44.04 88.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.852 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.4 tptm -68.99 -46.22 68.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.13 -32.46 63.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.3 tp -63.29 -46.03 88.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.688 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.47 -57.08 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.985 . . . . 0.0 110.163 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -57.24 -44.5 83.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.907 . . . . 0.0 110.175 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.7 m-20 -99.05 4.68 47.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.615 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.05 -51.48 13.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.857 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -69.29 -22.72 63.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.123 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -93.36 -26.58 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 33' ' ' ALA . 97.7 t -82.34 -35.02 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 17.8 mt -60.15 -51.45 80.3 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.2 Cg_endo -67.9 -19.41 46.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.554 2.169 . . . . 0.0 112.541 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -108.79 -48.86 3.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.035 -1.041 . . . . 0.0 109.78 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -61.82 -12.94 19.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 36' ' ' SER . 0.5 OUTLIER -156.23 112.2 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.058 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.57 -18.65 58.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.039 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.3 -36.14 60.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -51.23 133.14 28.72 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.32 -0.863 . . . . 0.0 109.346 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HD3' HG22 ' A' ' 56' ' ' THR . 36.5 tttp -87.13 -54.05 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 36.5 m -165.31 158.51 16.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.481 HG22 ' CG2' ' A' ' 55' ' ' ILE . 83.0 t -142.88 142.9 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.833 . . . . 0.0 109.208 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -153.73 150.68 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t-20 -84.68 133.63 34.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.287 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 7.9 m -104.93 -28.2 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' HB3' HG12 ' A' ' 52' ' ' ILE . 71.5 tt0 -159.71 147.16 16.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 109.504 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 96.45 158.71 31.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -119.62 35.23 4.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -1.113 . . . . 0.0 109.523 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.39 -17.03 60.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.08 36.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.94 137.32 34.66 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.737 2.292 . . . . 0.0 111.742 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.8 4.79 67.07 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 52' ' ' ILE . 53.0 m -73.37 148.4 43.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -1.15 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 4.1 mm -115.69 126.98 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.249 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 70.8 mttt -124.93 149.97 47.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 67' ' ' LEU . 22.6 mttm -117.22 131.23 56.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.02 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 40' ' ' VAL . 23.0 mt -124.9 121.17 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 109.884 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 42.1 m -95.95 127.86 42.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.317 -0.864 . . . . 0.0 109.211 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE1' HG12 ' A' ' 66' ' ' VAL . 33.7 p90 -130.34 168.24 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.732 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD11 ' N ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -102.0 149.94 23.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -0.855 . . . . 0.0 109.286 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' N ' HD11 ' A' ' 58' ' ' LEU . 73.0 tt0 -164.41 123.07 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 55.77 39.19 30.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.47 16.14 54.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -115.81 134.14 55.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -1.148 . . . . 0.0 109.523 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.4 m -81.83 122.18 27.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.441 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -131.28 170.25 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 2.4 p90 -141.06 156.2 46.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.589 HG12 ' CE1' ' A' ' 57' ' ' PHE . 27.9 m -130.63 141.8 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.612 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 7.2 mp -112.47 129.25 56.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -121.43 137.72 54.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 81.2 tttt -117.36 151.93 35.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.368 -0.833 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.3 mt -111.06 129.1 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 75.2 mt-10 -97.73 -24.42 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.322 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.3 t 179.4 145.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.333 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.04 141.67 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -130.89 87.18 2.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.09 -37.57 87.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.95 83.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.43 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 17.8 m-20 -92.47 11.53 25.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 2.0 mt 47.69 34.86 3.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.25 152.72 19.57 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 25.1 p90 -150.19 169.11 22.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -1.168 . . . . 0.0 109.085 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 71' ' ' GLU . 77.4 p -128.64 140.88 51.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 22.1 p90 -155.34 161.27 41.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 p -146.54 157.38 43.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 90' ' ' LEU . 37.3 t -90.83 126.93 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.271 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.47 0.55 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.662 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.524 ' CA ' HD12 ' A' ' 90' ' ' LEU . . . 175.28 175.87 43.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 120.09 161.32 11.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -21.18 66.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.439 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.433 ' CB ' ' HE3' ' A' ' 138' ' ' LYS . . . -79.93 -7.1 58.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' CA ' ' A' ' 86' ' ' GLY . 1.0 OUTLIER -79.81 116.97 64.87 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.515 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.02 148.03 68.93 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.762 2.308 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -79.79 -29.92 40.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.696 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.471 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 24.1 p -79.7 -8.7 59.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.585 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . . . -116.68 127.62 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 82.8 mt-10 -65.63 -47.06 76.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 1.5 mtpm? -158.88 169.65 23.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.513 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 51.0 mt -136.59 127.54 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.413 -0.805 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 3.9 m -109.03 124.08 50.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.393 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 69.9 m-85 -110.22 124.03 50.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 47.6 t0 -115.87 108.22 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.174 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.406 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 35.4 t -116.3 136.33 53.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.154 -0.966 . . . . 0.0 109.834 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.481 ' O ' HD23 ' A' ' 103' ' ' LEU . 65.4 tttt -119.23 153.01 35.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 108.931 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 102' ' ' LYS . 38.2 mt -131.23 123.76 29.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.007 -1.058 . . . . 0.0 109.738 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 35.5 m -138.96 143.17 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.382 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.09 147.7 53.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.87 170.0 23.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.47 -1.47 8.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.674 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -75.74 -23.84 56.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.63 7.51 56.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.26 -141.64 4.85 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.488 ' HB2' ' CA ' ' A' ' 15' ' ' PRO . 2.1 t -109.31 142.93 39.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -147.14 146.14 29.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.26 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.64 -166.09 32.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 12.9 tttp -124.38 143.38 50.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -1.142 . . . . 0.0 109.419 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -120.89 124.11 44.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.94 . . . . 0.0 109.602 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.6 m -108.26 135.21 49.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' THR . 24.0 t -110.91 127.84 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.531 ' CE ' HG23 ' A' ' 2' ' ' VAL . 71.6 tttt -110.99 118.61 36.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 0.0 108.849 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 32.5 t80 -122.65 109.0 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.951 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 2' ' ' VAL . 62.1 tt0 -96.7 145.86 25.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.124 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.492 ' CG2' ' HD3' ' A' ' 127' ' ' PRO . 17.3 p -115.26 179.14 4.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.998 . . . . 0.0 109.587 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 93' ' ' THR . 57.6 mttt -62.03 -36.13 80.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.0 -94.0 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.39 -21.14 53.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 137.65 57.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 3' ' ' PHE . 61.9 tt0 -127.74 126.85 24.01 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HD3' ' CG2' ' A' ' 121' ' ' THR . 50.0 Cg_endo -70.15 147.05 59.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.765 2.31 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.8 m-20 -72.69 169.23 17.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.47 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.4 -41.94 97.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.5 -43.76 93.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 61.2 mt -60.29 -37.46 80.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.372 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -69.41 -41.23 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.0 m -59.59 -41.22 89.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.67 89.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -68.97 -40.2 79.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.05 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.517 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.433 ' HE3' ' CB ' ' A' ' 89' ' ' ALA . 22.9 tttm -62.45 -45.82 91.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 109.425 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.47 70.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -53.26 -39.54 63.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.93 52.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.367 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 145' ' ' ALA . 62.8 tp -64.37 -41.05 96.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -55.26 -53.02 61.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.923 . . . . 0.0 109.322 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -53.54 -35.07 60.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.193 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . -57.55 -50.05 74.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.242 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.445 HG23 HG11 ' A' ' 29' ' ' VAL . 6.0 mm -55.73 -41.68 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.289 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 83.5 tt0 -62.82 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 -37.59 14.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.182 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 149' ' ' TYR . 31.8 t80 -66.74 -43.41 84.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.525 HD12 ' CD2' ' A' ' 18' ' ' LEU . 6.7 mt -56.13 -33.33 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.74 48.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.52 -19.43 57.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -127.38 83.81 65.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.82 -20.22 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.683 2.255 . . . . 0.0 111.774 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 14.2 p-10 -83.6 -2.6 56.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.56 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.448 ' OH ' ' OD2' ' A' ' 25' ' ' ASP . 73.0 t80 -69.02 132.16 46.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.494 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.44 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.391 0.615 . . . . 0.0 109.764 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -124.26 145.77 49.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.284 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.6 m -118.26 146.93 43.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.497 ' CE2' HD11 ' A' ' 132' ' ' LEU . 72.0 m-85 -139.12 162.19 35.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.04 132.87 45.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -131.88 164.56 25.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.13 149.3 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 69.7 mt -123.92 129.8 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -140.65 131.32 25.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -144.6 140.61 16.71 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.12 -10.65 28.76 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.698 2.265 . . . . 0.0 111.714 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 14' ' ' ALA . 42.1 t -83.34 151.12 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' N ' HG12 ' A' ' 13' ' ' VAL . . . -61.25 137.56 94.38 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.342 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.9 -28.64 35.74 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.682 2.255 . . . . 0.0 111.75 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.14 -41.72 57.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.509 ' CG2' ' OXT' ' A' ' 157' ' ' ASN . 55.2 m -77.47 -41.01 41.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.535 HD13 ' CD1' ' A' ' 150' ' ' LEU . 41.9 tp -67.11 -38.34 85.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.55 ' CD2' HD21 ' A' ' 78' ' ' LEU . 91.3 t80 -67.55 -41.83 83.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.687 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' THR . 7.8 tptt -66.17 -46.84 75.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.47 -27.76 61.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -66.07 -48.1 72.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.39 -50.81 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.535 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.3 m -64.7 -48.77 73.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 109.988 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' VAL . 3.7 m-20 -92.31 3.94 54.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.622 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -46.25 -52.8 11.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.312 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.7 m-20 -66.14 -25.13 66.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 93.8 m-20 -88.89 -27.64 20.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.947 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' ASP . 9.1 p -83.57 -38.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 109.637 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.6 mt -52.31 -46.45 94.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.141 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.4 Cg_endo -68.47 -17.47 43.73 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.8 mttp -108.1 -29.35 9.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.93 81.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.558 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 22.7 tp -91.58 111.81 23.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.98 -44.4 87.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -89.74 29.96 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.048 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 47.5 t80 -63.44 132.75 52.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 39' ' ' SER . 49.7 tttp -96.08 -47.68 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.189 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.496 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 34.9 p -179.95 174.16 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.006 -1.059 . . . . 0.0 110.03 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 40' ' ' VAL . 5.1 p -136.25 130.33 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 109.343 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -129.86 144.78 51.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.629 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.69 126.51 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.363 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 36.7 t -80.05 -41.58 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.625 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 51' ' ' THR . 50.8 tp10 -166.96 156.75 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.512 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 98.77 170.23 31.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -119.06 31.79 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -1.189 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.76 -11.62 66.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 51' ' ' THR . . . -76.93 -170.97 33.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.58 148.76 60.48 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.669 2.246 . . . . 0.0 111.745 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 80.04 3.32 89.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 44' ' ' GLU . 87.9 m -69.71 149.87 47.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.617 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.516 ' N ' HG23 ' A' ' 51' ' ' THR . 29.9 mm -114.96 124.97 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -119.68 144.15 47.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 109.557 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . 17.2 tttt -114.48 127.62 55.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 64.3 mt -115.49 145.01 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m -128.72 112.11 13.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 30.4 p90 -115.64 173.02 6.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.98 142.57 47.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -143.54 131.3 21.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 53.18 21.88 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.94 71.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.86 155.44 18.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -1.105 . . . . 0.0 109.482 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.3 27.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 52.1 mttm -120.68 162.57 19.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 3.2 p90 -145.74 158.91 43.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.501 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.0 OUTLIER -138.79 147.81 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 67' ' ' LEU . 3.5 mp -116.26 136.12 53.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 0.0 108.918 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -129.5 142.45 50.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.743 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.511 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 81.7 tttt -124.03 149.31 46.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 24.4 mm -107.68 132.66 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.624 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 98' ' ' THR . 95.8 mt-10 -89.3 -39.24 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.346 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -173.62 140.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.68 136.03 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -128.66 78.57 1.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -58.91 -39.33 81.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.55 -52.09 42.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -92.22 14.37 16.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.505 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 19' ' ' TYR . 6.0 mt 45.49 42.21 7.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.66 21.7 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CE1' HD21 ' A' ' 22' ' ' LEU . 18.3 p90 -151.6 169.6 21.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -1.155 . . . . 0.0 109.195 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -128.56 138.75 52.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.2 p90 -154.26 158.67 40.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 96.6 p -146.84 156.6 43.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.411 HG23 ' HB1' ' A' ' 89' ' ' ALA . 9.6 p -94.4 135.5 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.213 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 67' ' ' LEU . 3.8 m -118.79 3.61 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.73 164.64 35.55 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.71 178.22 28.25 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.05 45.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.411 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -80.04 -8.69 59.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.72 104.21 41.1 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.503 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.5 Cg_endo -69.66 153.82 68.92 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.692 2.261 . . . . 0.0 111.699 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 65.2 m-20 -80.06 -35.9 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -80.01 8.38 7.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.576 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -136.88 130.66 32.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.555 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -56.65 -56.48 20.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 20.1 pttm -169.09 160.65 9.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 83' ' ' SER . 59.8 mt -117.17 136.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 8.4 m -106.54 141.21 38.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.585 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 73.8 m-85 -119.83 120.57 36.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.968 . . . . 0.0 109.955 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -119.57 101.73 8.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 108.976 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -115.07 141.18 48.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' HD12 ' A' ' 103' ' ' LEU . 19.8 tttm -127.3 145.37 50.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.436 -0.79 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.9 mm? -126.45 126.75 44.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 27.4 m -137.22 142.65 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.28 145.72 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.49 172.87 22.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.0 0.5 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.43 -25.7 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.25 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.39 -134.59 2.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 13' ' ' VAL . 72.6 m -116.9 142.08 47.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -1.122 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.47 147.13 30.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.34 -159.73 22.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.94 142.43 49.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -1.135 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 2.3 tt -116.86 135.66 53.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.432 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 38.8 m -127.32 125.88 41.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.841 . . . . 0.0 109.266 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' A' ' 136' ' ' LYS . 50.8 t -109.69 134.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 63.5 tttt -113.88 120.95 42.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.003 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.562 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 14.9 t80 -102.58 125.33 49.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.975 . . . . 0.0 109.743 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.469 ' OE1' ' NZ ' ' A' ' 96' ' ' LYS . 86.1 mt-10 -107.66 135.33 49.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 26.9 p -116.48 166.15 12.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 24.4 mttm -62.82 -35.66 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.4 -86.5 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -62.4 -27.98 69.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.15 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.71 136.04 52.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -132.32 106.91 13.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 49.6 Cg_endo -70.57 122.42 8.88 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.698 2.266 . . . . 0.0 111.867 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -60.64 154.52 21.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -58.23 -36.15 72.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.52 -32.37 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.9 -32.6 51.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -62.0 -38.41 88.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.396 -0.815 . . . . 0.0 109.093 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -64.75 -45.44 86.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.0 m -57.2 -37.65 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.272 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.75 -46.52 93.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.428 ' HG2' HG21 ' A' ' 117' ' ' VAL . 65.0 mttp -53.44 -36.45 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -1.092 . . . . 0.0 109.246 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -56.79 -35.05 68.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.173 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.29 -47.01 78.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.48 39.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.399 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -57.3 -33.41 67.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -58.33 -40.21 81.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.22 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.2 tp -73.12 -47.58 43.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -56.53 -55.35 34.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.066 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -50.76 -39.13 51.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -0.918 . . . . 0.0 109.358 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 47.7 mt -69.06 -55.1 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.307 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -48.63 -57.82 5.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.918 . . . . 0.0 109.156 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.62 -38.56 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 108.847 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 36.0 t80 -67.13 -41.67 85.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD1' HD13 ' A' ' 18' ' ' LEU . 28.5 mt -57.35 -36.16 70.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.02 -28.41 63.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.59 -16.25 62.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -134.13 88.04 32.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.21 -14.83 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.719 2.279 . . . . 0.0 111.806 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -85.69 5.64 31.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.512 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 76.3 t80 -80.01 142.02 35.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.509 ' OXT' ' CG2' ' A' ' 17' ' ' THR . 81.6 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.546 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.356 0.598 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -81.37 117.45 21.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -109.83 116.82 32.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -109.84 157.9 18.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -125.79 127.97 46.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.257 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.73 164.9 17.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.618 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -97.53 149.78 21.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.23 134.72 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 109.517 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.16 109.7 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -131.92 131.84 22.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.1 -2.74 10.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.745 2.297 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' A' ' 18' ' ' LEU . 41.3 t -92.81 151.49 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.22 75.84 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.23 -34.23 22.29 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.801 2.334 . . . . 0.0 111.908 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -75.26 -38.3 60.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 157' ' ' ASN . 94.9 m -76.9 -37.5 55.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.588 ' CD2' ' CD1' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -69.64 -39.44 77.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.518 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 86.1 t80 -66.23 -46.25 77.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.803 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 19.1 tptt -61.29 -46.74 89.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.562 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -71.9 -20.19 61.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 23.1 tp -80.19 -48.83 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.912 . . . . 0.0 109.835 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.3 t -97.99 -53.03 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.306 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 20' ' ' LYS . 4.0 m -64.36 -50.41 67.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 110.449 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 5.4 t70 -90.32 2.57 55.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.013 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.67 -53.16 12.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.011 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.473 ' HA ' HD11 ' A' ' 30' ' ' ILE . 88.9 m-20 -63.57 -25.1 68.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 63.4 m-20 -90.35 -24.15 20.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 25' ' ' ASP . 37.9 t -81.93 -39.16 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.7 mt -50.61 -48.58 82.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.867 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.5 Cg_endo -67.67 -18.34 48.1 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.407 2.071 . . . . 0.0 111.814 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 21.2 mttt -103.66 -54.62 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.314 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.43 -50.82 66.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.051 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD22 ' CB ' ' A' ' 57' ' ' PHE . 29.9 tp -71.77 102.0 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 0.0 108.938 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.42 -41.22 76.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 110.352 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -97.05 29.26 3.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.881 -1.137 . . . . 0.0 110.174 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.19 123.01 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.088 -1.008 . . . . 0.0 109.218 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -87.17 -54.04 4.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 0.0 109.848 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 24.5 p -174.21 167.61 4.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.094 -1.003 . . . . 0.0 110.035 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.456 ' C ' ' HG3' ' A' ' 41' ' ' GLU . 94.2 t -142.43 141.62 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.157 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 76.5 mt-10 -149.88 163.08 39.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ILE . 7.7 t-20 -101.02 127.48 47.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 20.0 m -93.62 -29.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.877 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 63.1 mm-40 -159.14 147.49 17.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 95.9 156.57 31.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.77 34.13 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.62 65.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.42 -166.97 27.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.5 143.99 48.84 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 111.801 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.19 1.67 90.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.513 HG22 ' N ' ' A' ' 52' ' ' ILE . 98.3 m -67.62 147.95 52.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -1.153 . . . . 0.0 109.733 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 11.1 mm -114.19 123.77 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -118.11 143.25 46.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.646 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 64.1 tttt -118.94 132.48 56.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.457 HD11 HD13 ' A' ' 30' ' ' ILE . 46.3 mt -125.38 145.85 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 0.0 109.659 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -124.69 124.79 42.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.377 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.536 ' CB ' HD22 ' A' ' 34' ' ' LEU . 49.5 p90 -127.24 156.78 41.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.412 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.26 136.9 37.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -151.68 135.97 16.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.04 38.88 21.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.34 21.92 60.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -124.37 134.12 53.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.319 -1.107 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.5 m -79.97 118.58 21.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.491 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 88.9 mttt -121.08 160.42 23.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.0 p90 -141.61 154.67 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.459 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 24.3 m -134.52 144.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -110.92 126.09 54.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.198 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -116.32 134.4 54.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.492 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 16.2 tttt -119.54 149.51 41.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 48.8 mt -112.32 133.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.646 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.66 -32.57 12.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.8 p -171.47 146.18 2.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.01 138.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -133.66 76.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.292 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.7 mt-10 -59.66 -37.15 77.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.68 70.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.557 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.87 12.9 26.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.544 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.38 38.04 6.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.129 -0.982 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.34 20.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 21.3 p90 -149.88 169.56 20.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -1.171 . . . . 0.0 109.19 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -128.88 139.95 51.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 109.486 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 25.5 p90 -154.0 160.02 41.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.6 p -145.2 156.18 43.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.499 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 89' ' ' ALA . 82.0 t -93.05 130.16 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 90' ' ' LEU . 4.5 m -121.89 -0.61 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.706 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -162.02 152.48 22.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 109.03 176.9 21.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 138' ' ' LYS . . . -60.51 -14.16 18.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -80.09 -5.1 55.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.441 HD23 ' HA2' ' A' ' 86' ' ' GLY . 9.1 tp -95.57 100.57 6.3 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.4 Cg_endo -69.08 150.1 72.0 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.774 2.316 . . . . 0.0 111.872 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.72 -32.26 41.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.619 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 94' ' ' ALA . 7.6 t -88.58 -15.72 34.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.655 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . . . -111.08 114.82 28.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -45.78 -48.51 15.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -176.63 166.7 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.669 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.467 HG21 ' O ' ' A' ' 118' ' ' LYS . 64.0 mt -124.89 134.49 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.473 ' OG1' ' HE2' ' A' ' 118' ' ' LYS . 33.1 m -106.32 128.39 53.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 95.4 m-85 -106.43 125.14 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.04 104.05 9.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.194 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.5 t -116.17 141.09 48.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.959 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttpm? -128.91 145.09 51.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 102' ' ' LYS . 83.4 mt -127.53 131.98 49.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.0 110.081 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -142.99 168.96 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.522 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -76.79 136.84 38.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 160.69 15.6 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.52 1.27 5.11 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.657 2.238 . . . . 0.0 111.888 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -80.73 -20.99 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.426 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.75 19.07 11.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.52 -142.01 3.61 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.3 t -104.91 148.03 27.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -146.63 151.66 37.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.265 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.02 -156.55 17.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -139.89 142.74 36.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -1.117 . . . . 0.0 109.379 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 116' ' ' THR . 2.2 tt -118.59 131.87 56.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.403 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 34.0 m -119.32 130.2 55.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.406 HG21 ' HD3' ' A' ' 136' ' ' LYS . 85.0 t -108.18 130.69 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' CG ' HG21 ' A' ' 2' ' ' VAL . 32.1 ttpt -112.3 123.6 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 94' ' ' ALA . 38.2 t80 -116.55 115.23 25.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.686 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' HG2' HG12 ' A' ' 2' ' ' VAL . 82.7 mt-10 -99.06 143.41 29.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.017 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.528 ' CG2' ' HD3' ' A' ' 127' ' ' PRO . 68.3 p -121.99 162.68 20.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 93' ' ' THR . 21.7 mttp -49.72 -39.79 38.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.65 -95.2 0.11 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -71.7 -28.39 63.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.46 133.92 40.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -124.58 125.44 25.55 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 51.4 Cg_endo -70.77 142.71 44.13 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.727 2.284 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.4 m-20 -81.75 165.57 20.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -66.47 -40.58 89.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -59.76 -49.04 79.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.3 -42.41 98.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.02 -43.44 98.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.22 -50.16 74.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.5 m -58.25 -37.39 74.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.335 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.14 -42.38 99.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.406 ' HD3' HG21 ' A' ' 117' ' ' VAL . 8.8 tptt -68.2 -39.91 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.28 28.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' A' ' 89' ' ' ALA . 14.3 tttp -67.67 -41.7 83.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.4 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.52 -55.49 10.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -52.19 -32.12 34.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.27 -39.5 75.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 1.3 tm? -69.37 -40.63 77.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.344 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -70.57 -54.31 12.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.137 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -50.78 -31.19 16.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.43 64.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 50.8 mt -65.15 -54.13 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 151' ' ' LEU . 76.6 tt0 -44.7 -51.45 9.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.237 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.84 71.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 37.3 t80 -68.1 -37.14 80.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 0.0 109.468 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 40.7 mt -60.39 -38.43 83.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 109.401 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 147' ' ' GLU . 1.3 mt -73.41 -28.39 61.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 153' ' ' HIS . . . -69.29 -18.52 63.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.406 ' CD2' ' C ' ' A' ' 152' ' ' ALA . 17.1 m-70 -133.37 93.8 21.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.386 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.83 -13.94 32.35 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.683 2.255 . . . . 0.0 111.907 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -86.73 -18.24 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.727 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.517 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 55.7 t80 -68.11 109.97 3.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' C ' ' CG2' ' A' ' 17' ' ' THR . 7.3 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.93 146.63 49.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.486 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -127.59 124.26 37.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.596 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 132' ' ' LEU . 95.8 m-85 -118.74 137.38 53.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 60.7 tt0 -105.42 133.56 49.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 33.5 t0 -138.56 152.97 48.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mt-10 -92.24 160.45 15.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 64.8 mt -117.71 145.13 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 78.4 m-20 -136.56 127.0 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 1.5 m -151.88 125.86 4.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.502 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.36 -2.9 11.36 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.583 2.188 . . . . 0.0 111.761 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 14' ' ' ALA . 90.4 t -89.17 151.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 13' ' ' VAL . . . -57.93 134.79 83.57 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 47.1 Cg_endo -68.64 -27.18 32.66 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.747 2.298 . . . . 0.0 111.793 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.13 -43.91 49.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.599 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' CG2' ' OXT' ' A' ' 157' ' ' ASN . 95.0 m -77.38 -40.35 44.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.59 -39.81 77.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.546 ' CD2' HD23 ' A' ' 78' ' ' LEU . 75.8 t80 -67.08 -37.11 83.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.523 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.5 tptm -69.86 -46.5 65.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.65 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.578 ' HB1' ' CZ ' ' A' ' 156' ' ' TYR . . . -75.23 -20.86 59.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.966 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 23.4 tp -72.08 -49.49 35.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.1 t -97.42 -50.15 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 109.844 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -62.23 -48.54 79.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.92 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 29' ' ' VAL . 21.7 m-20 -95.46 5.95 50.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.753 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.29 -52.8 11.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.581 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 38.3 t0 -67.44 -22.18 65.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.907 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 84.5 m-20 -91.72 -26.76 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 26' ' ' ALA . 7.7 p -81.61 -35.56 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.669 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.8 mt -57.78 -47.87 98.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.81 -38.19 14.14 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 57.7 mttp -85.39 -29.91 24.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 109.181 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -66.94 -30.51 70.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 108.849 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 15.6 tp -95.78 113.06 24.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 108.819 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.99 -34.7 76.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.533 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 p -98.03 27.15 4.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.845 -1.159 . . . . 0.0 109.991 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 58.4 t80 -60.33 137.1 58.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 55.1 tttm -98.01 -48.42 5.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.55 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -178.74 171.76 1.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.895 -1.128 . . . . 0.0 110.019 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HB ' ' HZ ' ' A' ' 37' ' ' PHE . 4.0 p -137.83 133.05 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -141.58 130.72 23.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.0 m-20 -84.31 136.47 33.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.45 -79.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.11 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 51' ' ' THR . 90.5 mt-10 -115.57 164.16 14.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 51' ' ' THR . . . 85.4 157.84 29.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.63 13.61 31.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.338 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.4 42.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.93 -160.03 23.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 72' ' ' SER . 50.7 Cg_endo -70.31 130.8 19.25 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.764 2.31 . . . . 0.0 111.85 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.92 0.98 82.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 52' ' ' ILE . 43.5 m -71.98 151.71 43.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -1.177 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.511 ' N ' HG22 ' A' ' 51' ' ' THR . 17.9 mm -117.61 128.15 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 33.2 mttt -125.67 149.68 48.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.929 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 19.0 tttt -116.29 127.57 54.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 62.8 mt -113.03 137.1 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 48.0 m -128.81 128.07 43.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.467 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.545 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 28.8 p90 -137.68 176.51 8.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 38' ' ' LYS . 4.0 mm? -103.35 145.33 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.578 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -147.74 126.21 12.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 52.43 23.43 2.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.77 11.85 73.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -112.0 159.71 18.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.6 m -99.8 111.52 23.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -119.33 162.51 18.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 4.1 p90 -146.72 159.2 43.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -137.29 146.07 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.596 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.562 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 3.6 mp -116.17 137.3 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.045 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -134.14 145.69 49.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.045 -1.034 . . . . 0.0 109.835 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HE2' ' HA2' ' A' ' 50' ' ' GLY . 32.9 tttt -120.32 147.43 45.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.9 mt -108.89 132.77 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 26.1 mt-10 -86.41 -44.27 12.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 23.3 t -177.14 134.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -100.45 139.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -132.55 73.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.79 -29.33 59.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.61 73.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.438 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . 91.0 m-20 -90.16 14.12 13.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.546 HD23 ' CD2' ' A' ' 19' ' ' TYR . 20.9 mt 46.81 46.2 15.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 109.6 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.51 154.68 26.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -150.72 169.35 21.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -1.211 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 100' ' ' ASP . 67.1 m -134.38 140.6 46.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.88 158.76 41.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.7 p -145.51 156.13 43.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.03 133.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.418 ' C ' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -119.81 1.26 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.894 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.39 36.95 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.13 176.59 19.1 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.52 -13.37 62.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -1.117 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.98 -9.12 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.418 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -90.59 110.3 40.29 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.6 Cg_endo -70.58 148.61 60.11 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.641 2.227 . . . . 0.0 111.7 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.408 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 61.6 m-20 -79.09 -32.54 44.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -79.85 5.83 12.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.557 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -131.98 134.71 45.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.057 -1.027 . . . . 0.0 109.63 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 88.0 mt-10 -63.38 -46.51 86.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 3.8 pttm 179.64 159.62 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.404 HD13 HG22 ' A' ' 97' ' ' ILE . 59.2 mt -116.73 136.32 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.3 m -111.84 124.83 53.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.865 . . . . 0.0 109.216 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 89.6 m-85 -108.7 124.27 50.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.97 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 16.6 t70 -119.18 107.04 12.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.065 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.502 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . 76.8 p -121.11 140.61 51.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.479 ' O ' HD11 ' A' ' 103' ' ' LEU . 61.2 tttm -121.03 154.42 36.08 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 103' ' ' LEU . 3.1 mm? -131.17 127.2 37.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.003 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG21 ' N ' ' A' ' 105' ' ' ALA . 1.3 m -144.97 167.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 108.982 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.45 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -77.06 134.39 38.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.533 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.16 159.31 15.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.75 24.39 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.669 2.246 . . . . 0.0 111.867 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -70.1 -22.83 62.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.47 23.53 10.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.82 3.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.5 t -98.67 149.19 23.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -1.123 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -145.91 159.12 43.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.15 -174.54 43.62 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 10.2 ttmt -117.02 141.13 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -1.121 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 34.9 tp -116.15 136.45 53.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.453 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 21.6 m -128.16 126.85 41.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.3 t -108.66 134.19 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.508 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 21.0 tttm -121.63 114.3 20.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.548 ' CE2' ' HB2' ' A' ' 94' ' ' ALA . 39.2 t80 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE2' ' NZ ' ' A' ' 118' ' ' LYS . 93.8 mt-10 -106.66 138.04 43.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 21.8 p -117.07 157.09 26.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 52.8 mttt -49.62 -44.94 47.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.04 -71.12 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 27.8 p30 -78.72 -17.04 56.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.097 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.52 132.49 41.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.9 107.5 25.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.878 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.537 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 49.6 Cg_endo -69.65 119.62 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.95 158.92 26.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.54 -37.16 75.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.09 -31.67 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -78.64 -33.57 47.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 108.951 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -61.73 -43.2 99.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -59.25 -48.7 80.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.205 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.5 m -61.23 -40.1 92.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.36 -49.95 72.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -62.81 -37.89 88.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -1.18 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.42 -28.71 45.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -61.13 -46.74 89.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.272 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.27 -52.59 53.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -50.53 -39.07 47.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.03 86.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.87 -30.62 50.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.03 -52.09 67.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.145 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -52.1 -37.68 54.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.02 78.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 29' ' ' VAL . 8.4 mm -57.62 -42.53 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.307 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 93.5 mt-10 -73.59 -43.37 59.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.91 67.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 153' ' ' HIS . 38.8 t80 -68.23 -44.05 76.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.471 HD23 HG11 ' A' ' 13' ' ' VAL . 4.8 mp -57.62 -35.46 70.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -31.64 44.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.558 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.89 -21.82 60.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 149' ' ' TYR . 74.9 m-70 -129.81 87.38 52.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.84 -17.8 37.01 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.695 2.263 . . . . 0.0 111.79 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.39 -0.78 23.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.578 ' CZ ' ' HB1' ' A' ' 21' ' ' ALA . 74.6 t80 -75.69 136.48 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.411 ' OXT' ' CG2' ' A' ' 17' ' ' THR . 7.9 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.7 t . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.2 m-85 -123.27 149.66 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -127.19 135.0 50.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.305 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.0 157.76 38.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.116 -0.99 . . . . 0.0 109.599 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -126.43 132.67 51.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 3.1 t70 -131.88 164.81 25.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.552 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 94.4 mt-10 -103.15 149.95 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.53 129.38 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -139.58 122.13 16.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -144.9 136.66 12.89 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG2' HD23 ' A' ' 151' ' ' LEU . 50.4 Cg_endo -70.2 -1.13 8.32 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.597 2.198 . . . . 0.0 111.731 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.514 ' CG1' ' OE1' ' A' ' 147' ' ' GLU . 1.8 p -92.21 152.28 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.61 137.2 86.26 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' CA ' ' HB3' ' A' ' 111' ' ' SER . 46.1 Cg_endo -68.19 -30.4 31.25 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.749 2.299 . . . . 0.0 111.8 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.58 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 157' ' ' ASN . 61.6 m -80.16 -35.84 35.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.56 ' CD1' HD11 ' A' ' 150' ' ' LEU . 7.6 tp -70.04 -39.44 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 85.4 t80 -70.12 -40.29 74.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 52.0 tptt -66.0 -47.17 75.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' CA ' ' HB2' ' A' ' 25' ' ' ASP . . . -71.37 -47.89 53.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.055 -1.028 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 61.5 tp -47.5 -43.52 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.4 t -98.44 -56.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -64.02 -48.39 76.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.065 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.538 ' HB2' ' CA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -90.64 2.81 55.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.756 -179.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.36 -50.9 15.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 0.0 109.497 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.3 m-20 -66.11 -28.88 69.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.031 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -87.9 -29.33 20.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 146' ' ' ILE . 92.3 t -83.4 -38.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.669 ' CG2' ' CE2' ' A' ' 37' ' ' PHE . 6.1 mt -49.22 -48.26 74.27 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.795 . . . . 0.0 110.002 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.4 Cg_endo -68.93 -19.45 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.408 2.072 . . . . 0.0 111.899 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 53.1 mttm -99.21 -34.1 10.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -34.51 78.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.25 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 10.3 tp -92.54 109.74 21.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 108.965 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.83 -26.52 65.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 p -109.04 26.98 9.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.0 110.203 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.669 ' CE2' ' CG2' ' A' ' 30' ' ' ILE . 4.9 t80 -59.17 137.54 57.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.44 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.466 ' CE ' ' CD2' ' A' ' 58' ' ' LEU . 13.3 mttm -101.06 -49.52 4.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.942 . . . . 0.0 110.259 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.5 p -175.07 167.13 3.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.957 -1.089 . . . . 0.0 110.21 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.665 ' CG2' ' CE1' ' A' ' 37' ' ' PHE . 13.8 t -135.2 128.14 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.549 -0.719 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -138.65 151.46 47.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 27.1 p-10 -98.44 140.85 32.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.48 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.471 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -97.98 -29.9 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.526 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 51' ' ' THR . 77.6 mt-10 -157.93 145.59 18.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.56 159.74 30.92 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -97.37 5.58 49.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.56 -10.51 30.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.44 -158.13 9.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.06 138.09 36.09 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.744 2.296 . . . . 0.0 111.859 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.53 7.14 88.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 44' ' ' GLU . 15.1 m -79.55 157.29 27.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -1.159 . . . . 0.0 109.661 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 16.1 mm -117.85 126.7 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.2 mttm -119.13 144.14 46.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.865 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 23.4 tttt -115.41 127.36 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.062 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.585 HG22 ' CZ ' ' A' ' 37' ' ' PHE . 35.7 mt -121.22 145.3 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 0.0 110.032 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 57.7 m -131.9 127.31 36.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -0.769 . . . . 0.0 109.244 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 23.8 p90 -134.76 170.72 15.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.466 ' CD2' ' CE ' ' A' ' 38' ' ' LYS . 1.9 mm? -107.84 133.53 52.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.366 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -141.41 140.01 33.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 48.46 22.2 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 109.62 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.83 29.34 39.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -132.62 145.16 50.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.445 ' HA ' HD21 ' A' ' 58' ' ' LEU . 27.5 m -85.03 109.25 18.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -113.17 156.86 22.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 12.2 p90 -141.24 153.05 45.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.4 p -138.88 147.52 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -115.11 134.48 55.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.226 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -124.51 138.0 54.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.514 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 51.9 tttt -118.4 144.1 46.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 52.5 mt -105.39 129.46 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 97.0 mt-10 -87.75 -40.73 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.28 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.1 p -171.74 151.77 2.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.84 133.85 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -128.14 82.12 2.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.85 -35.2 75.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -0.991 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.61 -52.35 62.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-20 -89.7 15.0 10.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.538 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 44.11 46.39 7.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.15 156.47 25.6 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.6 p90 -151.64 169.7 21.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.188 . . . . 0.0 109.071 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 21.2 m -126.73 138.46 53.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.579 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.8 p90 -154.42 158.62 40.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.852 . . . . 0.0 109.582 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 71.9 p -148.54 156.91 43.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 109.325 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 89' ' ' ALA . 10.0 p -97.85 132.82 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.959 . . . . 0.0 109.199 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.44 5.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.009 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.65 153.28 23.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.32 -176.22 23.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.47 -13.58 62.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 0.0 109.389 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -79.92 -8.61 59.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.72 101.8 34.81 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.347 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 50.1 Cg_endo -69.7 152.7 69.69 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.755 2.303 . . . . 0.0 111.601 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 63.0 m-20 -79.55 -34.92 40.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.628 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -79.96 7.75 8.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.913 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.569 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -138.02 127.53 24.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -52.02 -58.67 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 42.6 pttt -167.46 164.44 14.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 97' ' ' ILE . 60.1 mt -118.26 135.41 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.403 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 7.7 m -107.01 145.91 31.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.631 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.621 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.9 m-85 -123.96 120.07 31.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.124 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -118.37 101.64 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.065 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.439 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 29.1 t -117.32 139.62 50.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.296 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.492 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 35.7 ttpt -120.81 155.76 33.36 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.534 ' N ' HD23 ' A' ' 103' ' ' LEU . 3.1 mm? -133.07 123.97 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.008 -1.058 . . . . 0.0 110.042 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.15 142.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.087 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.01 145.88 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.764 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 169.65 23.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.69 1.76 4.73 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.723 2.282 . . . . 0.0 111.844 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.25 -28.53 64.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.51 21.82 10.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.99 -131.41 1.63 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.559 ' HB3' ' CA ' ' A' ' 15' ' ' PRO . 1.1 p -120.18 142.78 48.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -1.134 . . . . 0.0 109.586 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.76 160.5 38.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.402 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.4 168.21 31.05 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -111.49 147.32 35.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.127 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.474 HD21 ' N ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -117.23 131.39 56.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.487 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.474 ' N ' HD21 ' A' ' 115' ' ' LEU . 27.7 m -125.23 126.18 44.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.174 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.454 HG11 ' CE1' ' A' ' 99' ' ' PHE . 57.9 t -111.54 134.22 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.691 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HE2' ' OG1' ' A' ' 98' ' ' THR . 38.0 ttpt -106.91 126.33 52.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 127' ' ' PRO . 36.8 t80 -106.94 121.07 43.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.401 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 91.3 mt-10 -104.83 138.96 40.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 26.2 p -119.31 161.86 19.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.5 mttt -63.31 -32.1 73.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.17 -108.52 0.31 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' O ' ' OE1' ' A' ' 126' ' ' GLU . 81.4 m-20 -63.43 -34.29 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.142 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.89 127.49 28.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -143.23 127.65 9.59 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 119' ' ' TYR . 50.8 Cg_endo -70.46 163.85 37.36 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.7 2.267 . . . . 0.0 111.795 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -93.22 163.66 13.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -52.08 -40.39 61.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -61.35 -46.49 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -57.61 -44.77 85.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.44 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -39.07 86.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 109.424 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.08 -43.95 85.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.8 m -58.51 -40.22 82.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.314 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.08 92.88 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ASP . 42.8 mttt -69.36 -40.25 77.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.62 73.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -75.26 -44.82 43.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 142' ' ' LEU . . . -79.65 -26.42 41.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 136' ' ' LYS . 12.9 t0 -60.68 -40.11 90.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.89 68.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 21.2 mt -54.78 -51.75 64.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.201 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -60.74 -53.91 51.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.16 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -56.36 -37.25 69.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.04 -54.38 45.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.186 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 29' ' ' VAL . 6.6 mt -67.8 -53.39 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.885 . . . . 0.0 109.192 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.514 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 15.2 tp10 -52.97 -47.48 68.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.63 69.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.2 t80 -68.9 -31.15 69.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.287 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.56 HD11 ' CD1' ' A' ' 18' ' ' LEU . 15.3 mt -69.84 -46.03 66.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.405 HD23 ' HG2' ' A' ' 12' ' ' PRO . 70.3 mt -66.08 -30.01 70.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.94 -16.5 60.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -124.28 94.6 44.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.64 -21.36 29.49 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.734 2.289 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.3 -20.49 60.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.513 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 69.2 t80 -77.45 131.07 37.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.664 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' THR . 72.2 m-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 95.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 119' ' ' TYR . 83.5 m-85 -130.98 120.92 24.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 109.538 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 51.5 m -109.02 144.16 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.456 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.608 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 86.4 m-85 -135.17 135.79 41.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.4 mt-10 -106.12 131.34 53.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.917 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 21.1 t0 -130.08 164.41 24.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -101.8 160.01 14.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 10.5 mt -133.2 132.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -133.69 131.43 39.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.449 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 47.8 m -152.55 137.01 10.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 0.0 109.353 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' HD23 ' A' ' 151' ' ' LEU . 51.5 Cg_endo -70.13 -31.55 18.66 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.676 2.25 . . . . 0.0 111.815 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 18' ' ' LEU . 1.5 p -60.29 152.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' N ' HG21 ' A' ' 13' ' ' VAL . . . -63.48 142.26 97.9 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.448 ' N ' ' HB3' ' A' ' 111' ' ' SER . 46.9 Cg_endo -68.19 -37.42 14.34 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.735 2.29 . . . . 0.0 111.775 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.05 82.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 157' ' ' ASN . 52.6 m -78.77 -36.88 42.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 150' ' ' LEU . 11.6 tp -69.9 -39.53 76.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 86.7 t80 -68.06 -42.37 80.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.828 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 24' ' ' THR . 20.5 tptt -63.81 -46.63 84.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.933 . . . . 0.0 109.728 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.15 -25.64 60.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 2.8 tm? -69.63 -46.89 65.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.37 -53.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -62.81 -48.57 78.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 109.956 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -94.85 8.79 41.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 109.617 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -47.06 -53.42 12.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 9.0 p-10 -69.37 -27.04 64.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 86.1 m-20 -83.34 -28.21 29.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 25' ' ' ASP . 88.0 t -81.53 -36.76 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.5 mt -49.64 -49.37 72.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.102 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.8 Cg_endo -67.4 -20.1 48.68 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.503 2.135 . . . . 0.0 111.921 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.64 -54.11 3.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.188 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.9 65.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.064 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 9.8 mp -78.2 99.57 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.2 -29.32 60.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.9 p -110.27 27.16 9.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -52.57 123.97 12.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -89.6 -55.77 3.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.7 p -171.95 164.22 6.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.956 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG22 ' C ' ' A' ' 39' ' ' SER . 74.7 t -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.805 . . . . 0.0 109.123 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 61.4 mt-10 -152.46 160.77 43.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.129 -0.982 . . . . 0.0 109.765 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 80.0 m-20 -98.97 131.05 45.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.7 m -90.69 -29.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.676 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.84 144.74 17.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' A' ' 51' ' ' THR . . . 97.37 168.21 32.82 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.8 6.25 33.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -1.101 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 51' ' ' THR . . . 110.22 -9.56 31.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.91 -157.57 8.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.29 137.07 33.09 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.651 2.234 . . . . 0.0 111.862 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.07 7.5 88.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 52' ' ' ILE . 100.0 m -76.65 153.81 34.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.192 . . . . 0.0 109.625 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.497 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 24.3 mm -114.18 123.28 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 109.239 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 29.8 mtmt -119.82 145.42 46.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.917 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 20.4 tttm -114.98 126.71 55.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 20.7 mt -116.4 143.82 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.465 ' N ' HG23 ' A' ' 55' ' ' ILE . 65.1 m -127.04 128.0 45.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 64' ' ' LYS . 52.7 p90 -133.51 156.06 48.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 140.63 31.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -150.34 134.13 16.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 52.04 32.47 10.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.99 74.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -112.02 139.57 47.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -88.0 119.44 28.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 86.3 mttt -120.35 165.86 14.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 27.8 p90 -145.03 157.78 44.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.515 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.3 p -138.69 146.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.773 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.529 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 40.1 mt -113.65 133.26 55.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.871 . . . . 0.0 108.95 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.446 ' NE2' HG21 ' A' ' 66' ' ' VAL . 33.2 m170 -126.17 139.5 53.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 24.1 tttt -117.52 144.41 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.052 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 mt -102.71 127.44 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 94.9 mt-10 -89.16 -36.63 15.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 32.0 t 178.08 132.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -103.9 137.27 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.314 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -126.57 82.42 2.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.6 mt-10 -58.28 -34.57 70.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 109.284 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.12 65.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.423 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 77.6 m-20 -87.79 15.52 6.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.908 . . . . 0.0 109.189 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 14.8 mt 43.25 46.02 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.425 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -145.23 159.71 27.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' A' ' 82' ' ' TYR . 19.9 p90 -152.17 169.78 21.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -1.202 . . . . 0.0 109.291 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 41.3 t -125.38 137.81 54.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 99' ' ' PHE . 14.2 p90 -151.36 153.97 35.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 98' ' ' THR . 10.9 t -142.44 155.19 45.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.2 p -96.43 132.52 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.122 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.564 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 1.3 p -127.63 2.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.912 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -157.95 148.04 16.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.09 -174.9 19.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.06 -12.37 61.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -1.074 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.87 8.78 6.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 85' ' ' VAL . 10.2 tt -121.22 101.08 44.69 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.308 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.1 Cg_endo -69.21 154.59 69.7 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.72 2.28 . . . . 0.0 112.003 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 61.4 m-20 -79.92 -31.7 40.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.2 p -79.76 2.12 24.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.722 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.567 ' HB1' ' CE2' ' A' ' 119' ' ' TYR . . . -134.11 137.26 44.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -65.51 -56.01 14.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HE2' ' OE1' ' A' ' 120' ' ' GLU . 43.9 pttt -169.0 159.05 9.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 109.461 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' A' ' 83' ' ' SER . 29.1 mt -118.96 137.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 83' ' ' SER . 24.2 m -113.12 120.77 42.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.655 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 91.8 m-85 -96.0 126.04 40.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.753 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 116' ' ' THR . 17.2 t70 -119.33 113.95 21.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.329 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.513 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 22.5 t -135.81 140.68 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.47 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 103' ' ' LEU . 29.9 tttt -119.26 160.74 21.64 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.536 ' N ' ' HG2' ' A' ' 102' ' ' LYS . 3.6 mm? -124.15 126.77 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.881 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 29.8 m -137.35 142.93 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.92 146.12 49.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.718 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.25 165.3 21.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -2.16 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.662 2.242 . . . . 0.0 111.894 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.51 18.14 31.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -140.91 3.8 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 11' ' ' SER . 13.6 p -119.66 145.56 46.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -1.151 . . . . 0.0 109.606 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.43 147.7 31.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 109.146 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -161.9 170.04 37.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -99.31 146.51 26.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 30.4 tp -112.21 137.37 50.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 53.8 m -140.44 113.68 8.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -110.11 139.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 110.354 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.488 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.8 tttp -111.79 119.0 37.14 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 127' ' ' PRO . 12.7 t80 -102.54 123.48 46.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.099 -1.001 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 92.0 mt-10 -106.34 137.98 43.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.534 HG22 ' CD ' ' A' ' 127' ' ' PRO . 56.5 p -117.6 159.38 23.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.562 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 59.2 mttt -62.32 -40.95 98.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.31 -83.03 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.39 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -1.211 . . . . 0.0 109.517 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.99 134.66 56.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -136.79 107.03 8.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.597 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.576 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 48.7 Cg_endo -69.77 131.73 21.84 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 111.885 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.21 149.53 35.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.366 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -52.75 -36.0 57.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -57.11 -31.61 65.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.98 -36.18 59.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.157 -0.964 . . . . 0.0 108.574 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.608 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -58.25 -40.93 83.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -52.65 -54.26 35.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.42 -0.8 . . . . 0.0 109.177 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.5 m -58.71 -37.93 77.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.09 97.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 140' ' ' ASP . 24.7 mttt -63.78 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -1.119 . . . . 0.0 109.214 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -62.35 -34.31 76.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.352 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.66 -46.37 46.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.56 -27.13 51.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.153 -0.967 . . . . 0.0 109.18 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 136' ' ' LYS . 86.1 m-20 -80.15 -21.88 42.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.282 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -69.12 -39.4 78.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.28 -45.88 87.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -59.28 -55.21 37.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.802 . . . . 0.0 109.25 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -49.75 -41.12 43.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.64 78.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 108.945 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 21.3 mt -72.89 -54.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.7 -49.52 47.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.234 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.003 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -67.43 -37.56 83.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.23 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.532 ' CD1' HD13 ' A' ' 18' ' ' LEU . 14.1 mt -65.41 -43.16 91.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.376 -0.828 . . . . 0.0 109.396 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.479 HD23 ' HG2' ' A' ' 12' ' ' PRO . 73.8 mt -69.42 -31.7 70.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 153' ' ' HIS . . . -73.89 -19.08 60.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 152' ' ' ALA . 7.4 m-70 -127.13 89.35 52.06 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.87 -19.32 35.78 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.71 2.273 . . . . 0.0 111.805 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.82 -11.7 60.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.508 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 71.2 t80 -77.48 133.7 38.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 17' ' ' THR . 48.0 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 126' ' ' GLU . 97.2 m-85 -126.27 141.65 51.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 37.4 m -121.37 130.38 53.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 132' ' ' LEU . 87.6 m-85 -123.11 136.73 54.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -110.08 132.18 54.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -133.81 165.8 24.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.525 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -99.6 145.35 27.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.335 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -106.55 142.34 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -154.92 128.89 8.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -152.97 140.92 13.6 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.479 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.13 -1.43 8.76 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.674 2.25 . . . . 0.0 111.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.516 HG11 ' N ' ' A' ' 14' ' ' ALA . 64.5 t -97.49 149.47 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.516 ' N ' HG11 ' A' ' 13' ' ' VAL . . . -61.9 140.52 95.63 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.4 -31.07 28.71 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.729 2.286 . . . . 0.0 111.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 -41.9 53.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.457 ' CG2' ' CB ' ' A' ' 157' ' ' ASN . 93.1 m -75.27 -43.74 49.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.466 HD13 ' CD1' ' A' ' 150' ' ' LEU . 68.1 tp -67.48 -37.29 82.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.6 t80 -66.75 -41.24 88.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.607 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' THR . 17.1 tptm -67.12 -46.49 73.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.631 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -74.78 -17.3 60.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 26.1 tp -74.23 -51.37 15.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.53 -44.72 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.971 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.533 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.25 -47.97 74.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.949 . . . . 0.0 110.103 -179.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 29' ' ' VAL . 53.6 m-20 -98.51 11.28 38.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.035 . . . . 0.0 109.833 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -53.88 -51.57 63.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 20.2 t70 -70.57 -21.37 62.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 110.141 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.16 -27.2 16.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' ASP . 7.9 p -80.95 -33.85 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.81 . . . . 0.0 109.67 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.634 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 5.8 mt -61.91 -49.55 85.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.15 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 48.5 Cg_endo -68.92 -22.78 35.56 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.513 2.142 . . . . 0.0 112.445 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 33' ' ' ALA . 22.4 mttt -106.14 -35.72 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.535 ' O ' ' CD2' ' A' ' 34' ' ' LEU . . . -43.23 -38.67 2.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -155.44 144.0 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.442 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.8 -18.71 50.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 68.0 m -55.14 -38.12 67.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.398 -0.814 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 40' ' ' VAL . 1.3 t80 -49.93 135.52 19.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.087 -1.008 . . . . 0.0 109.294 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 40.2 tttp -81.07 -57.28 3.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 110.295 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -162.46 155.57 20.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.02 -1.05 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' A' ' 37' ' ' PHE . 92.3 t -134.67 133.55 54.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.458 -0.776 . . . . 0.0 109.065 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 84.3 mt-10 -159.34 168.1 27.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.95 . . . . 0.0 109.634 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 65.9 m-20 -97.03 152.6 18.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 2.5 t -96.1 -33.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.558 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 51' ' ' THR . 45.3 tp10 -166.79 156.44 11.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 88.96 -172.97 40.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -120.99 17.35 11.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.93 -1.43 56.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.14 -164.01 23.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.95 126.41 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.623 2.215 . . . . 0.0 111.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 92.77 4.13 65.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.529 HG21 ' N ' ' A' ' 52' ' ' ILE . 86.1 m -75.34 150.4 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -1.121 . . . . 0.0 109.58 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.529 ' N ' HG21 ' A' ' 51' ' ' THR . 9.4 mm -111.56 122.25 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 21.8 tttt -116.98 142.1 47.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 110.108 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 17.9 tttm -117.25 130.24 56.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -130.46 138.25 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.981 -1.075 . . . . 0.0 110.004 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.1 m -120.52 114.67 22.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.386 -0.821 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 50.8 p90 -114.96 171.05 7.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -111.14 151.32 28.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' GLU . 60.5 tt0 -154.28 138.58 16.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.311 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 2.8 p-10 44.13 26.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . 81.58 24.29 56.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' GLU . 72.7 mt-10 -121.74 140.88 51.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.44 HG22 ' HD2' ' A' ' 38' ' ' LYS . 16.2 m -91.07 110.28 21.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -116.18 162.04 18.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 14.2 p90 -141.85 153.79 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 5.6 p -140.6 148.82 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.712 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -110.81 128.78 55.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.914 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -122.52 138.55 54.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 22.1 tttm -119.57 146.94 45.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.5 mt -104.93 130.52 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 72' ' ' SER . 48.4 mm-40 -93.56 -27.79 16.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.292 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.2 t 178.27 144.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 73' ' ' ILE . 73.8 mt -115.44 138.15 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.373 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 94.0 m-20 -130.79 81.97 2.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.32 -37.01 81.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.54 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.514 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 22.0 m-20 -97.58 12.11 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt 47.88 29.31 1.6 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -121.24 150.86 17.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.3 p90 -151.24 169.76 21.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -1.225 . . . . 0.0 109.123 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 47.4 t -128.56 138.88 52.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -153.97 158.91 41.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 80.7 p -145.23 157.07 44.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.643 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 11.0 p -96.48 129.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 67' ' ' LEU . 3.6 m -116.57 4.86 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.448 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -169.18 159.51 32.53 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 105.02 -171.54 18.99 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.88 61.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -1.079 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.91 -4.02 50.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.86 86.35 45.82 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -69.54 165.91 29.12 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.505 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 38.9 m-20 -70.44 -27.82 64.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.9 p -79.77 -23.94 41.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.601 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.585 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -106.32 121.58 44.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.972 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 92.8 mt-10 -64.97 -49.12 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 71.8 mttt -161.2 158.42 27.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CD1' ' CE2' ' A' ' 119' ' ' TYR . 62.7 mt -123.61 133.68 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.84 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.2 m -108.91 131.29 55.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 99.8 m-85 -115.11 122.39 45.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.446 ' O ' HD22 ' A' ' 115' ' ' LEU . 42.5 t0 -116.11 119.9 37.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.888 . . . . 0.0 109.188 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.497 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 9.9 t -138.48 134.93 34.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.514 ' CE ' ' HB3' ' A' ' 77' ' ' ASN . 20.0 tttm -125.77 149.09 48.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 2.2 mp -130.1 128.88 42.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 109.954 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 32.6 m -138.96 143.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 109.164 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.04 139.65 22.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.28 168.16 21.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.16 -16.36 35.87 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.73 2.287 . . . . 0.0 111.729 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -64.86 -22.56 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.03 42.78 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.76 -140.42 4.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 m -101.93 141.36 34.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -148.02 139.5 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.4 13.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -129.82 141.68 50.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.299 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.497 ' HG ' ' CB ' ' A' ' 101' ' ' SER . 3.1 tt -124.52 119.8 30.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 110.005 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.477 ' N ' HD22 ' A' ' 115' ' ' LEU . 71.2 m -116.65 128.32 55.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 108.788 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -117.03 131.97 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 110.062 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 37.1 ttpt -111.08 115.61 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.585 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.7 t80 -99.45 128.92 45.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.234 -0.916 . . . . 0.0 109.647 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -102.9 144.43 31.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.312 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 70.1 p -123.72 152.84 41.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 12.5 mttm -55.15 -29.21 57.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.0 -108.11 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.65 -27.27 58.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.04 135.83 57.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -141.33 119.59 7.91 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.5 146.66 56.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.844 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -87.55 177.25 7.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.94 -36.15 80.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.26 -41.92 94.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.458 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -66.96 -42.77 84.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 5' ' ' PHE . 79.7 mt -63.39 -42.1 98.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -63.13 -47.39 82.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 109.411 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.7 m -58.2 -37.88 75.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.407 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.82 95.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -67.45 -39.66 85.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.62 63.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' HD23 ' A' ' 142' ' ' LEU . 15.5 tttp -61.55 -49.38 76.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.61 86.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.32 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -57.41 -38.53 74.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . -57.79 -49.07 77.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.2 mm? -75.9 -37.24 59.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.309 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -58.35 -51.81 68.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -62.87 -32.17 73.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.411 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.94 70.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 109.319 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.55 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 29.4 mt -62.91 -45.13 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' HG23 ' A' ' 13' ' ' VAL . 82.7 tt0 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.267 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.4 -37.26 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.149 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.605 ' CE2' ' CE1' ' A' ' 153' ' ' HIS . 49.1 t80 -67.92 -41.25 82.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 12.9 mt -55.44 -34.9 64.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.427 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.2 mt -78.58 -28.25 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -20.79 59.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.455 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.605 ' CE1' ' CE2' ' A' ' 149' ' ' TYR . 74.9 m80 -130.32 90.3 41.97 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.46 -16.12 34.55 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.779 2.319 . . . . 0.0 111.815 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.37 -17.49 60.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 21' ' ' ALA . 79.3 t80 -75.1 121.45 22.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CG2' ' A' ' 17' ' ' THR . 5.8 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.463 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 91.5 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -129.39 130.98 46.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 98.4 m -113.35 145.01 41.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 91.3 m-85 -136.37 128.63 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.978 . . . . 0.0 109.676 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 77.0 tt0 -96.43 131.3 43.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 136' ' ' LYS . 6.5 m-20 -128.0 164.93 21.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -100.9 151.56 21.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.97 128.57 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.14 125.4 37.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.58 129.67 5.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.35 -0.03 6.8 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.661 2.241 . . . . 0.0 111.865 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 14' ' ' ALA . 95.7 t -87.59 151.36 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' N ' HG13 ' A' ' 13' ' ' VAL . . . -67.23 142.92 97.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 109.503 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.9 Cg_endo -68.55 -35.78 16.5 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.769 2.312 . . . . 0.0 111.814 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.32 80.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 HG23 ' C ' ' A' ' 157' ' ' ASN . 56.2 m -79.23 -40.93 29.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 22.3 tp -67.41 -38.8 85.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.606 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.584 ' CE1' ' HA ' ' A' ' 78' ' ' LEU . 68.1 t80 -69.55 -40.43 76.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 38.1 tptt -65.64 -46.93 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -75.03 -30.35 61.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 8.4 mt -58.71 -49.24 78.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.783 . . . . 0.0 109.722 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.51 -46.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.889 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -71.81 -50.87 25.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 62.5 t0 -85.15 7.56 21.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.012 . . . . 0.0 109.727 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -59.21 -49.7 76.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.937 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.7 m-20 -66.32 -31.27 71.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.819 . . . . 0.0 109.986 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 24.4 m-20 -87.3 -28.39 22.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.686 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ASP . 7.6 p -81.24 -36.75 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.655 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.664 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.7 mt -53.24 -48.31 92.81 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.984 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -67.94 -34.55 23.16 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 111.943 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 18.2 mttp -83.23 -40.59 19.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.163 -0.961 . . . . 0.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.42 -61.7 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 47.5 tp -64.55 108.8 1.77 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 108.927 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.44 -35.41 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -96.81 27.18 4.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.941 -1.099 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.616 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 50.9 t80 -59.33 136.29 57.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' SER . 55.0 tttt -97.87 -49.77 4.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 110.051 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.51 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 83.1 p -178.69 171.87 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.986 . . . . 0.0 109.753 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 5.4 p -134.25 122.56 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.4 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 42' ' ' ASN . 18.0 tt0 -126.13 158.25 35.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' N ' ' CG ' ' A' ' 41' ' ' GLU . 45.4 m-20 -105.7 154.39 20.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.545 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.2 m -117.53 -34.92 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 85.1 mt-10 -158.3 145.78 18.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.481 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 98.43 162.0 30.34 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.78 2.86 49.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -1.113 . . . . 0.0 109.566 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 112.6 -10.32 25.9 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.24 -153.37 10.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.29 139.5 38.54 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 C-N-CA 122.714 2.276 . . . . 0.0 111.798 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.59 -1.18 86.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.526 HG21 ' N ' ' A' ' 52' ' ' ILE . 90.8 m -71.91 153.5 41.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -1.21 . . . . 0.0 109.63 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 14.6 mm -117.91 127.83 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -123.78 148.37 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 109.786 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 27.1 tttm -115.32 126.16 54.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 84.9 mt -113.73 143.22 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.568 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 40.7 m -129.74 128.69 42.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.586 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 30.5 p90 -134.5 169.03 17.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 142.9 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.419 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.5 128.91 15.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 49.74 24.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 28.25 41.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -122.36 154.4 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.6 m -98.49 107.13 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.334 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -116.09 160.08 20.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -144.93 157.03 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 17.1 m -137.25 145.82 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.707 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 8.5 mt -114.18 133.89 55.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.878 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -126.1 139.32 53.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 38.3 tttm -121.11 144.78 48.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.285 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 10.6 mm -102.79 125.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.443 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 92.0 mt-10 -82.97 -54.2 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.865 . . . . 0.0 109.33 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.6 t -162.39 136.97 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt -113.41 134.76 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.403 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -129.83 79.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -50.96 -34.99 31.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.25 -49.43 64.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.674 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.482 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 59.9 m-20 -100.52 14.57 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 40.1 mt 42.43 41.21 2.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.84 106.42 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -109.79 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.691 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 p -136.07 142.83 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.4 p90 -152.85 157.6 40.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 109.656 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 97' ' ' ILE . 12.4 p -142.2 153.91 44.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.37 128.31 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.524 HG13 ' CE ' ' A' ' 96' ' ' LYS . 2.3 m -122.3 6.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -158.89 147.88 16.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.89 179.66 16.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.22 -13.81 59.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.99 -8.94 59.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 85' ' ' VAL . 4.5 tp -100.0 102.73 18.72 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -68.65 152.29 74.55 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.724 2.282 . . . . 0.0 111.836 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.96 -29.32 60.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.867 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.7 p -79.57 3.75 17.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.078 -1.014 . . . . 0.0 109.818 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.576 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -125.37 128.92 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 5.7 tt0 -63.82 -55.0 26.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 89.5 mttt -161.51 160.94 29.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 83' ' ' SER . 17.0 mt -126.15 132.78 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 34.6 m -118.55 115.89 25.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.641 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 69.5 m-85 -94.41 128.53 41.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 109.67 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 116' ' ' THR . 13.8 t0 -116.84 116.52 27.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.254 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 12.2 t -133.06 136.34 45.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 77' ' ' ASN . 28.9 tttt -122.74 144.81 48.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.4 mm? -128.36 124.04 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -133.75 162.55 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 109.059 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -60.87 125.33 23.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.057 -1.027 . . . . 0.0 109.514 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.79 150.28 19.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.58 2.33 4.1 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.647 2.231 . . . . 0.0 111.971 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.24 5.7 50.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.605 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.73 22.14 51.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -138.67 3.49 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -120.46 142.59 49.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -1.187 . . . . 0.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' O ' HG11 ' A' ' 104' ' ' VAL . . . -147.28 147.37 30.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -166.26 -151.94 7.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -133.44 142.73 48.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -1.128 . . . . 0.0 109.261 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 116' ' ' THR . 4.8 tt -120.61 126.53 50.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.784 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.528 ' N ' HD22 ' A' ' 115' ' ' LEU . 68.0 m -125.72 124.85 41.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 108.849 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.641 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 1.1 p -108.08 142.47 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.061 -1.025 . . . . 0.0 110.128 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 69.2 tttt -119.93 116.61 26.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 108.964 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.524 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.3 t80 -102.68 130.51 49.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.137 -0.977 . . . . 0.0 109.667 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -111.75 127.22 55.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 32.8 p -110.94 157.52 19.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.543 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -58.36 -39.23 78.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 -93.21 0.1 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -67.41 -31.65 72.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.13 115.19 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.89 108.48 28.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 117.95 5.4 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.783 2.322 . . . . 0.0 111.844 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -59.87 157.06 13.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -56.35 -38.57 71.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.82 -31.34 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.252 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 63.2 mm-40 -74.38 -36.85 63.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 108.7 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -56.98 -35.8 69.6 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -60.63 -48.03 83.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.18 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.2 m -58.33 -39.02 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.44 99.35 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 7' ' ' ASP . 29.5 tttt -73.06 -41.78 63.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -1.111 . . . . 0.0 109.362 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.05 -34.96 70.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -71.25 -44.76 64.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.252 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.93 89.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.837 . . . . 0.0 109.353 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.5 ' HB3' ' HE3' ' A' ' 144' ' ' LYS . 89.5 m-20 -50.95 -47.54 61.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.291 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 145' ' ' ALA . . . -54.03 -33.33 57.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.464 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 3.1 tm? -70.62 -53.36 16.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.93 -53.63 54.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 108.948 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 140' ' ' ASP . 49.4 mttt -51.93 -37.85 54.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 141' ' ' ALA . . . -56.45 -45.83 80.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.28 -0.887 . . . . 0.0 108.989 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 16.7 mt -69.07 -54.72 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.225 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -59.64 -52.65 64.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.341 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . -48.83 -39.19 24.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.062 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.535 ' OH ' ' CD2' ' A' ' 153' ' ' HIS . 35.1 t80 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.211 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 24.6 mt -58.82 -41.09 86.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.27 -29.64 67.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.918 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.0 -17.66 56.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CD2' ' OH ' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -125.74 85.77 58.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.575 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.44 -20.54 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.682 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -79.38 -1.45 37.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 157' ' ' ASN . 59.6 t80 -68.81 143.56 54.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 7.2 m120 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' N ' ' OE2' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 70.0 t -138.15 137.43 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -1.145 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 89.0 m-85 -125.06 143.04 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.0 m -126.13 125.29 42.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.9 m-85 -121.72 139.1 54.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -112.9 133.56 54.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD2' ' CE ' ' A' ' 136' ' ' LYS . 49.1 t0 -132.3 165.0 25.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.84 157.9 16.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 27.2 mt -124.28 135.93 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 23.6 m120 -142.14 130.93 22.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.23 135.17 9.18 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.912 . . . . 0.0 109.481 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.49 -6.27 18.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.653 2.236 . . . . 0.0 111.794 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.489 HG23 ' CD2' ' A' ' 150' ' ' LEU . 2.7 p -87.16 150.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.33 136.84 60.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.07 -32.32 28.16 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.19 64.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -75.37 -38.63 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 39.6 tp -69.49 -39.65 77.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.9 t80 -64.68 -46.89 80.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 24' ' ' THR . 5.7 tptm -63.29 -46.16 88.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.12 -17.91 61.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 44.6 tp -80.05 -50.17 10.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.815 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 -45.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -71.09 -50.46 33.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 4.3 t70 -95.03 17.09 14.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -54.55 -52.84 60.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 44.8 t0 -66.32 -26.07 67.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 59.0 m-20 -88.04 -26.61 22.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 109.449 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG13 ' CG2' ' A' ' 146' ' ' ILE . 75.3 t -82.27 -40.15 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.8 mt -49.47 -48.68 74.86 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.31 -34.61 20.77 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.355 2.036 . . . . 0.0 111.839 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 48.4 mttt -79.96 -40.43 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.063 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.96 88.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.268 -0.895 . . . . 0.0 108.878 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 40.5 tp -83.54 102.54 12.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 108.967 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.41 -35.6 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.3 p -97.73 29.5 3.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.982 . . . . 0.0 109.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 39' ' ' SER . 17.2 t80 -54.69 119.83 5.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -84.89 -55.66 3.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.618 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.592 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 60.6 p -175.1 168.23 3.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.63 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 7.2 p -144.08 142.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 40' ' ' VAL . 65.2 mt-10 -149.89 155.64 40.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 85.4 m-20 -96.57 121.97 38.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.4 m -79.97 -27.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 26.0 mt-10 -163.17 152.02 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 51' ' ' THR . . . 90.4 157.69 33.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.97 9.44 43.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.566 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.62 -6.93 36.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.36 -160.46 22.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HA ' HG21 ' A' ' 70' ' ' ILE . 49.1 Cg_endo -70.0 129.04 16.67 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.691 2.261 . . . . 0.0 111.714 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 89.88 2.31 75.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.453 HG22 ' HA3' ' A' ' 45' ' ' GLY . 14.3 m -75.05 152.46 38.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -1.148 . . . . 0.0 109.604 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 8.3 mm -114.05 124.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.072 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 96.8 mttt -118.78 143.65 46.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 15.6 tttp -115.95 128.49 55.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 49.2 mt -117.95 143.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 28.2 m -120.54 133.22 55.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.36 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CZ ' ' CB ' ' A' ' 64' ' ' LYS . 33.5 p90 -134.47 154.26 51.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.97 123.46 40.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.301 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -136.63 126.85 26.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.616 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 56.89 35.53 26.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.68 9.98 53.29 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -109.04 133.88 52.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -79.2 119.4 22.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 57' ' ' PHE . 24.3 mttt -123.64 165.6 16.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 32.7 p90 -146.01 159.87 42.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 35.7 m -134.82 143.37 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 109.728 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 8.5 mt -112.42 131.86 55.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 0.0 109.105 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -127.79 141.25 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.611 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 28.3 tttt -121.32 150.94 40.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.267 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 37.9 mt -112.59 133.95 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 94.2 mt-10 -92.02 -32.69 15.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.6 p -176.97 147.2 0.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 73' ' ' ILE . 63.2 mt -113.85 138.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -133.36 76.12 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.45 -37.72 84.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.17 -47.31 68.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -95.57 11.96 31.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 48.45 51.21 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.56 148.72 20.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 19.4 p90 -151.05 167.76 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 109.215 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 37.4 m -126.88 138.57 53.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.454 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.581 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 15.5 p90 -152.53 155.43 37.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.0 p -146.83 156.16 42.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.04 133.37 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.406 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.423 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.9 t -123.77 0.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.018 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.446 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -167.34 157.18 29.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.35 173.52 21.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.94 -13.01 29.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.89 16.84 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 85' ' ' VAL . 1.2 tt -120.97 103.82 42.35 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 46.2 Cg_endo -68.38 151.19 76.25 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.739 2.293 . . . . 0.0 111.866 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 47.7 m-20 -79.36 -32.55 43.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.6 p -79.6 -0.97 35.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.756 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 119' ' ' TYR . . . -127.38 126.85 43.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.379 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 46.4 mt-10 -58.85 -54.11 50.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 85.9 mttt -160.82 163.63 31.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.467 HG22 ' CE2' ' A' ' 99' ' ' PHE . 30.5 mt -122.99 132.98 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 2.2 m -108.87 144.53 36.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.642 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.2 m-85 -126.52 120.86 30.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 0.0 109.8 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 59.2 t0 -119.9 102.4 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.15 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.534 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.9 t -119.06 140.58 49.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.128 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 61.6 tttt -119.36 163.72 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 109.122 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -133.45 123.46 25.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.63 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.67 143.03 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 109.315 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.37 58.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.528 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -126.6 162.65 20.72 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.82 -13.38 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.694 2.263 . . . . 0.0 111.776 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.57 -23.29 65.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.88 18.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.02 -140.06 3.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 87.0 p -110.08 145.92 36.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.6 41.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.83 171.19 35.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -105.53 142.45 35.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -1.189 . . . . 0.0 109.377 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 60.9 tp -115.55 136.89 52.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.585 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 30.4 m -127.8 125.57 40.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.35 131.95 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.52 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -113.39 122.16 46.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 40.1 t80 -110.76 119.99 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.553 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -103.45 145.33 30.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 26.2 p -120.62 151.69 39.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 28.0 mttt -49.78 -43.42 48.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 177.24 -111.64 0.34 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.45 -44.13 89.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.74 134.47 36.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.574 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 98.9 mt-10 -149.6 132.1 7.97 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.58 139.52 37.55 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.679 2.253 . . . . 0.0 111.783 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -64.15 177.48 0.81 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.315 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.02 -42.29 89.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.62 -47.11 86.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.6 -40.41 79.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 79.7 mt -61.92 -37.33 84.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -59.97 -49.48 77.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.265 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.3 m -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.02 -41.87 98.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' CE ' ' OD2' ' A' ' 7' ' ' ASP . 49.6 tttp -70.28 -40.39 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -1.109 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.19 64.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.424 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -65.25 -46.21 81.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.78 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 70.5 m-20 -50.81 -29.77 12.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.77 76.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.872 . . . . 0.0 109.239 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.2 mt -76.01 -43.86 42.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -56.03 -54.68 41.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 77.4 mttt -50.46 -40.49 50.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.71 -48.81 80.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.237 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.539 ' CG2' HG13 ' A' ' 29' ' ' VAL . 34.0 mt -68.81 -44.48 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -62.34 -45.06 94.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.325 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.08 70.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 39.5 t80 -67.14 -46.0 75.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 13' ' ' VAL . 9.5 mp -61.22 -43.49 98.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.6 mt -69.38 -36.17 76.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.26 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -127.07 84.05 64.46 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.68 -19.24 36.77 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.645 2.23 . . . . 0.0 111.725 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.79 -12.26 60.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 157' ' ' ASN . 41.7 t80 -77.52 125.87 30.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.569 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 7.3 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG23 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -129.92 147.64 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.164 . . . . 0.0 109.348 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.452 ' CE1' ' HD2' ' A' ' 127' ' ' PRO . 97.1 m-85 -80.05 118.73 22.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 28.8 m -111.17 116.53 31.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.3 m-85 -108.91 163.67 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.688 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 46.0 mt-10 -130.34 132.47 45.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.253 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -132.91 166.23 22.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.27 140.99 36.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.15 136.69 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.307 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -151.76 138.99 19.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' OE1' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -153.07 144.7 16.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HG2' HD13 ' A' ' 151' ' ' LEU . 49.4 Cg_endo -70.25 -5.02 15.54 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.699 2.266 . . . . 0.0 111.794 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.48 ' CG1' ' OE1' ' A' ' 147' ' ' GLU . 7.1 p -92.88 151.62 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.14 79.19 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.3 Cg_endo -68.07 -30.61 31.73 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.71 2.273 . . . . 0.0 111.85 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.0 61.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 157' ' ' ASN . 58.6 m -76.7 -38.89 53.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.495 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 150' ' ' LEU . 33.3 tp -68.13 -39.36 82.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 85.2 t80 -66.04 -44.59 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 0.0 109.785 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HE3' ' CG2' ' A' ' 24' ' ' THR . 43.1 tptt -63.83 -46.76 83.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 109.681 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 156' ' ' TYR . . . -72.56 -17.67 61.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.544 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 51.1 tp -79.52 -49.05 12.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.39 -48.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 1.9 m -64.99 -49.43 70.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.9 m-20 -97.27 12.19 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -48.66 -53.56 18.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.338 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 73.7 m-20 -66.92 -23.56 65.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.927 . . . . 0.0 109.543 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 92.0 m-20 -87.23 -26.76 23.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 25' ' ' ASP . 85.7 t -81.55 -35.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.651 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 12.4 mt -53.68 -48.59 92.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.25 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.9 Cg_endo -67.23 -19.73 50.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.524 2.149 . . . . 0.0 112.251 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 35.4 mttm -104.12 -45.82 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 109.347 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.8 91.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.578 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 55.0 tp -79.63 107.13 12.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 108.878 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.46 -44.73 85.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -92.14 29.75 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.828 -1.17 . . . . 0.0 110.344 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 54.4 t80 -58.38 123.75 17.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.02 -1.05 . . . . 0.0 109.363 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.36 -52.4 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.588 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -177.49 170.37 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.493 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.73 135.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -135.18 134.97 40.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.13 137.8 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.1 m -99.96 -36.83 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.433 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 43' ' ' VAL . 55.9 mt-10 -158.7 146.25 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.65 155.18 20.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -109.38 29.72 7.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -1.142 . . . . 0.0 109.583 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.78 -21.98 38.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.48 -162.42 5.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.4 160.55 49.14 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.66 2.24 . . . . 0.0 111.749 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 63.16 12.12 42.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -76.36 153.69 35.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.0 109.521 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.526 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 9.4 mm -117.39 126.94 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -119.88 144.51 47.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.706 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.7 tttt -115.29 128.97 56.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 67.8 mt -117.41 145.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.3 m -124.43 125.15 43.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 109.298 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 48.0 p90 -133.66 158.21 43.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 58' ' ' LEU . 4.2 mm? -99.22 150.14 22.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' OE1' ' CE ' ' A' ' 64' ' ' LYS . 57.7 tt0 -152.97 129.81 10.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.566 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 48.13 23.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.38 29.4 36.73 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' GLU . 96.9 mt-10 -123.71 155.39 37.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.8 m -97.86 112.26 24.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 62.3 mttt -124.67 158.63 32.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 30.0 p90 -142.76 157.6 44.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 33.3 m -132.76 142.8 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.131 -0.98 . . . . 0.0 109.608 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' HB2' ' N ' ' A' ' 86' ' ' GLY . 10.5 mt -110.29 125.42 53.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -116.01 133.86 55.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 64.0 tttt -120.59 146.06 46.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.195 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 66.1 mt -113.31 138.28 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.551 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.1 -42.61 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -161.58 142.75 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 109.499 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 73' ' ' ILE . 68.3 mt -109.88 140.71 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.48 77.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.398 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.6 mt-10 -57.29 -38.17 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.443 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.05 -47.73 64.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -95.01 12.67 27.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.1 mt 47.72 31.54 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.408 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.94 152.79 19.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.511 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.5 p90 -150.24 169.65 20.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -1.124 . . . . 0.0 109.26 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -125.97 139.28 53.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 25.9 p90 -154.29 160.76 41.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.7 p -146.19 156.48 43.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -86.36 132.15 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG12 ' HE2' ' A' ' 96' ' ' LYS . 4.1 t -117.67 -5.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.781 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -171.96 162.71 34.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 122.54 160.43 10.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.05 -15.16 20.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -1.079 . . . . 0.0 109.296 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.93 -6.03 56.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.338 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tt -79.98 110.19 15.13 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 109.356 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.21 146.42 63.52 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.747 2.298 . . . . 0.0 111.695 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.451 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 62.5 m-20 -78.89 -32.65 45.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.9 p -79.86 -5.44 55.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.727 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . . . -122.75 136.92 55.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.058 -1.026 . . . . 0.0 109.624 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 81.1 mt-10 -70.63 -51.31 28.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 31.7 mttt -161.21 163.55 31.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' SER . 60.3 mt -124.01 133.1 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' A' ' 118' ' ' LYS . 6.1 m -109.52 125.52 52.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.0 m-85 -108.79 122.87 48.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 56.7 t0 -120.42 102.63 8.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.933 . . . . 0.0 109.252 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.441 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 17.1 m -119.44 139.57 51.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.909 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 103' ' ' LEU . 31.6 ttpt -120.58 156.87 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 62.3 mt -129.54 127.5 40.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 27.5 m -139.61 142.97 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.33 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.25 170.63 22.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.13 -8.94 24.84 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.684 2.256 . . . . 0.0 111.853 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -67.9 -24.94 65.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.32 44.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.98 -143.32 4.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 85.3 p -106.1 144.74 32.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.47 147.12 30.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.41 -165.52 32.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.11 145.14 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -117.69 132.37 56.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.465 ' N ' HD22 ' A' ' 115' ' ' LEU . 20.1 m -122.11 128.69 51.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.269 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' THR . 49.2 t -107.7 131.35 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' CG ' HG23 ' A' ' 2' ' ' VAL . 31.8 tttm -112.66 121.41 44.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.84 . . . . 0.0 109.225 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t80 -116.48 114.32 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.544 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' HG2' HG11 ' A' ' 2' ' ' VAL . 82.7 mt-10 -101.12 138.05 38.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.092 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.9 p -116.42 164.32 14.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.451 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 41.3 mttt -55.22 -43.05 74.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.47 -106.88 0.21 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 86.1 m-20 -63.32 -42.84 99.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 109.449 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -44.63 130.47 6.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 4.9 mt-10 -134.91 133.17 20.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.4 Cg_endo -70.44 158.13 56.99 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.613 2.209 . . . . 0.0 111.742 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.7 OUTLIER -90.93 164.99 13.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.95 -40.66 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.41 -46.63 89.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 64.7 mm-40 -58.11 -45.61 86.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.55 -38.31 80.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -61.27 -48.55 80.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.35 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.4 m -58.83 -38.54 78.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.324 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -46.0 95.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' CD ' HG21 ' A' ' 117' ' ' VAL . 4.8 mtmt -64.94 -38.82 92.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.0 62.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.49 -45.99 84.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.359 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.3 -55.35 10.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -54.06 -35.72 62.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.39 -46.96 82.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 142' ' ' LEU . 2.8 tm? -71.19 -33.57 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.202 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -56.07 -52.75 63.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.953 . . . . 0.0 109.125 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -51.76 -39.84 59.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.156 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.03 -38.71 73.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.305 -0.872 . . . . 0.0 109.053 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.476 HD11 ' CG1' ' A' ' 29' ' ' VAL . 7.6 mm -71.68 -44.35 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.234 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 30.6 tp10 -67.69 -41.63 83.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.86 -34.28 74.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.95 -46.68 64.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 18' ' ' LEU . 6.7 mp -63.26 -43.77 97.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD12 ' HG3' ' A' ' 147' ' ' GLU . 82.0 mt -68.05 -33.48 74.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.71 -17.82 61.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -129.56 95.07 30.72 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.6 -16.58 34.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.699 2.266 . . . . 0.0 111.72 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -73.43 -20.73 60.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.55 ' CZ ' ' HB1' ' A' ' 21' ' ' ALA . 70.8 t80 -79.89 129.92 34.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.427 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' HA2' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 1' ' ' GLY . 87.0 t -138.26 137.67 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.571 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.4 m-85 -124.28 146.5 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.6 m -128.31 135.0 49.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 71.5 m-85 -126.39 160.0 31.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 71.7 mt-10 -135.93 129.26 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -133.26 165.13 25.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 8' ' ' GLU . 68.5 mm-40 -104.68 151.83 23.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 47.4 mt -121.53 134.91 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 25.7 m120 -144.72 131.34 19.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.549 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 2.0 p -148.02 144.54 19.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.0 Cg_endo -71.48 1.38 5.63 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.415 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CG1' ' OG ' ' A' ' 11' ' ' SER . 2.4 p -97.89 152.78 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.55 137.9 61.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HB3' ' HA ' ' A' ' 111' ' ' SER . 47.1 Cg_endo -67.98 -35.16 21.2 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.744 2.296 . . . . 0.0 111.826 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.89 68.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.29 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 157' ' ' ASN . 68.1 m -78.55 -35.25 46.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 150' ' ' LEU . 14.5 tp -70.62 -40.59 73.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.481 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.51 -49.78 67.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' THR . 7.3 tptm -59.77 -46.26 89.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.562 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -70.54 -18.63 62.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 13.4 mt -80.13 -46.16 16.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 109.749 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.52 -45.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.17 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 16.4 m -74.78 -50.05 18.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.334 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 4.6 t70 -92.12 9.18 34.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.0 109.819 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -51.05 -52.45 43.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' A' ' 30' ' ' ILE . 93.8 m-20 -65.19 -29.48 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.379 -0.826 . . . . 0.0 109.748 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 85.7 m-20 -84.41 -26.36 28.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG11 ' CG2' ' A' ' 146' ' ' ILE . 45.0 t -80.77 -37.14 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.628 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.4 mt -50.04 -49.48 74.76 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.37 -25.23 36.2 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.357 2.038 . . . . 0.0 111.97 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 59.6 mmtt -91.94 -33.31 14.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.149 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.65 -43.05 60.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -0.868 . . . . 0.0 109.046 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.61 106.6 18.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.016 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.26 -33.26 69.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.944 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 m -98.2 29.55 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 0.0 109.882 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 56.3 t80 -58.35 126.48 27.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -92.08 -52.04 4.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.611 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 54.3 p -177.66 170.85 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 109.722 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' CG2' ' CD1' ' A' ' 55' ' ' ILE . 5.6 p -142.33 140.32 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.308 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -145.93 153.79 41.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 7.1 m-20 -87.23 140.67 29.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 2.7 t -91.17 -39.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.644 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 87.9 mt-10 -161.03 149.21 15.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' HA3' HG22 ' A' ' 51' ' ' THR . . . 96.16 167.36 34.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -98.14 8.14 45.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.91 -6.37 35.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.79 17.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.69 130.7 19.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.658 2.239 . . . . 0.0 111.758 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.5 3.49 69.04 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 52' ' ' ILE . 91.7 m -77.76 155.19 31.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -1.178 . . . . 0.0 109.571 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.51 ' N ' HG23 ' A' ' 51' ' ' THR . 21.1 mm -118.79 128.31 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.942 . . . . 0.0 109.308 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.7 mttp -122.52 147.72 46.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 36.3 tttm -116.98 129.3 55.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.491 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 14.8 mm -116.28 146.21 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.528 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.5 m -130.71 121.59 25.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.903 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 47.6 p90 -129.1 160.8 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 62' ' ' GLU . 4.2 mm? -96.25 148.56 22.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -150.37 127.74 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.36 22.71 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.45 10.86 72.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 58' ' ' LEU . 93.1 mt-10 -108.35 159.12 16.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -1.11 . . . . 0.0 109.453 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 58' ' ' LEU . 31.6 m -104.93 115.47 30.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -121.22 164.68 16.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.49 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 45.6 p90 -143.75 156.47 44.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.516 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 27.1 m -135.85 144.7 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.557 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mt -109.87 126.79 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.219 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -118.5 134.84 54.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 17.8 tttm -116.05 147.21 41.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 50' ' ' GLY . 12.2 mm -106.83 126.54 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.32 -42.88 12.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 p -168.04 148.46 4.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.01 135.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.12 75.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.352 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.25 -36.67 78.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -48.74 72.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 49.3 m-20 -90.63 13.01 17.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.481 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 7.7 mt 47.53 49.27 16.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.472 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -148.73 153.9 25.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.3 p90 -150.38 169.47 21.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -1.124 . . . . 0.0 109.133 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.7 m -131.09 140.75 50.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 24.1 p90 -155.76 162.6 40.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.578 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 51.9 p -146.36 156.53 43.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.51 133.32 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 19.4 t -106.87 -7.93 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' N ' HD12 ' A' ' 90' ' ' LEU . . . 171.27 -179.06 43.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.75 166.02 27.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.84 -20.75 2.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -1.116 . . . . 0.0 109.379 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.92 -15.73 56.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 86' ' ' GLY . 0.7 OUTLIER -90.65 106.96 17.15 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.307 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.5 Cg_endo -69.58 146.26 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.728 2.285 . . . . 0.0 111.901 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.45 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 79.3 m-20 -77.47 -30.97 53.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 p -79.95 1.18 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.849 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.565 ' HB1' ' CZ ' ' A' ' 119' ' ' TYR . . . -127.56 126.32 41.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' OE1' ' OE2' ' A' ' 120' ' ' GLU . 92.8 mt-10 -58.15 -42.4 85.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -178.54 157.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.359 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.481 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 63.8 mt -119.67 135.56 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.532 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 34.6 m -109.62 128.2 55.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 94.2 m-85 -111.27 124.65 52.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -120.09 105.0 10.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.482 ' CB ' HD11 ' A' ' 115' ' ' LEU . 8.5 t -114.5 141.0 48.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.445 ' O ' HD21 ' A' ' 103' ' ' LEU . 74.1 tttt -127.7 146.86 50.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.86 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 46.5 mt -122.68 127.6 49.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.799 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 35.8 m -138.86 143.43 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.454 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -62.65 139.77 58.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.52 165.3 22.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.01 22.51 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.647 2.231 . . . . 0.0 111.831 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.16 -28.14 69.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.79 10.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.35 -134.44 2.08 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 100.0 p -108.42 143.16 37.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -1.129 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.94 141.97 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.57 -168.54 35.45 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' A' ' 6' ' ' GLU . 69.2 tttt -125.83 140.72 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -1.121 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.482 HD11 ' CB ' ' A' ' 101' ' ' SER . 25.0 tp -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 5' ' ' PHE . 59.1 m -126.83 127.1 44.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.494 HG13 ' CE1' ' A' ' 99' ' ' PHE . 58.6 t -111.81 132.7 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.8 ttpt -111.72 125.31 53.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CZ ' ' HB1' ' A' ' 94' ' ' ALA . 55.6 t80 -113.0 118.75 35.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 87.0 tt0 -103.44 146.78 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.399 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.483 HG23 ' CD ' ' A' ' 127' ' ' PRO . 11.8 p -119.77 157.19 29.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.397 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.2 mttt -45.9 -37.71 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.66 -96.4 0.16 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.18 -32.15 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -1.148 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.51 137.77 57.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -145.59 110.44 4.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.54 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 47.9 Cg_endo -69.77 144.48 54.1 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.728 2.285 . . . . 0.0 111.772 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.418 ' OD1' ' HG3' ' A' ' 131' ' ' GLU . 48.4 p30 -70.49 172.87 7.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.71 -35.1 78.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.47 -44.3 89.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.418 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 94.4 mt-10 -66.84 -39.99 87.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 95.7 mt -63.77 -42.93 97.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.46 -44.72 90.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.268 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.3 m -57.53 -38.66 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.04 97.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -62.98 -38.61 91.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HA ' ' OD2' ' A' ' 140' ' ' ASP . . . -51.71 -32.04 28.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.444 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -75.86 -36.65 59.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.22 -55.29 8.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.877 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 4.2 p30 -62.11 -26.03 68.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.499 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -58.76 -50.98 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.895 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.24 -38.16 76.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.883 . . . . 0.0 109.292 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.02 -54.95 38.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.128 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -51.54 -33.74 33.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.85 -53.72 53.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.247 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.518 ' CG2' HG11 ' A' ' 29' ' ' VAL . 45.0 mt -67.37 -53.55 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -50.48 -51.0 51.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.46 70.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.9 t80 -66.5 -39.72 88.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.394 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 18' ' ' LEU . 13.0 mt -61.21 -43.12 99.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.466 HD21 ' HG2' ' A' ' 12' ' ' PRO . 83.3 mt -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.37 61.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.595 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 93.85 46.59 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.81 -21.46 33.2 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.683 2.255 . . . . 0.0 111.759 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -75.42 -17.88 60.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 57.5 t80 -78.74 118.67 21.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 17' ' ' THR . 75.6 m-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' CG1' ' HE3' ' A' ' 118' ' ' LYS . 88.5 t -132.87 137.12 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.513 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.42 146.88 49.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -130.62 130.46 44.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 132' ' ' LEU . 88.0 m-85 -129.28 160.92 31.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -127.9 130.11 47.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -126.22 164.71 20.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -94.51 160.47 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 61.4 mt -128.12 142.38 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.36 132.11 42.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -152.42 112.67 2.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.25 -2.22 10.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.581 2.187 . . . . 0.0 111.726 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 68.0 t -95.2 154.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 132.39 26.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.0 Cg_endo -67.93 -29.64 34.15 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.745 2.296 . . . . 0.0 111.939 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.88 -34.05 62.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -77.31 -37.4 52.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.548 ' CD1' ' HB ' ' A' ' 13' ' ' VAL . 9.0 mt -69.24 -40.25 78.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.54 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 68.6 t80 -65.88 -45.54 81.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.3 OUTLIER -64.48 -47.6 78.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -70.34 -20.84 62.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.333 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 7.2 tt -80.13 -45.49 18.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 HG22 HD23 ' A' ' 22' ' ' LEU . 24.8 t -98.36 -54.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 20.7 m -63.69 -49.5 72.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.577 ' OD2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 m-20 -95.61 13.59 25.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.074 -1.017 . . . . 0.0 109.938 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -53.3 -52.87 57.71 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.193 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 63.9 t0 -67.61 -23.02 65.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.97 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 7.6 m120 -90.94 -27.42 18.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.9 p -83.51 -35.07 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.7 mt -56.63 -46.47 99.83 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.4 Cg_endo -66.72 -22.18 50.42 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.456 2.104 . . . . 0.0 112.42 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -108.47 -26.0 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.115 -0.991 . . . . 0.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -63.49 -28.61 70.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.969 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 42.2 tp -101.02 117.52 35.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.032 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.77 -44.07 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.532 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 57.9 m -93.02 28.17 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.891 -1.131 . . . . 0.0 110.072 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CE1' HG21 ' A' ' 30' ' ' ILE . 46.6 t80 -58.83 131.61 51.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.0 tttp -93.03 -51.08 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.933 . . . . 0.0 110.103 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.464 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 67.0 p -179.91 173.77 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 109.938 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 9.7 p -135.69 128.35 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.205 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 70.0 mm-40 -130.0 144.03 51.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.27 125.64 30.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 50.0 t -82.69 -44.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.562 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' O ' ' CG2' ' A' ' 51' ' ' THR . 81.7 tt0 -158.49 145.59 17.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.4 168.21 28.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.84 5.68 50.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -1.152 . . . . 0.0 109.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.28 -8.45 28.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -156.76 12.35 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.02 135.68 30.44 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.701 2.267 . . . . 0.0 111.774 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.25 1.5 84.06 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 44' ' ' GLU . 91.5 m -80.02 127.68 32.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 109.481 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.515 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 20.6 mm -93.29 134.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -125.77 150.75 47.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HE2' ' CG ' ' A' ' 65' ' ' PHE . 22.5 tttt -115.33 126.45 54.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.537 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 56.4 mt -111.77 141.01 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -125.39 123.41 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 41.1 p90 -128.71 166.84 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.27 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.0 mm? -99.35 151.39 21.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.501 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -154.13 119.0 4.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.927 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.12 31.78 7.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.26 -7.09 65.15 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' OE2' ' HE2' ' A' ' 64' ' ' LYS . 72.8 tt0 -91.25 144.51 25.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -1.145 . . . . 0.0 109.419 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.7 m -95.79 120.15 35.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 12.7 mmtt -125.69 169.81 12.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 5.0 p90 -147.93 161.39 41.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 21.8 m -137.94 147.18 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.558 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 3.9 mp -115.3 134.3 55.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -128.67 141.99 51.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 66.4 tttt -120.82 147.68 45.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.356 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.7 mt -108.61 132.2 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 92.9 mt-10 -87.6 -38.8 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.425 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 p -176.78 150.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.448 HG23 HG11 ' A' ' 23' ' ' VAL . 71.3 mt -116.03 137.16 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -131.46 79.43 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -61.86 -37.76 85.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.55 63.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 56.5 m-20 -90.58 13.32 16.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 9.8 mt 47.31 47.63 16.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.89 152.95 24.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CE1' HD21 ' A' ' 22' ' ' LEU . 17.3 p90 -151.12 169.35 22.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 109.14 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 22.7 t -137.76 142.03 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.9 p90 -154.64 160.7 41.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.349 -0.845 . . . . 0.0 109.533 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.4 p -145.55 156.49 43.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 90' ' ' LEU . 73.4 t -89.67 133.09 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.359 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -115.04 -1.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.863 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.52 168.09 39.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.32 166.28 18.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.0 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -1.148 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -81.35 -10.54 59.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.486 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -88.27 107.78 18.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.3 Cg_endo -69.43 148.29 66.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.647 2.231 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -79.37 -33.41 42.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -81.31 0.26 37.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -130.43 139.45 50.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 122' ' ' LYS . 89.7 mt-10 -67.03 -54.73 18.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 109.508 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 51.2 pttt -171.91 163.54 6.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 56.2 mt -118.98 135.75 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.5 m -110.15 122.6 48.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.221 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 92.4 m-85 -104.04 125.17 50.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.841 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 48.7 t0 -120.34 102.22 8.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.46 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 27.0 m -115.13 141.43 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.0 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 50.3 tttt -123.24 153.8 39.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 108.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 40.4 mt -129.88 126.45 37.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.94 143.26 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -70.4 148.3 48.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.48 168.07 24.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 -6.0 17.52 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.71 2.273 . . . . 0.0 111.701 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -63.81 -27.3 69.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.7 18.32 25.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.51 -139.09 3.42 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 31.0 t -117.0 145.99 43.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.682 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.11 166.13 25.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.885 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 169.2 169.43 32.55 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -109.51 144.93 37.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -1.164 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HG ' ' OG ' ' A' ' 101' ' ' SER . 1.2 tt -114.98 136.19 53.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.575 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 25.3 m -127.16 126.13 42.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.4 HG12 ' CE1' ' A' ' 99' ' ' PHE . 48.0 t -111.24 130.5 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.651 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.487 ' HE3' ' CG1' ' A' ' 2' ' ' VAL . 63.9 tttt -112.6 122.08 46.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 109.152 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.571 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 22.8 t80 -112.1 118.41 35.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 109.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.442 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 88.8 mt-10 -101.24 145.52 28.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.208 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 15.7 p -124.09 171.28 9.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HD3' ' HG3' ' A' ' 95' ' ' GLU . 41.9 mmtt -79.8 1.52 26.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.28 -88.46 0.46 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -57.79 -37.45 73.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.89 137.66 58.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 110.69 3.78 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.432 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' ' CD1' ' A' ' 119' ' ' TYR . 50.4 Cg_endo -70.28 147.22 59.04 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.732 2.288 . . . . 0.0 111.835 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.8 OUTLIER -84.61 163.51 19.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.448 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.61 -40.12 78.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.66 -45.56 91.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -59.36 -42.88 92.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 5' ' ' PHE . 90.9 mt -58.16 -35.32 71.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -65.39 -44.12 88.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.6 m -57.79 -39.6 77.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.29 98.8 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -63.3 -39.2 93.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -1.155 . . . . 0.0 109.448 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.16 -33.1 38.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.95 -43.24 93.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.99 -50.66 67.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.336 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 84.4 m-20 -51.57 -33.67 33.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.36 97.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.269 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 2.9 tm? -79.18 -36.45 40.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.12 -51.84 68.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 80.6 mttt -51.78 -39.87 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 0.0 109.212 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.32 81.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.143 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.09 -45.06 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.372 -0.83 . . . . 0.0 109.191 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 94.2 mt-10 -71.19 -37.82 72.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.83 79.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.162 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -71.33 -52.33 19.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 8.1 mp -60.97 -36.69 80.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.52 -31.69 68.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.46 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.71 -2.1 51.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -127.94 75.42 78.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.71 -14.17 35.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.673 2.249 . . . . 0.0 111.782 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -76.23 -26.1 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.577 ' CZ ' ' OD2' ' A' ' 25' ' ' ASP . 81.6 t80 -79.88 125.58 29.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.433 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 3' ' ' PHE . 97.1 t -115.65 136.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' OE1' ' A' ' 126' ' ' GLU . 97.6 m-85 -124.61 147.13 48.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.49 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -127.6 120.69 28.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.586 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 91.8 m-85 -123.16 133.66 54.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -101.9 132.69 47.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 53.3 t0 -127.74 160.58 31.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.47 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 90.4 mt-10 -92.09 160.2 15.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 77.0 mt -117.67 143.8 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -138.03 112.26 8.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 51.1 m -149.33 126.78 5.58 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.68 -35.96 9.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 18' ' ' LEU . 6.4 p -55.21 149.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.525 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -61.58 134.33 93.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.599 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HB3' ' HB3' ' A' ' 111' ' ' SER . 47.6 Cg_endo -68.67 -24.23 35.42 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.785 2.323 . . . . 0.0 111.826 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -44.16 49.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.667 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.8 m -76.27 -42.83 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.157 -0.965 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 16.1 tp -65.12 -38.35 90.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 109.639 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.516 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 83.7 t80 -66.17 -43.86 85.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.7 tptt -64.51 -46.74 81.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.689 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.26 -16.84 60.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 61.0 tp -77.02 -51.03 11.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.5 -48.25 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -61.59 -48.77 79.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 109.778 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' VAL . 65.3 m-20 -101.54 15.26 29.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.32 -52.68 12.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' HD13 ' A' ' 30' ' ' ILE . 86.3 m-20 -67.45 -23.16 65.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.541 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 m120 -88.53 -27.75 21.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.87 . . . . 0.0 109.317 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.0 p -82.76 -37.2 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.651 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.4 mt -49.74 -48.9 76.02 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.869 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.2 Cg_endo -68.48 -33.45 22.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.396 2.064 . . . . 0.0 111.87 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -82.33 -52.91 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.136 -0.978 . . . . 0.0 109.133 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.06 -38.07 62.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 108.974 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.571 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 26.8 tp -84.39 105.42 15.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.77 -39.33 77.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.079 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.6 p -95.61 28.28 3.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 109.862 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -56.44 125.7 23.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HB2' HD12 ' A' ' 58' ' ' LEU . 51.7 tptt -92.83 -52.69 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 m -170.34 162.92 8.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.717 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' SER . 96.3 t -143.03 142.42 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 86.1 mt-10 -150.97 161.86 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 109.54 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -88.51 135.4 33.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 109.446 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 28.5 t -83.27 -42.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 55.6 mm-40 -159.57 147.25 17.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.72 -154.09 21.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -140.66 13.21 2.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.13 31.04 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.87 -162.66 25.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.71 134.94 27.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.731 2.287 . . . . 0.0 111.866 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.98 0.25 90.19 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 52' ' ' ILE . 89.5 m -70.2 151.57 45.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.63 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.51 ' N ' HG22 ' A' ' 51' ' ' THR . 37.8 mm -115.65 124.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -117.91 143.39 46.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.002 . . . . 0.0 109.763 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 12.6 tttm -123.5 136.3 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.223 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.527 ' CD1' HG21 ' A' ' 30' ' ' ILE . 71.9 mt -128.92 146.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.804 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 30.3 m -120.14 121.99 40.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.279 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.571 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 51.4 p90 -122.32 162.27 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.546 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -101.07 149.98 23.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.27 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -164.89 131.29 2.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 53.85 28.81 8.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.05 67.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -107.74 129.0 55.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -1.207 . . . . 0.0 109.401 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -80.12 124.44 28.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 73.9 mttt -124.21 169.91 11.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.551 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 37.7 p90 -142.5 154.58 44.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.477 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 29.7 m -130.53 139.19 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.56 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -108.67 126.96 53.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -125.89 140.4 52.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.588 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 36.4 tttm -121.39 148.95 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.32 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 50' ' ' GLY . 57.7 mt -108.6 132.09 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' OE2' HG23 ' A' ' 98' ' ' THR . 97.2 mt-10 -88.29 -36.43 16.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 109.355 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -175.16 150.27 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.73 136.38 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -132.81 78.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 45.9 mt-10 -57.23 -39.41 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.5 -46.99 57.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.925 . . . . 0.0 109.421 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.481 ' HB3' ' NZ ' ' A' ' 102' ' ' LYS . 47.2 m-20 -93.77 13.68 21.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.281 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 7.6 mt 47.03 35.87 3.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.98 154.22 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.9 p90 -150.71 169.72 20.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 109.068 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 72.5 m -129.72 139.51 51.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.674 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.9 p90 -153.27 158.7 42.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -148.04 157.71 43.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.08 125.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.285 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.48 2.47 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.56 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -164.59 154.33 25.09 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 113.9 159.14 13.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -13.42 32.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.115 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.45 9.33 7.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.596 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.59 122.41 42.0 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.371 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 51.1 Cg_endo -70.5 145.2 52.22 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.691 2.261 . . . . 0.0 111.826 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -79.76 -32.28 40.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -80.18 -2.77 46.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 119' ' ' TYR . . . -125.0 117.98 25.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.967 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -49.94 -43.64 50.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -176.85 161.46 2.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.56 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 69.6 mt -122.65 134.04 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 50.8 m -107.89 129.81 55.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.8 m-85 -113.78 123.6 50.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.9 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -123.0 101.57 7.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.017 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.44 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 4.3 m -113.31 145.89 40.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.035 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 77' ' ' ASN . 19.4 tttt -123.27 158.39 31.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 77.0 mt -138.93 129.91 26.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.006 . . . . 0.0 110.139 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -142.83 169.68 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 0.0 108.979 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.526 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.32 137.47 39.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 109.516 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.89 161.09 19.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.62 -0.45 6.82 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.689 2.26 . . . . 0.0 111.74 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.93 -23.43 41.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.31 12.52 33.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.96 -146.43 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.45 145.89 24.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.661 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -146.78 143.13 28.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.363 -0.835 . . . . 0.0 109.197 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.16 -161.12 26.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.532 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 2.1 tt -116.73 136.78 52.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.7 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.447 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.0 m -123.27 127.72 48.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 99' ' ' PHE . 98.5 t -112.28 129.06 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 87.3 tttt -114.45 120.77 41.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.323 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.572 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 39.4 t80 -112.45 119.24 37.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 92.9 mt-10 -99.77 146.47 26.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 66.2 p -123.8 160.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -52.74 -43.55 65.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.17 -82.14 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 18.1 p30 -76.78 -15.38 59.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.6 138.04 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' OE1' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -134.92 111.25 11.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.561 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 50.3 Cg_endo -70.89 140.35 38.24 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.729 2.286 . . . . 0.0 111.795 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.92 156.6 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -53.37 -34.78 58.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -59.05 -45.99 89.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 68.8 mm-40 -60.32 -41.5 93.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.586 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 54.2 mt -60.88 -38.64 86.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.377 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -71.44 -37.53 71.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 58.8 m -58.72 -42.16 88.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.26 -32.03 71.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -68.99 -40.44 78.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.327 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.17 -37.02 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' O ' HD21 ' A' ' 142' ' ' LEU . 26.3 mttp -66.65 -42.95 85.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.306 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.79 -50.2 67.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.839 . . . . 0.0 109.285 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -56.37 -33.25 65.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.339 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.25 -54.46 40.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.34 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.7 mm? -76.34 -32.3 58.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -63.15 -50.79 69.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.381 -0.825 . . . . 0.0 109.259 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -62.4 -34.5 76.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.92 -44.38 82.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.484 HG12 HG22 ' A' ' 29' ' ' VAL . 26.6 mt -67.59 -46.59 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.341 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 38.3 mt-10 -64.65 -40.38 95.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.855 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.38 71.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -69.29 -43.24 74.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.887 . . . . 0.0 109.351 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' A' ' 18' ' ' LEU . 8.1 mp -70.56 -35.81 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.92 -37.28 64.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.616 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.63 -15.21 61.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -131.49 91.06 35.63 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -16.42 33.95 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.719 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -78.29 -9.63 59.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.72 142.09 15.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.538 HG12 ' CG ' ' A' ' 118' ' ' LYS . 91.5 t -112.91 144.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -1.147 . . . . 0.0 109.293 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 59.9 m-85 -79.85 126.63 31.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.719 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.3 m -123.16 116.45 23.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 90.9 m-85 -103.8 167.09 10.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -140.81 130.92 24.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -139.87 165.37 27.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.31 140.92 37.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 70.3 mt -106.62 141.54 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.559 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -142.9 128.88 19.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 14.8 m -152.77 134.63 8.64 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 -0.78 7.76 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 111.679 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.4 p -92.51 149.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.494 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' GLY . . . -61.73 133.79 93.71 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.685 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 47.0 Cg_endo -68.34 -26.84 34.84 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.759 2.306 . . . . 0.0 111.695 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.67 -39.28 57.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.442 ' CG2' ' OXT' ' A' ' 157' ' ' ASN . 15.6 m -75.52 -43.49 48.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.537 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 3.8 tp -70.81 -39.81 72.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.1 t80 -66.83 -41.69 87.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 24' ' ' THR . 30.7 tptt -66.34 -46.3 77.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.8 -24.49 59.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.203 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 16.3 tp -66.44 -49.62 66.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.19 -46.21 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.545 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -67.66 -48.35 66.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.651 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.4 m-20 -94.2 6.36 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 29' ' ' VAL . . . -45.89 -52.57 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' HA ' HD11 ' A' ' 30' ' ' ILE . 19.6 t70 -67.06 -26.27 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.747 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.3 m-20 -87.12 -27.04 23.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.125 -0.985 . . . . 0.0 109.73 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.3 p -81.94 -35.54 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.619 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.1 mt -52.58 -47.49 93.69 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.324 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.2 Cg_endo -67.07 -17.39 50.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.352 2.035 . . . . 0.0 112.057 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 19.5 mttm -107.5 -35.78 6.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.471 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.44 -41.74 88.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 109.175 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 45.7 tp -86.69 109.05 18.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -57.51 -43.45 84.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.29 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -91.23 29.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 66.1 t80 -60.73 127.18 30.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.117 -0.99 . . . . 0.0 109.502 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 58' ' ' LEU . 41.3 mtmt -96.38 -49.85 5.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 109.551 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -178.15 170.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -138.81 141.81 38.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.412 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 34.4 t30 -77.63 129.67 35.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.445 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.425 ' CG2' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -79.85 -41.3 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.526 ' HG2' ' N ' ' A' ' 45' ' ' GLY . 81.8 tt0 -167.46 157.53 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.498 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.526 ' N ' ' HG2' ' A' ' 44' ' ' GLU . . . 97.42 173.31 33.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.09 3.9 22.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -1.164 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.04 -9.13 25.15 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.62 -160.77 26.44 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.15 125.41 11.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.616 2.211 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 100.29 0.06 55.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 52' ' ' ILE . 62.6 m -75.67 152.54 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 51' ' ' THR . 27.3 mm -115.78 125.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.854 . . . . 0.0 109.186 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 87.4 mttt -118.7 143.92 46.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.897 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HE2' ' CG ' ' A' ' 65' ' ' PHE . 22.2 tttt -115.54 128.48 56.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 66.2 mt -115.03 133.37 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -112.78 124.97 53.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.555 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 53.2 p90 -134.38 161.19 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.473 ' CD2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -101.73 135.94 42.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.368 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -137.51 128.43 27.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.586 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 50.77 22.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.546 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.02 59.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -117.06 140.67 49.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -1.089 . . . . 0.0 109.52 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.6 m -81.22 111.69 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -128.03 164.65 21.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 67' ' ' LEU . 10.8 p90 -149.66 165.6 31.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.527 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 25.8 m -137.13 146.28 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 65' ' ' PHE . 4.5 mp -115.32 134.57 55.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -131.19 144.32 51.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 31.9 tttt -125.42 150.21 47.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLY . 63.1 mt -106.48 133.07 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.8 pt-20 -107.53 -29.83 8.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.788 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 22.7 t -158.96 139.79 12.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.052 -1.03 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.39 131.57 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.078 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -131.99 81.73 1.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.284 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.1 -34.78 75.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.49 81.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -89.59 12.12 17.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' C ' ' CE2' ' A' ' 19' ' ' TYR . 4.8 mt 50.03 28.96 3.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.42 149.31 17.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 20.7 p90 -150.98 169.06 22.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.133 . . . . 0.0 109.04 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.464 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 42.3 m -135.84 141.4 44.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 26.6 p90 -154.28 160.47 41.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.341 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -142.46 155.59 45.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.9 132.87 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.46 0.47 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.26 171.3 42.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.66 171.35 24.59 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.72 -17.03 31.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.21 59.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.93 106.0 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.26 148.35 61.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.706 2.271 . . . . 0.0 111.781 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.444 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 80.6 m-20 -79.36 -32.95 43.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.82 . . . . 0.0 109.561 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 p -80.27 3.77 19.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.717 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -131.21 131.94 44.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.072 -1.018 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 89.6 mt-10 -59.73 -43.64 94.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 12.3 pttp -179.11 163.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 62.0 mt -122.68 133.39 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 28.7 m -105.88 136.8 44.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.299 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.548 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.5 m-85 -116.49 122.12 43.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 20.9 t70 -118.79 102.25 8.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -116.04 138.4 51.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.784 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 54.5 tttm -131.49 141.02 49.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.119 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.0 mm? -123.67 129.13 50.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 0.0 109.608 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 1.6 m -89.06 146.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HA ' ' CG ' ' A' ' 15' ' ' PRO . . . -78.4 103.71 8.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.634 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.67 137.47 19.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.47 -16.84 34.63 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.728 2.285 . . . . 0.0 111.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.5 -2.97 50.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . 104.26 -29.93 11.1 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.38 171.42 8.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 53.0 p -126.4 137.48 53.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.07 139.56 26.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -168.78 -157.09 11.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -131.69 144.54 51.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 1.3 tt -119.13 128.19 54.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 24.6 m -116.73 129.97 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.349 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 136' ' ' LYS . 58.3 t -112.26 128.12 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.538 ' CG ' HG12 ' A' ' 2' ' ' VAL . 18.5 tttt -115.81 119.62 36.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 40.4 t80 -110.0 118.67 37.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.141 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.498 ' HA ' HG13 ' A' ' 2' ' ' VAL . 78.4 tt0 -102.14 146.32 28.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.1 p -117.78 167.15 11.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 40.7 mttt -55.41 -32.63 62.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.67 -102.15 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -59.34 -19.82 49.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.44 132.71 48.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -133.49 107.89 12.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.468 ' CD ' HG22 ' A' ' 121' ' ' THR . 49.7 Cg_endo -70.2 146.91 58.83 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.655 2.237 . . . . 0.0 111.776 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -60.3 161.23 7.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.579 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -65.83 -36.45 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.45 -42.5 98.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.21 -40.0 80.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 85.8 mt -64.86 -39.28 93.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -68.13 -46.28 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.42 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.6 m -57.82 -36.51 72.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.08 99.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 117' ' ' VAL . 21.5 tttm -64.63 -37.81 88.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.515 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.64 -28.19 53.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -63.59 -45.62 89.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.06 90.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 80.8 m-20 -53.98 -33.74 57.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.71 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.509 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 3.3 tm? -77.79 -45.15 25.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -55.01 -53.14 59.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 45.3 mttm -54.85 -37.87 66.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . -56.37 -53.51 56.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.451 HD11 ' CD1' ' A' ' 22' ' ' LEU . 29.7 mt -68.02 -42.97 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -61.32 -44.64 96.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.98 71.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 26.7 t80 -68.44 -42.5 78.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 18' ' ' LEU . 6.9 mp -67.33 -41.85 84.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.65 -35.0 79.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.419 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.74 -13.41 59.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.84 86.8 57.03 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -20.17 33.47 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 111.788 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -75.85 -15.82 60.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 66.0 t80 -59.04 141.65 53.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.442 ' OXT' ' CG2' ' A' ' 17' ' ' THR . 98.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.537 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.447 HG11 ' HG2' ' A' ' 120' ' ' GLU . 92.7 t -135.25 136.22 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -1.138 . . . . 0.0 109.354 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.18 145.03 48.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -125.2 131.74 53.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.867 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 132' ' ' LEU . 75.6 m-85 -126.71 156.18 41.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -128.01 132.62 49.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.23 165.13 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -99.56 152.06 20.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.444 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 69.0 mt -120.05 136.78 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 96.0 m-20 -139.13 134.25 32.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.5 126.44 4.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' OE2' ' A' ' 147' ' ' GLU . 49.6 Cg_endo -70.22 -5.02 15.52 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.728 2.285 . . . . 0.0 111.81 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.478 ' O ' ' OG ' ' A' ' 111' ' ' SER . 2.3 p -89.81 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 126.37 65.83 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.4 Cg_endo -68.23 -24.06 38.33 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.762 2.308 . . . . 0.0 111.834 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.46 64.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.48 ' CG2' ' C ' ' A' ' 157' ' ' ASN . 89.7 m -76.91 -36.22 56.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.567 HD21 ' CZ ' ' A' ' 143' ' ' PHE . 18.5 tp -70.24 -39.6 74.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.49 -44.22 87.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' THR . 22.4 tptm -66.15 -46.33 77.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.02 -20.59 60.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.375 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.541 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 42.3 tp -73.56 -49.1 28.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.655 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.96 -47.47 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.748 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.4 m -65.78 -46.94 76.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' VAL . 7.6 m-20 -98.51 9.35 43.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.822 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.31 -53.23 11.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.414 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HA ' HD11 ' A' ' 30' ' ' ILE . 54.5 t0 -68.41 -24.78 64.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.717 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.9 m120 -87.23 -26.78 23.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.59 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 30' ' ' ILE . 9.0 p -82.66 -36.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.66 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.5 mt -51.29 -47.99 86.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.3 Cg_endo -68.43 -21.63 40.3 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.352 2.035 . . . . 0.0 111.923 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 40.6 mttm -96.27 -35.15 11.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.293 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.38 -39.47 74.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 37' ' ' PHE . 15.9 tp -88.73 106.66 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.32 -29.8 66.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -104.54 27.93 7.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 109.95 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 39' ' ' SER . 20.2 t80 -56.74 127.84 33.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.153 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -92.31 -52.37 4.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -178.28 171.3 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 0.0 109.838 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' CD1' ' A' ' 55' ' ' ILE . 5.9 p -142.62 140.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 109.227 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 85.2 mt-10 -151.33 143.74 24.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 70.0 m-20 -84.09 127.38 33.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -83.82 -29.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 94.9 mt-10 -156.72 142.43 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 104.33 162.59 24.49 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -102.9 3.29 36.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 109.53 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.42 -14.9 13.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.7 -161.11 6.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.75 148.42 58.61 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.653 2.235 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 9.39 84.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.477 HG21 ' N ' ' A' ' 52' ' ' ILE . 25.0 m -79.98 157.24 26.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 109.545 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 15.6 mm -116.94 124.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.5 mttm -116.78 143.02 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HE2' ' CG ' ' A' ' 65' ' ' PHE . 20.3 tttm -117.42 129.29 55.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.316 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.553 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 11.9 mm -115.12 144.52 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 m -126.22 126.03 43.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.592 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CB ' HD23 ' A' ' 34' ' ' LEU . 30.8 p90 -129.78 175.22 9.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 4.3 mm? -110.04 147.42 33.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 109.543 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -156.58 123.03 5.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 54.34 33.01 17.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.06 4.72 63.68 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -102.37 138.17 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.389 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.5 m -86.38 119.99 27.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -125.44 167.92 14.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.599 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.3 p90 -147.71 161.73 40.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 28.7 m -134.64 143.78 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.321 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.599 HD13 ' CE1' ' A' ' 65' ' ' PHE . 5.4 mp -112.57 131.57 55.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -126.27 139.66 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.525 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 tttt -118.03 146.72 43.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -108.72 130.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.9 mt-10 -88.94 -33.33 17.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.4 m -177.49 157.65 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.16 132.99 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -129.48 78.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.2 mt-10 -64.84 -30.08 71.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -48.98 79.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.377 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 54.5 m-20 -89.86 14.25 12.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 16.2 mt 47.18 52.58 11.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.486 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -153.75 156.56 26.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.4 p90 -150.9 169.85 20.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.0 109.018 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 70.1 m -130.11 139.33 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.89 158.42 40.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 94.8 p -146.35 156.48 43.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.491 ' CG1' HD23 ' A' ' 90' ' ' LEU . 93.0 t -86.11 132.87 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.954 . . . . 0.0 109.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 4.8 t -109.48 -2.73 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.8 42.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.9 175.56 24.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.06 65.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -1.182 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.13 -11.92 59.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.491 HD23 ' CG1' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -99.68 108.73 52.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.343 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.8 Cg_endo -69.88 152.91 68.86 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.69 2.26 . . . . 0.0 111.935 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 83.7 m-20 -79.43 -30.12 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.421 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 15.8 p -79.99 7.1 9.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.566 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -132.15 131.29 42.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.489 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 91.9 mt-10 -61.08 -44.05 97.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 3.8 pttm 179.74 159.21 0.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.942 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' SER . 70.3 mt -118.38 135.7 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.676 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.9 m -107.41 138.76 43.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 76.6 m-85 -119.76 120.25 35.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.25 113.95 23.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.093 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.512 ' OG ' ' CD1' ' A' ' 115' ' ' LEU . 2.6 m -128.13 136.38 51.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 47.6 tttt -132.78 124.5 28.19 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 53.2 mt -108.57 132.9 53.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.062 -1.023 . . . . 0.0 110.266 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.8 143.05 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.06 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.34 141.17 51.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.47 166.03 22.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.4 -4.94 15.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.622 2.215 . . . . 0.0 111.792 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.98 -27.36 66.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.82 23.42 11.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.43 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -149.96 -131.1 1.87 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.518 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 68.9 m -118.73 143.98 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.3 166.06 25.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.274 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 164.86 -177.6 40.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 28.2 ttpt -123.24 143.25 50.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -1.089 . . . . 0.0 109.396 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.512 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 30.2 tp -116.5 135.3 53.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -124.25 125.93 45.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.94 132.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.6 tttt -116.43 116.04 26.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.474 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 33.3 t80 -105.9 122.09 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' HG2' HG11 ' A' ' 2' ' ' VAL . 90.9 mt-10 -105.63 141.44 37.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' GLY . 16.6 p -118.29 164.61 14.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -0.978 . . . . 0.0 109.552 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 92.7 mttt -56.99 -40.06 75.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.45 -92.22 0.11 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -37.2 83.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -1.175 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.43 135.58 39.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.29 109.83 15.09 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 51.3 Cg_endo -70.24 124.29 10.75 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.675 2.25 . . . . 0.0 111.875 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.471 ' O ' HD22 ' A' ' 132' ' ' LEU . 1.7 m-20 -60.04 161.05 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.42 -36.15 80.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -56.03 -31.43 63.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.03 -34.95 61.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.271 -0.893 . . . . 0.0 108.729 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.61 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -61.53 -39.29 90.51 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -60.22 -48.31 82.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.5 m -57.22 -36.75 71.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.3 99.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -60.37 -37.1 79.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -1.091 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.448 ' O ' ' HB1' ' A' ' 141' ' ' ALA . . . -55.72 -30.43 61.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.252 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -66.0 -44.86 83.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.21 -55.41 10.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.9 -34.92 63.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 137' ' ' ALA . . . -57.49 -38.97 75.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.276 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 146' ' ' ILE . 29.8 mt -74.94 -44.0 50.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.567 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 73.9 t80 -61.62 -55.78 26.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.166 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -49.49 -46.73 48.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.303 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.94 77.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.153 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.3 mt -67.11 -44.11 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.251 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 12' ' ' PRO . 80.0 tt0 -60.46 -44.91 95.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . -60.52 -31.11 70.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 21.6 t80 -66.79 -38.88 87.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.85 . . . . 0.0 109.303 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 18' ' ' LEU . 7.5 mp -72.86 -40.85 65.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.18 -37.78 78.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 148' ' ' ALA . . . -74.51 -15.84 60.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -126.7 90.25 50.17 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.1 -18.91 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.61 2.207 . . . . 0.0 111.793 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -74.12 -12.68 60.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 63.8 t80 -80.01 125.48 29.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.48 ' C ' ' CG2' ' A' ' 17' ' ' THR . 8.5 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.412 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' HE2' ' A' ' 118' ' ' LYS . 89.4 t -141.44 137.93 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.61 149.53 42.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.7 m -129.81 128.84 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 0.0 109.428 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.81 163.34 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -135.59 133.81 38.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.411 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.29 166.09 25.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.15 151.17 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 9' ' ' ILE . 65.1 mt -114.36 128.22 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -128.95 127.61 42.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -153.43 132.92 7.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -19.0 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.677 2.251 . . . . 0.0 111.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 18' ' ' LEU . 2.2 p -70.39 153.1 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.545 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 139.77 97.73 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.22 -26.78 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.81 2.34 . . . . 0.0 111.91 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.52 -39.24 53.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -79.76 -41.85 25.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.77 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 13' ' ' VAL . 3.9 tp -67.15 -38.5 85.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.401 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 79.0 t80 -70.63 -36.4 73.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' THR . 43.9 tptt -67.17 -47.21 71.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 109.781 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' CA ' ' HB2' ' A' ' 25' ' ' ASP . . . -72.27 -40.13 67.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 146' ' ' ILE . 64.5 tp -53.33 -45.66 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -97.3 -53.63 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.974 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.531 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.1 m -66.38 -50.09 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -92.44 19.66 6.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -60.46 -51.61 68.71 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.155 -0.966 . . . . 0.0 109.143 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.6 m-20 -66.69 -31.24 71.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.648 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 75.2 m-20 -83.23 -29.57 28.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' ASP . 77.4 t -78.64 -34.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 12.0 mt -51.33 -51.71 66.17 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.929 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.9 Cg_endo -68.39 -34.87 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.552 2.168 . . . . 0.0 111.888 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.561 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 50.9 mttm -79.95 -40.75 27.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.089 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 145' ' ' ALA . . . -65.88 -38.08 87.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.874 . . . . 0.0 108.909 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 41.0 tp -87.16 106.0 17.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 108.968 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.11 -28.18 67.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -105.38 27.49 8.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.966 -1.084 . . . . 0.0 109.879 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 44.6 t80 -53.24 125.43 17.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -90.9 -56.22 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.806 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.57 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 28.8 p -174.27 166.56 4.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.681 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' C ' ' HG3' ' A' ' 41' ' ' GLU . 2.9 p -144.79 143.48 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.9 mt-10 -147.17 152.1 37.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.559 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -79.55 131.08 35.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 13.8 t -83.65 -44.38 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.315 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 80.8 mt-10 -159.38 146.87 17.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 95.59 -175.68 33.11 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -110.73 6.17 21.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 109.74 -3.7 30.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.63 -156.35 13.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.24 138.76 37.03 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.741 2.294 . . . . 0.0 111.811 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.46 -4.04 75.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.472 HG23 ' HA3' ' A' ' 45' ' ' GLY . 26.1 m -69.18 155.01 41.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 109.566 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' N ' HG21 ' A' ' 51' ' ' THR . 20.4 mm -119.33 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.19 147.35 46.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.846 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 22.4 tttt -116.89 127.35 54.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.22 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 66' ' ' VAL . 63.7 mt -115.25 145.35 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -0.999 . . . . 0.0 109.848 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.438 ' N ' HG21 ' A' ' 55' ' ' ILE . 24.0 m -128.1 123.0 33.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.201 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 64' ' ' LYS . 23.8 p90 -125.53 174.27 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.637 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.63 138.25 49.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' OE1' ' HE3' ' A' ' 64' ' ' LYS . 75.8 tt0 -148.49 127.76 12.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 53.12 34.62 17.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.77 66.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -107.3 134.14 50.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 m -82.73 116.16 21.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 23.0 mttm -116.74 164.21 14.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.532 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 18.5 p90 -145.87 157.75 43.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.522 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.7 p -141.2 149.68 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.898 . . . . 0.0 109.618 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.534 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 48.2 mt -112.6 130.98 55.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.241 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -122.55 136.88 55.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 42.3 tttm -119.08 145.18 46.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.5 mt -105.87 127.05 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 93.6 mt-10 -82.46 -53.45 5.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -162.73 137.59 6.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.78 133.73 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.91 . . . . 0.0 109.338 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -129.18 76.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.559 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 86.8 mt-10 -54.61 -37.61 65.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.19 57.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 78' ' ' LEU . 64.6 m-20 -90.67 17.0 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.377 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 11.6 mt 43.57 46.24 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.576 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.49 158.9 27.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.5 p90 -152.02 170.04 20.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -1.217 . . . . 0.0 109.131 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 4.7 m -126.3 138.84 53.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -156.06 160.67 40.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.458 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 54.8 p -150.41 158.22 43.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.483 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 89' ' ' ALA . 14.5 p -97.41 135.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 109.086 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' HD22 ' A' ' 90' ' ' LEU . 1.1 m -130.16 3.87 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -156.19 146.26 13.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.01 -174.29 16.79 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.17 62.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -80.85 1.49 30.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -112.9 83.52 6.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.328 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -68.9 163.43 37.48 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.897 2.398 . . . . 0.0 111.998 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 70.1 m-20 -80.12 -32.71 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.912 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 33.9 p -79.55 -11.99 59.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 110.026 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.585 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -119.95 127.75 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -62.51 -50.79 70.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -177.33 156.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.41 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 70.3 mt -113.42 137.55 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 1.4 m -107.42 138.2 44.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.848 . . . . 0.0 109.135 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.2 m-85 -118.56 120.58 37.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.881 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -117.2 106.39 13.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -115.59 136.13 53.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.773 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 20.3 tttt -132.96 131.26 40.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.833 . . . . 0.0 109.123 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 1.7 mm? -118.18 127.44 53.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.364 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 105' ' ' ALA . 2.0 m -120.48 172.58 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -80.25 127.14 32.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.206 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.99 155.54 17.93 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 -1.95 8.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.578 2.185 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -74.11 -15.55 61.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 7.15 63.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.56 -138.08 4.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' A' ' 103' ' ' LEU . 2.7 t -122.25 140.65 52.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -1.113 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.42 147.81 31.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.207 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -174.08 -143.63 4.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.05 138.95 32.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.353 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' A' ' 116' ' ' THR . 3.9 tt -115.31 136.4 53.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.497 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 14.5 m -125.5 126.89 45.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.35 136.16 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.331 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' HE2' ' CG1' ' A' ' 2' ' ' VAL . 26.6 tttt -116.07 121.02 40.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.574 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 30.3 t80 -103.58 126.56 50.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 2' ' ' VAL . 82.9 mt-10 -109.73 130.94 55.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' GLY . 19.5 p -107.4 156.73 18.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 73.5 mmtt -60.13 -37.0 78.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.82 -103.84 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.35 -35.52 72.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -1.187 . . . . 0.0 109.468 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.9 136.98 33.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -149.34 107.66 3.36 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.2 Cg_endo -70.04 151.55 67.52 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.734 2.289 . . . . 0.0 111.699 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -83.22 178.73 7.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 92.9 mt-30 -67.89 -35.35 78.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.59 -48.53 80.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -61.14 -39.14 88.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.38 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.64 -35.79 81.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 26.2 mttt -64.22 -48.53 75.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.8 m -56.22 -33.24 65.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.343 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.22 -43.13 99.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HG2' ' OD1' ' A' ' 140' ' ' ASP . 23.9 tttp -67.14 -39.58 86.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -1.149 . . . . 0.0 109.497 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -31.22 64.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.29 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -77.3 -40.7 43.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.05 -26.41 53.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.825 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.422 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 96.9 m-20 -60.78 -41.64 95.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -44.95 82.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 23.0 mt -54.71 -46.19 74.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -61.61 -50.26 73.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 148' ' ' ALA . 88.6 mttt -63.22 -33.56 75.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . . . -56.7 -52.46 64.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.471 HG12 HG13 ' A' ' 29' ' ' VAL . 11.7 mt -68.47 -51.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.479 ' HG3' HG12 ' A' ' 13' ' ' VAL . 81.4 tt0 -59.21 -45.22 91.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.697 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 144' ' ' LYS . . . -59.63 -31.39 69.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.519 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.566 ' CZ ' ' CE1' ' A' ' 153' ' ' HIS . 34.4 t80 -69.3 -41.14 77.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 7.8 mp -66.43 -46.3 76.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.636 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.39 -33.79 74.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.96 -11.9 57.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.566 ' CE1' ' CZ ' ' A' ' 149' ' ' TYR . 74.4 m80 -122.06 90.16 48.72 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.26 -21.57 30.95 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.673 2.249 . . . . 0.0 111.767 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -70.87 -17.88 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.436 ' CD2' ' CG2' ' A' ' 17' ' ' THR . 42.3 t80 -67.31 158.8 30.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 17' ' ' THR . 74.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -130.37 149.4 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 0.0 109.472 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 97.6 m-85 -81.51 126.87 32.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 117.88 27.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.309 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.566 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 97.8 m-85 -110.25 164.23 12.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.624 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 88.2 mt-10 -134.05 134.24 42.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -137.09 165.0 27.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -104.13 158.59 16.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 42.3 mt -129.14 137.37 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.71 137.0 34.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.9 OUTLIER -152.58 138.68 11.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.09 0.74 6.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.665 2.243 . . . . 0.0 111.96 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 14' ' ' ALA . 69.4 t -98.17 155.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.559 ' O ' ' CD1' ' A' ' 18' ' ' LEU . . . -64.21 127.64 92.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.511 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' N ' ' OG ' ' A' ' 111' ' ' SER . 44.4 Cg_endo -66.84 -25.51 45.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.801 2.334 . . . . 0.0 111.904 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.928 . . . . 0.0 109.036 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 157' ' ' ASN . 76.5 m -72.7 -38.86 67.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.182 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 14' ' ' ALA . 2.4 mp -70.29 -38.63 75.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 72.5 t80 -63.92 -50.27 69.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 24' ' ' THR . 12.2 tptt -65.05 -46.38 81.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.749 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -71.63 -28.33 63.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 44.4 tp -67.01 -47.36 71.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.857 . . . . 0.0 109.67 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -97.96 -51.7 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.492 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 2.1 m -62.62 -45.64 91.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.7 m-20 -98.44 6.14 47.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.08 -1.012 . . . . 0.0 109.767 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -45.96 -53.27 10.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.6 m-20 -67.54 -23.3 65.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.772 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.432 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 90.9 m-20 -89.84 -25.79 20.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG11 ' N ' ' A' ' 30' ' ' ILE . 7.9 p -83.39 -35.98 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 109.545 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.676 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.3 mt -55.36 -47.07 99.44 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 110.211 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.6 Cg_endo -68.08 -35.97 18.46 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.307 2.004 . . . . 0.0 112.193 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 32.3 mttm -87.91 -29.28 20.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.421 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -69.42 -34.77 74.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.257 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 54.5 tp -96.18 113.31 24.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.32 -40.92 92.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.663 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -93.71 26.8 2.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.811 -1.181 . . . . 0.0 110.117 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 57.2 t80 -59.91 134.11 56.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.124 -0.985 . . . . 0.0 109.409 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 39' ' ' SER . 33.6 tttm -95.28 -49.12 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.312 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 68.9 p -178.59 172.13 1.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 40' ' ' VAL . 6.0 p -135.91 129.97 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.274 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -135.53 145.47 47.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 109.613 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.97 128.08 34.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 13.9 t -85.17 -41.0 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.673 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 96.5 mt-10 -158.58 145.44 17.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.601 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 159.04 30.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -94.59 5.36 52.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.93 -9.28 23.28 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.03 -158.66 13.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HA ' HG21 ' A' ' 70' ' ' ILE . 49.5 Cg_endo -70.05 131.16 20.26 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.644 2.23 . . . . 0.0 111.687 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 93.23 0.44 67.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.521 HG23 ' N ' ' A' ' 52' ' ' ILE . 90.3 m -76.01 154.78 35.5 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.307 -1.114 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 51' ' ' THR . 71.2 mt -129.89 138.32 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -126.67 152.39 46.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.6 tttm -112.87 125.74 54.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.425 -0.797 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 83.9 mt -113.88 142.95 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.2 m -131.36 119.54 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.56 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 39.0 p90 -124.5 171.55 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.348 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 145.85 31.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 62' ' ' GLU . 84.9 tt0 -141.84 123.74 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 49.66 27.73 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.66 71.38 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' GLU . 99.6 mt-10 -106.47 157.58 17.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -1.085 . . . . 0.0 109.421 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.456 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.2 m -104.94 112.55 25.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.413 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' HG21 ' A' ' 56' ' ' THR . 56.0 mttm -120.35 162.95 18.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -145.66 158.96 43.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 22.4 m -138.31 147.05 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.546 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 12.8 mt -116.63 137.82 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.065 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.72 141.82 50.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.752 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HG3' HG12 ' A' ' 52' ' ' ILE . 19.4 tttm -117.77 146.41 43.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.87 . . . . 0.0 109.121 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.0 mt -104.75 126.57 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -88.18 -40.19 13.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 t -173.74 150.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.58 132.67 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -127.03 85.51 2.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' OH ' ' A' ' 19' ' ' TYR . 97.0 mt-10 -64.24 -31.69 72.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.85 84.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -89.3 14.86 10.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.539 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 19.4 mt 47.52 51.86 13.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.27 27.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 28.7 p90 -150.96 168.4 24.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 108.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -126.67 138.64 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 19.4 p90 -152.49 155.82 38.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.382 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 97' ' ' ILE . 12.9 t -144.85 156.06 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 84' ' ' VAL . 10.0 p -98.52 128.35 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 ' HE3' ' A' ' 96' ' ' LYS . 1.5 t -127.49 4.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.729 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.546 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -158.46 148.48 17.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 128.0 152.29 7.8 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.38 47.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.275 -1.132 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' HB2' ' NZ ' ' A' ' 138' ' ' LYS . . . -79.89 -7.92 59.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.81 116.28 59.89 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.553 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 47.3 Cg_endo -68.48 146.6 68.7 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.767 2.311 . . . . 0.0 111.911 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 66.2 m-20 -78.84 -29.57 44.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.632 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.454 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 29.4 p -79.82 -7.49 58.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 119' ' ' TYR . . . -118.27 123.57 45.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.339 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 86.3 mt-10 -62.28 -52.18 64.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.703 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.4 mtpm? -159.1 161.65 36.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 109.721 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.473 HG23 ' CE2' ' A' ' 99' ' ' PHE . 62.8 mt -125.4 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CE ' ' A' ' 118' ' ' LYS . 8.9 m -109.83 137.58 47.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.8 m-85 -120.23 121.29 38.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 58.5 t0 -117.02 110.51 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.204 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -123.25 136.64 54.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.538 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 75.8 tttt -130.72 127.43 38.78 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.6 mm? -107.62 130.19 54.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.057 -1.027 . . . . 0.0 110.152 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -138.03 143.02 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.03 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 139.52 57.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.104 -0.998 . . . . 0.0 109.718 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.43 22.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.78 -9.71 26.76 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.774 2.316 . . . . 0.0 111.825 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.49 -31.95 68.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.84 27.93 6.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -157.94 -125.16 0.82 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 13' ' ' VAL . 73.9 m -118.54 144.91 45.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 9' ' ' ILE . . . -143.58 162.49 35.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.763 . . . . 0.0 108.991 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 171.63 176.15 40.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -112.08 141.22 46.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.439 -1.036 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 29.0 tp -116.33 131.62 56.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.519 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' PHE . 26.0 m -130.0 122.11 27.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -0.926 . . . . 0.0 109.144 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.67 135.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.557 ' CG ' HG22 ' A' ' 2' ' ' VAL . 7.0 ttpt -115.0 116.71 28.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.15 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 36.6 t80 -107.73 120.92 43.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.672 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.441 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 98.2 mt-10 -106.32 133.52 50.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.518 ' CG2' ' HD3' ' A' ' 127' ' ' PRO . 17.4 p -109.92 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.4 mttt -54.85 -42.31 71.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.56 -92.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ALA . 82.1 m-20 -69.2 -35.8 76.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -45.03 133.79 6.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -126.24 121.13 23.78 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.563 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 49.3 Cg_endo -69.96 149.85 66.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.717 2.278 . . . . 0.0 111.743 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.7 m-20 -92.16 155.31 18.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -50.42 -38.33 42.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.24 -48.54 81.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.33 -42.08 90.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 5' ' ' PHE . 74.3 mt -60.15 -34.52 73.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.46 -46.47 82.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.259 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.5 m -57.4 -36.97 71.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.13 -47.36 91.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 140' ' ' ASP . 11.0 mtmm -57.09 -36.6 70.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -1.146 . . . . 0.0 109.391 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 140' ' ' ASP . . . -58.23 -33.49 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 89' ' ' ALA . 69.5 tttt -74.34 -43.14 57.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -69.76 -49.06 56.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 7.5 p30 -68.43 -22.56 64.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -56.86 -48.69 77.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 146' ' ' ILE . 12.7 tp -56.39 -35.52 67.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -74.33 -53.23 10.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 109.14 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -52.73 -37.92 59.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 -49.56 56.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 29' ' ' VAL . 51.7 mt -63.07 -55.33 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 150' ' ' LEU . 80.3 tt0 -45.55 -50.31 13.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.18 -37.82 72.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 41.1 t80 -68.44 -38.13 80.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.547 ' CD1' ' HG ' ' A' ' 18' ' ' LEU . 45.8 mt -59.16 -38.31 79.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mt -75.04 -27.68 60.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.61 61.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -128.5 91.88 42.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.27 -18.06 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.737 2.291 . . . . 0.0 111.747 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -77.26 -17.69 58.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.528 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 76.8 t80 -67.77 120.09 13.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.498 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.2 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' O ' ' CG2' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 60.0 t -128.84 138.85 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -1.174 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -132.07 122.54 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.624 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 79.2 m -110.67 144.24 39.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' N ' HG22 ' A' ' 4' ' ' THR . 89.4 m-85 -132.7 132.62 42.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.0 mt-10 -106.14 133.74 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -137.15 164.98 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.385 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.87 157.61 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.4 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 9' ' ' ILE . 14.6 mt -125.65 134.42 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 109.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 97.9 m-20 -140.68 132.87 28.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 147' ' ' GLU . 27.3 m -152.78 138.63 11.81 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.52 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.26 -0.45 7.34 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.602 2.201 . . . . 0.0 111.714 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 HG13 ' CD2' ' A' ' 18' ' ' LEU . 98.1 t -94.73 153.49 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' N ' HG12 ' A' ' 13' ' ' VAL . . . -63.6 139.31 97.59 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 46.7 Cg_endo -68.01 -25.77 37.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.734 2.289 . . . . 0.0 111.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.36 -37.6 60.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 150' ' ' LEU . 60.3 m -75.01 -39.39 61.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 150' ' ' LEU . 20.0 mt -68.69 -39.11 80.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 78.0 t80 -64.54 -50.03 68.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.585 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.5 tptm -63.4 -46.43 86.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -73.18 -24.51 60.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 18.4 tp -75.37 -48.83 21.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.686 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.75 -49.89 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -65.82 -48.83 70.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.957 . . . . 0.0 110.145 -179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 29' ' ' VAL . 6.3 t70 -91.01 14.67 13.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.723 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -56.09 -52.16 65.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.263 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 22.1 t70 -66.1 -25.89 67.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.946 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.0 m120 -90.92 -26.06 19.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.601 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.0 p -83.87 -39.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 109.575 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.7 mt -52.88 -45.46 97.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.63 -21.84 45.04 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.394 2.063 . . . . 0.0 112.242 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' ALA . 41.8 mttm -108.98 -51.77 2.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 109.585 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -42.28 -33.19 0.59 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 44.8 tp -92.52 112.62 24.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.067 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.4 -47.16 82.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.526 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.9 m -88.38 29.36 0.98 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.915 -1.116 . . . . 0.0 110.173 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 67.2 t80 -61.89 130.54 46.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.505 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' A' ' 58' ' ' LEU . 3.6 mtpm? -102.42 -48.58 4.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.639 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 37' ' ' PHE . 54.8 p -172.51 164.89 5.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 41' ' ' GLU . 3.9 p -143.3 141.81 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 109.326 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' N ' HG21 ' A' ' 40' ' ' VAL . 82.4 mt-10 -144.08 148.36 35.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.61 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -80.64 132.07 35.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 19.0 t -79.99 -42.12 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 71.2 mt-10 -161.74 149.33 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.72 -168.85 36.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -132.12 35.08 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -1.92 76.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' O ' ' OG1' ' A' ' 51' ' ' THR . . . -76.73 -168.31 28.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.74 139.88 41.4 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.691 2.261 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 77.14 2.96 80.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 52' ' ' ILE . 85.9 m -69.23 150.44 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.58 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.509 ' N ' HG21 ' A' ' 51' ' ' THR . 25.1 mm -114.62 123.44 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -118.06 143.83 46.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.856 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 86.8 tttt -116.35 128.25 55.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 109.081 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 58.7 mt -114.28 140.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.1 m -119.42 120.74 37.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.216 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 40.5 p90 -131.5 176.02 8.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.405 ' CD2' ' HD2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -116.98 131.2 57.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -137.12 130.96 31.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 55.14 20.83 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.92 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.32 20.55 64.28 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -118.28 141.61 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.6 m -80.9 111.79 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 70.7 mttt -121.89 163.06 19.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 36.0 p90 -144.27 158.11 43.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.385 -0.822 . . . . 0.0 109.226 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 34.1 m -133.55 142.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 109.705 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 10.7 mt -111.23 130.55 55.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 109.003 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -126.23 139.83 53.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.146 -0.971 . . . . 0.0 109.71 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -122.52 150.81 42.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.238 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.7 mt -111.46 133.05 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 94.0 mt-10 -89.42 -33.57 16.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.243 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -172.82 155.39 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.54 131.86 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.327 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.56 81.51 2.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 78.3 mt-10 -59.18 -36.84 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.29 -41.31 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.634 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 6.4 m-20 -101.1 14.01 33.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.546 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.75 25.98 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.318 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.24 150.73 17.79 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.89 169.16 22.95 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -1.208 . . . . 0.0 109.166 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -130.96 139.01 49.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.98 . . . . 0.0 109.375 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 14.1 p90 -151.87 154.79 36.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 79.9 p -144.41 155.8 43.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.355 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.8 131.16 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.244 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -124.14 2.04 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.605 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -163.77 153.38 23.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 117.07 172.13 16.03 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.21 -13.05 62.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -1.099 . . . . 0.0 109.46 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.04 59.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 4.8 tt -100.2 107.22 46.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 47.9 Cg_endo -69.43 149.86 69.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.68 2.253 . . . . 0.0 111.912 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 83.6 m-20 -76.76 -28.71 55.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -79.86 6.6 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.7 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -133.7 142.52 48.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.596 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 122' ' ' LYS . 77.4 mt-10 -69.14 -54.6 14.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 16.1 pttm -175.64 159.71 2.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.347 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 83' ' ' SER . 55.4 mt -118.18 136.2 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.509 ' CG2' ' OE2' ' A' ' 71' ' ' GLU . 7.9 m -112.12 117.85 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.126 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 89.0 m-85 -96.28 125.41 40.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.826 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 116' ' ' THR . 89.9 m-20 -117.74 129.3 55.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 109.206 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.8 t -146.63 136.81 23.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 103' ' ' LEU . 28.3 tttt -117.2 159.1 23.17 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 33.6 mt -133.42 123.77 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.877 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.66 142.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.24 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.35 57.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.46 166.93 23.25 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.5 -0.05 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.646 2.231 . . . . 0.0 111.821 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -69.37 -28.34 66.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.11 26.78 8.14 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -156.14 -127.16 1.01 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 99.5 p -121.77 142.8 49.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -1.134 . . . . 0.0 109.746 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.57 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 162.95 168.64 25.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -105.29 147.66 27.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.137 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 49.6 tp -115.01 136.56 52.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 100' ' ' ASP . 24.6 m -138.78 119.31 13.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.043 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.652 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 2.7 p -112.33 138.68 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 110.142 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 31.9 tttt -114.29 120.08 39.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 37.4 t80 -102.72 126.82 49.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 96' ' ' LYS . 82.0 mt-10 -111.41 126.65 55.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.353 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 1' ' ' GLY . 34.2 p -99.91 165.91 11.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 20.4 mmtp -71.01 -36.34 72.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.19 -100.0 0.16 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -65.08 -28.57 69.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.92 137.07 58.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -147.18 112.51 4.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.44 141.33 42.2 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.715 2.277 . . . . 0.0 111.7 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -69.78 168.65 14.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.89 . . . . 0.0 109.55 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.34 -39.64 87.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.882 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.85 -43.86 97.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.27 -39.34 82.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.457 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 25.0 mt -64.65 -36.82 85.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.63 -49.5 76.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 85.5 m -57.45 -32.45 66.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.89 -47.98 86.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . 27.9 ttpp -65.27 -38.32 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -1.133 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 140' ' ' ASP . . . -54.41 -28.4 43.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -76.21 -38.18 56.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.453 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.13 -55.08 8.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 3.9 p30 -63.43 -25.05 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -61.22 -53.44 56.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 109.319 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.445 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 19.0 mt -59.53 -35.21 73.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.15 -52.69 62.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -53.12 -38.42 62.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 142' ' ' LEU . . . -58.39 -39.63 80.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.361 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 29' ' ' VAL . 16.9 mm -62.73 -43.62 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.391 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.464 ' OE2' ' OG ' ' A' ' 11' ' ' SER . 90.6 mt-10 -64.28 -37.27 86.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . -60.52 -37.53 81.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -70.53 -52.5 21.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 18' ' ' LEU . 9.3 mp -63.77 -36.52 84.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.7 tp -76.1 -36.44 58.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 148' ' ' ALA . . . -72.21 -20.43 61.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -134.38 98.58 13.76 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -11.42 30.22 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 111.788 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.72 -26.66 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.45 ' CE2' ' HB1' ' A' ' 21' ' ' ALA . 62.5 t80 -64.43 138.79 58.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.428 ' O ' ' CE2' ' A' ' 156' ' ' TYR . 2.3 p-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -134.83 148.49 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -1.061 . . . . 0.0 109.31 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.547 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 88.4 m-85 -80.83 120.57 24.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 19.8 m -109.94 117.09 32.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 132' ' ' LEU . 97.0 m-85 -114.61 142.11 46.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 81.4 tt0 -109.3 133.34 53.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.265 -0.897 . . . . 0.0 109.63 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -130.01 164.41 24.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.58 153.59 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 54.1 mt -119.23 144.2 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 22.7 m120 -142.45 128.88 20.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.434 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -152.64 138.23 11.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.503 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.39 -12.82 32.36 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.702 2.268 . . . . 0.0 111.785 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 150' ' ' LEU . 1.6 p -81.49 152.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 141.69 95.88 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.92 -28.51 35.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.735 2.29 . . . . 0.0 111.747 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.96 -41.39 59.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.3 m -76.21 -37.43 57.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.347 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 150' ' ' LEU . 11.9 tp -69.15 -39.93 78.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 79.5 t80 -64.89 -44.81 88.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 24' ' ' THR . 12.8 tptm -65.18 -46.72 79.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.733 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -73.1 -17.77 61.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 19.5 tp -79.18 -48.25 14.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.91 -52.22 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 4.3 m -63.39 -49.37 74.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.943 . . . . 0.0 110.208 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m-20 -95.34 8.08 44.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.61 -53.22 11.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 109.292 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HA ' HD12 ' A' ' 30' ' ' ILE . 56.7 t0 -65.07 -24.89 67.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 95.3 m-20 -87.16 -26.81 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' A' ' 25' ' ' ASP . 98.2 t -82.66 -35.53 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 mt -50.98 -47.84 86.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 110.327 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.8 Cg_endo -67.53 -28.08 38.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.44 2.093 . . . . 0.0 112.183 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -90.73 -45.41 8.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.4 mp -76.04 102.22 5.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -54.89 -46.25 74.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.871 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 88.4 p -91.51 30.1 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -57.23 122.56 12.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.07 -53.56 4.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.675 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 34.9 p -174.9 167.89 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.752 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 39' ' ' SER . 99.6 t -143.92 143.91 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.148 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 73.8 mt-10 -155.0 158.4 39.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 73.2 m-20 -96.65 124.9 40.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 6.8 m -82.01 -27.9 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 56.9 mm-40 -161.33 151.26 17.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.87 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA3' HG22 ' A' ' 51' ' ' THR . . . 105.09 168.61 24.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -121.68 27.43 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -1.197 . . . . 0.0 109.62 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.97 -19.05 56.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' O ' ' OG1' ' A' ' 51' ' ' THR . . . -76.38 -169.18 28.72 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.95 140.97 43.26 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 111.71 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 88.64 5.64 74.44 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 52' ' ' ILE . 59.6 m -75.12 150.78 38.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -1.153 . . . . 0.0 109.759 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 51' ' ' THR . 17.2 mm -112.5 123.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 108.994 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.4 mttm -119.76 144.67 47.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.853 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 2.2 ttmt -120.41 133.78 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.133 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 74.8 mt -123.91 143.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 36.0 m -124.63 122.26 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 43.1 p90 -127.24 165.84 18.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 1.2 mp -100.23 143.29 30.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.4 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -156.19 131.81 9.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 56.41 28.39 13.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.69 0.49 63.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 49.2 tp10 -107.24 138.95 42.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -1.186 . . . . 0.0 109.537 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.4 m -86.03 124.94 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 34.0 mttp -128.63 172.47 11.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 6.5 p90 -147.31 161.32 41.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.516 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.408 ' C ' HD11 ' A' ' 67' ' ' LEU . 32.6 m -135.53 145.05 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.43 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 4.4 mp -114.49 133.02 56.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.923 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -132.04 145.32 51.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 16.1 tttm -124.5 146.55 48.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 7.0 mm -101.58 131.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.3 pt-20 -103.5 -32.68 9.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.995 . . . . 0.0 109.828 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 35.9 t -165.78 138.43 4.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.909 -1.119 . . . . 0.0 109.955 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.35 136.25 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 91.4 m-20 -130.69 83.18 2.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.43 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.4 mt-10 -63.67 -34.58 78.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.05 67.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.286 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -87.26 12.59 11.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.485 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 8.7 mt 48.02 37.25 7.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.474 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -132.64 151.96 20.13 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -151.63 166.44 31.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.065 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.543 ' HB3' ' CG ' ' A' ' 71' ' ' GLU . 29.0 t -137.37 143.17 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.2 p90 -153.05 160.62 42.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.339 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 97' ' ' ILE . 15.2 t -139.12 153.8 48.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 67' ' ' LEU . 14.4 p -85.1 133.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 69' ' ' LYS . 10.0 t -109.97 -4.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.49 43.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.05 164.27 15.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.59 -14.25 12.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -1.126 . . . . 0.0 109.452 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.89 -12.08 58.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.64 115.34 60.23 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.978 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.08 147.56 61.11 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.677 2.252 . . . . 0.0 111.829 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.508 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 90.6 m-20 -79.57 -31.93 41.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.615 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 p -83.79 3.74 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.715 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -132.43 143.23 49.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 109.624 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' OE2' ' HG2' ' A' ' 122' ' ' LYS . 62.6 mm-40 -69.27 -51.57 36.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.421 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -171.28 163.09 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.548 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' O ' ' OG ' ' A' ' 83' ' ' SER . 69.4 mt -120.56 137.21 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -108.21 126.8 53.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.2 m-85 -108.3 125.81 52.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 115' ' ' LEU . 25.6 t0 -120.11 102.81 8.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.188 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 9' ' ' ILE . 34.1 t -111.95 142.15 44.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.473 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 19.3 tttm -127.1 146.71 50.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 108.896 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.5 mm? -125.69 129.75 50.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.855 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 m -143.91 167.31 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 109.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -74.92 133.94 41.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.22 163.21 16.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.75 -3.96 13.06 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.628 2.219 . . . . 0.0 111.689 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.15 -23.84 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.87 24.98 10.07 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.71 -138.44 2.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -99.13 145.14 27.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -147.79 140.62 24.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.113 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -175.84 -170.58 38.8 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mttt -127.11 139.36 53.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -1.119 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 3.0 tt -114.31 137.73 51.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 m -114.3 133.4 55.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.178 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 4' ' ' THR . 96.2 t -109.26 127.72 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.55 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' CG ' HG21 ' A' ' 2' ' ' VAL . 37.5 tttp -115.09 122.24 45.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.592 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 42.8 t80 -117.59 115.32 24.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.61 140.36 37.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 17.5 p -106.49 165.77 11.03 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.612 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 75.1 mttt -73.85 -34.01 64.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.48 -145.91 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.14 -13.04 61.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.197 . . . . 0.0 109.468 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.69 130.16 24.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.07 131.49 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.592 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.7 Cg_endo -70.06 157.5 59.59 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.771 2.314 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.467 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 1.5 m-20 -86.94 175.15 8.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -71.13 -41.51 70.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -57.63 -47.13 83.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 69.4 mm-40 -58.03 -41.07 82.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.556 HD12 ' CE2' ' A' ' 5' ' ' PHE . 89.7 mt -62.55 -44.95 95.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -61.27 -46.41 90.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.335 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -58.99 -40.75 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.01 97.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -66.92 -39.84 87.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.338 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.85 80.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 109.284 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 39.8 mttm -60.78 -52.89 63.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.37 -56.07 6.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 52.0 t0 -50.04 -26.73 4.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.652 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 138' ' ' LYS . . . -55.15 -44.64 75.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 146' ' ' ILE . 1.3 tp -59.0 -45.53 90.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.199 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -68.6 -34.82 76.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.38 -0.825 . . . . 0.0 109.358 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 85.6 mttt -64.04 -44.85 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.16 68.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.917 . . . . 0.0 109.312 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 71.0 mt -58.6 -54.32 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -46.07 -53.74 9.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.85 69.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.877 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -65.7 -32.77 74.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.306 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 17.1 mt -70.28 -44.33 68.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.372 -0.83 . . . . 0.0 109.529 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.11 -34.5 78.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.62 61.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -130.1 83.23 63.94 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.48 -19.34 37.58 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.682 2.255 . . . . 0.0 111.726 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -93.92 16.36 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -60.75 135.61 57.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.551 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.0 t -125.63 140.16 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' VAL . 97.5 m-85 -126.42 135.77 51.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.9 m -116.89 130.49 56.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -128.78 158.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -133.15 139.76 47.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.461 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -142.33 165.71 26.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -108.29 150.15 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 52.9 mt -115.02 142.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.399 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 40.5 m-20 -134.69 129.43 34.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 m -151.9 129.16 5.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.68 0.15 6.78 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.753 2.302 . . . . 0.0 111.693 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG12 HD12 ' A' ' 150' ' ' LEU . 46.8 t -93.09 152.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.643 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 134.42 91.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.19 -29.57 32.58 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.74 2.293 . . . . 0.0 111.935 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.11 -37.24 61.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.523 HG23 ' CB ' ' A' ' 157' ' ' ASN . 39.7 m -80.13 -40.4 27.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 150' ' ' LEU . 3.8 tp -68.38 -38.29 81.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 84.4 t80 -71.2 -36.61 71.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.923 . . . . 0.0 109.773 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 24' ' ' THR . 48.6 tptt -68.92 -47.24 66.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.842 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' CA ' ' HB2' ' A' ' 25' ' ' ASP . . . -75.9 -37.19 59.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.485 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 22.7 tp -52.87 -47.18 68.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.7 t -97.48 -53.34 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 110.077 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.544 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -63.64 -47.17 82.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.162 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 29' ' ' VAL . 15.2 m-20 -95.62 17.64 14.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -66.34 -47.27 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 49.2 t0 -69.27 -29.08 66.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.94 . . . . 0.0 109.936 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -91.08 -31.61 16.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.963 . . . . 0.0 109.705 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 77.6 t -80.4 -42.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 42.0 mt -49.49 -51.86 54.91 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.381 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.7 Cg_endo -68.83 -46.69 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.532 2.154 . . . . 0.0 112.638 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -79.92 -44.68 19.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.0 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -48.13 -36.03 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.53 ' CD2' ' HB3' ' A' ' 36' ' ' SER . 14.5 tp -142.65 133.55 25.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.74 -26.73 50.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.145 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.53 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 3.0 t -54.01 -36.82 63.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CD1' ' CG2' ' A' ' 30' ' ' ILE . 62.8 t80 -52.74 135.74 34.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.428 -0.795 . . . . 0.0 109.124 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HE3' ' CG2' ' A' ' 63' ' ' THR . 9.9 mttm -90.17 -54.82 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.487 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 1.7 t -178.9 172.34 1.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 55' ' ' ILE . 10.9 p -139.07 134.75 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.776 . . . . 0.0 109.268 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -142.45 148.31 37.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 81.7 m-20 -92.18 119.39 31.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.6 m -80.13 -31.18 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.924 . . . . 0.0 109.456 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 51' ' ' THR . 79.4 tt0 -157.09 143.71 18.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.436 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.77 164.79 32.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -100.57 6.51 44.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 109.71 -8.67 32.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.25 -158.79 14.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 129.92 18.03 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.618 2.212 . . . . 0.0 111.718 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.36 3.66 69.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 52' ' ' ILE . 8.3 m -80.04 158.16 26.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -1.135 . . . . 0.0 109.697 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.538 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 13.9 mm -124.12 133.32 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 45.4 mtmt -129.02 153.96 47.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 78.9 tttt -111.89 121.92 46.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.281 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CG1' ' A' ' 66' ' ' VAL . 5.5 mm -106.35 138.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 43.2 m -131.65 120.25 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -134.23 175.01 9.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.15 139.23 38.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 83.1 tt0 -148.94 130.63 15.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 52.8 37.45 24.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.26 8.84 52.59 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.08 126.03 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.521 ' CG2' ' HE3' ' A' ' 38' ' ' LYS . 79.1 m -72.34 119.21 16.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HD2' ' OE1' ' A' ' 59' ' ' GLU . 64.7 mttm -119.6 167.29 12.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 23.1 p90 -144.68 156.63 44.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.368 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 3.1 p -143.43 152.01 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.781 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.3 mt -110.72 127.62 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' HG12 ' A' ' 66' ' ' VAL . 39.3 m80 -114.64 131.04 56.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.784 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 20.4 tttt -113.13 134.02 54.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 108.983 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 50' ' ' GLY . 46.5 mt -97.94 127.73 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 93.5 mt-10 -89.63 -33.25 16.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.224 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 81' ' ' SER . 65.3 p -174.86 154.75 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.88 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.68 84.34 2.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.333 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.39 -40.2 81.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.55 60.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.509 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 93.1 m-20 -94.39 14.63 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.9 mt 44.35 27.62 0.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.68 157.98 18.19 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 31.7 p90 -150.84 170.07 20.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 109.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 72' ' ' SER . 3.0 p -120.3 137.63 54.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 99' ' ' PHE . 19.7 p90 -152.91 156.67 39.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 77.3 p -148.02 158.19 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.605 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 90' ' ' LEU . 39.7 t -91.95 130.1 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 67' ' ' LEU . 4.2 m -118.92 -0.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.148 -0.97 . . . . 0.0 110.0 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -173.02 163.1 34.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.48 169.4 14.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.4 62.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -1.128 . . . . 0.0 109.305 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.14 -14.67 58.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 91' ' ' PRO . 6.5 tt -84.2 114.45 54.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.371 -0.83 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.0 Cg_endo -69.8 143.56 51.03 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.657 2.238 . . . . 0.0 111.757 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 73.9 m-20 -74.88 -28.47 60.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.5 p -79.87 2.62 22.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.961 . . . . 0.0 109.689 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -127.27 132.94 50.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 109.548 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.68 -43.97 87.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -176.28 159.0 1.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 83' ' ' SER . 76.2 mt -122.97 133.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 59.0 m -102.07 145.89 28.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 82' ' ' TYR . 96.3 m-85 -127.49 119.34 25.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.47 106.83 13.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 0.0 109.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.446 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 6.3 m -120.85 137.73 54.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 77' ' ' ASN . 33.6 tttt -116.04 159.83 21.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.083 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 24.1 mt -135.67 122.43 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 109.641 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 112' ' ' ALA . 27.7 m -140.27 143.96 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.15 150.26 46.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.81 175.19 21.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.07 -0.24 6.88 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.673 2.248 . . . . 0.0 111.842 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -74.34 -24.74 59.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.99 17.44 35.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.08 -132.88 2.62 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 t -117.28 140.55 49.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 104' ' ' VAL . . . -144.75 148.3 33.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.388 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.33 -167.24 35.36 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -122.36 145.21 48.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -1.119 . . . . 0.0 109.463 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 116' ' ' THR . 2.0 tt -120.31 125.72 48.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.392 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.487 ' N ' HD23 ' A' ' 115' ' ' LEU . 19.2 m -121.42 129.88 53.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 99' ' ' PHE . 81.6 t -121.2 121.39 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.9 ttpt -99.23 130.43 45.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 15.3 t80 -112.4 120.0 40.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.8 138.01 40.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.323 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 1' ' ' GLY . 29.6 p -120.02 150.48 40.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.518 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.8 mttm -52.55 -36.26 55.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.15 -93.16 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.43 -36.67 78.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 109.422 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.66 134.91 35.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -134.58 111.11 11.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.8 Cg_endo -70.09 126.47 13.13 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.751 2.301 . . . . 0.0 111.781 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -72.14 161.12 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.329 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.91 -34.18 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -56.44 -31.44 63.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.127 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.1 -35.9 48.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.0 108.758 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.6 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -58.63 -35.17 72.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -71.19 -38.83 72.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.235 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 98.2 m -59.39 -42.26 91.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.15 -37.64 91.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -68.44 -40.36 81.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.247 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.51 66.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.832 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -62.54 -47.44 83.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.29 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.45 -46.34 90.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.14 -32.45 55.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.878 . . . . 0.0 109.466 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.47 86.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.8 mm? -78.59 -36.01 44.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -59.21 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -57.11 -37.1 71.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 -50.35 72.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.304 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.531 ' N ' HD13 ' A' ' 146' ' ' ILE . 4.6 mm -54.31 -46.13 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -66.05 -53.05 43.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -70.84 -45.55 64.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 13' ' ' VAL . 5.2 mt -55.09 -38.6 68.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.2 -28.31 48.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.29 66.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -135.44 93.95 15.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -12.04 31.52 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.697 2.264 . . . . 0.0 111.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -79.03 -16.18 57.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.432 ' CE2' ' OD2' ' A' ' 25' ' ' ASP . 51.1 t80 -74.6 107.53 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.523 ' CB ' HG23 ' A' ' 17' ' ' THR . 71.0 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.531 HG23 ' CE ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -134.09 148.96 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -1.145 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CZ ' ' HG3' ' A' ' 126' ' ' GLU . 94.3 m-85 -80.66 119.17 22.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 25.2 m -110.72 116.45 31.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.561 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -109.68 165.3 11.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 60.8 mt-10 -131.15 135.59 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.96 165.86 26.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 0.0 109.519 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -110.01 148.95 30.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.49 147.55 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -148.01 133.72 18.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.55 138.28 11.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -12.14 31.5 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.646 2.231 . . . . 0.0 111.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 88.0 t -86.05 153.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -57.27 137.82 80.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' CA ' ' HB2' ' A' ' 111' ' ' SER . 45.8 Cg_endo -67.86 -30.2 33.76 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.926 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.61 -33.23 62.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -77.09 -36.94 55.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.564 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 1.8 mt -71.07 -40.43 71.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 69.0 t80 -65.46 -44.04 88.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.852 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.4 tptm -68.99 -46.22 68.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.13 -32.46 63.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.3 tp -63.29 -46.03 88.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.688 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.47 -57.08 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.985 . . . . 0.0 110.163 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -57.24 -44.5 83.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.907 . . . . 0.0 110.175 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.7 m-20 -99.05 4.68 47.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.615 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.05 -51.48 13.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.857 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -69.29 -22.72 63.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.123 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -93.36 -26.58 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 33' ' ' ALA . 97.7 t -82.34 -35.02 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 17.8 mt -60.15 -51.45 80.3 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.2 Cg_endo -67.9 -19.41 46.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.554 2.169 . . . . 0.0 112.541 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -108.79 -48.86 3.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.035 -1.041 . . . . 0.0 109.78 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -61.82 -12.94 19.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 36' ' ' SER . 0.5 OUTLIER -156.23 112.2 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.058 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.57 -18.65 58.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.039 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.3 -36.14 60.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -51.23 133.14 28.72 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.32 -0.863 . . . . 0.0 109.346 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HD3' HG22 ' A' ' 56' ' ' THR . 36.5 tttp -87.13 -54.05 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 36.5 m -165.31 158.51 16.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG22 ' CG2' ' A' ' 55' ' ' ILE . 83.0 t -142.88 142.9 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.833 . . . . 0.0 109.208 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -153.73 150.68 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t-20 -84.68 133.63 34.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.287 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 7.9 m -104.93 -28.2 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' HB3' HG12 ' A' ' 52' ' ' ILE . 71.5 tt0 -159.71 147.16 16.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 109.504 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 96.45 158.71 31.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -119.62 35.23 4.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -1.113 . . . . 0.0 109.523 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.39 -17.03 60.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.08 36.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.94 137.32 34.66 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.737 2.292 . . . . 0.0 111.742 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.8 4.79 67.07 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 52' ' ' ILE . 53.0 m -73.37 148.4 43.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -1.15 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 4.1 mm -115.69 126.98 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.249 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 70.8 mttt -124.93 149.97 47.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 67' ' ' LEU . 22.6 mttm -117.22 131.23 56.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.02 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 40' ' ' VAL . 23.0 mt -124.9 121.17 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 109.884 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 42.1 m -95.95 127.86 42.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.317 -0.864 . . . . 0.0 109.211 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE1' HG12 ' A' ' 66' ' ' VAL . 33.7 p90 -130.34 168.24 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.732 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD11 ' N ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -102.0 149.94 23.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -0.855 . . . . 0.0 109.286 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' N ' HD11 ' A' ' 58' ' ' LEU . 73.0 tt0 -164.41 123.07 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 55.77 39.19 30.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.47 16.14 54.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -115.81 134.14 55.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -1.148 . . . . 0.0 109.523 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.4 m -81.83 122.18 27.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.441 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -131.28 170.25 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 2.4 p90 -141.06 156.2 46.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.589 HG12 ' CE1' ' A' ' 57' ' ' PHE . 27.9 m -130.63 141.8 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.612 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 7.2 mp -112.47 129.25 56.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -121.43 137.72 54.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 81.2 tttt -117.36 151.93 35.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.368 -0.833 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.3 mt -111.06 129.1 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 75.2 mt-10 -97.73 -24.42 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.322 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.3 t 179.4 145.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.333 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.04 141.67 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -130.89 87.18 2.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.09 -37.57 87.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.95 83.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 17.8 m-20 -92.47 11.53 25.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 2.0 mt 47.69 34.86 3.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.25 152.72 19.57 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 25.1 p90 -150.19 169.11 22.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -1.168 . . . . 0.0 109.085 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 71' ' ' GLU . 77.4 p -128.64 140.88 51.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 22.1 p90 -155.34 161.27 41.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 p -146.54 157.38 43.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 90' ' ' LEU . 37.3 t -90.83 126.93 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.271 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.47 0.55 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.662 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.524 ' CA ' HD12 ' A' ' 90' ' ' LEU . . . 175.28 175.87 43.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 120.09 161.32 11.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -21.18 66.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.439 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.433 ' CB ' ' HE3' ' A' ' 138' ' ' LYS . . . -79.93 -7.1 58.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' CA ' ' A' ' 86' ' ' GLY . 1.0 OUTLIER -79.81 116.97 64.87 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.515 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.02 148.03 68.93 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.762 2.308 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -79.79 -29.92 40.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.696 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.471 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 24.1 p -79.7 -8.7 59.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.585 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . . . -116.68 127.62 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 82.8 mt-10 -65.63 -47.06 76.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 1.5 mtpm? -158.88 169.65 23.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.513 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 51.0 mt -136.59 127.54 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.413 -0.805 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 3.9 m -109.03 124.08 50.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.393 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 69.9 m-85 -110.22 124.03 50.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 47.6 t0 -115.87 108.22 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.174 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.406 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 35.4 t -116.3 136.33 53.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.154 -0.966 . . . . 0.0 109.834 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.481 ' O ' HD23 ' A' ' 103' ' ' LEU . 65.4 tttt -119.23 153.01 35.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 108.931 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 102' ' ' LYS . 38.2 mt -131.23 123.76 29.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.007 -1.058 . . . . 0.0 109.738 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 35.5 m -138.96 143.17 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.382 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.09 147.7 53.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.87 170.0 23.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.47 -1.47 8.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.674 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -75.74 -23.84 56.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.63 7.51 56.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.26 -141.64 4.85 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.488 ' HB2' ' CA ' ' A' ' 15' ' ' PRO . 2.1 t -109.31 142.93 39.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -147.14 146.14 29.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.26 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.64 -166.09 32.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 12.9 tttp -124.38 143.38 50.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -1.142 . . . . 0.0 109.419 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -120.89 124.11 44.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.94 . . . . 0.0 109.602 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.6 m -108.26 135.21 49.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' THR . 24.0 t -110.91 127.84 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.531 ' CE ' HG23 ' A' ' 2' ' ' VAL . 71.6 tttt -110.99 118.61 36.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 0.0 108.849 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 32.5 t80 -122.65 109.0 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.951 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 2' ' ' VAL . 62.1 tt0 -96.7 145.86 25.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.124 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.492 ' CG2' ' HD3' ' A' ' 127' ' ' PRO . 17.3 p -115.26 179.14 4.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.998 . . . . 0.0 109.587 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 93' ' ' THR . 57.6 mttt -62.03 -36.13 80.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.0 -94.0 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.39 -21.14 53.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 137.65 57.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 3' ' ' PHE . 61.9 tt0 -127.74 126.85 24.01 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HD3' ' CG2' ' A' ' 121' ' ' THR . 50.0 Cg_endo -70.15 147.05 59.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.765 2.31 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.8 m-20 -72.69 169.23 17.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.47 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.4 -41.94 97.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.5 -43.76 93.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 61.2 mt -60.29 -37.46 80.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.372 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -69.41 -41.23 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.0 m -59.59 -41.22 89.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.67 89.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -68.97 -40.2 79.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.05 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.517 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.433 ' HE3' ' CB ' ' A' ' 89' ' ' ALA . 22.9 tttm -62.45 -45.82 91.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 109.425 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.47 70.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -53.26 -39.54 63.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.93 52.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.367 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 145' ' ' ALA . 62.8 tp -64.37 -41.05 96.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -55.26 -53.02 61.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.923 . . . . 0.0 109.322 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -53.54 -35.07 60.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.193 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . -57.55 -50.05 74.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.242 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.445 HG23 HG11 ' A' ' 29' ' ' VAL . 6.0 mm -55.73 -41.68 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.289 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 83.5 tt0 -62.82 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 -37.59 14.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.182 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 149' ' ' TYR . 31.8 t80 -66.74 -43.41 84.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.525 HD12 ' CD2' ' A' ' 18' ' ' LEU . 6.7 mt -56.13 -33.33 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.74 48.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.52 -19.43 57.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -127.38 83.81 65.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.82 -20.22 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.683 2.255 . . . . 0.0 111.774 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 14.2 p-10 -83.6 -2.6 56.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.56 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.448 ' OH ' ' OD2' ' A' ' 25' ' ' ASP . 73.0 t80 -69.02 132.16 46.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.494 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.44 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -152.38 143.65 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -1.141 . . . . 0.0 109.764 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -124.26 145.77 49.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.284 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.6 m -118.26 146.93 43.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.497 ' CE2' HD11 ' A' ' 132' ' ' LEU . 72.0 m-85 -139.12 162.19 35.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.04 132.87 45.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -131.88 164.56 25.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.13 149.3 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 69.7 mt -123.92 129.8 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -140.65 131.32 25.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -144.6 140.61 16.71 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.12 -10.65 28.76 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.698 2.265 . . . . 0.0 111.714 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 14' ' ' ALA . 42.1 t -83.34 151.12 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' N ' HG12 ' A' ' 13' ' ' VAL . . . -61.25 137.56 94.38 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.342 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.9 -28.64 35.74 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.682 2.255 . . . . 0.0 111.75 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.14 -41.72 57.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.509 ' CG2' ' OXT' ' A' ' 157' ' ' ASN . 55.2 m -77.47 -41.01 41.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.535 HD13 ' CD1' ' A' ' 150' ' ' LEU . 41.9 tp -67.11 -38.34 85.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.55 ' CD2' HD21 ' A' ' 78' ' ' LEU . 91.3 t80 -67.55 -41.83 83.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.687 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' THR . 7.8 tptt -66.17 -46.84 75.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.47 -27.76 61.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -66.07 -48.1 72.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.39 -50.81 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.535 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.3 m -64.7 -48.77 73.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 109.988 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' VAL . 3.7 m-20 -92.31 3.94 54.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.622 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -46.25 -52.8 11.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.312 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.7 m-20 -66.14 -25.13 66.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 93.8 m-20 -88.89 -27.64 20.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.947 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' ASP . 9.1 p -83.57 -38.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 109.637 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.6 mt -52.31 -46.45 94.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.141 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.4 Cg_endo -68.47 -17.47 43.73 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.8 mttp -108.1 -29.35 9.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.93 81.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.558 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 22.7 tp -91.58 111.81 23.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.98 -44.4 87.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -89.74 29.96 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.048 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 47.5 t80 -63.44 132.75 52.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 39' ' ' SER . 49.7 tttp -96.08 -47.68 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.189 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.496 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 34.9 p -179.95 174.16 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.006 -1.059 . . . . 0.0 110.03 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 40' ' ' VAL . 5.1 p -136.25 130.33 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 109.343 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -129.86 144.78 51.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.629 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.69 126.51 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.363 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 36.7 t -80.05 -41.58 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.625 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 51' ' ' THR . 50.8 tp10 -166.96 156.75 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.512 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 98.77 170.23 31.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -119.06 31.79 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -1.189 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.76 -11.62 66.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 51' ' ' THR . . . -76.93 -170.97 33.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.58 148.76 60.48 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.669 2.246 . . . . 0.0 111.745 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 80.04 3.32 89.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 44' ' ' GLU . 87.9 m -69.71 149.87 47.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.617 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.516 ' N ' HG23 ' A' ' 51' ' ' THR . 29.9 mm -114.96 124.97 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -119.68 144.15 47.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 109.557 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . 17.2 tttt -114.48 127.62 55.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 64.3 mt -115.49 145.01 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m -128.72 112.11 13.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 30.4 p90 -115.64 173.02 6.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.98 142.57 47.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -143.54 131.3 21.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 53.18 21.88 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.94 71.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.86 155.44 18.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -1.105 . . . . 0.0 109.482 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.3 27.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 52.1 mttm -120.68 162.57 19.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 3.2 p90 -145.74 158.91 43.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.501 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.0 OUTLIER -138.79 147.81 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 67' ' ' LEU . 3.5 mp -116.26 136.12 53.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 0.0 108.918 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -129.5 142.45 50.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.743 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.511 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 81.7 tttt -124.03 149.31 46.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 24.4 mm -107.68 132.66 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.624 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 98' ' ' THR . 95.8 mt-10 -89.3 -39.24 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.346 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -173.62 140.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.68 136.03 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -128.66 78.57 1.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -58.91 -39.33 81.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.55 -52.09 42.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -92.22 14.37 16.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.505 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 19' ' ' TYR . 6.0 mt 45.49 42.21 7.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.66 21.7 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CE1' HD21 ' A' ' 22' ' ' LEU . 18.3 p90 -151.6 169.6 21.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -1.155 . . . . 0.0 109.195 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -128.56 138.75 52.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.2 p90 -154.26 158.67 40.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 96.6 p -146.84 156.6 43.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.411 HG23 ' HB1' ' A' ' 89' ' ' ALA . 9.6 p -94.4 135.5 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.213 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 67' ' ' LEU . 3.8 m -118.79 3.61 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.73 164.64 35.55 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.71 178.22 28.25 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.05 45.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.411 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -80.04 -8.69 59.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.72 104.21 41.1 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.503 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.5 Cg_endo -69.66 153.82 68.92 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.692 2.261 . . . . 0.0 111.699 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 65.2 m-20 -80.06 -35.9 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -80.01 8.38 7.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.576 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -136.88 130.66 32.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.555 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -56.65 -56.48 20.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 20.1 pttm -169.09 160.65 9.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 83' ' ' SER . 59.8 mt -117.17 136.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 8.4 m -106.54 141.21 38.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 73.8 m-85 -119.83 120.57 36.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.968 . . . . 0.0 109.955 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -119.57 101.73 8.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 108.976 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -115.07 141.18 48.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' HD12 ' A' ' 103' ' ' LEU . 19.8 tttm -127.3 145.37 50.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.436 -0.79 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.9 mm? -126.45 126.75 44.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 27.4 m -137.22 142.65 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.28 145.72 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.49 172.87 22.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.0 0.5 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.43 -25.7 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.25 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.39 -134.59 2.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 13' ' ' VAL . 72.6 m -116.9 142.08 47.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -1.122 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.47 147.13 30.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.34 -159.73 22.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.94 142.43 49.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -1.135 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 2.3 tt -116.86 135.66 53.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.432 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 38.8 m -127.32 125.88 41.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.841 . . . . 0.0 109.266 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' A' ' 136' ' ' LYS . 50.8 t -109.69 134.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 63.5 tttt -113.88 120.95 42.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.003 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.562 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 14.9 t80 -102.58 125.33 49.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.975 . . . . 0.0 109.743 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.469 ' OE1' ' NZ ' ' A' ' 96' ' ' LYS . 86.1 mt-10 -107.66 135.33 49.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' GLY . 26.9 p -116.48 166.15 12.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 24.4 mttm -62.82 -35.66 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.4 -86.5 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -62.4 -27.98 69.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.15 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.71 136.04 52.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -132.32 106.91 13.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 49.6 Cg_endo -70.57 122.42 8.88 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.698 2.266 . . . . 0.0 111.867 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -60.64 154.52 21.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -58.23 -36.15 72.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.52 -32.37 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.9 -32.6 51.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -62.0 -38.41 88.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.396 -0.815 . . . . 0.0 109.093 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -64.75 -45.44 86.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.0 m -57.2 -37.65 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.272 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.75 -46.52 93.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.428 ' HG2' HG21 ' A' ' 117' ' ' VAL . 65.0 mttp -53.44 -36.45 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -1.092 . . . . 0.0 109.246 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -56.79 -35.05 68.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.173 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.29 -47.01 78.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.48 39.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.399 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -57.3 -33.41 67.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -58.33 -40.21 81.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.22 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.2 tp -73.12 -47.58 43.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -56.53 -55.35 34.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.066 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -50.76 -39.13 51.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -0.918 . . . . 0.0 109.358 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 47.7 mt -69.06 -55.1 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.307 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -48.63 -57.82 5.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.918 . . . . 0.0 109.156 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.62 -38.56 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 108.847 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 36.0 t80 -67.13 -41.67 85.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD1' HD13 ' A' ' 18' ' ' LEU . 28.5 mt -57.35 -36.16 70.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.02 -28.41 63.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.59 -16.25 62.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -134.13 88.04 32.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.21 -14.83 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.719 2.279 . . . . 0.0 111.806 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -85.69 5.64 31.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.512 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 76.3 t80 -80.01 142.02 35.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.509 ' OXT' ' CG2' ' A' ' 17' ' ' THR . 81.6 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.546 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -131.99 148.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -1.181 . . . . 0.0 109.449 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -81.37 117.45 21.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -109.83 116.82 32.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -109.84 157.9 18.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -125.79 127.97 46.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.257 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.73 164.9 17.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.618 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -97.53 149.78 21.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.23 134.72 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 109.517 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.16 109.7 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -131.92 131.84 22.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.1 -2.74 10.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.745 2.297 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' A' ' 18' ' ' LEU . 41.3 t -92.81 151.49 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.22 75.84 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.23 -34.23 22.29 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.801 2.334 . . . . 0.0 111.908 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -75.26 -38.3 60.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 157' ' ' ASN . 94.9 m -76.9 -37.5 55.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.588 ' CD2' ' CD1' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -69.64 -39.44 77.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.518 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 86.1 t80 -66.23 -46.25 77.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.803 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 19.1 tptt -61.29 -46.74 89.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.562 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -71.9 -20.19 61.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 23.1 tp -80.19 -48.83 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.912 . . . . 0.0 109.835 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.3 t -97.99 -53.03 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.306 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 20' ' ' LYS . 4.0 m -64.36 -50.41 67.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 110.449 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.562 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 5.4 t70 -90.32 2.57 55.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.013 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.67 -53.16 12.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.011 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' HA ' HD11 ' A' ' 30' ' ' ILE . 88.9 m-20 -63.57 -25.1 68.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 63.4 m-20 -90.35 -24.15 20.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 25' ' ' ASP . 37.9 t -81.93 -39.16 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.7 mt -50.61 -48.58 82.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.867 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.5 Cg_endo -67.67 -18.34 48.1 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.407 2.071 . . . . 0.0 111.814 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 21.2 mttt -103.66 -54.62 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.314 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.43 -50.82 66.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.051 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD22 ' CB ' ' A' ' 57' ' ' PHE . 29.9 tp -71.77 102.0 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 0.0 108.938 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.42 -41.22 76.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 110.352 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -97.05 29.26 3.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.881 -1.137 . . . . 0.0 110.174 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -56.19 123.01 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.088 -1.008 . . . . 0.0 109.218 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -87.17 -54.04 4.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 0.0 109.848 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 24.5 p -174.21 167.61 4.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.094 -1.003 . . . . 0.0 110.035 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.456 ' C ' ' HG3' ' A' ' 41' ' ' GLU . 94.2 t -142.43 141.62 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.157 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 76.5 mt-10 -149.88 163.08 39.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ILE . 7.7 t-20 -101.02 127.48 47.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 20.0 m -93.62 -29.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.877 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 63.1 mm-40 -159.14 147.49 17.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 95.9 156.57 31.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.77 34.13 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.62 65.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.42 -166.97 27.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.5 143.99 48.84 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 111.801 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.19 1.67 90.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.513 HG22 ' N ' ' A' ' 52' ' ' ILE . 98.3 m -67.62 147.95 52.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -1.153 . . . . 0.0 109.733 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 11.1 mm -114.19 123.77 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -118.11 143.25 46.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.646 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 64.1 tttt -118.94 132.48 56.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.457 HD11 HD13 ' A' ' 30' ' ' ILE . 46.3 mt -125.38 145.85 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 0.0 109.659 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -124.69 124.79 42.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.377 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.536 ' CB ' HD22 ' A' ' 34' ' ' LEU . 49.5 p90 -127.24 156.78 41.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.412 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.26 136.9 37.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -151.68 135.97 16.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.04 38.88 21.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.34 21.92 60.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -124.37 134.12 53.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.319 -1.107 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.5 m -79.97 118.58 21.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.491 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 88.9 mttt -121.08 160.42 23.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.0 p90 -141.61 154.67 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 24.3 m -134.52 144.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -110.92 126.09 54.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.198 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -116.32 134.4 54.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.492 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 16.2 tttt -119.54 149.51 41.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 48.8 mt -112.32 133.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.646 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.66 -32.57 12.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.8 p -171.47 146.18 2.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.01 138.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -133.66 76.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.292 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.7 mt-10 -59.66 -37.15 77.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.68 70.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.557 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.87 12.9 26.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.544 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.38 38.04 6.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.129 -0.982 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.34 20.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 21.3 p90 -149.88 169.56 20.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -1.171 . . . . 0.0 109.19 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -128.88 139.95 51.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 109.486 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 25.5 p90 -154.0 160.02 41.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.6 p -145.2 156.18 43.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.499 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 89' ' ' ALA . 82.0 t -93.05 130.16 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 90' ' ' LEU . 4.5 m -121.89 -0.61 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.706 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -162.02 152.48 22.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 109.03 176.9 21.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 138' ' ' LYS . . . -60.51 -14.16 18.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -80.09 -5.1 55.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.441 HD23 ' HA2' ' A' ' 86' ' ' GLY . 9.1 tp -95.57 100.57 6.3 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.4 Cg_endo -69.08 150.1 72.0 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.774 2.316 . . . . 0.0 111.872 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.72 -32.26 41.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.619 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 94' ' ' ALA . 7.6 t -88.58 -15.72 34.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.655 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . . . -111.08 114.82 28.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -45.78 -48.51 15.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -176.63 166.7 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.669 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.467 HG21 ' O ' ' A' ' 118' ' ' LYS . 64.0 mt -124.89 134.49 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.473 ' OG1' ' HE2' ' A' ' 118' ' ' LYS . 33.1 m -106.32 128.39 53.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 95.4 m-85 -106.43 125.14 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.04 104.05 9.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.194 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.5 t -116.17 141.09 48.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.959 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttpm? -128.91 145.09 51.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 102' ' ' LYS . 83.4 mt -127.53 131.98 49.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.0 110.081 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -142.99 168.96 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.522 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -76.79 136.84 38.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 160.69 15.6 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.52 1.27 5.11 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.657 2.238 . . . . 0.0 111.888 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -80.73 -20.99 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.426 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.75 19.07 11.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.52 -142.01 3.61 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.3 t -104.91 148.03 27.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -146.63 151.66 37.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.265 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.02 -156.55 17.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -139.89 142.74 36.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -1.117 . . . . 0.0 109.379 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 116' ' ' THR . 2.2 tt -118.59 131.87 56.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.403 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 34.0 m -119.32 130.2 55.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.406 HG21 ' HD3' ' A' ' 136' ' ' LYS . 85.0 t -108.18 130.69 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' CG ' HG21 ' A' ' 2' ' ' VAL . 32.1 ttpt -112.3 123.6 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 94' ' ' ALA . 38.2 t80 -116.55 115.23 25.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.686 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' HG2' HG12 ' A' ' 2' ' ' VAL . 82.7 mt-10 -99.06 143.41 29.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.017 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.528 ' CG2' ' HD3' ' A' ' 127' ' ' PRO . 68.3 p -121.99 162.68 20.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 93' ' ' THR . 21.7 mttp -49.72 -39.79 38.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.65 -95.2 0.11 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -71.7 -28.39 63.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.46 133.92 40.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -124.58 125.44 25.55 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 51.4 Cg_endo -70.77 142.71 44.13 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.727 2.284 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.4 m-20 -81.75 165.57 20.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -66.47 -40.58 89.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -59.76 -49.04 79.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.3 -42.41 98.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.02 -43.44 98.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.22 -50.16 74.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.5 m -58.25 -37.39 74.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.335 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.14 -42.38 99.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.406 ' HD3' HG21 ' A' ' 117' ' ' VAL . 8.8 tptt -68.2 -39.91 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.28 28.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' A' ' 89' ' ' ALA . 14.3 tttp -67.67 -41.7 83.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.4 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.52 -55.49 10.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -52.19 -32.12 34.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.27 -39.5 75.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 1.3 tm? -69.37 -40.63 77.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.344 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -70.57 -54.31 12.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.137 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -50.78 -31.19 16.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.43 64.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 50.8 mt -65.15 -54.13 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 151' ' ' LEU . 76.6 tt0 -44.7 -51.45 9.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.237 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.84 71.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 37.3 t80 -68.1 -37.14 80.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 0.0 109.468 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 40.7 mt -60.39 -38.43 83.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 109.401 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 147' ' ' GLU . 1.3 mt -73.41 -28.39 61.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 153' ' ' HIS . . . -69.29 -18.52 63.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' CD2' ' C ' ' A' ' 152' ' ' ALA . 17.1 m-70 -133.37 93.8 21.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.386 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.83 -13.94 32.35 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.683 2.255 . . . . 0.0 111.907 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -86.73 -18.24 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.727 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.517 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 55.7 t80 -68.11 109.97 3.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' C ' ' CG2' ' A' ' 17' ' ' THR . 7.3 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.6 t -150.99 137.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.461 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.93 146.63 49.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.486 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -127.59 124.26 37.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.596 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 132' ' ' LEU . 95.8 m-85 -118.74 137.38 53.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 60.7 tt0 -105.42 133.56 49.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 33.5 t0 -138.56 152.97 48.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mt-10 -92.24 160.45 15.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 64.8 mt -117.71 145.13 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 78.4 m-20 -136.56 127.0 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 1.5 m -151.88 125.86 4.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.502 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.36 -2.9 11.36 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.583 2.188 . . . . 0.0 111.761 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 14' ' ' ALA . 90.4 t -89.17 151.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 13' ' ' VAL . . . -57.93 134.79 83.57 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 47.1 Cg_endo -68.64 -27.18 32.66 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.747 2.298 . . . . 0.0 111.793 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.13 -43.91 49.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.599 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' CG2' ' OXT' ' A' ' 157' ' ' ASN . 95.0 m -77.38 -40.35 44.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.59 -39.81 77.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.546 ' CD2' HD23 ' A' ' 78' ' ' LEU . 75.8 t80 -67.08 -37.11 83.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.523 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.5 tptm -69.86 -46.5 65.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.65 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.578 ' HB1' ' CZ ' ' A' ' 156' ' ' TYR . . . -75.23 -20.86 59.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.966 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 23.4 tp -72.08 -49.49 35.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.1 t -97.42 -50.15 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 109.844 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -62.23 -48.54 79.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.92 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 29' ' ' VAL . 21.7 m-20 -95.46 5.95 50.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.753 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.29 -52.8 11.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.581 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 38.3 t0 -67.44 -22.18 65.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.907 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 84.5 m-20 -91.72 -26.76 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 26' ' ' ALA . 7.7 p -81.61 -35.56 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.669 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.8 mt -57.78 -47.87 98.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.81 -38.19 14.14 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 57.7 mttp -85.39 -29.91 24.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 109.181 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -66.94 -30.51 70.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 108.849 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 15.6 tp -95.78 113.06 24.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 108.819 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.99 -34.7 76.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.533 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 p -98.03 27.15 4.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.845 -1.159 . . . . 0.0 109.991 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 58.4 t80 -60.33 137.1 58.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 55.1 tttm -98.01 -48.42 5.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.55 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -178.74 171.76 1.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.895 -1.128 . . . . 0.0 110.019 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HB ' ' HZ ' ' A' ' 37' ' ' PHE . 4.0 p -137.83 133.05 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -141.58 130.72 23.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.0 m-20 -84.31 136.47 33.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.45 -79.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.11 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 51' ' ' THR . 90.5 mt-10 -115.57 164.16 14.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 51' ' ' THR . . . 85.4 157.84 29.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.63 13.61 31.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.338 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.4 42.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.93 -160.03 23.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 72' ' ' SER . 50.7 Cg_endo -70.31 130.8 19.25 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.764 2.31 . . . . 0.0 111.85 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.92 0.98 82.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 52' ' ' ILE . 43.5 m -71.98 151.71 43.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -1.177 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.511 ' N ' HG22 ' A' ' 51' ' ' THR . 17.9 mm -117.61 128.15 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 33.2 mttt -125.67 149.68 48.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.929 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 19.0 tttt -116.29 127.57 54.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 62.8 mt -113.03 137.1 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 48.0 m -128.81 128.07 43.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.467 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.545 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 28.8 p90 -137.68 176.51 8.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 38' ' ' LYS . 4.0 mm? -103.35 145.33 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.578 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -147.74 126.21 12.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 52.43 23.43 2.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.77 11.85 73.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -112.0 159.71 18.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.6 m -99.8 111.52 23.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -119.33 162.51 18.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CD1' ' C ' ' A' ' 65' ' ' PHE . 4.1 p90 -146.72 159.2 43.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -137.29 146.07 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.596 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.562 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 3.6 mp -116.17 137.3 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.045 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -134.14 145.69 49.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.045 -1.034 . . . . 0.0 109.835 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HE2' ' HA2' ' A' ' 50' ' ' GLY . 32.9 tttt -120.32 147.43 45.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.9 mt -108.89 132.77 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 26.1 mt-10 -86.41 -44.27 12.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 23.3 t -177.14 134.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -100.45 139.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -132.55 73.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.79 -29.33 59.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.61 73.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.438 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . 91.0 m-20 -90.16 14.12 13.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.546 HD23 ' CD2' ' A' ' 19' ' ' TYR . 20.9 mt 46.81 46.2 15.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 109.6 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.51 154.68 26.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -150.72 169.35 21.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -1.211 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 100' ' ' ASP . 67.1 m -134.38 140.6 46.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.88 158.76 41.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.7 p -145.51 156.13 43.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.03 133.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' C ' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -119.81 1.26 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.894 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.39 36.95 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.13 176.59 19.1 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.52 -13.37 62.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -1.117 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.98 -9.12 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.418 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -90.59 110.3 40.29 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 49.6 Cg_endo -70.58 148.61 60.11 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.641 2.227 . . . . 0.0 111.7 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.408 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 61.6 m-20 -79.09 -32.54 44.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -79.85 5.83 12.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.557 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -131.98 134.71 45.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.057 -1.027 . . . . 0.0 109.63 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 88.0 mt-10 -63.38 -46.51 86.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 3.8 pttm 179.64 159.62 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.404 HD13 HG22 ' A' ' 97' ' ' ILE . 59.2 mt -116.73 136.32 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.3 m -111.84 124.83 53.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.865 . . . . 0.0 109.216 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 89.6 m-85 -108.7 124.27 50.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.97 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 16.6 t70 -119.18 107.04 12.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.065 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.502 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . 76.8 p -121.11 140.61 51.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.479 ' O ' HD11 ' A' ' 103' ' ' LEU . 61.2 tttm -121.03 154.42 36.08 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 103' ' ' LEU . 3.1 mm? -131.17 127.2 37.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.003 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG21 ' N ' ' A' ' 105' ' ' ALA . 1.3 m -144.97 167.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 108.982 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.45 ' N ' HG21 ' A' ' 104' ' ' VAL . . . -77.06 134.39 38.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.533 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.16 159.31 15.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.75 24.39 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.669 2.246 . . . . 0.0 111.867 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -70.1 -22.83 62.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.47 23.53 10.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.82 3.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.5 t -98.67 149.19 23.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -1.123 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -145.91 159.12 43.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.15 -174.54 43.62 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 10.2 ttmt -117.02 141.13 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -1.121 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 34.9 tp -116.15 136.45 53.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.453 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 21.6 m -128.16 126.85 41.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.3 t -108.66 134.19 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 21.0 tttm -121.63 114.3 20.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.548 ' CE2' ' HB2' ' A' ' 94' ' ' ALA . 39.2 t80 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE2' ' NZ ' ' A' ' 118' ' ' LYS . 93.8 mt-10 -106.66 138.04 43.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 21.8 p -117.07 157.09 26.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 52.8 mttt -49.62 -44.94 47.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.04 -71.12 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 27.8 p30 -78.72 -17.04 56.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.097 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.52 132.49 41.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.9 107.5 25.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.878 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.537 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 49.6 Cg_endo -69.65 119.62 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.95 158.92 26.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.54 -37.16 75.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.09 -31.67 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -78.64 -33.57 47.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 108.951 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -61.73 -43.2 99.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -59.25 -48.7 80.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.205 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.5 m -61.23 -40.1 92.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.36 -49.95 72.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -62.81 -37.89 88.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -1.18 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.42 -28.71 45.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -61.13 -46.74 89.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.272 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.27 -52.59 53.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -50.53 -39.07 47.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.03 86.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.87 -30.62 50.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.03 -52.09 67.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.145 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -52.1 -37.68 54.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.02 78.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 29' ' ' VAL . 8.4 mm -57.62 -42.53 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.307 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 93.5 mt-10 -73.59 -43.37 59.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.91 67.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 153' ' ' HIS . 38.8 t80 -68.23 -44.05 76.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD23 HG11 ' A' ' 13' ' ' VAL . 4.8 mp -57.62 -35.46 70.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -31.64 44.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.558 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.89 -21.82 60.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 149' ' ' TYR . 74.9 m-70 -129.81 87.38 52.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.84 -17.8 37.01 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.695 2.263 . . . . 0.0 111.79 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.39 -0.78 23.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.578 ' CZ ' ' HB1' ' A' ' 21' ' ' ALA . 74.6 t80 -75.69 136.48 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.411 ' OXT' ' CG2' ' A' ' 17' ' ' THR . 7.9 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.7 t -134.91 137.42 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -1.113 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.2 m-85 -123.27 149.66 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -127.19 135.0 50.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.305 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.0 157.76 38.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.116 -0.99 . . . . 0.0 109.599 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -126.43 132.67 51.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 3.1 t70 -131.88 164.81 25.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.552 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 94.4 mt-10 -103.15 149.95 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.53 129.38 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -139.58 122.13 16.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -144.9 136.66 12.89 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG2' HD23 ' A' ' 151' ' ' LEU . 50.4 Cg_endo -70.2 -1.13 8.32 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.597 2.198 . . . . 0.0 111.731 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.514 ' CG1' ' OE1' ' A' ' 147' ' ' GLU . 1.8 p -92.21 152.28 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.61 137.2 86.26 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' CA ' ' HB3' ' A' ' 111' ' ' SER . 46.1 Cg_endo -68.19 -30.4 31.25 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.749 2.299 . . . . 0.0 111.8 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.58 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 157' ' ' ASN . 61.6 m -80.16 -35.84 35.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.56 ' CD1' HD11 ' A' ' 150' ' ' LEU . 7.6 tp -70.04 -39.44 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 85.4 t80 -70.12 -40.29 74.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 52.0 tptt -66.0 -47.17 75.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' CA ' ' HB2' ' A' ' 25' ' ' ASP . . . -71.37 -47.89 53.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.055 -1.028 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 61.5 tp -47.5 -43.52 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.4 t -98.44 -56.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -64.02 -48.39 76.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.065 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.538 ' HB2' ' CA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -90.64 2.81 55.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.756 -179.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -46.36 -50.9 15.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 0.0 109.497 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.3 m-20 -66.11 -28.88 69.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.031 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -87.9 -29.33 20.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 146' ' ' ILE . 92.3 t -83.4 -38.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.669 ' CG2' ' CE2' ' A' ' 37' ' ' PHE . 6.1 mt -49.22 -48.26 74.27 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.795 . . . . 0.0 110.002 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.4 Cg_endo -68.93 -19.45 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.408 2.072 . . . . 0.0 111.899 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 53.1 mttm -99.21 -34.1 10.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -34.51 78.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.25 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 10.3 tp -92.54 109.74 21.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 108.965 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.83 -26.52 65.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 p -109.04 26.98 9.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.0 110.203 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.669 ' CE2' ' CG2' ' A' ' 30' ' ' ILE . 4.9 t80 -59.17 137.54 57.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.44 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.466 ' CE ' ' CD2' ' A' ' 58' ' ' LEU . 13.3 mttm -101.06 -49.52 4.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.942 . . . . 0.0 110.259 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.5 p -175.07 167.13 3.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.957 -1.089 . . . . 0.0 110.21 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.665 ' CG2' ' CE1' ' A' ' 37' ' ' PHE . 13.8 t -135.2 128.14 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.549 -0.719 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -138.65 151.46 47.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 27.1 p-10 -98.44 140.85 32.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.48 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.471 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -97.98 -29.9 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.526 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 51' ' ' THR . 77.6 mt-10 -157.93 145.59 18.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.56 159.74 30.92 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -97.37 5.58 49.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.56 -10.51 30.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.44 -158.13 9.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.06 138.09 36.09 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.744 2.296 . . . . 0.0 111.859 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.53 7.14 88.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 44' ' ' GLU . 15.1 m -79.55 157.29 27.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -1.159 . . . . 0.0 109.661 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 16.1 mm -117.85 126.7 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.2 mttm -119.13 144.14 46.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.865 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 23.4 tttt -115.41 127.36 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.062 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.585 HG22 ' CZ ' ' A' ' 37' ' ' PHE . 35.7 mt -121.22 145.3 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 0.0 110.032 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 57.7 m -131.9 127.31 36.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -0.769 . . . . 0.0 109.244 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 23.8 p90 -134.76 170.72 15.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.466 ' CD2' ' CE ' ' A' ' 38' ' ' LYS . 1.9 mm? -107.84 133.53 52.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.366 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -141.41 140.01 33.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 48.46 22.2 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 109.62 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.83 29.34 39.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -132.62 145.16 50.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.445 ' HA ' HD21 ' A' ' 58' ' ' LEU . 27.5 m -85.03 109.25 18.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -113.17 156.86 22.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 12.2 p90 -141.24 153.05 45.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.4 p -138.88 147.52 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -115.11 134.48 55.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.226 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -124.51 138.0 54.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.514 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 51.9 tttt -118.4 144.1 46.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 52.5 mt -105.39 129.46 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 97.0 mt-10 -87.75 -40.73 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.28 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.1 p -171.74 151.77 2.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.84 133.85 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -128.14 82.12 2.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.85 -35.2 75.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -0.991 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.61 -52.35 62.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-20 -89.7 15.0 10.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.538 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 44.11 46.39 7.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.15 156.47 25.6 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.6 p90 -151.64 169.7 21.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.188 . . . . 0.0 109.071 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 21.2 m -126.73 138.46 53.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.579 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.8 p90 -154.42 158.62 40.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.852 . . . . 0.0 109.582 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 71.9 p -148.54 156.91 43.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 109.325 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 89' ' ' ALA . 10.0 p -97.85 132.82 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.959 . . . . 0.0 109.199 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.44 5.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.009 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.65 153.28 23.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.32 -176.22 23.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.47 -13.58 62.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 0.0 109.389 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -79.92 -8.61 59.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.72 101.8 34.81 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.347 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 50.1 Cg_endo -69.7 152.7 69.69 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.755 2.303 . . . . 0.0 111.601 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 63.0 m-20 -79.55 -34.92 40.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.628 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -79.96 7.75 8.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.913 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.569 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -138.02 127.53 24.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -52.02 -58.67 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 42.6 pttt -167.46 164.44 14.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 97' ' ' ILE . 60.1 mt -118.26 135.41 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.403 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 7.7 m -107.01 145.91 31.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.631 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.621 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.9 m-85 -123.96 120.07 31.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.124 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -118.37 101.64 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.065 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.439 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 29.1 t -117.32 139.62 50.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.296 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 35.7 ttpt -120.81 155.76 33.36 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.534 ' N ' HD23 ' A' ' 103' ' ' LEU . 3.1 mm? -133.07 123.97 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.008 -1.058 . . . . 0.0 110.042 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.15 142.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.087 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.01 145.88 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.764 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 169.65 23.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.69 1.76 4.73 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.723 2.282 . . . . 0.0 111.844 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.25 -28.53 64.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.51 21.82 10.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.99 -131.41 1.63 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.559 ' HB3' ' CA ' ' A' ' 15' ' ' PRO . 1.1 p -120.18 142.78 48.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -1.134 . . . . 0.0 109.586 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.76 160.5 38.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.402 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.4 168.21 31.05 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -111.49 147.32 35.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.127 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.474 HD21 ' N ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -117.23 131.39 56.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.487 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.474 ' N ' HD21 ' A' ' 115' ' ' LEU . 27.7 m -125.23 126.18 44.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.174 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.454 HG11 ' CE1' ' A' ' 99' ' ' PHE . 57.9 t -111.54 134.22 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.691 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HE2' ' OG1' ' A' ' 98' ' ' THR . 38.0 ttpt -106.91 126.33 52.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 127' ' ' PRO . 36.8 t80 -106.94 121.07 43.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 91.3 mt-10 -104.83 138.96 40.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 26.2 p -119.31 161.86 19.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.5 mttt -63.31 -32.1 73.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.17 -108.52 0.31 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' O ' ' OE1' ' A' ' 126' ' ' GLU . 81.4 m-20 -63.43 -34.29 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.142 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.89 127.49 28.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -143.23 127.65 9.59 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 119' ' ' TYR . 50.8 Cg_endo -70.46 163.85 37.36 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.7 2.267 . . . . 0.0 111.795 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -93.22 163.66 13.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -52.08 -40.39 61.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -61.35 -46.49 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -57.61 -44.77 85.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.44 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -39.07 86.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 109.424 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.08 -43.95 85.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.8 m -58.51 -40.22 82.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.314 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.08 92.88 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ASP . 42.8 mttt -69.36 -40.25 77.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.62 73.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -75.26 -44.82 43.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 142' ' ' LEU . . . -79.65 -26.42 41.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 136' ' ' LYS . 12.9 t0 -60.68 -40.11 90.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.89 68.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 21.2 mt -54.78 -51.75 64.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.201 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -60.74 -53.91 51.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.16 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -56.36 -37.25 69.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.04 -54.38 45.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.186 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 29' ' ' VAL . 6.6 mt -67.8 -53.39 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.885 . . . . 0.0 109.192 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.514 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 15.2 tp10 -52.97 -47.48 68.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.63 69.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.2 t80 -68.9 -31.15 69.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.287 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.56 HD11 ' CD1' ' A' ' 18' ' ' LEU . 15.3 mt -69.84 -46.03 66.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.405 HD23 ' HG2' ' A' ' 12' ' ' PRO . 70.3 mt -66.08 -30.01 70.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.94 -16.5 60.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -124.28 94.6 44.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.64 -21.36 29.49 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.734 2.289 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.3 -20.49 60.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.513 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 69.2 t80 -77.45 131.07 37.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.664 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' THR . 72.2 m-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' CA ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 95.2 t -138.32 137.74 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.534 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 119' ' ' TYR . 83.5 m-85 -130.98 120.92 24.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 109.538 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 51.5 m -109.02 144.16 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.456 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.608 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 86.4 m-85 -135.17 135.79 41.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.4 mt-10 -106.12 131.34 53.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.917 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 21.1 t0 -130.08 164.41 24.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -101.8 160.01 14.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 10.5 mt -133.2 132.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -133.69 131.43 39.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.449 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 47.8 m -152.55 137.01 10.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 0.0 109.353 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' HD23 ' A' ' 151' ' ' LEU . 51.5 Cg_endo -70.13 -31.55 18.66 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.676 2.25 . . . . 0.0 111.815 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 18' ' ' LEU . 1.5 p -60.29 152.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' N ' HG21 ' A' ' 13' ' ' VAL . . . -63.48 142.26 97.9 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.448 ' N ' ' HB3' ' A' ' 111' ' ' SER . 46.9 Cg_endo -68.19 -37.42 14.34 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.735 2.29 . . . . 0.0 111.775 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.05 82.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 157' ' ' ASN . 52.6 m -78.77 -36.88 42.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 150' ' ' LEU . 11.6 tp -69.9 -39.53 76.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 86.7 t80 -68.06 -42.37 80.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.828 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 24' ' ' THR . 20.5 tptt -63.81 -46.63 84.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.933 . . . . 0.0 109.728 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' CB ' ' OH ' ' A' ' 156' ' ' TYR . . . -73.15 -25.64 60.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 2.8 tm? -69.63 -46.89 65.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.37 -53.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -62.81 -48.57 78.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 109.956 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -94.85 8.79 41.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 109.617 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -47.06 -53.42 12.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 9.0 p-10 -69.37 -27.04 64.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 86.1 m-20 -83.34 -28.21 29.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 25' ' ' ASP . 88.0 t -81.53 -36.76 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.5 mt -49.64 -49.37 72.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.102 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.8 Cg_endo -67.4 -20.1 48.68 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.503 2.135 . . . . 0.0 111.921 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.64 -54.11 3.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.188 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.9 65.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.064 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 9.8 mp -78.2 99.57 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.2 -29.32 60.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.9 p -110.27 27.16 9.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -52.57 123.97 12.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -89.6 -55.77 3.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.7 p -171.95 164.22 6.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.956 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG22 ' C ' ' A' ' 39' ' ' SER . 74.7 t -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.805 . . . . 0.0 109.123 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 61.4 mt-10 -152.46 160.77 43.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.129 -0.982 . . . . 0.0 109.765 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 80.0 m-20 -98.97 131.05 45.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.7 m -90.69 -29.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.676 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.84 144.74 17.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' A' ' 51' ' ' THR . . . 97.37 168.21 32.82 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.8 6.25 33.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -1.101 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 51' ' ' THR . . . 110.22 -9.56 31.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.91 -157.57 8.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.29 137.07 33.09 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.651 2.234 . . . . 0.0 111.862 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.07 7.5 88.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 52' ' ' ILE . 100.0 m -76.65 153.81 34.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.192 . . . . 0.0 109.625 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.497 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 24.3 mm -114.18 123.28 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 109.239 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 29.8 mtmt -119.82 145.42 46.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.917 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 20.4 tttm -114.98 126.71 55.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 20.7 mt -116.4 143.82 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.465 ' N ' HG23 ' A' ' 55' ' ' ILE . 65.1 m -127.04 128.0 45.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 64' ' ' LYS . 52.7 p90 -133.51 156.06 48.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 140.63 31.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -150.34 134.13 16.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 52.04 32.47 10.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.99 74.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -112.02 139.57 47.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -88.0 119.44 28.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 86.3 mttt -120.35 165.86 14.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 27.8 p90 -145.03 157.78 44.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.515 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.3 p -138.69 146.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.773 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.529 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 40.1 mt -113.65 133.26 55.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.871 . . . . 0.0 108.95 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.446 ' NE2' HG21 ' A' ' 66' ' ' VAL . 33.2 m170 -126.17 139.5 53.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 24.1 tttt -117.52 144.41 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.052 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 mt -102.71 127.44 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 94.9 mt-10 -89.16 -36.63 15.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 32.0 t 178.08 132.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -103.9 137.27 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.314 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -126.57 82.42 2.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.6 mt-10 -58.28 -34.57 70.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 109.284 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.12 65.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.423 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 77.6 m-20 -87.79 15.52 6.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.908 . . . . 0.0 109.189 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 14.8 mt 43.25 46.02 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -145.23 159.71 27.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' A' ' 82' ' ' TYR . 19.9 p90 -152.17 169.78 21.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -1.202 . . . . 0.0 109.291 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 41.3 t -125.38 137.81 54.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 99' ' ' PHE . 14.2 p90 -151.36 153.97 35.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 98' ' ' THR . 10.9 t -142.44 155.19 45.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 12.2 p -96.43 132.52 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.122 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.564 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 1.3 p -127.63 2.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.912 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -157.95 148.04 16.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.09 -174.9 19.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.06 -12.37 61.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -1.074 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.87 8.78 6.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 85' ' ' VAL . 10.2 tt -121.22 101.08 44.69 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.308 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.1 Cg_endo -69.21 154.59 69.7 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.72 2.28 . . . . 0.0 112.003 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 61.4 m-20 -79.92 -31.7 40.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.2 p -79.76 2.12 24.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.722 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.567 ' HB1' ' CE2' ' A' ' 119' ' ' TYR . . . -134.11 137.26 44.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -65.51 -56.01 14.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HE2' ' OE1' ' A' ' 120' ' ' GLU . 43.9 pttt -169.0 159.05 9.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 109.461 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' A' ' 83' ' ' SER . 29.1 mt -118.96 137.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 83' ' ' SER . 24.2 m -113.12 120.77 42.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.655 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 91.8 m-85 -96.0 126.04 40.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.753 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 116' ' ' THR . 17.2 t70 -119.33 113.95 21.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.329 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.513 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 22.5 t -135.81 140.68 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.47 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 103' ' ' LEU . 29.9 tttt -119.26 160.74 21.64 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.536 ' N ' ' HG2' ' A' ' 102' ' ' LYS . 3.6 mm? -124.15 126.77 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.881 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 29.8 m -137.35 142.93 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.92 146.12 49.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.718 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.25 165.3 21.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -2.16 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.662 2.242 . . . . 0.0 111.894 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.51 18.14 31.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -140.91 3.8 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 11' ' ' SER . 13.6 p -119.66 145.56 46.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -1.151 . . . . 0.0 109.606 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -146.43 147.7 31.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 109.146 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -161.9 170.04 37.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -99.31 146.51 26.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 30.4 tp -112.21 137.37 50.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 53.8 m -140.44 113.68 8.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -110.11 139.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 110.354 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.488 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.8 tttp -111.79 119.0 37.14 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 127' ' ' PRO . 12.7 t80 -102.54 123.48 46.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.099 -1.001 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 92.0 mt-10 -106.34 137.98 43.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.534 HG22 ' CD ' ' A' ' 127' ' ' PRO . 56.5 p -117.6 159.38 23.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.562 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 59.2 mttt -62.32 -40.95 98.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.31 -83.03 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.39 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -1.211 . . . . 0.0 109.517 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.99 134.66 56.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -136.79 107.03 8.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.597 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.576 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 48.7 Cg_endo -69.77 131.73 21.84 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 111.885 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.21 149.53 35.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.366 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -52.75 -36.0 57.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -57.11 -31.61 65.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.98 -36.18 59.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.157 -0.964 . . . . 0.0 108.574 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.608 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -58.25 -40.93 83.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -52.65 -54.26 35.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.42 -0.8 . . . . 0.0 109.177 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.5 m -58.71 -37.93 77.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.09 97.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 140' ' ' ASP . 24.7 mttt -63.78 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -1.119 . . . . 0.0 109.214 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -62.35 -34.31 76.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.352 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.66 -46.37 46.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.56 -27.13 51.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.153 -0.967 . . . . 0.0 109.18 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 136' ' ' LYS . 86.1 m-20 -80.15 -21.88 42.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.282 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -69.12 -39.4 78.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.28 -45.88 87.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -59.28 -55.21 37.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.802 . . . . 0.0 109.25 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -49.75 -41.12 43.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.64 78.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 108.945 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 21.3 mt -72.89 -54.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.7 -49.52 47.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.234 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.003 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -67.43 -37.56 83.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.23 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.532 ' CD1' HD13 ' A' ' 18' ' ' LEU . 14.1 mt -65.41 -43.16 91.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.376 -0.828 . . . . 0.0 109.396 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.479 HD23 ' HG2' ' A' ' 12' ' ' PRO . 73.8 mt -69.42 -31.7 70.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 153' ' ' HIS . . . -73.89 -19.08 60.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 152' ' ' ALA . 7.4 m-70 -127.13 89.35 52.06 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.87 -19.32 35.78 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.71 2.273 . . . . 0.0 111.805 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.82 -11.7 60.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.508 ' OH ' ' CB ' ' A' ' 21' ' ' ALA . 71.2 t80 -77.48 133.7 38.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 17' ' ' THR . 48.0 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.69 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -1.164 . . . . 0.0 109.48 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 126' ' ' GLU . 97.2 m-85 -126.27 141.65 51.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 37.4 m -121.37 130.38 53.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 132' ' ' LEU . 87.6 m-85 -123.11 136.73 54.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -110.08 132.18 54.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -133.81 165.8 24.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.525 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -99.6 145.35 27.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.335 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -106.55 142.34 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -154.92 128.89 8.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -152.97 140.92 13.6 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.479 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.13 -1.43 8.76 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.674 2.25 . . . . 0.0 111.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG11 ' N ' ' A' ' 14' ' ' ALA . 64.5 t -97.49 149.47 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.516 ' N ' HG11 ' A' ' 13' ' ' VAL . . . -61.9 140.52 95.63 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.4 -31.07 28.71 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.729 2.286 . . . . 0.0 111.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 -41.9 53.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.457 ' CG2' ' CB ' ' A' ' 157' ' ' ASN . 93.1 m -75.27 -43.74 49.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.466 HD13 ' CD1' ' A' ' 150' ' ' LEU . 68.1 tp -67.48 -37.29 82.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.6 t80 -66.75 -41.24 88.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.607 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' THR . 17.1 tptm -67.12 -46.49 73.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.631 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -74.78 -17.3 60.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 26.1 tp -74.23 -51.37 15.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.53 -44.72 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.971 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.533 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.25 -47.97 74.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.949 . . . . 0.0 110.103 -179.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 29' ' ' VAL . 53.6 m-20 -98.51 11.28 38.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.035 . . . . 0.0 109.833 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -53.88 -51.57 63.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 20.2 t70 -70.57 -21.37 62.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 110.141 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.16 -27.2 16.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 25' ' ' ASP . 7.9 p -80.95 -33.85 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.81 . . . . 0.0 109.67 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.634 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 5.8 mt -61.91 -49.55 85.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.15 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 48.5 Cg_endo -68.92 -22.78 35.56 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.513 2.142 . . . . 0.0 112.445 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 33' ' ' ALA . 22.4 mttt -106.14 -35.72 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.535 ' O ' ' CD2' ' A' ' 34' ' ' LEU . . . -43.23 -38.67 2.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -155.44 144.0 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.442 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.8 -18.71 50.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 68.0 m -55.14 -38.12 67.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.398 -0.814 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 40' ' ' VAL . 1.3 t80 -49.93 135.52 19.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.087 -1.008 . . . . 0.0 109.294 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 40.2 tttp -81.07 -57.28 3.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 110.295 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -162.46 155.57 20.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.02 -1.05 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' A' ' 37' ' ' PHE . 92.3 t -134.67 133.55 54.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.458 -0.776 . . . . 0.0 109.065 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 84.3 mt-10 -159.34 168.1 27.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.95 . . . . 0.0 109.634 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 65.9 m-20 -97.03 152.6 18.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 2.5 t -96.1 -33.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.558 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 51' ' ' THR . 45.3 tp10 -166.79 156.44 11.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 88.96 -172.97 40.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -120.99 17.35 11.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.93 -1.43 56.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.14 -164.01 23.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.95 126.41 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.623 2.215 . . . . 0.0 111.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 92.77 4.13 65.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.529 HG21 ' N ' ' A' ' 52' ' ' ILE . 86.1 m -75.34 150.4 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -1.121 . . . . 0.0 109.58 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.529 ' N ' HG21 ' A' ' 51' ' ' THR . 9.4 mm -111.56 122.25 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 21.8 tttt -116.98 142.1 47.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 110.108 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 17.9 tttm -117.25 130.24 56.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -130.46 138.25 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.981 -1.075 . . . . 0.0 110.004 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.1 m -120.52 114.67 22.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.386 -0.821 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 50.8 p90 -114.96 171.05 7.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -111.14 151.32 28.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' GLU . 60.5 tt0 -154.28 138.58 16.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.311 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 2.8 p-10 44.13 26.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . 81.58 24.29 56.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' GLU . 72.7 mt-10 -121.74 140.88 51.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.44 HG22 ' HD2' ' A' ' 38' ' ' LYS . 16.2 m -91.07 110.28 21.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -116.18 162.04 18.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 14.2 p90 -141.85 153.79 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 5.6 p -140.6 148.82 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.712 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -110.81 128.78 55.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.914 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -122.52 138.55 54.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 22.1 tttm -119.57 146.94 45.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.5 mt -104.93 130.52 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 72' ' ' SER . 48.4 mm-40 -93.56 -27.79 16.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.292 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.2 t 178.27 144.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 73' ' ' ILE . 73.8 mt -115.44 138.15 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.373 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 94.0 m-20 -130.79 81.97 2.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.32 -37.01 81.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.54 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.514 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 22.0 m-20 -97.58 12.11 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt 47.88 29.31 1.6 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -121.24 150.86 17.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.3 p90 -151.24 169.76 21.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -1.225 . . . . 0.0 109.123 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 47.4 t -128.56 138.88 52.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -153.97 158.91 41.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 80.7 p -145.23 157.07 44.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.643 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 11.0 p -96.48 129.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 67' ' ' LEU . 3.6 m -116.57 4.86 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.448 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -169.18 159.51 32.53 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 105.02 -171.54 18.99 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.88 61.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -1.079 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.91 -4.02 50.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.86 86.35 45.82 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -69.54 165.91 29.12 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.505 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 38.9 m-20 -70.44 -27.82 64.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.9 p -79.77 -23.94 41.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.601 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.585 ' HB1' ' CE1' ' A' ' 119' ' ' TYR . . . -106.32 121.58 44.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.972 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 92.8 mt-10 -64.97 -49.12 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 71.8 mttt -161.2 158.42 27.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CD1' ' CE2' ' A' ' 119' ' ' TYR . 62.7 mt -123.61 133.68 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.84 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.2 m -108.91 131.29 55.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 99.8 m-85 -115.11 122.39 45.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.446 ' O ' HD22 ' A' ' 115' ' ' LEU . 42.5 t0 -116.11 119.9 37.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.888 . . . . 0.0 109.188 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.497 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 9.9 t -138.48 134.93 34.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.514 ' CE ' ' HB3' ' A' ' 77' ' ' ASN . 20.0 tttm -125.77 149.09 48.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 2.2 mp -130.1 128.88 42.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 109.954 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 112' ' ' ALA . 32.6 m -138.96 143.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 109.164 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.04 139.65 22.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.28 168.16 21.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.16 -16.36 35.87 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.73 2.287 . . . . 0.0 111.729 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -64.86 -22.56 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.03 42.78 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.76 -140.42 4.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 m -101.93 141.36 34.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' O ' ' CG2' ' A' ' 104' ' ' VAL . . . -148.02 139.5 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.4 13.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -129.82 141.68 50.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.299 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.497 ' HG ' ' CB ' ' A' ' 101' ' ' SER . 3.1 tt -124.52 119.8 30.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 110.005 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.477 ' N ' HD22 ' A' ' 115' ' ' LEU . 71.2 m -116.65 128.32 55.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 108.788 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -117.03 131.97 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 110.062 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 37.1 ttpt -111.08 115.61 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.585 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.7 t80 -99.45 128.92 45.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.234 -0.916 . . . . 0.0 109.647 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -102.9 144.43 31.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.312 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 70.1 p -123.72 152.84 41.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 12.5 mttm -55.15 -29.21 57.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.0 -108.11 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.65 -27.27 58.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.04 135.83 57.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -141.33 119.59 7.91 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.5 146.66 56.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.844 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -87.55 177.25 7.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.94 -36.15 80.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.26 -41.92 94.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.458 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -66.96 -42.77 84.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 5' ' ' PHE . 79.7 mt -63.39 -42.1 98.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -63.13 -47.39 82.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 109.411 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.7 m -58.2 -37.88 75.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.407 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.82 95.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -67.45 -39.66 85.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.62 63.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' HD23 ' A' ' 142' ' ' LEU . 15.5 tttp -61.55 -49.38 76.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.61 86.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.32 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -57.41 -38.53 74.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . -57.79 -49.07 77.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.2 mm? -75.9 -37.24 59.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.309 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -58.35 -51.81 68.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -62.87 -32.17 73.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.411 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.94 70.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 109.319 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.55 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 29.4 mt -62.91 -45.13 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' HG23 ' A' ' 13' ' ' VAL . 82.7 tt0 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.267 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.4 -37.26 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.149 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.605 ' CE2' ' CE1' ' A' ' 153' ' ' HIS . 49.1 t80 -67.92 -41.25 82.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 12.9 mt -55.44 -34.9 64.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.427 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.2 mt -78.58 -28.25 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -20.79 59.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.455 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.605 ' CE1' ' CE2' ' A' ' 149' ' ' TYR . 74.9 m80 -130.32 90.3 41.97 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.46 -16.12 34.55 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.779 2.319 . . . . 0.0 111.815 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.37 -17.49 60.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 21' ' ' ALA . 79.3 t80 -75.1 121.45 22.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CG2' ' A' ' 17' ' ' THR . 5.8 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.463 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 91.5 t -133.2 138.02 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -1.121 . . . . 0.0 109.487 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -129.39 130.98 46.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 98.4 m -113.35 145.01 41.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 91.3 m-85 -136.37 128.63 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.978 . . . . 0.0 109.676 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 77.0 tt0 -96.43 131.3 43.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 136' ' ' LYS . 6.5 m-20 -128.0 164.93 21.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -100.9 151.56 21.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.97 128.57 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.14 125.4 37.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.58 129.67 5.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.35 -0.03 6.8 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.661 2.241 . . . . 0.0 111.865 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 14' ' ' ALA . 95.7 t -87.59 151.36 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' N ' HG13 ' A' ' 13' ' ' VAL . . . -67.23 142.92 97.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 109.503 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.9 Cg_endo -68.55 -35.78 16.5 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.769 2.312 . . . . 0.0 111.814 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.32 80.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 HG23 ' C ' ' A' ' 157' ' ' ASN . 56.2 m -79.23 -40.93 29.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 22.3 tp -67.41 -38.8 85.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.606 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.584 ' CE1' ' HA ' ' A' ' 78' ' ' LEU . 68.1 t80 -69.55 -40.43 76.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 38.1 tptt -65.64 -46.93 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -75.03 -30.35 61.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 8.4 mt -58.71 -49.24 78.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.783 . . . . 0.0 109.722 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.51 -46.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.889 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -71.81 -50.87 25.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 62.5 t0 -85.15 7.56 21.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.012 . . . . 0.0 109.727 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -59.21 -49.7 76.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.937 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.7 m-20 -66.32 -31.27 71.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.819 . . . . 0.0 109.986 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 24.4 m-20 -87.3 -28.39 22.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.686 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ASP . 7.6 p -81.24 -36.75 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.655 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.664 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.7 mt -53.24 -48.31 92.81 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.984 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -67.94 -34.55 23.16 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 111.943 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 18.2 mttp -83.23 -40.59 19.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.163 -0.961 . . . . 0.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.42 -61.7 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 47.5 tp -64.55 108.8 1.77 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 108.927 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.44 -35.41 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -96.81 27.18 4.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.941 -1.099 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.616 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 50.9 t80 -59.33 136.29 57.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' SER . 55.0 tttt -97.87 -49.77 4.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 110.051 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.51 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 83.1 p -178.69 171.87 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.986 . . . . 0.0 109.753 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 5.4 p -134.25 122.56 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.4 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 42' ' ' ASN . 18.0 tt0 -126.13 158.25 35.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' N ' ' CG ' ' A' ' 41' ' ' GLU . 45.4 m-20 -105.7 154.39 20.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.545 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.2 m -117.53 -34.92 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 85.1 mt-10 -158.3 145.78 18.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.481 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 98.43 162.0 30.34 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.78 2.86 49.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -1.113 . . . . 0.0 109.566 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 112.6 -10.32 25.9 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.24 -153.37 10.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.29 139.5 38.54 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 C-N-CA 122.714 2.276 . . . . 0.0 111.798 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.59 -1.18 86.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.526 HG21 ' N ' ' A' ' 52' ' ' ILE . 90.8 m -71.91 153.5 41.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -1.21 . . . . 0.0 109.63 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 14.6 mm -117.91 127.83 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -123.78 148.37 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 109.786 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 27.1 tttm -115.32 126.16 54.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 66' ' ' VAL . 84.9 mt -113.73 143.22 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.568 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 40.7 m -129.74 128.69 42.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.586 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 30.5 p90 -134.5 169.03 17.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 142.9 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.419 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.5 128.91 15.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 49.74 24.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 28.25 41.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -122.36 154.4 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.6 m -98.49 107.13 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.334 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -116.09 160.08 20.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -144.93 157.03 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 17.1 m -137.25 145.82 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.707 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' CD1' ' HA3' ' A' ' 86' ' ' GLY . 8.5 mt -114.18 133.89 55.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.878 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -126.1 139.32 53.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 38.3 tttm -121.11 144.78 48.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.285 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 10.6 mm -102.79 125.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.443 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 92.0 mt-10 -82.97 -54.2 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.865 . . . . 0.0 109.33 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.6 t -162.39 136.97 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt -113.41 134.76 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.403 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -129.83 79.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -50.96 -34.99 31.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.25 -49.43 64.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.674 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.482 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 59.9 m-20 -100.52 14.57 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 40.1 mt 42.43 41.21 2.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.84 106.42 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -109.79 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.691 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 p -136.07 142.83 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.4 p90 -152.85 157.6 40.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 109.656 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 97' ' ' ILE . 12.4 p -142.2 153.91 44.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.37 128.31 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.524 HG13 ' CE ' ' A' ' 96' ' ' LYS . 2.3 m -122.3 6.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 67' ' ' LEU . . . -158.89 147.88 16.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.89 179.66 16.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.22 -13.81 59.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.99 -8.94 59.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 85' ' ' VAL . 4.5 tp -100.0 102.73 18.72 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -68.65 152.29 74.55 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.724 2.282 . . . . 0.0 111.836 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.96 -29.32 60.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.867 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.7 p -79.57 3.75 17.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.078 -1.014 . . . . 0.0 109.818 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.576 ' CB ' ' HG2' ' A' ' 91' ' ' PRO . . . -125.37 128.92 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 5.7 tt0 -63.82 -55.0 26.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 89.5 mttt -161.51 160.94 29.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 83' ' ' SER . 17.0 mt -126.15 132.78 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 34.6 m -118.55 115.89 25.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.641 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 69.5 m-85 -94.41 128.53 41.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 109.67 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 116' ' ' THR . 13.8 t0 -116.84 116.52 27.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.254 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 12.2 t -133.06 136.34 45.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 77' ' ' ASN . 28.9 tttt -122.74 144.81 48.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.4 mm? -128.36 124.04 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -133.75 162.55 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 109.059 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -60.87 125.33 23.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.057 -1.027 . . . . 0.0 109.514 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.79 150.28 19.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.58 2.33 4.1 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.647 2.231 . . . . 0.0 111.971 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.24 5.7 50.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.605 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.73 22.14 51.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -138.67 3.49 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -120.46 142.59 49.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -1.187 . . . . 0.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' O ' HG11 ' A' ' 104' ' ' VAL . . . -147.28 147.37 30.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -166.26 -151.94 7.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -133.44 142.73 48.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -1.128 . . . . 0.0 109.261 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 116' ' ' THR . 4.8 tt -120.61 126.53 50.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.784 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.528 ' N ' HD22 ' A' ' 115' ' ' LEU . 68.0 m -125.72 124.85 41.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 108.849 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.641 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 1.1 p -108.08 142.47 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.061 -1.025 . . . . 0.0 110.128 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 69.2 tttt -119.93 116.61 26.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 108.964 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.524 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.3 t80 -102.68 130.51 49.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.137 -0.977 . . . . 0.0 109.667 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -111.75 127.22 55.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 1' ' ' GLY . 32.8 p -110.94 157.52 19.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.543 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -58.36 -39.23 78.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 -93.21 0.1 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -67.41 -31.65 72.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.13 115.19 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.89 108.48 28.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 117.95 5.4 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.783 2.322 . . . . 0.0 111.844 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -59.87 157.06 13.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -56.35 -38.57 71.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.82 -31.34 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.252 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 63.2 mm-40 -74.38 -36.85 63.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 108.7 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -56.98 -35.8 69.6 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -60.63 -48.03 83.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.18 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.2 m -58.33 -39.02 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.44 99.35 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 7' ' ' ASP . 29.5 tttt -73.06 -41.78 63.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -1.111 . . . . 0.0 109.362 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.05 -34.96 70.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -71.25 -44.76 64.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.252 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.93 89.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.837 . . . . 0.0 109.353 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.5 ' HB3' ' HE3' ' A' ' 144' ' ' LYS . 89.5 m-20 -50.95 -47.54 61.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.291 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 145' ' ' ALA . . . -54.03 -33.33 57.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.464 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 3.1 tm? -70.62 -53.36 16.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.93 -53.63 54.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 108.948 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 140' ' ' ASP . 49.4 mttt -51.93 -37.85 54.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 141' ' ' ALA . . . -56.45 -45.83 80.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.28 -0.887 . . . . 0.0 108.989 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 16.7 mt -69.07 -54.72 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.225 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -59.64 -52.65 64.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.341 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . -48.83 -39.19 24.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.062 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.535 ' OH ' ' CD2' ' A' ' 153' ' ' HIS . 35.1 t80 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.211 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 24.6 mt -58.82 -41.09 86.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.27 -29.64 67.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.918 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.0 -17.66 56.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CD2' ' OH ' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -125.74 85.77 58.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.575 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.44 -20.54 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.682 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -79.38 -1.45 37.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 157' ' ' ASN . 59.6 t80 -68.81 143.56 54.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.482 ' O ' ' CD2' ' A' ' 156' ' ' TYR . 7.2 m120 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 120' ' ' GLU . 70.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.707 ' HE2' HG21 ' A' ' 121' ' ' THR . 89.0 m-85 -125.06 143.04 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.0 m -126.13 125.29 42.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.832 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.9 m-85 -121.72 139.1 54.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -112.9 133.56 54.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD2' ' CE ' ' A' ' 136' ' ' LYS . 49.1 t0 -132.3 165.0 25.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 87.2 mt-10 -101.84 157.9 16.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 27.2 mt -124.28 135.93 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -142.14 130.93 22.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.23 135.17 9.18 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.912 . . . . 0.0 109.481 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.49 -6.27 18.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.653 2.236 . . . . 0.0 111.794 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.935 HG21 HD23 ' A' ' 150' ' ' LEU . 2.7 p -87.16 150.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.33 136.84 60.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.07 -32.32 28.16 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.19 64.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -75.37 -38.63 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD22 ' A' ' 150' ' ' LEU . 39.6 tp -69.49 -39.65 77.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.9 t80 -64.68 -46.89 80.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HE2' HG21 ' A' ' 24' ' ' THR . 5.7 tptm -63.29 -46.16 88.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 156' ' ' TYR . . . -72.12 -17.91 61.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.949 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.6 tp -80.05 -50.17 10.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.815 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 -45.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.535 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -71.09 -50.46 33.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.3 t70 -95.03 17.09 14.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -54.55 -52.84 60.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' OD1' HG11 ' A' ' 40' ' ' VAL . 44.8 t0 -66.32 -26.07 67.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 59.0 m-20 -88.04 -26.61 22.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 109.449 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.077 HG11 HG23 ' A' ' 146' ' ' ILE . 75.3 t -82.27 -40.15 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.939 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.8 mt -49.47 -48.68 74.86 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.31 -34.61 20.77 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.355 2.036 . . . . 0.0 111.839 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 48.4 mttt -79.96 -40.43 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.063 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.96 88.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.268 -0.895 . . . . 0.0 108.878 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.849 HD21 ' HB2' ' A' ' 57' ' ' PHE . 40.5 tp -83.54 102.54 12.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 108.967 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.41 -35.6 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.3 p -97.73 29.5 3.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.982 . . . . 0.0 109.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.763 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.2 t80 -54.69 119.83 5.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -84.89 -55.66 3.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.618 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.602 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 60.6 p -175.1 168.23 3.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.63 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.576 HG11 ' OD1' ' A' ' 27' ' ' ASP . 7.2 p -144.08 142.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 40' ' ' VAL . 65.2 mt-10 -149.89 155.64 40.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 85.4 m-20 -96.57 121.97 38.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.4 m -79.97 -27.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' THR . 26.0 mt-10 -163.17 152.02 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 90.4 157.69 33.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.97 9.44 43.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.566 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 51' ' ' THR . . . 107.62 -6.93 36.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.36 -160.46 22.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.0 129.04 16.67 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.691 2.261 . . . . 0.0 111.714 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 89.88 2.31 75.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.491 ' C ' HD13 ' A' ' 52' ' ' ILE . 14.3 m -75.05 152.46 38.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -1.148 . . . . 0.0 109.604 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 8.3 mm -114.05 124.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.072 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 96.8 mttt -118.78 143.65 46.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 15.6 tttp -115.95 128.49 55.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 30' ' ' ILE . 49.2 mt -117.95 143.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 28.2 m -120.54 133.22 55.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.36 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.849 ' HB2' HD21 ' A' ' 34' ' ' LEU . 33.5 p90 -134.47 154.26 51.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -96.97 123.46 40.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.301 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -136.63 126.85 26.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.616 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 56.89 35.53 26.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.68 9.98 53.29 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -109.04 133.88 52.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -79.2 119.4 22.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 57' ' ' PHE . 24.3 mttt -123.64 165.6 16.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 32.7 p90 -146.01 159.87 42.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.637 ' C ' HD23 ' A' ' 67' ' ' LEU . 35.7 m -134.82 143.37 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 109.728 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.637 HD23 ' C ' ' A' ' 66' ' ' VAL . 8.5 mt -112.42 131.86 55.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 0.0 109.105 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -127.79 141.25 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.611 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 28.3 tttt -121.32 150.94 40.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.267 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 37.9 mt -112.59 133.95 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 94.2 mt-10 -92.02 -32.69 15.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.6 p -176.97 147.2 0.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.85 138.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -133.36 76.12 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.45 -37.72 84.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.17 -47.31 68.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -95.57 11.96 31.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 48.45 51.21 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.56 148.72 20.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 19.4 p90 -151.05 167.76 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 109.215 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 37.4 m -126.88 138.57 53.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.454 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 15.5 p90 -152.53 155.43 37.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.0 p -146.83 156.16 42.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 89' ' ' ALA . 6.7 p -93.04 133.37 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG13 ' CE ' ' A' ' 96' ' ' LYS . 2.9 t -123.77 0.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.018 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -167.34 157.18 29.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.35 173.52 21.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.94 -13.01 29.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -82.89 16.84 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 1.2 tt -120.97 103.82 42.35 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.13 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.2 Cg_endo -68.38 151.19 76.25 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.739 2.293 . . . . 0.0 111.866 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 47.7 m-20 -79.36 -32.55 43.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.6 p -79.6 -0.97 35.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.756 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.13 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.38 126.85 43.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.379 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 46.4 mt-10 -58.85 -54.11 50.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 85.9 mttt -160.82 163.63 31.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 mt -122.99 132.98 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 2.2 m -108.87 144.53 36.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.642 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.606 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.2 m-85 -126.52 120.86 30.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 0.0 109.8 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 59.2 t0 -119.9 102.4 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.15 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.522 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.9 t -119.06 140.58 49.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.128 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 1.039 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.6 tttt -119.36 163.72 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 109.122 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.039 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -133.45 123.46 25.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.63 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.67 143.03 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 109.315 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.37 58.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.528 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -126.6 162.65 20.72 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.82 -13.38 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.694 2.263 . . . . 0.0 111.776 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.57 -23.29 65.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.88 18.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.02 -140.06 3.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 87.0 p -110.08 145.92 36.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.6 41.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.83 171.19 35.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -105.53 142.45 35.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -1.189 . . . . 0.0 109.377 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 60.9 tp -115.55 136.89 52.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.585 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 30.4 m -127.8 125.57 40.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.35 131.95 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.52 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -113.39 122.16 46.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.957 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.1 t80 -110.76 119.99 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.553 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' HG3' HG22 ' A' ' 2' ' ' VAL . 77.1 tt0 -103.45 145.33 30.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.707 HG21 ' HE2' ' A' ' 3' ' ' PHE . 26.2 p -120.62 151.69 39.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 28.0 mttt -49.78 -43.42 48.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 177.24 -111.64 0.34 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.45 -44.13 89.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.74 134.47 36.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.574 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.6 132.1 7.97 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.603 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.58 139.52 37.55 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.679 2.253 . . . . 0.0 111.783 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -64.15 177.48 0.81 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.315 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.02 -42.29 89.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.62 -47.11 86.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.6 -40.41 79.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.832 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 79.7 mt -61.92 -37.33 84.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -59.97 -49.48 77.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.265 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.3 m -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.02 -41.87 98.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' CE ' ' OD2' ' A' ' 7' ' ' ASP . 49.6 tttp -70.28 -40.39 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -1.109 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.19 64.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.424 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -65.25 -46.21 81.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.78 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 70.5 m-20 -50.81 -29.77 12.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.77 76.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.872 . . . . 0.0 109.239 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 142' ' ' LEU . 20.2 mt -76.01 -43.86 42.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 18' ' ' LEU . 75.2 t80 -56.03 -54.68 41.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 77.4 mttt -50.46 -40.49 50.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.71 -48.81 80.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.237 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.077 HG23 HG11 ' A' ' 29' ' ' VAL . 34.0 mt -68.81 -44.48 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -62.34 -45.06 94.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.325 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.08 70.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 39.5 t80 -67.14 -46.0 75.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.935 HD23 HG21 ' A' ' 13' ' ' VAL . 9.5 mp -61.22 -43.49 98.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.6 mt -69.38 -36.17 76.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.26 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -127.07 84.05 64.46 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.68 -19.24 36.77 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.645 2.23 . . . . 0.0 111.725 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.79 -12.26 60.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 41.7 t80 -77.52 125.87 30.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.569 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 68.7 m-20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.635 HG11 ' NZ ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.456 ' CE1' ' HD2' ' A' ' 127' ' ' PRO . 97.1 m-85 -80.05 118.73 22.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 28.8 m -111.17 116.53 31.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.704 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.3 m-85 -108.91 163.67 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.688 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 46.0 mt-10 -130.34 132.47 45.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.253 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -132.91 166.23 22.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.27 140.99 36.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HG ' ' A' ' 115' ' ' LEU . 74.6 mt -114.15 136.69 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.307 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -151.76 138.99 19.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.479 ' HB3' ' OE1' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -153.07 144.7 16.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HG2' HD11 ' A' ' 151' ' ' LEU . 49.4 Cg_endo -70.25 -5.02 15.54 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.699 2.266 . . . . 0.0 111.794 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.94 HG21 HD23 ' A' ' 150' ' ' LEU . 7.1 p -92.88 151.62 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.14 79.19 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.3 Cg_endo -68.07 -30.61 31.73 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.71 2.273 . . . . 0.0 111.85 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.24 -36.0 61.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 157' ' ' ASN . 58.6 m -76.7 -38.89 53.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.495 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 150' ' ' LEU . 33.3 tp -68.13 -39.36 82.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 85.2 t80 -66.04 -44.59 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 0.0 109.785 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.872 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.1 tptt -63.83 -46.76 83.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 109.681 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -72.56 -17.67 61.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.544 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.948 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 51.1 tp -79.52 -49.05 12.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.39 -48.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.872 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.9 m -64.99 -49.43 70.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.9 m-20 -97.27 12.19 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -48.66 -53.56 18.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.338 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.798 ' HA ' HD12 ' A' ' 30' ' ' ILE . 73.7 m-20 -66.92 -23.56 65.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.927 . . . . 0.0 109.543 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 92.0 m-20 -87.23 -26.76 23.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD12 ' A' ' 146' ' ' ILE . 85.7 t -81.55 -35.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.4 mt -53.68 -48.59 92.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.25 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.9 Cg_endo -67.23 -19.73 50.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.524 2.149 . . . . 0.0 112.251 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 35.4 mttm -104.12 -45.82 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 109.347 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -59.89 -45.8 91.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 57' ' ' PHE . 55.0 tp -79.63 107.13 12.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 108.878 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.46 -44.73 85.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -92.14 29.75 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.828 -1.17 . . . . 0.0 110.344 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 54.4 t80 -58.38 123.75 17.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.02 -1.05 . . . . 0.0 109.363 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.36 -52.4 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -177.49 170.37 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.493 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.73 135.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -135.18 134.97 40.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.13 137.8 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.1 m -99.96 -36.83 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.433 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 43' ' ' VAL . 55.9 mt-10 -158.7 146.25 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.65 155.18 20.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -109.38 29.72 7.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -1.142 . . . . 0.0 109.583 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.78 -21.98 38.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.48 -162.42 5.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.4 160.55 49.14 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.66 2.24 . . . . 0.0 111.749 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 63.16 12.12 42.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -76.36 153.69 35.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.0 109.521 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 9.4 mm -117.39 126.94 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -119.88 144.51 47.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.706 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.7 tttt -115.29 128.97 56.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 66' ' ' VAL . 67.8 mt -117.41 145.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.3 m -124.43 125.15 43.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 109.298 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.893 ' HB2' HD21 ' A' ' 34' ' ' LEU . 48.0 p90 -133.66 158.21 43.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -99.22 150.14 22.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.482 ' OE1' ' CE ' ' A' ' 64' ' ' LYS . 57.7 tt0 -152.97 129.81 10.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.566 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 48.13 23.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.38 29.4 36.73 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' GLU . 96.9 mt-10 -123.71 155.39 37.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.8 m -97.86 112.26 24.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 62.3 mttt -124.67 158.63 32.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 30.0 p90 -142.76 157.6 44.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 55' ' ' ILE . 33.3 m -132.76 142.8 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.131 -0.98 . . . . 0.0 109.608 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.599 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.5 mt -110.29 125.42 53.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -116.01 133.86 55.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 64.0 tttt -120.59 146.06 46.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.195 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 66.1 mt -113.31 138.28 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.551 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.1 -42.61 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -161.58 142.75 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 109.499 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -109.88 140.71 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.48 77.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.398 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.488 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.6 mt-10 -57.29 -38.17 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.443 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.05 -47.73 64.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -95.01 12.67 27.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.1 mt 47.72 31.54 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.408 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.94 152.79 19.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.511 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.5 p90 -150.24 169.65 20.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -1.124 . . . . 0.0 109.26 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -125.97 139.28 53.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 25.9 p90 -154.29 160.76 41.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.7 p -146.19 156.48 43.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -86.36 132.15 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG13 ' HE2' ' A' ' 96' ' ' LYS . 4.1 t -117.67 -5.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.781 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -171.96 162.71 34.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 122.54 160.43 10.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.05 -15.16 20.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -1.079 . . . . 0.0 109.296 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.93 -6.03 56.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.338 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tt -79.98 110.19 15.13 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 109.356 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.027 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.21 146.42 63.52 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.747 2.298 . . . . 0.0 111.695 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 62.5 m-20 -78.89 -32.65 45.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.9 p -79.86 -5.44 55.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.727 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -122.75 136.92 55.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.058 -1.026 . . . . 0.0 109.624 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 81.1 mt-10 -70.63 -51.31 28.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' HG13 ' A' ' 85' ' ' VAL . 31.7 mttt -161.21 163.55 31.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 118' ' ' LYS . 60.3 mt -124.01 133.1 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 6.1 m -109.52 125.52 52.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.0 m-85 -108.79 122.87 48.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 56.7 t0 -120.42 102.63 8.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.933 . . . . 0.0 109.252 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 17.1 m -119.44 139.57 51.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.909 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HD23 ' A' ' 103' ' ' LEU . 31.6 ttpt -120.58 156.87 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 62.3 mt -129.54 127.5 40.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.5 m -139.61 142.97 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.33 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.25 170.63 22.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.13 -8.94 24.84 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.684 2.256 . . . . 0.0 111.853 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -67.9 -24.94 65.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.32 44.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.98 -143.32 4.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 85.3 p -106.1 144.74 32.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.12 30.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.41 -165.52 32.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.11 145.14 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -117.69 132.37 56.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 115' ' ' LEU . 20.1 m -122.11 128.69 51.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.269 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 4' ' ' THR . 49.2 t -107.7 131.35 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 31.8 tttm -112.66 121.41 44.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.84 . . . . 0.0 109.225 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.657 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t80 -116.48 114.32 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.544 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -101.12 138.05 38.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.092 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.9 p -116.42 164.32 14.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 41.3 mttt -55.22 -43.05 74.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.47 -106.88 0.21 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 125' ' ' ALA . 86.1 m-20 -63.32 -42.84 99.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 109.449 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -44.63 130.47 6.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 4.9 mt-10 -134.91 133.17 20.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.4 Cg_endo -70.44 158.13 56.99 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.613 2.209 . . . . 0.0 111.742 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.7 OUTLIER -90.93 164.99 13.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.95 -40.66 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.41 -46.63 89.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 64.7 mm-40 -58.11 -45.61 86.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.704 HD13 ' CE2' ' A' ' 5' ' ' PHE . 58.4 mt -59.55 -38.31 80.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -61.27 -48.55 80.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.35 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.4 m -58.83 -38.54 78.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.324 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -46.0 95.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.466 ' CD ' HG21 ' A' ' 117' ' ' VAL . 4.8 mtmt -64.94 -38.82 92.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.0 62.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.49 -45.99 84.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.359 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.3 -55.35 10.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -54.06 -35.72 62.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.39 -46.96 82.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.992 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.8 tm? -71.19 -33.57 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.202 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -56.07 -52.75 63.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.953 . . . . 0.0 109.125 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -51.76 -39.84 59.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.156 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.03 -38.71 73.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.305 -0.872 . . . . 0.0 109.053 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 142' ' ' LEU . 7.6 mm -71.68 -44.35 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.234 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.501 ' OE1' HG12 ' A' ' 13' ' ' VAL . 30.6 tp10 -67.69 -41.63 83.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.86 -34.28 74.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.95 -46.68 64.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.94 HD23 HG21 ' A' ' 13' ' ' VAL . 6.7 mp -63.26 -43.77 97.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 12' ' ' PRO . 82.0 mt -68.05 -33.48 74.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.71 -17.82 61.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -129.56 95.07 30.72 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.6 -16.58 34.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.699 2.266 . . . . 0.0 111.72 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -73.43 -20.73 60.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 70.8 t80 -79.89 129.92 34.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.657 HG22 ' HG3' ' A' ' 120' ' ' GLU . 87.0 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.4 m-85 -124.28 146.5 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.6 m -128.31 135.0 49.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 71.5 m-85 -126.39 160.0 31.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.413 ' CD ' ' HE2' ' A' ' 114' ' ' LYS . 71.7 mt-10 -135.93 129.26 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -133.26 165.13 25.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 8' ' ' GLU . 68.5 mm-40 -104.68 151.83 23.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 115' ' ' LEU . 47.4 mt -121.53 134.91 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -144.72 131.34 19.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.549 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 2.0 p -148.02 144.54 19.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.787 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.0 Cg_endo -71.48 1.38 5.63 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.415 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CG1' ' OG ' ' A' ' 11' ' ' SER . 2.4 p -97.89 152.78 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.55 137.9 61.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 111' ' ' SER . 47.1 Cg_endo -67.98 -35.16 21.2 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.744 2.296 . . . . 0.0 111.826 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.89 68.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.29 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 157' ' ' ASN . 68.1 m -78.55 -35.25 46.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 150' ' ' LEU . 14.5 tp -70.62 -40.59 73.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.771 ' HB2' HD12 ' A' ' 103' ' ' LEU . 91.3 t80 -65.51 -49.78 67.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.682 ' CE ' HG21 ' A' ' 24' ' ' THR . 7.3 tptm -59.77 -46.26 89.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -70.54 -18.63 62.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.04 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 13.4 mt -80.13 -46.16 16.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 109.749 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.52 -45.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.17 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.682 HG21 ' CE ' ' A' ' 20' ' ' LYS . 16.4 m -74.78 -50.05 18.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.334 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.6 t70 -92.12 9.18 34.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.0 109.819 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.04 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -51.05 -52.45 43.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 93.8 m-20 -65.19 -29.48 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.379 -0.826 . . . . 0.0 109.748 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.504 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 85.7 m-20 -84.41 -26.36 28.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 146' ' ' ILE . 45.0 t -80.77 -37.14 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -50.04 -49.48 74.76 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.37 -25.23 36.2 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.357 2.038 . . . . 0.0 111.97 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 59.6 mmtt -91.94 -33.31 14.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.149 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.65 -43.05 60.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -0.868 . . . . 0.0 109.046 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.61 106.6 18.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.016 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.26 -33.26 69.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.944 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 9.7 m -98.2 29.55 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 0.0 109.882 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 39' ' ' SER . 56.3 t80 -58.35 126.48 27.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -92.08 -52.04 4.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.62 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 54.3 p -177.66 170.85 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 109.722 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.6 p -142.33 140.32 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.308 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -145.93 153.79 41.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 7.1 m-20 -87.23 140.67 29.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 2.7 t -91.17 -39.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.644 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 51' ' ' THR . 87.9 mt-10 -161.03 149.21 15.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.448 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 96.16 167.36 34.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -98.14 8.14 45.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.91 -6.37 35.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.79 17.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.69 130.7 19.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.658 2.239 . . . . 0.0 111.758 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.5 3.49 69.04 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.7 m -77.76 155.19 31.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -1.178 . . . . 0.0 109.571 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 43' ' ' VAL . 21.1 mm -118.79 128.31 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.942 . . . . 0.0 109.308 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.7 mttp -122.52 147.72 46.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.614 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.3 tttm -116.98 129.3 55.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 40' ' ' VAL . 14.8 mm -116.28 146.21 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.528 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 23.5 m -130.71 121.59 25.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.903 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 47.6 p90 -129.1 160.8 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -96.25 148.56 22.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -150.37 127.74 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.36 22.71 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.45 10.86 72.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -108.35 159.12 16.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -1.11 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.6 m -104.93 115.47 30.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -121.22 164.68 16.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.49 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 45.6 p90 -143.75 156.47 44.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.844 ' C ' HD23 ' A' ' 67' ' ' LEU . 27.1 m -135.85 144.7 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.557 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.844 HD23 ' C ' ' A' ' 66' ' ' VAL . 2.5 mt -109.87 126.79 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.219 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -118.5 134.84 54.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 17.8 tttm -116.05 147.21 41.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' GLY . 12.2 mm -106.83 126.54 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.4 mt-10 -87.32 -42.88 12.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 p -168.04 148.46 4.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.01 135.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.12 75.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.352 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.25 -36.67 78.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -48.74 72.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.463 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 49.3 m-20 -90.63 13.01 17.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.7 mt 47.53 49.27 16.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.472 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -148.73 153.9 25.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.3 p90 -150.38 169.47 21.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -1.124 . . . . 0.0 109.133 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 62.7 m -131.09 140.75 50.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 24.1 p90 -155.76 162.6 40.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.578 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 51.9 p -146.36 156.53 43.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.51 133.32 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.541 ' C ' HD13 ' A' ' 90' ' ' LEU . 19.4 t -106.87 -7.93 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.478 ' C ' ' HG ' ' A' ' 67' ' ' LEU . . . 171.27 -179.06 43.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.75 166.02 27.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.84 -20.75 2.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -1.116 . . . . 0.0 109.379 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.92 -15.73 56.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -90.65 106.96 17.15 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.307 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.033 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.5 Cg_endo -69.58 146.26 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.728 2.285 . . . . 0.0 111.901 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.45 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 79.3 m-20 -77.47 -30.97 53.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 p -79.95 1.18 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.849 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.56 126.32 41.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' OE1' ' OE2' ' A' ' 120' ' ' GLU . 92.8 mt-10 -58.15 -42.4 85.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -178.54 157.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.359 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 118' ' ' LYS . 63.8 mt -119.67 135.56 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.532 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 34.6 m -109.62 128.2 55.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.752 ' CE1' HG13 ' A' ' 117' ' ' VAL . 94.2 m-85 -111.27 124.65 52.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.508 ' O ' HD12 ' A' ' 115' ' ' LEU . 57.2 t0 -120.09 105.0 10.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.647 ' CB ' HD13 ' A' ' 115' ' ' LEU . 8.5 t -114.5 141.0 48.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 103' ' ' LEU . 74.1 tttt -127.7 146.86 50.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.86 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 19' ' ' TYR . 46.5 mt -122.68 127.6 49.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.799 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.8 m -138.86 143.43 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -62.65 139.77 58.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.52 165.3 22.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.01 22.51 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.647 2.231 . . . . 0.0 111.831 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.16 -28.14 69.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.79 10.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.35 -134.44 2.08 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 100.0 p -108.42 143.16 37.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -1.129 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.94 141.97 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.57 -168.54 35.45 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HE2' ' CD ' ' A' ' 6' ' ' GLU . 69.2 tttt -125.83 140.72 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -1.121 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 101' ' ' SER . 25.0 tp -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.1 m -126.83 127.1 44.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' CE1' ' A' ' 99' ' ' PHE . 58.6 t -111.81 132.7 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 97' ' ' ILE . 33.8 ttpt -111.72 125.31 53.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 55.6 t80 -113.0 118.75 35.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 2' ' ' VAL . 87.0 tt0 -103.44 146.78 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.399 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.8 p -119.77 157.19 29.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.397 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.2 mttt -45.9 -37.71 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.66 -96.4 0.16 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.18 -32.15 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -1.148 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.51 137.77 57.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -145.59 110.44 4.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 47.9 Cg_endo -69.77 144.48 54.1 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.728 2.285 . . . . 0.0 111.772 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 131' ' ' GLU . 48.4 p30 -70.49 172.87 7.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.71 -35.1 78.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.47 -44.3 89.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.405 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 94.4 mt-10 -66.84 -39.99 87.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 95.7 mt -63.77 -42.93 97.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.46 -44.72 90.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.268 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.3 m -57.53 -38.66 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.04 97.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -62.98 -38.61 91.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -51.71 -32.04 28.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.444 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -75.86 -36.65 59.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.22 -55.29 8.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.877 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 4.2 p30 -62.11 -26.03 68.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.499 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -58.76 -50.98 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.895 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 6.4 tp -58.24 -38.16 76.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.883 . . . . 0.0 109.292 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.02 -54.95 38.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.128 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -51.54 -33.74 33.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -60.85 -53.72 53.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.247 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.919 HG23 HG11 ' A' ' 29' ' ' VAL . 45.0 mt -67.37 -53.55 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -50.48 -51.0 51.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.46 70.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.9 t80 -66.5 -39.72 88.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.394 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 18' ' ' LEU . 13.0 mt -61.21 -43.12 99.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 ' HG2' ' A' ' 12' ' ' PRO . 83.3 mt -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.37 61.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.595 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 93.85 46.59 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.81 -21.46 33.2 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.683 2.255 . . . . 0.0 111.759 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -75.42 -17.88 60.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 57.5 t80 -78.74 118.67 21.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.47 ' HA ' HG21 ' A' ' 17' ' ' THR . 75.6 m-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.609 HG11 ' HE3' ' A' ' 118' ' ' LYS . 88.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.42 146.88 49.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -130.62 130.46 44.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 132' ' ' LEU . 88.0 m-85 -129.28 160.92 31.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -127.9 130.11 47.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -126.22 164.71 20.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -94.51 160.47 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 61.4 mt -128.12 142.38 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.36 132.11 42.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -152.42 112.67 2.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.25 -2.22 10.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.581 2.187 . . . . 0.0 111.726 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.061 ' HB ' HD11 ' A' ' 18' ' ' LEU . 68.0 t -95.2 154.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 132.39 26.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.0 Cg_endo -67.93 -29.64 34.15 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.745 2.296 . . . . 0.0 111.939 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.88 -34.05 62.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 157' ' ' ASN . 90.2 m -77.31 -37.4 52.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.061 HD11 ' HB ' ' A' ' 13' ' ' VAL . 9.0 mt -69.24 -40.25 78.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.54 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 68.6 t80 -65.88 -45.54 81.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.3 OUTLIER -64.48 -47.6 78.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -70.34 -20.84 62.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.333 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.2 tt -80.13 -45.49 18.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.36 -54.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 20.7 m -63.69 -49.5 72.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.577 ' OD2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 m-20 -95.61 13.59 25.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.074 -1.017 . . . . 0.0 109.938 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.01 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -53.3 -52.87 57.71 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.193 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 63.9 t0 -67.61 -23.02 65.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.97 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 55.3 m-20 -90.94 -27.42 18.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.9 p -83.51 -35.07 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.01 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -56.63 -46.47 99.83 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.4 Cg_endo -66.72 -22.18 50.42 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.456 2.104 . . . . 0.0 112.42 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -108.47 -26.0 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.115 -0.991 . . . . 0.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -63.49 -28.61 70.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.969 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 57' ' ' PHE . 42.2 tp -101.02 117.52 35.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.032 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.77 -44.07 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.532 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 57.9 m -93.02 28.17 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.891 -1.131 . . . . 0.0 110.072 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CE1' HG22 ' A' ' 30' ' ' ILE . 46.6 t80 -58.83 131.61 51.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.0 tttp -93.03 -51.08 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.933 . . . . 0.0 110.103 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.464 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 67.0 p -179.91 173.77 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 109.938 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 9.7 p -135.69 128.35 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.205 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 70.0 mm-40 -130.0 144.03 51.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.27 125.64 30.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 50.0 t -82.69 -44.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.562 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 51' ' ' THR . 81.7 tt0 -158.49 145.59 17.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.4 168.21 28.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.84 5.68 50.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -1.152 . . . . 0.0 109.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.28 -8.45 28.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -156.76 12.35 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.02 135.68 30.44 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.701 2.267 . . . . 0.0 111.774 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.25 1.5 84.06 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.5 m -80.02 127.68 32.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 109.481 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 20.6 mm -93.29 134.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -125.77 150.75 47.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.742 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.5 tttt -115.33 126.45 54.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.644 ' HB ' HG22 ' A' ' 66' ' ' VAL . 56.4 mt -111.77 141.01 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -125.39 123.41 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.894 ' HB2' HD21 ' A' ' 34' ' ' LEU . 41.1 p90 -128.71 166.84 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.27 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -99.35 151.39 21.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.501 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -154.13 119.0 4.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.927 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.12 31.78 7.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.26 -7.09 65.15 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' OE2' ' HE2' ' A' ' 64' ' ' LYS . 72.8 tt0 -91.25 144.51 25.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -1.145 . . . . 0.0 109.419 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.7 m -95.79 120.15 35.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 12.7 mmtt -125.69 169.81 12.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 67' ' ' LEU . 5.0 p90 -147.93 161.39 41.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.668 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.8 m -137.94 147.18 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.742 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.9 mp -115.3 134.3 55.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -128.67 141.99 51.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 66.4 tttt -120.82 147.68 45.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.356 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.7 mt -108.61 132.2 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 92.9 mt-10 -87.6 -38.8 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.425 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 p -176.78 150.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.03 137.16 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -131.46 79.43 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -61.86 -37.76 85.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.55 63.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.455 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 56.5 m-20 -90.58 13.32 16.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 9.8 mt 47.31 47.63 16.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.89 152.95 24.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 17.3 p90 -151.12 169.35 22.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 109.14 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 22.7 t -137.76 142.03 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.9 p90 -154.64 160.7 41.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.349 -0.845 . . . . 0.0 109.533 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.4 p -145.55 156.49 43.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 90' ' ' LEU . 73.4 t -89.67 133.09 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.359 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -115.04 -1.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.863 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.52 168.09 39.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.32 166.28 18.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.0 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -1.148 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -81.35 -10.54 59.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -88.27 107.78 18.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.08 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.3 Cg_endo -69.43 148.29 66.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.647 2.231 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -79.37 -33.41 42.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -81.31 0.26 37.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.08 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -130.43 139.45 50.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HG3' ' HD3' ' A' ' 122' ' ' LYS . 89.7 mt-10 -67.03 -54.73 18.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 109.508 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 51.2 pttt -171.91 163.54 6.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 118' ' ' LYS . 56.2 mt -118.98 135.75 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.5 m -110.15 122.6 48.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.221 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.629 ' CE1' HG13 ' A' ' 117' ' ' VAL . 92.4 m-85 -104.04 125.17 50.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.841 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 48.7 t0 -120.34 102.22 8.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.466 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 27.0 m -115.13 141.43 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.0 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.62 ' O ' HD23 ' A' ' 103' ' ' LEU . 50.3 tttt -123.24 153.8 39.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 108.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 102' ' ' LYS . 40.4 mt -129.88 126.45 37.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.94 143.26 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -70.4 148.3 48.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.48 168.07 24.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 -6.0 17.52 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.71 2.273 . . . . 0.0 111.701 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -63.81 -27.3 69.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.7 18.32 25.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.51 -139.09 3.42 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 31.0 t -117.0 145.99 43.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.682 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.11 166.13 25.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.885 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 169.2 169.43 32.55 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -109.51 144.93 37.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -1.164 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' THR . 1.2 tt -114.98 136.19 53.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.575 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.3 m -127.16 126.13 42.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 99' ' ' PHE . 48.0 t -111.24 130.5 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.651 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 97' ' ' ILE . 63.9 tttt -112.6 122.08 46.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 109.152 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.575 ' CD1' ' HG3' ' A' ' 127' ' ' PRO . 22.8 t80 -112.1 118.41 35.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 109.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.463 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 88.8 mt-10 -101.24 145.52 28.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.208 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 15.7 p -124.09 171.28 9.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HD3' ' HG3' ' A' ' 95' ' ' GLU . 41.9 mmtt -79.8 1.52 26.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.28 -88.46 0.46 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -57.79 -37.45 73.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.89 137.66 58.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 110.69 3.78 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.432 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CD1' ' A' ' 119' ' ' TYR . 50.4 Cg_endo -70.28 147.22 59.04 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.732 2.288 . . . . 0.0 111.835 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.8 OUTLIER -84.61 163.51 19.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.448 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.61 -40.12 78.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.66 -45.56 91.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -59.36 -42.88 92.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.62 HD13 ' CE2' ' A' ' 5' ' ' PHE . 90.9 mt -58.16 -35.32 71.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -65.39 -44.12 88.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.6 m -57.79 -39.6 77.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.29 98.8 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -63.3 -39.2 93.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -1.155 . . . . 0.0 109.448 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.16 -33.1 38.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.95 -43.24 93.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.99 -50.66 67.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.336 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 84.4 m-20 -51.57 -33.67 33.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.36 97.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.269 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.947 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.9 tm? -79.18 -36.45 40.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.12 -51.84 68.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 80.6 mttt -51.78 -39.87 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 0.0 109.212 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.28 -42.32 81.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.143 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.09 -45.06 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.372 -0.83 . . . . 0.0 109.191 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.437 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 94.2 mt-10 -71.19 -37.82 72.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.83 79.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.162 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -71.33 -52.33 19.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.595 HD22 HD23 ' A' ' 18' ' ' LEU . 8.1 mp -60.97 -36.69 80.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.52 -31.69 68.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.46 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.71 -2.1 51.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -127.94 75.42 78.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.71 -14.17 35.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.673 2.249 . . . . 0.0 111.782 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -76.23 -26.1 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.659 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 81.6 t80 -79.88 125.58 29.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG11 ' CE ' ' A' ' 118' ' ' LYS . 97.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' OE1' ' A' ' 126' ' ' GLU . 97.6 m-85 -124.61 147.13 48.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.49 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -127.6 120.69 28.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.797 ' CE2' HD13 ' A' ' 132' ' ' LEU . 91.8 m-85 -123.16 133.66 54.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -101.9 132.69 47.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 53.3 t0 -127.74 160.58 31.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 90.4 mt-10 -92.09 160.2 15.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 77.0 mt -117.67 143.8 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -138.03 112.26 8.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 51.1 m -149.33 126.78 5.58 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.68 -35.96 9.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.21 149.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.525 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 134.33 93.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.599 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' SER . 47.6 Cg_endo -68.67 -24.23 35.42 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.785 2.323 . . . . 0.0 111.826 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -44.16 49.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.667 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.8 m -76.27 -42.83 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.157 -0.965 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 HD22 ' A' ' 150' ' ' LEU . 16.1 tp -65.12 -38.35 90.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 109.639 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 83.7 t80 -66.17 -43.86 85.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.7 tptt -64.51 -46.74 81.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.689 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.26 -16.84 60.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.0 tp -77.02 -51.03 11.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.5 -48.25 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -61.59 -48.77 79.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 109.778 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' VAL . 65.3 m-20 -101.54 15.26 29.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.32 -52.68 12.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -67.45 -23.16 65.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.541 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 48.1 m-20 -88.53 -27.75 21.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.87 . . . . 0.0 109.317 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.058 HG21 HG23 ' A' ' 146' ' ' ILE . 8.0 p -82.76 -37.2 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.05 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -49.74 -48.9 76.02 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.869 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.2 Cg_endo -68.48 -33.45 22.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.396 2.064 . . . . 0.0 111.87 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.0 mttt -82.33 -52.91 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.136 -0.978 . . . . 0.0 109.133 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -53.06 -38.07 62.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 108.974 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.053 HD21 ' HB2' ' A' ' 57' ' ' PHE . 26.8 tp -84.39 105.42 15.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.77 -39.33 77.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.079 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.6 p -95.61 28.28 3.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 109.862 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -56.44 125.7 23.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB2' HD12 ' A' ' 58' ' ' LEU . 51.7 tptt -92.83 -52.69 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 m -170.34 162.92 8.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.717 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.092 HG22 HG23 ' A' ' 55' ' ' ILE . 96.3 t -143.03 142.42 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 86.1 mt-10 -150.97 161.86 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 109.54 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -88.51 135.4 33.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 109.446 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 28.5 t -83.27 -42.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.776 ' O ' HG23 ' A' ' 51' ' ' THR . 55.6 mm-40 -159.57 147.25 17.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.72 -154.09 21.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -140.66 13.21 2.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' H ' HG21 ' A' ' 51' ' ' THR . . . 109.36 -2.13 31.04 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.87 -162.66 25.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.71 134.94 27.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.731 2.287 . . . . 0.0 111.866 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.98 0.25 90.19 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 44' ' ' GLU . 89.5 m -70.2 151.57 45.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.63 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 37.8 mm -115.65 124.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -117.91 143.39 46.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.002 . . . . 0.0 109.763 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 12.6 tttm -123.5 136.3 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.223 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.092 HG23 HG22 ' A' ' 40' ' ' VAL . 71.9 mt -128.92 146.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.804 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 30.3 m -120.14 121.99 40.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.279 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 1.053 ' HB2' HD21 ' A' ' 34' ' ' LEU . 51.4 p90 -122.32 162.27 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.546 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -101.07 149.98 23.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.27 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -164.89 131.29 2.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 53.85 28.81 8.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.05 67.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -107.74 129.0 55.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -1.207 . . . . 0.0 109.401 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -80.12 124.44 28.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 73.9 mttt -124.21 169.91 11.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.551 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 37.7 p90 -142.5 154.58 44.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.505 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 29.7 m -130.53 139.19 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.885 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -108.67 126.96 53.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -125.89 140.4 52.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.588 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 36.4 tttm -121.39 148.95 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.32 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 50' ' ' GLY . 57.7 mt -108.6 132.09 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.2 mt-10 -88.29 -36.43 16.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 109.355 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -175.16 150.27 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.73 136.38 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -132.81 78.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 45.9 mt-10 -57.23 -39.41 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.5 -46.99 57.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.925 . . . . 0.0 109.421 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.494 ' HB3' ' NZ ' ' A' ' 102' ' ' LYS . 47.2 m-20 -93.77 13.68 21.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.281 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.6 mt 47.03 35.87 3.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.98 154.22 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.9 p90 -150.71 169.72 20.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 109.068 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 72.5 m -129.72 139.51 51.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.674 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.612 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.9 p90 -153.27 158.7 42.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 91.1 p -148.04 157.71 43.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.6 p -97.08 125.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.285 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.48 2.47 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.885 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -164.59 154.33 25.09 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 113.9 159.14 13.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -13.42 32.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.115 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.45 9.33 7.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.596 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.59 122.41 42.0 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.371 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.0 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 51.1 Cg_endo -70.5 145.2 52.22 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.691 2.261 . . . . 0.0 111.826 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -79.76 -32.28 40.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -80.18 -2.77 46.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.0 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.0 117.98 25.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.967 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -49.94 -43.64 50.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 14.3 pttt -176.85 161.46 2.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.6 mt -122.65 134.04 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 50.8 m -107.89 129.81 55.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.612 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.8 m-85 -113.78 123.6 50.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.9 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -123.0 101.57 7.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.017 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.446 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 4.3 m -113.31 145.89 40.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.035 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.778 ' O ' HD23 ' A' ' 103' ' ' LEU . 19.4 tttt -123.27 158.39 31.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 102' ' ' LYS . 77.0 mt -138.93 129.91 26.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.006 . . . . 0.0 110.139 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -142.83 169.68 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 0.0 108.979 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.639 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.32 137.47 39.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 109.516 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.89 161.09 19.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.62 -0.45 6.82 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.689 2.26 . . . . 0.0 111.74 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.93 -23.43 41.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.31 12.52 33.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.96 -146.43 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.45 145.89 24.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.661 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.78 143.13 28.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.363 -0.835 . . . . 0.0 109.197 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.16 -161.12 26.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 116' ' ' THR . 2.1 tt -116.73 136.78 52.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.7 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.801 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.0 m -123.27 127.72 48.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.28 129.06 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 97' ' ' ILE . 87.3 tttt -114.45 120.77 41.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.323 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.839 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.4 t80 -112.45 119.24 37.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.9 mt-10 -99.77 146.47 26.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 127' ' ' PRO . 66.2 p -123.8 160.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -52.74 -43.55 65.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.17 -82.14 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 18.1 p30 -76.78 -15.38 59.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.6 138.04 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' OE1' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -134.92 111.25 11.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 50.3 Cg_endo -70.89 140.35 38.24 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.729 2.286 . . . . 0.0 111.795 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.92 156.6 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -53.37 -34.78 58.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -59.05 -45.99 89.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 68.8 mm-40 -60.32 -41.5 93.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.797 HD13 ' CE2' ' A' ' 5' ' ' PHE . 54.2 mt -60.88 -38.64 86.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.377 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -71.44 -37.53 71.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 58.8 m -58.72 -42.16 88.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.26 -32.03 71.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -68.99 -40.44 78.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.327 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.17 -37.02 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -66.65 -42.95 85.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.306 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.79 -50.2 67.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.839 . . . . 0.0 109.285 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' PHE . 86.7 m-20 -56.37 -33.25 65.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.339 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.25 -54.46 40.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.34 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.7 mm? -76.34 -32.3 58.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' ASP . 86.6 t80 -63.15 -50.79 69.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.381 -0.825 . . . . 0.0 109.259 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -62.4 -34.5 76.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.92 -44.38 82.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.058 HG23 HG21 ' A' ' 29' ' ' VAL . 26.6 mt -67.59 -46.59 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.341 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 38.3 mt-10 -64.65 -40.38 95.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.855 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.38 71.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 18.6 t80 -69.29 -43.24 74.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.887 . . . . 0.0 109.351 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 HD12 ' A' ' 18' ' ' LEU . 8.1 mp -70.56 -35.81 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.92 -37.28 64.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.616 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.63 -15.21 61.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -131.49 91.06 35.63 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -16.42 33.95 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.719 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -78.29 -9.63 59.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.72 142.09 15.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.472 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.737 HG22 ' HG3' ' A' ' 120' ' ' GLU . 91.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 59.9 m-85 -79.85 126.63 31.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.719 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.3 m -123.16 116.45 23.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 90.9 m-85 -103.8 167.09 10.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -140.81 130.92 24.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -139.87 165.37 27.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.31 140.92 37.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 70.3 mt -106.62 141.54 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.559 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -142.9 128.88 19.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.418 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 14.8 m -152.77 134.63 8.64 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 -0.78 7.76 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 111.679 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.4 p -92.51 149.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.494 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' GLY . . . -61.73 133.79 93.71 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.685 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 47.0 Cg_endo -68.34 -26.84 34.84 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.759 2.306 . . . . 0.0 111.695 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.67 -39.28 57.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.695 HG23 ' OXT' ' A' ' 157' ' ' ASN . 15.6 m -75.52 -43.49 48.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 150' ' ' LEU . 3.8 tp -70.81 -39.81 72.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.1 t80 -66.83 -41.69 87.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HE3' HG21 ' A' ' 24' ' ' THR . 30.7 tptt -66.34 -46.3 77.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.8 -24.49 59.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.203 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.916 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 16.3 tp -66.44 -49.62 66.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.19 -46.21 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.763 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -67.66 -48.35 66.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.651 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.4 m-20 -94.2 6.36 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.95 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -45.89 -52.57 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 19.6 t70 -67.06 -26.27 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.747 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.3 m-20 -87.12 -27.04 23.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.125 -0.985 . . . . 0.0 109.73 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG21 HG23 ' A' ' 146' ' ' ILE . 8.3 p -81.94 -35.54 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.619 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.95 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.1 mt -52.58 -47.49 93.69 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.324 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.2 Cg_endo -67.07 -17.39 50.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.352 2.035 . . . . 0.0 112.057 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 19.5 mttm -107.5 -35.78 6.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.471 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.44 -41.74 88.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 109.175 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 57' ' ' PHE . 45.7 tp -86.69 109.05 18.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -57.51 -43.45 84.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.29 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -91.23 29.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.804 ' HA ' HD23 ' A' ' 34' ' ' LEU . 66.1 t80 -60.73 127.18 30.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.117 -0.99 . . . . 0.0 109.502 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.734 ' HD3' HD23 ' A' ' 58' ' ' LEU . 41.3 mtmt -96.38 -49.85 5.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 109.551 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -178.15 170.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -138.81 141.81 38.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 34.4 t30 -77.63 129.67 35.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.445 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -79.85 -41.3 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 45' ' ' GLY . 81.8 tt0 -167.46 157.53 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.498 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.42 173.31 33.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.09 3.9 22.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -1.164 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.04 -9.13 25.15 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.62 -160.77 26.44 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.15 125.41 11.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.616 2.211 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 100.29 0.06 55.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.543 HG23 ' HA3' ' A' ' 45' ' ' GLY . 62.6 m -75.67 152.54 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 51' ' ' THR . 27.3 mm -115.78 125.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.854 . . . . 0.0 109.186 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 87.4 mttt -118.7 143.92 46.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.897 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.2 tttt -115.54 128.48 56.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 66' ' ' VAL . 66.2 mt -115.03 133.37 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -112.78 124.97 53.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.842 ' HB2' HD21 ' A' ' 34' ' ' LEU . 53.2 p90 -134.38 161.19 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.734 HD23 ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -101.73 135.94 42.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.368 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -137.51 128.43 27.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.586 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 50.77 22.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.546 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.02 59.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 58' ' ' LEU . 85.0 mt-10 -117.06 140.67 49.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -1.089 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.703 HG23 ' NZ ' ' A' ' 38' ' ' LYS . 86.6 m -81.22 111.69 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -128.03 164.65 21.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE1' HD13 ' A' ' 67' ' ' LEU . 10.8 p90 -149.66 165.6 31.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 67' ' ' LEU . 25.8 m -137.13 146.28 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.695 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.5 mp -115.32 134.57 55.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -131.19 144.32 51.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 31.9 tttt -125.42 150.21 47.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLY . 63.1 mt -106.48 133.07 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 81' ' ' SER . 3.8 pt-20 -107.53 -29.83 8.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.788 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 22.7 t -158.96 139.79 12.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.052 -1.03 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 70' ' ' ILE . 65.4 mt -128.39 131.57 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.078 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -131.99 81.73 1.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.284 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.1 -34.78 75.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.49 81.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -89.59 12.12 17.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.8 mt 50.03 28.96 3.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.42 149.31 17.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 20.7 p90 -150.98 169.06 22.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.133 . . . . 0.0 109.04 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.505 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 42.3 m -135.84 141.4 44.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 26.6 p90 -154.28 160.47 41.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.341 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -142.46 155.59 45.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 67' ' ' LEU . 6.1 p -90.9 132.87 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 109.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' HD13 ' A' ' 90' ' ' LEU . 6.0 m -113.46 0.47 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 90' ' ' LEU . . . 179.26 171.3 42.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.66 171.35 24.59 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.72 -17.03 31.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.21 59.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' C ' ' A' ' 85' ' ' VAL . 1.1 tp -94.93 106.0 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.12 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.26 148.35 61.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.706 2.271 . . . . 0.0 111.781 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 80.6 m-20 -79.36 -32.95 43.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.82 . . . . 0.0 109.561 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 p -80.27 3.77 19.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.717 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.12 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.21 131.94 44.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.072 -1.018 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 89.6 mt-10 -59.73 -43.64 94.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 12.3 pttp -179.11 163.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.0 mt -122.68 133.39 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 28.7 m -105.88 136.8 44.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.299 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.5 m-85 -116.49 122.12 43.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 20.9 t70 -118.79 102.25 8.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -116.04 138.4 51.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.784 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.749 ' C ' HD22 ' A' ' 103' ' ' LEU . 54.5 tttm -131.49 141.02 49.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.119 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.0 mm? -123.67 129.13 50.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 0.0 109.608 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 112' ' ' ALA . 1.6 m -89.06 146.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 15' ' ' PRO . . . -78.4 103.71 8.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.634 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.67 137.47 19.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.47 -16.84 34.63 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.728 2.285 . . . . 0.0 111.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.5 -2.97 50.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . 104.26 -29.93 11.1 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.38 171.42 8.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 53.0 p -126.4 137.48 53.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.07 139.56 26.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -168.78 -157.09 11.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -131.69 144.54 51.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 116' ' ' THR . 1.3 tt -119.13 128.19 54.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 115' ' ' LEU . 24.6 m -116.73 129.97 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.349 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 136' ' ' LYS . 58.3 t -112.26 128.12 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.55 ' CG ' HG11 ' A' ' 2' ' ' VAL . 18.5 tttt -115.81 119.62 36.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.4 t80 -110.0 118.67 37.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.141 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.737 ' HG3' HG22 ' A' ' 2' ' ' VAL . 78.4 tt0 -102.14 146.32 28.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.1 p -117.78 167.15 11.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 40.7 mttt -55.41 -32.63 62.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.67 -102.15 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -59.34 -19.82 49.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.44 132.71 48.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -133.49 107.89 12.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.2 146.91 58.83 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.655 2.237 . . . . 0.0 111.776 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -60.3 161.23 7.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.579 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -65.83 -36.45 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.45 -42.5 98.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.21 -40.0 80.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 85.8 mt -64.86 -39.28 93.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -68.13 -46.28 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.42 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.6 m -57.82 -36.51 72.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.08 99.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HG3' HG21 ' A' ' 117' ' ' VAL . 21.5 tttm -64.63 -37.81 88.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.515 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.64 -28.19 53.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -63.59 -45.62 89.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.06 90.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 80.8 m-20 -53.98 -33.74 57.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.71 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 142' ' ' LEU . 3.3 tm? -77.79 -45.15 25.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -55.01 -53.14 59.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 45.3 mttm -54.85 -37.87 66.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.37 -53.51 56.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 22' ' ' LEU . 29.7 mt -68.02 -42.97 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -61.32 -44.64 96.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.98 71.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 26.7 t80 -68.44 -42.5 78.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 18' ' ' LEU . 6.9 mp -67.33 -41.85 84.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.65 -35.0 79.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.419 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.74 -13.41 59.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.84 86.8 57.03 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -20.17 33.47 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 111.788 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -75.85 -15.82 60.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.756 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 66.0 t80 -59.04 141.65 53.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.695 ' OXT' HG23 ' A' ' 17' ' ' THR . 98.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.537 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HE3' ' A' ' 118' ' ' LYS . 92.7 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.18 145.03 48.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -125.2 131.74 53.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.867 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.716 ' CE2' HD12 ' A' ' 132' ' ' LEU . 75.6 m-85 -126.71 156.18 41.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -128.01 132.62 49.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.23 165.13 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -99.56 152.06 20.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.0 mt -120.05 136.78 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 96.0 m-20 -139.13 134.25 32.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.5 126.44 4.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HD2' ' OE2' ' A' ' 147' ' ' GLU . 49.6 Cg_endo -70.22 -5.02 15.52 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.728 2.285 . . . . 0.0 111.81 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.81 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.398 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 126.37 65.83 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.4 Cg_endo -68.23 -24.06 38.33 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.762 2.308 . . . . 0.0 111.834 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.46 64.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.625 HG23 ' C ' ' A' ' 157' ' ' ASN . 89.7 m -76.91 -36.22 56.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' CE1' ' A' ' 143' ' ' PHE . 18.5 tp -70.24 -39.6 74.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.49 -44.22 87.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.874 ' HE2' HG21 ' A' ' 24' ' ' THR . 22.4 tptm -66.15 -46.33 77.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.02 -20.59 60.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.375 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.927 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 42.3 tp -73.56 -49.1 28.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.655 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.96 -47.47 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.748 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.874 HG21 ' HE2' ' A' ' 20' ' ' LYS . 1.4 m -65.78 -46.94 76.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' VAL . 7.6 m-20 -98.51 9.35 43.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.822 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.31 -53.23 11.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.414 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' OD1' HG11 ' A' ' 40' ' ' VAL . 54.5 t0 -68.41 -24.78 64.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.717 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.9 m120 -87.23 -26.78 23.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.59 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 146' ' ' ILE . 9.0 p -82.66 -36.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.5 mt -51.29 -47.99 86.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.3 Cg_endo -68.43 -21.63 40.3 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.352 2.035 . . . . 0.0 111.923 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 40.6 mttm -96.27 -35.15 11.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.293 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.38 -39.47 74.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 57' ' ' PHE . 15.9 tp -88.73 106.66 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.32 -29.8 66.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -104.54 27.93 7.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 109.95 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' ' 39' ' ' SER . 20.2 t80 -56.74 127.84 33.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.153 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -92.31 -52.37 4.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -178.28 171.3 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 0.0 109.838 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.93 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.9 p -142.62 140.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 109.227 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 85.2 mt-10 -151.33 143.74 24.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 70.0 m-20 -84.09 127.38 33.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -83.82 -29.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 94.9 mt-10 -156.72 142.43 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 104.33 162.59 24.49 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -102.9 3.29 36.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 109.53 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.42 -14.9 13.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.7 -161.11 6.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.75 148.42 58.61 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.653 2.235 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 9.39 84.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 52' ' ' ILE . 25.0 m -79.98 157.24 26.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 109.545 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 15.6 mm -116.94 124.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.5 mttm -116.78 143.02 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.687 ' HG3' HD11 ' A' ' 67' ' ' LEU . 20.3 tttm -117.42 129.29 55.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.316 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.93 ' CD1' HG23 ' A' ' 40' ' ' VAL . 11.9 mm -115.12 144.52 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 m -126.22 126.03 43.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.592 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.743 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.8 p90 -129.78 175.22 9.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 57' ' ' PHE . 4.3 mm? -110.04 147.42 33.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 109.543 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -156.58 123.03 5.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 54.34 33.01 17.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.06 4.72 63.68 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -102.37 138.17 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.389 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.5 m -86.38 119.99 27.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -125.44 167.92 14.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.726 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.3 p90 -147.71 161.73 40.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.619 HG13 ' HE1' ' A' ' 57' ' ' PHE . 28.7 m -134.64 143.78 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.321 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 65' ' ' PHE . 5.4 mp -112.57 131.57 55.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -126.27 139.66 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 tttt -118.03 146.72 43.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -108.72 130.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.9 mt-10 -88.94 -33.33 17.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -177.49 157.65 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.16 132.99 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -129.48 78.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.2 mt-10 -64.84 -30.08 71.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -48.98 79.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.377 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 54.5 m-20 -89.86 14.25 12.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 16.2 mt 47.18 52.58 11.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.486 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -153.75 156.56 26.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.4 p90 -150.9 169.85 20.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.0 109.018 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 70.1 m -130.11 139.33 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.89 158.42 40.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 94.8 p -146.35 156.48 43.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG12 HD23 ' A' ' 90' ' ' LEU . 93.0 t -86.11 132.87 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.954 . . . . 0.0 109.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 4.8 t -109.48 -2.73 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.8 42.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.9 175.56 24.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.06 65.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -1.182 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.13 -11.92 59.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.721 HD23 HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -99.68 108.73 52.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.343 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.987 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.8 Cg_endo -69.88 152.91 68.86 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.69 2.26 . . . . 0.0 111.935 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 83.7 m-20 -79.43 -30.12 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.437 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 15.8 p -79.99 7.1 9.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.15 131.29 42.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.489 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 91.9 mt-10 -61.08 -44.05 97.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HA ' HD21 ' A' ' 90' ' ' LEU . 3.8 pttm 179.74 159.21 0.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.942 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' SER . 70.3 mt -118.38 135.7 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.676 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.9 m -107.41 138.76 43.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 76.6 m-85 -119.76 120.25 35.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.564 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -116.25 113.95 23.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.093 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.512 ' OG ' ' CD1' ' A' ' 115' ' ' LEU . 2.6 m -128.13 136.38 51.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.562 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 47.6 tttt -132.78 124.5 28.19 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 53.2 mt -108.57 132.9 53.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.062 -1.023 . . . . 0.0 110.266 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.8 143.05 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.06 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.34 141.17 51.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.47 166.03 22.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.4 -4.94 15.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.622 2.215 . . . . 0.0 111.792 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.98 -27.36 66.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.82 23.42 11.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -149.96 -131.1 1.87 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.511 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 68.9 m -118.73 143.98 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.3 166.06 25.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.274 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 164.86 -177.6 40.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 28.2 ttpt -123.24 143.25 50.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -1.089 . . . . 0.0 109.396 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HB2' HD11 ' A' ' 9' ' ' ILE . 30.2 tp -116.5 135.3 53.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -124.25 125.93 45.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.94 132.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.598 ' HE3' HG11 ' A' ' 2' ' ' VAL . 23.6 tttt -116.43 116.04 26.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.676 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 33.3 t80 -105.9 122.09 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 90.9 mt-10 -105.63 141.44 37.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.658 HG21 ' CD ' ' A' ' 127' ' ' PRO . 16.6 p -118.29 164.61 14.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -0.978 . . . . 0.0 109.552 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 92.7 mttt -56.99 -40.06 75.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.45 -92.22 0.11 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -37.2 83.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -1.175 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.43 135.58 39.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.29 109.83 15.09 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.658 ' CD ' HG21 ' A' ' 121' ' ' THR . 51.3 Cg_endo -70.24 124.29 10.75 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.675 2.25 . . . . 0.0 111.875 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -60.04 161.05 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.42 -36.15 80.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -56.03 -31.43 63.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.03 -34.95 61.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.271 -0.893 . . . . 0.0 108.729 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.716 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.53 -39.29 90.51 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -60.22 -48.31 82.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.5 m -57.22 -36.75 71.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.3 99.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -60.37 -37.1 79.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -1.091 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.72 -30.43 61.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.252 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -66.0 -44.86 83.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.21 -55.41 10.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.9 -34.92 63.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.97 75.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.276 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 146' ' ' ILE . 29.8 mt -74.94 -44.0 50.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.91 ' CE1' HD21 ' A' ' 18' ' ' LEU . 73.9 t80 -61.62 -55.78 26.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.166 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -49.49 -46.73 48.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.303 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.94 77.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.153 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 29' ' ' VAL . 34.3 mt -67.11 -44.11 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.251 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 12' ' ' PRO . 80.0 tt0 -60.46 -44.91 95.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -31.11 70.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.21 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 21.6 t80 -66.79 -38.88 87.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.85 . . . . 0.0 109.303 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.512 HD22 ' CD1' ' A' ' 18' ' ' LEU . 7.5 mp -72.86 -40.85 65.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.18 -37.78 78.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.51 -15.84 60.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.382 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -126.7 90.25 50.17 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.1 -18.91 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.61 2.207 . . . . 0.0 111.793 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -74.12 -12.68 60.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 63.8 t80 -80.01 125.48 29.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.625 ' C ' HG23 ' A' ' 17' ' ' THR . 63.7 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.412 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 118' ' ' LYS . 89.4 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.316 0.579 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.61 149.53 42.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.7 m -129.81 128.84 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 0.0 109.428 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.734 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.4 m-85 -119.81 163.34 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -135.59 133.81 38.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.411 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.29 166.09 25.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.15 151.17 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.508 HG21 HD11 ' A' ' 103' ' ' LEU . 65.1 mt -114.36 128.22 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -128.95 127.61 42.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 13' ' ' VAL . 75.7 m -153.43 132.92 7.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -19.0 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.677 2.251 . . . . 0.0 111.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 18' ' ' LEU . 2.2 p -70.39 153.1 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.545 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 139.77 97.73 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.22 -26.78 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.81 2.34 . . . . 0.0 111.91 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.52 -39.24 53.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -79.76 -41.85 25.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.77 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.757 HD13 HG11 ' A' ' 13' ' ' VAL . 3.9 tp -67.15 -38.5 85.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.401 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 79.0 t80 -70.63 -36.4 73.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.9 tptt -67.17 -47.21 71.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 109.781 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -72.27 -40.13 67.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.836 ' CD1' HD13 ' A' ' 146' ' ' ILE . 64.5 tp -53.33 -45.66 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -97.3 -53.63 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.974 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.575 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.1 m -66.38 -50.09 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.694 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -92.44 19.66 6.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -60.46 -51.61 68.71 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.155 -0.966 . . . . 0.0 109.143 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.87 ' HA ' HD12 ' A' ' 30' ' ' ILE . 86.6 m-20 -66.69 -31.24 71.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.648 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 75.2 m-20 -83.23 -29.57 28.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 25' ' ' ASP . 77.4 t -78.64 -34.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.0 mt -51.33 -51.71 66.17 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.929 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.9 Cg_endo -68.39 -34.87 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.552 2.168 . . . . 0.0 111.888 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 50.9 mttm -79.95 -40.75 27.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.089 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -65.88 -38.08 87.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.874 . . . . 0.0 108.909 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 57' ' ' PHE . 41.0 tp -87.16 106.0 17.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 108.968 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.11 -28.18 67.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -105.38 27.49 8.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.966 -1.084 . . . . 0.0 109.879 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.807 ' HA ' HD23 ' A' ' 34' ' ' LEU . 44.6 t80 -53.24 125.43 17.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -90.9 -56.22 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.806 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 28.8 p -174.27 166.56 4.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.681 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.69 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 2.9 p -144.79 143.48 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.9 mt-10 -147.17 152.1 37.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.559 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -79.55 131.08 35.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 13.8 t -83.65 -44.38 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.315 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 51' ' ' THR . 80.8 mt-10 -159.38 146.87 17.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 95.59 -175.68 33.11 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -110.73 6.17 21.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' HG21 ' A' ' 51' ' ' THR . . . 109.74 -3.7 30.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.63 -156.35 13.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.24 138.76 37.03 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.741 2.294 . . . . 0.0 111.811 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.46 -4.04 75.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 44' ' ' GLU . 26.1 m -69.18 155.01 41.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 109.566 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 20.4 mm -119.33 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.19 147.35 46.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.846 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.662 ' HG3' HD21 ' A' ' 67' ' ' LEU . 22.4 tttt -116.89 127.35 54.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.22 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 63.7 mt -115.25 145.35 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -0.999 . . . . 0.0 109.848 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 24.0 m -128.1 123.0 33.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.201 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.883 ' HB2' HD21 ' A' ' 34' ' ' LEU . 23.8 p90 -125.53 174.27 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.637 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 57' ' ' PHE . 3.2 mm? -112.63 138.25 49.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE1' ' HE3' ' A' ' 64' ' ' LYS . 75.8 tt0 -148.49 127.76 12.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 53.12 34.62 17.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.77 66.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -107.3 134.14 50.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 m -82.73 116.16 21.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 23.0 mttm -116.74 164.21 14.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 18.5 p90 -145.87 157.75 43.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.7 p -141.2 149.68 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.898 . . . . 0.0 109.618 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 54' ' ' LYS . 48.2 mt -112.6 130.98 55.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.241 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -122.55 136.88 55.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 42.3 tttm -119.08 145.18 46.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.87 127.05 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 93.6 mt-10 -82.46 -53.45 5.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -162.73 137.59 6.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.78 133.73 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.91 . . . . 0.0 109.338 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -129.18 76.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 86.8 mt-10 -54.61 -37.61 65.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.19 57.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 78' ' ' LEU . 64.6 m-20 -90.67 17.0 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.377 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 11.6 mt 43.57 46.24 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.576 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.49 158.9 27.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.5 p90 -152.02 170.04 20.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -1.217 . . . . 0.0 109.131 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 4.7 m -126.3 138.84 53.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -156.06 160.67 40.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 54.8 p -150.41 158.22 43.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.483 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 89' ' ' ALA . 14.5 p -97.41 135.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 109.086 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.1 m -130.16 3.87 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -156.19 146.26 13.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.01 -174.29 16.79 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.17 62.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.85 1.49 30.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -112.9 83.52 6.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.328 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -68.9 163.43 37.48 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.897 2.398 . . . . 0.0 111.998 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 70.1 m-20 -80.12 -32.71 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.912 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 33.9 p -79.55 -11.99 59.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 110.026 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -119.95 127.75 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -62.51 -50.79 70.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -177.33 156.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.42 137.55 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 1.4 m -107.42 138.2 44.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.848 . . . . 0.0 109.135 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.2 m-85 -118.56 120.58 37.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.881 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -117.2 106.39 13.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -115.59 136.13 53.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.773 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.618 ' C ' HD22 ' A' ' 103' ' ' LEU . 20.3 tttt -132.96 131.26 40.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.833 . . . . 0.0 109.123 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 103' ' ' LEU . 1.7 mm? -118.18 127.44 53.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.364 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -120.48 172.58 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -80.25 127.14 32.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.206 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.99 155.54 17.93 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 -1.95 8.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.578 2.185 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -74.11 -15.55 61.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 7.15 63.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.56 -138.08 4.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 103' ' ' LEU . 2.7 t -122.25 140.65 52.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -1.113 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.698 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.42 147.81 31.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.207 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -174.08 -143.63 4.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.05 138.95 32.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.353 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 116' ' ' THR . 3.9 tt -115.31 136.4 53.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.969 ' N ' HD23 ' A' ' 115' ' ' LEU . 14.5 m -125.5 126.89 45.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.35 136.16 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.331 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 2' ' ' VAL . 26.6 tttt -116.07 121.02 40.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.732 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 30.3 t80 -103.58 126.56 50.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HA ' HG22 ' A' ' 2' ' ' VAL . 82.9 mt-10 -109.73 130.94 55.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.5 p -107.4 156.73 18.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 73.5 mmtt -60.13 -37.0 78.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.82 -103.84 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.35 -35.52 72.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -1.187 . . . . 0.0 109.468 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.9 136.98 33.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -149.34 107.66 3.36 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.2 Cg_endo -70.04 151.55 67.52 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.734 2.289 . . . . 0.0 111.699 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -83.22 178.73 7.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 132' ' ' LEU . 92.9 mt-30 -67.89 -35.35 78.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.59 -48.53 80.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -61.14 -39.14 88.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.38 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.734 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 67.0 mt -63.64 -35.79 81.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 26.2 mttt -64.22 -48.53 75.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 138' ' ' LYS . 86.8 m -56.22 -33.24 65.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.343 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.22 -43.13 99.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 140' ' ' ASP . 23.9 tttp -67.14 -39.58 86.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -1.149 . . . . 0.0 109.497 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -31.22 64.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.29 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 134' ' ' THR . 46.3 mttm -77.3 -40.7 43.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.05 -26.41 53.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.825 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 96.9 m-20 -60.78 -41.64 95.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -44.95 82.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 142' ' ' LEU . 23.0 mt -54.71 -46.19 74.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -61.61 -50.26 73.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 148' ' ' ALA . 88.6 mttt -63.22 -33.56 75.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.7 -52.46 64.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.836 HD13 ' CD1' ' A' ' 22' ' ' LEU . 11.7 mt -68.47 -51.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.21 -45.22 91.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.697 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 144' ' ' LYS . . . -59.63 -31.39 69.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.519 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.4 t80 -69.3 -41.14 77.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.64 HD22 HD12 ' A' ' 18' ' ' LEU . 7.8 mp -66.43 -46.3 76.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.636 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.39 -33.79 74.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.96 -11.9 57.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.566 ' CE1' ' CZ ' ' A' ' 149' ' ' TYR . 74.4 m80 -122.06 90.16 48.72 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.26 -21.57 30.95 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.673 2.249 . . . . 0.0 111.767 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -70.87 -17.88 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 42.3 t80 -67.31 158.8 30.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.571 ' O ' HG21 ' A' ' 17' ' ' THR . 74.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.639 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.566 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 97.6 m-85 -81.51 126.87 32.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 117.88 27.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.309 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.944 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.8 m-85 -110.25 164.23 12.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.624 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 88.2 mt-10 -134.05 134.24 42.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -137.09 165.0 27.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -104.13 158.59 16.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 42.3 mt -129.14 137.37 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.71 137.0 34.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.9 OUTLIER -152.58 138.68 11.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.09 0.74 6.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.665 2.243 . . . . 0.0 111.96 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.867 ' CG1' HD11 ' A' ' 18' ' ' LEU . 69.4 t -98.17 155.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.829 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -64.21 127.64 92.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.511 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 44.4 Cg_endo -66.84 -25.51 45.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.801 2.334 . . . . 0.0 111.904 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.928 . . . . 0.0 109.036 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 157' ' ' ASN . 76.5 m -72.7 -38.86 67.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.182 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.867 HD11 ' CG1' ' A' ' 13' ' ' VAL . 2.4 mp -70.29 -38.63 75.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 72.5 t80 -63.92 -50.27 69.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE3' HG21 ' A' ' 24' ' ' THR . 12.2 tptt -65.05 -46.38 81.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.749 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.63 -28.33 63.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.964 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.4 tp -67.01 -47.36 71.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.857 . . . . 0.0 109.67 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -97.96 -51.7 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.576 HG21 ' HE3' ' A' ' 20' ' ' LYS . 2.1 m -62.62 -45.64 91.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.7 m-20 -98.44 6.14 47.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.08 -1.012 . . . . 0.0 109.767 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.964 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -45.96 -53.27 10.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.6 m-20 -67.54 -23.3 65.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.772 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 90.9 m-20 -89.84 -25.79 20.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -83.39 -35.98 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 109.545 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.952 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.3 mt -55.36 -47.07 99.44 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 110.211 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.6 Cg_endo -68.08 -35.97 18.46 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.307 2.004 . . . . 0.0 112.193 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 32.3 mttm -87.91 -29.28 20.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.421 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -69.42 -34.77 74.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.257 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 57' ' ' PHE . 54.5 tp -96.18 113.31 24.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.32 -40.92 92.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.663 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -93.71 26.8 2.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.811 -1.181 . . . . 0.0 110.117 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 30' ' ' ILE . 57.2 t80 -59.91 134.11 56.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.124 -0.985 . . . . 0.0 109.409 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' SER . 33.6 tttm -95.28 -49.12 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.312 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 68.9 p -178.59 172.13 1.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 40' ' ' VAL . 6.0 p -135.91 129.97 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.274 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -135.53 145.47 47.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 109.613 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.97 128.08 34.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 13.9 t -85.17 -41.0 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.673 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 51' ' ' THR . 96.5 mt-10 -158.58 145.44 17.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.601 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 159.04 30.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -94.59 5.36 52.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.93 -9.28 23.28 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.03 -158.66 13.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.05 131.16 20.26 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.644 2.23 . . . . 0.0 111.687 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 93.23 0.44 67.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 44' ' ' GLU . 90.3 m -76.01 154.78 35.5 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.307 -1.114 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 69' ' ' LYS . 71.2 mt -129.89 138.32 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -126.67 152.39 46.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.6 tttm -112.87 125.74 54.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.425 -0.797 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 66' ' ' VAL . 83.9 mt -113.88 142.95 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.2 m -131.36 119.54 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.962 ' HB2' HD21 ' A' ' 34' ' ' LEU . 39.0 p90 -124.5 171.55 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.348 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 145.85 31.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 62' ' ' GLU . 84.9 tt0 -141.84 123.74 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 49.66 27.73 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.66 71.38 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' GLU . 99.6 mt-10 -106.47 157.58 17.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -1.085 . . . . 0.0 109.421 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.2 m -104.94 112.55 25.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.413 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -120.35 162.95 18.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -145.66 158.96 43.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 55' ' ' ILE . 22.4 m -138.31 147.05 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 86' ' ' GLY . 12.8 mt -116.63 137.82 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.065 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.72 141.82 50.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.752 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' HG12 ' A' ' 52' ' ' ILE . 19.4 tttm -117.77 146.41 43.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.87 . . . . 0.0 109.121 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.0 mt -104.75 126.57 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -88.18 -40.19 13.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 t -173.74 150.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.58 132.67 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -127.03 85.51 2.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' OH ' ' A' ' 19' ' ' TYR . 97.0 mt-10 -64.24 -31.69 72.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.85 84.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -89.3 14.86 10.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.539 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 19.4 mt 47.52 51.86 13.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.27 27.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 28.7 p90 -150.96 168.4 24.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 108.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -126.67 138.64 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 19.4 p90 -152.49 155.82 38.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.382 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 t -144.85 156.06 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.624 HG22 HD12 ' A' ' 90' ' ' LEU . 10.0 p -98.52 128.35 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HE2' ' A' ' 96' ' ' LYS . 1.5 t -127.49 4.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.729 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.46 148.48 17.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 128.0 152.29 7.8 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.38 47.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.275 -1.132 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 138' ' ' LYS . . . -79.89 -7.92 59.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -79.81 116.28 59.89 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.3 Cg_endo -68.48 146.6 68.7 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.767 2.311 . . . . 0.0 111.911 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 66.2 m-20 -78.84 -29.57 44.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.632 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 29.4 p -79.82 -7.49 58.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -118.27 123.57 45.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.339 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 86.3 mt-10 -62.28 -52.18 64.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.703 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' A' ' 85' ' ' VAL . 7.4 mtpm? -159.1 161.65 36.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 109.721 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.4 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CE ' ' A' ' 118' ' ' LYS . 8.9 m -109.83 137.58 47.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.95 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 78.8 m-85 -120.23 121.29 38.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 58.5 t0 -117.02 110.51 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.204 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -123.25 136.64 54.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.559 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 75.8 tttt -130.72 127.43 38.78 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.6 mm? -107.62 130.19 54.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.057 -1.027 . . . . 0.0 110.152 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -138.03 143.02 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.03 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 139.52 57.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.104 -0.998 . . . . 0.0 109.718 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.43 22.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.78 -9.71 26.76 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.774 2.316 . . . . 0.0 111.825 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.49 -31.95 68.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.84 27.93 6.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -157.94 -125.16 0.82 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 73.9 m -118.54 144.91 45.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 9' ' ' ILE . . . -143.58 162.49 35.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.763 . . . . 0.0 108.991 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 171.63 176.15 40.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -112.08 141.22 46.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.439 -1.036 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 29.0 tp -116.33 131.62 56.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.519 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 26.0 m -130.0 122.11 27.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -0.926 . . . . 0.0 109.144 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.67 135.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.639 ' CG ' HG21 ' A' ' 2' ' ' VAL . 7.0 ttpt -115.0 116.71 28.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.15 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 36.6 t80 -107.73 120.92 43.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.672 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 98.2 mt-10 -106.32 133.52 50.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.866 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.4 p -109.92 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.4 mttt -54.85 -42.31 71.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.56 -92.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ALA . 82.1 m-20 -69.2 -35.8 76.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -45.03 133.79 6.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -126.24 121.13 23.78 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.866 ' HD3' HG21 ' A' ' 121' ' ' THR . 49.3 Cg_endo -69.96 149.85 66.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.717 2.278 . . . . 0.0 111.743 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.7 m-20 -92.16 155.31 18.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -50.42 -38.33 42.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.24 -48.54 81.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.33 -42.08 90.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.944 HD13 ' CE2' ' A' ' 5' ' ' PHE . 74.3 mt -60.15 -34.52 73.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.46 -46.47 82.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.259 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.5 m -57.4 -36.97 71.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.13 -47.36 91.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 140' ' ' ASP . 11.0 mtmm -57.09 -36.6 70.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -1.146 . . . . 0.0 109.391 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -58.23 -33.49 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 89' ' ' ALA . 69.5 tttt -74.34 -43.14 57.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -69.76 -49.06 56.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 7.5 p30 -68.43 -22.56 64.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -56.86 -48.69 77.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.7 tp -56.39 -35.52 67.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -74.33 -53.23 10.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 109.14 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -52.73 -37.92 59.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 -49.56 56.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.922 HG23 HG21 ' A' ' 29' ' ' VAL . 51.7 mt -63.07 -55.33 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.55 -50.31 13.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.18 -37.82 72.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 41.1 t80 -68.44 -38.13 80.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 18' ' ' LEU . 45.8 mt -59.16 -38.31 79.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mt -75.04 -27.68 60.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.61 61.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -128.5 91.88 42.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.27 -18.06 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.737 2.291 . . . . 0.0 111.747 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -77.26 -17.69 58.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.816 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.8 t80 -67.77 120.09 13.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.541 ' CB ' HG23 ' A' ' 17' ' ' THR . 6.2 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 119' ' ' TYR . 60.0 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -132.07 122.54 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.624 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 117' ' ' VAL . 79.2 m -110.67 144.24 39.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 89.4 m-85 -132.7 132.62 42.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.0 mt-10 -106.14 133.74 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -137.15 164.98 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.385 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.87 157.61 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.4 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.424 HD11 ' OG ' ' A' ' 101' ' ' SER . 14.6 mt -125.65 134.42 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 109.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 97.9 m-20 -140.68 132.87 28.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' OE2' ' A' ' 147' ' ' GLU . 27.3 m -152.78 138.63 11.81 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.52 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.26 -0.45 7.34 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.602 2.201 . . . . 0.0 111.714 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.87 ' HB ' HD11 ' A' ' 18' ' ' LEU . 98.1 t -94.73 153.49 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.6 139.31 97.59 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 46.7 Cg_endo -68.01 -25.77 37.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.734 2.289 . . . . 0.0 111.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.36 -37.6 60.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 157' ' ' ASN . 60.3 m -75.01 -39.39 61.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 13' ' ' VAL . 20.0 mt -68.69 -39.11 80.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 78.0 t80 -64.54 -50.03 68.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.585 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 24' ' ' THR . 8.5 tptm -63.4 -46.43 86.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -73.18 -24.51 60.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 18.4 tp -75.37 -48.83 21.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.686 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.75 -49.89 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.886 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -65.82 -48.83 70.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.957 . . . . 0.0 110.145 -179.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 6.3 t70 -91.01 14.67 13.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.723 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -56.09 -52.16 65.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.263 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 22.1 t70 -66.1 -25.89 67.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.946 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.0 m120 -90.92 -26.06 19.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.601 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' ALA . 8.0 p -83.87 -39.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 109.575 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.7 mt -52.88 -45.46 97.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.63 -21.84 45.04 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.394 2.063 . . . . 0.0 112.242 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' ALA . 41.8 mttm -108.98 -51.77 2.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 109.585 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . -42.28 -33.19 0.59 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.978 HD21 ' HB2' ' A' ' 57' ' ' PHE . 44.8 tp -92.52 112.62 24.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.067 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.4 -47.16 82.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.526 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.9 m -88.38 29.36 0.98 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.915 -1.116 . . . . 0.0 110.173 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 67.2 t80 -61.89 130.54 46.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.505 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' CD ' HD23 ' A' ' 58' ' ' LEU . 3.6 mtpm? -102.42 -48.58 4.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.639 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 37' ' ' PHE . 54.8 p -172.51 164.89 5.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 3.9 p -143.3 141.81 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 109.326 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -144.08 148.36 35.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.61 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -80.64 132.07 35.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 19.0 t -79.99 -42.12 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 51' ' ' THR . 71.2 mt-10 -161.74 149.33 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.72 -168.85 36.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -132.12 35.08 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.742 ' H ' HG21 ' A' ' 51' ' ' THR . . . 91.55 -1.92 76.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 51' ' ' THR . . . -76.73 -168.31 28.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.74 139.88 41.4 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.691 2.261 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 77.14 2.96 80.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 44' ' ' GLU . 85.9 m -69.23 150.44 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.58 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 25.1 mm -114.62 123.44 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -118.06 143.83 46.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.856 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . 86.8 tttt -116.35 128.25 55.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 109.081 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.666 ' HB ' HG22 ' A' ' 66' ' ' VAL . 58.7 mt -114.28 140.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.1 m -119.42 120.74 37.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.216 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.978 ' HB2' HD21 ' A' ' 34' ' ' LEU . 40.5 p90 -131.5 176.02 8.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -116.98 131.2 57.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -137.12 130.96 31.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 55.14 20.83 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.92 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.32 20.55 64.28 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.8 mt-10 -118.28 141.61 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.6 m -80.9 111.79 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 70.7 mttt -121.89 163.06 19.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 36.0 p90 -144.27 158.11 43.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.385 -0.822 . . . . 0.0 109.226 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' HE1' ' A' ' 57' ' ' PHE . 34.1 m -133.55 142.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 109.705 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.86 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.7 mt -111.23 130.55 55.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 109.003 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -126.23 139.83 53.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.146 -0.971 . . . . 0.0 109.71 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -122.52 150.81 42.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.238 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.7 mt -111.46 133.05 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.554 ' OE2' HG21 ' A' ' 98' ' ' THR . 94.0 mt-10 -89.42 -33.57 16.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.243 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -172.82 155.39 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.54 131.86 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.327 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.56 81.51 2.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 78.3 mt-10 -59.18 -36.84 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.29 -41.31 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.634 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 6.4 m-20 -101.1 14.01 33.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.546 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.75 25.98 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.318 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.24 150.73 17.79 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.89 169.16 22.95 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -1.208 . . . . 0.0 109.166 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 61.0 m -130.96 139.01 49.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.98 . . . . 0.0 109.375 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.618 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 14.1 p90 -151.87 154.79 36.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 79.9 p -144.41 155.8 43.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.355 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.1 p -95.8 131.16 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.244 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -124.14 2.04 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.605 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.86 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -163.77 153.38 23.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 117.07 172.13 16.03 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.21 -13.05 62.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -1.099 . . . . 0.0 109.46 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.04 59.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 4.8 tt -100.2 107.22 46.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.991 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.9 Cg_endo -69.43 149.86 69.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.68 2.253 . . . . 0.0 111.912 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 83.6 m-20 -76.76 -28.71 55.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -79.86 6.6 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.7 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.991 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -133.7 142.52 48.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.596 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 122' ' ' LYS . 77.4 mt-10 -69.14 -54.6 14.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -175.64 159.71 2.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.347 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 83' ' ' SER . 55.4 mt -118.18 136.2 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.554 HG21 ' OE2' ' A' ' 71' ' ' GLU . 7.9 m -112.12 117.85 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.126 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.915 ' CD1' HG23 ' A' ' 117' ' ' VAL . 89.0 m-85 -96.28 125.41 40.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.826 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 116' ' ' THR . 89.9 m-20 -117.74 129.3 55.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 109.206 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.8 t -146.63 136.81 23.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 103' ' ' LEU . 28.3 tttt -117.2 159.1 23.17 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 102' ' ' LYS . 33.6 mt -133.42 123.77 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.877 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.66 142.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.24 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.35 57.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.46 166.93 23.25 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.5 -0.05 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.646 2.231 . . . . 0.0 111.821 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -69.37 -28.34 66.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.11 26.78 8.14 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -156.14 -127.16 1.01 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 99.5 p -121.77 142.8 49.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -1.134 . . . . 0.0 109.746 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.57 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 162.95 168.64 25.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -105.29 147.66 27.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.137 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 100' ' ' ASP . 49.6 tp -115.01 136.56 52.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 100' ' ' ASP . 24.6 m -138.78 119.31 13.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.043 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.915 HG23 ' CD1' ' A' ' 99' ' ' PHE . 2.7 p -112.33 138.68 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 110.142 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 31.9 tttt -114.29 120.08 39.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 2' ' ' VAL . 37.4 t80 -102.72 126.82 49.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -111.41 126.65 55.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.353 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 34.2 p -99.91 165.91 11.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 20.4 mmtp -71.01 -36.34 72.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.19 -100.0 0.16 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -65.08 -28.57 69.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.92 137.07 58.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -147.18 112.51 4.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.44 141.33 42.2 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.715 2.277 . . . . 0.0 111.7 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -69.78 168.65 14.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.89 . . . . 0.0 109.55 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HA ' HD12 ' A' ' 132' ' ' LEU . 46.6 tt0 -60.34 -39.64 87.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.882 . . . . 0.0 109.444 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.85 -43.86 97.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.27 -39.34 82.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 25.0 mt -64.65 -36.82 85.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.63 -49.5 76.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 85.5 m -57.45 -32.45 66.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.89 -47.98 86.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . 27.9 ttpp -65.27 -38.32 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -1.133 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -54.41 -28.4 43.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -76.21 -38.18 56.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.453 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.13 -55.08 8.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 3.9 p30 -63.43 -25.05 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -61.22 -53.44 56.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 109.319 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 142' ' ' LEU . 19.0 mt -59.53 -35.21 73.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.15 -52.69 62.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -53.12 -38.42 62.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.39 -39.63 80.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.361 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 mm -62.73 -43.62 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.391 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.463 ' OE2' ' OG ' ' A' ' 11' ' ' SER . 90.6 mt-10 -64.28 -37.27 86.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.53 81.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.401 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 33.9 t80 -70.53 -52.5 21.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 18' ' ' LEU . 9.3 mp -63.77 -36.52 84.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.7 tp -76.1 -36.44 58.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.21 -20.43 61.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -134.38 98.58 13.76 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -11.42 30.22 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 111.788 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.72 -26.66 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.957 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 62.5 t80 -64.43 138.79 58.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' THR . 2.3 p-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.509 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 88.4 m-85 -80.83 120.57 24.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 19.8 m -109.94 117.09 32.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 97.0 m-85 -114.61 142.11 46.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 81.4 tt0 -109.3 133.34 53.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.265 -0.897 . . . . 0.0 109.63 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -130.01 164.41 24.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.58 153.59 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 54.1 mt -119.23 144.2 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -142.45 128.88 20.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.64 138.23 11.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.503 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.39 -12.82 32.36 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.702 2.268 . . . . 0.0 111.785 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.604 HG11 HD12 ' A' ' 150' ' ' LEU . 1.6 p -81.49 152.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 141.69 95.88 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.92 -28.51 35.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.735 2.29 . . . . 0.0 111.747 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.96 -41.39 59.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.3 m -76.21 -37.43 57.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.347 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.719 ' CD1' HD11 ' A' ' 150' ' ' LEU . 11.9 tp -69.15 -39.93 78.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 79.5 t80 -64.89 -44.81 88.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HE2' HG21 ' A' ' 24' ' ' THR . 12.8 tptm -65.18 -46.72 79.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.733 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -73.1 -17.77 61.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.967 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 19.5 tp -79.18 -48.25 14.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.91 -52.22 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.77 HG21 ' HE2' ' A' ' 20' ' ' LYS . 4.3 m -63.39 -49.37 74.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.943 . . . . 0.0 110.208 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m-20 -95.34 8.08 44.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.967 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.61 -53.22 11.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 109.292 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.792 ' HA ' HD12 ' A' ' 30' ' ' ILE . 56.7 t0 -65.07 -24.89 67.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 95.3 m-20 -87.16 -26.81 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 146' ' ' ILE . 98.2 t -82.66 -35.53 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 27' ' ' ASP . 7.0 mt -50.98 -47.84 86.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 110.327 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.8 Cg_endo -67.53 -28.08 38.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.44 2.093 . . . . 0.0 112.183 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -90.73 -45.41 8.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.559 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.4 mp -76.04 102.22 5.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -54.89 -46.25 74.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.871 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 88.4 p -91.51 30.1 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -57.23 122.56 12.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.07 -53.56 4.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.675 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 34.9 p -174.9 167.89 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.752 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.828 HG22 HG23 ' A' ' 55' ' ' ILE . 99.6 t -143.92 143.91 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.148 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.8 mt-10 -155.0 158.4 39.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 73.2 m-20 -96.65 124.9 40.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 6.8 m -82.01 -27.9 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 56.9 mm-40 -161.33 151.26 17.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.87 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.749 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 105.09 168.61 24.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -121.68 27.43 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -1.197 . . . . 0.0 109.62 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.97 -19.05 56.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.38 -169.18 28.72 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.95 140.97 43.26 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 111.71 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 88.64 5.64 74.44 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.749 HG23 ' HA3' ' A' ' 45' ' ' GLY . 59.6 m -75.12 150.78 38.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -1.153 . . . . 0.0 109.759 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 17.2 mm -112.5 123.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 108.994 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.4 mttm -119.76 144.67 47.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.853 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.705 ' HG3' HD11 ' A' ' 67' ' ' LEU . 2.2 ttmt -120.41 133.78 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.133 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.828 HG23 HG22 ' A' ' 40' ' ' VAL . 74.8 mt -123.91 143.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 36.0 m -124.63 122.26 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 43.1 p90 -127.24 165.84 18.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 1.2 mp -100.23 143.29 30.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.4 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -156.19 131.81 9.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 56.41 28.39 13.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.69 0.49 63.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 49.2 tp10 -107.24 138.95 42.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -1.186 . . . . 0.0 109.537 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.4 m -86.03 124.94 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 34.0 mttp -128.63 172.47 11.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.798 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.5 p90 -147.31 161.32 41.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.516 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.605 ' O ' HD12 ' A' ' 67' ' ' LEU . 32.6 m -135.53 145.05 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.43 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.798 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.4 mp -114.49 133.02 56.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.923 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -132.04 145.32 51.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 16.1 tttm -124.5 146.55 48.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 7.0 mm -101.58 131.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.3 pt-20 -103.5 -32.68 9.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.995 . . . . 0.0 109.828 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 35.9 t -165.78 138.43 4.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.909 -1.119 . . . . 0.0 109.955 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.35 136.25 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 91.4 m-20 -130.69 83.18 2.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.43 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.4 mt-10 -63.67 -34.58 78.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.05 67.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.286 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -87.26 12.59 11.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 8.7 mt 48.02 37.25 7.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.474 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -132.64 151.96 20.13 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -151.63 166.44 31.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.065 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 71' ' ' GLU . 29.0 t -137.37 143.17 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.2 p90 -153.05 160.62 42.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.339 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 t -139.12 153.8 48.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 67' ' ' LEU . 14.4 p -85.1 133.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 10.0 t -109.97 -4.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.49 43.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.05 164.27 15.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.59 -14.25 12.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -1.126 . . . . 0.0 109.452 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 138' ' ' LYS . . . -81.89 -12.08 58.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.64 115.34 60.23 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.978 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.08 147.56 61.11 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.677 2.252 . . . . 0.0 111.829 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.48 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 90.6 m-20 -79.57 -31.93 41.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.615 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 p -83.79 3.74 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.715 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.43 143.23 49.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 109.624 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' OE2' ' HG2' ' A' ' 122' ' ' LYS . 62.6 mm-40 -69.27 -51.57 36.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.421 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -171.28 163.09 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.548 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.4 mt -120.56 137.21 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -108.21 126.8 53.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.2 m-85 -108.3 125.81 52.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 115' ' ' LEU . 25.6 t0 -120.11 102.81 8.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.188 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 9' ' ' ILE . 34.1 t -111.95 142.15 44.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.842 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.3 tttm -127.1 146.71 50.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 108.896 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.842 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.5 mm? -125.69 129.75 50.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.855 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 112' ' ' ALA . 1.2 m -143.91 167.31 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 109.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.585 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -74.92 133.94 41.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.22 163.21 16.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.75 -3.96 13.06 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.628 2.219 . . . . 0.0 111.689 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.15 -23.84 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.87 24.98 10.07 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.71 -138.44 2.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -99.13 145.14 27.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.686 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.79 140.62 24.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.113 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -175.84 -170.58 38.8 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.422 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mttt -127.11 139.36 53.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -1.119 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.87 HD23 ' N ' ' A' ' 116' ' ' THR . 3.0 tt -114.31 137.73 51.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.87 ' N ' HD23 ' A' ' 115' ' ' LEU . 13.9 m -114.3 133.4 55.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 4' ' ' THR . 96.2 t -109.26 127.72 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.55 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 97' ' ' ILE . 37.5 tttp -115.09 122.24 45.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 42.8 t80 -117.59 115.32 24.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 95.7 mt-10 -103.61 140.36 37.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 17.5 p -106.49 165.77 11.03 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.612 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 75.1 mttt -73.85 -34.01 64.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.48 -145.91 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.14 -13.04 61.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.197 . . . . 0.0 109.468 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.69 130.16 24.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.07 131.49 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.7 Cg_endo -70.06 157.5 59.59 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.771 2.314 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.476 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 1.5 m-20 -86.94 175.15 8.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -71.13 -41.51 70.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -57.63 -47.13 83.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 69.4 mm-40 -58.03 -41.07 82.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' A' ' 5' ' ' PHE . 89.7 mt -62.55 -44.95 95.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -61.27 -46.41 90.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.335 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -58.99 -40.75 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.01 97.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -66.92 -39.84 87.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.338 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.85 80.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 109.284 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 39.8 mttm -60.78 -52.89 63.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.37 -56.07 6.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 52.0 t0 -50.04 -26.73 4.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.652 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.64 75.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 146' ' ' ILE . 1.3 tp -59.0 -45.53 90.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.199 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.474 ' HE1' HD21 ' A' ' 18' ' ' LEU . 68.7 t80 -68.6 -34.82 76.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.38 -0.825 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 85.6 mttt -64.04 -44.85 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.16 68.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.917 . . . . 0.0 109.312 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 29' ' ' VAL . 71.0 mt -58.6 -54.32 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -46.07 -53.74 9.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.85 69.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.877 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -65.7 -32.77 74.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.306 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 18' ' ' LEU . 17.1 mt -70.28 -44.33 68.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.372 -0.83 . . . . 0.0 109.529 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.11 -34.5 78.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.62 61.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -130.1 83.23 63.94 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.48 -19.34 37.58 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.682 2.255 . . . . 0.0 111.726 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -93.92 16.36 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.425 ' HE2' ' HB2' ' A' ' 21' ' ' ALA . 61.7 t80 -60.75 135.61 57.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.551 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.0 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.268 0.556 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.42 135.77 51.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.9 m -116.89 130.49 56.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 132' ' ' LEU . 83.7 m-85 -128.78 158.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -133.15 139.76 47.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.461 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -142.33 165.71 26.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -108.29 150.15 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 52.9 mt -115.02 142.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.399 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 40.5 m-20 -134.69 129.43 34.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 m -151.9 129.16 5.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.68 0.15 6.78 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.753 2.302 . . . . 0.0 111.693 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.09 152.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.643 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 134.42 91.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.19 -29.57 32.58 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.74 2.293 . . . . 0.0 111.935 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.11 -37.24 61.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 HD22 ' A' ' 157' ' ' ASN . 39.7 m -80.13 -40.4 27.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 150' ' ' LEU . 3.8 tp -68.38 -38.29 81.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 84.4 t80 -71.2 -36.61 71.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.923 . . . . 0.0 109.773 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 24' ' ' THR . 48.6 tptt -68.92 -47.24 66.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.842 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -75.9 -37.19 59.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.485 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 22.7 tp -52.87 -47.18 68.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.7 t -97.48 -53.34 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 110.077 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.544 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -63.64 -47.17 82.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.162 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.781 ' HB3' HG23 ' A' ' 29' ' ' VAL . 15.2 m-20 -95.62 17.64 14.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.004 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -66.34 -47.27 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.2 t0 -69.27 -29.08 66.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.94 . . . . 0.0 109.936 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -91.08 -31.61 16.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.963 . . . . 0.0 109.705 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' ASP . 77.6 t -80.4 -42.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 26' ' ' ALA . 42.0 mt -49.49 -51.86 54.91 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.381 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.7 Cg_endo -68.83 -46.69 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.532 2.154 . . . . 0.0 112.638 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -79.92 -44.68 19.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.0 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -48.13 -36.03 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 36' ' ' SER . 14.5 tp -142.65 133.55 25.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.74 -26.73 50.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.145 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.897 ' HB3' HD21 ' A' ' 34' ' ' LEU . 3.0 t -54.01 -36.82 63.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.661 ' HE1' HG23 ' A' ' 55' ' ' ILE . 62.8 t80 -52.74 135.74 34.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.428 -0.795 . . . . 0.0 109.124 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HE2' HD21 ' A' ' 58' ' ' LEU . 9.9 mttm -90.17 -54.82 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.487 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 1.7 t -178.9 172.34 1.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.972 HG23 ' CD1' ' A' ' 55' ' ' ILE . 10.9 p -139.07 134.75 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.776 . . . . 0.0 109.268 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -142.45 148.31 37.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 81.7 m-20 -92.18 119.39 31.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.6 m -80.13 -31.18 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.924 . . . . 0.0 109.456 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' THR . 79.4 tt0 -157.09 143.71 18.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.436 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.77 164.79 32.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -100.57 6.51 44.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 109.71 -8.67 32.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.25 -158.79 14.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 129.92 18.03 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.618 2.212 . . . . 0.0 111.718 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.36 3.66 69.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.862 ' O ' HD13 ' A' ' 52' ' ' ILE . 8.3 m -80.04 158.16 26.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -1.135 . . . . 0.0 109.697 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 51' ' ' THR . 13.9 mm -124.12 133.32 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 45.4 mtmt -129.02 153.96 47.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 78.9 tttt -111.89 121.92 46.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.281 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.972 ' CD1' HG23 ' A' ' 40' ' ' VAL . 5.5 mm -106.35 138.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 43.2 m -131.65 120.25 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -134.23 175.01 9.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' HE2' ' A' ' 38' ' ' LYS . 1.8 mm? -103.15 139.23 38.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 83.1 tt0 -148.94 130.63 15.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 52.8 37.45 24.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.26 8.84 52.59 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.08 126.03 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' ' HE3' ' A' ' 38' ' ' LYS . 79.1 m -72.34 119.21 16.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' A' ' 59' ' ' GLU . 64.7 mttm -119.6 167.29 12.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 23.1 p90 -144.68 156.63 44.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.368 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.651 HG13 ' HB ' ' A' ' 55' ' ' ILE . 3.1 p -143.43 152.01 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.781 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG22 ' A' ' 85' ' ' VAL . 12.3 mt -110.72 127.62 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -114.64 131.04 56.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.784 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 20.4 tttt -113.13 134.02 54.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 108.983 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' GLY . 46.5 mt -97.94 127.73 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 93.5 mt-10 -89.63 -33.25 16.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.224 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 81' ' ' SER . 65.3 p -174.86 154.75 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.88 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.68 84.34 2.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.333 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.39 -40.2 81.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.55 60.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.51 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 93.1 m-20 -94.39 14.63 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.9 mt 44.35 27.62 0.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.68 157.98 18.19 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 31.7 p90 -150.84 170.07 20.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 109.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 72' ' ' SER . 3.0 p -120.3 137.63 54.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 99' ' ' PHE . 19.7 p90 -152.91 156.67 39.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 77.3 p -148.02 158.19 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.605 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 90' ' ' LEU . 39.7 t -91.95 130.1 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.2 m -118.92 -0.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.148 -0.97 . . . . 0.0 110.0 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.02 163.1 34.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.48 169.4 14.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.4 62.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -1.128 . . . . 0.0 109.305 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.14 -14.67 58.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 84' ' ' VAL . 6.5 tt -84.2 114.45 54.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.371 -0.83 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.025 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.0 Cg_endo -69.8 143.56 51.03 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.657 2.238 . . . . 0.0 111.757 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 73.9 m-20 -74.88 -28.47 60.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.554 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 19.5 p -79.87 2.62 22.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.961 . . . . 0.0 109.689 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.025 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.27 132.94 50.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 109.548 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.68 -43.97 87.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -176.28 159.0 1.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.2 mt -122.97 133.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 59.0 m -102.07 145.89 28.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD1' HG22 ' A' ' 117' ' ' VAL . 96.3 m-85 -127.49 119.34 25.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.47 106.83 13.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 0.0 109.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.455 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 6.3 m -120.85 137.73 54.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 103' ' ' LEU . 33.6 tttt -116.04 159.83 21.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.083 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 102' ' ' LYS . 24.1 mt -135.67 122.43 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 109.641 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.7 m -140.27 143.96 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.15 150.26 46.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.81 175.19 21.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.07 -0.24 6.88 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.673 2.248 . . . . 0.0 111.842 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -74.34 -24.74 59.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.99 17.44 35.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.08 -132.88 2.62 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 t -117.28 140.55 49.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -144.75 148.3 33.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.388 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.33 -167.24 35.36 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -122.36 145.21 48.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -1.119 . . . . 0.0 109.463 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 116' ' ' THR . 2.0 tt -120.31 125.72 48.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.392 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.855 ' N ' HD23 ' A' ' 115' ' ' LEU . 19.2 m -121.42 129.88 53.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.672 HG22 ' HD1' ' A' ' 99' ' ' PHE . 81.6 t -121.2 121.39 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 97' ' ' ILE . 35.9 ttpt -99.23 130.43 45.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.579 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 15.3 t80 -112.4 120.0 40.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.8 138.01 40.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.323 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 29.6 p -120.02 150.48 40.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.518 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.8 mttm -52.55 -36.26 55.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.15 -93.16 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.43 -36.67 78.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 109.422 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -52.66 134.91 35.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.553 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -134.58 111.11 11.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.8 Cg_endo -70.09 126.47 13.13 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.751 2.301 . . . . 0.0 111.781 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -72.14 161.12 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.329 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.91 -34.18 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -56.44 -31.44 63.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.127 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.1 -35.9 48.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.0 108.758 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -58.63 -35.17 72.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -71.19 -38.83 72.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.235 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 138' ' ' LYS . 98.2 m -59.39 -42.26 91.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.15 -37.64 91.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -68.44 -40.36 81.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.247 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.51 66.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.832 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 134' ' ' THR . 31.1 mttp -62.54 -47.44 83.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.29 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.45 -46.34 90.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.14 -32.45 55.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.878 . . . . 0.0 109.466 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.47 86.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.8 mm? -78.59 -36.01 44.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -59.21 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -57.11 -37.1 71.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 -50.35 72.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.304 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 146' ' ' ILE . 4.6 mm -54.31 -46.13 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -66.05 -53.05 43.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.625 ' HD1' HD23 ' A' ' 150' ' ' LEU . 43.3 t80 -70.84 -45.55 64.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.625 HD23 ' HD1' ' A' ' 149' ' ' TYR . 5.2 mt -55.09 -38.6 68.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.2 -28.31 48.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.29 66.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -135.44 93.95 15.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -12.04 31.52 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.697 2.264 . . . . 0.0 111.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -79.03 -16.18 57.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 51.1 t80 -74.6 107.53 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.611 HD22 HG23 ' A' ' 17' ' ' THR . 71.0 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.73 HG12 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 94.3 m-85 -80.66 119.17 22.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 25.2 m -110.72 116.45 31.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.854 ' CE2' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -109.68 165.3 11.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 60.8 mt-10 -131.15 135.59 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.96 165.86 26.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 0.0 109.519 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -110.01 148.95 30.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.49 147.55 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -148.01 133.72 18.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.55 138.28 11.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -12.14 31.5 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.646 2.231 . . . . 0.0 111.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.974 ' HB ' HD11 ' A' ' 18' ' ' LEU . 88.0 t -86.05 153.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.91 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -57.27 137.82 80.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' CA ' ' HB2' ' A' ' 111' ' ' SER . 45.8 Cg_endo -67.86 -30.2 33.76 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.926 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.61 -33.23 62.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -77.09 -36.94 55.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 13' ' ' VAL . 1.8 mt -71.07 -40.43 71.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 69.0 t80 -65.46 -44.04 88.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.852 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.4 tptm -68.99 -46.22 68.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.13 -32.46 63.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.968 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 47.3 tp -63.29 -46.03 88.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.688 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.47 -57.08 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.985 . . . . 0.0 110.163 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -57.24 -44.5 83.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.907 . . . . 0.0 110.175 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.7 m-20 -99.05 4.68 47.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.615 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.968 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.05 -51.48 13.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.857 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -69.29 -22.72 63.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.123 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -93.36 -26.58 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HG23 ' A' ' 146' ' ' ILE . 97.7 t -82.34 -35.02 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 26' ' ' ALA . 17.8 mt -60.15 -51.45 80.3 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.2 Cg_endo -67.9 -19.41 46.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.554 2.169 . . . . 0.0 112.541 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -108.79 -48.86 3.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.035 -1.041 . . . . 0.0 109.78 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -61.82 -12.94 19.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 36' ' ' SER . 0.5 OUTLIER -156.23 112.2 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.058 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.57 -18.65 58.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.039 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.546 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.3 -36.14 60.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -51.23 133.14 28.72 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.32 -0.863 . . . . 0.0 109.346 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HD3' HG21 ' A' ' 56' ' ' THR . 36.5 tttp -87.13 -54.05 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 36.5 m -165.31 158.51 16.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.833 HG23 ' CE2' ' A' ' 37' ' ' PHE . 83.0 t -142.88 142.9 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.833 . . . . 0.0 109.208 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 71.1 mt-10 -153.73 150.68 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 0.0 109.631 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t-20 -84.68 133.63 34.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.287 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 7.9 m -104.93 -28.2 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 51' ' ' THR . 71.5 tt0 -159.71 147.16 16.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 109.504 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 96.45 158.71 31.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.62 35.23 4.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -1.113 . . . . 0.0 109.523 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.39 -17.03 60.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.08 36.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.94 137.32 34.66 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.737 2.292 . . . . 0.0 111.742 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.8 4.79 67.07 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.727 ' C ' HD13 ' A' ' 52' ' ' ILE . 53.0 m -73.37 148.4 43.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -1.15 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.727 HD13 ' C ' ' A' ' 51' ' ' THR . 4.1 mm -115.69 126.98 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.249 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 70.8 mttt -124.93 149.97 47.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 67' ' ' LEU . 22.6 mttm -117.22 131.23 56.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.02 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.701 HG23 ' CG2' ' A' ' 40' ' ' VAL . 23.0 mt -124.9 121.17 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 109.884 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 42.1 m -95.95 127.86 42.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.317 -0.864 . . . . 0.0 109.211 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.801 ' CE1' HG13 ' A' ' 66' ' ' VAL . 33.7 p90 -130.34 168.24 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.732 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -102.0 149.94 23.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -0.855 . . . . 0.0 109.286 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.77 ' H ' HD13 ' A' ' 58' ' ' LEU . 73.0 tt0 -164.41 123.07 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 55.77 39.19 30.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.47 16.14 54.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 83.5 tt0 -115.81 134.14 55.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -1.148 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.4 m -81.83 122.18 27.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.441 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HE2' ' CD ' ' A' ' 62' ' ' GLU . 75.9 mttt -131.28 170.25 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.4 p90 -141.06 156.2 46.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.801 HG13 ' CE1' ' A' ' 57' ' ' PHE . 27.9 m -130.63 141.8 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 65' ' ' PHE . 7.2 mp -112.47 129.25 56.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -121.43 137.72 54.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 81.2 tttt -117.36 151.93 35.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.368 -0.833 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.3 mt -111.06 129.1 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 75.2 mt-10 -97.73 -24.42 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.322 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.3 t 179.4 145.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.333 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.04 141.67 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -130.89 87.18 2.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.09 -37.57 87.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.95 83.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 17.8 m-20 -92.47 11.53 25.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 2.0 mt 47.69 34.86 3.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.25 152.72 19.57 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 25.1 p90 -150.19 169.11 22.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -1.168 . . . . 0.0 109.085 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 71' ' ' GLU . 77.4 p -128.64 140.88 51.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 22.1 p90 -155.34 161.27 41.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 35.5 p -146.54 157.38 43.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 HD12 ' A' ' 90' ' ' LEU . 37.3 t -90.83 126.93 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.271 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG13 ' HE3' ' A' ' 96' ' ' LYS . 3.1 t -108.47 0.55 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 90' ' ' LEU . . . 175.28 175.87 43.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 120.09 161.32 11.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -21.18 66.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.439 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.792 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . . . -79.93 -7.1 58.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.956 HD12 HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -79.81 116.97 64.87 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.515 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.075 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.02 148.03 68.93 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.762 2.308 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -79.79 -29.92 40.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.696 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.486 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 24.1 p -79.7 -8.7 59.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.075 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -116.68 127.62 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 82.8 mt-10 -65.63 -47.06 76.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 1.5 mtpm? -158.88 169.65 23.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 118' ' ' LYS . 51.0 mt -136.59 127.54 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.413 -0.805 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 3.9 m -109.03 124.08 50.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.393 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.814 ' CE1' HG13 ' A' ' 117' ' ' VAL . 69.9 m-85 -110.22 124.03 50.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 47.6 t0 -115.87 108.22 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.174 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 t -116.3 136.33 53.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.154 -0.966 . . . . 0.0 109.834 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.672 ' O ' HD23 ' A' ' 103' ' ' LEU . 65.4 tttt -119.23 153.01 35.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 108.931 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 102' ' ' LYS . 38.2 mt -131.23 123.76 29.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.007 -1.058 . . . . 0.0 109.738 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.5 m -138.96 143.17 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.382 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.09 147.7 53.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.87 170.0 23.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.47 -1.47 8.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.674 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -75.74 -23.84 56.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.63 7.51 56.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.26 -141.64 4.85 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB2' ' CA ' ' A' ' 15' ' ' PRO . 2.1 t -109.31 142.93 39.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.576 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -147.14 146.14 29.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.26 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.64 -166.09 32.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 12.9 tttp -124.38 143.38 50.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -1.142 . . . . 0.0 109.419 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -120.89 124.11 44.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.94 . . . . 0.0 109.602 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.728 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.6 m -108.26 135.21 49.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.814 HG13 ' CE1' ' A' ' 99' ' ' PHE . 24.0 t -110.91 127.84 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.561 ' CG ' HG21 ' A' ' 2' ' ' VAL . 71.6 tttt -110.99 118.61 36.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 0.0 108.849 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.904 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 32.5 t80 -122.65 109.0 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.951 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.73 ' HG3' HG12 ' A' ' 2' ' ' VAL . 62.1 tt0 -96.7 145.86 25.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.124 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.6 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.3 p -115.26 179.14 4.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.998 . . . . 0.0 109.587 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 93' ' ' THR . 57.6 mttt -62.03 -36.13 80.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.0 -94.0 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.39 -21.14 53.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 137.65 57.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 3' ' ' PHE . 61.9 tt0 -127.74 126.85 24.01 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.6 ' HD3' HG21 ' A' ' 121' ' ' THR . 50.0 Cg_endo -70.15 147.05 59.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.765 2.31 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.8 m-20 -72.69 169.23 17.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.47 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.4 -41.94 97.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.5 -43.76 93.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.854 HD13 ' CE2' ' A' ' 5' ' ' PHE . 61.2 mt -60.29 -37.46 80.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.372 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -69.41 -41.23 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.0 m -59.59 -41.22 89.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.67 89.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -68.97 -40.2 79.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.05 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.517 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.792 ' HE3' ' HB2' ' A' ' 89' ' ' ALA . 22.9 tttm -62.45 -45.82 91.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 109.425 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.47 70.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -53.26 -39.54 63.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.93 52.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.367 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 62.8 tp -64.37 -41.05 96.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -55.26 -53.02 61.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.923 . . . . 0.0 109.322 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -53.54 -35.07 60.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.193 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -57.55 -50.05 74.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.242 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.707 HG23 HG11 ' A' ' 29' ' ' VAL . 6.0 mm -55.73 -41.68 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.289 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 83.5 tt0 -62.82 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 -37.59 14.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.182 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.584 ' HD1' HD23 ' A' ' 150' ' ' LEU . 31.8 t80 -66.74 -43.41 84.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.645 HD13 HG11 ' A' ' 13' ' ' VAL . 6.7 mt -56.13 -33.33 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.74 48.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.52 -19.43 57.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -127.38 83.81 65.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.82 -20.22 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.683 2.255 . . . . 0.0 111.774 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 14.2 p-10 -83.6 -2.6 56.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.56 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -69.02 132.16 46.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.494 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.44 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.391 0.615 . . . . 0.0 109.764 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -124.26 145.77 49.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.284 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.6 m -118.26 146.93 43.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 132' ' ' LEU . 72.0 m-85 -139.12 162.19 35.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.04 132.87 45.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -131.88 164.56 25.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.13 149.3 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.7 mt -123.92 129.8 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -140.65 131.32 25.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -144.6 140.61 16.71 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.12 -10.65 28.76 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.698 2.265 . . . . 0.0 111.714 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -83.34 151.12 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.25 137.56 94.38 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.342 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.9 -28.64 35.74 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.682 2.255 . . . . 0.0 111.75 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.14 -41.72 57.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.851 HG23 ' OXT' ' A' ' 157' ' ' ASN . 55.2 m -77.47 -41.01 41.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 150' ' ' LEU . 41.9 tp -67.11 -38.34 85.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -67.55 -41.83 83.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.687 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' THR . 7.8 tptt -66.17 -46.84 75.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.896 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.47 -27.76 61.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.957 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -66.07 -48.1 72.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.652 HG23 HD23 ' A' ' 22' ' ' LEU . 72.7 t -97.39 -50.81 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.535 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.3 m -64.7 -48.77 73.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 109.988 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' VAL . 3.7 m-20 -92.31 3.94 54.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.622 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.007 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.25 -52.8 11.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.312 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.7 m-20 -66.14 -25.13 66.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 93.8 m-20 -88.89 -27.64 20.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.947 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.957 HG21 HG23 ' A' ' 146' ' ' ILE . 9.1 p -83.57 -38.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 109.637 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.007 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.6 mt -52.31 -46.45 94.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.141 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.4 Cg_endo -68.47 -17.47 43.73 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.8 mttp -108.1 -29.35 9.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.93 81.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 57' ' ' PHE . 22.7 tp -91.58 111.81 23.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.98 -44.4 87.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -89.74 29.96 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.048 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.772 ' CE1' HG22 ' A' ' 30' ' ' ILE . 47.5 t80 -63.44 132.75 52.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 39' ' ' SER . 49.7 tttp -96.08 -47.68 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.189 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.496 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 34.9 p -179.95 174.16 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.006 -1.059 . . . . 0.0 110.03 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.1 p -136.25 130.33 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 109.343 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -129.86 144.78 51.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.629 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.69 126.51 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.363 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 36.7 t -80.05 -41.58 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.625 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 51' ' ' THR . 50.8 tp10 -166.96 156.75 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 98.77 170.23 31.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -119.06 31.79 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -1.189 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.76 -11.62 66.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 -170.97 33.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.58 148.76 60.48 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.669 2.246 . . . . 0.0 111.745 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 80.04 3.32 89.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' GLU . 87.9 m -69.71 149.87 47.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.617 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 29.9 mm -114.96 124.97 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -119.68 144.15 47.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 109.557 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.775 ' HG3' HD11 ' A' ' 67' ' ' LEU . 17.2 tttt -114.48 127.62 55.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.58 ' HB ' HG13 ' A' ' 66' ' ' VAL . 64.3 mt -115.49 145.01 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m -128.72 112.11 13.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.915 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.4 p90 -115.64 173.02 6.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.98 142.57 47.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -143.54 131.3 21.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 53.18 21.88 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.94 71.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.86 155.44 18.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -1.105 . . . . 0.0 109.482 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.3 27.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 52.1 mttm -120.68 162.57 19.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.737 ' CE1' HD13 ' A' ' 67' ' ' LEU . 3.2 p90 -145.74 158.91 43.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.675 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -138.79 147.81 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.5 mp -116.26 136.12 53.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 0.0 108.918 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -129.5 142.45 50.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.743 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 81.7 tttt -124.03 149.31 46.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 24.4 mm -107.68 132.66 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.624 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.8 mt-10 -89.3 -39.24 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.346 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -173.62 140.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.68 136.03 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -128.66 78.57 1.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -58.91 -39.33 81.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.55 -52.09 42.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 74.8 m-20 -92.22 14.37 16.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 6.0 mt 45.49 42.21 7.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.66 21.7 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -151.6 169.6 21.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -1.155 . . . . 0.0 109.195 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 19.5 m -128.56 138.75 52.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.599 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.2 p90 -154.26 158.67 40.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 96.6 p -146.84 156.6 43.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 89' ' ' ALA . 9.6 p -94.4 135.5 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.213 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 67' ' ' LEU . 3.8 m -118.79 3.61 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.73 164.64 35.55 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.71 178.22 28.25 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.05 45.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.845 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.04 -8.69 59.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -103.72 104.21 41.1 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.503 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.5 Cg_endo -69.66 153.82 68.92 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.692 2.261 . . . . 0.0 111.699 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 65.2 m-20 -80.06 -35.9 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -80.01 8.38 7.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.048 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -136.88 130.66 32.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.555 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -56.65 -56.48 20.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 20.1 pttm -169.09 160.65 9.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 83' ' ' SER . 59.8 mt -117.17 136.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 8.4 m -106.54 141.21 38.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 73.8 m-85 -119.83 120.57 36.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.968 . . . . 0.0 109.955 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -119.57 101.73 8.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 108.976 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -115.07 141.18 48.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.905 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.8 tttm -127.3 145.37 50.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.436 -0.79 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.905 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.9 mm? -126.45 126.75 44.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.4 m -137.22 142.65 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.28 145.72 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.49 172.87 22.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.0 0.5 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.43 -25.7 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.25 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.39 -134.59 2.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.6 m -116.9 142.08 47.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -1.122 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.13 30.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.34 -159.73 22.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.94 142.43 49.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -1.135 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 116' ' ' THR . 2.3 tt -116.86 135.66 53.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.878 ' N ' HD23 ' A' ' 115' ' ' LEU . 38.8 m -127.32 125.88 41.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.841 . . . . 0.0 109.266 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 136' ' ' LYS . 50.8 t -109.69 134.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 63.5 tttt -113.88 120.95 42.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.003 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.571 ' CD2' ' HG3' ' A' ' 127' ' ' PRO . 14.9 t80 -102.58 125.33 49.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.975 . . . . 0.0 109.743 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 86.1 mt-10 -107.66 135.33 49.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.683 HG21 ' CD ' ' A' ' 127' ' ' PRO . 26.9 p -116.48 166.15 12.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 24.4 mttm -62.82 -35.66 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.4 -86.5 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -62.4 -27.98 69.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.15 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.71 136.04 52.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -132.32 106.91 13.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.683 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -70.57 122.42 8.88 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.698 2.266 . . . . 0.0 111.867 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -60.64 154.52 21.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -58.23 -36.15 72.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.52 -32.37 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.9 -32.6 51.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.0 -38.41 88.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.396 -0.815 . . . . 0.0 109.093 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -64.75 -45.44 86.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.0 m -57.2 -37.65 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.272 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.75 -46.52 93.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.42 ' HG2' HG21 ' A' ' 117' ' ' VAL . 65.0 mttp -53.44 -36.45 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -1.092 . . . . 0.0 109.246 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.79 -35.05 68.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.173 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.29 -47.01 78.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -67.36 -52.48 39.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -57.3 -33.41 67.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.21 81.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.22 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 142' ' ' LEU . 22.2 tp -73.12 -47.58 43.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 75.6 t80 -56.53 -55.35 34.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.066 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -50.76 -39.13 51.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -0.918 . . . . 0.0 109.358 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.957 HG23 HG21 ' A' ' 29' ' ' VAL . 47.7 mt -69.06 -55.1 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.307 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -48.63 -57.82 5.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.918 . . . . 0.0 109.156 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.62 -38.56 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 108.847 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.13 -41.67 85.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 18' ' ' LEU . 28.5 mt -57.35 -36.16 70.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.02 -28.41 63.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.59 -16.25 62.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -134.13 88.04 32.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.21 -14.83 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.719 2.279 . . . . 0.0 111.806 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -85.69 5.64 31.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.896 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.3 t80 -80.01 142.02 35.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.851 ' OXT' HG23 ' A' ' 17' ' ' THR . 81.6 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.356 0.598 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.402 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 77.9 m-85 -81.37 117.45 21.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -109.83 116.82 32.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 92.7 m-85 -109.84 157.9 18.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -125.79 127.97 46.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.257 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.73 164.9 17.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.618 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -97.53 149.78 21.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 115' ' ' LEU . 64.0 mt -118.23 134.72 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 109.517 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.16 109.7 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -131.92 131.84 22.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.1 -2.74 10.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.745 2.297 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 150' ' ' LEU . 41.3 t -92.81 151.49 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.22 75.84 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.23 -34.23 22.29 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.801 2.334 . . . . 0.0 111.908 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.639 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.26 -38.3 60.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.669 HG23 ' C ' ' A' ' 157' ' ' ASN . 94.9 m -76.9 -37.5 55.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -69.64 -39.44 77.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.518 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 86.1 t80 -66.23 -46.25 77.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.803 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HE3' HG21 ' A' ' 24' ' ' THR . 19.1 tptt -61.29 -46.74 89.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.9 -20.19 61.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.009 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.1 tp -80.19 -48.83 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.912 . . . . 0.0 109.835 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.3 t -97.99 -53.03 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.306 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 ' HE3' ' A' ' 20' ' ' LYS . 4.0 m -64.36 -50.41 67.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 110.449 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.4 t70 -90.32 2.57 55.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.013 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.009 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.67 -53.16 12.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.011 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 88.9 m-20 -63.57 -25.1 68.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 63.4 m-20 -90.35 -24.15 20.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 25' ' ' ASP . 37.9 t -81.93 -39.16 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.7 mt -50.61 -48.58 82.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.867 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.5 Cg_endo -67.67 -18.34 48.1 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.407 2.071 . . . . 0.0 111.814 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 21.2 mttt -103.66 -54.62 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.314 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.43 -50.82 66.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.051 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.941 HD21 ' CB ' ' A' ' 57' ' ' PHE . 29.9 tp -71.77 102.0 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 0.0 108.938 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.42 -41.22 76.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 110.352 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -97.05 29.26 3.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.881 -1.137 . . . . 0.0 110.174 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -56.19 123.01 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.088 -1.008 . . . . 0.0 109.218 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -87.17 -54.04 4.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 0.0 109.848 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.613 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 24.5 p -174.21 167.61 4.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.094 -1.003 . . . . 0.0 110.035 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.841 HG23 ' HE2' ' A' ' 37' ' ' PHE . 94.2 t -142.43 141.62 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.157 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 76.5 mt-10 -149.88 163.08 39.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ILE . 7.7 t-20 -101.02 127.48 47.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 20.0 m -93.62 -29.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.877 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 63.1 mm-40 -159.14 147.49 17.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 95.9 156.57 31.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.77 34.13 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.62 65.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.42 -166.97 27.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.5 143.99 48.84 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 111.801 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.19 1.67 90.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.564 ' C ' HD13 ' A' ' 52' ' ' ILE . 98.3 m -67.62 147.95 52.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -1.153 . . . . 0.0 109.733 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.564 HD13 ' C ' ' A' ' 51' ' ' THR . 11.1 mm -114.19 123.77 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -118.11 143.25 46.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.646 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 64.1 tttt -118.94 132.48 56.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 40' ' ' VAL . 46.3 mt -125.38 145.85 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 0.0 109.659 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 20.4 m -124.69 124.79 42.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.377 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CB ' HD21 ' A' ' 34' ' ' LEU . 49.5 p90 -127.24 156.78 41.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.412 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.26 136.9 37.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -151.68 135.97 16.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.04 38.88 21.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.34 21.92 60.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -124.37 134.12 53.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.319 -1.107 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.5 m -79.97 118.58 21.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.491 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 88.9 mttt -121.08 160.42 23.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.0 p90 -141.61 154.67 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.52 ' C ' HD23 ' A' ' 67' ' ' LEU . 24.3 m -134.52 144.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -110.92 126.09 54.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.198 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -116.32 134.4 54.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 16.2 tttt -119.54 149.51 41.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 48.8 mt -112.32 133.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.646 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.66 -32.57 12.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.8 p -171.47 146.18 2.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.01 138.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -133.66 76.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.292 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.7 mt-10 -59.66 -37.15 77.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.68 70.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.557 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.87 12.9 26.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 16' ' ' ALA . 3.8 mt 47.38 38.04 6.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.129 -0.982 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.34 20.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 21.3 p90 -149.88 169.56 20.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -1.171 . . . . 0.0 109.19 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -128.88 139.95 51.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 109.486 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 25.5 p90 -154.0 160.02 41.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.6 p -145.2 156.18 43.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.499 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.072 HG11 ' HB3' ' A' ' 89' ' ' ALA . 82.0 t -93.05 130.16 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.643 ' O ' HD22 ' A' ' 90' ' ' LEU . 4.5 m -121.89 -0.61 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.706 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -162.02 152.48 22.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 109.03 176.9 21.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.51 -14.16 18.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.434 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.072 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -80.09 -5.1 55.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD22 ' O ' ' A' ' 85' ' ' VAL . 9.1 tp -95.57 100.57 6.3 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.04 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 49.4 Cg_endo -69.08 150.1 72.0 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.774 2.316 . . . . 0.0 111.872 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.72 -32.26 41.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.619 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 122' ' ' LYS . 7.6 t -88.58 -15.72 34.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.655 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.04 ' HB3' ' CG ' ' A' ' 91' ' ' PRO . . . -111.08 114.82 28.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -45.78 -48.51 15.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -176.63 166.7 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.669 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 118' ' ' LYS . 64.0 mt -124.89 134.49 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 118' ' ' LYS . 33.1 m -106.32 128.39 53.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 95.4 m-85 -106.43 125.14 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.04 104.05 9.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.194 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.5 t -116.17 141.09 48.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.959 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttpm? -128.91 145.09 51.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 83.4 mt -127.53 131.98 49.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.0 110.081 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -142.99 168.96 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.629 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.79 136.84 38.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 160.69 15.6 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.52 1.27 5.11 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.657 2.238 . . . . 0.0 111.888 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -80.73 -20.99 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.426 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.75 19.07 11.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.52 -142.01 3.61 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.3 t -104.91 148.03 27.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.63 151.66 37.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.265 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.02 -156.55 17.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -139.89 142.74 36.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -1.117 . . . . 0.0 109.379 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 116' ' ' THR . 2.2 tt -118.59 131.87 56.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 115' ' ' LEU . 34.0 m -119.32 130.2 55.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.522 HG21 ' HD3' ' A' ' 136' ' ' LYS . 85.0 t -108.18 130.69 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.722 ' O ' HG23 ' A' ' 97' ' ' ILE . 32.1 ttpt -112.3 123.6 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 38.2 t80 -116.55 115.23 25.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.686 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -99.06 143.41 29.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.017 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.817 HG21 ' HD3' ' A' ' 127' ' ' PRO . 68.3 p -121.99 162.68 20.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 93' ' ' THR . 21.7 mttp -49.72 -39.79 38.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.65 -95.2 0.11 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -71.7 -28.39 63.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.46 133.92 40.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -124.58 125.44 25.55 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.817 ' HD3' HG21 ' A' ' 121' ' ' THR . 51.4 Cg_endo -70.77 142.71 44.13 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.727 2.284 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.4 m-20 -81.75 165.57 20.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -66.47 -40.58 89.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -59.76 -49.04 79.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.3 -42.41 98.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.02 -43.44 98.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.22 -50.16 74.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.5 m -58.25 -37.39 74.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.335 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.14 -42.38 99.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 117' ' ' VAL . 8.8 tptt -68.2 -39.91 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.28 28.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.951 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 14.3 tttp -67.67 -41.7 83.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.4 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.52 -55.49 10.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -52.19 -32.12 34.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.27 -39.5 75.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.849 ' O ' HD13 ' A' ' 142' ' ' LEU . 1.3 tm? -69.37 -40.63 77.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.344 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -70.57 -54.31 12.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.137 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -50.78 -31.19 16.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.43 64.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 142' ' ' LEU . 50.8 mt -65.15 -54.13 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.416 ' O ' HD12 ' A' ' 151' ' ' LEU . 76.6 tt0 -44.7 -51.45 9.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.237 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.84 71.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.441 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 37.3 t80 -68.1 -37.14 80.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 0.0 109.468 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 40.7 mt -60.39 -38.43 83.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 109.401 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 147' ' ' GLU . 1.3 mt -73.41 -28.39 61.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.29 -18.52 63.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -133.37 93.8 21.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.386 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.83 -13.94 32.35 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.683 2.255 . . . . 0.0 111.907 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -86.73 -18.24 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.727 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 55.7 t80 -68.11 109.97 3.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.669 ' C ' HG23 ' A' ' 17' ' ' THR . 47.6 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.93 146.63 49.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.486 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -127.59 124.26 37.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.596 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.709 ' CE1' HD12 ' A' ' 132' ' ' LEU . 95.8 m-85 -118.74 137.38 53.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.406 ' CD ' ' HD3' ' A' ' 114' ' ' LYS . 60.7 tt0 -105.42 133.56 49.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 33.5 t0 -138.56 152.97 48.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mt-10 -92.24 160.45 15.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 64.8 mt -117.71 145.13 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 78.4 m-20 -136.56 127.0 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 1.5 m -151.88 125.86 4.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.502 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.36 -2.9 11.36 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.583 2.188 . . . . 0.0 111.761 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.861 HG11 HD23 ' A' ' 150' ' ' LEU . 90.4 t -89.17 151.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 134.79 83.57 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 47.1 Cg_endo -68.64 -27.18 32.66 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.747 2.298 . . . . 0.0 111.793 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.13 -43.91 49.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.599 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.454 HG23 ' OXT' ' A' ' 157' ' ' ASN . 95.0 m -77.38 -40.35 44.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.59 -39.81 77.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.586 ' HD1' HD23 ' A' ' 103' ' ' LEU . 75.8 t80 -67.08 -37.11 83.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.523 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.846 ' HE2' HG21 ' A' ' 24' ' ' THR . 18.5 tptm -69.86 -46.5 65.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.65 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -75.23 -20.86 59.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.966 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.93 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.4 tp -72.08 -49.49 35.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.1 t -97.42 -50.15 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 109.844 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.846 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -62.23 -48.54 79.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.92 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 29' ' ' VAL . 21.7 m-20 -95.46 5.95 50.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.753 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.29 -52.8 11.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.581 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 40' ' ' VAL . 38.3 t0 -67.44 -22.18 65.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.907 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 84.5 m-20 -91.72 -26.76 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 146' ' ' ILE . 7.7 p -81.61 -35.56 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.8 mt -57.78 -47.87 98.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.81 -38.19 14.14 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 57.7 mttp -85.39 -29.91 24.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 109.181 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -66.94 -30.51 70.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 108.849 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 15.6 tp -95.78 113.06 24.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 108.819 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.99 -34.7 76.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.533 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 p -98.03 27.15 4.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.845 -1.159 . . . . 0.0 109.991 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 58.4 t80 -60.33 137.1 58.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 55.1 tttm -98.01 -48.42 5.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.55 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -178.74 171.76 1.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.895 -1.128 . . . . 0.0 110.019 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 27' ' ' ASP . 4.0 p -137.83 133.05 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -141.58 130.72 23.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.0 m-20 -84.31 136.47 33.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.45 -79.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.11 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 51' ' ' THR . 90.5 mt-10 -115.57 164.16 14.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.4 157.84 29.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.63 13.61 31.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.338 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.4 42.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.93 -160.03 23.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 72' ' ' SER . 50.7 Cg_endo -70.31 130.8 19.25 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.764 2.31 . . . . 0.0 111.85 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.92 0.98 82.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 44' ' ' GLU . 43.5 m -71.98 151.71 43.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -1.177 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.61 128.15 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 33.2 mttt -125.67 149.68 48.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.929 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.754 ' HG3' HD11 ' A' ' 67' ' ' LEU . 19.0 tttt -116.29 127.57 54.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 30' ' ' ILE . 62.8 mt -113.03 137.1 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 48.0 m -128.81 128.07 43.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.467 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.564 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 28.8 p90 -137.68 176.51 8.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -103.35 145.33 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.578 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -147.74 126.21 12.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 52.43 23.43 2.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.77 11.85 73.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -112.0 159.71 18.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.6 m -99.8 111.52 23.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -119.33 162.51 18.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 67' ' ' LEU . 4.1 p90 -146.72 159.2 43.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 30.9 m -137.29 146.07 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.596 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.754 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.6 mp -116.17 137.3 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.045 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -134.14 145.69 49.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.045 -1.034 . . . . 0.0 109.835 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HE2' ' HA2' ' A' ' 50' ' ' GLY . 32.9 tttt -120.32 147.43 45.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.9 mt -108.89 132.77 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 26.1 mt-10 -86.41 -44.27 12.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 23.3 t -177.14 134.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -100.45 139.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -132.55 73.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.79 -29.33 59.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.61 73.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . 91.0 m-20 -90.16 14.12 13.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 20.9 mt 46.81 46.2 15.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 109.6 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.51 154.68 26.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -150.72 169.35 21.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -1.211 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 67.1 m -134.38 140.6 46.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.88 158.76 41.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.7 p -145.51 156.13 43.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.03 133.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' C ' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -119.81 1.26 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.894 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.39 36.95 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.13 176.59 19.1 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.52 -13.37 62.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -1.117 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.98 -9.12 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -90.59 110.3 40.29 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.022 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.6 Cg_endo -70.58 148.61 60.11 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.641 2.227 . . . . 0.0 111.7 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.432 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 61.6 m-20 -79.09 -32.54 44.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -79.85 5.83 12.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.022 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.98 134.71 45.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.057 -1.027 . . . . 0.0 109.63 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 88.0 mt-10 -63.38 -46.51 86.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 3.8 pttm 179.64 159.62 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.2 mt -116.73 136.32 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.3 m -111.84 124.83 53.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.865 . . . . 0.0 109.216 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 89.6 m-85 -108.7 124.27 50.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.97 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 16.6 t70 -119.18 107.04 12.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.065 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB3' HD13 ' A' ' 115' ' ' LEU . 76.8 p -121.11 140.61 51.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.977 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.2 tttm -121.03 154.42 36.08 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.977 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -131.17 127.2 37.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.003 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 105' ' ' ALA . 1.3 m -144.97 167.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 108.982 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.577 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -77.06 134.39 38.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.533 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.16 159.31 15.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.75 24.39 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.669 2.246 . . . . 0.0 111.867 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -70.1 -22.83 62.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.47 23.53 10.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.82 3.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.5 t -98.67 149.19 23.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -1.123 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -145.91 159.12 43.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.15 -174.54 43.62 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HD3' ' CD ' ' A' ' 6' ' ' GLU . 10.2 ttmt -117.02 141.13 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -1.121 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 101' ' ' SER . 34.9 tp -116.15 136.45 53.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.453 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 21.6 m -128.16 126.85 41.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.3 t -108.66 134.19 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.508 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 21.0 tttm -121.63 114.3 20.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.781 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.2 t80 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE2' ' NZ ' ' A' ' 118' ' ' LYS . 93.8 mt-10 -106.66 138.04 43.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.638 HG21 ' CD ' ' A' ' 127' ' ' PRO . 21.8 p -117.07 157.09 26.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 52.8 mttt -49.62 -44.94 47.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.04 -71.12 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 27.8 p30 -78.72 -17.04 56.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.097 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.52 132.49 41.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.9 107.5 25.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.878 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.638 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -69.65 119.62 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.95 158.92 26.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.54 -37.16 75.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.09 -31.67 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -78.64 -33.57 47.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 108.951 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.73 -43.2 99.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -59.25 -48.7 80.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.205 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.5 m -61.23 -40.1 92.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.36 -49.95 72.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -62.81 -37.89 88.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -1.18 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.42 -28.71 45.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -61.13 -46.74 89.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.272 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.27 -52.59 53.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -50.53 -39.07 47.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.03 86.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.87 -30.62 50.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.03 -52.09 67.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.145 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -52.1 -37.68 54.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.48 -48.02 78.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.072 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 29' ' ' VAL . 8.4 mm -57.62 -42.53 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.307 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 151' ' ' LEU . 93.5 mt-10 -73.59 -43.37 59.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.91 67.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -68.23 -44.05 76.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.861 HD23 HG11 ' A' ' 13' ' ' VAL . 4.8 mp -57.62 -35.46 70.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 147' ' ' GLU . 0.7 OUTLIER -79.14 -31.64 44.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.558 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.89 -21.82 60.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -129.81 87.38 52.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.84 -17.8 37.01 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.695 2.263 . . . . 0.0 111.79 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.39 -0.78 23.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 74.6 t80 -75.69 136.48 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.454 ' OXT' HG23 ' A' ' 17' ' ' THR . 47.2 m-20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.7 t . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.2 m-85 -123.27 149.66 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -127.19 135.0 50.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.305 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.807 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -127.0 157.76 38.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.116 -0.99 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -126.43 132.67 51.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 3.1 t70 -131.88 164.81 25.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.552 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 94.4 mt-10 -103.15 149.95 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.53 129.38 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -139.58 122.13 16.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -144.9 136.66 12.89 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.2 -1.13 8.32 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.597 2.198 . . . . 0.0 111.731 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.797 HG11 ' OE1' ' A' ' 147' ' ' GLU . 1.8 p -92.21 152.28 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.61 137.2 86.26 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.58 ' CA ' ' HB3' ' A' ' 111' ' ' SER . 46.1 Cg_endo -68.19 -30.4 31.25 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.749 2.299 . . . . 0.0 111.8 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.58 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 157' ' ' ASN . 61.6 m -80.16 -35.84 35.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 150' ' ' LEU . 7.6 tp -70.04 -39.44 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 85.4 t80 -70.12 -40.29 74.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.744 ' HE3' HG21 ' A' ' 24' ' ' THR . 52.0 tptt -66.0 -47.17 75.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.814 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.37 -47.89 53.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.055 -1.028 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.993 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.5 tp -47.5 -43.52 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.4 t -98.44 -56.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.744 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -64.02 -48.39 76.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.065 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HB2' ' CA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -90.64 2.81 55.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.756 -179.606 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.36 -50.9 15.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 0.0 109.497 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.3 m-20 -66.11 -28.88 69.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.031 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -87.9 -29.33 20.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.045 ' CG1' HG23 ' A' ' 146' ' ' ILE . 92.3 t -83.4 -38.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.1 mt -49.22 -48.26 74.27 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.795 . . . . 0.0 110.002 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.4 Cg_endo -68.93 -19.45 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.408 2.072 . . . . 0.0 111.899 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 53.1 mttm -99.21 -34.1 10.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -64.07 -34.51 78.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.25 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 10.3 tp -92.54 109.74 21.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 108.965 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.83 -26.52 65.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 p -109.04 26.98 9.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.0 110.203 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.066 ' CE1' HG23 ' A' ' 40' ' ' VAL . 4.9 t80 -59.17 137.54 57.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.44 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HE2' HD23 ' A' ' 58' ' ' LEU . 13.3 mttm -101.06 -49.52 4.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.942 . . . . 0.0 110.259 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.5 p -175.07 167.13 3.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.957 -1.089 . . . . 0.0 110.21 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.066 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.8 t -135.2 128.14 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.549 -0.719 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -138.65 151.46 47.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 27.1 p-10 -98.44 140.85 32.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.48 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -97.98 -29.9 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.526 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 51' ' ' THR . 77.6 mt-10 -157.93 145.59 18.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.56 159.74 30.92 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -97.37 5.58 49.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.56 -10.51 30.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.44 -158.13 9.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.06 138.09 36.09 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.744 2.296 . . . . 0.0 111.859 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.53 7.14 88.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' GLU . 15.1 m -79.55 157.29 27.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -1.159 . . . . 0.0 109.661 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 16.1 mm -117.85 126.7 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.2 mttm -119.13 144.14 46.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.865 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 23.4 tttt -115.41 127.36 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.062 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' CZ ' ' A' ' 37' ' ' PHE . 35.7 mt -121.22 145.3 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 0.0 110.032 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 57.7 m -131.9 127.31 36.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -0.769 . . . . 0.0 109.244 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 23.8 p90 -134.76 170.72 15.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 62' ' ' GLU . 1.9 mm? -107.84 133.53 52.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.366 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -141.41 140.01 33.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 48.46 22.2 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 109.62 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.83 29.34 39.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.759 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.0 mt-10 -132.62 145.16 50.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -85.03 109.25 18.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -113.17 156.86 22.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 12.2 p90 -141.24 153.05 45.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.553 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.4 p -138.88 147.52 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -115.11 134.48 55.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.226 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -124.51 138.0 54.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.514 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 51.9 tttt -118.4 144.1 46.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 52.5 mt -105.39 129.46 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 97.0 mt-10 -87.75 -40.73 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.28 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.1 p -171.74 151.77 2.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.84 133.85 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -128.14 82.12 2.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.85 -35.2 75.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -0.991 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.61 -52.35 62.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-20 -89.7 15.0 10.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.538 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 44.11 46.39 7.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.15 156.47 25.6 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.6 p90 -151.64 169.7 21.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.188 . . . . 0.0 109.071 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 21.2 m -126.73 138.46 53.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.579 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.8 p90 -154.42 158.62 40.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.852 . . . . 0.0 109.582 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 71.9 p -148.54 156.91 43.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 109.325 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.088 HG21 ' HB3' ' A' ' 89' ' ' ALA . 10.0 p -97.85 132.82 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.959 . . . . 0.0 109.199 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 90' ' ' LEU . 3.7 m -123.44 5.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.009 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.65 153.28 23.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.32 -176.22 23.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.47 -13.58 62.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 0.0 109.389 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.088 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.92 -8.61 59.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 85' ' ' VAL . 2.2 tp -105.72 101.8 34.81 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.055 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 50.1 Cg_endo -69.7 152.7 69.69 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.755 2.303 . . . . 0.0 111.601 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 63.0 m-20 -79.55 -34.92 40.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.628 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -79.96 7.75 8.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.913 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.055 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -138.02 127.53 24.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -52.02 -58.67 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 42.6 pttt -167.46 164.44 14.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 83' ' ' SER . 60.1 mt -118.26 135.41 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.403 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 7.7 m -107.01 145.91 31.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.631 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.9 m-85 -123.96 120.07 31.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.124 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -118.37 101.64 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.065 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.437 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 29.1 t -117.32 139.62 50.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.296 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 1.014 ' C ' HD22 ' A' ' 103' ' ' LEU . 35.7 ttpt -120.81 155.76 33.36 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.014 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -133.07 123.97 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.008 -1.058 . . . . 0.0 110.042 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.15 142.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.087 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.01 145.88 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.764 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 169.65 23.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.69 1.76 4.73 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.723 2.282 . . . . 0.0 111.844 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.25 -28.53 64.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.51 21.82 10.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.466 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.99 -131.41 1.63 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.58 ' HB3' ' CA ' ' A' ' 15' ' ' PRO . 1.1 p -120.18 142.78 48.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -1.134 . . . . 0.0 109.586 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.76 160.5 38.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.402 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.4 168.21 31.05 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -111.49 147.32 35.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.127 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -117.23 131.39 56.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.487 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.658 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.7 m -125.23 126.18 44.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.174 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.429 HG22 ' CD1' ' A' ' 99' ' ' PHE . 57.9 t -111.54 134.22 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.691 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 38.0 ttpt -106.91 126.33 52.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.662 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 36.8 t80 -106.94 121.07 43.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 91.3 mt-10 -104.83 138.96 40.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.624 HG22 ' HE1' ' A' ' 119' ' ' TYR . 26.2 p -119.31 161.86 19.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.5 mttt -63.31 -32.1 73.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.17 -108.52 0.31 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' O ' ' OE1' ' A' ' 126' ' ' GLU . 81.4 m-20 -63.43 -34.29 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.142 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.89 127.49 28.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -143.23 127.65 9.59 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.8 Cg_endo -70.46 163.85 37.36 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.7 2.267 . . . . 0.0 111.795 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -93.22 163.66 13.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -52.08 -40.39 61.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -61.35 -46.49 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -57.61 -44.77 85.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.44 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.807 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 78.9 mt -60.65 -39.07 86.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 109.424 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.08 -43.95 85.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.8 m -58.51 -40.22 82.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.314 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.08 92.88 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ASP . 42.8 mttt -69.36 -40.25 77.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.62 73.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -75.26 -44.82 43.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 142' ' ' LEU . . . -79.65 -26.42 41.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 136' ' ' LYS . 12.9 t0 -60.68 -40.11 90.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.89 68.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 142' ' ' LEU . 21.2 mt -54.78 -51.75 64.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.201 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -60.74 -53.91 51.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.16 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -56.36 -37.25 69.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.04 -54.38 45.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.186 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 ' CG1' ' A' ' 29' ' ' VAL . 6.6 mt -67.8 -53.39 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.885 . . . . 0.0 109.192 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.797 ' OE1' HG11 ' A' ' 13' ' ' VAL . 15.2 tp10 -52.97 -47.48 68.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.63 69.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.2 t80 -68.9 -31.15 69.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.287 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 18' ' ' LEU . 15.3 mt -69.84 -46.03 66.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.08 -30.01 70.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.94 -16.5 60.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -124.28 94.6 44.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.64 -21.36 29.49 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.734 2.289 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.3 -20.49 60.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.814 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 69.2 t80 -77.45 131.07 37.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.664 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.445 ' C ' HG23 ' A' ' 17' ' ' THR . 72.2 m-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 95.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HE2' HG21 ' A' ' 121' ' ' THR . 83.5 m-85 -130.98 120.92 24.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 109.538 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 117' ' ' VAL . 51.5 m -109.02 144.16 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.456 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.833 ' CE1' HD12 ' A' ' 132' ' ' LEU . 86.4 m-85 -135.17 135.79 41.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.4 mt-10 -106.12 131.34 53.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.917 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.662 ' HB3' HD23 ' A' ' 115' ' ' LEU . 21.1 t0 -130.08 164.41 24.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -101.8 160.01 14.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 10.5 mt -133.2 132.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -133.69 131.43 39.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 47.8 m -152.55 137.01 10.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 0.0 109.353 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.5 Cg_endo -70.13 -31.55 18.66 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.676 2.25 . . . . 0.0 111.815 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' H ' HG12 ' A' ' 13' ' ' VAL . 1.5 p -60.29 152.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 142.26 97.9 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' N ' ' HB3' ' A' ' 111' ' ' SER . 46.9 Cg_endo -68.19 -37.42 14.34 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.735 2.29 . . . . 0.0 111.775 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.05 82.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 157' ' ' ASN . 52.6 m -78.77 -36.88 42.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.702 HD12 HD11 ' A' ' 150' ' ' LEU . 11.6 tp -69.9 -39.53 76.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 86.7 t80 -68.06 -42.37 80.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.828 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HE3' HG21 ' A' ' 24' ' ' THR . 20.5 tptt -63.81 -46.63 84.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.933 . . . . 0.0 109.728 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.15 -25.64 60.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.905 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 2.8 tm? -69.63 -46.89 65.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.37 -53.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.593 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.7 m -62.81 -48.57 78.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 109.956 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -94.85 8.79 41.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 109.617 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.905 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -47.06 -53.42 12.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.602 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 p-10 -69.37 -27.04 64.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.1 m-20 -83.34 -28.21 29.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.063 HG11 HG23 ' A' ' 146' ' ' ILE . 88.0 t -81.53 -36.76 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.5 mt -49.64 -49.37 72.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.102 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.8 Cg_endo -67.4 -20.1 48.68 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.503 2.135 . . . . 0.0 111.921 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 72.9 mttt -97.64 -54.11 3.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.188 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.9 65.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.064 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 9.8 mp -78.2 99.57 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.2 -29.32 60.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.9 p -110.27 27.16 9.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.746 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.57 123.97 12.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -89.6 -55.77 3.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.7 p -171.95 164.22 6.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.956 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.746 HG23 ' HE2' ' A' ' 37' ' ' PHE . 74.7 t -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.805 . . . . 0.0 109.123 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 61.4 mt-10 -152.46 160.77 43.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.129 -0.982 . . . . 0.0 109.765 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 80.0 m-20 -98.97 131.05 45.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.7 m -90.69 -29.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.676 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.84 144.74 17.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.37 168.21 32.82 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.8 6.25 33.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -1.101 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.22 -9.56 31.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.91 -157.57 8.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.29 137.07 33.09 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.651 2.234 . . . . 0.0 111.862 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.07 7.5 88.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.488 HG23 ' HA3' ' A' ' 45' ' ' GLY . 100.0 m -76.65 153.81 34.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.192 . . . . 0.0 109.625 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.503 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 24.3 mm -114.18 123.28 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 109.239 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 29.8 mtmt -119.82 145.42 46.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.917 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.606 ' HG3' HD21 ' A' ' 67' ' ' LEU . 20.4 tttm -114.98 126.71 55.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.709 HG23 HG22 ' A' ' 40' ' ' VAL . 20.7 mt -116.4 143.82 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 65.1 m -127.04 128.0 45.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 64' ' ' LYS . 52.7 p90 -133.51 156.06 48.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 140.63 31.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -150.34 134.13 16.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 52.04 32.47 10.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.99 74.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -112.02 139.57 47.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -88.0 119.44 28.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 86.3 mttt -120.35 165.86 14.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 27.8 p90 -145.03 157.78 44.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.537 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.3 p -138.69 146.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.773 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 HD21 ' HG3' ' A' ' 54' ' ' LYS . 40.1 mt -113.65 133.26 55.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.871 . . . . 0.0 108.95 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.438 ' NE2' HG21 ' A' ' 66' ' ' VAL . 33.2 m170 -126.17 139.5 53.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 24.1 tttt -117.52 144.41 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.052 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 mt -102.71 127.44 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 94.9 mt-10 -89.16 -36.63 15.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 32.0 t 178.08 132.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -103.9 137.27 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.314 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -126.57 82.42 2.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.6 mt-10 -58.28 -34.57 70.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 109.284 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.12 65.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.433 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 77.6 m-20 -87.79 15.52 6.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.908 . . . . 0.0 109.189 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 14.8 mt 43.25 46.02 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.425 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -145.23 159.71 27.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 82' ' ' TYR . 19.9 p90 -152.17 169.78 21.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -1.202 . . . . 0.0 109.291 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 41.3 t -125.38 137.81 54.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 99' ' ' PHE . 14.2 p90 -151.36 153.97 35.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 98' ' ' THR . 10.9 t -142.44 155.19 45.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.071 HG21 ' HB3' ' A' ' 89' ' ' ALA . 12.2 p -96.43 132.52 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.122 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 p -127.63 2.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.912 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.591 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -157.95 148.04 16.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.09 -174.9 19.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.06 -12.37 61.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -1.074 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.071 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.87 8.78 6.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 85' ' ' VAL . 10.2 tt -121.22 101.08 44.69 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.308 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 1.017 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.1 Cg_endo -69.21 154.59 69.7 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.72 2.28 . . . . 0.0 112.003 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 61.4 m-20 -79.92 -31.7 40.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.483 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 26.2 p -79.76 2.12 24.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.722 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.017 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -134.11 137.26 44.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -65.51 -56.01 14.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' OE1' ' A' ' 120' ' ' GLU . 43.9 pttt -169.0 159.05 9.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 109.461 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 119' ' ' TYR . 29.1 mt -118.96 137.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 24.2 m -113.12 120.77 42.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 117' ' ' VAL . 91.8 m-85 -96.0 126.04 40.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.753 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' THR . 17.2 t70 -119.33 113.95 21.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.329 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.502 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 22.5 t -135.81 140.68 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.47 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.82 ' C ' HD22 ' A' ' 103' ' ' LEU . 29.9 tttt -119.26 160.74 21.64 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -124.15 126.77 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.881 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 112' ' ' ALA . 29.8 m -137.35 142.93 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.92 146.12 49.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.718 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.25 165.3 21.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -2.16 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.662 2.242 . . . . 0.0 111.894 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.51 18.14 31.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -140.91 3.8 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 13.6 p -119.66 145.56 46.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -1.151 . . . . 0.0 109.606 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.43 147.7 31.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 109.146 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -161.9 170.04 37.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -99.31 146.51 26.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 7' ' ' ASP . 30.4 tp -112.21 137.37 50.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 53.8 m -140.44 113.68 8.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.816 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -110.11 139.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 110.354 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.8 tttp -111.79 119.0 37.14 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 127' ' ' PRO . 12.7 t80 -102.54 123.48 46.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.099 -1.001 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 92.0 mt-10 -106.34 137.98 43.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 3' ' ' PHE . 56.5 p -117.6 159.38 23.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.562 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 59.2 mttt -62.32 -40.95 98.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.31 -83.03 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.39 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -1.211 . . . . 0.0 109.517 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -61.99 134.66 56.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -136.79 107.03 8.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.597 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 48.7 Cg_endo -69.77 131.73 21.84 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 111.885 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.21 149.53 35.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.366 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -52.75 -36.0 57.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -57.11 -31.61 65.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.98 -36.18 59.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.157 -0.964 . . . . 0.0 108.574 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.833 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -58.25 -40.93 83.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -52.65 -54.26 35.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.42 -0.8 . . . . 0.0 109.177 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.5 m -58.71 -37.93 77.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.09 97.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 140' ' ' ASP . 24.7 mttt -63.78 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -1.119 . . . . 0.0 109.214 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.31 76.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.66 -46.37 46.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.56 -27.13 51.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.153 -0.967 . . . . 0.0 109.18 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 136' ' ' LYS . 86.1 m-20 -80.15 -21.88 42.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.282 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.4 78.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.28 -45.88 87.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -59.28 -55.21 37.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.802 . . . . 0.0 109.25 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -49.75 -41.12 43.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.64 78.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 108.945 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.063 HG23 HG11 ' A' ' 29' ' ' VAL . 21.3 mt -72.89 -54.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.7 -49.52 47.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.234 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.003 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.43 -37.56 83.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.23 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 18' ' ' LEU . 14.1 mt -65.41 -43.16 91.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.376 -0.828 . . . . 0.0 109.396 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.47 HD21 ' HG2' ' A' ' 12' ' ' PRO . 73.8 mt -69.42 -31.7 70.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.08 60.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -127.13 89.35 52.06 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.87 -19.32 35.78 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.71 2.273 . . . . 0.0 111.805 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.82 -11.7 60.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.748 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 71.2 t80 -77.48 133.7 38.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.588 ' C ' HG23 ' A' ' 17' ' ' THR . 48.0 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.47 HG11 ' HD2' ' A' ' 118' ' ' LYS . 48.3 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 126' ' ' GLU . 97.2 m-85 -126.27 141.65 51.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 37.4 m -121.37 130.38 53.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 132' ' ' LEU . 87.6 m-85 -123.11 136.73 54.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -110.08 132.18 54.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -133.81 165.8 24.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.525 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -99.6 145.35 27.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.335 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.755 HG21 HD11 ' A' ' 103' ' ' LEU . 70.8 mt -106.55 142.34 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -154.92 128.89 8.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -152.97 140.92 13.6 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.479 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.13 -1.43 8.76 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.674 2.25 . . . . 0.0 111.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.723 HG21 ' HG3' ' A' ' 147' ' ' GLU . 64.5 t -97.49 149.47 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.52 95.63 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.4 -31.07 28.71 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.729 2.286 . . . . 0.0 111.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 -41.9 53.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.696 HG23 ' CB ' ' A' ' 157' ' ' ASN . 93.1 m -75.27 -43.74 49.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' CZ ' ' A' ' 143' ' ' PHE . 68.1 tp -67.48 -37.29 82.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.6 t80 -66.75 -41.24 88.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.607 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HE2' HG21 ' A' ' 24' ' ' THR . 17.1 tptm -67.12 -46.49 73.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.631 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -74.78 -17.3 60.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.001 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 26.1 tp -74.23 -51.37 15.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.53 -44.72 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.971 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.863 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.25 -47.97 74.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.949 . . . . 0.0 110.103 -179.413 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 29' ' ' VAL . 53.6 m-20 -98.51 11.28 38.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.035 . . . . 0.0 109.833 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.001 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -53.88 -51.57 63.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 20.2 t70 -70.57 -21.37 62.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 110.141 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.16 -27.2 16.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -80.95 -33.85 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.81 . . . . 0.0 109.67 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 26' ' ' ALA . 5.8 mt -61.91 -49.55 85.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.15 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 48.5 Cg_endo -68.92 -22.78 35.56 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.513 2.142 . . . . 0.0 112.445 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 33' ' ' ALA . 22.4 mttt -106.14 -35.72 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.004 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -43.23 -38.67 2.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.004 HD23 ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -155.44 144.0 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.442 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.8 -18.71 50.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' HD13 ' A' ' 58' ' ' LEU . 68.0 m -55.14 -38.12 67.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.398 -0.814 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 55' ' ' ILE . 1.3 t80 -49.93 135.52 19.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.087 -1.008 . . . . 0.0 109.294 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 40.2 tttp -81.07 -57.28 3.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 110.295 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -162.46 155.57 20.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.02 -1.05 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 55' ' ' ILE . 92.3 t -134.67 133.55 54.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.458 -0.776 . . . . 0.0 109.065 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 84.3 mt-10 -159.34 168.1 27.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.95 . . . . 0.0 109.634 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 65.9 m-20 -97.03 152.6 18.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 2.5 t -96.1 -33.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.558 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.803 ' O ' HG23 ' A' ' 51' ' ' THR . 45.3 tp10 -166.79 156.44 11.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 88.96 -172.97 40.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -120.99 17.35 11.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 51' ' ' THR . . . 99.93 -1.43 56.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.14 -164.01 23.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.95 126.41 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.623 2.215 . . . . 0.0 111.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 92.77 4.13 65.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 44' ' ' GLU . 86.1 m -75.34 150.4 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -1.121 . . . . 0.0 109.58 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' C ' ' A' ' 51' ' ' THR . 9.4 mm -111.56 122.25 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 21.8 tttt -116.98 142.1 47.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 110.108 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 43' ' ' VAL . 17.9 tttm -117.25 130.24 56.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.024 HG22 HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -130.46 138.25 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.981 -1.075 . . . . 0.0 110.004 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.1 m -120.52 114.67 22.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.386 -0.821 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 50.8 p90 -114.96 171.05 7.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -111.14 151.32 28.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' GLU . 60.5 tt0 -154.28 138.58 16.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.311 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 2.8 p-10 44.13 26.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . 81.58 24.29 56.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' GLU . 72.7 mt-10 -121.74 140.88 51.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.445 ' CG2' ' HD2' ' A' ' 38' ' ' LYS . 16.2 m -91.07 110.28 21.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -116.18 162.04 18.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 14.2 p90 -141.85 153.79 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 5.6 p -140.6 148.82 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.712 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -110.81 128.78 55.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.914 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -122.52 138.55 54.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 22.1 tttm -119.57 146.94 45.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.5 mt -104.93 130.52 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 72' ' ' SER . 48.4 mm-40 -93.56 -27.79 16.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.292 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.2 t 178.27 144.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.44 138.15 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.373 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 94.0 m-20 -130.79 81.97 2.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.32 -37.01 81.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.54 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.53 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 22.0 m-20 -97.58 12.11 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt 47.88 29.31 1.6 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -121.24 150.86 17.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.3 p90 -151.24 169.76 21.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -1.225 . . . . 0.0 109.123 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 47.4 t -128.56 138.88 52.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -153.97 158.91 41.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 80.7 p -145.23 157.07 44.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.643 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.049 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.0 p -96.48 129.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 67' ' ' LEU . 3.6 m -116.57 4.86 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.432 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -169.18 159.51 32.53 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 105.02 -171.54 18.99 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.88 61.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -1.079 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.049 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.91 -4.02 50.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 90' ' ' LEU . 7.4 tt -121.86 86.35 45.82 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.756 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -69.54 165.91 29.12 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.505 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 38.9 m-20 -70.44 -27.82 64.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.9 p -79.77 -23.94 41.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.601 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -106.32 121.58 44.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.972 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 92.8 mt-10 -64.97 -49.12 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 71.8 mttt -161.2 158.42 27.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CD1' ' CE2' ' A' ' 119' ' ' TYR . 62.7 mt -123.61 133.68 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.84 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.2 m -108.91 131.29 55.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 99.8 m-85 -115.11 122.39 45.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.47 ' O ' HD23 ' A' ' 115' ' ' LEU . 42.5 t0 -116.11 119.9 37.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.888 . . . . 0.0 109.188 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.506 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 9.9 t -138.48 134.93 34.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.797 ' O ' HD12 ' A' ' 103' ' ' LEU . 20.0 tttm -125.77 149.09 48.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.2 mp -130.1 128.88 42.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 109.954 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 112' ' ' ALA . 32.6 m -138.96 143.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 109.164 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.04 139.65 22.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.28 168.16 21.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.16 -16.36 35.87 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.73 2.287 . . . . 0.0 111.729 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -64.86 -22.56 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.03 42.78 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.76 -140.42 4.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 m -101.93 141.36 34.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -148.02 139.5 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.4 13.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -129.82 141.68 50.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.299 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 101' ' ' SER . 3.1 tt -124.52 119.8 30.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 110.005 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.478 ' N ' HD23 ' A' ' 115' ' ' LEU . 71.2 m -116.65 128.32 55.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 108.788 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -117.03 131.97 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 110.062 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 37.1 ttpt -111.08 115.61 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 15.7 t80 -99.45 128.92 45.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.234 -0.916 . . . . 0.0 109.647 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -102.9 144.43 31.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.312 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 70.1 p -123.72 152.84 41.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 12.5 mttm -55.15 -29.21 57.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.0 -108.11 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.65 -27.27 58.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.04 135.83 57.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -141.33 119.59 7.91 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.5 146.66 56.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.844 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -87.55 177.25 7.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.94 -36.15 80.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.26 -41.92 94.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.458 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -66.96 -42.77 84.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.555 HD13 ' CE2' ' A' ' 5' ' ' PHE . 79.7 mt -63.39 -42.1 98.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -63.13 -47.39 82.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 109.411 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.7 m -58.2 -37.88 75.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.407 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.82 95.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -67.45 -39.66 85.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.62 63.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.55 -49.38 76.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.61 86.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.32 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -57.41 -38.53 74.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . -57.79 -49.07 77.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.728 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.2 mm? -75.9 -37.24 59.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.309 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.604 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 51.2 t80 -58.35 -51.81 68.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -62.87 -32.17 73.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.411 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.94 70.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 109.319 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.722 HG23 HG21 ' A' ' 29' ' ' VAL . 29.4 mt -62.91 -45.13 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.723 ' HG3' HG21 ' A' ' 13' ' ' VAL . 82.7 tt0 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.267 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.4 -37.26 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.149 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.605 ' CE2' ' CE1' ' A' ' 153' ' ' HIS . 49.1 t80 -67.92 -41.25 82.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 12.9 mt -55.44 -34.9 64.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.427 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.2 mt -78.58 -28.25 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -20.79 59.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.455 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.605 ' CE1' ' CE2' ' A' ' 149' ' ' TYR . 74.9 m80 -130.32 90.3 41.97 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.46 -16.12 34.55 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.779 2.319 . . . . 0.0 111.815 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.37 -17.49 60.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.605 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 79.3 t80 -75.1 121.45 22.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.696 ' CB ' HG23 ' A' ' 17' ' ' THR . 5.8 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.463 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 119' ' ' TYR . 91.5 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -129.39 130.98 46.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' VAL . 98.4 m -113.35 145.01 41.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 91.3 m-85 -136.37 128.63 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.978 . . . . 0.0 109.676 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 77.0 tt0 -96.43 131.3 43.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 136' ' ' LYS . 6.5 m-20 -128.0 164.93 21.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -100.9 151.56 21.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.97 128.57 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.14 125.4 37.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.58 129.67 5.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.35 -0.03 6.8 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.661 2.241 . . . . 0.0 111.865 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -87.59 151.36 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.675 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.23 142.92 97.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 109.503 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.9 Cg_endo -68.55 -35.78 16.5 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.769 2.312 . . . . 0.0 111.814 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.32 80.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 157' ' ' ASN . 56.2 m -79.23 -40.93 29.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 HD11 ' A' ' 150' ' ' LEU . 22.3 tp -67.41 -38.8 85.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.606 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.648 ' CG ' HD22 ' A' ' 78' ' ' LEU . 68.1 t80 -69.55 -40.43 76.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 38.1 tptt -65.64 -46.93 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -75.03 -30.35 61.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.906 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.4 mt -58.71 -49.24 78.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.783 . . . . 0.0 109.722 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.51 -46.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.889 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -71.81 -50.87 25.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 62.5 t0 -85.15 7.56 21.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.012 . . . . 0.0 109.727 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -59.21 -49.7 76.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.937 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.7 m-20 -66.32 -31.27 71.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.819 . . . . 0.0 109.986 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 24.4 m-20 -87.3 -28.39 22.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.686 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 HG23 ' A' ' 146' ' ' ILE . 7.6 p -81.24 -36.75 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.655 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -53.24 -48.31 92.81 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.984 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -67.94 -34.55 23.16 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 111.943 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 18.2 mttp -83.23 -40.59 19.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.163 -0.961 . . . . 0.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -58.42 -61.7 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.938 HD21 ' HB2' ' A' ' 57' ' ' PHE . 47.5 tp -64.55 108.8 1.77 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 108.927 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.44 -35.41 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -96.81 27.18 4.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.941 -1.099 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.853 ' HA ' HD23 ' A' ' 34' ' ' LEU . 50.9 t80 -59.33 136.29 57.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 39' ' ' SER . 55.0 tttt -97.87 -49.77 4.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 110.051 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.51 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 83.1 p -178.69 171.87 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.986 . . . . 0.0 109.753 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.4 p -134.25 122.56 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.4 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 42' ' ' ASN . 18.0 tt0 -126.13 158.25 35.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' N ' ' CG ' ' A' ' 41' ' ' GLU . 45.4 m-20 -105.7 154.39 20.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.2 m -117.53 -34.92 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 85.1 mt-10 -158.3 145.78 18.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 98.43 162.0 30.34 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.78 2.86 49.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -1.113 . . . . 0.0 109.566 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 112.6 -10.32 25.9 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.24 -153.37 10.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.29 139.5 38.54 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 C-N-CA 122.714 2.276 . . . . 0.0 111.798 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.59 -1.18 86.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.639 ' O ' HD13 ' A' ' 52' ' ' ILE . 90.8 m -71.91 153.5 41.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -1.21 . . . . 0.0 109.63 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 51' ' ' THR . 14.6 mm -117.91 127.83 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -123.78 148.37 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 109.786 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 27.1 tttm -115.32 126.16 54.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 66' ' ' VAL . 84.9 mt -113.73 143.22 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.568 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 40.7 m -129.74 128.69 42.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.938 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.5 p90 -134.5 169.03 17.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 142.9 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.419 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.5 128.91 15.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 49.74 24.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 28.25 41.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -122.36 154.4 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.6 m -98.49 107.13 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.334 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 36.0 mttt -116.09 160.08 20.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -144.93 157.03 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.627 ' C ' HD23 ' A' ' 67' ' ' LEU . 17.1 m -137.25 145.82 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.707 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.775 HD12 ' HA3' ' A' ' 86' ' ' GLY . 8.5 mt -114.18 133.89 55.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.878 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -126.1 139.32 53.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 38.3 tttm -121.11 144.78 48.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.285 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 10.6 mm -102.79 125.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.443 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 92.0 mt-10 -82.97 -54.2 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.865 . . . . 0.0 109.33 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.6 t -162.39 136.97 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 70' ' ' ILE . 58.1 mt -113.41 134.76 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.403 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -129.83 79.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -50.96 -34.99 31.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.25 -49.43 64.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.674 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.497 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 59.9 m-20 -100.52 14.57 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.648 HD22 ' CG ' ' A' ' 19' ' ' TYR . 40.1 mt 42.43 41.21 2.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.84 106.42 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -109.79 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.691 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 p -136.07 142.83 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.4 p90 -152.85 157.6 40.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 109.656 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 12.4 p -142.2 153.91 44.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.4 p -103.37 128.31 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.577 HG12 ' CD ' ' A' ' 96' ' ' LYS . 2.3 m -122.3 6.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.775 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.89 147.88 16.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.89 179.66 16.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.22 -13.81 59.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' ' NZ ' ' A' ' 138' ' ' LYS . . . -79.99 -8.94 59.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 85' ' ' VAL . 4.5 tp -100.0 102.73 18.72 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.874 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -68.65 152.29 74.55 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.724 2.282 . . . . 0.0 111.836 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.96 -29.32 60.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.867 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.7 p -79.57 3.75 17.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.078 -1.014 . . . . 0.0 109.818 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.874 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.37 128.92 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 5.7 tt0 -63.82 -55.0 26.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' HG12 ' A' ' 85' ' ' VAL . 89.5 mttt -161.51 160.94 29.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 83' ' ' SER . 17.0 mt -126.15 132.78 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 34.6 m -118.55 115.89 25.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.842 ' CD1' HG23 ' A' ' 117' ' ' VAL . 69.5 m-85 -94.41 128.53 41.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 109.67 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 116' ' ' THR . 13.8 t0 -116.84 116.52 27.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.254 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 12.2 t -133.06 136.34 45.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.919 ' C ' HD22 ' A' ' 103' ' ' LEU . 28.9 tttt -122.74 144.81 48.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.919 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.4 mm? -128.36 124.04 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -133.75 162.55 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 109.059 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -60.87 125.33 23.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.057 -1.027 . . . . 0.0 109.514 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.79 150.28 19.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.58 2.33 4.1 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.647 2.231 . . . . 0.0 111.971 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.24 5.7 50.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.605 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.73 22.14 51.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -138.67 3.49 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -120.46 142.59 49.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -1.187 . . . . 0.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.55 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.28 147.37 30.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -166.26 -151.94 7.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -133.44 142.73 48.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -1.128 . . . . 0.0 109.261 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 116' ' ' THR . 4.8 tt -120.61 126.53 50.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.784 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.677 ' N ' HD23 ' A' ' 115' ' ' LEU . 68.0 m -125.72 124.85 41.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 108.849 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 99' ' ' PHE . 1.1 p -108.08 142.47 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.061 -1.025 . . . . 0.0 110.128 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 69.2 tttt -119.93 116.61 26.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 108.964 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.656 ' O ' HG13 ' A' ' 2' ' ' VAL . 15.3 t80 -102.68 130.51 49.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.137 -0.977 . . . . 0.0 109.667 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 2' ' ' VAL . 79.2 mt-10 -111.75 127.22 55.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 32.8 p -110.94 157.52 19.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.543 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -58.36 -39.23 78.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 -93.21 0.1 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -67.41 -31.65 72.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.13 115.19 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.89 108.48 28.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 117.95 5.4 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.783 2.322 . . . . 0.0 111.844 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -59.87 157.06 13.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -56.35 -38.57 71.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.82 -31.34 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.252 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 131' ' ' GLU . 63.2 mm-40 -74.38 -36.85 63.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 108.7 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.98 -35.8 69.6 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -60.63 -48.03 83.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.18 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.2 m -58.33 -39.02 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.44 99.35 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 7' ' ' ASP . 29.5 tttt -73.06 -41.78 63.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -1.111 . . . . 0.0 109.362 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.05 -34.96 70.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.642 ' NZ ' ' HB2' ' A' ' 89' ' ' ALA . 41.2 tttm -71.25 -44.76 64.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.252 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.93 89.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.837 . . . . 0.0 109.353 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.534 ' HB3' ' HE3' ' A' ' 144' ' ' LYS . 89.5 m-20 -50.95 -47.54 61.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.291 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.33 57.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.464 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 142' ' ' LEU . 3.1 tm? -70.62 -53.36 16.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.93 -53.63 54.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 108.948 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.534 ' HE3' ' HB3' ' A' ' 140' ' ' ASP . 49.4 mttt -51.93 -37.85 54.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.45 -45.83 80.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.28 -0.887 . . . . 0.0 108.989 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 29' ' ' VAL . 16.7 mt -69.07 -54.72 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.225 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -59.64 -52.65 64.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.341 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . -48.83 -39.19 24.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.062 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.1 t80 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.211 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 24.6 mt -58.82 -41.09 86.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.27 -29.64 67.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.918 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' A' ' 153' ' ' HIS . . . -78.0 -17.66 56.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.66 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.564 ' HD2' ' O ' ' A' ' 152' ' ' ALA . 2.1 m170 -125.74 85.77 58.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.575 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.44 -20.54 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.682 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -79.38 -1.45 37.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 157' ' ' ASN . 59.6 t80 -68.81 143.56 54.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 17' ' ' THR . 61.3 m-20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' N ' ' OE2' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 120' ' ' GLU . 70.0 t -138.15 137.43 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -1.145 . . . . 0.0 109.501 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.707 ' HE2' HG21 ' A' ' 121' ' ' THR . 89.0 m-85 -125.06 143.04 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.0 m -126.13 125.29 42.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.832 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.9 m-85 -121.72 139.1 54.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -112.9 133.56 54.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD2' ' CE ' ' A' ' 136' ' ' LYS . 49.1 t0 -132.3 165.0 25.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 87.2 mt-10 -101.84 157.9 16.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 27.2 mt -124.28 135.93 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -142.14 130.93 22.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.23 135.17 9.18 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.912 . . . . 0.0 109.481 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.49 -6.27 18.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.653 2.236 . . . . 0.0 111.794 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.935 HG21 HD23 ' A' ' 150' ' ' LEU . 2.7 p -87.16 150.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.33 136.84 60.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.07 -32.32 28.16 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.19 64.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -75.37 -38.63 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD22 ' A' ' 150' ' ' LEU . 39.6 tp -69.49 -39.65 77.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.9 t80 -64.68 -46.89 80.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HE2' HG21 ' A' ' 24' ' ' THR . 5.7 tptm -63.29 -46.16 88.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 156' ' ' TYR . . . -72.12 -17.91 61.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.949 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.6 tp -80.05 -50.17 10.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.815 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 -45.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.535 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -71.09 -50.46 33.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.3 t70 -95.03 17.09 14.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -54.55 -52.84 60.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' OD1' HG11 ' A' ' 40' ' ' VAL . 44.8 t0 -66.32 -26.07 67.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 59.0 m-20 -88.04 -26.61 22.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 109.449 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.077 HG11 HG23 ' A' ' 146' ' ' ILE . 75.3 t -82.27 -40.15 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.939 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.8 mt -49.47 -48.68 74.86 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.31 -34.61 20.77 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.355 2.036 . . . . 0.0 111.839 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 48.4 mttt -79.96 -40.43 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.063 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.96 88.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.268 -0.895 . . . . 0.0 108.878 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.849 HD21 ' HB2' ' A' ' 57' ' ' PHE . 40.5 tp -83.54 102.54 12.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 108.967 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.41 -35.6 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.3 p -97.73 29.5 3.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.982 . . . . 0.0 109.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.763 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.2 t80 -54.69 119.83 5.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -84.89 -55.66 3.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.618 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.602 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 60.6 p -175.1 168.23 3.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.63 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.576 HG11 ' OD1' ' A' ' 27' ' ' ASP . 7.2 p -144.08 142.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 40' ' ' VAL . 65.2 mt-10 -149.89 155.64 40.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 85.4 m-20 -96.57 121.97 38.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.4 m -79.97 -27.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' THR . 26.0 mt-10 -163.17 152.02 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 90.4 157.69 33.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.97 9.44 43.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.566 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 51' ' ' THR . . . 107.62 -6.93 36.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.36 -160.46 22.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.0 129.04 16.67 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.691 2.261 . . . . 0.0 111.714 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 89.88 2.31 75.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.491 ' C ' HD13 ' A' ' 52' ' ' ILE . 14.3 m -75.05 152.46 38.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -1.148 . . . . 0.0 109.604 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 8.3 mm -114.05 124.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.072 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 96.8 mttt -118.78 143.65 46.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 15.6 tttp -115.95 128.49 55.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 30' ' ' ILE . 49.2 mt -117.95 143.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 28.2 m -120.54 133.22 55.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.36 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.849 ' HB2' HD21 ' A' ' 34' ' ' LEU . 33.5 p90 -134.47 154.26 51.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -96.97 123.46 40.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.301 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -136.63 126.85 26.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.616 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 56.89 35.53 26.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.68 9.98 53.29 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -109.04 133.88 52.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -79.2 119.4 22.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 57' ' ' PHE . 24.3 mttt -123.64 165.6 16.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 32.7 p90 -146.01 159.87 42.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.637 ' C ' HD23 ' A' ' 67' ' ' LEU . 35.7 m -134.82 143.37 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 109.728 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.637 HD23 ' C ' ' A' ' 66' ' ' VAL . 8.5 mt -112.42 131.86 55.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 0.0 109.105 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -127.79 141.25 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.611 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 28.3 tttt -121.32 150.94 40.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.267 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 37.9 mt -112.59 133.95 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 94.2 mt-10 -92.02 -32.69 15.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.6 p -176.97 147.2 0.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.85 138.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -133.36 76.12 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.45 -37.72 84.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.17 -47.31 68.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -95.57 11.96 31.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 48.45 51.21 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.56 148.72 20.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 19.4 p90 -151.05 167.76 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 109.215 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 37.4 m -126.88 138.57 53.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.454 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 15.5 p90 -152.53 155.43 37.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.0 p -146.83 156.16 42.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 89' ' ' ALA . 6.7 p -93.04 133.37 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG13 ' CE ' ' A' ' 96' ' ' LYS . 2.9 t -123.77 0.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.018 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -167.34 157.18 29.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.35 173.52 21.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.94 -13.01 29.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -82.89 16.84 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 1.2 tt -120.97 103.82 42.35 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.13 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.2 Cg_endo -68.38 151.19 76.25 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.739 2.293 . . . . 0.0 111.866 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 47.7 m-20 -79.36 -32.55 43.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.6 p -79.6 -0.97 35.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.756 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.13 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.38 126.85 43.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.379 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 46.4 mt-10 -58.85 -54.11 50.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 85.9 mttt -160.82 163.63 31.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 mt -122.99 132.98 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 2.2 m -108.87 144.53 36.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.642 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.606 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.2 m-85 -126.52 120.86 30.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 0.0 109.8 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 59.2 t0 -119.9 102.4 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.15 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.522 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.9 t -119.06 140.58 49.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.128 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 1.039 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.6 tttt -119.36 163.72 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 109.122 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.039 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -133.45 123.46 25.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.63 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.67 143.03 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 109.315 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.37 58.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.528 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -126.6 162.65 20.72 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.82 -13.38 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.694 2.263 . . . . 0.0 111.776 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.57 -23.29 65.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.88 18.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.02 -140.06 3.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 87.0 p -110.08 145.92 36.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.6 41.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.83 171.19 35.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -105.53 142.45 35.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -1.189 . . . . 0.0 109.377 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 60.9 tp -115.55 136.89 52.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.585 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 30.4 m -127.8 125.57 40.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.35 131.95 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.52 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -113.39 122.16 46.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.957 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.1 t80 -110.76 119.99 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.553 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' HG3' HG22 ' A' ' 2' ' ' VAL . 77.1 tt0 -103.45 145.33 30.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.707 HG21 ' HE2' ' A' ' 3' ' ' PHE . 26.2 p -120.62 151.69 39.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 28.0 mttt -49.78 -43.42 48.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 177.24 -111.64 0.34 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.45 -44.13 89.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.74 134.47 36.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.574 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 98.9 mt-10 -149.6 132.1 7.97 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.603 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.58 139.52 37.55 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.679 2.253 . . . . 0.0 111.783 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -64.15 177.48 0.81 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.315 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.02 -42.29 89.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.62 -47.11 86.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.6 -40.41 79.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.832 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 79.7 mt -61.92 -37.33 84.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -59.97 -49.48 77.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.265 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.3 m -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.02 -41.87 98.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' CE ' ' OD2' ' A' ' 7' ' ' ASP . 49.6 tttp -70.28 -40.39 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -1.109 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.19 64.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.424 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -65.25 -46.21 81.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.78 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 70.5 m-20 -50.81 -29.77 12.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.77 76.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.872 . . . . 0.0 109.239 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 142' ' ' LEU . 20.2 mt -76.01 -43.86 42.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 18' ' ' LEU . 75.2 t80 -56.03 -54.68 41.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 77.4 mttt -50.46 -40.49 50.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.71 -48.81 80.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.237 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.077 HG23 HG11 ' A' ' 29' ' ' VAL . 34.0 mt -68.81 -44.48 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -62.34 -45.06 94.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.325 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.08 70.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 39.5 t80 -67.14 -46.0 75.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.935 HD23 HG21 ' A' ' 13' ' ' VAL . 9.5 mp -61.22 -43.49 98.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.6 mt -69.38 -36.17 76.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.26 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -127.07 84.05 64.46 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.68 -19.24 36.77 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.645 2.23 . . . . 0.0 111.725 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.79 -12.26 60.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 41.7 t80 -77.52 125.87 30.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.569 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 68.7 m-20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.635 HG11 ' NZ ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -129.92 147.64 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.164 . . . . 0.0 109.348 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.456 ' CE1' ' HD2' ' A' ' 127' ' ' PRO . 97.1 m-85 -80.05 118.73 22.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 28.8 m -111.17 116.53 31.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.704 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.3 m-85 -108.91 163.67 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.688 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 46.0 mt-10 -130.34 132.47 45.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.253 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -132.91 166.23 22.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.27 140.99 36.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HG ' ' A' ' 115' ' ' LEU . 74.6 mt -114.15 136.69 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.307 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -151.76 138.99 19.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' HB3' ' OE1' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -153.07 144.7 16.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HG2' HD11 ' A' ' 151' ' ' LEU . 49.4 Cg_endo -70.25 -5.02 15.54 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.699 2.266 . . . . 0.0 111.794 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.94 HG21 HD23 ' A' ' 150' ' ' LEU . 7.1 p -92.88 151.62 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.14 79.19 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.3 Cg_endo -68.07 -30.61 31.73 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.71 2.273 . . . . 0.0 111.85 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.24 -36.0 61.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 157' ' ' ASN . 58.6 m -76.7 -38.89 53.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.495 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 150' ' ' LEU . 33.3 tp -68.13 -39.36 82.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 85.2 t80 -66.04 -44.59 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 0.0 109.785 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.872 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.1 tptt -63.83 -46.76 83.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 109.681 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -72.56 -17.67 61.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.544 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.948 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 51.1 tp -79.52 -49.05 12.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.39 -48.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.872 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.9 m -64.99 -49.43 70.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.9 m-20 -97.27 12.19 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -48.66 -53.56 18.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.338 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.798 ' HA ' HD12 ' A' ' 30' ' ' ILE . 73.7 m-20 -66.92 -23.56 65.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.927 . . . . 0.0 109.543 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 92.0 m-20 -87.23 -26.76 23.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD12 ' A' ' 146' ' ' ILE . 85.7 t -81.55 -35.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.4 mt -53.68 -48.59 92.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.25 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.9 Cg_endo -67.23 -19.73 50.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.524 2.149 . . . . 0.0 112.251 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 35.4 mttm -104.12 -45.82 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 109.347 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -59.89 -45.8 91.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 57' ' ' PHE . 55.0 tp -79.63 107.13 12.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 108.878 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.46 -44.73 85.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -92.14 29.75 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.828 -1.17 . . . . 0.0 110.344 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 54.4 t80 -58.38 123.75 17.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.02 -1.05 . . . . 0.0 109.363 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.36 -52.4 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -177.49 170.37 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.493 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.73 135.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -135.18 134.97 40.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.13 137.8 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.1 m -99.96 -36.83 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.433 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 43' ' ' VAL . 55.9 mt-10 -158.7 146.25 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.65 155.18 20.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -109.38 29.72 7.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -1.142 . . . . 0.0 109.583 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.78 -21.98 38.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.48 -162.42 5.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.4 160.55 49.14 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.66 2.24 . . . . 0.0 111.749 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 63.16 12.12 42.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -76.36 153.69 35.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.0 109.521 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 9.4 mm -117.39 126.94 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -119.88 144.51 47.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.706 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.7 tttt -115.29 128.97 56.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 66' ' ' VAL . 67.8 mt -117.41 145.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.3 m -124.43 125.15 43.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 109.298 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.893 ' HB2' HD21 ' A' ' 34' ' ' LEU . 48.0 p90 -133.66 158.21 43.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -99.22 150.14 22.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' OE1' ' CE ' ' A' ' 64' ' ' LYS . 57.7 tt0 -152.97 129.81 10.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.566 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 48.13 23.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.38 29.4 36.73 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' GLU . 96.9 mt-10 -123.71 155.39 37.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.8 m -97.86 112.26 24.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 62.3 mttt -124.67 158.63 32.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 30.0 p90 -142.76 157.6 44.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 55' ' ' ILE . 33.3 m -132.76 142.8 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.131 -0.98 . . . . 0.0 109.608 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.599 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.5 mt -110.29 125.42 53.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -116.01 133.86 55.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 64.0 tttt -120.59 146.06 46.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.195 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 66.1 mt -113.31 138.28 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.551 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.1 -42.61 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -161.58 142.75 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 109.499 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -109.88 140.71 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.48 77.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.398 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.488 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.6 mt-10 -57.29 -38.17 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.443 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.05 -47.73 64.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -95.01 12.67 27.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.1 mt 47.72 31.54 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.408 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.94 152.79 19.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.511 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.5 p90 -150.24 169.65 20.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -1.124 . . . . 0.0 109.26 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -125.97 139.28 53.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 25.9 p90 -154.29 160.76 41.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.7 p -146.19 156.48 43.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -86.36 132.15 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG13 ' HE2' ' A' ' 96' ' ' LYS . 4.1 t -117.67 -5.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.781 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -171.96 162.71 34.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 122.54 160.43 10.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.05 -15.16 20.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -1.079 . . . . 0.0 109.296 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.93 -6.03 56.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.338 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tt -79.98 110.19 15.13 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 109.356 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.027 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.21 146.42 63.52 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.747 2.298 . . . . 0.0 111.695 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 62.5 m-20 -78.89 -32.65 45.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.9 p -79.86 -5.44 55.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.727 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -122.75 136.92 55.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.058 -1.026 . . . . 0.0 109.624 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 81.1 mt-10 -70.63 -51.31 28.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' HG13 ' A' ' 85' ' ' VAL . 31.7 mttt -161.21 163.55 31.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 118' ' ' LYS . 60.3 mt -124.01 133.1 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 6.1 m -109.52 125.52 52.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.0 m-85 -108.79 122.87 48.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 56.7 t0 -120.42 102.63 8.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.933 . . . . 0.0 109.252 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 17.1 m -119.44 139.57 51.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.909 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HD23 ' A' ' 103' ' ' LEU . 31.6 ttpt -120.58 156.87 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 62.3 mt -129.54 127.5 40.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.5 m -139.61 142.97 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.33 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.25 170.63 22.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.13 -8.94 24.84 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.684 2.256 . . . . 0.0 111.853 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -67.9 -24.94 65.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.32 44.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.98 -143.32 4.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 85.3 p -106.1 144.74 32.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.12 30.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.41 -165.52 32.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.11 145.14 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -117.69 132.37 56.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 115' ' ' LEU . 20.1 m -122.11 128.69 51.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.269 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 4' ' ' THR . 49.2 t -107.7 131.35 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 31.8 tttm -112.66 121.41 44.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.84 . . . . 0.0 109.225 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.657 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t80 -116.48 114.32 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.544 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -101.12 138.05 38.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.092 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.9 p -116.42 164.32 14.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 41.3 mttt -55.22 -43.05 74.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.47 -106.88 0.21 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 125' ' ' ALA . 86.1 m-20 -63.32 -42.84 99.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 109.449 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -44.63 130.47 6.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 4.9 mt-10 -134.91 133.17 20.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.4 Cg_endo -70.44 158.13 56.99 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.613 2.209 . . . . 0.0 111.742 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.7 OUTLIER -90.93 164.99 13.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.95 -40.66 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.41 -46.63 89.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 64.7 mm-40 -58.11 -45.61 86.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.704 HD13 ' CE2' ' A' ' 5' ' ' PHE . 58.4 mt -59.55 -38.31 80.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -61.27 -48.55 80.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.35 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.4 m -58.83 -38.54 78.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.324 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -46.0 95.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.466 ' CD ' HG21 ' A' ' 117' ' ' VAL . 4.8 mtmt -64.94 -38.82 92.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.0 62.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.49 -45.99 84.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.359 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.3 -55.35 10.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -54.06 -35.72 62.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.39 -46.96 82.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.992 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.8 tm? -71.19 -33.57 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.202 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -56.07 -52.75 63.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.953 . . . . 0.0 109.125 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -51.76 -39.84 59.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.156 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.03 -38.71 73.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.305 -0.872 . . . . 0.0 109.053 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 142' ' ' LEU . 7.6 mm -71.68 -44.35 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.234 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.501 ' OE1' HG12 ' A' ' 13' ' ' VAL . 30.6 tp10 -67.69 -41.63 83.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.86 -34.28 74.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.95 -46.68 64.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.94 HD23 HG21 ' A' ' 13' ' ' VAL . 6.7 mp -63.26 -43.77 97.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 12' ' ' PRO . 82.0 mt -68.05 -33.48 74.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.71 -17.82 61.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -129.56 95.07 30.72 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.6 -16.58 34.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.699 2.266 . . . . 0.0 111.72 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -73.43 -20.73 60.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 70.8 t80 -79.89 129.92 34.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG22 ' HG3' ' A' ' 120' ' ' GLU . 87.0 t -138.26 137.67 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.571 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.4 m-85 -124.28 146.5 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.6 m -128.31 135.0 49.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 71.5 m-85 -126.39 160.0 31.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' CD ' ' HE2' ' A' ' 114' ' ' LYS . 71.7 mt-10 -135.93 129.26 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -133.26 165.13 25.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 8' ' ' GLU . 68.5 mm-40 -104.68 151.83 23.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 115' ' ' LEU . 47.4 mt -121.53 134.91 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -144.72 131.34 19.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.549 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 2.0 p -148.02 144.54 19.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.787 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.0 Cg_endo -71.48 1.38 5.63 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.415 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CG1' ' OG ' ' A' ' 11' ' ' SER . 2.4 p -97.89 152.78 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.55 137.9 61.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 111' ' ' SER . 47.1 Cg_endo -67.98 -35.16 21.2 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.744 2.296 . . . . 0.0 111.826 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.89 68.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.29 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 157' ' ' ASN . 68.1 m -78.55 -35.25 46.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 150' ' ' LEU . 14.5 tp -70.62 -40.59 73.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.771 ' HB2' HD12 ' A' ' 103' ' ' LEU . 91.3 t80 -65.51 -49.78 67.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.682 ' CE ' HG21 ' A' ' 24' ' ' THR . 7.3 tptm -59.77 -46.26 89.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -70.54 -18.63 62.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.04 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 13.4 mt -80.13 -46.16 16.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 109.749 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.52 -45.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.17 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.682 HG21 ' CE ' ' A' ' 20' ' ' LYS . 16.4 m -74.78 -50.05 18.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.334 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.6 t70 -92.12 9.18 34.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.0 109.819 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.04 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -51.05 -52.45 43.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 93.8 m-20 -65.19 -29.48 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.379 -0.826 . . . . 0.0 109.748 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.504 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 85.7 m-20 -84.41 -26.36 28.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 146' ' ' ILE . 45.0 t -80.77 -37.14 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -50.04 -49.48 74.76 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.37 -25.23 36.2 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.357 2.038 . . . . 0.0 111.97 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 59.6 mmtt -91.94 -33.31 14.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.149 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.65 -43.05 60.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -0.868 . . . . 0.0 109.046 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.61 106.6 18.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.016 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.26 -33.26 69.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.944 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 9.7 m -98.2 29.55 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 0.0 109.882 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 39' ' ' SER . 56.3 t80 -58.35 126.48 27.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -92.08 -52.04 4.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.62 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 54.3 p -177.66 170.85 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 109.722 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.6 p -142.33 140.32 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.308 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -145.93 153.79 41.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 7.1 m-20 -87.23 140.67 29.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 2.7 t -91.17 -39.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.644 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 51' ' ' THR . 87.9 mt-10 -161.03 149.21 15.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.448 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 96.16 167.36 34.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -98.14 8.14 45.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.91 -6.37 35.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.79 17.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.69 130.7 19.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.658 2.239 . . . . 0.0 111.758 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.5 3.49 69.04 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.7 m -77.76 155.19 31.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -1.178 . . . . 0.0 109.571 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 43' ' ' VAL . 21.1 mm -118.79 128.31 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.942 . . . . 0.0 109.308 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.7 mttp -122.52 147.72 46.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.614 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.3 tttm -116.98 129.3 55.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 40' ' ' VAL . 14.8 mm -116.28 146.21 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.528 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 23.5 m -130.71 121.59 25.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.903 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 47.6 p90 -129.1 160.8 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -96.25 148.56 22.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -150.37 127.74 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.36 22.71 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.45 10.86 72.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -108.35 159.12 16.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -1.11 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.6 m -104.93 115.47 30.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -121.22 164.68 16.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.49 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 45.6 p90 -143.75 156.47 44.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.844 ' C ' HD23 ' A' ' 67' ' ' LEU . 27.1 m -135.85 144.7 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.557 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.844 HD23 ' C ' ' A' ' 66' ' ' VAL . 2.5 mt -109.87 126.79 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.219 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -118.5 134.84 54.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 17.8 tttm -116.05 147.21 41.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' GLY . 12.2 mm -106.83 126.54 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.4 mt-10 -87.32 -42.88 12.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 p -168.04 148.46 4.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.01 135.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.12 75.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.352 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.25 -36.67 78.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -48.74 72.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.463 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 49.3 m-20 -90.63 13.01 17.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.7 mt 47.53 49.27 16.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.472 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -148.73 153.9 25.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.3 p90 -150.38 169.47 21.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -1.124 . . . . 0.0 109.133 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 62.7 m -131.09 140.75 50.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 24.1 p90 -155.76 162.6 40.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.578 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 51.9 p -146.36 156.53 43.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.51 133.32 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.541 ' C ' HD13 ' A' ' 90' ' ' LEU . 19.4 t -106.87 -7.93 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.478 ' C ' ' HG ' ' A' ' 67' ' ' LEU . . . 171.27 -179.06 43.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.75 166.02 27.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.84 -20.75 2.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -1.116 . . . . 0.0 109.379 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.92 -15.73 56.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -90.65 106.96 17.15 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.307 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.033 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.5 Cg_endo -69.58 146.26 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.728 2.285 . . . . 0.0 111.901 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.45 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 79.3 m-20 -77.47 -30.97 53.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 p -79.95 1.18 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.849 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.56 126.32 41.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' OE1' ' OE2' ' A' ' 120' ' ' GLU . 92.8 mt-10 -58.15 -42.4 85.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -178.54 157.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.359 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 118' ' ' LYS . 63.8 mt -119.67 135.56 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.532 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 34.6 m -109.62 128.2 55.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.752 ' CE1' HG13 ' A' ' 117' ' ' VAL . 94.2 m-85 -111.27 124.65 52.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.508 ' O ' HD12 ' A' ' 115' ' ' LEU . 57.2 t0 -120.09 105.0 10.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.647 ' CB ' HD13 ' A' ' 115' ' ' LEU . 8.5 t -114.5 141.0 48.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 103' ' ' LEU . 74.1 tttt -127.7 146.86 50.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.86 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 19' ' ' TYR . 46.5 mt -122.68 127.6 49.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.799 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.8 m -138.86 143.43 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -62.65 139.77 58.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.52 165.3 22.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.01 22.51 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.647 2.231 . . . . 0.0 111.831 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.16 -28.14 69.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.79 10.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.35 -134.44 2.08 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 100.0 p -108.42 143.16 37.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -1.129 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.94 141.97 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.57 -168.54 35.45 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HE2' ' CD ' ' A' ' 6' ' ' GLU . 69.2 tttt -125.83 140.72 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -1.121 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 101' ' ' SER . 25.0 tp -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.1 m -126.83 127.1 44.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' CE1' ' A' ' 99' ' ' PHE . 58.6 t -111.81 132.7 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 97' ' ' ILE . 33.8 ttpt -111.72 125.31 53.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 55.6 t80 -113.0 118.75 35.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 2' ' ' VAL . 87.0 tt0 -103.44 146.78 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.399 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.8 p -119.77 157.19 29.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.397 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.2 mttt -45.9 -37.71 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.66 -96.4 0.16 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.18 -32.15 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -1.148 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.51 137.77 57.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -145.59 110.44 4.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 47.9 Cg_endo -69.77 144.48 54.1 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.728 2.285 . . . . 0.0 111.772 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 131' ' ' GLU . 48.4 p30 -70.49 172.87 7.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.71 -35.1 78.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.47 -44.3 89.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.405 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 94.4 mt-10 -66.84 -39.99 87.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 95.7 mt -63.77 -42.93 97.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.46 -44.72 90.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.268 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.3 m -57.53 -38.66 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.04 97.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -62.98 -38.61 91.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -51.71 -32.04 28.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.444 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -75.86 -36.65 59.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.22 -55.29 8.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.877 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 4.2 p30 -62.11 -26.03 68.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.499 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -58.76 -50.98 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.895 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 6.4 tp -58.24 -38.16 76.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.883 . . . . 0.0 109.292 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.02 -54.95 38.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.128 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -51.54 -33.74 33.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -60.85 -53.72 53.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.247 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.919 HG23 HG11 ' A' ' 29' ' ' VAL . 45.0 mt -67.37 -53.55 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -50.48 -51.0 51.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.46 70.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.9 t80 -66.5 -39.72 88.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.394 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 18' ' ' LEU . 13.0 mt -61.21 -43.12 99.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 ' HG2' ' A' ' 12' ' ' PRO . 83.3 mt -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.37 61.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.595 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 93.85 46.59 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.81 -21.46 33.2 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.683 2.255 . . . . 0.0 111.759 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -75.42 -17.88 60.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 57.5 t80 -78.74 118.67 21.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.47 ' HA ' HG21 ' A' ' 17' ' ' THR . 75.6 m-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.609 HG11 ' HE3' ' A' ' 118' ' ' LYS . 88.5 t -132.87 137.12 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.513 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.42 146.88 49.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -130.62 130.46 44.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 132' ' ' LEU . 88.0 m-85 -129.28 160.92 31.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -127.9 130.11 47.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -126.22 164.71 20.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -94.51 160.47 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 61.4 mt -128.12 142.38 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.36 132.11 42.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -152.42 112.67 2.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.25 -2.22 10.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.581 2.187 . . . . 0.0 111.726 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.061 ' HB ' HD11 ' A' ' 18' ' ' LEU . 68.0 t -95.2 154.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 132.39 26.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.0 Cg_endo -67.93 -29.64 34.15 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.745 2.296 . . . . 0.0 111.939 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.88 -34.05 62.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 157' ' ' ASN . 90.2 m -77.31 -37.4 52.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.061 HD11 ' HB ' ' A' ' 13' ' ' VAL . 9.0 mt -69.24 -40.25 78.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.54 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 68.6 t80 -65.88 -45.54 81.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.3 OUTLIER -64.48 -47.6 78.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -70.34 -20.84 62.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.333 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.2 tt -80.13 -45.49 18.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.36 -54.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 20.7 m -63.69 -49.5 72.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.577 ' OD2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 m-20 -95.61 13.59 25.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.074 -1.017 . . . . 0.0 109.938 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.01 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -53.3 -52.87 57.71 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.193 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 63.9 t0 -67.61 -23.02 65.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.97 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 55.3 m-20 -90.94 -27.42 18.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.9 p -83.51 -35.07 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.01 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -56.63 -46.47 99.83 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.4 Cg_endo -66.72 -22.18 50.42 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.456 2.104 . . . . 0.0 112.42 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -108.47 -26.0 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.115 -0.991 . . . . 0.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -63.49 -28.61 70.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.969 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 57' ' ' PHE . 42.2 tp -101.02 117.52 35.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.032 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.77 -44.07 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.532 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 57.9 m -93.02 28.17 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.891 -1.131 . . . . 0.0 110.072 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CE1' HG22 ' A' ' 30' ' ' ILE . 46.6 t80 -58.83 131.61 51.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.0 tttp -93.03 -51.08 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.933 . . . . 0.0 110.103 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.464 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 67.0 p -179.91 173.77 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 109.938 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 9.7 p -135.69 128.35 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.205 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 70.0 mm-40 -130.0 144.03 51.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.27 125.64 30.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 50.0 t -82.69 -44.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.562 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 51' ' ' THR . 81.7 tt0 -158.49 145.59 17.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.4 168.21 28.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.84 5.68 50.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -1.152 . . . . 0.0 109.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.28 -8.45 28.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -156.76 12.35 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.02 135.68 30.44 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.701 2.267 . . . . 0.0 111.774 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.25 1.5 84.06 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.5 m -80.02 127.68 32.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 109.481 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 20.6 mm -93.29 134.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -125.77 150.75 47.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.742 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.5 tttt -115.33 126.45 54.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.644 ' HB ' HG22 ' A' ' 66' ' ' VAL . 56.4 mt -111.77 141.01 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -125.39 123.41 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.894 ' HB2' HD21 ' A' ' 34' ' ' LEU . 41.1 p90 -128.71 166.84 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.27 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -99.35 151.39 21.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.501 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -154.13 119.0 4.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.927 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.12 31.78 7.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.26 -7.09 65.15 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' OE2' ' HE2' ' A' ' 64' ' ' LYS . 72.8 tt0 -91.25 144.51 25.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -1.145 . . . . 0.0 109.419 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.7 m -95.79 120.15 35.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 12.7 mmtt -125.69 169.81 12.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 67' ' ' LEU . 5.0 p90 -147.93 161.39 41.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.668 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.8 m -137.94 147.18 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.742 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.9 mp -115.3 134.3 55.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -128.67 141.99 51.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 66.4 tttt -120.82 147.68 45.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.356 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.7 mt -108.61 132.2 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 92.9 mt-10 -87.6 -38.8 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.425 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 p -176.78 150.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.03 137.16 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -131.46 79.43 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -61.86 -37.76 85.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.55 63.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.455 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 56.5 m-20 -90.58 13.32 16.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 9.8 mt 47.31 47.63 16.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.89 152.95 24.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 17.3 p90 -151.12 169.35 22.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 109.14 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 22.7 t -137.76 142.03 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.9 p90 -154.64 160.7 41.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.349 -0.845 . . . . 0.0 109.533 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.4 p -145.55 156.49 43.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 90' ' ' LEU . 73.4 t -89.67 133.09 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.359 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -115.04 -1.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.863 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.52 168.09 39.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.32 166.28 18.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.0 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -1.148 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -81.35 -10.54 59.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -88.27 107.78 18.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.08 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.3 Cg_endo -69.43 148.29 66.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.647 2.231 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -79.37 -33.41 42.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -81.31 0.26 37.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.08 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -130.43 139.45 50.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HG3' ' HD3' ' A' ' 122' ' ' LYS . 89.7 mt-10 -67.03 -54.73 18.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 109.508 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 51.2 pttt -171.91 163.54 6.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 118' ' ' LYS . 56.2 mt -118.98 135.75 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.5 m -110.15 122.6 48.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.221 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.629 ' CE1' HG13 ' A' ' 117' ' ' VAL . 92.4 m-85 -104.04 125.17 50.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.841 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 48.7 t0 -120.34 102.22 8.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.466 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 27.0 m -115.13 141.43 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.0 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.62 ' O ' HD23 ' A' ' 103' ' ' LEU . 50.3 tttt -123.24 153.8 39.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 108.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 102' ' ' LYS . 40.4 mt -129.88 126.45 37.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.94 143.26 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -70.4 148.3 48.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.48 168.07 24.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 -6.0 17.52 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.71 2.273 . . . . 0.0 111.701 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -63.81 -27.3 69.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.7 18.32 25.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.51 -139.09 3.42 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 31.0 t -117.0 145.99 43.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.682 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.11 166.13 25.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.885 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 169.2 169.43 32.55 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -109.51 144.93 37.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -1.164 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' THR . 1.2 tt -114.98 136.19 53.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.575 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.3 m -127.16 126.13 42.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 99' ' ' PHE . 48.0 t -111.24 130.5 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.651 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 97' ' ' ILE . 63.9 tttt -112.6 122.08 46.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 109.152 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.575 ' CD1' ' HG3' ' A' ' 127' ' ' PRO . 22.8 t80 -112.1 118.41 35.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 109.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.463 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 88.8 mt-10 -101.24 145.52 28.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.208 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 15.7 p -124.09 171.28 9.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HD3' ' HG3' ' A' ' 95' ' ' GLU . 41.9 mmtt -79.8 1.52 26.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.28 -88.46 0.46 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -57.79 -37.45 73.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.89 137.66 58.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 110.69 3.78 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.432 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CD1' ' A' ' 119' ' ' TYR . 50.4 Cg_endo -70.28 147.22 59.04 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.732 2.288 . . . . 0.0 111.835 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.8 OUTLIER -84.61 163.51 19.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.448 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.61 -40.12 78.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.66 -45.56 91.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -59.36 -42.88 92.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.62 HD13 ' CE2' ' A' ' 5' ' ' PHE . 90.9 mt -58.16 -35.32 71.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -65.39 -44.12 88.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.6 m -57.79 -39.6 77.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.29 98.8 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -63.3 -39.2 93.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -1.155 . . . . 0.0 109.448 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.16 -33.1 38.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.95 -43.24 93.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.99 -50.66 67.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.336 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 84.4 m-20 -51.57 -33.67 33.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.36 97.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.269 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.947 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.9 tm? -79.18 -36.45 40.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.12 -51.84 68.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 80.6 mttt -51.78 -39.87 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 0.0 109.212 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.28 -42.32 81.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.143 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.09 -45.06 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.372 -0.83 . . . . 0.0 109.191 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.437 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 94.2 mt-10 -71.19 -37.82 72.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.83 79.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.162 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -71.33 -52.33 19.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.595 HD22 HD23 ' A' ' 18' ' ' LEU . 8.1 mp -60.97 -36.69 80.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.52 -31.69 68.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.46 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.71 -2.1 51.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -127.94 75.42 78.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.71 -14.17 35.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.673 2.249 . . . . 0.0 111.782 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -76.23 -26.1 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.659 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 81.6 t80 -79.88 125.58 29.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG11 ' CE ' ' A' ' 118' ' ' LYS . 97.1 t -115.65 136.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' OE1' ' A' ' 126' ' ' GLU . 97.6 m-85 -124.61 147.13 48.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.49 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -127.6 120.69 28.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.797 ' CE2' HD13 ' A' ' 132' ' ' LEU . 91.8 m-85 -123.16 133.66 54.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -101.9 132.69 47.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 53.3 t0 -127.74 160.58 31.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 90.4 mt-10 -92.09 160.2 15.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 77.0 mt -117.67 143.8 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -138.03 112.26 8.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 51.1 m -149.33 126.78 5.58 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.68 -35.96 9.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.21 149.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.525 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 134.33 93.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.599 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' SER . 47.6 Cg_endo -68.67 -24.23 35.42 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.785 2.323 . . . . 0.0 111.826 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -44.16 49.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.667 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.8 m -76.27 -42.83 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.157 -0.965 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 HD22 ' A' ' 150' ' ' LEU . 16.1 tp -65.12 -38.35 90.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 109.639 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 83.7 t80 -66.17 -43.86 85.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.7 tptt -64.51 -46.74 81.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.689 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.26 -16.84 60.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.0 tp -77.02 -51.03 11.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.5 -48.25 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -61.59 -48.77 79.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 109.778 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' VAL . 65.3 m-20 -101.54 15.26 29.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.32 -52.68 12.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -67.45 -23.16 65.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.541 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 48.1 m-20 -88.53 -27.75 21.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.87 . . . . 0.0 109.317 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.058 HG21 HG23 ' A' ' 146' ' ' ILE . 8.0 p -82.76 -37.2 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.05 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -49.74 -48.9 76.02 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.869 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.2 Cg_endo -68.48 -33.45 22.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.396 2.064 . . . . 0.0 111.87 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.0 mttt -82.33 -52.91 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.136 -0.978 . . . . 0.0 109.133 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -53.06 -38.07 62.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 108.974 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.053 HD21 ' HB2' ' A' ' 57' ' ' PHE . 26.8 tp -84.39 105.42 15.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.77 -39.33 77.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.079 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.6 p -95.61 28.28 3.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 109.862 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -56.44 125.7 23.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB2' HD12 ' A' ' 58' ' ' LEU . 51.7 tptt -92.83 -52.69 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 m -170.34 162.92 8.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.717 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.092 HG22 HG23 ' A' ' 55' ' ' ILE . 96.3 t -143.03 142.42 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 86.1 mt-10 -150.97 161.86 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 109.54 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -88.51 135.4 33.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 109.446 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 28.5 t -83.27 -42.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.776 ' O ' HG23 ' A' ' 51' ' ' THR . 55.6 mm-40 -159.57 147.25 17.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.72 -154.09 21.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -140.66 13.21 2.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' H ' HG21 ' A' ' 51' ' ' THR . . . 109.36 -2.13 31.04 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.87 -162.66 25.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.71 134.94 27.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.731 2.287 . . . . 0.0 111.866 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.98 0.25 90.19 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 44' ' ' GLU . 89.5 m -70.2 151.57 45.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.63 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 37.8 mm -115.65 124.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -117.91 143.39 46.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.002 . . . . 0.0 109.763 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 12.6 tttm -123.5 136.3 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.223 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.092 HG23 HG22 ' A' ' 40' ' ' VAL . 71.9 mt -128.92 146.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.804 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 30.3 m -120.14 121.99 40.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.279 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 1.053 ' HB2' HD21 ' A' ' 34' ' ' LEU . 51.4 p90 -122.32 162.27 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.546 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -101.07 149.98 23.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.27 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -164.89 131.29 2.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 53.85 28.81 8.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.05 67.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -107.74 129.0 55.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -1.207 . . . . 0.0 109.401 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -80.12 124.44 28.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 73.9 mttt -124.21 169.91 11.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.551 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 37.7 p90 -142.5 154.58 44.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.505 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 29.7 m -130.53 139.19 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.885 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -108.67 126.96 53.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -125.89 140.4 52.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.588 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 36.4 tttm -121.39 148.95 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.32 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 50' ' ' GLY . 57.7 mt -108.6 132.09 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.2 mt-10 -88.29 -36.43 16.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 109.355 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -175.16 150.27 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.73 136.38 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -132.81 78.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 45.9 mt-10 -57.23 -39.41 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.5 -46.99 57.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.925 . . . . 0.0 109.421 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.494 ' HB3' ' NZ ' ' A' ' 102' ' ' LYS . 47.2 m-20 -93.77 13.68 21.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.281 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.6 mt 47.03 35.87 3.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.98 154.22 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.9 p90 -150.71 169.72 20.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 109.068 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 72.5 m -129.72 139.51 51.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.674 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.612 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.9 p90 -153.27 158.7 42.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 91.1 p -148.04 157.71 43.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.6 p -97.08 125.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.285 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.48 2.47 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.885 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -164.59 154.33 25.09 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 113.9 159.14 13.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -13.42 32.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.115 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.45 9.33 7.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.596 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.59 122.41 42.0 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.371 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.0 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 51.1 Cg_endo -70.5 145.2 52.22 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.691 2.261 . . . . 0.0 111.826 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -79.76 -32.28 40.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -80.18 -2.77 46.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.0 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.0 117.98 25.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.967 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -49.94 -43.64 50.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 14.3 pttt -176.85 161.46 2.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.6 mt -122.65 134.04 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 50.8 m -107.89 129.81 55.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.612 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.8 m-85 -113.78 123.6 50.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.9 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -123.0 101.57 7.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.017 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.446 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 4.3 m -113.31 145.89 40.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.035 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.778 ' O ' HD23 ' A' ' 103' ' ' LEU . 19.4 tttt -123.27 158.39 31.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 102' ' ' LYS . 77.0 mt -138.93 129.91 26.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.006 . . . . 0.0 110.139 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -142.83 169.68 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 0.0 108.979 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.639 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.32 137.47 39.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 109.516 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.89 161.09 19.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.62 -0.45 6.82 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.689 2.26 . . . . 0.0 111.74 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.93 -23.43 41.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.31 12.52 33.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.96 -146.43 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.45 145.89 24.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.661 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.78 143.13 28.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.363 -0.835 . . . . 0.0 109.197 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.16 -161.12 26.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 116' ' ' THR . 2.1 tt -116.73 136.78 52.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.7 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.801 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.0 m -123.27 127.72 48.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.28 129.06 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 97' ' ' ILE . 87.3 tttt -114.45 120.77 41.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.323 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.839 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.4 t80 -112.45 119.24 37.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.9 mt-10 -99.77 146.47 26.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 127' ' ' PRO . 66.2 p -123.8 160.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -52.74 -43.55 65.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.17 -82.14 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 18.1 p30 -76.78 -15.38 59.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.6 138.04 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' OE1' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -134.92 111.25 11.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 50.3 Cg_endo -70.89 140.35 38.24 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.729 2.286 . . . . 0.0 111.795 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.92 156.6 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -53.37 -34.78 58.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -59.05 -45.99 89.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 68.8 mm-40 -60.32 -41.5 93.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.797 HD13 ' CE2' ' A' ' 5' ' ' PHE . 54.2 mt -60.88 -38.64 86.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.377 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -71.44 -37.53 71.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 58.8 m -58.72 -42.16 88.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.26 -32.03 71.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -68.99 -40.44 78.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.327 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.17 -37.02 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -66.65 -42.95 85.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.306 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.79 -50.2 67.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.839 . . . . 0.0 109.285 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' PHE . 86.7 m-20 -56.37 -33.25 65.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.339 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.25 -54.46 40.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.34 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.7 mm? -76.34 -32.3 58.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' ASP . 86.6 t80 -63.15 -50.79 69.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.381 -0.825 . . . . 0.0 109.259 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -62.4 -34.5 76.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.92 -44.38 82.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.058 HG23 HG21 ' A' ' 29' ' ' VAL . 26.6 mt -67.59 -46.59 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.341 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 38.3 mt-10 -64.65 -40.38 95.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.855 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.38 71.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 18.6 t80 -69.29 -43.24 74.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.887 . . . . 0.0 109.351 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 HD12 ' A' ' 18' ' ' LEU . 8.1 mp -70.56 -35.81 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.92 -37.28 64.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.616 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.63 -15.21 61.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -131.49 91.06 35.63 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -16.42 33.95 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.719 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -78.29 -9.63 59.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.72 142.09 15.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.472 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.737 HG22 ' HG3' ' A' ' 120' ' ' GLU . 91.5 t -112.91 144.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -1.147 . . . . 0.0 109.293 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 59.9 m-85 -79.85 126.63 31.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.719 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.3 m -123.16 116.45 23.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 90.9 m-85 -103.8 167.09 10.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -140.81 130.92 24.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -139.87 165.37 27.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.31 140.92 37.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 70.3 mt -106.62 141.54 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.559 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -142.9 128.88 19.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 14.8 m -152.77 134.63 8.64 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 -0.78 7.76 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 111.679 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.4 p -92.51 149.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.494 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' GLY . . . -61.73 133.79 93.71 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.685 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 47.0 Cg_endo -68.34 -26.84 34.84 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.759 2.306 . . . . 0.0 111.695 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.67 -39.28 57.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.695 HG23 ' OXT' ' A' ' 157' ' ' ASN . 15.6 m -75.52 -43.49 48.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 150' ' ' LEU . 3.8 tp -70.81 -39.81 72.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.1 t80 -66.83 -41.69 87.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HE3' HG21 ' A' ' 24' ' ' THR . 30.7 tptt -66.34 -46.3 77.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.8 -24.49 59.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.203 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.916 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 16.3 tp -66.44 -49.62 66.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.19 -46.21 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.763 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -67.66 -48.35 66.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.651 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.4 m-20 -94.2 6.36 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.95 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -45.89 -52.57 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 19.6 t70 -67.06 -26.27 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.747 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.3 m-20 -87.12 -27.04 23.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.125 -0.985 . . . . 0.0 109.73 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG21 HG23 ' A' ' 146' ' ' ILE . 8.3 p -81.94 -35.54 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.619 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.95 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.1 mt -52.58 -47.49 93.69 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.324 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.2 Cg_endo -67.07 -17.39 50.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.352 2.035 . . . . 0.0 112.057 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 19.5 mttm -107.5 -35.78 6.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.471 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.44 -41.74 88.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 109.175 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 57' ' ' PHE . 45.7 tp -86.69 109.05 18.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -57.51 -43.45 84.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.29 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -91.23 29.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.804 ' HA ' HD23 ' A' ' 34' ' ' LEU . 66.1 t80 -60.73 127.18 30.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.117 -0.99 . . . . 0.0 109.502 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.734 ' HD3' HD23 ' A' ' 58' ' ' LEU . 41.3 mtmt -96.38 -49.85 5.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 109.551 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -178.15 170.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -138.81 141.81 38.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 34.4 t30 -77.63 129.67 35.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.445 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -79.85 -41.3 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 45' ' ' GLY . 81.8 tt0 -167.46 157.53 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.498 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.42 173.31 33.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.09 3.9 22.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -1.164 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.04 -9.13 25.15 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.62 -160.77 26.44 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.15 125.41 11.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.616 2.211 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 100.29 0.06 55.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.543 HG23 ' HA3' ' A' ' 45' ' ' GLY . 62.6 m -75.67 152.54 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 51' ' ' THR . 27.3 mm -115.78 125.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.854 . . . . 0.0 109.186 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 87.4 mttt -118.7 143.92 46.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.897 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.2 tttt -115.54 128.48 56.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 66' ' ' VAL . 66.2 mt -115.03 133.37 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -112.78 124.97 53.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.842 ' HB2' HD21 ' A' ' 34' ' ' LEU . 53.2 p90 -134.38 161.19 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.734 HD23 ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -101.73 135.94 42.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.368 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -137.51 128.43 27.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.586 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 50.77 22.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.546 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.02 59.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 58' ' ' LEU . 85.0 mt-10 -117.06 140.67 49.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -1.089 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.703 HG23 ' NZ ' ' A' ' 38' ' ' LYS . 86.6 m -81.22 111.69 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -128.03 164.65 21.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE1' HD13 ' A' ' 67' ' ' LEU . 10.8 p90 -149.66 165.6 31.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 67' ' ' LEU . 25.8 m -137.13 146.28 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.695 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.5 mp -115.32 134.57 55.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -131.19 144.32 51.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 31.9 tttt -125.42 150.21 47.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLY . 63.1 mt -106.48 133.07 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 81' ' ' SER . 3.8 pt-20 -107.53 -29.83 8.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.788 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 22.7 t -158.96 139.79 12.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.052 -1.03 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 70' ' ' ILE . 65.4 mt -128.39 131.57 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.078 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -131.99 81.73 1.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.284 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.1 -34.78 75.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.49 81.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -89.59 12.12 17.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.8 mt 50.03 28.96 3.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.42 149.31 17.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 20.7 p90 -150.98 169.06 22.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.133 . . . . 0.0 109.04 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.505 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 42.3 m -135.84 141.4 44.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 26.6 p90 -154.28 160.47 41.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.341 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -142.46 155.59 45.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 67' ' ' LEU . 6.1 p -90.9 132.87 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 109.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' HD13 ' A' ' 90' ' ' LEU . 6.0 m -113.46 0.47 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 90' ' ' LEU . . . 179.26 171.3 42.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.66 171.35 24.59 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.72 -17.03 31.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.21 59.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' C ' ' A' ' 85' ' ' VAL . 1.1 tp -94.93 106.0 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.12 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.26 148.35 61.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.706 2.271 . . . . 0.0 111.781 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 80.6 m-20 -79.36 -32.95 43.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.82 . . . . 0.0 109.561 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 p -80.27 3.77 19.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.717 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.12 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.21 131.94 44.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.072 -1.018 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 89.6 mt-10 -59.73 -43.64 94.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 12.3 pttp -179.11 163.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.0 mt -122.68 133.39 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 28.7 m -105.88 136.8 44.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.299 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.5 m-85 -116.49 122.12 43.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 20.9 t70 -118.79 102.25 8.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -116.04 138.4 51.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.784 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.749 ' C ' HD22 ' A' ' 103' ' ' LEU . 54.5 tttm -131.49 141.02 49.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.119 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.0 mm? -123.67 129.13 50.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 0.0 109.608 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 112' ' ' ALA . 1.6 m -89.06 146.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 15' ' ' PRO . . . -78.4 103.71 8.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.634 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.67 137.47 19.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.47 -16.84 34.63 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.728 2.285 . . . . 0.0 111.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.5 -2.97 50.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . 104.26 -29.93 11.1 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.38 171.42 8.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 53.0 p -126.4 137.48 53.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.07 139.56 26.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -168.78 -157.09 11.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -131.69 144.54 51.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 116' ' ' THR . 1.3 tt -119.13 128.19 54.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 115' ' ' LEU . 24.6 m -116.73 129.97 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.349 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 136' ' ' LYS . 58.3 t -112.26 128.12 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.55 ' CG ' HG11 ' A' ' 2' ' ' VAL . 18.5 tttt -115.81 119.62 36.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.4 t80 -110.0 118.67 37.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.141 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.737 ' HG3' HG22 ' A' ' 2' ' ' VAL . 78.4 tt0 -102.14 146.32 28.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.1 p -117.78 167.15 11.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 40.7 mttt -55.41 -32.63 62.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.67 -102.15 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -59.34 -19.82 49.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.44 132.71 48.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -133.49 107.89 12.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.2 146.91 58.83 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.655 2.237 . . . . 0.0 111.776 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -60.3 161.23 7.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.579 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -65.83 -36.45 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.45 -42.5 98.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.21 -40.0 80.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 85.8 mt -64.86 -39.28 93.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -68.13 -46.28 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.42 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.6 m -57.82 -36.51 72.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.08 99.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HG3' HG21 ' A' ' 117' ' ' VAL . 21.5 tttm -64.63 -37.81 88.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.515 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.64 -28.19 53.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -63.59 -45.62 89.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.06 90.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 80.8 m-20 -53.98 -33.74 57.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.71 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 142' ' ' LEU . 3.3 tm? -77.79 -45.15 25.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -55.01 -53.14 59.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 45.3 mttm -54.85 -37.87 66.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.37 -53.51 56.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 22' ' ' LEU . 29.7 mt -68.02 -42.97 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -61.32 -44.64 96.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.98 71.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 26.7 t80 -68.44 -42.5 78.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 18' ' ' LEU . 6.9 mp -67.33 -41.85 84.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.65 -35.0 79.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.419 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.74 -13.41 59.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.84 86.8 57.03 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -20.17 33.47 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 111.788 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -75.85 -15.82 60.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.756 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 66.0 t80 -59.04 141.65 53.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.695 ' OXT' HG23 ' A' ' 17' ' ' THR . 98.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.537 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HE3' ' A' ' 118' ' ' LYS . 92.7 t -135.25 136.22 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -1.138 . . . . 0.0 109.354 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.18 145.03 48.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -125.2 131.74 53.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.867 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.716 ' CE2' HD12 ' A' ' 132' ' ' LEU . 75.6 m-85 -126.71 156.18 41.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -128.01 132.62 49.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.23 165.13 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -99.56 152.06 20.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.0 mt -120.05 136.78 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 96.0 m-20 -139.13 134.25 32.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.5 126.44 4.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HD2' ' OE2' ' A' ' 147' ' ' GLU . 49.6 Cg_endo -70.22 -5.02 15.52 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.728 2.285 . . . . 0.0 111.81 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.81 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.398 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 126.37 65.83 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.4 Cg_endo -68.23 -24.06 38.33 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.762 2.308 . . . . 0.0 111.834 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.46 64.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.625 HG23 ' C ' ' A' ' 157' ' ' ASN . 89.7 m -76.91 -36.22 56.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' CE1' ' A' ' 143' ' ' PHE . 18.5 tp -70.24 -39.6 74.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.49 -44.22 87.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.874 ' HE2' HG21 ' A' ' 24' ' ' THR . 22.4 tptm -66.15 -46.33 77.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.02 -20.59 60.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.375 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.927 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 42.3 tp -73.56 -49.1 28.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.655 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.96 -47.47 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.748 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.874 HG21 ' HE2' ' A' ' 20' ' ' LYS . 1.4 m -65.78 -46.94 76.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' VAL . 7.6 m-20 -98.51 9.35 43.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.822 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.31 -53.23 11.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.414 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' OD1' HG11 ' A' ' 40' ' ' VAL . 54.5 t0 -68.41 -24.78 64.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.717 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.9 m120 -87.23 -26.78 23.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.59 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 146' ' ' ILE . 9.0 p -82.66 -36.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.5 mt -51.29 -47.99 86.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.3 Cg_endo -68.43 -21.63 40.3 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.352 2.035 . . . . 0.0 111.923 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 40.6 mttm -96.27 -35.15 11.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.293 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.38 -39.47 74.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 57' ' ' PHE . 15.9 tp -88.73 106.66 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.32 -29.8 66.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -104.54 27.93 7.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 109.95 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' ' 39' ' ' SER . 20.2 t80 -56.74 127.84 33.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.153 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -92.31 -52.37 4.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -178.28 171.3 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 0.0 109.838 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.93 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.9 p -142.62 140.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 109.227 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 85.2 mt-10 -151.33 143.74 24.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 70.0 m-20 -84.09 127.38 33.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -83.82 -29.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 94.9 mt-10 -156.72 142.43 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 104.33 162.59 24.49 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -102.9 3.29 36.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 109.53 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.42 -14.9 13.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.7 -161.11 6.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.75 148.42 58.61 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.653 2.235 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 9.39 84.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 52' ' ' ILE . 25.0 m -79.98 157.24 26.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 109.545 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 15.6 mm -116.94 124.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.5 mttm -116.78 143.02 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.687 ' HG3' HD11 ' A' ' 67' ' ' LEU . 20.3 tttm -117.42 129.29 55.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.316 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.93 ' CD1' HG23 ' A' ' 40' ' ' VAL . 11.9 mm -115.12 144.52 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 m -126.22 126.03 43.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.592 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.743 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.8 p90 -129.78 175.22 9.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 57' ' ' PHE . 4.3 mm? -110.04 147.42 33.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 109.543 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -156.58 123.03 5.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 54.34 33.01 17.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.06 4.72 63.68 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -102.37 138.17 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.389 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.5 m -86.38 119.99 27.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -125.44 167.92 14.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.726 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.3 p90 -147.71 161.73 40.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.619 HG13 ' HE1' ' A' ' 57' ' ' PHE . 28.7 m -134.64 143.78 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.321 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 65' ' ' PHE . 5.4 mp -112.57 131.57 55.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -126.27 139.66 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 tttt -118.03 146.72 43.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -108.72 130.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.9 mt-10 -88.94 -33.33 17.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -177.49 157.65 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.16 132.99 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -129.48 78.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.2 mt-10 -64.84 -30.08 71.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -48.98 79.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.377 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 54.5 m-20 -89.86 14.25 12.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 16.2 mt 47.18 52.58 11.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.486 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -153.75 156.56 26.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.4 p90 -150.9 169.85 20.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.0 109.018 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 70.1 m -130.11 139.33 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.89 158.42 40.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 94.8 p -146.35 156.48 43.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG12 HD23 ' A' ' 90' ' ' LEU . 93.0 t -86.11 132.87 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.954 . . . . 0.0 109.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 4.8 t -109.48 -2.73 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.8 42.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.9 175.56 24.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.06 65.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -1.182 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.13 -11.92 59.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.721 HD23 HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -99.68 108.73 52.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.343 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.987 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.8 Cg_endo -69.88 152.91 68.86 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.69 2.26 . . . . 0.0 111.935 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 83.7 m-20 -79.43 -30.12 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.437 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 15.8 p -79.99 7.1 9.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.15 131.29 42.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.489 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 91.9 mt-10 -61.08 -44.05 97.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HA ' HD21 ' A' ' 90' ' ' LEU . 3.8 pttm 179.74 159.21 0.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.942 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' SER . 70.3 mt -118.38 135.7 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.676 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.9 m -107.41 138.76 43.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 76.6 m-85 -119.76 120.25 35.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.564 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -116.25 113.95 23.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.093 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.512 ' OG ' ' CD1' ' A' ' 115' ' ' LEU . 2.6 m -128.13 136.38 51.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.562 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 47.6 tttt -132.78 124.5 28.19 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 53.2 mt -108.57 132.9 53.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.062 -1.023 . . . . 0.0 110.266 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.8 143.05 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.06 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.34 141.17 51.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.47 166.03 22.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.4 -4.94 15.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.622 2.215 . . . . 0.0 111.792 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.98 -27.36 66.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.82 23.42 11.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -149.96 -131.1 1.87 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.511 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 68.9 m -118.73 143.98 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.3 166.06 25.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.274 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 164.86 -177.6 40.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 28.2 ttpt -123.24 143.25 50.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -1.089 . . . . 0.0 109.396 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HB2' HD11 ' A' ' 9' ' ' ILE . 30.2 tp -116.5 135.3 53.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -124.25 125.93 45.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.94 132.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.598 ' HE3' HG11 ' A' ' 2' ' ' VAL . 23.6 tttt -116.43 116.04 26.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.676 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 33.3 t80 -105.9 122.09 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 90.9 mt-10 -105.63 141.44 37.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.658 HG21 ' CD ' ' A' ' 127' ' ' PRO . 16.6 p -118.29 164.61 14.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -0.978 . . . . 0.0 109.552 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 92.7 mttt -56.99 -40.06 75.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.45 -92.22 0.11 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -37.2 83.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -1.175 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.43 135.58 39.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.29 109.83 15.09 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.658 ' CD ' HG21 ' A' ' 121' ' ' THR . 51.3 Cg_endo -70.24 124.29 10.75 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.675 2.25 . . . . 0.0 111.875 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -60.04 161.05 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.42 -36.15 80.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -56.03 -31.43 63.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.03 -34.95 61.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.271 -0.893 . . . . 0.0 108.729 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.716 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.53 -39.29 90.51 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -60.22 -48.31 82.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.5 m -57.22 -36.75 71.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.3 99.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -60.37 -37.1 79.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -1.091 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.72 -30.43 61.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.252 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -66.0 -44.86 83.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.21 -55.41 10.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.9 -34.92 63.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.97 75.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.276 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 146' ' ' ILE . 29.8 mt -74.94 -44.0 50.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.91 ' CE1' HD21 ' A' ' 18' ' ' LEU . 73.9 t80 -61.62 -55.78 26.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.166 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -49.49 -46.73 48.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.303 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.94 77.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.153 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 29' ' ' VAL . 34.3 mt -67.11 -44.11 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.251 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 12' ' ' PRO . 80.0 tt0 -60.46 -44.91 95.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -31.11 70.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.21 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 21.6 t80 -66.79 -38.88 87.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.85 . . . . 0.0 109.303 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.512 HD22 ' CD1' ' A' ' 18' ' ' LEU . 7.5 mp -72.86 -40.85 65.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.18 -37.78 78.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.51 -15.84 60.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.382 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -126.7 90.25 50.17 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.1 -18.91 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.61 2.207 . . . . 0.0 111.793 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -74.12 -12.68 60.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 63.8 t80 -80.01 125.48 29.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.625 ' C ' HG23 ' A' ' 17' ' ' THR . 63.7 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.412 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.45 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 118' ' ' LYS . 89.4 t -141.44 137.93 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.61 149.53 42.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.7 m -129.81 128.84 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 0.0 109.428 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.734 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.4 m-85 -119.81 163.34 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -135.59 133.81 38.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.411 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.29 166.09 25.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.15 151.17 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.508 HG21 HD11 ' A' ' 103' ' ' LEU . 65.1 mt -114.36 128.22 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -128.95 127.61 42.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 13' ' ' VAL . 75.7 m -153.43 132.92 7.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -19.0 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.677 2.251 . . . . 0.0 111.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 18' ' ' LEU . 2.2 p -70.39 153.1 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.545 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 139.77 97.73 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.22 -26.78 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.81 2.34 . . . . 0.0 111.91 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.52 -39.24 53.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -79.76 -41.85 25.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.77 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.757 HD13 HG11 ' A' ' 13' ' ' VAL . 3.9 tp -67.15 -38.5 85.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.401 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 79.0 t80 -70.63 -36.4 73.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.9 tptt -67.17 -47.21 71.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 109.781 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -72.27 -40.13 67.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.836 ' CD1' HD13 ' A' ' 146' ' ' ILE . 64.5 tp -53.33 -45.66 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -97.3 -53.63 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.974 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.575 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.1 m -66.38 -50.09 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.694 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -92.44 19.66 6.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -60.46 -51.61 68.71 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.155 -0.966 . . . . 0.0 109.143 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.87 ' HA ' HD12 ' A' ' 30' ' ' ILE . 86.6 m-20 -66.69 -31.24 71.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.648 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 75.2 m-20 -83.23 -29.57 28.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 25' ' ' ASP . 77.4 t -78.64 -34.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.0 mt -51.33 -51.71 66.17 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.929 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.9 Cg_endo -68.39 -34.87 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.552 2.168 . . . . 0.0 111.888 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 50.9 mttm -79.95 -40.75 27.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.089 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -65.88 -38.08 87.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.874 . . . . 0.0 108.909 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 57' ' ' PHE . 41.0 tp -87.16 106.0 17.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 108.968 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.11 -28.18 67.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -105.38 27.49 8.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.966 -1.084 . . . . 0.0 109.879 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.807 ' HA ' HD23 ' A' ' 34' ' ' LEU . 44.6 t80 -53.24 125.43 17.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -90.9 -56.22 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.806 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 28.8 p -174.27 166.56 4.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.681 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.69 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 2.9 p -144.79 143.48 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.9 mt-10 -147.17 152.1 37.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.559 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -79.55 131.08 35.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 13.8 t -83.65 -44.38 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.315 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 51' ' ' THR . 80.8 mt-10 -159.38 146.87 17.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 95.59 -175.68 33.11 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -110.73 6.17 21.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' HG21 ' A' ' 51' ' ' THR . . . 109.74 -3.7 30.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.63 -156.35 13.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.24 138.76 37.03 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.741 2.294 . . . . 0.0 111.811 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.46 -4.04 75.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 44' ' ' GLU . 26.1 m -69.18 155.01 41.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 109.566 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 20.4 mm -119.33 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.19 147.35 46.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.846 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.662 ' HG3' HD21 ' A' ' 67' ' ' LEU . 22.4 tttt -116.89 127.35 54.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.22 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 63.7 mt -115.25 145.35 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -0.999 . . . . 0.0 109.848 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 24.0 m -128.1 123.0 33.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.201 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.883 ' HB2' HD21 ' A' ' 34' ' ' LEU . 23.8 p90 -125.53 174.27 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.637 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 57' ' ' PHE . 3.2 mm? -112.63 138.25 49.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE1' ' HE3' ' A' ' 64' ' ' LYS . 75.8 tt0 -148.49 127.76 12.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 53.12 34.62 17.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.77 66.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -107.3 134.14 50.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 m -82.73 116.16 21.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 23.0 mttm -116.74 164.21 14.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 18.5 p90 -145.87 157.75 43.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.7 p -141.2 149.68 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.898 . . . . 0.0 109.618 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 54' ' ' LYS . 48.2 mt -112.6 130.98 55.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.241 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -122.55 136.88 55.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 42.3 tttm -119.08 145.18 46.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.87 127.05 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 93.6 mt-10 -82.46 -53.45 5.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -162.73 137.59 6.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.78 133.73 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.91 . . . . 0.0 109.338 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -129.18 76.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 86.8 mt-10 -54.61 -37.61 65.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.19 57.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 78' ' ' LEU . 64.6 m-20 -90.67 17.0 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.377 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 11.6 mt 43.57 46.24 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.576 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.49 158.9 27.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.5 p90 -152.02 170.04 20.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -1.217 . . . . 0.0 109.131 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 4.7 m -126.3 138.84 53.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -156.06 160.67 40.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 54.8 p -150.41 158.22 43.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.483 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 89' ' ' ALA . 14.5 p -97.41 135.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 109.086 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.1 m -130.16 3.87 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -156.19 146.26 13.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.01 -174.29 16.79 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.17 62.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.85 1.49 30.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -112.9 83.52 6.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.328 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -68.9 163.43 37.48 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.897 2.398 . . . . 0.0 111.998 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 70.1 m-20 -80.12 -32.71 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.912 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 33.9 p -79.55 -11.99 59.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 110.026 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -119.95 127.75 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -62.51 -50.79 70.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -177.33 156.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.42 137.55 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 1.4 m -107.42 138.2 44.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.848 . . . . 0.0 109.135 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.2 m-85 -118.56 120.58 37.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.881 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -117.2 106.39 13.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -115.59 136.13 53.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.773 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.618 ' C ' HD22 ' A' ' 103' ' ' LEU . 20.3 tttt -132.96 131.26 40.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.833 . . . . 0.0 109.123 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 103' ' ' LEU . 1.7 mm? -118.18 127.44 53.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.364 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -120.48 172.58 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -80.25 127.14 32.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.206 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.99 155.54 17.93 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 -1.95 8.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.578 2.185 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -74.11 -15.55 61.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 7.15 63.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.56 -138.08 4.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 103' ' ' LEU . 2.7 t -122.25 140.65 52.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -1.113 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.698 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.42 147.81 31.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.207 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -174.08 -143.63 4.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.05 138.95 32.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.353 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 116' ' ' THR . 3.9 tt -115.31 136.4 53.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.969 ' N ' HD23 ' A' ' 115' ' ' LEU . 14.5 m -125.5 126.89 45.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.35 136.16 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.331 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 2' ' ' VAL . 26.6 tttt -116.07 121.02 40.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.732 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 30.3 t80 -103.58 126.56 50.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HA ' HG22 ' A' ' 2' ' ' VAL . 82.9 mt-10 -109.73 130.94 55.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.5 p -107.4 156.73 18.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 73.5 mmtt -60.13 -37.0 78.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.82 -103.84 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.35 -35.52 72.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -1.187 . . . . 0.0 109.468 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.9 136.98 33.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -149.34 107.66 3.36 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.2 Cg_endo -70.04 151.55 67.52 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.734 2.289 . . . . 0.0 111.699 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -83.22 178.73 7.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 132' ' ' LEU . 92.9 mt-30 -67.89 -35.35 78.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.59 -48.53 80.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -61.14 -39.14 88.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.38 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.734 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 67.0 mt -63.64 -35.79 81.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 26.2 mttt -64.22 -48.53 75.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 138' ' ' LYS . 86.8 m -56.22 -33.24 65.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.343 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.22 -43.13 99.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 140' ' ' ASP . 23.9 tttp -67.14 -39.58 86.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -1.149 . . . . 0.0 109.497 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -31.22 64.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.29 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 134' ' ' THR . 46.3 mttm -77.3 -40.7 43.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.05 -26.41 53.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.825 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 96.9 m-20 -60.78 -41.64 95.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -44.95 82.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 142' ' ' LEU . 23.0 mt -54.71 -46.19 74.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -61.61 -50.26 73.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 148' ' ' ALA . 88.6 mttt -63.22 -33.56 75.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.7 -52.46 64.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.836 HD13 ' CD1' ' A' ' 22' ' ' LEU . 11.7 mt -68.47 -51.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.21 -45.22 91.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.697 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 144' ' ' LYS . . . -59.63 -31.39 69.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.519 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.4 t80 -69.3 -41.14 77.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.64 HD22 HD12 ' A' ' 18' ' ' LEU . 7.8 mp -66.43 -46.3 76.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.636 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.39 -33.79 74.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.96 -11.9 57.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.566 ' CE1' ' CZ ' ' A' ' 149' ' ' TYR . 74.4 m80 -122.06 90.16 48.72 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.26 -21.57 30.95 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.673 2.249 . . . . 0.0 111.767 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -70.87 -17.88 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 42.3 t80 -67.31 158.8 30.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.571 ' O ' HG21 ' A' ' 17' ' ' THR . 74.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.639 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -130.37 149.4 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 0.0 109.472 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.566 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 97.6 m-85 -81.51 126.87 32.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 117.88 27.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.309 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.944 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.8 m-85 -110.25 164.23 12.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.624 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 88.2 mt-10 -134.05 134.24 42.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -137.09 165.0 27.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -104.13 158.59 16.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 42.3 mt -129.14 137.37 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.71 137.0 34.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.9 OUTLIER -152.58 138.68 11.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.09 0.74 6.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.665 2.243 . . . . 0.0 111.96 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.867 ' CG1' HD11 ' A' ' 18' ' ' LEU . 69.4 t -98.17 155.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.829 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -64.21 127.64 92.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.511 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 44.4 Cg_endo -66.84 -25.51 45.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.801 2.334 . . . . 0.0 111.904 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.928 . . . . 0.0 109.036 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 157' ' ' ASN . 76.5 m -72.7 -38.86 67.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.182 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.867 HD11 ' CG1' ' A' ' 13' ' ' VAL . 2.4 mp -70.29 -38.63 75.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 72.5 t80 -63.92 -50.27 69.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE3' HG21 ' A' ' 24' ' ' THR . 12.2 tptt -65.05 -46.38 81.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.749 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.63 -28.33 63.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.964 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.4 tp -67.01 -47.36 71.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.857 . . . . 0.0 109.67 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -97.96 -51.7 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.576 HG21 ' HE3' ' A' ' 20' ' ' LYS . 2.1 m -62.62 -45.64 91.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.7 m-20 -98.44 6.14 47.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.08 -1.012 . . . . 0.0 109.767 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.964 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -45.96 -53.27 10.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.6 m-20 -67.54 -23.3 65.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.772 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 90.9 m-20 -89.84 -25.79 20.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -83.39 -35.98 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 109.545 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.952 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.3 mt -55.36 -47.07 99.44 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 110.211 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.6 Cg_endo -68.08 -35.97 18.46 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.307 2.004 . . . . 0.0 112.193 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 32.3 mttm -87.91 -29.28 20.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.421 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -69.42 -34.77 74.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.257 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 57' ' ' PHE . 54.5 tp -96.18 113.31 24.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.32 -40.92 92.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.663 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -93.71 26.8 2.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.811 -1.181 . . . . 0.0 110.117 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 30' ' ' ILE . 57.2 t80 -59.91 134.11 56.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.124 -0.985 . . . . 0.0 109.409 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' SER . 33.6 tttm -95.28 -49.12 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.312 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 68.9 p -178.59 172.13 1.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 40' ' ' VAL . 6.0 p -135.91 129.97 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.274 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -135.53 145.47 47.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 109.613 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.97 128.08 34.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 13.9 t -85.17 -41.0 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.673 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 51' ' ' THR . 96.5 mt-10 -158.58 145.44 17.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.601 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 159.04 30.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -94.59 5.36 52.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.93 -9.28 23.28 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.03 -158.66 13.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.05 131.16 20.26 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.644 2.23 . . . . 0.0 111.687 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 93.23 0.44 67.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 44' ' ' GLU . 90.3 m -76.01 154.78 35.5 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.307 -1.114 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 69' ' ' LYS . 71.2 mt -129.89 138.32 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -126.67 152.39 46.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.6 tttm -112.87 125.74 54.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.425 -0.797 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 66' ' ' VAL . 83.9 mt -113.88 142.95 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.2 m -131.36 119.54 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.962 ' HB2' HD21 ' A' ' 34' ' ' LEU . 39.0 p90 -124.5 171.55 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.348 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 145.85 31.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 62' ' ' GLU . 84.9 tt0 -141.84 123.74 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 49.66 27.73 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.66 71.38 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' GLU . 99.6 mt-10 -106.47 157.58 17.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -1.085 . . . . 0.0 109.421 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.2 m -104.94 112.55 25.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.413 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -120.35 162.95 18.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -145.66 158.96 43.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 55' ' ' ILE . 22.4 m -138.31 147.05 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 86' ' ' GLY . 12.8 mt -116.63 137.82 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.065 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.72 141.82 50.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.752 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' HG12 ' A' ' 52' ' ' ILE . 19.4 tttm -117.77 146.41 43.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.87 . . . . 0.0 109.121 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.0 mt -104.75 126.57 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -88.18 -40.19 13.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 t -173.74 150.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.58 132.67 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -127.03 85.51 2.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' OH ' ' A' ' 19' ' ' TYR . 97.0 mt-10 -64.24 -31.69 72.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.85 84.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -89.3 14.86 10.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.539 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 19.4 mt 47.52 51.86 13.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.27 27.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 28.7 p90 -150.96 168.4 24.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 108.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -126.67 138.64 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 19.4 p90 -152.49 155.82 38.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.382 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 t -144.85 156.06 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.624 HG22 HD12 ' A' ' 90' ' ' LEU . 10.0 p -98.52 128.35 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HE2' ' A' ' 96' ' ' LYS . 1.5 t -127.49 4.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.729 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.46 148.48 17.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 128.0 152.29 7.8 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.38 47.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.275 -1.132 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 138' ' ' LYS . . . -79.89 -7.92 59.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -79.81 116.28 59.89 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.3 Cg_endo -68.48 146.6 68.7 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.767 2.311 . . . . 0.0 111.911 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 66.2 m-20 -78.84 -29.57 44.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.632 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 29.4 p -79.82 -7.49 58.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -118.27 123.57 45.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.339 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 86.3 mt-10 -62.28 -52.18 64.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.703 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' A' ' 85' ' ' VAL . 7.4 mtpm? -159.1 161.65 36.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 109.721 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.4 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CE ' ' A' ' 118' ' ' LYS . 8.9 m -109.83 137.58 47.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.95 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 78.8 m-85 -120.23 121.29 38.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 58.5 t0 -117.02 110.51 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.204 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -123.25 136.64 54.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.559 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 75.8 tttt -130.72 127.43 38.78 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.6 mm? -107.62 130.19 54.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.057 -1.027 . . . . 0.0 110.152 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -138.03 143.02 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.03 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 139.52 57.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.104 -0.998 . . . . 0.0 109.718 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.43 22.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.78 -9.71 26.76 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.774 2.316 . . . . 0.0 111.825 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.49 -31.95 68.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.84 27.93 6.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -157.94 -125.16 0.82 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 73.9 m -118.54 144.91 45.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 9' ' ' ILE . . . -143.58 162.49 35.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.763 . . . . 0.0 108.991 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 171.63 176.15 40.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -112.08 141.22 46.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.439 -1.036 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 29.0 tp -116.33 131.62 56.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.519 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 26.0 m -130.0 122.11 27.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -0.926 . . . . 0.0 109.144 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.67 135.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.639 ' CG ' HG21 ' A' ' 2' ' ' VAL . 7.0 ttpt -115.0 116.71 28.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.15 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 36.6 t80 -107.73 120.92 43.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.672 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 98.2 mt-10 -106.32 133.52 50.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.866 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.4 p -109.92 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.4 mttt -54.85 -42.31 71.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.56 -92.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ALA . 82.1 m-20 -69.2 -35.8 76.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -45.03 133.79 6.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -126.24 121.13 23.78 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.866 ' HD3' HG21 ' A' ' 121' ' ' THR . 49.3 Cg_endo -69.96 149.85 66.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.717 2.278 . . . . 0.0 111.743 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.7 m-20 -92.16 155.31 18.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -50.42 -38.33 42.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.24 -48.54 81.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.33 -42.08 90.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.944 HD13 ' CE2' ' A' ' 5' ' ' PHE . 74.3 mt -60.15 -34.52 73.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.46 -46.47 82.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.259 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.5 m -57.4 -36.97 71.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.13 -47.36 91.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 140' ' ' ASP . 11.0 mtmm -57.09 -36.6 70.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -1.146 . . . . 0.0 109.391 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -58.23 -33.49 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 89' ' ' ALA . 69.5 tttt -74.34 -43.14 57.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -69.76 -49.06 56.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 7.5 p30 -68.43 -22.56 64.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -56.86 -48.69 77.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.7 tp -56.39 -35.52 67.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -74.33 -53.23 10.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 109.14 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -52.73 -37.92 59.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 -49.56 56.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.922 HG23 HG21 ' A' ' 29' ' ' VAL . 51.7 mt -63.07 -55.33 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.55 -50.31 13.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.18 -37.82 72.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 41.1 t80 -68.44 -38.13 80.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 18' ' ' LEU . 45.8 mt -59.16 -38.31 79.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mt -75.04 -27.68 60.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.61 61.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -128.5 91.88 42.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.27 -18.06 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.737 2.291 . . . . 0.0 111.747 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -77.26 -17.69 58.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.816 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.8 t80 -67.77 120.09 13.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.541 ' CB ' HG23 ' A' ' 17' ' ' THR . 6.2 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.711 ' O ' HG23 ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 119' ' ' TYR . 60.0 t -128.84 138.85 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -1.174 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -132.07 122.54 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.624 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 117' ' ' VAL . 79.2 m -110.67 144.24 39.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 89.4 m-85 -132.7 132.62 42.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.0 mt-10 -106.14 133.74 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -137.15 164.98 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.385 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.87 157.61 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.4 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.424 HD11 ' OG ' ' A' ' 101' ' ' SER . 14.6 mt -125.65 134.42 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 109.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 97.9 m-20 -140.68 132.87 28.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' OE2' ' A' ' 147' ' ' GLU . 27.3 m -152.78 138.63 11.81 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.52 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.26 -0.45 7.34 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.602 2.201 . . . . 0.0 111.714 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.87 ' HB ' HD11 ' A' ' 18' ' ' LEU . 98.1 t -94.73 153.49 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.6 139.31 97.59 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 46.7 Cg_endo -68.01 -25.77 37.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.734 2.289 . . . . 0.0 111.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.36 -37.6 60.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 157' ' ' ASN . 60.3 m -75.01 -39.39 61.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 13' ' ' VAL . 20.0 mt -68.69 -39.11 80.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 78.0 t80 -64.54 -50.03 68.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.585 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 24' ' ' THR . 8.5 tptm -63.4 -46.43 86.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -73.18 -24.51 60.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 18.4 tp -75.37 -48.83 21.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.686 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.75 -49.89 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.886 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -65.82 -48.83 70.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.957 . . . . 0.0 110.145 -179.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 6.3 t70 -91.01 14.67 13.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.723 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -56.09 -52.16 65.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.263 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 22.1 t70 -66.1 -25.89 67.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.946 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.0 m120 -90.92 -26.06 19.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.601 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' ALA . 8.0 p -83.87 -39.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 109.575 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.7 mt -52.88 -45.46 97.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.63 -21.84 45.04 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.394 2.063 . . . . 0.0 112.242 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' ALA . 41.8 mttm -108.98 -51.77 2.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 109.585 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . -42.28 -33.19 0.59 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.978 HD21 ' HB2' ' A' ' 57' ' ' PHE . 44.8 tp -92.52 112.62 24.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.067 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.4 -47.16 82.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.526 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.9 m -88.38 29.36 0.98 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.915 -1.116 . . . . 0.0 110.173 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 67.2 t80 -61.89 130.54 46.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.505 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' CD ' HD23 ' A' ' 58' ' ' LEU . 3.6 mtpm? -102.42 -48.58 4.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.639 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 37' ' ' PHE . 54.8 p -172.51 164.89 5.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 3.9 p -143.3 141.81 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 109.326 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -144.08 148.36 35.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.61 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -80.64 132.07 35.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 19.0 t -79.99 -42.12 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 51' ' ' THR . 71.2 mt-10 -161.74 149.33 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.72 -168.85 36.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -132.12 35.08 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.742 ' H ' HG21 ' A' ' 51' ' ' THR . . . 91.55 -1.92 76.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 51' ' ' THR . . . -76.73 -168.31 28.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.74 139.88 41.4 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.691 2.261 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 77.14 2.96 80.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 44' ' ' GLU . 85.9 m -69.23 150.44 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.58 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 25.1 mm -114.62 123.44 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -118.06 143.83 46.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.856 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . 86.8 tttt -116.35 128.25 55.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 109.081 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.666 ' HB ' HG22 ' A' ' 66' ' ' VAL . 58.7 mt -114.28 140.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.1 m -119.42 120.74 37.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.216 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.978 ' HB2' HD21 ' A' ' 34' ' ' LEU . 40.5 p90 -131.5 176.02 8.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -116.98 131.2 57.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -137.12 130.96 31.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 55.14 20.83 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.92 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.32 20.55 64.28 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.8 mt-10 -118.28 141.61 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.6 m -80.9 111.79 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 70.7 mttt -121.89 163.06 19.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 36.0 p90 -144.27 158.11 43.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.385 -0.822 . . . . 0.0 109.226 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' HE1' ' A' ' 57' ' ' PHE . 34.1 m -133.55 142.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 109.705 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.86 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.7 mt -111.23 130.55 55.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 109.003 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -126.23 139.83 53.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.146 -0.971 . . . . 0.0 109.71 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -122.52 150.81 42.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.238 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.7 mt -111.46 133.05 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.554 ' OE2' HG21 ' A' ' 98' ' ' THR . 94.0 mt-10 -89.42 -33.57 16.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.243 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -172.82 155.39 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.54 131.86 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.327 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.56 81.51 2.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 78.3 mt-10 -59.18 -36.84 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.29 -41.31 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.634 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 6.4 m-20 -101.1 14.01 33.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.546 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.75 25.98 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.318 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.24 150.73 17.79 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.89 169.16 22.95 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -1.208 . . . . 0.0 109.166 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 61.0 m -130.96 139.01 49.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.98 . . . . 0.0 109.375 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.618 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 14.1 p90 -151.87 154.79 36.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 79.9 p -144.41 155.8 43.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.355 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.1 p -95.8 131.16 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.244 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -124.14 2.04 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.605 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.86 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -163.77 153.38 23.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 117.07 172.13 16.03 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.21 -13.05 62.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -1.099 . . . . 0.0 109.46 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.04 59.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 4.8 tt -100.2 107.22 46.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.991 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.9 Cg_endo -69.43 149.86 69.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.68 2.253 . . . . 0.0 111.912 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 83.6 m-20 -76.76 -28.71 55.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -79.86 6.6 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.7 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.991 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -133.7 142.52 48.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.596 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 122' ' ' LYS . 77.4 mt-10 -69.14 -54.6 14.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -175.64 159.71 2.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.347 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 83' ' ' SER . 55.4 mt -118.18 136.2 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.554 HG21 ' OE2' ' A' ' 71' ' ' GLU . 7.9 m -112.12 117.85 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.126 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.915 ' CD1' HG23 ' A' ' 117' ' ' VAL . 89.0 m-85 -96.28 125.41 40.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.826 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 116' ' ' THR . 89.9 m-20 -117.74 129.3 55.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 109.206 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.8 t -146.63 136.81 23.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 103' ' ' LEU . 28.3 tttt -117.2 159.1 23.17 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 102' ' ' LYS . 33.6 mt -133.42 123.77 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.877 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.66 142.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.24 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.35 57.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.46 166.93 23.25 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.5 -0.05 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.646 2.231 . . . . 0.0 111.821 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -69.37 -28.34 66.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.11 26.78 8.14 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -156.14 -127.16 1.01 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 99.5 p -121.77 142.8 49.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -1.134 . . . . 0.0 109.746 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.57 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 162.95 168.64 25.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -105.29 147.66 27.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.137 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 100' ' ' ASP . 49.6 tp -115.01 136.56 52.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 100' ' ' ASP . 24.6 m -138.78 119.31 13.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.043 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.915 HG23 ' CD1' ' A' ' 99' ' ' PHE . 2.7 p -112.33 138.68 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 110.142 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 31.9 tttt -114.29 120.08 39.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 2' ' ' VAL . 37.4 t80 -102.72 126.82 49.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -111.41 126.65 55.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.353 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 1' ' ' GLY . 34.2 p -99.91 165.91 11.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 20.4 mmtp -71.01 -36.34 72.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.19 -100.0 0.16 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -65.08 -28.57 69.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.92 137.07 58.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -147.18 112.51 4.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.44 141.33 42.2 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.715 2.277 . . . . 0.0 111.7 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -69.78 168.65 14.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.89 . . . . 0.0 109.55 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HA ' HD12 ' A' ' 132' ' ' LEU . 46.6 tt0 -60.34 -39.64 87.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.882 . . . . 0.0 109.444 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.85 -43.86 97.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.27 -39.34 82.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 25.0 mt -64.65 -36.82 85.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.63 -49.5 76.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 85.5 m -57.45 -32.45 66.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.89 -47.98 86.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . 27.9 ttpp -65.27 -38.32 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -1.133 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -54.41 -28.4 43.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -76.21 -38.18 56.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.453 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.13 -55.08 8.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 3.9 p30 -63.43 -25.05 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -61.22 -53.44 56.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 109.319 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 142' ' ' LEU . 19.0 mt -59.53 -35.21 73.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.15 -52.69 62.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -53.12 -38.42 62.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.39 -39.63 80.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.361 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 mm -62.73 -43.62 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.391 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.463 ' OE2' ' OG ' ' A' ' 11' ' ' SER . 90.6 mt-10 -64.28 -37.27 86.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.53 81.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.401 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 33.9 t80 -70.53 -52.5 21.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 18' ' ' LEU . 9.3 mp -63.77 -36.52 84.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.7 tp -76.1 -36.44 58.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.21 -20.43 61.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -134.38 98.58 13.76 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -11.42 30.22 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 111.788 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.72 -26.66 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.957 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 62.5 t80 -64.43 138.79 58.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' THR . 2.3 p-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -134.83 148.49 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -1.061 . . . . 0.0 109.31 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 88.4 m-85 -80.83 120.57 24.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 19.8 m -109.94 117.09 32.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 97.0 m-85 -114.61 142.11 46.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 81.4 tt0 -109.3 133.34 53.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.265 -0.897 . . . . 0.0 109.63 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -130.01 164.41 24.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.58 153.59 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 54.1 mt -119.23 144.2 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -142.45 128.88 20.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.64 138.23 11.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.503 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.39 -12.82 32.36 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.702 2.268 . . . . 0.0 111.785 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.604 HG11 HD12 ' A' ' 150' ' ' LEU . 1.6 p -81.49 152.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 141.69 95.88 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.92 -28.51 35.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.735 2.29 . . . . 0.0 111.747 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.96 -41.39 59.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.3 m -76.21 -37.43 57.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.347 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.719 ' CD1' HD11 ' A' ' 150' ' ' LEU . 11.9 tp -69.15 -39.93 78.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 79.5 t80 -64.89 -44.81 88.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HE2' HG21 ' A' ' 24' ' ' THR . 12.8 tptm -65.18 -46.72 79.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.733 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -73.1 -17.77 61.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.967 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 19.5 tp -79.18 -48.25 14.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.91 -52.22 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.77 HG21 ' HE2' ' A' ' 20' ' ' LYS . 4.3 m -63.39 -49.37 74.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.943 . . . . 0.0 110.208 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m-20 -95.34 8.08 44.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.967 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.61 -53.22 11.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 109.292 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.792 ' HA ' HD12 ' A' ' 30' ' ' ILE . 56.7 t0 -65.07 -24.89 67.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 95.3 m-20 -87.16 -26.81 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 146' ' ' ILE . 98.2 t -82.66 -35.53 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 27' ' ' ASP . 7.0 mt -50.98 -47.84 86.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 110.327 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.8 Cg_endo -67.53 -28.08 38.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.44 2.093 . . . . 0.0 112.183 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -90.73 -45.41 8.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.559 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.4 mp -76.04 102.22 5.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -54.89 -46.25 74.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.871 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 88.4 p -91.51 30.1 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -57.23 122.56 12.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.07 -53.56 4.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.675 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 34.9 p -174.9 167.89 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.752 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.828 HG22 HG23 ' A' ' 55' ' ' ILE . 99.6 t -143.92 143.91 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.148 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.8 mt-10 -155.0 158.4 39.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 73.2 m-20 -96.65 124.9 40.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 6.8 m -82.01 -27.9 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 56.9 mm-40 -161.33 151.26 17.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.87 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.749 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 105.09 168.61 24.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -121.68 27.43 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -1.197 . . . . 0.0 109.62 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.97 -19.05 56.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.38 -169.18 28.72 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.95 140.97 43.26 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 111.71 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 88.64 5.64 74.44 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.749 HG23 ' HA3' ' A' ' 45' ' ' GLY . 59.6 m -75.12 150.78 38.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -1.153 . . . . 0.0 109.759 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 17.2 mm -112.5 123.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 108.994 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.4 mttm -119.76 144.67 47.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.853 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.705 ' HG3' HD11 ' A' ' 67' ' ' LEU . 2.2 ttmt -120.41 133.78 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.133 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.828 HG23 HG22 ' A' ' 40' ' ' VAL . 74.8 mt -123.91 143.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 36.0 m -124.63 122.26 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 43.1 p90 -127.24 165.84 18.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 1.2 mp -100.23 143.29 30.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.4 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -156.19 131.81 9.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 56.41 28.39 13.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.69 0.49 63.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 49.2 tp10 -107.24 138.95 42.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -1.186 . . . . 0.0 109.537 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.4 m -86.03 124.94 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 34.0 mttp -128.63 172.47 11.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.798 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.5 p90 -147.31 161.32 41.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.516 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.605 ' O ' HD12 ' A' ' 67' ' ' LEU . 32.6 m -135.53 145.05 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.43 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.798 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.4 mp -114.49 133.02 56.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.923 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -132.04 145.32 51.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 16.1 tttm -124.5 146.55 48.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 7.0 mm -101.58 131.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.3 pt-20 -103.5 -32.68 9.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.995 . . . . 0.0 109.828 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 35.9 t -165.78 138.43 4.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.909 -1.119 . . . . 0.0 109.955 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.35 136.25 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 91.4 m-20 -130.69 83.18 2.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.43 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.4 mt-10 -63.67 -34.58 78.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.05 67.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.286 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -87.26 12.59 11.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 8.7 mt 48.02 37.25 7.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.474 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -132.64 151.96 20.13 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -151.63 166.44 31.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.065 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 71' ' ' GLU . 29.0 t -137.37 143.17 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.2 p90 -153.05 160.62 42.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.339 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 t -139.12 153.8 48.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 67' ' ' LEU . 14.4 p -85.1 133.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 10.0 t -109.97 -4.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.49 43.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.05 164.27 15.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.59 -14.25 12.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -1.126 . . . . 0.0 109.452 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 138' ' ' LYS . . . -81.89 -12.08 58.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.64 115.34 60.23 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.978 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.08 147.56 61.11 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.677 2.252 . . . . 0.0 111.829 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.48 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 90.6 m-20 -79.57 -31.93 41.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.615 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 p -83.79 3.74 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.715 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.43 143.23 49.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 109.624 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' OE2' ' HG2' ' A' ' 122' ' ' LYS . 62.6 mm-40 -69.27 -51.57 36.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.421 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -171.28 163.09 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.548 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.4 mt -120.56 137.21 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -108.21 126.8 53.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.2 m-85 -108.3 125.81 52.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 115' ' ' LEU . 25.6 t0 -120.11 102.81 8.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.188 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 9' ' ' ILE . 34.1 t -111.95 142.15 44.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.842 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.3 tttm -127.1 146.71 50.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 108.896 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.842 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.5 mm? -125.69 129.75 50.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.855 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 112' ' ' ALA . 1.2 m -143.91 167.31 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 109.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.585 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -74.92 133.94 41.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.22 163.21 16.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.75 -3.96 13.06 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.628 2.219 . . . . 0.0 111.689 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.15 -23.84 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.87 24.98 10.07 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.71 -138.44 2.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -99.13 145.14 27.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.686 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.79 140.62 24.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.113 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -175.84 -170.58 38.8 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mttt -127.11 139.36 53.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -1.119 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.87 HD23 ' N ' ' A' ' 116' ' ' THR . 3.0 tt -114.31 137.73 51.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.87 ' N ' HD23 ' A' ' 115' ' ' LEU . 13.9 m -114.3 133.4 55.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 4' ' ' THR . 96.2 t -109.26 127.72 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.55 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 97' ' ' ILE . 37.5 tttp -115.09 122.24 45.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 42.8 t80 -117.59 115.32 24.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 95.7 mt-10 -103.61 140.36 37.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 17.5 p -106.49 165.77 11.03 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.612 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 75.1 mttt -73.85 -34.01 64.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.48 -145.91 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.14 -13.04 61.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.197 . . . . 0.0 109.468 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.69 130.16 24.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.07 131.49 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.7 Cg_endo -70.06 157.5 59.59 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.771 2.314 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.476 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 1.5 m-20 -86.94 175.15 8.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -71.13 -41.51 70.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -57.63 -47.13 83.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 69.4 mm-40 -58.03 -41.07 82.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' A' ' 5' ' ' PHE . 89.7 mt -62.55 -44.95 95.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -61.27 -46.41 90.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.335 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -58.99 -40.75 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.01 97.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -66.92 -39.84 87.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.338 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.85 80.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 109.284 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 39.8 mttm -60.78 -52.89 63.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.37 -56.07 6.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 52.0 t0 -50.04 -26.73 4.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.652 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.64 75.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 146' ' ' ILE . 1.3 tp -59.0 -45.53 90.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.199 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.474 ' HE1' HD21 ' A' ' 18' ' ' LEU . 68.7 t80 -68.6 -34.82 76.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.38 -0.825 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 85.6 mttt -64.04 -44.85 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.16 68.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.917 . . . . 0.0 109.312 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 29' ' ' VAL . 71.0 mt -58.6 -54.32 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -46.07 -53.74 9.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.85 69.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.877 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -65.7 -32.77 74.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.306 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 18' ' ' LEU . 17.1 mt -70.28 -44.33 68.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.372 -0.83 . . . . 0.0 109.529 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.11 -34.5 78.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.62 61.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -130.1 83.23 63.94 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.48 -19.34 37.58 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.682 2.255 . . . . 0.0 111.726 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -93.92 16.36 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' HE2' ' HB2' ' A' ' 21' ' ' ALA . 61.7 t80 -60.75 135.61 57.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.551 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.0 t -125.63 140.16 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.42 135.77 51.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.9 m -116.89 130.49 56.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 132' ' ' LEU . 83.7 m-85 -128.78 158.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -133.15 139.76 47.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.461 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -142.33 165.71 26.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -108.29 150.15 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 52.9 mt -115.02 142.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.399 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 40.5 m-20 -134.69 129.43 34.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 m -151.9 129.16 5.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.68 0.15 6.78 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.753 2.302 . . . . 0.0 111.693 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.09 152.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.643 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 134.42 91.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.19 -29.57 32.58 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.74 2.293 . . . . 0.0 111.935 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.11 -37.24 61.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 HD22 ' A' ' 157' ' ' ASN . 39.7 m -80.13 -40.4 27.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 150' ' ' LEU . 3.8 tp -68.38 -38.29 81.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 84.4 t80 -71.2 -36.61 71.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.923 . . . . 0.0 109.773 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 24' ' ' THR . 48.6 tptt -68.92 -47.24 66.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.842 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -75.9 -37.19 59.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.485 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 22.7 tp -52.87 -47.18 68.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.7 t -97.48 -53.34 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 110.077 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.544 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -63.64 -47.17 82.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.162 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.781 ' HB3' HG23 ' A' ' 29' ' ' VAL . 15.2 m-20 -95.62 17.64 14.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.004 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -66.34 -47.27 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.2 t0 -69.27 -29.08 66.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.94 . . . . 0.0 109.936 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -91.08 -31.61 16.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.963 . . . . 0.0 109.705 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' ASP . 77.6 t -80.4 -42.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 26' ' ' ALA . 42.0 mt -49.49 -51.86 54.91 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.381 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.7 Cg_endo -68.83 -46.69 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.532 2.154 . . . . 0.0 112.638 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -79.92 -44.68 19.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.0 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -48.13 -36.03 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 36' ' ' SER . 14.5 tp -142.65 133.55 25.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.74 -26.73 50.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.145 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.897 ' HB3' HD21 ' A' ' 34' ' ' LEU . 3.0 t -54.01 -36.82 63.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.661 ' HE1' HG23 ' A' ' 55' ' ' ILE . 62.8 t80 -52.74 135.74 34.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.428 -0.795 . . . . 0.0 109.124 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HE2' HD21 ' A' ' 58' ' ' LEU . 9.9 mttm -90.17 -54.82 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.487 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 1.7 t -178.9 172.34 1.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.972 HG23 ' CD1' ' A' ' 55' ' ' ILE . 10.9 p -139.07 134.75 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.776 . . . . 0.0 109.268 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -142.45 148.31 37.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 81.7 m-20 -92.18 119.39 31.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.6 m -80.13 -31.18 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.924 . . . . 0.0 109.456 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' THR . 79.4 tt0 -157.09 143.71 18.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.436 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.77 164.79 32.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -100.57 6.51 44.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 109.71 -8.67 32.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.25 -158.79 14.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 129.92 18.03 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.618 2.212 . . . . 0.0 111.718 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.36 3.66 69.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.862 ' O ' HD13 ' A' ' 52' ' ' ILE . 8.3 m -80.04 158.16 26.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -1.135 . . . . 0.0 109.697 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 51' ' ' THR . 13.9 mm -124.12 133.32 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 45.4 mtmt -129.02 153.96 47.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 78.9 tttt -111.89 121.92 46.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.281 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.972 ' CD1' HG23 ' A' ' 40' ' ' VAL . 5.5 mm -106.35 138.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 43.2 m -131.65 120.25 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -134.23 175.01 9.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' HE2' ' A' ' 38' ' ' LYS . 1.8 mm? -103.15 139.23 38.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 83.1 tt0 -148.94 130.63 15.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 52.8 37.45 24.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.26 8.84 52.59 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.08 126.03 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' ' HE3' ' A' ' 38' ' ' LYS . 79.1 m -72.34 119.21 16.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' A' ' 59' ' ' GLU . 64.7 mttm -119.6 167.29 12.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 23.1 p90 -144.68 156.63 44.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.368 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.651 HG13 ' HB ' ' A' ' 55' ' ' ILE . 3.1 p -143.43 152.01 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.781 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG22 ' A' ' 85' ' ' VAL . 12.3 mt -110.72 127.62 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -114.64 131.04 56.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.784 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 20.4 tttt -113.13 134.02 54.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 108.983 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' GLY . 46.5 mt -97.94 127.73 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 93.5 mt-10 -89.63 -33.25 16.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.224 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 81' ' ' SER . 65.3 p -174.86 154.75 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.88 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.68 84.34 2.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.333 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.39 -40.2 81.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.55 60.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.51 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 93.1 m-20 -94.39 14.63 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.9 mt 44.35 27.62 0.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.68 157.98 18.19 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 31.7 p90 -150.84 170.07 20.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 109.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 72' ' ' SER . 3.0 p -120.3 137.63 54.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 99' ' ' PHE . 19.7 p90 -152.91 156.67 39.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 77.3 p -148.02 158.19 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.605 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 90' ' ' LEU . 39.7 t -91.95 130.1 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.2 m -118.92 -0.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.148 -0.97 . . . . 0.0 110.0 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.02 163.1 34.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.48 169.4 14.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.4 62.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -1.128 . . . . 0.0 109.305 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.14 -14.67 58.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 84' ' ' VAL . 6.5 tt -84.2 114.45 54.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.371 -0.83 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.025 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.0 Cg_endo -69.8 143.56 51.03 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.657 2.238 . . . . 0.0 111.757 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 73.9 m-20 -74.88 -28.47 60.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.554 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 19.5 p -79.87 2.62 22.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.961 . . . . 0.0 109.689 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.025 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.27 132.94 50.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 109.548 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.68 -43.97 87.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -176.28 159.0 1.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.2 mt -122.97 133.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 59.0 m -102.07 145.89 28.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD1' HG22 ' A' ' 117' ' ' VAL . 96.3 m-85 -127.49 119.34 25.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.47 106.83 13.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 0.0 109.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.455 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 6.3 m -120.85 137.73 54.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 103' ' ' LEU . 33.6 tttt -116.04 159.83 21.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.083 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 102' ' ' LYS . 24.1 mt -135.67 122.43 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 109.641 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.7 m -140.27 143.96 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.15 150.26 46.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.81 175.19 21.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.07 -0.24 6.88 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.673 2.248 . . . . 0.0 111.842 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -74.34 -24.74 59.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.99 17.44 35.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.08 -132.88 2.62 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 t -117.28 140.55 49.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -144.75 148.3 33.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.388 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.33 -167.24 35.36 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -122.36 145.21 48.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -1.119 . . . . 0.0 109.463 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 116' ' ' THR . 2.0 tt -120.31 125.72 48.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.392 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.855 ' N ' HD23 ' A' ' 115' ' ' LEU . 19.2 m -121.42 129.88 53.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.672 HG22 ' HD1' ' A' ' 99' ' ' PHE . 81.6 t -121.2 121.39 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 97' ' ' ILE . 35.9 ttpt -99.23 130.43 45.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.579 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 15.3 t80 -112.4 120.0 40.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.8 138.01 40.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.323 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 1' ' ' GLY . 29.6 p -120.02 150.48 40.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.518 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.8 mttm -52.55 -36.26 55.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.15 -93.16 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.43 -36.67 78.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 109.422 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -52.66 134.91 35.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.553 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -134.58 111.11 11.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.8 Cg_endo -70.09 126.47 13.13 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.751 2.301 . . . . 0.0 111.781 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -72.14 161.12 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.329 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.91 -34.18 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -56.44 -31.44 63.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.127 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.1 -35.9 48.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.0 108.758 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -58.63 -35.17 72.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -71.19 -38.83 72.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.235 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 138' ' ' LYS . 98.2 m -59.39 -42.26 91.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.15 -37.64 91.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -68.44 -40.36 81.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.247 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.51 66.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.832 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 134' ' ' THR . 31.1 mttp -62.54 -47.44 83.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.29 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.45 -46.34 90.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.14 -32.45 55.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.878 . . . . 0.0 109.466 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.47 86.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.8 mm? -78.59 -36.01 44.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -59.21 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -57.11 -37.1 71.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 -50.35 72.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.304 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 146' ' ' ILE . 4.6 mm -54.31 -46.13 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -66.05 -53.05 43.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.625 ' HD1' HD23 ' A' ' 150' ' ' LEU . 43.3 t80 -70.84 -45.55 64.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.625 HD23 ' HD1' ' A' ' 149' ' ' TYR . 5.2 mt -55.09 -38.6 68.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.2 -28.31 48.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.29 66.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -135.44 93.95 15.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -12.04 31.52 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.697 2.264 . . . . 0.0 111.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -79.03 -16.18 57.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 51.1 t80 -74.6 107.53 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.611 HD22 HG23 ' A' ' 17' ' ' THR . 71.0 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.73 HG12 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -134.09 148.96 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -1.145 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 94.3 m-85 -80.66 119.17 22.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 25.2 m -110.72 116.45 31.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.854 ' CE2' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -109.68 165.3 11.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 60.8 mt-10 -131.15 135.59 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.96 165.86 26.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 0.0 109.519 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -110.01 148.95 30.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.49 147.55 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -148.01 133.72 18.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.55 138.28 11.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -12.14 31.5 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.646 2.231 . . . . 0.0 111.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.974 ' HB ' HD11 ' A' ' 18' ' ' LEU . 88.0 t -86.05 153.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.91 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -57.27 137.82 80.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' CA ' ' HB2' ' A' ' 111' ' ' SER . 45.8 Cg_endo -67.86 -30.2 33.76 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.926 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.61 -33.23 62.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -77.09 -36.94 55.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 13' ' ' VAL . 1.8 mt -71.07 -40.43 71.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 69.0 t80 -65.46 -44.04 88.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.852 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.4 tptm -68.99 -46.22 68.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.13 -32.46 63.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.968 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 47.3 tp -63.29 -46.03 88.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.688 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.47 -57.08 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.985 . . . . 0.0 110.163 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -57.24 -44.5 83.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.907 . . . . 0.0 110.175 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.7 m-20 -99.05 4.68 47.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.615 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.968 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.05 -51.48 13.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.857 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -69.29 -22.72 63.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.123 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -93.36 -26.58 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HG23 ' A' ' 146' ' ' ILE . 97.7 t -82.34 -35.02 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 26' ' ' ALA . 17.8 mt -60.15 -51.45 80.3 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.2 Cg_endo -67.9 -19.41 46.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.554 2.169 . . . . 0.0 112.541 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -108.79 -48.86 3.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.035 -1.041 . . . . 0.0 109.78 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -61.82 -12.94 19.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 36' ' ' SER . 0.5 OUTLIER -156.23 112.2 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.058 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.57 -18.65 58.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.039 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.546 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.3 -36.14 60.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -51.23 133.14 28.72 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.32 -0.863 . . . . 0.0 109.346 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HD3' HG21 ' A' ' 56' ' ' THR . 36.5 tttp -87.13 -54.05 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 36.5 m -165.31 158.51 16.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.833 HG23 ' CE2' ' A' ' 37' ' ' PHE . 83.0 t -142.88 142.9 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.833 . . . . 0.0 109.208 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 71.1 mt-10 -153.73 150.68 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 0.0 109.631 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t-20 -84.68 133.63 34.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.287 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 7.9 m -104.93 -28.2 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 51' ' ' THR . 71.5 tt0 -159.71 147.16 16.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 109.504 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 96.45 158.71 31.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.62 35.23 4.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -1.113 . . . . 0.0 109.523 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.39 -17.03 60.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.08 36.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.94 137.32 34.66 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.737 2.292 . . . . 0.0 111.742 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.8 4.79 67.07 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.727 ' C ' HD13 ' A' ' 52' ' ' ILE . 53.0 m -73.37 148.4 43.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -1.15 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.727 HD13 ' C ' ' A' ' 51' ' ' THR . 4.1 mm -115.69 126.98 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.249 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 70.8 mttt -124.93 149.97 47.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 67' ' ' LEU . 22.6 mttm -117.22 131.23 56.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.02 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.701 HG23 ' CG2' ' A' ' 40' ' ' VAL . 23.0 mt -124.9 121.17 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 109.884 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 42.1 m -95.95 127.86 42.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.317 -0.864 . . . . 0.0 109.211 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.801 ' CE1' HG13 ' A' ' 66' ' ' VAL . 33.7 p90 -130.34 168.24 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.732 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -102.0 149.94 23.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -0.855 . . . . 0.0 109.286 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.77 ' H ' HD13 ' A' ' 58' ' ' LEU . 73.0 tt0 -164.41 123.07 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 55.77 39.19 30.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.47 16.14 54.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 83.5 tt0 -115.81 134.14 55.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -1.148 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.4 m -81.83 122.18 27.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.441 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HE2' ' CD ' ' A' ' 62' ' ' GLU . 75.9 mttt -131.28 170.25 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.4 p90 -141.06 156.2 46.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.801 HG13 ' CE1' ' A' ' 57' ' ' PHE . 27.9 m -130.63 141.8 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 65' ' ' PHE . 7.2 mp -112.47 129.25 56.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -121.43 137.72 54.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 81.2 tttt -117.36 151.93 35.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.368 -0.833 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.3 mt -111.06 129.1 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 75.2 mt-10 -97.73 -24.42 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.322 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.3 t 179.4 145.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.333 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.04 141.67 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -130.89 87.18 2.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.09 -37.57 87.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.95 83.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 17.8 m-20 -92.47 11.53 25.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 2.0 mt 47.69 34.86 3.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.25 152.72 19.57 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 25.1 p90 -150.19 169.11 22.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -1.168 . . . . 0.0 109.085 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 71' ' ' GLU . 77.4 p -128.64 140.88 51.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 22.1 p90 -155.34 161.27 41.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 35.5 p -146.54 157.38 43.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 HD12 ' A' ' 90' ' ' LEU . 37.3 t -90.83 126.93 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.271 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG13 ' HE3' ' A' ' 96' ' ' LYS . 3.1 t -108.47 0.55 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 90' ' ' LEU . . . 175.28 175.87 43.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 120.09 161.32 11.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -21.18 66.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.439 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.792 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . . . -79.93 -7.1 58.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.956 HD12 HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -79.81 116.97 64.87 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.515 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.075 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.02 148.03 68.93 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.762 2.308 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -79.79 -29.92 40.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.696 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.486 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 24.1 p -79.7 -8.7 59.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.075 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -116.68 127.62 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 82.8 mt-10 -65.63 -47.06 76.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 1.5 mtpm? -158.88 169.65 23.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 118' ' ' LYS . 51.0 mt -136.59 127.54 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.413 -0.805 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 3.9 m -109.03 124.08 50.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.393 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.814 ' CE1' HG13 ' A' ' 117' ' ' VAL . 69.9 m-85 -110.22 124.03 50.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 47.6 t0 -115.87 108.22 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.174 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 t -116.3 136.33 53.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.154 -0.966 . . . . 0.0 109.834 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.672 ' O ' HD23 ' A' ' 103' ' ' LEU . 65.4 tttt -119.23 153.01 35.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 108.931 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 102' ' ' LYS . 38.2 mt -131.23 123.76 29.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.007 -1.058 . . . . 0.0 109.738 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.5 m -138.96 143.17 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.382 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.09 147.7 53.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.87 170.0 23.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.47 -1.47 8.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.674 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -75.74 -23.84 56.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.63 7.51 56.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.26 -141.64 4.85 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB2' ' CA ' ' A' ' 15' ' ' PRO . 2.1 t -109.31 142.93 39.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.576 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -147.14 146.14 29.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.26 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.64 -166.09 32.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 12.9 tttp -124.38 143.38 50.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -1.142 . . . . 0.0 109.419 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -120.89 124.11 44.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.94 . . . . 0.0 109.602 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.728 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.6 m -108.26 135.21 49.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.814 HG13 ' CE1' ' A' ' 99' ' ' PHE . 24.0 t -110.91 127.84 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.561 ' CG ' HG21 ' A' ' 2' ' ' VAL . 71.6 tttt -110.99 118.61 36.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 0.0 108.849 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.904 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 32.5 t80 -122.65 109.0 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.951 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.73 ' HG3' HG12 ' A' ' 2' ' ' VAL . 62.1 tt0 -96.7 145.86 25.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.124 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.6 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.3 p -115.26 179.14 4.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.998 . . . . 0.0 109.587 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 93' ' ' THR . 57.6 mttt -62.03 -36.13 80.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.0 -94.0 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.39 -21.14 53.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 137.65 57.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 3' ' ' PHE . 61.9 tt0 -127.74 126.85 24.01 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.6 ' HD3' HG21 ' A' ' 121' ' ' THR . 50.0 Cg_endo -70.15 147.05 59.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.765 2.31 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.8 m-20 -72.69 169.23 17.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.47 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.4 -41.94 97.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.5 -43.76 93.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.854 HD13 ' CE2' ' A' ' 5' ' ' PHE . 61.2 mt -60.29 -37.46 80.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.372 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -69.41 -41.23 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.0 m -59.59 -41.22 89.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.67 89.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -68.97 -40.2 79.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.05 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.517 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.792 ' HE3' ' HB2' ' A' ' 89' ' ' ALA . 22.9 tttm -62.45 -45.82 91.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 109.425 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.47 70.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -53.26 -39.54 63.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.93 52.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.367 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 62.8 tp -64.37 -41.05 96.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -55.26 -53.02 61.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.923 . . . . 0.0 109.322 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -53.54 -35.07 60.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.193 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -57.55 -50.05 74.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.242 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.707 HG23 HG11 ' A' ' 29' ' ' VAL . 6.0 mm -55.73 -41.68 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.289 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 83.5 tt0 -62.82 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 -37.59 14.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.182 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.584 ' HD1' HD23 ' A' ' 150' ' ' LEU . 31.8 t80 -66.74 -43.41 84.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.645 HD13 HG11 ' A' ' 13' ' ' VAL . 6.7 mt -56.13 -33.33 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.74 48.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.52 -19.43 57.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -127.38 83.81 65.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.82 -20.22 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.683 2.255 . . . . 0.0 111.774 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 14.2 p-10 -83.6 -2.6 56.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.56 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -69.02 132.16 46.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.494 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.44 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -152.38 143.65 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -1.141 . . . . 0.0 109.764 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -124.26 145.77 49.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.284 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.6 m -118.26 146.93 43.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 132' ' ' LEU . 72.0 m-85 -139.12 162.19 35.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.04 132.87 45.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -131.88 164.56 25.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.13 149.3 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.7 mt -123.92 129.8 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -140.65 131.32 25.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -144.6 140.61 16.71 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.12 -10.65 28.76 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.698 2.265 . . . . 0.0 111.714 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -83.34 151.12 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.25 137.56 94.38 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.342 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.9 -28.64 35.74 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.682 2.255 . . . . 0.0 111.75 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.14 -41.72 57.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.851 HG23 ' OXT' ' A' ' 157' ' ' ASN . 55.2 m -77.47 -41.01 41.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 150' ' ' LEU . 41.9 tp -67.11 -38.34 85.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -67.55 -41.83 83.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.687 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' THR . 7.8 tptt -66.17 -46.84 75.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.896 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.47 -27.76 61.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.957 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -66.07 -48.1 72.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.652 HG23 HD23 ' A' ' 22' ' ' LEU . 72.7 t -97.39 -50.81 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.535 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.3 m -64.7 -48.77 73.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 109.988 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' VAL . 3.7 m-20 -92.31 3.94 54.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.622 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.007 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.25 -52.8 11.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.312 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.7 m-20 -66.14 -25.13 66.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 93.8 m-20 -88.89 -27.64 20.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.947 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.957 HG21 HG23 ' A' ' 146' ' ' ILE . 9.1 p -83.57 -38.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 109.637 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.007 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.6 mt -52.31 -46.45 94.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.141 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.4 Cg_endo -68.47 -17.47 43.73 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.8 mttp -108.1 -29.35 9.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.93 81.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 57' ' ' PHE . 22.7 tp -91.58 111.81 23.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.98 -44.4 87.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -89.74 29.96 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.048 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.772 ' CE1' HG22 ' A' ' 30' ' ' ILE . 47.5 t80 -63.44 132.75 52.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 39' ' ' SER . 49.7 tttp -96.08 -47.68 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.189 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.496 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 34.9 p -179.95 174.16 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.006 -1.059 . . . . 0.0 110.03 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.1 p -136.25 130.33 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 109.343 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -129.86 144.78 51.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.629 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.69 126.51 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.363 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 36.7 t -80.05 -41.58 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.625 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 51' ' ' THR . 50.8 tp10 -166.96 156.75 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 98.77 170.23 31.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -119.06 31.79 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -1.189 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.76 -11.62 66.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 -170.97 33.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.58 148.76 60.48 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.669 2.246 . . . . 0.0 111.745 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 80.04 3.32 89.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' GLU . 87.9 m -69.71 149.87 47.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.617 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 29.9 mm -114.96 124.97 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -119.68 144.15 47.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 109.557 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.775 ' HG3' HD11 ' A' ' 67' ' ' LEU . 17.2 tttt -114.48 127.62 55.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.58 ' HB ' HG13 ' A' ' 66' ' ' VAL . 64.3 mt -115.49 145.01 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m -128.72 112.11 13.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.915 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.4 p90 -115.64 173.02 6.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.98 142.57 47.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -143.54 131.3 21.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 53.18 21.88 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.94 71.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.86 155.44 18.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -1.105 . . . . 0.0 109.482 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.3 27.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 52.1 mttm -120.68 162.57 19.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.737 ' CE1' HD13 ' A' ' 67' ' ' LEU . 3.2 p90 -145.74 158.91 43.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.675 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -138.79 147.81 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.5 mp -116.26 136.12 53.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 0.0 108.918 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -129.5 142.45 50.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.743 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 81.7 tttt -124.03 149.31 46.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 24.4 mm -107.68 132.66 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.624 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.8 mt-10 -89.3 -39.24 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.346 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -173.62 140.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.68 136.03 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -128.66 78.57 1.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -58.91 -39.33 81.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.55 -52.09 42.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 74.8 m-20 -92.22 14.37 16.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 6.0 mt 45.49 42.21 7.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.66 21.7 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -151.6 169.6 21.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -1.155 . . . . 0.0 109.195 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 19.5 m -128.56 138.75 52.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.599 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.2 p90 -154.26 158.67 40.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 96.6 p -146.84 156.6 43.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 89' ' ' ALA . 9.6 p -94.4 135.5 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.213 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 67' ' ' LEU . 3.8 m -118.79 3.61 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.73 164.64 35.55 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.71 178.22 28.25 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.05 45.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.845 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.04 -8.69 59.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -103.72 104.21 41.1 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.503 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.5 Cg_endo -69.66 153.82 68.92 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.692 2.261 . . . . 0.0 111.699 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 65.2 m-20 -80.06 -35.9 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -80.01 8.38 7.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.048 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -136.88 130.66 32.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.555 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -56.65 -56.48 20.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 20.1 pttm -169.09 160.65 9.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 83' ' ' SER . 59.8 mt -117.17 136.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 8.4 m -106.54 141.21 38.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 73.8 m-85 -119.83 120.57 36.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.968 . . . . 0.0 109.955 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -119.57 101.73 8.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 108.976 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -115.07 141.18 48.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.905 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.8 tttm -127.3 145.37 50.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.436 -0.79 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.905 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.9 mm? -126.45 126.75 44.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.4 m -137.22 142.65 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.28 145.72 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.49 172.87 22.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.0 0.5 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.43 -25.7 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.25 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.39 -134.59 2.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.6 m -116.9 142.08 47.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -1.122 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.13 30.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.34 -159.73 22.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.94 142.43 49.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -1.135 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 116' ' ' THR . 2.3 tt -116.86 135.66 53.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.878 ' N ' HD23 ' A' ' 115' ' ' LEU . 38.8 m -127.32 125.88 41.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.841 . . . . 0.0 109.266 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 136' ' ' LYS . 50.8 t -109.69 134.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 63.5 tttt -113.88 120.95 42.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.003 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.571 ' CD2' ' HG3' ' A' ' 127' ' ' PRO . 14.9 t80 -102.58 125.33 49.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.975 . . . . 0.0 109.743 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 86.1 mt-10 -107.66 135.33 49.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.683 HG21 ' CD ' ' A' ' 127' ' ' PRO . 26.9 p -116.48 166.15 12.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 24.4 mttm -62.82 -35.66 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.4 -86.5 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -62.4 -27.98 69.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.15 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.71 136.04 52.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -132.32 106.91 13.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.683 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -70.57 122.42 8.88 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.698 2.266 . . . . 0.0 111.867 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -60.64 154.52 21.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -58.23 -36.15 72.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.52 -32.37 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.9 -32.6 51.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.0 -38.41 88.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.396 -0.815 . . . . 0.0 109.093 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -64.75 -45.44 86.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.0 m -57.2 -37.65 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.272 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.75 -46.52 93.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' HG2' HG21 ' A' ' 117' ' ' VAL . 65.0 mttp -53.44 -36.45 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -1.092 . . . . 0.0 109.246 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.79 -35.05 68.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.173 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.29 -47.01 78.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -67.36 -52.48 39.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -57.3 -33.41 67.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.21 81.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.22 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 142' ' ' LEU . 22.2 tp -73.12 -47.58 43.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 75.6 t80 -56.53 -55.35 34.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.066 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -50.76 -39.13 51.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -0.918 . . . . 0.0 109.358 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.957 HG23 HG21 ' A' ' 29' ' ' VAL . 47.7 mt -69.06 -55.1 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.307 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -48.63 -57.82 5.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.918 . . . . 0.0 109.156 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.62 -38.56 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 108.847 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.13 -41.67 85.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 18' ' ' LEU . 28.5 mt -57.35 -36.16 70.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.02 -28.41 63.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.59 -16.25 62.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -134.13 88.04 32.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.21 -14.83 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.719 2.279 . . . . 0.0 111.806 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -85.69 5.64 31.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.896 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.3 t80 -80.01 142.02 35.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.851 ' OXT' HG23 ' A' ' 17' ' ' THR . 81.6 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -131.99 148.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -1.181 . . . . 0.0 109.449 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.402 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 77.9 m-85 -81.37 117.45 21.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -109.83 116.82 32.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 92.7 m-85 -109.84 157.9 18.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -125.79 127.97 46.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.257 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.73 164.9 17.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.618 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -97.53 149.78 21.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 115' ' ' LEU . 64.0 mt -118.23 134.72 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 109.517 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.16 109.7 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -131.92 131.84 22.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.1 -2.74 10.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.745 2.297 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 150' ' ' LEU . 41.3 t -92.81 151.49 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.22 75.84 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.23 -34.23 22.29 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.801 2.334 . . . . 0.0 111.908 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.639 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.26 -38.3 60.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.669 HG23 ' C ' ' A' ' 157' ' ' ASN . 94.9 m -76.9 -37.5 55.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -69.64 -39.44 77.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.518 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 86.1 t80 -66.23 -46.25 77.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.803 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HE3' HG21 ' A' ' 24' ' ' THR . 19.1 tptt -61.29 -46.74 89.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.9 -20.19 61.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.009 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.1 tp -80.19 -48.83 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.912 . . . . 0.0 109.835 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.3 t -97.99 -53.03 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.306 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 ' HE3' ' A' ' 20' ' ' LYS . 4.0 m -64.36 -50.41 67.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 110.449 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.4 t70 -90.32 2.57 55.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.013 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.009 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.67 -53.16 12.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.011 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 88.9 m-20 -63.57 -25.1 68.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 63.4 m-20 -90.35 -24.15 20.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 25' ' ' ASP . 37.9 t -81.93 -39.16 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.7 mt -50.61 -48.58 82.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.867 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.5 Cg_endo -67.67 -18.34 48.1 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.407 2.071 . . . . 0.0 111.814 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 21.2 mttt -103.66 -54.62 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.314 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.43 -50.82 66.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.051 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.941 HD21 ' CB ' ' A' ' 57' ' ' PHE . 29.9 tp -71.77 102.0 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 0.0 108.938 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.42 -41.22 76.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 110.352 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -97.05 29.26 3.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.881 -1.137 . . . . 0.0 110.174 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -56.19 123.01 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.088 -1.008 . . . . 0.0 109.218 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -87.17 -54.04 4.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 0.0 109.848 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.613 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 24.5 p -174.21 167.61 4.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.094 -1.003 . . . . 0.0 110.035 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.841 HG23 ' HE2' ' A' ' 37' ' ' PHE . 94.2 t -142.43 141.62 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.157 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 76.5 mt-10 -149.88 163.08 39.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ILE . 7.7 t-20 -101.02 127.48 47.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 20.0 m -93.62 -29.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.877 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 63.1 mm-40 -159.14 147.49 17.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 95.9 156.57 31.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.77 34.13 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.62 65.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.42 -166.97 27.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.5 143.99 48.84 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 111.801 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.19 1.67 90.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.564 ' C ' HD13 ' A' ' 52' ' ' ILE . 98.3 m -67.62 147.95 52.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -1.153 . . . . 0.0 109.733 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.564 HD13 ' C ' ' A' ' 51' ' ' THR . 11.1 mm -114.19 123.77 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -118.11 143.25 46.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.646 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 64.1 tttt -118.94 132.48 56.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 40' ' ' VAL . 46.3 mt -125.38 145.85 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 0.0 109.659 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 20.4 m -124.69 124.79 42.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.377 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CB ' HD21 ' A' ' 34' ' ' LEU . 49.5 p90 -127.24 156.78 41.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.412 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.26 136.9 37.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -151.68 135.97 16.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.04 38.88 21.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.34 21.92 60.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -124.37 134.12 53.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.319 -1.107 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.5 m -79.97 118.58 21.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.491 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 88.9 mttt -121.08 160.42 23.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.0 p90 -141.61 154.67 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.52 ' C ' HD23 ' A' ' 67' ' ' LEU . 24.3 m -134.52 144.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -110.92 126.09 54.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.198 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -116.32 134.4 54.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 16.2 tttt -119.54 149.51 41.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 48.8 mt -112.32 133.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.646 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.66 -32.57 12.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.8 p -171.47 146.18 2.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.01 138.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -133.66 76.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.292 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.7 mt-10 -59.66 -37.15 77.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.68 70.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.557 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.87 12.9 26.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 16' ' ' ALA . 3.8 mt 47.38 38.04 6.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.129 -0.982 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.34 20.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 21.3 p90 -149.88 169.56 20.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -1.171 . . . . 0.0 109.19 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -128.88 139.95 51.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 109.486 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 25.5 p90 -154.0 160.02 41.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.6 p -145.2 156.18 43.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.499 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.072 HG11 ' HB3' ' A' ' 89' ' ' ALA . 82.0 t -93.05 130.16 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.643 ' O ' HD22 ' A' ' 90' ' ' LEU . 4.5 m -121.89 -0.61 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.706 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -162.02 152.48 22.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 109.03 176.9 21.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.51 -14.16 18.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.434 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.072 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -80.09 -5.1 55.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD22 ' O ' ' A' ' 85' ' ' VAL . 9.1 tp -95.57 100.57 6.3 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.04 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 49.4 Cg_endo -69.08 150.1 72.0 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.774 2.316 . . . . 0.0 111.872 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.72 -32.26 41.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.619 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 122' ' ' LYS . 7.6 t -88.58 -15.72 34.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.655 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.04 ' HB3' ' CG ' ' A' ' 91' ' ' PRO . . . -111.08 114.82 28.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -45.78 -48.51 15.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -176.63 166.7 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.669 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 118' ' ' LYS . 64.0 mt -124.89 134.49 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 118' ' ' LYS . 33.1 m -106.32 128.39 53.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 95.4 m-85 -106.43 125.14 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.04 104.05 9.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.194 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.5 t -116.17 141.09 48.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.959 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttpm? -128.91 145.09 51.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 83.4 mt -127.53 131.98 49.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.0 110.081 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -142.99 168.96 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.629 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.79 136.84 38.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 160.69 15.6 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.52 1.27 5.11 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.657 2.238 . . . . 0.0 111.888 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -80.73 -20.99 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.426 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.75 19.07 11.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.52 -142.01 3.61 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.3 t -104.91 148.03 27.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.63 151.66 37.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.265 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.02 -156.55 17.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -139.89 142.74 36.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -1.117 . . . . 0.0 109.379 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 116' ' ' THR . 2.2 tt -118.59 131.87 56.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 115' ' ' LEU . 34.0 m -119.32 130.2 55.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.522 HG21 ' HD3' ' A' ' 136' ' ' LYS . 85.0 t -108.18 130.69 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.722 ' O ' HG23 ' A' ' 97' ' ' ILE . 32.1 ttpt -112.3 123.6 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 38.2 t80 -116.55 115.23 25.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.686 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -99.06 143.41 29.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.017 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.817 HG21 ' HD3' ' A' ' 127' ' ' PRO . 68.3 p -121.99 162.68 20.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 93' ' ' THR . 21.7 mttp -49.72 -39.79 38.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.65 -95.2 0.11 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -71.7 -28.39 63.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.46 133.92 40.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -124.58 125.44 25.55 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.817 ' HD3' HG21 ' A' ' 121' ' ' THR . 51.4 Cg_endo -70.77 142.71 44.13 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.727 2.284 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.4 m-20 -81.75 165.57 20.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -66.47 -40.58 89.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -59.76 -49.04 79.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.3 -42.41 98.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.02 -43.44 98.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.22 -50.16 74.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.5 m -58.25 -37.39 74.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.335 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.14 -42.38 99.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 117' ' ' VAL . 8.8 tptt -68.2 -39.91 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.28 28.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.951 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 14.3 tttp -67.67 -41.7 83.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.4 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.52 -55.49 10.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -52.19 -32.12 34.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.27 -39.5 75.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.849 ' O ' HD13 ' A' ' 142' ' ' LEU . 1.3 tm? -69.37 -40.63 77.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.344 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -70.57 -54.31 12.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.137 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -50.78 -31.19 16.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.43 64.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 142' ' ' LEU . 50.8 mt -65.15 -54.13 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.416 ' O ' HD12 ' A' ' 151' ' ' LEU . 76.6 tt0 -44.7 -51.45 9.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.237 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.84 71.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.441 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 37.3 t80 -68.1 -37.14 80.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 0.0 109.468 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 40.7 mt -60.39 -38.43 83.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 109.401 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 147' ' ' GLU . 1.3 mt -73.41 -28.39 61.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.29 -18.52 63.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -133.37 93.8 21.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.386 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.83 -13.94 32.35 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.683 2.255 . . . . 0.0 111.907 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -86.73 -18.24 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.727 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 55.7 t80 -68.11 109.97 3.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.669 ' C ' HG23 ' A' ' 17' ' ' THR . 47.6 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.6 t -150.99 137.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.461 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.93 146.63 49.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.486 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -127.59 124.26 37.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.596 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.709 ' CE1' HD12 ' A' ' 132' ' ' LEU . 95.8 m-85 -118.74 137.38 53.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' CD ' ' HD3' ' A' ' 114' ' ' LYS . 60.7 tt0 -105.42 133.56 49.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 33.5 t0 -138.56 152.97 48.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mt-10 -92.24 160.45 15.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 64.8 mt -117.71 145.13 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 78.4 m-20 -136.56 127.0 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 1.5 m -151.88 125.86 4.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.502 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.36 -2.9 11.36 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.583 2.188 . . . . 0.0 111.761 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.861 HG11 HD23 ' A' ' 150' ' ' LEU . 90.4 t -89.17 151.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 134.79 83.57 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 47.1 Cg_endo -68.64 -27.18 32.66 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.747 2.298 . . . . 0.0 111.793 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.13 -43.91 49.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.599 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 HG23 ' OXT' ' A' ' 157' ' ' ASN . 95.0 m -77.38 -40.35 44.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.59 -39.81 77.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.586 ' HD1' HD23 ' A' ' 103' ' ' LEU . 75.8 t80 -67.08 -37.11 83.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.523 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.846 ' HE2' HG21 ' A' ' 24' ' ' THR . 18.5 tptm -69.86 -46.5 65.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.65 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -75.23 -20.86 59.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.966 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.93 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.4 tp -72.08 -49.49 35.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.1 t -97.42 -50.15 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 109.844 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.846 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -62.23 -48.54 79.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.92 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 29' ' ' VAL . 21.7 m-20 -95.46 5.95 50.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.753 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.29 -52.8 11.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.581 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 40' ' ' VAL . 38.3 t0 -67.44 -22.18 65.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.907 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 84.5 m-20 -91.72 -26.76 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 146' ' ' ILE . 7.7 p -81.61 -35.56 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.8 mt -57.78 -47.87 98.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.81 -38.19 14.14 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 57.7 mttp -85.39 -29.91 24.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 109.181 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -66.94 -30.51 70.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 108.849 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 15.6 tp -95.78 113.06 24.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 108.819 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.99 -34.7 76.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.533 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 p -98.03 27.15 4.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.845 -1.159 . . . . 0.0 109.991 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 58.4 t80 -60.33 137.1 58.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 55.1 tttm -98.01 -48.42 5.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.55 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -178.74 171.76 1.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.895 -1.128 . . . . 0.0 110.019 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 27' ' ' ASP . 4.0 p -137.83 133.05 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -141.58 130.72 23.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.0 m-20 -84.31 136.47 33.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.45 -79.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.11 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 51' ' ' THR . 90.5 mt-10 -115.57 164.16 14.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.4 157.84 29.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.63 13.61 31.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.338 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.4 42.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.93 -160.03 23.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 72' ' ' SER . 50.7 Cg_endo -70.31 130.8 19.25 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.764 2.31 . . . . 0.0 111.85 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.92 0.98 82.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 44' ' ' GLU . 43.5 m -71.98 151.71 43.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -1.177 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.61 128.15 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 33.2 mttt -125.67 149.68 48.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.929 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.754 ' HG3' HD11 ' A' ' 67' ' ' LEU . 19.0 tttt -116.29 127.57 54.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 30' ' ' ILE . 62.8 mt -113.03 137.1 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 48.0 m -128.81 128.07 43.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.467 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 28.8 p90 -137.68 176.51 8.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -103.35 145.33 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.578 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -147.74 126.21 12.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 52.43 23.43 2.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.77 11.85 73.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -112.0 159.71 18.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.6 m -99.8 111.52 23.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -119.33 162.51 18.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 67' ' ' LEU . 4.1 p90 -146.72 159.2 43.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 30.9 m -137.29 146.07 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.596 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.754 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.6 mp -116.17 137.3 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.045 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -134.14 145.69 49.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.045 -1.034 . . . . 0.0 109.835 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HE2' ' HA2' ' A' ' 50' ' ' GLY . 32.9 tttt -120.32 147.43 45.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.9 mt -108.89 132.77 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 26.1 mt-10 -86.41 -44.27 12.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 23.3 t -177.14 134.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -100.45 139.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -132.55 73.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.79 -29.33 59.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.61 73.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . 91.0 m-20 -90.16 14.12 13.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 20.9 mt 46.81 46.2 15.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 109.6 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.51 154.68 26.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -150.72 169.35 21.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -1.211 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 67.1 m -134.38 140.6 46.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.88 158.76 41.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.7 p -145.51 156.13 43.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.03 133.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' C ' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -119.81 1.26 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.894 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.39 36.95 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.13 176.59 19.1 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.52 -13.37 62.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -1.117 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.98 -9.12 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -90.59 110.3 40.29 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.022 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.6 Cg_endo -70.58 148.61 60.11 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.641 2.227 . . . . 0.0 111.7 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.432 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 61.6 m-20 -79.09 -32.54 44.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -79.85 5.83 12.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.022 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.98 134.71 45.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.057 -1.027 . . . . 0.0 109.63 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 88.0 mt-10 -63.38 -46.51 86.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 3.8 pttm 179.64 159.62 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.2 mt -116.73 136.32 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.3 m -111.84 124.83 53.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.865 . . . . 0.0 109.216 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 89.6 m-85 -108.7 124.27 50.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.97 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 16.6 t70 -119.18 107.04 12.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.065 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB3' HD13 ' A' ' 115' ' ' LEU . 76.8 p -121.11 140.61 51.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.977 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.2 tttm -121.03 154.42 36.08 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.977 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -131.17 127.2 37.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.003 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 105' ' ' ALA . 1.3 m -144.97 167.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 108.982 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.577 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -77.06 134.39 38.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.533 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.16 159.31 15.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.75 24.39 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.669 2.246 . . . . 0.0 111.867 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -70.1 -22.83 62.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.47 23.53 10.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.82 3.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.5 t -98.67 149.19 23.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -1.123 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -145.91 159.12 43.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.15 -174.54 43.62 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HD3' ' CD ' ' A' ' 6' ' ' GLU . 10.2 ttmt -117.02 141.13 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -1.121 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 101' ' ' SER . 34.9 tp -116.15 136.45 53.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.453 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 21.6 m -128.16 126.85 41.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.3 t -108.66 134.19 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 21.0 tttm -121.63 114.3 20.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.781 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.2 t80 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE2' ' NZ ' ' A' ' 118' ' ' LYS . 93.8 mt-10 -106.66 138.04 43.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.638 HG21 ' CD ' ' A' ' 127' ' ' PRO . 21.8 p -117.07 157.09 26.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 52.8 mttt -49.62 -44.94 47.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.04 -71.12 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 27.8 p30 -78.72 -17.04 56.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.097 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.52 132.49 41.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.9 107.5 25.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.878 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.638 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -69.65 119.62 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.95 158.92 26.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.54 -37.16 75.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.09 -31.67 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -78.64 -33.57 47.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 108.951 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.73 -43.2 99.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -59.25 -48.7 80.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.205 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.5 m -61.23 -40.1 92.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.36 -49.95 72.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -62.81 -37.89 88.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -1.18 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.42 -28.71 45.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -61.13 -46.74 89.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.272 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.27 -52.59 53.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -50.53 -39.07 47.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.03 86.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.87 -30.62 50.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.03 -52.09 67.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.145 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -52.1 -37.68 54.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.48 -48.02 78.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.072 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 29' ' ' VAL . 8.4 mm -57.62 -42.53 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.307 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 151' ' ' LEU . 93.5 mt-10 -73.59 -43.37 59.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.91 67.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -68.23 -44.05 76.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.861 HD23 HG11 ' A' ' 13' ' ' VAL . 4.8 mp -57.62 -35.46 70.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 147' ' ' GLU . 0.7 OUTLIER -79.14 -31.64 44.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.558 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.89 -21.82 60.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -129.81 87.38 52.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.84 -17.8 37.01 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.695 2.263 . . . . 0.0 111.79 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.39 -0.78 23.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 74.6 t80 -75.69 136.48 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.454 ' OXT' HG23 ' A' ' 17' ' ' THR . 47.2 m-20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.7 t -134.91 137.42 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -1.113 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.2 m-85 -123.27 149.66 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -127.19 135.0 50.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.305 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.807 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -127.0 157.76 38.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.116 -0.99 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -126.43 132.67 51.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 3.1 t70 -131.88 164.81 25.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.552 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 94.4 mt-10 -103.15 149.95 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.53 129.38 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -139.58 122.13 16.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -144.9 136.66 12.89 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.2 -1.13 8.32 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.597 2.198 . . . . 0.0 111.731 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.797 HG11 ' OE1' ' A' ' 147' ' ' GLU . 1.8 p -92.21 152.28 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.61 137.2 86.26 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' CA ' ' HB3' ' A' ' 111' ' ' SER . 46.1 Cg_endo -68.19 -30.4 31.25 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.749 2.299 . . . . 0.0 111.8 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.58 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 157' ' ' ASN . 61.6 m -80.16 -35.84 35.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 150' ' ' LEU . 7.6 tp -70.04 -39.44 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 85.4 t80 -70.12 -40.29 74.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.744 ' HE3' HG21 ' A' ' 24' ' ' THR . 52.0 tptt -66.0 -47.17 75.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.814 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.37 -47.89 53.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.055 -1.028 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.993 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.5 tp -47.5 -43.52 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.4 t -98.44 -56.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.744 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -64.02 -48.39 76.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.065 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HB2' ' CA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -90.64 2.81 55.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.756 -179.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.36 -50.9 15.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 0.0 109.497 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.3 m-20 -66.11 -28.88 69.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.031 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -87.9 -29.33 20.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.045 ' CG1' HG23 ' A' ' 146' ' ' ILE . 92.3 t -83.4 -38.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.1 mt -49.22 -48.26 74.27 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.795 . . . . 0.0 110.002 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.4 Cg_endo -68.93 -19.45 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.408 2.072 . . . . 0.0 111.899 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 53.1 mttm -99.21 -34.1 10.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -64.07 -34.51 78.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.25 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 10.3 tp -92.54 109.74 21.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 108.965 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.83 -26.52 65.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 p -109.04 26.98 9.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.0 110.203 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.066 ' CE1' HG23 ' A' ' 40' ' ' VAL . 4.9 t80 -59.17 137.54 57.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.44 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HE2' HD23 ' A' ' 58' ' ' LEU . 13.3 mttm -101.06 -49.52 4.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.942 . . . . 0.0 110.259 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.5 p -175.07 167.13 3.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.957 -1.089 . . . . 0.0 110.21 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.066 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.8 t -135.2 128.14 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.549 -0.719 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -138.65 151.46 47.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 27.1 p-10 -98.44 140.85 32.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.48 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -97.98 -29.9 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.526 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 51' ' ' THR . 77.6 mt-10 -157.93 145.59 18.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.56 159.74 30.92 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -97.37 5.58 49.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.56 -10.51 30.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.44 -158.13 9.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.06 138.09 36.09 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.744 2.296 . . . . 0.0 111.859 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.53 7.14 88.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' GLU . 15.1 m -79.55 157.29 27.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -1.159 . . . . 0.0 109.661 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 16.1 mm -117.85 126.7 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.2 mttm -119.13 144.14 46.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.865 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 23.4 tttt -115.41 127.36 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.062 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' CZ ' ' A' ' 37' ' ' PHE . 35.7 mt -121.22 145.3 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 0.0 110.032 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 57.7 m -131.9 127.31 36.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -0.769 . . . . 0.0 109.244 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 23.8 p90 -134.76 170.72 15.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 62' ' ' GLU . 1.9 mm? -107.84 133.53 52.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.366 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -141.41 140.01 33.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 48.46 22.2 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 109.62 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.83 29.34 39.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.759 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.0 mt-10 -132.62 145.16 50.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -85.03 109.25 18.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -113.17 156.86 22.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 12.2 p90 -141.24 153.05 45.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.553 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.4 p -138.88 147.52 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -115.11 134.48 55.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.226 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -124.51 138.0 54.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.514 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 51.9 tttt -118.4 144.1 46.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 52.5 mt -105.39 129.46 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 97.0 mt-10 -87.75 -40.73 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.28 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.1 p -171.74 151.77 2.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.84 133.85 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -128.14 82.12 2.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.85 -35.2 75.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -0.991 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.61 -52.35 62.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-20 -89.7 15.0 10.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.538 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 44.11 46.39 7.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.15 156.47 25.6 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.6 p90 -151.64 169.7 21.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.188 . . . . 0.0 109.071 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 21.2 m -126.73 138.46 53.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.579 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.8 p90 -154.42 158.62 40.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.852 . . . . 0.0 109.582 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 71.9 p -148.54 156.91 43.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 109.325 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.088 HG21 ' HB3' ' A' ' 89' ' ' ALA . 10.0 p -97.85 132.82 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.959 . . . . 0.0 109.199 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 90' ' ' LEU . 3.7 m -123.44 5.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.009 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.65 153.28 23.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.32 -176.22 23.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.47 -13.58 62.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 0.0 109.389 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.088 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.92 -8.61 59.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 85' ' ' VAL . 2.2 tp -105.72 101.8 34.81 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.055 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 50.1 Cg_endo -69.7 152.7 69.69 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.755 2.303 . . . . 0.0 111.601 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 63.0 m-20 -79.55 -34.92 40.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.628 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -79.96 7.75 8.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.913 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.055 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -138.02 127.53 24.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -52.02 -58.67 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 42.6 pttt -167.46 164.44 14.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 83' ' ' SER . 60.1 mt -118.26 135.41 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.403 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 7.7 m -107.01 145.91 31.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.631 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.9 m-85 -123.96 120.07 31.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.124 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -118.37 101.64 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.065 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.437 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 29.1 t -117.32 139.62 50.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.296 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 1.014 ' C ' HD22 ' A' ' 103' ' ' LEU . 35.7 ttpt -120.81 155.76 33.36 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.014 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -133.07 123.97 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.008 -1.058 . . . . 0.0 110.042 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.15 142.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.087 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.01 145.88 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.764 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 169.65 23.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.69 1.76 4.73 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.723 2.282 . . . . 0.0 111.844 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.25 -28.53 64.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.51 21.82 10.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.99 -131.41 1.63 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.58 ' HB3' ' CA ' ' A' ' 15' ' ' PRO . 1.1 p -120.18 142.78 48.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -1.134 . . . . 0.0 109.586 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.76 160.5 38.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.402 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.4 168.21 31.05 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -111.49 147.32 35.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.127 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -117.23 131.39 56.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.487 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.658 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.7 m -125.23 126.18 44.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.174 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.429 HG22 ' CD1' ' A' ' 99' ' ' PHE . 57.9 t -111.54 134.22 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.691 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 38.0 ttpt -106.91 126.33 52.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.662 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 36.8 t80 -106.94 121.07 43.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 91.3 mt-10 -104.83 138.96 40.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.624 HG22 ' HE1' ' A' ' 119' ' ' TYR . 26.2 p -119.31 161.86 19.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.5 mttt -63.31 -32.1 73.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.17 -108.52 0.31 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' O ' ' OE1' ' A' ' 126' ' ' GLU . 81.4 m-20 -63.43 -34.29 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.142 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.89 127.49 28.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -143.23 127.65 9.59 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.8 Cg_endo -70.46 163.85 37.36 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.7 2.267 . . . . 0.0 111.795 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -93.22 163.66 13.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -52.08 -40.39 61.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -61.35 -46.49 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -57.61 -44.77 85.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.44 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.807 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 78.9 mt -60.65 -39.07 86.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 109.424 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.08 -43.95 85.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.8 m -58.51 -40.22 82.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.314 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.08 92.88 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ASP . 42.8 mttt -69.36 -40.25 77.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.62 73.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -75.26 -44.82 43.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 142' ' ' LEU . . . -79.65 -26.42 41.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 136' ' ' LYS . 12.9 t0 -60.68 -40.11 90.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.89 68.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 142' ' ' LEU . 21.2 mt -54.78 -51.75 64.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.201 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -60.74 -53.91 51.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.16 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -56.36 -37.25 69.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.04 -54.38 45.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.186 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 ' CG1' ' A' ' 29' ' ' VAL . 6.6 mt -67.8 -53.39 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.885 . . . . 0.0 109.192 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.797 ' OE1' HG11 ' A' ' 13' ' ' VAL . 15.2 tp10 -52.97 -47.48 68.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.63 69.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.2 t80 -68.9 -31.15 69.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.287 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 18' ' ' LEU . 15.3 mt -69.84 -46.03 66.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.08 -30.01 70.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.94 -16.5 60.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -124.28 94.6 44.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.64 -21.36 29.49 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.734 2.289 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.3 -20.49 60.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.814 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 69.2 t80 -77.45 131.07 37.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.664 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.445 ' C ' HG23 ' A' ' 17' ' ' THR . 72.2 m-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' CA ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 95.2 t -138.32 137.74 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.534 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HE2' HG21 ' A' ' 121' ' ' THR . 83.5 m-85 -130.98 120.92 24.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 109.538 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 117' ' ' VAL . 51.5 m -109.02 144.16 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.456 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.833 ' CE1' HD12 ' A' ' 132' ' ' LEU . 86.4 m-85 -135.17 135.79 41.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.4 mt-10 -106.12 131.34 53.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.917 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.662 ' HB3' HD23 ' A' ' 115' ' ' LEU . 21.1 t0 -130.08 164.41 24.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -101.8 160.01 14.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 10.5 mt -133.2 132.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -133.69 131.43 39.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 47.8 m -152.55 137.01 10.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 0.0 109.353 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.5 Cg_endo -70.13 -31.55 18.66 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.676 2.25 . . . . 0.0 111.815 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' H ' HG12 ' A' ' 13' ' ' VAL . 1.5 p -60.29 152.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 142.26 97.9 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' N ' ' HB3' ' A' ' 111' ' ' SER . 46.9 Cg_endo -68.19 -37.42 14.34 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.735 2.29 . . . . 0.0 111.775 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.05 82.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 157' ' ' ASN . 52.6 m -78.77 -36.88 42.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.702 HD12 HD11 ' A' ' 150' ' ' LEU . 11.6 tp -69.9 -39.53 76.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 86.7 t80 -68.06 -42.37 80.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.828 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HE3' HG21 ' A' ' 24' ' ' THR . 20.5 tptt -63.81 -46.63 84.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.933 . . . . 0.0 109.728 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.15 -25.64 60.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.905 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 2.8 tm? -69.63 -46.89 65.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.37 -53.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.593 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.7 m -62.81 -48.57 78.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 109.956 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -94.85 8.79 41.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 109.617 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.905 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -47.06 -53.42 12.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.602 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 p-10 -69.37 -27.04 64.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.1 m-20 -83.34 -28.21 29.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.063 HG11 HG23 ' A' ' 146' ' ' ILE . 88.0 t -81.53 -36.76 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.5 mt -49.64 -49.37 72.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.102 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.8 Cg_endo -67.4 -20.1 48.68 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.503 2.135 . . . . 0.0 111.921 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 72.9 mttt -97.64 -54.11 3.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.188 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.9 65.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.064 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 9.8 mp -78.2 99.57 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.2 -29.32 60.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.9 p -110.27 27.16 9.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.746 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.57 123.97 12.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -89.6 -55.77 3.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.7 p -171.95 164.22 6.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.956 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.746 HG23 ' HE2' ' A' ' 37' ' ' PHE . 74.7 t -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.805 . . . . 0.0 109.123 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 61.4 mt-10 -152.46 160.77 43.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.129 -0.982 . . . . 0.0 109.765 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 80.0 m-20 -98.97 131.05 45.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.7 m -90.69 -29.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.676 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.84 144.74 17.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.37 168.21 32.82 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.8 6.25 33.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -1.101 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.22 -9.56 31.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.91 -157.57 8.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.29 137.07 33.09 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.651 2.234 . . . . 0.0 111.862 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.07 7.5 88.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.488 HG23 ' HA3' ' A' ' 45' ' ' GLY . 100.0 m -76.65 153.81 34.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.192 . . . . 0.0 109.625 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.503 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 24.3 mm -114.18 123.28 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 109.239 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 29.8 mtmt -119.82 145.42 46.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.917 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.606 ' HG3' HD21 ' A' ' 67' ' ' LEU . 20.4 tttm -114.98 126.71 55.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.709 HG23 HG22 ' A' ' 40' ' ' VAL . 20.7 mt -116.4 143.82 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 65.1 m -127.04 128.0 45.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 64' ' ' LYS . 52.7 p90 -133.51 156.06 48.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 140.63 31.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -150.34 134.13 16.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 52.04 32.47 10.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.99 74.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -112.02 139.57 47.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -88.0 119.44 28.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 86.3 mttt -120.35 165.86 14.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 27.8 p90 -145.03 157.78 44.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.537 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.3 p -138.69 146.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.773 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 HD21 ' HG3' ' A' ' 54' ' ' LYS . 40.1 mt -113.65 133.26 55.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.871 . . . . 0.0 108.95 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.438 ' NE2' HG21 ' A' ' 66' ' ' VAL . 33.2 m170 -126.17 139.5 53.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 24.1 tttt -117.52 144.41 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.052 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 mt -102.71 127.44 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 94.9 mt-10 -89.16 -36.63 15.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 32.0 t 178.08 132.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -103.9 137.27 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.314 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -126.57 82.42 2.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.6 mt-10 -58.28 -34.57 70.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 109.284 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.12 65.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.433 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 77.6 m-20 -87.79 15.52 6.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.908 . . . . 0.0 109.189 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 14.8 mt 43.25 46.02 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -145.23 159.71 27.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 82' ' ' TYR . 19.9 p90 -152.17 169.78 21.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -1.202 . . . . 0.0 109.291 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 41.3 t -125.38 137.81 54.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 99' ' ' PHE . 14.2 p90 -151.36 153.97 35.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 98' ' ' THR . 10.9 t -142.44 155.19 45.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.071 HG21 ' HB3' ' A' ' 89' ' ' ALA . 12.2 p -96.43 132.52 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.122 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 p -127.63 2.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.912 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.591 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -157.95 148.04 16.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.09 -174.9 19.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.06 -12.37 61.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -1.074 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.071 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.87 8.78 6.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 85' ' ' VAL . 10.2 tt -121.22 101.08 44.69 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.308 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.017 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.1 Cg_endo -69.21 154.59 69.7 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.72 2.28 . . . . 0.0 112.003 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 61.4 m-20 -79.92 -31.7 40.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.483 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 26.2 p -79.76 2.12 24.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.722 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.017 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -134.11 137.26 44.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -65.51 -56.01 14.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' OE1' ' A' ' 120' ' ' GLU . 43.9 pttt -169.0 159.05 9.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 109.461 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 119' ' ' TYR . 29.1 mt -118.96 137.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 24.2 m -113.12 120.77 42.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 117' ' ' VAL . 91.8 m-85 -96.0 126.04 40.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.753 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' THR . 17.2 t70 -119.33 113.95 21.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.329 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.502 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 22.5 t -135.81 140.68 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.47 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.82 ' C ' HD22 ' A' ' 103' ' ' LEU . 29.9 tttt -119.26 160.74 21.64 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -124.15 126.77 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.881 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 112' ' ' ALA . 29.8 m -137.35 142.93 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.92 146.12 49.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.718 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.25 165.3 21.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -2.16 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.662 2.242 . . . . 0.0 111.894 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.51 18.14 31.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -140.91 3.8 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 13.6 p -119.66 145.56 46.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -1.151 . . . . 0.0 109.606 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.43 147.7 31.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 109.146 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -161.9 170.04 37.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -99.31 146.51 26.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 7' ' ' ASP . 30.4 tp -112.21 137.37 50.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 53.8 m -140.44 113.68 8.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.816 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -110.11 139.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 110.354 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.8 tttp -111.79 119.0 37.14 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 127' ' ' PRO . 12.7 t80 -102.54 123.48 46.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.099 -1.001 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 92.0 mt-10 -106.34 137.98 43.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 3' ' ' PHE . 56.5 p -117.6 159.38 23.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.562 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 59.2 mttt -62.32 -40.95 98.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.31 -83.03 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.39 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -1.211 . . . . 0.0 109.517 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -61.99 134.66 56.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -136.79 107.03 8.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.597 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 48.7 Cg_endo -69.77 131.73 21.84 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 111.885 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.21 149.53 35.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.366 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -52.75 -36.0 57.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -57.11 -31.61 65.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.98 -36.18 59.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.157 -0.964 . . . . 0.0 108.574 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.833 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -58.25 -40.93 83.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -52.65 -54.26 35.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.42 -0.8 . . . . 0.0 109.177 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.5 m -58.71 -37.93 77.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.09 97.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 140' ' ' ASP . 24.7 mttt -63.78 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -1.119 . . . . 0.0 109.214 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.31 76.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.66 -46.37 46.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.56 -27.13 51.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.153 -0.967 . . . . 0.0 109.18 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 136' ' ' LYS . 86.1 m-20 -80.15 -21.88 42.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.282 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.4 78.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.28 -45.88 87.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -59.28 -55.21 37.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.802 . . . . 0.0 109.25 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -49.75 -41.12 43.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.64 78.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 108.945 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.063 HG23 HG11 ' A' ' 29' ' ' VAL . 21.3 mt -72.89 -54.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.7 -49.52 47.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.234 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.003 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.43 -37.56 83.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.23 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 18' ' ' LEU . 14.1 mt -65.41 -43.16 91.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.376 -0.828 . . . . 0.0 109.396 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.47 HD21 ' HG2' ' A' ' 12' ' ' PRO . 73.8 mt -69.42 -31.7 70.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.08 60.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -127.13 89.35 52.06 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.87 -19.32 35.78 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.71 2.273 . . . . 0.0 111.805 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.82 -11.7 60.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.748 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 71.2 t80 -77.48 133.7 38.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.588 ' C ' HG23 ' A' ' 17' ' ' THR . 48.0 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG11 ' HD2' ' A' ' 118' ' ' LYS . 48.3 t -127.69 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -1.164 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 126' ' ' GLU . 97.2 m-85 -126.27 141.65 51.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 37.4 m -121.37 130.38 53.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 132' ' ' LEU . 87.6 m-85 -123.11 136.73 54.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -110.08 132.18 54.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -133.81 165.8 24.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.525 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -99.6 145.35 27.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.335 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.755 HG21 HD11 ' A' ' 103' ' ' LEU . 70.8 mt -106.55 142.34 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -154.92 128.89 8.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -152.97 140.92 13.6 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.479 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.13 -1.43 8.76 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.674 2.25 . . . . 0.0 111.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.723 HG21 ' HG3' ' A' ' 147' ' ' GLU . 64.5 t -97.49 149.47 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.52 95.63 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.4 -31.07 28.71 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.729 2.286 . . . . 0.0 111.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 -41.9 53.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.696 HG23 ' CB ' ' A' ' 157' ' ' ASN . 93.1 m -75.27 -43.74 49.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' CZ ' ' A' ' 143' ' ' PHE . 68.1 tp -67.48 -37.29 82.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.6 t80 -66.75 -41.24 88.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.607 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HE2' HG21 ' A' ' 24' ' ' THR . 17.1 tptm -67.12 -46.49 73.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.631 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -74.78 -17.3 60.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.001 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 26.1 tp -74.23 -51.37 15.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.53 -44.72 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.971 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.863 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.25 -47.97 74.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.949 . . . . 0.0 110.103 -179.413 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 29' ' ' VAL . 53.6 m-20 -98.51 11.28 38.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.035 . . . . 0.0 109.833 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.001 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -53.88 -51.57 63.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 20.2 t70 -70.57 -21.37 62.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 110.141 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.16 -27.2 16.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -80.95 -33.85 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.81 . . . . 0.0 109.67 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 26' ' ' ALA . 5.8 mt -61.91 -49.55 85.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.15 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 48.5 Cg_endo -68.92 -22.78 35.56 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.513 2.142 . . . . 0.0 112.445 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 33' ' ' ALA . 22.4 mttt -106.14 -35.72 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.004 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -43.23 -38.67 2.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.004 HD23 ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -155.44 144.0 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.442 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.8 -18.71 50.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' HD13 ' A' ' 58' ' ' LEU . 68.0 m -55.14 -38.12 67.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.398 -0.814 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 55' ' ' ILE . 1.3 t80 -49.93 135.52 19.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.087 -1.008 . . . . 0.0 109.294 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 40.2 tttp -81.07 -57.28 3.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 110.295 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -162.46 155.57 20.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.02 -1.05 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 55' ' ' ILE . 92.3 t -134.67 133.55 54.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.458 -0.776 . . . . 0.0 109.065 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 84.3 mt-10 -159.34 168.1 27.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.95 . . . . 0.0 109.634 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 65.9 m-20 -97.03 152.6 18.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 2.5 t -96.1 -33.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.558 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.803 ' O ' HG23 ' A' ' 51' ' ' THR . 45.3 tp10 -166.79 156.44 11.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 88.96 -172.97 40.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -120.99 17.35 11.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 51' ' ' THR . . . 99.93 -1.43 56.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.14 -164.01 23.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.95 126.41 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.623 2.215 . . . . 0.0 111.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 92.77 4.13 65.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 44' ' ' GLU . 86.1 m -75.34 150.4 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -1.121 . . . . 0.0 109.58 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' C ' ' A' ' 51' ' ' THR . 9.4 mm -111.56 122.25 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 21.8 tttt -116.98 142.1 47.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 110.108 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 43' ' ' VAL . 17.9 tttm -117.25 130.24 56.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.024 HG22 HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -130.46 138.25 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.981 -1.075 . . . . 0.0 110.004 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.1 m -120.52 114.67 22.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.386 -0.821 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 50.8 p90 -114.96 171.05 7.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -111.14 151.32 28.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' GLU . 60.5 tt0 -154.28 138.58 16.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.311 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 2.8 p-10 44.13 26.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . 81.58 24.29 56.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' GLU . 72.7 mt-10 -121.74 140.88 51.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.445 ' CG2' ' HD2' ' A' ' 38' ' ' LYS . 16.2 m -91.07 110.28 21.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -116.18 162.04 18.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 14.2 p90 -141.85 153.79 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 5.6 p -140.6 148.82 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.712 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -110.81 128.78 55.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.914 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -122.52 138.55 54.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 22.1 tttm -119.57 146.94 45.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.5 mt -104.93 130.52 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 72' ' ' SER . 48.4 mm-40 -93.56 -27.79 16.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.292 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.2 t 178.27 144.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.44 138.15 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.373 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 94.0 m-20 -130.79 81.97 2.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.32 -37.01 81.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.54 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.53 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 22.0 m-20 -97.58 12.11 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt 47.88 29.31 1.6 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -121.24 150.86 17.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.3 p90 -151.24 169.76 21.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -1.225 . . . . 0.0 109.123 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 47.4 t -128.56 138.88 52.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -153.97 158.91 41.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 80.7 p -145.23 157.07 44.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.643 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.049 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.0 p -96.48 129.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 67' ' ' LEU . 3.6 m -116.57 4.86 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -169.18 159.51 32.53 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 105.02 -171.54 18.99 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.88 61.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -1.079 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.049 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.91 -4.02 50.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 90' ' ' LEU . 7.4 tt -121.86 86.35 45.82 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.756 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -69.54 165.91 29.12 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.505 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 38.9 m-20 -70.44 -27.82 64.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.9 p -79.77 -23.94 41.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.601 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -106.32 121.58 44.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.972 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 92.8 mt-10 -64.97 -49.12 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 71.8 mttt -161.2 158.42 27.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CD1' ' CE2' ' A' ' 119' ' ' TYR . 62.7 mt -123.61 133.68 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.84 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.2 m -108.91 131.29 55.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 99.8 m-85 -115.11 122.39 45.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.47 ' O ' HD23 ' A' ' 115' ' ' LEU . 42.5 t0 -116.11 119.9 37.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.888 . . . . 0.0 109.188 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.506 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 9.9 t -138.48 134.93 34.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.797 ' O ' HD12 ' A' ' 103' ' ' LEU . 20.0 tttm -125.77 149.09 48.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.2 mp -130.1 128.88 42.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 109.954 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 112' ' ' ALA . 32.6 m -138.96 143.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 109.164 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.04 139.65 22.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.28 168.16 21.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.16 -16.36 35.87 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.73 2.287 . . . . 0.0 111.729 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -64.86 -22.56 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.03 42.78 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.76 -140.42 4.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 m -101.93 141.36 34.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -148.02 139.5 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.4 13.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -129.82 141.68 50.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.299 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 101' ' ' SER . 3.1 tt -124.52 119.8 30.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 110.005 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.478 ' N ' HD23 ' A' ' 115' ' ' LEU . 71.2 m -116.65 128.32 55.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 108.788 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -117.03 131.97 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 110.062 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 37.1 ttpt -111.08 115.61 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 15.7 t80 -99.45 128.92 45.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.234 -0.916 . . . . 0.0 109.647 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -102.9 144.43 31.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.312 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 70.1 p -123.72 152.84 41.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 12.5 mttm -55.15 -29.21 57.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.0 -108.11 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.65 -27.27 58.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.04 135.83 57.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -141.33 119.59 7.91 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.5 146.66 56.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.844 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -87.55 177.25 7.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.94 -36.15 80.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.26 -41.92 94.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.458 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -66.96 -42.77 84.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.555 HD13 ' CE2' ' A' ' 5' ' ' PHE . 79.7 mt -63.39 -42.1 98.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -63.13 -47.39 82.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 109.411 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.7 m -58.2 -37.88 75.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.407 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.82 95.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -67.45 -39.66 85.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.62 63.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.55 -49.38 76.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.61 86.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.32 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -57.41 -38.53 74.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . -57.79 -49.07 77.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.728 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.2 mm? -75.9 -37.24 59.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.309 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.604 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 51.2 t80 -58.35 -51.81 68.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -62.87 -32.17 73.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.411 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.94 70.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 109.319 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.722 HG23 HG21 ' A' ' 29' ' ' VAL . 29.4 mt -62.91 -45.13 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.723 ' HG3' HG21 ' A' ' 13' ' ' VAL . 82.7 tt0 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.267 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.4 -37.26 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.149 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.605 ' CE2' ' CE1' ' A' ' 153' ' ' HIS . 49.1 t80 -67.92 -41.25 82.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 12.9 mt -55.44 -34.9 64.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.427 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.2 mt -78.58 -28.25 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -20.79 59.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.455 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.605 ' CE1' ' CE2' ' A' ' 149' ' ' TYR . 74.9 m80 -130.32 90.3 41.97 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.46 -16.12 34.55 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.779 2.319 . . . . 0.0 111.815 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.37 -17.49 60.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.605 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 79.3 t80 -75.1 121.45 22.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.696 ' CB ' HG23 ' A' ' 17' ' ' THR . 5.8 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.463 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 119' ' ' TYR . 91.5 t -133.2 138.02 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -1.121 . . . . 0.0 109.487 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -129.39 130.98 46.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' VAL . 98.4 m -113.35 145.01 41.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 91.3 m-85 -136.37 128.63 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.978 . . . . 0.0 109.676 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 77.0 tt0 -96.43 131.3 43.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 136' ' ' LYS . 6.5 m-20 -128.0 164.93 21.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -100.9 151.56 21.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.97 128.57 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.14 125.4 37.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.58 129.67 5.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.35 -0.03 6.8 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.661 2.241 . . . . 0.0 111.865 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -87.59 151.36 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.675 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.23 142.92 97.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 109.503 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.9 Cg_endo -68.55 -35.78 16.5 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.769 2.312 . . . . 0.0 111.814 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.32 80.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 157' ' ' ASN . 56.2 m -79.23 -40.93 29.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 HD11 ' A' ' 150' ' ' LEU . 22.3 tp -67.41 -38.8 85.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.606 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.648 ' CG ' HD22 ' A' ' 78' ' ' LEU . 68.1 t80 -69.55 -40.43 76.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 38.1 tptt -65.64 -46.93 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -75.03 -30.35 61.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.906 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.4 mt -58.71 -49.24 78.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.783 . . . . 0.0 109.722 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.51 -46.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.889 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -71.81 -50.87 25.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 62.5 t0 -85.15 7.56 21.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.012 . . . . 0.0 109.727 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -59.21 -49.7 76.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.937 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.7 m-20 -66.32 -31.27 71.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.819 . . . . 0.0 109.986 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 24.4 m-20 -87.3 -28.39 22.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.686 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 HG23 ' A' ' 146' ' ' ILE . 7.6 p -81.24 -36.75 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.655 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -53.24 -48.31 92.81 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.984 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -67.94 -34.55 23.16 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 111.943 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 18.2 mttp -83.23 -40.59 19.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.163 -0.961 . . . . 0.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -58.42 -61.7 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.938 HD21 ' HB2' ' A' ' 57' ' ' PHE . 47.5 tp -64.55 108.8 1.77 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 108.927 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.44 -35.41 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -96.81 27.18 4.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.941 -1.099 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.853 ' HA ' HD23 ' A' ' 34' ' ' LEU . 50.9 t80 -59.33 136.29 57.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 39' ' ' SER . 55.0 tttt -97.87 -49.77 4.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 110.051 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.51 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 83.1 p -178.69 171.87 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.986 . . . . 0.0 109.753 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.4 p -134.25 122.56 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.4 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 42' ' ' ASN . 18.0 tt0 -126.13 158.25 35.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' N ' ' CG ' ' A' ' 41' ' ' GLU . 45.4 m-20 -105.7 154.39 20.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.2 m -117.53 -34.92 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 85.1 mt-10 -158.3 145.78 18.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 98.43 162.0 30.34 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.78 2.86 49.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -1.113 . . . . 0.0 109.566 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 112.6 -10.32 25.9 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.24 -153.37 10.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.29 139.5 38.54 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 C-N-CA 122.714 2.276 . . . . 0.0 111.798 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.59 -1.18 86.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.639 ' O ' HD13 ' A' ' 52' ' ' ILE . 90.8 m -71.91 153.5 41.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -1.21 . . . . 0.0 109.63 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 51' ' ' THR . 14.6 mm -117.91 127.83 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -123.78 148.37 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 109.786 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 27.1 tttm -115.32 126.16 54.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 66' ' ' VAL . 84.9 mt -113.73 143.22 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.568 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 40.7 m -129.74 128.69 42.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.938 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.5 p90 -134.5 169.03 17.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 142.9 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.419 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.5 128.91 15.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 49.74 24.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 28.25 41.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -122.36 154.4 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.6 m -98.49 107.13 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.334 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 36.0 mttt -116.09 160.08 20.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -144.93 157.03 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.627 ' C ' HD23 ' A' ' 67' ' ' LEU . 17.1 m -137.25 145.82 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.707 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.775 HD12 ' HA3' ' A' ' 86' ' ' GLY . 8.5 mt -114.18 133.89 55.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.878 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -126.1 139.32 53.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 38.3 tttm -121.11 144.78 48.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.285 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 10.6 mm -102.79 125.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.443 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 92.0 mt-10 -82.97 -54.2 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.865 . . . . 0.0 109.33 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.6 t -162.39 136.97 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 70' ' ' ILE . 58.1 mt -113.41 134.76 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.403 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -129.83 79.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -50.96 -34.99 31.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.25 -49.43 64.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.674 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.497 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 59.9 m-20 -100.52 14.57 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.648 HD22 ' CG ' ' A' ' 19' ' ' TYR . 40.1 mt 42.43 41.21 2.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.84 106.42 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -109.79 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.691 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 p -136.07 142.83 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.4 p90 -152.85 157.6 40.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 109.656 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 12.4 p -142.2 153.91 44.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.4 p -103.37 128.31 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.577 HG12 ' CD ' ' A' ' 96' ' ' LYS . 2.3 m -122.3 6.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.775 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.89 147.88 16.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.89 179.66 16.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.22 -13.81 59.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' ' NZ ' ' A' ' 138' ' ' LYS . . . -79.99 -8.94 59.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 85' ' ' VAL . 4.5 tp -100.0 102.73 18.72 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.874 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -68.65 152.29 74.55 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.724 2.282 . . . . 0.0 111.836 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.96 -29.32 60.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.867 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.7 p -79.57 3.75 17.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.078 -1.014 . . . . 0.0 109.818 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.874 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.37 128.92 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 5.7 tt0 -63.82 -55.0 26.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' HG12 ' A' ' 85' ' ' VAL . 89.5 mttt -161.51 160.94 29.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 83' ' ' SER . 17.0 mt -126.15 132.78 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 34.6 m -118.55 115.89 25.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.842 ' CD1' HG23 ' A' ' 117' ' ' VAL . 69.5 m-85 -94.41 128.53 41.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 109.67 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 116' ' ' THR . 13.8 t0 -116.84 116.52 27.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.254 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 12.2 t -133.06 136.34 45.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.919 ' C ' HD22 ' A' ' 103' ' ' LEU . 28.9 tttt -122.74 144.81 48.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.919 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.4 mm? -128.36 124.04 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -133.75 162.55 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 109.059 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -60.87 125.33 23.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.057 -1.027 . . . . 0.0 109.514 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.79 150.28 19.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.58 2.33 4.1 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.647 2.231 . . . . 0.0 111.971 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.24 5.7 50.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.605 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.73 22.14 51.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -138.67 3.49 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -120.46 142.59 49.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -1.187 . . . . 0.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.55 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.28 147.37 30.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -166.26 -151.94 7.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -133.44 142.73 48.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -1.128 . . . . 0.0 109.261 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 116' ' ' THR . 4.8 tt -120.61 126.53 50.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.784 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.677 ' N ' HD23 ' A' ' 115' ' ' LEU . 68.0 m -125.72 124.85 41.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 108.849 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 99' ' ' PHE . 1.1 p -108.08 142.47 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.061 -1.025 . . . . 0.0 110.128 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 69.2 tttt -119.93 116.61 26.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 108.964 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.656 ' O ' HG13 ' A' ' 2' ' ' VAL . 15.3 t80 -102.68 130.51 49.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.137 -0.977 . . . . 0.0 109.667 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 2' ' ' VAL . 79.2 mt-10 -111.75 127.22 55.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 32.8 p -110.94 157.52 19.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.543 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -58.36 -39.23 78.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 -93.21 0.1 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -67.41 -31.65 72.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.13 115.19 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.89 108.48 28.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 117.95 5.4 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.783 2.322 . . . . 0.0 111.844 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -59.87 157.06 13.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -56.35 -38.57 71.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.82 -31.34 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.252 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 131' ' ' GLU . 63.2 mm-40 -74.38 -36.85 63.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 108.7 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.98 -35.8 69.6 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -60.63 -48.03 83.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.18 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.2 m -58.33 -39.02 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.44 99.35 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 7' ' ' ASP . 29.5 tttt -73.06 -41.78 63.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -1.111 . . . . 0.0 109.362 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.05 -34.96 70.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.642 ' NZ ' ' HB2' ' A' ' 89' ' ' ALA . 41.2 tttm -71.25 -44.76 64.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.252 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.93 89.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.837 . . . . 0.0 109.353 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.534 ' HB3' ' HE3' ' A' ' 144' ' ' LYS . 89.5 m-20 -50.95 -47.54 61.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.291 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.33 57.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.464 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 142' ' ' LEU . 3.1 tm? -70.62 -53.36 16.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.93 -53.63 54.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 108.948 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.534 ' HE3' ' HB3' ' A' ' 140' ' ' ASP . 49.4 mttt -51.93 -37.85 54.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.45 -45.83 80.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.28 -0.887 . . . . 0.0 108.989 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 29' ' ' VAL . 16.7 mt -69.07 -54.72 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.225 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -59.64 -52.65 64.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.341 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . -48.83 -39.19 24.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.062 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.1 t80 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.211 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 24.6 mt -58.82 -41.09 86.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.27 -29.64 67.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.918 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' A' ' 153' ' ' HIS . . . -78.0 -17.66 56.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.66 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.564 ' HD2' ' O ' ' A' ' 152' ' ' ALA . 2.1 m170 -125.74 85.77 58.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.575 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.44 -20.54 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.682 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -79.38 -1.45 37.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 157' ' ' ASN . 59.6 t80 -68.81 143.56 54.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 17' ' ' THR . 61.3 m-20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 120' ' ' GLU . 70.0 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.707 ' HE2' HG21 ' A' ' 121' ' ' THR . 89.0 m-85 -125.06 143.04 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.0 m -126.13 125.29 42.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.832 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.9 m-85 -121.72 139.1 54.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -112.9 133.56 54.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD2' ' CE ' ' A' ' 136' ' ' LYS . 49.1 t0 -132.3 165.0 25.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 87.2 mt-10 -101.84 157.9 16.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 27.2 mt -124.28 135.93 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 23.6 m120 -142.14 130.93 22.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.23 135.17 9.18 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.912 . . . . 0.0 109.481 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.49 -6.27 18.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.653 2.236 . . . . 0.0 111.794 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.935 HG21 HD23 ' A' ' 150' ' ' LEU . 2.7 p -87.16 150.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.33 136.84 60.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.07 -32.32 28.16 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.19 64.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -75.37 -38.63 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD22 ' A' ' 150' ' ' LEU . 39.6 tp -69.49 -39.65 77.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.9 t80 -64.68 -46.89 80.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HE2' HG21 ' A' ' 24' ' ' THR . 5.7 tptm -63.29 -46.16 88.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 156' ' ' TYR . . . -72.12 -17.91 61.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.949 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.6 tp -80.05 -50.17 10.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.815 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 -45.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.535 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -71.09 -50.46 33.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.3 t70 -95.03 17.09 14.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -54.55 -52.84 60.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' OD1' HG11 ' A' ' 40' ' ' VAL . 44.8 t0 -66.32 -26.07 67.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 59.0 m-20 -88.04 -26.61 22.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 109.449 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.077 HG11 HG23 ' A' ' 146' ' ' ILE . 75.3 t -82.27 -40.15 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.939 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.8 mt -49.47 -48.68 74.86 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.31 -34.61 20.77 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.355 2.036 . . . . 0.0 111.839 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 48.4 mttt -79.96 -40.43 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.063 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.96 88.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.268 -0.895 . . . . 0.0 108.878 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.849 HD21 ' HB2' ' A' ' 57' ' ' PHE . 40.5 tp -83.54 102.54 12.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 108.967 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.41 -35.6 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.3 p -97.73 29.5 3.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.982 . . . . 0.0 109.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.763 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.2 t80 -54.69 119.83 5.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -84.89 -55.66 3.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.618 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.602 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 60.6 p -175.1 168.23 3.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.63 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.576 HG11 ' OD1' ' A' ' 27' ' ' ASP . 7.2 p -144.08 142.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 40' ' ' VAL . 65.2 mt-10 -149.89 155.64 40.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 85.4 m-20 -96.57 121.97 38.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.4 m -79.97 -27.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' THR . 26.0 mt-10 -163.17 152.02 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 90.4 157.69 33.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.97 9.44 43.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.566 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 51' ' ' THR . . . 107.62 -6.93 36.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.36 -160.46 22.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.0 129.04 16.67 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.691 2.261 . . . . 0.0 111.714 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 89.88 2.31 75.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.491 ' C ' HD13 ' A' ' 52' ' ' ILE . 14.3 m -75.05 152.46 38.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -1.148 . . . . 0.0 109.604 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 8.3 mm -114.05 124.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.072 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 96.8 mttt -118.78 143.65 46.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 15.6 tttp -115.95 128.49 55.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 30' ' ' ILE . 49.2 mt -117.95 143.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 28.2 m -120.54 133.22 55.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.36 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.849 ' HB2' HD21 ' A' ' 34' ' ' LEU . 33.5 p90 -134.47 154.26 51.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -96.97 123.46 40.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.301 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -136.63 126.85 26.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.616 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 56.89 35.53 26.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.68 9.98 53.29 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -109.04 133.88 52.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -79.2 119.4 22.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 57' ' ' PHE . 24.3 mttt -123.64 165.6 16.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 32.7 p90 -146.01 159.87 42.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.637 ' C ' HD23 ' A' ' 67' ' ' LEU . 35.7 m -134.82 143.37 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 109.728 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.637 HD23 ' C ' ' A' ' 66' ' ' VAL . 8.5 mt -112.42 131.86 55.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 0.0 109.105 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -127.79 141.25 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.611 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 28.3 tttt -121.32 150.94 40.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.267 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 37.9 mt -112.59 133.95 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 94.2 mt-10 -92.02 -32.69 15.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.6 p -176.97 147.2 0.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.85 138.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -133.36 76.12 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.45 -37.72 84.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.17 -47.31 68.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -95.57 11.96 31.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 48.45 51.21 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.56 148.72 20.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 19.4 p90 -151.05 167.76 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 109.215 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 37.4 m -126.88 138.57 53.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.454 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 15.5 p90 -152.53 155.43 37.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.0 p -146.83 156.16 42.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 89' ' ' ALA . 6.7 p -93.04 133.37 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG13 ' CE ' ' A' ' 96' ' ' LYS . 2.9 t -123.77 0.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.018 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -167.34 157.18 29.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.35 173.52 21.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.94 -13.01 29.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -82.89 16.84 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 1.2 tt -120.97 103.82 42.35 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.13 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.2 Cg_endo -68.38 151.19 76.25 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.739 2.293 . . . . 0.0 111.866 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 47.7 m-20 -79.36 -32.55 43.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.6 p -79.6 -0.97 35.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.756 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.13 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.38 126.85 43.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.379 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 46.4 mt-10 -58.85 -54.11 50.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 85.9 mttt -160.82 163.63 31.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 mt -122.99 132.98 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 2.2 m -108.87 144.53 36.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.642 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.606 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.2 m-85 -126.52 120.86 30.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 0.0 109.8 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 59.2 t0 -119.9 102.4 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.15 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.522 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.9 t -119.06 140.58 49.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.128 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 1.039 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.6 tttt -119.36 163.72 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 109.122 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.039 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -133.45 123.46 25.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.63 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.67 143.03 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 109.315 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.37 58.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.528 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -126.6 162.65 20.72 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.82 -13.38 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.694 2.263 . . . . 0.0 111.776 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.57 -23.29 65.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.88 18.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.02 -140.06 3.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 87.0 p -110.08 145.92 36.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.6 41.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.83 171.19 35.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -105.53 142.45 35.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -1.189 . . . . 0.0 109.377 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 60.9 tp -115.55 136.89 52.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.585 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 30.4 m -127.8 125.57 40.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.35 131.95 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.52 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -113.39 122.16 46.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.957 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.1 t80 -110.76 119.99 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.553 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' HG3' HG22 ' A' ' 2' ' ' VAL . 77.1 tt0 -103.45 145.33 30.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.707 HG21 ' HE2' ' A' ' 3' ' ' PHE . 26.2 p -120.62 151.69 39.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 28.0 mttt -49.78 -43.42 48.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 177.24 -111.64 0.34 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.45 -44.13 89.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.74 134.47 36.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.574 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.6 132.1 7.97 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.603 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.58 139.52 37.55 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.679 2.253 . . . . 0.0 111.783 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -64.15 177.48 0.81 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.315 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.02 -42.29 89.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.62 -47.11 86.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.6 -40.41 79.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.832 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 79.7 mt -61.92 -37.33 84.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -59.97 -49.48 77.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.265 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.3 m -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.02 -41.87 98.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' CE ' ' OD2' ' A' ' 7' ' ' ASP . 49.6 tttp -70.28 -40.39 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -1.109 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.19 64.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.424 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -65.25 -46.21 81.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.78 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 70.5 m-20 -50.81 -29.77 12.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.77 76.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.872 . . . . 0.0 109.239 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 142' ' ' LEU . 20.2 mt -76.01 -43.86 42.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 18' ' ' LEU . 75.2 t80 -56.03 -54.68 41.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 77.4 mttt -50.46 -40.49 50.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.71 -48.81 80.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.237 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.077 HG23 HG11 ' A' ' 29' ' ' VAL . 34.0 mt -68.81 -44.48 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -62.34 -45.06 94.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.325 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.08 70.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 39.5 t80 -67.14 -46.0 75.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.935 HD23 HG21 ' A' ' 13' ' ' VAL . 9.5 mp -61.22 -43.49 98.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.6 mt -69.38 -36.17 76.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.26 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -127.07 84.05 64.46 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.68 -19.24 36.77 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.645 2.23 . . . . 0.0 111.725 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.79 -12.26 60.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 41.7 t80 -77.52 125.87 30.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.569 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 7.3 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.635 HG11 ' NZ ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.456 ' CE1' ' HD2' ' A' ' 127' ' ' PRO . 97.1 m-85 -80.05 118.73 22.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 28.8 m -111.17 116.53 31.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.704 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.3 m-85 -108.91 163.67 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.688 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 46.0 mt-10 -130.34 132.47 45.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.253 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -132.91 166.23 22.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.27 140.99 36.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HG ' ' A' ' 115' ' ' LEU . 74.6 mt -114.15 136.69 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.307 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -151.76 138.99 19.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.479 ' HB3' ' OE1' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -153.07 144.7 16.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HG2' HD11 ' A' ' 151' ' ' LEU . 49.4 Cg_endo -70.25 -5.02 15.54 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.699 2.266 . . . . 0.0 111.794 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.94 HG21 HD23 ' A' ' 150' ' ' LEU . 7.1 p -92.88 151.62 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.14 79.19 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.3 Cg_endo -68.07 -30.61 31.73 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.71 2.273 . . . . 0.0 111.85 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.24 -36.0 61.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 157' ' ' ASN . 58.6 m -76.7 -38.89 53.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.495 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 150' ' ' LEU . 33.3 tp -68.13 -39.36 82.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 85.2 t80 -66.04 -44.59 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 0.0 109.785 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.872 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.1 tptt -63.83 -46.76 83.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 109.681 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -72.56 -17.67 61.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.544 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.948 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 51.1 tp -79.52 -49.05 12.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.39 -48.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.872 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.9 m -64.99 -49.43 70.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.9 m-20 -97.27 12.19 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -48.66 -53.56 18.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.338 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.798 ' HA ' HD12 ' A' ' 30' ' ' ILE . 73.7 m-20 -66.92 -23.56 65.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.927 . . . . 0.0 109.543 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 92.0 m-20 -87.23 -26.76 23.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD12 ' A' ' 146' ' ' ILE . 85.7 t -81.55 -35.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.4 mt -53.68 -48.59 92.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.25 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.9 Cg_endo -67.23 -19.73 50.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.524 2.149 . . . . 0.0 112.251 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 35.4 mttm -104.12 -45.82 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 109.347 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -59.89 -45.8 91.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 57' ' ' PHE . 55.0 tp -79.63 107.13 12.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 108.878 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.46 -44.73 85.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -92.14 29.75 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.828 -1.17 . . . . 0.0 110.344 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 54.4 t80 -58.38 123.75 17.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.02 -1.05 . . . . 0.0 109.363 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.36 -52.4 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -177.49 170.37 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.493 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.73 135.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -135.18 134.97 40.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.13 137.8 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.1 m -99.96 -36.83 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.433 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 43' ' ' VAL . 55.9 mt-10 -158.7 146.25 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.65 155.18 20.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -109.38 29.72 7.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -1.142 . . . . 0.0 109.583 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.78 -21.98 38.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.48 -162.42 5.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.4 160.55 49.14 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.66 2.24 . . . . 0.0 111.749 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 63.16 12.12 42.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -76.36 153.69 35.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.0 109.521 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 9.4 mm -117.39 126.94 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -119.88 144.51 47.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.706 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.7 tttt -115.29 128.97 56.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 66' ' ' VAL . 67.8 mt -117.41 145.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.3 m -124.43 125.15 43.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 109.298 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.893 ' HB2' HD21 ' A' ' 34' ' ' LEU . 48.0 p90 -133.66 158.21 43.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -99.22 150.14 22.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.482 ' OE1' ' CE ' ' A' ' 64' ' ' LYS . 57.7 tt0 -152.97 129.81 10.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.566 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 48.13 23.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.38 29.4 36.73 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' GLU . 96.9 mt-10 -123.71 155.39 37.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.8 m -97.86 112.26 24.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 62.3 mttt -124.67 158.63 32.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 30.0 p90 -142.76 157.6 44.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 55' ' ' ILE . 33.3 m -132.76 142.8 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.131 -0.98 . . . . 0.0 109.608 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.599 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.5 mt -110.29 125.42 53.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -116.01 133.86 55.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 64.0 tttt -120.59 146.06 46.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.195 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 66.1 mt -113.31 138.28 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.551 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.1 -42.61 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -161.58 142.75 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 109.499 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -109.88 140.71 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.48 77.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.398 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.488 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.6 mt-10 -57.29 -38.17 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.443 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.05 -47.73 64.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -95.01 12.67 27.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.1 mt 47.72 31.54 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.408 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.94 152.79 19.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.511 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.5 p90 -150.24 169.65 20.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -1.124 . . . . 0.0 109.26 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -125.97 139.28 53.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 25.9 p90 -154.29 160.76 41.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.7 p -146.19 156.48 43.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -86.36 132.15 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG13 ' HE2' ' A' ' 96' ' ' LYS . 4.1 t -117.67 -5.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.781 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -171.96 162.71 34.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 122.54 160.43 10.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.05 -15.16 20.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -1.079 . . . . 0.0 109.296 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.93 -6.03 56.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.338 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tt -79.98 110.19 15.13 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 109.356 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.027 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.21 146.42 63.52 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.747 2.298 . . . . 0.0 111.695 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 62.5 m-20 -78.89 -32.65 45.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.9 p -79.86 -5.44 55.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.727 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -122.75 136.92 55.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.058 -1.026 . . . . 0.0 109.624 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 81.1 mt-10 -70.63 -51.31 28.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' HG13 ' A' ' 85' ' ' VAL . 31.7 mttt -161.21 163.55 31.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 118' ' ' LYS . 60.3 mt -124.01 133.1 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 6.1 m -109.52 125.52 52.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.0 m-85 -108.79 122.87 48.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 56.7 t0 -120.42 102.63 8.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.933 . . . . 0.0 109.252 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 17.1 m -119.44 139.57 51.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.909 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HD23 ' A' ' 103' ' ' LEU . 31.6 ttpt -120.58 156.87 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 62.3 mt -129.54 127.5 40.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.5 m -139.61 142.97 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.33 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.25 170.63 22.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.13 -8.94 24.84 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.684 2.256 . . . . 0.0 111.853 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -67.9 -24.94 65.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.32 44.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.98 -143.32 4.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 85.3 p -106.1 144.74 32.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.12 30.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.41 -165.52 32.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.11 145.14 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -117.69 132.37 56.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 115' ' ' LEU . 20.1 m -122.11 128.69 51.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.269 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 4' ' ' THR . 49.2 t -107.7 131.35 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 31.8 tttm -112.66 121.41 44.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.84 . . . . 0.0 109.225 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.657 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t80 -116.48 114.32 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.544 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -101.12 138.05 38.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.092 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.9 p -116.42 164.32 14.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 41.3 mttt -55.22 -43.05 74.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.47 -106.88 0.21 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 125' ' ' ALA . 86.1 m-20 -63.32 -42.84 99.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 109.449 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -44.63 130.47 6.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 4.9 mt-10 -134.91 133.17 20.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.4 Cg_endo -70.44 158.13 56.99 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.613 2.209 . . . . 0.0 111.742 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.7 OUTLIER -90.93 164.99 13.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.95 -40.66 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.41 -46.63 89.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 64.7 mm-40 -58.11 -45.61 86.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.704 HD13 ' CE2' ' A' ' 5' ' ' PHE . 58.4 mt -59.55 -38.31 80.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -61.27 -48.55 80.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.35 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.4 m -58.83 -38.54 78.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.324 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -46.0 95.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.466 ' CD ' HG21 ' A' ' 117' ' ' VAL . 4.8 mtmt -64.94 -38.82 92.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.0 62.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.49 -45.99 84.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.359 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.3 -55.35 10.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -54.06 -35.72 62.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.39 -46.96 82.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.992 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.8 tm? -71.19 -33.57 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.202 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -56.07 -52.75 63.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.953 . . . . 0.0 109.125 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -51.76 -39.84 59.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.156 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.03 -38.71 73.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.305 -0.872 . . . . 0.0 109.053 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 142' ' ' LEU . 7.6 mm -71.68 -44.35 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.234 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.501 ' OE1' HG12 ' A' ' 13' ' ' VAL . 30.6 tp10 -67.69 -41.63 83.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.86 -34.28 74.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.95 -46.68 64.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.94 HD23 HG21 ' A' ' 13' ' ' VAL . 6.7 mp -63.26 -43.77 97.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 12' ' ' PRO . 82.0 mt -68.05 -33.48 74.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.71 -17.82 61.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -129.56 95.07 30.72 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.6 -16.58 34.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.699 2.266 . . . . 0.0 111.72 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -73.43 -20.73 60.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 70.8 t80 -79.89 129.92 34.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.657 HG22 ' HG3' ' A' ' 120' ' ' GLU . 87.0 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.4 m-85 -124.28 146.5 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.6 m -128.31 135.0 49.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 71.5 m-85 -126.39 160.0 31.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.413 ' CD ' ' HE2' ' A' ' 114' ' ' LYS . 71.7 mt-10 -135.93 129.26 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -133.26 165.13 25.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 8' ' ' GLU . 68.5 mm-40 -104.68 151.83 23.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 115' ' ' LEU . 47.4 mt -121.53 134.91 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 25.7 m120 -144.72 131.34 19.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.549 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 2.0 p -148.02 144.54 19.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.787 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.0 Cg_endo -71.48 1.38 5.63 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.415 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CG1' ' OG ' ' A' ' 11' ' ' SER . 2.4 p -97.89 152.78 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.55 137.9 61.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 111' ' ' SER . 47.1 Cg_endo -67.98 -35.16 21.2 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.744 2.296 . . . . 0.0 111.826 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.89 68.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.29 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 157' ' ' ASN . 68.1 m -78.55 -35.25 46.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 150' ' ' LEU . 14.5 tp -70.62 -40.59 73.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.771 ' HB2' HD12 ' A' ' 103' ' ' LEU . 91.3 t80 -65.51 -49.78 67.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.682 ' CE ' HG21 ' A' ' 24' ' ' THR . 7.3 tptm -59.77 -46.26 89.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -70.54 -18.63 62.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.04 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 13.4 mt -80.13 -46.16 16.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 109.749 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.52 -45.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.17 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.682 HG21 ' CE ' ' A' ' 20' ' ' LYS . 16.4 m -74.78 -50.05 18.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.334 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.6 t70 -92.12 9.18 34.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.0 109.819 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.04 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -51.05 -52.45 43.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 93.8 m-20 -65.19 -29.48 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.379 -0.826 . . . . 0.0 109.748 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.504 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 85.7 m-20 -84.41 -26.36 28.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 146' ' ' ILE . 45.0 t -80.77 -37.14 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -50.04 -49.48 74.76 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.37 -25.23 36.2 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.357 2.038 . . . . 0.0 111.97 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 59.6 mmtt -91.94 -33.31 14.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.149 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.65 -43.05 60.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -0.868 . . . . 0.0 109.046 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.61 106.6 18.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.016 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.26 -33.26 69.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.944 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 9.7 m -98.2 29.55 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 0.0 109.882 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 39' ' ' SER . 56.3 t80 -58.35 126.48 27.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -92.08 -52.04 4.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.62 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 54.3 p -177.66 170.85 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 109.722 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.6 p -142.33 140.32 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.308 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -145.93 153.79 41.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 7.1 m-20 -87.23 140.67 29.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 2.7 t -91.17 -39.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.644 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 51' ' ' THR . 87.9 mt-10 -161.03 149.21 15.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.448 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 96.16 167.36 34.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -98.14 8.14 45.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.91 -6.37 35.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.79 17.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.69 130.7 19.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.658 2.239 . . . . 0.0 111.758 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.5 3.49 69.04 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.7 m -77.76 155.19 31.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -1.178 . . . . 0.0 109.571 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 43' ' ' VAL . 21.1 mm -118.79 128.31 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.942 . . . . 0.0 109.308 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.7 mttp -122.52 147.72 46.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.614 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.3 tttm -116.98 129.3 55.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 40' ' ' VAL . 14.8 mm -116.28 146.21 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.528 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 23.5 m -130.71 121.59 25.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.903 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 47.6 p90 -129.1 160.8 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -96.25 148.56 22.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -150.37 127.74 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.36 22.71 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.45 10.86 72.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -108.35 159.12 16.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -1.11 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.6 m -104.93 115.47 30.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -121.22 164.68 16.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.49 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 45.6 p90 -143.75 156.47 44.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.844 ' C ' HD23 ' A' ' 67' ' ' LEU . 27.1 m -135.85 144.7 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.557 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.844 HD23 ' C ' ' A' ' 66' ' ' VAL . 2.5 mt -109.87 126.79 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.219 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -118.5 134.84 54.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 17.8 tttm -116.05 147.21 41.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' GLY . 12.2 mm -106.83 126.54 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.4 mt-10 -87.32 -42.88 12.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 p -168.04 148.46 4.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.01 135.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.12 75.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.352 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.25 -36.67 78.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -48.74 72.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.463 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 49.3 m-20 -90.63 13.01 17.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.7 mt 47.53 49.27 16.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.472 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -148.73 153.9 25.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.3 p90 -150.38 169.47 21.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -1.124 . . . . 0.0 109.133 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 62.7 m -131.09 140.75 50.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 24.1 p90 -155.76 162.6 40.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.578 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 51.9 p -146.36 156.53 43.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.51 133.32 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.541 ' C ' HD13 ' A' ' 90' ' ' LEU . 19.4 t -106.87 -7.93 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.478 ' C ' ' HG ' ' A' ' 67' ' ' LEU . . . 171.27 -179.06 43.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.75 166.02 27.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.84 -20.75 2.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -1.116 . . . . 0.0 109.379 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.92 -15.73 56.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -90.65 106.96 17.15 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.307 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.033 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.5 Cg_endo -69.58 146.26 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.728 2.285 . . . . 0.0 111.901 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.45 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 79.3 m-20 -77.47 -30.97 53.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 p -79.95 1.18 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.849 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.56 126.32 41.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' OE1' ' OE2' ' A' ' 120' ' ' GLU . 92.8 mt-10 -58.15 -42.4 85.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -178.54 157.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.359 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 118' ' ' LYS . 63.8 mt -119.67 135.56 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.532 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 34.6 m -109.62 128.2 55.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.752 ' CE1' HG13 ' A' ' 117' ' ' VAL . 94.2 m-85 -111.27 124.65 52.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.508 ' O ' HD12 ' A' ' 115' ' ' LEU . 57.2 t0 -120.09 105.0 10.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.647 ' CB ' HD13 ' A' ' 115' ' ' LEU . 8.5 t -114.5 141.0 48.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 103' ' ' LEU . 74.1 tttt -127.7 146.86 50.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.86 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 19' ' ' TYR . 46.5 mt -122.68 127.6 49.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.799 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.8 m -138.86 143.43 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -62.65 139.77 58.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.52 165.3 22.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.01 22.51 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.647 2.231 . . . . 0.0 111.831 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.16 -28.14 69.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.79 10.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.35 -134.44 2.08 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 100.0 p -108.42 143.16 37.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -1.129 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.94 141.97 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.57 -168.54 35.45 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HE2' ' CD ' ' A' ' 6' ' ' GLU . 69.2 tttt -125.83 140.72 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -1.121 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 101' ' ' SER . 25.0 tp -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.1 m -126.83 127.1 44.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' CE1' ' A' ' 99' ' ' PHE . 58.6 t -111.81 132.7 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 97' ' ' ILE . 33.8 ttpt -111.72 125.31 53.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 55.6 t80 -113.0 118.75 35.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 2' ' ' VAL . 87.0 tt0 -103.44 146.78 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.399 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.8 p -119.77 157.19 29.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.397 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.2 mttt -45.9 -37.71 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.66 -96.4 0.16 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.18 -32.15 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -1.148 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.51 137.77 57.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -145.59 110.44 4.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 47.9 Cg_endo -69.77 144.48 54.1 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.728 2.285 . . . . 0.0 111.772 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 131' ' ' GLU . 48.4 p30 -70.49 172.87 7.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.71 -35.1 78.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.47 -44.3 89.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.405 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 94.4 mt-10 -66.84 -39.99 87.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 95.7 mt -63.77 -42.93 97.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.46 -44.72 90.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.268 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.3 m -57.53 -38.66 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.04 97.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -62.98 -38.61 91.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -51.71 -32.04 28.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.444 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -75.86 -36.65 59.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.22 -55.29 8.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.877 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 4.2 p30 -62.11 -26.03 68.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.499 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -58.76 -50.98 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.895 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 6.4 tp -58.24 -38.16 76.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.883 . . . . 0.0 109.292 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.02 -54.95 38.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.128 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -51.54 -33.74 33.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -60.85 -53.72 53.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.247 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.919 HG23 HG11 ' A' ' 29' ' ' VAL . 45.0 mt -67.37 -53.55 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -50.48 -51.0 51.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.46 70.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.9 t80 -66.5 -39.72 88.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.394 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 18' ' ' LEU . 13.0 mt -61.21 -43.12 99.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 ' HG2' ' A' ' 12' ' ' PRO . 83.3 mt -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.37 61.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.595 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 93.85 46.59 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.81 -21.46 33.2 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.683 2.255 . . . . 0.0 111.759 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -75.42 -17.88 60.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 57.5 t80 -78.74 118.67 21.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.47 ' HA ' HG21 ' A' ' 17' ' ' THR . 75.6 m-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.609 HG11 ' HE3' ' A' ' 118' ' ' LYS . 88.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.42 146.88 49.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -130.62 130.46 44.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 132' ' ' LEU . 88.0 m-85 -129.28 160.92 31.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -127.9 130.11 47.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -126.22 164.71 20.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -94.51 160.47 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 61.4 mt -128.12 142.38 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.36 132.11 42.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -152.42 112.67 2.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.25 -2.22 10.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.581 2.187 . . . . 0.0 111.726 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.061 ' HB ' HD11 ' A' ' 18' ' ' LEU . 68.0 t -95.2 154.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 132.39 26.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.0 Cg_endo -67.93 -29.64 34.15 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.745 2.296 . . . . 0.0 111.939 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.88 -34.05 62.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 157' ' ' ASN . 90.2 m -77.31 -37.4 52.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.061 HD11 ' HB ' ' A' ' 13' ' ' VAL . 9.0 mt -69.24 -40.25 78.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.54 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 68.6 t80 -65.88 -45.54 81.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.3 OUTLIER -64.48 -47.6 78.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -70.34 -20.84 62.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.333 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.2 tt -80.13 -45.49 18.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.36 -54.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 20.7 m -63.69 -49.5 72.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.577 ' OD2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 m-20 -95.61 13.59 25.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.074 -1.017 . . . . 0.0 109.938 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.01 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -53.3 -52.87 57.71 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.193 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 63.9 t0 -67.61 -23.02 65.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.97 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 7.6 m120 -90.94 -27.42 18.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.9 p -83.51 -35.07 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.01 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -56.63 -46.47 99.83 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.4 Cg_endo -66.72 -22.18 50.42 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.456 2.104 . . . . 0.0 112.42 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -108.47 -26.0 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.115 -0.991 . . . . 0.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -63.49 -28.61 70.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.969 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 57' ' ' PHE . 42.2 tp -101.02 117.52 35.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.032 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.77 -44.07 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.532 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 57.9 m -93.02 28.17 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.891 -1.131 . . . . 0.0 110.072 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CE1' HG22 ' A' ' 30' ' ' ILE . 46.6 t80 -58.83 131.61 51.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.0 tttp -93.03 -51.08 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.933 . . . . 0.0 110.103 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.464 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 67.0 p -179.91 173.77 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 109.938 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 9.7 p -135.69 128.35 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.205 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 70.0 mm-40 -130.0 144.03 51.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.27 125.64 30.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 50.0 t -82.69 -44.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.562 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 51' ' ' THR . 81.7 tt0 -158.49 145.59 17.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.4 168.21 28.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.84 5.68 50.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -1.152 . . . . 0.0 109.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.28 -8.45 28.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -156.76 12.35 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.02 135.68 30.44 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.701 2.267 . . . . 0.0 111.774 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.25 1.5 84.06 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.5 m -80.02 127.68 32.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 109.481 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 20.6 mm -93.29 134.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -125.77 150.75 47.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.742 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.5 tttt -115.33 126.45 54.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.644 ' HB ' HG22 ' A' ' 66' ' ' VAL . 56.4 mt -111.77 141.01 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -125.39 123.41 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.894 ' HB2' HD21 ' A' ' 34' ' ' LEU . 41.1 p90 -128.71 166.84 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.27 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -99.35 151.39 21.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.501 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -154.13 119.0 4.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.927 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.12 31.78 7.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.26 -7.09 65.15 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' OE2' ' HE2' ' A' ' 64' ' ' LYS . 72.8 tt0 -91.25 144.51 25.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -1.145 . . . . 0.0 109.419 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.7 m -95.79 120.15 35.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 12.7 mmtt -125.69 169.81 12.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 67' ' ' LEU . 5.0 p90 -147.93 161.39 41.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.668 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.8 m -137.94 147.18 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.742 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.9 mp -115.3 134.3 55.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.489 ' HD2' HG22 ' A' ' 84' ' ' VAL . 39.9 m170 -128.67 141.99 51.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 66.4 tttt -120.82 147.68 45.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.356 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.7 mt -108.61 132.2 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 92.9 mt-10 -87.6 -38.8 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.425 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 p -176.78 150.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.03 137.16 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -131.46 79.43 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -61.86 -37.76 85.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.55 63.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.455 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 56.5 m-20 -90.58 13.32 16.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 9.8 mt 47.31 47.63 16.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.89 152.95 24.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 17.3 p90 -151.12 169.35 22.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 109.14 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 22.7 t -137.76 142.03 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.9 p90 -154.64 160.7 41.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.349 -0.845 . . . . 0.0 109.533 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.4 p -145.55 156.49 43.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 90' ' ' LEU . 73.4 t -89.67 133.09 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.359 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -115.04 -1.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.863 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.52 168.09 39.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.32 166.28 18.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.0 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -1.148 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -81.35 -10.54 59.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -88.27 107.78 18.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.08 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.3 Cg_endo -69.43 148.29 66.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.647 2.231 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -79.37 -33.41 42.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -81.31 0.26 37.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.08 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -130.43 139.45 50.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HG3' ' HD3' ' A' ' 122' ' ' LYS . 89.7 mt-10 -67.03 -54.73 18.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 109.508 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 51.2 pttt -171.91 163.54 6.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 118' ' ' LYS . 56.2 mt -118.98 135.75 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.5 m -110.15 122.6 48.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.221 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.629 ' CE1' HG13 ' A' ' 117' ' ' VAL . 92.4 m-85 -104.04 125.17 50.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.841 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 48.7 t0 -120.34 102.22 8.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.466 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 27.0 m -115.13 141.43 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.0 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.62 ' O ' HD23 ' A' ' 103' ' ' LEU . 50.3 tttt -123.24 153.8 39.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 108.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 102' ' ' LYS . 40.4 mt -129.88 126.45 37.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.94 143.26 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -70.4 148.3 48.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.48 168.07 24.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 -6.0 17.52 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.71 2.273 . . . . 0.0 111.701 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -63.81 -27.3 69.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.7 18.32 25.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.51 -139.09 3.42 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 31.0 t -117.0 145.99 43.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.682 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.11 166.13 25.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.885 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 169.2 169.43 32.55 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -109.51 144.93 37.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -1.164 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' THR . 1.2 tt -114.98 136.19 53.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.575 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.3 m -127.16 126.13 42.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 99' ' ' PHE . 48.0 t -111.24 130.5 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.651 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 97' ' ' ILE . 63.9 tttt -112.6 122.08 46.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 109.152 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.575 ' CD1' ' HG3' ' A' ' 127' ' ' PRO . 22.8 t80 -112.1 118.41 35.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 109.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.463 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 88.8 mt-10 -101.24 145.52 28.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.208 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 15.7 p -124.09 171.28 9.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HD3' ' HG3' ' A' ' 95' ' ' GLU . 41.9 mmtt -79.8 1.52 26.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.28 -88.46 0.46 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -57.79 -37.45 73.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.89 137.66 58.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 110.69 3.78 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.432 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CD1' ' A' ' 119' ' ' TYR . 50.4 Cg_endo -70.28 147.22 59.04 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.732 2.288 . . . . 0.0 111.835 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.8 OUTLIER -84.61 163.51 19.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.448 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.61 -40.12 78.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.66 -45.56 91.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -59.36 -42.88 92.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.62 HD13 ' CE2' ' A' ' 5' ' ' PHE . 90.9 mt -58.16 -35.32 71.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -65.39 -44.12 88.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.6 m -57.79 -39.6 77.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.29 98.8 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -63.3 -39.2 93.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -1.155 . . . . 0.0 109.448 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.16 -33.1 38.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.95 -43.24 93.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.99 -50.66 67.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.336 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 84.4 m-20 -51.57 -33.67 33.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.36 97.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.269 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.947 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.9 tm? -79.18 -36.45 40.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.12 -51.84 68.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 80.6 mttt -51.78 -39.87 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 0.0 109.212 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.28 -42.32 81.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.143 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.09 -45.06 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.372 -0.83 . . . . 0.0 109.191 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.437 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 94.2 mt-10 -71.19 -37.82 72.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.83 79.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.162 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -71.33 -52.33 19.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.595 HD22 HD23 ' A' ' 18' ' ' LEU . 8.1 mp -60.97 -36.69 80.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.52 -31.69 68.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.46 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.71 -2.1 51.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -127.94 75.42 78.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.71 -14.17 35.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.673 2.249 . . . . 0.0 111.782 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -76.23 -26.1 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.659 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 81.6 t80 -79.88 125.58 29.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 8.5 m120 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG11 ' CE ' ' A' ' 118' ' ' LYS . 97.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' OE1' ' A' ' 126' ' ' GLU . 97.6 m-85 -124.61 147.13 48.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.49 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -127.6 120.69 28.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.797 ' CE2' HD13 ' A' ' 132' ' ' LEU . 91.8 m-85 -123.16 133.66 54.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -101.9 132.69 47.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 53.3 t0 -127.74 160.58 31.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 90.4 mt-10 -92.09 160.2 15.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 77.0 mt -117.67 143.8 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -138.03 112.26 8.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 51.1 m -149.33 126.78 5.58 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.68 -35.96 9.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.21 149.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.525 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 134.33 93.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.599 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' SER . 47.6 Cg_endo -68.67 -24.23 35.42 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.785 2.323 . . . . 0.0 111.826 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -44.16 49.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.667 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.8 m -76.27 -42.83 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.157 -0.965 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 HD22 ' A' ' 150' ' ' LEU . 16.1 tp -65.12 -38.35 90.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 109.639 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 83.7 t80 -66.17 -43.86 85.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.7 tptt -64.51 -46.74 81.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.689 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.26 -16.84 60.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.0 tp -77.02 -51.03 11.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.5 -48.25 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -61.59 -48.77 79.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 109.778 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' VAL . 65.3 m-20 -101.54 15.26 29.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.32 -52.68 12.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -67.45 -23.16 65.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.541 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 m120 -88.53 -27.75 21.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.87 . . . . 0.0 109.317 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.058 HG21 HG23 ' A' ' 146' ' ' ILE . 8.0 p -82.76 -37.2 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.05 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -49.74 -48.9 76.02 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.869 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.2 Cg_endo -68.48 -33.45 22.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.396 2.064 . . . . 0.0 111.87 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.0 mttt -82.33 -52.91 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.136 -0.978 . . . . 0.0 109.133 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -53.06 -38.07 62.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 108.974 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.053 HD21 ' HB2' ' A' ' 57' ' ' PHE . 26.8 tp -84.39 105.42 15.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.77 -39.33 77.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.079 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.6 p -95.61 28.28 3.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 109.862 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -56.44 125.7 23.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB2' HD12 ' A' ' 58' ' ' LEU . 51.7 tptt -92.83 -52.69 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 m -170.34 162.92 8.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.717 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.092 HG22 HG23 ' A' ' 55' ' ' ILE . 96.3 t -143.03 142.42 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 86.1 mt-10 -150.97 161.86 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 109.54 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -88.51 135.4 33.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 109.446 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 28.5 t -83.27 -42.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.776 ' O ' HG23 ' A' ' 51' ' ' THR . 55.6 mm-40 -159.57 147.25 17.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.72 -154.09 21.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -140.66 13.21 2.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' H ' HG21 ' A' ' 51' ' ' THR . . . 109.36 -2.13 31.04 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.87 -162.66 25.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.71 134.94 27.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.731 2.287 . . . . 0.0 111.866 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.98 0.25 90.19 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 44' ' ' GLU . 89.5 m -70.2 151.57 45.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.63 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 37.8 mm -115.65 124.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -117.91 143.39 46.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.002 . . . . 0.0 109.763 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 12.6 tttm -123.5 136.3 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.223 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.092 HG23 HG22 ' A' ' 40' ' ' VAL . 71.9 mt -128.92 146.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.804 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 30.3 m -120.14 121.99 40.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.279 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 1.053 ' HB2' HD21 ' A' ' 34' ' ' LEU . 51.4 p90 -122.32 162.27 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.546 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -101.07 149.98 23.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.27 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -164.89 131.29 2.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 53.85 28.81 8.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.05 67.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -107.74 129.0 55.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -1.207 . . . . 0.0 109.401 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -80.12 124.44 28.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 73.9 mttt -124.21 169.91 11.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.551 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 37.7 p90 -142.5 154.58 44.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.505 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 29.7 m -130.53 139.19 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.885 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -108.67 126.96 53.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -125.89 140.4 52.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.588 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 36.4 tttm -121.39 148.95 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.32 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 50' ' ' GLY . 57.7 mt -108.6 132.09 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.2 mt-10 -88.29 -36.43 16.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 109.355 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -175.16 150.27 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.73 136.38 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -132.81 78.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 45.9 mt-10 -57.23 -39.41 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.5 -46.99 57.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.925 . . . . 0.0 109.421 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.494 ' HB3' ' NZ ' ' A' ' 102' ' ' LYS . 47.2 m-20 -93.77 13.68 21.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.281 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.6 mt 47.03 35.87 3.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.98 154.22 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.9 p90 -150.71 169.72 20.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 109.068 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 72.5 m -129.72 139.51 51.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.674 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.612 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.9 p90 -153.27 158.7 42.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 91.1 p -148.04 157.71 43.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.6 p -97.08 125.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.285 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.48 2.47 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.885 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -164.59 154.33 25.09 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 113.9 159.14 13.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -13.42 32.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.115 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.45 9.33 7.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.596 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.59 122.41 42.0 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.371 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.0 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 51.1 Cg_endo -70.5 145.2 52.22 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.691 2.261 . . . . 0.0 111.826 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -79.76 -32.28 40.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -80.18 -2.77 46.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.0 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.0 117.98 25.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.967 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -49.94 -43.64 50.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 14.3 pttt -176.85 161.46 2.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.6 mt -122.65 134.04 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 50.8 m -107.89 129.81 55.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.612 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.8 m-85 -113.78 123.6 50.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.9 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -123.0 101.57 7.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.017 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.446 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 4.3 m -113.31 145.89 40.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.035 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.778 ' O ' HD23 ' A' ' 103' ' ' LEU . 19.4 tttt -123.27 158.39 31.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 102' ' ' LYS . 77.0 mt -138.93 129.91 26.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.006 . . . . 0.0 110.139 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -142.83 169.68 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 0.0 108.979 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.639 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.32 137.47 39.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 109.516 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.89 161.09 19.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.62 -0.45 6.82 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.689 2.26 . . . . 0.0 111.74 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.93 -23.43 41.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.31 12.52 33.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.96 -146.43 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.45 145.89 24.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.661 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.78 143.13 28.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.363 -0.835 . . . . 0.0 109.197 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.16 -161.12 26.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 116' ' ' THR . 2.1 tt -116.73 136.78 52.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.7 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.801 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.0 m -123.27 127.72 48.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.28 129.06 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 97' ' ' ILE . 87.3 tttt -114.45 120.77 41.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.323 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.839 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.4 t80 -112.45 119.24 37.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.9 mt-10 -99.77 146.47 26.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 127' ' ' PRO . 66.2 p -123.8 160.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -52.74 -43.55 65.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.17 -82.14 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 18.1 p30 -76.78 -15.38 59.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.6 138.04 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' OE1' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -134.92 111.25 11.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 50.3 Cg_endo -70.89 140.35 38.24 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.729 2.286 . . . . 0.0 111.795 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.92 156.6 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -53.37 -34.78 58.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -59.05 -45.99 89.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 68.8 mm-40 -60.32 -41.5 93.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.797 HD13 ' CE2' ' A' ' 5' ' ' PHE . 54.2 mt -60.88 -38.64 86.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.377 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -71.44 -37.53 71.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 58.8 m -58.72 -42.16 88.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.26 -32.03 71.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -68.99 -40.44 78.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.327 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.17 -37.02 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -66.65 -42.95 85.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.306 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.79 -50.2 67.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.839 . . . . 0.0 109.285 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' PHE . 86.7 m-20 -56.37 -33.25 65.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.339 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.25 -54.46 40.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.34 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.7 mm? -76.34 -32.3 58.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' ASP . 86.6 t80 -63.15 -50.79 69.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.381 -0.825 . . . . 0.0 109.259 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -62.4 -34.5 76.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.92 -44.38 82.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.058 HG23 HG21 ' A' ' 29' ' ' VAL . 26.6 mt -67.59 -46.59 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.341 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 38.3 mt-10 -64.65 -40.38 95.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.855 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.38 71.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 18.6 t80 -69.29 -43.24 74.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.887 . . . . 0.0 109.351 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 HD12 ' A' ' 18' ' ' LEU . 8.1 mp -70.56 -35.81 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.92 -37.28 64.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.616 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.63 -15.21 61.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -131.49 91.06 35.63 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -16.42 33.95 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.719 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -78.29 -9.63 59.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.72 142.09 15.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.737 HG22 ' HG3' ' A' ' 120' ' ' GLU . 91.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 59.9 m-85 -79.85 126.63 31.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.719 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.3 m -123.16 116.45 23.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 90.9 m-85 -103.8 167.09 10.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -140.81 130.92 24.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -139.87 165.37 27.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.31 140.92 37.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 70.3 mt -106.62 141.54 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.559 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -142.9 128.88 19.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.418 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 14.8 m -152.77 134.63 8.64 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 -0.78 7.76 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 111.679 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.4 p -92.51 149.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.494 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' GLY . . . -61.73 133.79 93.71 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.685 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 47.0 Cg_endo -68.34 -26.84 34.84 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.759 2.306 . . . . 0.0 111.695 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.67 -39.28 57.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.695 HG23 ' OXT' ' A' ' 157' ' ' ASN . 15.6 m -75.52 -43.49 48.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 150' ' ' LEU . 3.8 tp -70.81 -39.81 72.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.1 t80 -66.83 -41.69 87.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HE3' HG21 ' A' ' 24' ' ' THR . 30.7 tptt -66.34 -46.3 77.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.8 -24.49 59.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.203 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.916 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 16.3 tp -66.44 -49.62 66.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.19 -46.21 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.763 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -67.66 -48.35 66.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.651 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.4 m-20 -94.2 6.36 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.95 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -45.89 -52.57 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 19.6 t70 -67.06 -26.27 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.747 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.3 m-20 -87.12 -27.04 23.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.125 -0.985 . . . . 0.0 109.73 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG21 HG23 ' A' ' 146' ' ' ILE . 8.3 p -81.94 -35.54 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.619 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.95 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.1 mt -52.58 -47.49 93.69 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.324 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.2 Cg_endo -67.07 -17.39 50.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.352 2.035 . . . . 0.0 112.057 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 19.5 mttm -107.5 -35.78 6.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.471 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.44 -41.74 88.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 109.175 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 57' ' ' PHE . 45.7 tp -86.69 109.05 18.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -57.51 -43.45 84.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.29 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -91.23 29.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.804 ' HA ' HD23 ' A' ' 34' ' ' LEU . 66.1 t80 -60.73 127.18 30.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.117 -0.99 . . . . 0.0 109.502 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.734 ' HD3' HD23 ' A' ' 58' ' ' LEU . 41.3 mtmt -96.38 -49.85 5.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 109.551 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -178.15 170.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -138.81 141.81 38.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 34.4 t30 -77.63 129.67 35.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.445 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -79.85 -41.3 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 45' ' ' GLY . 81.8 tt0 -167.46 157.53 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.498 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.42 173.31 33.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.09 3.9 22.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -1.164 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.04 -9.13 25.15 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.62 -160.77 26.44 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.15 125.41 11.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.616 2.211 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 100.29 0.06 55.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.543 HG23 ' HA3' ' A' ' 45' ' ' GLY . 62.6 m -75.67 152.54 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 51' ' ' THR . 27.3 mm -115.78 125.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.854 . . . . 0.0 109.186 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 87.4 mttt -118.7 143.92 46.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.897 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.2 tttt -115.54 128.48 56.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 66' ' ' VAL . 66.2 mt -115.03 133.37 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -112.78 124.97 53.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.842 ' HB2' HD21 ' A' ' 34' ' ' LEU . 53.2 p90 -134.38 161.19 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.734 HD23 ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -101.73 135.94 42.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.368 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -137.51 128.43 27.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.586 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 50.77 22.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.546 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.02 59.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 58' ' ' LEU . 85.0 mt-10 -117.06 140.67 49.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -1.089 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.703 HG23 ' NZ ' ' A' ' 38' ' ' LYS . 86.6 m -81.22 111.69 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -128.03 164.65 21.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE1' HD13 ' A' ' 67' ' ' LEU . 10.8 p90 -149.66 165.6 31.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 67' ' ' LEU . 25.8 m -137.13 146.28 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.695 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.5 mp -115.32 134.57 55.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -131.19 144.32 51.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 31.9 tttt -125.42 150.21 47.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLY . 63.1 mt -106.48 133.07 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 81' ' ' SER . 3.8 pt-20 -107.53 -29.83 8.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.788 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 22.7 t -158.96 139.79 12.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.052 -1.03 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 70' ' ' ILE . 65.4 mt -128.39 131.57 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.078 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -131.99 81.73 1.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.284 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.1 -34.78 75.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.49 81.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -89.59 12.12 17.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.8 mt 50.03 28.96 3.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.42 149.31 17.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 20.7 p90 -150.98 169.06 22.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.133 . . . . 0.0 109.04 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.505 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 42.3 m -135.84 141.4 44.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 26.6 p90 -154.28 160.47 41.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.341 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -142.46 155.59 45.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 67' ' ' LEU . 6.1 p -90.9 132.87 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 109.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' HD13 ' A' ' 90' ' ' LEU . 6.0 m -113.46 0.47 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 90' ' ' LEU . . . 179.26 171.3 42.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.66 171.35 24.59 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.72 -17.03 31.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.21 59.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' C ' ' A' ' 85' ' ' VAL . 1.1 tp -94.93 106.0 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.12 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.26 148.35 61.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.706 2.271 . . . . 0.0 111.781 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 80.6 m-20 -79.36 -32.95 43.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.82 . . . . 0.0 109.561 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 p -80.27 3.77 19.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.717 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.12 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.21 131.94 44.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.072 -1.018 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 89.6 mt-10 -59.73 -43.64 94.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 12.3 pttp -179.11 163.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.0 mt -122.68 133.39 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 28.7 m -105.88 136.8 44.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.299 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.5 m-85 -116.49 122.12 43.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 20.9 t70 -118.79 102.25 8.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -116.04 138.4 51.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.784 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.749 ' C ' HD22 ' A' ' 103' ' ' LEU . 54.5 tttm -131.49 141.02 49.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.119 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.0 mm? -123.67 129.13 50.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 0.0 109.608 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 112' ' ' ALA . 1.6 m -89.06 146.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 15' ' ' PRO . . . -78.4 103.71 8.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.634 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.67 137.47 19.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.47 -16.84 34.63 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.728 2.285 . . . . 0.0 111.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.5 -2.97 50.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . 104.26 -29.93 11.1 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.38 171.42 8.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 53.0 p -126.4 137.48 53.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.07 139.56 26.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -168.78 -157.09 11.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -131.69 144.54 51.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 116' ' ' THR . 1.3 tt -119.13 128.19 54.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 115' ' ' LEU . 24.6 m -116.73 129.97 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.349 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 136' ' ' LYS . 58.3 t -112.26 128.12 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.55 ' CG ' HG11 ' A' ' 2' ' ' VAL . 18.5 tttt -115.81 119.62 36.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.4 t80 -110.0 118.67 37.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.141 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.737 ' HG3' HG22 ' A' ' 2' ' ' VAL . 78.4 tt0 -102.14 146.32 28.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.1 p -117.78 167.15 11.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 40.7 mttt -55.41 -32.63 62.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.67 -102.15 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -59.34 -19.82 49.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.44 132.71 48.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -133.49 107.89 12.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.2 146.91 58.83 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.655 2.237 . . . . 0.0 111.776 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -60.3 161.23 7.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.579 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -65.83 -36.45 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.45 -42.5 98.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.21 -40.0 80.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 85.8 mt -64.86 -39.28 93.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -68.13 -46.28 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.42 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.6 m -57.82 -36.51 72.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.08 99.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HG3' HG21 ' A' ' 117' ' ' VAL . 21.5 tttm -64.63 -37.81 88.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.515 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.64 -28.19 53.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -63.59 -45.62 89.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.06 90.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 80.8 m-20 -53.98 -33.74 57.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.71 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 142' ' ' LEU . 3.3 tm? -77.79 -45.15 25.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -55.01 -53.14 59.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 45.3 mttm -54.85 -37.87 66.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.37 -53.51 56.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 22' ' ' LEU . 29.7 mt -68.02 -42.97 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -61.32 -44.64 96.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.98 71.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 26.7 t80 -68.44 -42.5 78.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 18' ' ' LEU . 6.9 mp -67.33 -41.85 84.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.65 -35.0 79.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.419 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.74 -13.41 59.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.84 86.8 57.03 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -20.17 33.47 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 111.788 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -75.85 -15.82 60.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.756 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 66.0 t80 -59.04 141.65 53.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.695 ' OXT' HG23 ' A' ' 17' ' ' THR . 98.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.537 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HE3' ' A' ' 118' ' ' LYS . 92.7 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.18 145.03 48.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -125.2 131.74 53.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.867 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.716 ' CE2' HD12 ' A' ' 132' ' ' LEU . 75.6 m-85 -126.71 156.18 41.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -128.01 132.62 49.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.23 165.13 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -99.56 152.06 20.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.0 mt -120.05 136.78 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 96.0 m-20 -139.13 134.25 32.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.5 126.44 4.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HD2' ' OE2' ' A' ' 147' ' ' GLU . 49.6 Cg_endo -70.22 -5.02 15.52 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.728 2.285 . . . . 0.0 111.81 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.81 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.398 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 126.37 65.83 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.4 Cg_endo -68.23 -24.06 38.33 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.762 2.308 . . . . 0.0 111.834 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.46 64.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.625 HG23 ' C ' ' A' ' 157' ' ' ASN . 89.7 m -76.91 -36.22 56.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' CE1' ' A' ' 143' ' ' PHE . 18.5 tp -70.24 -39.6 74.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.49 -44.22 87.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.874 ' HE2' HG21 ' A' ' 24' ' ' THR . 22.4 tptm -66.15 -46.33 77.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.02 -20.59 60.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.375 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.927 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 42.3 tp -73.56 -49.1 28.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.655 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.96 -47.47 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.748 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.874 HG21 ' HE2' ' A' ' 20' ' ' LYS . 1.4 m -65.78 -46.94 76.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' VAL . 7.6 m-20 -98.51 9.35 43.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.822 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.31 -53.23 11.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.414 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' OD1' HG11 ' A' ' 40' ' ' VAL . 54.5 t0 -68.41 -24.78 64.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.717 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.9 m120 -87.23 -26.78 23.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.59 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 146' ' ' ILE . 9.0 p -82.66 -36.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.5 mt -51.29 -47.99 86.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.3 Cg_endo -68.43 -21.63 40.3 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.352 2.035 . . . . 0.0 111.923 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 40.6 mttm -96.27 -35.15 11.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.293 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.38 -39.47 74.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 57' ' ' PHE . 15.9 tp -88.73 106.66 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.32 -29.8 66.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -104.54 27.93 7.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 109.95 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' ' 39' ' ' SER . 20.2 t80 -56.74 127.84 33.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.153 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -92.31 -52.37 4.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -178.28 171.3 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 0.0 109.838 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.93 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.9 p -142.62 140.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 109.227 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 85.2 mt-10 -151.33 143.74 24.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 70.0 m-20 -84.09 127.38 33.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -83.82 -29.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 94.9 mt-10 -156.72 142.43 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 104.33 162.59 24.49 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -102.9 3.29 36.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 109.53 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.42 -14.9 13.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.7 -161.11 6.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.75 148.42 58.61 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.653 2.235 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 9.39 84.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 52' ' ' ILE . 25.0 m -79.98 157.24 26.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 109.545 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 15.6 mm -116.94 124.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.5 mttm -116.78 143.02 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.687 ' HG3' HD11 ' A' ' 67' ' ' LEU . 20.3 tttm -117.42 129.29 55.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.316 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.93 ' CD1' HG23 ' A' ' 40' ' ' VAL . 11.9 mm -115.12 144.52 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 m -126.22 126.03 43.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.592 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.743 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.8 p90 -129.78 175.22 9.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 57' ' ' PHE . 4.3 mm? -110.04 147.42 33.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 109.543 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -156.58 123.03 5.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 54.34 33.01 17.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.06 4.72 63.68 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -102.37 138.17 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.389 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.5 m -86.38 119.99 27.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -125.44 167.92 14.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.726 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.3 p90 -147.71 161.73 40.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.619 HG13 ' HE1' ' A' ' 57' ' ' PHE . 28.7 m -134.64 143.78 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.321 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 65' ' ' PHE . 5.4 mp -112.57 131.57 55.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -126.27 139.66 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 tttt -118.03 146.72 43.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -108.72 130.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.9 mt-10 -88.94 -33.33 17.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -177.49 157.65 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.16 132.99 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -129.48 78.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.2 mt-10 -64.84 -30.08 71.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -48.98 79.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.377 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 54.5 m-20 -89.86 14.25 12.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 16.2 mt 47.18 52.58 11.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.486 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -153.75 156.56 26.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.4 p90 -150.9 169.85 20.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.0 109.018 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 70.1 m -130.11 139.33 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.89 158.42 40.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 94.8 p -146.35 156.48 43.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG12 HD23 ' A' ' 90' ' ' LEU . 93.0 t -86.11 132.87 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.954 . . . . 0.0 109.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 4.8 t -109.48 -2.73 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.8 42.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.9 175.56 24.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.06 65.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -1.182 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.13 -11.92 59.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.721 HD23 HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -99.68 108.73 52.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.343 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.987 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.8 Cg_endo -69.88 152.91 68.86 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.69 2.26 . . . . 0.0 111.935 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 83.7 m-20 -79.43 -30.12 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.437 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 15.8 p -79.99 7.1 9.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.15 131.29 42.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.489 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 91.9 mt-10 -61.08 -44.05 97.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HA ' HD21 ' A' ' 90' ' ' LEU . 3.8 pttm 179.74 159.21 0.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.942 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' SER . 70.3 mt -118.38 135.7 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.676 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.9 m -107.41 138.76 43.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 76.6 m-85 -119.76 120.25 35.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.564 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -116.25 113.95 23.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.093 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.512 ' OG ' ' CD1' ' A' ' 115' ' ' LEU . 2.6 m -128.13 136.38 51.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.562 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 47.6 tttt -132.78 124.5 28.19 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 53.2 mt -108.57 132.9 53.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.062 -1.023 . . . . 0.0 110.266 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.8 143.05 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.06 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.34 141.17 51.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.47 166.03 22.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.4 -4.94 15.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.622 2.215 . . . . 0.0 111.792 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.98 -27.36 66.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.82 23.42 11.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -149.96 -131.1 1.87 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.511 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 68.9 m -118.73 143.98 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.3 166.06 25.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.274 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 164.86 -177.6 40.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 28.2 ttpt -123.24 143.25 50.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -1.089 . . . . 0.0 109.396 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HB2' HD11 ' A' ' 9' ' ' ILE . 30.2 tp -116.5 135.3 53.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -124.25 125.93 45.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.94 132.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.598 ' HE3' HG11 ' A' ' 2' ' ' VAL . 23.6 tttt -116.43 116.04 26.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.676 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 33.3 t80 -105.9 122.09 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 90.9 mt-10 -105.63 141.44 37.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.658 HG21 ' CD ' ' A' ' 127' ' ' PRO . 16.6 p -118.29 164.61 14.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -0.978 . . . . 0.0 109.552 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 92.7 mttt -56.99 -40.06 75.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.45 -92.22 0.11 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -37.2 83.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -1.175 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.43 135.58 39.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.29 109.83 15.09 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.658 ' CD ' HG21 ' A' ' 121' ' ' THR . 51.3 Cg_endo -70.24 124.29 10.75 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.675 2.25 . . . . 0.0 111.875 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -60.04 161.05 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.42 -36.15 80.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -56.03 -31.43 63.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.03 -34.95 61.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.271 -0.893 . . . . 0.0 108.729 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.716 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.53 -39.29 90.51 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -60.22 -48.31 82.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.5 m -57.22 -36.75 71.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.3 99.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -60.37 -37.1 79.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -1.091 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.72 -30.43 61.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.252 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -66.0 -44.86 83.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.21 -55.41 10.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.9 -34.92 63.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.97 75.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.276 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 146' ' ' ILE . 29.8 mt -74.94 -44.0 50.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.91 ' CE1' HD21 ' A' ' 18' ' ' LEU . 73.9 t80 -61.62 -55.78 26.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.166 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -49.49 -46.73 48.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.303 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.94 77.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.153 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 29' ' ' VAL . 34.3 mt -67.11 -44.11 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.251 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 12' ' ' PRO . 80.0 tt0 -60.46 -44.91 95.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -31.11 70.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.21 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 21.6 t80 -66.79 -38.88 87.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.85 . . . . 0.0 109.303 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.512 HD22 ' CD1' ' A' ' 18' ' ' LEU . 7.5 mp -72.86 -40.85 65.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.18 -37.78 78.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.51 -15.84 60.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.382 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -126.7 90.25 50.17 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.1 -18.91 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.61 2.207 . . . . 0.0 111.793 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -74.12 -12.68 60.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 63.8 t80 -80.01 125.48 29.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.625 ' C ' HG23 ' A' ' 17' ' ' THR . 8.5 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.412 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 118' ' ' LYS . 89.4 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.316 0.579 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.61 149.53 42.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.7 m -129.81 128.84 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 0.0 109.428 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.734 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.4 m-85 -119.81 163.34 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -135.59 133.81 38.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.411 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.29 166.09 25.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.15 151.17 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.508 HG21 HD11 ' A' ' 103' ' ' LEU . 65.1 mt -114.36 128.22 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -128.95 127.61 42.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 13' ' ' VAL . 75.7 m -153.43 132.92 7.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -19.0 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.677 2.251 . . . . 0.0 111.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 18' ' ' LEU . 2.2 p -70.39 153.1 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.545 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 139.77 97.73 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.22 -26.78 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.81 2.34 . . . . 0.0 111.91 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.52 -39.24 53.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -79.76 -41.85 25.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.77 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.757 HD13 HG11 ' A' ' 13' ' ' VAL . 3.9 tp -67.15 -38.5 85.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.401 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 79.0 t80 -70.63 -36.4 73.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.9 tptt -67.17 -47.21 71.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 109.781 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -72.27 -40.13 67.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.836 ' CD1' HD13 ' A' ' 146' ' ' ILE . 64.5 tp -53.33 -45.66 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -97.3 -53.63 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.974 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.575 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.1 m -66.38 -50.09 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.694 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -92.44 19.66 6.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -60.46 -51.61 68.71 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.155 -0.966 . . . . 0.0 109.143 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.87 ' HA ' HD12 ' A' ' 30' ' ' ILE . 86.6 m-20 -66.69 -31.24 71.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.648 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 75.2 m-20 -83.23 -29.57 28.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 25' ' ' ASP . 77.4 t -78.64 -34.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.0 mt -51.33 -51.71 66.17 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.929 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.9 Cg_endo -68.39 -34.87 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.552 2.168 . . . . 0.0 111.888 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 50.9 mttm -79.95 -40.75 27.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.089 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -65.88 -38.08 87.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.874 . . . . 0.0 108.909 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 57' ' ' PHE . 41.0 tp -87.16 106.0 17.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 108.968 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.11 -28.18 67.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -105.38 27.49 8.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.966 -1.084 . . . . 0.0 109.879 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.807 ' HA ' HD23 ' A' ' 34' ' ' LEU . 44.6 t80 -53.24 125.43 17.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -90.9 -56.22 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.806 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 28.8 p -174.27 166.56 4.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.681 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.69 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 2.9 p -144.79 143.48 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.9 mt-10 -147.17 152.1 37.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.559 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -79.55 131.08 35.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 13.8 t -83.65 -44.38 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.315 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 51' ' ' THR . 80.8 mt-10 -159.38 146.87 17.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 95.59 -175.68 33.11 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -110.73 6.17 21.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' HG21 ' A' ' 51' ' ' THR . . . 109.74 -3.7 30.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.63 -156.35 13.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.24 138.76 37.03 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.741 2.294 . . . . 0.0 111.811 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.46 -4.04 75.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 44' ' ' GLU . 26.1 m -69.18 155.01 41.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 109.566 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 20.4 mm -119.33 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.19 147.35 46.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.846 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.662 ' HG3' HD21 ' A' ' 67' ' ' LEU . 22.4 tttt -116.89 127.35 54.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.22 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 63.7 mt -115.25 145.35 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -0.999 . . . . 0.0 109.848 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 24.0 m -128.1 123.0 33.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.201 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.883 ' HB2' HD21 ' A' ' 34' ' ' LEU . 23.8 p90 -125.53 174.27 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.637 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 57' ' ' PHE . 3.2 mm? -112.63 138.25 49.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE1' ' HE3' ' A' ' 64' ' ' LYS . 75.8 tt0 -148.49 127.76 12.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 53.12 34.62 17.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.77 66.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -107.3 134.14 50.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 m -82.73 116.16 21.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 23.0 mttm -116.74 164.21 14.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 18.5 p90 -145.87 157.75 43.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.7 p -141.2 149.68 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.898 . . . . 0.0 109.618 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 54' ' ' LYS . 48.2 mt -112.6 130.98 55.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.241 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -122.55 136.88 55.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 42.3 tttm -119.08 145.18 46.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.87 127.05 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 93.6 mt-10 -82.46 -53.45 5.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -162.73 137.59 6.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.78 133.73 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.91 . . . . 0.0 109.338 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -129.18 76.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 86.8 mt-10 -54.61 -37.61 65.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.19 57.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 78' ' ' LEU . 64.6 m-20 -90.67 17.0 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.377 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 11.6 mt 43.57 46.24 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.576 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.49 158.9 27.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.5 p90 -152.02 170.04 20.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -1.217 . . . . 0.0 109.131 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 4.7 m -126.3 138.84 53.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -156.06 160.67 40.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 54.8 p -150.41 158.22 43.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.483 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 89' ' ' ALA . 14.5 p -97.41 135.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 109.086 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.1 m -130.16 3.87 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -156.19 146.26 13.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.01 -174.29 16.79 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.17 62.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.85 1.49 30.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -112.9 83.52 6.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.328 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -68.9 163.43 37.48 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.897 2.398 . . . . 0.0 111.998 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 70.1 m-20 -80.12 -32.71 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.912 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 33.9 p -79.55 -11.99 59.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 110.026 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -119.95 127.75 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -62.51 -50.79 70.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -177.33 156.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.42 137.55 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 1.4 m -107.42 138.2 44.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.848 . . . . 0.0 109.135 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.2 m-85 -118.56 120.58 37.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.881 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -117.2 106.39 13.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -115.59 136.13 53.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.773 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.618 ' C ' HD22 ' A' ' 103' ' ' LEU . 20.3 tttt -132.96 131.26 40.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.833 . . . . 0.0 109.123 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 103' ' ' LEU . 1.7 mm? -118.18 127.44 53.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.364 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -120.48 172.58 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -80.25 127.14 32.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.206 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.99 155.54 17.93 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 -1.95 8.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.578 2.185 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -74.11 -15.55 61.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 7.15 63.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.56 -138.08 4.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 103' ' ' LEU . 2.7 t -122.25 140.65 52.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -1.113 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.698 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.42 147.81 31.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.207 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -174.08 -143.63 4.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.05 138.95 32.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.353 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 116' ' ' THR . 3.9 tt -115.31 136.4 53.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.969 ' N ' HD23 ' A' ' 115' ' ' LEU . 14.5 m -125.5 126.89 45.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.35 136.16 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.331 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 2' ' ' VAL . 26.6 tttt -116.07 121.02 40.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.732 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 30.3 t80 -103.58 126.56 50.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HA ' HG22 ' A' ' 2' ' ' VAL . 82.9 mt-10 -109.73 130.94 55.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.5 p -107.4 156.73 18.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 73.5 mmtt -60.13 -37.0 78.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.82 -103.84 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.35 -35.52 72.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -1.187 . . . . 0.0 109.468 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.9 136.98 33.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -149.34 107.66 3.36 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.2 Cg_endo -70.04 151.55 67.52 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.734 2.289 . . . . 0.0 111.699 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -83.22 178.73 7.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 132' ' ' LEU . 92.9 mt-30 -67.89 -35.35 78.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.59 -48.53 80.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -61.14 -39.14 88.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.38 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.734 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 67.0 mt -63.64 -35.79 81.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 26.2 mttt -64.22 -48.53 75.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 138' ' ' LYS . 86.8 m -56.22 -33.24 65.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.343 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.22 -43.13 99.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 140' ' ' ASP . 23.9 tttp -67.14 -39.58 86.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -1.149 . . . . 0.0 109.497 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -31.22 64.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.29 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 134' ' ' THR . 46.3 mttm -77.3 -40.7 43.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.05 -26.41 53.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.825 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 96.9 m-20 -60.78 -41.64 95.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -44.95 82.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 142' ' ' LEU . 23.0 mt -54.71 -46.19 74.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -61.61 -50.26 73.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 148' ' ' ALA . 88.6 mttt -63.22 -33.56 75.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.7 -52.46 64.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.836 HD13 ' CD1' ' A' ' 22' ' ' LEU . 11.7 mt -68.47 -51.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.21 -45.22 91.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.697 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 144' ' ' LYS . . . -59.63 -31.39 69.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.519 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.4 t80 -69.3 -41.14 77.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.64 HD22 HD12 ' A' ' 18' ' ' LEU . 7.8 mp -66.43 -46.3 76.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.636 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.39 -33.79 74.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.96 -11.9 57.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.566 ' CE1' ' CZ ' ' A' ' 149' ' ' TYR . 74.4 m80 -122.06 90.16 48.72 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.26 -21.57 30.95 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.673 2.249 . . . . 0.0 111.767 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -70.87 -17.88 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 42.3 t80 -67.31 158.8 30.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.571 ' O ' HG21 ' A' ' 17' ' ' THR . 74.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.639 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.566 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 97.6 m-85 -81.51 126.87 32.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 117.88 27.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.309 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.944 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.8 m-85 -110.25 164.23 12.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.624 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 88.2 mt-10 -134.05 134.24 42.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -137.09 165.0 27.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -104.13 158.59 16.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 42.3 mt -129.14 137.37 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.71 137.0 34.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.9 OUTLIER -152.58 138.68 11.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.09 0.74 6.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.665 2.243 . . . . 0.0 111.96 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.867 ' CG1' HD11 ' A' ' 18' ' ' LEU . 69.4 t -98.17 155.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.829 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -64.21 127.64 92.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.511 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 44.4 Cg_endo -66.84 -25.51 45.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.801 2.334 . . . . 0.0 111.904 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.928 . . . . 0.0 109.036 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 157' ' ' ASN . 76.5 m -72.7 -38.86 67.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.182 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.867 HD11 ' CG1' ' A' ' 13' ' ' VAL . 2.4 mp -70.29 -38.63 75.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 72.5 t80 -63.92 -50.27 69.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE3' HG21 ' A' ' 24' ' ' THR . 12.2 tptt -65.05 -46.38 81.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.749 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.63 -28.33 63.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.964 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.4 tp -67.01 -47.36 71.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.857 . . . . 0.0 109.67 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -97.96 -51.7 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.576 HG21 ' HE3' ' A' ' 20' ' ' LYS . 2.1 m -62.62 -45.64 91.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.7 m-20 -98.44 6.14 47.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.08 -1.012 . . . . 0.0 109.767 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.964 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -45.96 -53.27 10.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.6 m-20 -67.54 -23.3 65.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.772 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 90.9 m-20 -89.84 -25.79 20.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -83.39 -35.98 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 109.545 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.952 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.3 mt -55.36 -47.07 99.44 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 110.211 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.6 Cg_endo -68.08 -35.97 18.46 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.307 2.004 . . . . 0.0 112.193 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 32.3 mttm -87.91 -29.28 20.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.421 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -69.42 -34.77 74.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.257 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 57' ' ' PHE . 54.5 tp -96.18 113.31 24.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.32 -40.92 92.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.663 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -93.71 26.8 2.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.811 -1.181 . . . . 0.0 110.117 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 30' ' ' ILE . 57.2 t80 -59.91 134.11 56.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.124 -0.985 . . . . 0.0 109.409 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' SER . 33.6 tttm -95.28 -49.12 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.312 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 68.9 p -178.59 172.13 1.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 40' ' ' VAL . 6.0 p -135.91 129.97 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.274 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -135.53 145.47 47.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 109.613 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.97 128.08 34.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 13.9 t -85.17 -41.0 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.673 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 51' ' ' THR . 96.5 mt-10 -158.58 145.44 17.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.601 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 159.04 30.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -94.59 5.36 52.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.93 -9.28 23.28 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.03 -158.66 13.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.05 131.16 20.26 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.644 2.23 . . . . 0.0 111.687 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 93.23 0.44 67.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 44' ' ' GLU . 90.3 m -76.01 154.78 35.5 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.307 -1.114 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 69' ' ' LYS . 71.2 mt -129.89 138.32 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -126.67 152.39 46.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.6 tttm -112.87 125.74 54.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.425 -0.797 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 66' ' ' VAL . 83.9 mt -113.88 142.95 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.2 m -131.36 119.54 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.962 ' HB2' HD21 ' A' ' 34' ' ' LEU . 39.0 p90 -124.5 171.55 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.348 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 145.85 31.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 62' ' ' GLU . 84.9 tt0 -141.84 123.74 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 49.66 27.73 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.66 71.38 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' GLU . 99.6 mt-10 -106.47 157.58 17.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -1.085 . . . . 0.0 109.421 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.2 m -104.94 112.55 25.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.413 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -120.35 162.95 18.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -145.66 158.96 43.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 55' ' ' ILE . 22.4 m -138.31 147.05 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 86' ' ' GLY . 12.8 mt -116.63 137.82 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.065 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.72 141.82 50.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.752 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' HG12 ' A' ' 52' ' ' ILE . 19.4 tttm -117.77 146.41 43.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.87 . . . . 0.0 109.121 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.0 mt -104.75 126.57 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -88.18 -40.19 13.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 t -173.74 150.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.58 132.67 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -127.03 85.51 2.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' OH ' ' A' ' 19' ' ' TYR . 97.0 mt-10 -64.24 -31.69 72.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.85 84.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -89.3 14.86 10.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.539 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 19.4 mt 47.52 51.86 13.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.27 27.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 28.7 p90 -150.96 168.4 24.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 108.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -126.67 138.64 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 19.4 p90 -152.49 155.82 38.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.382 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 t -144.85 156.06 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.624 HG22 HD12 ' A' ' 90' ' ' LEU . 10.0 p -98.52 128.35 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HE2' ' A' ' 96' ' ' LYS . 1.5 t -127.49 4.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.729 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.46 148.48 17.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 128.0 152.29 7.8 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.38 47.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.275 -1.132 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 138' ' ' LYS . . . -79.89 -7.92 59.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -79.81 116.28 59.89 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.3 Cg_endo -68.48 146.6 68.7 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.767 2.311 . . . . 0.0 111.911 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 66.2 m-20 -78.84 -29.57 44.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.632 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 29.4 p -79.82 -7.49 58.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -118.27 123.57 45.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.339 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 86.3 mt-10 -62.28 -52.18 64.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.703 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' A' ' 85' ' ' VAL . 7.4 mtpm? -159.1 161.65 36.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 109.721 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.4 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CE ' ' A' ' 118' ' ' LYS . 8.9 m -109.83 137.58 47.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.95 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 78.8 m-85 -120.23 121.29 38.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 58.5 t0 -117.02 110.51 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.204 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -123.25 136.64 54.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.559 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 75.8 tttt -130.72 127.43 38.78 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.6 mm? -107.62 130.19 54.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.057 -1.027 . . . . 0.0 110.152 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -138.03 143.02 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.03 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 139.52 57.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.104 -0.998 . . . . 0.0 109.718 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.43 22.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.78 -9.71 26.76 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.774 2.316 . . . . 0.0 111.825 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.49 -31.95 68.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.84 27.93 6.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -157.94 -125.16 0.82 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 73.9 m -118.54 144.91 45.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 9' ' ' ILE . . . -143.58 162.49 35.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.763 . . . . 0.0 108.991 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 171.63 176.15 40.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -112.08 141.22 46.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.439 -1.036 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 29.0 tp -116.33 131.62 56.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.519 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 26.0 m -130.0 122.11 27.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -0.926 . . . . 0.0 109.144 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.67 135.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.639 ' CG ' HG21 ' A' ' 2' ' ' VAL . 7.0 ttpt -115.0 116.71 28.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.15 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 36.6 t80 -107.73 120.92 43.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.672 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 98.2 mt-10 -106.32 133.52 50.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.866 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.4 p -109.92 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.4 mttt -54.85 -42.31 71.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.56 -92.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ALA . 82.1 m-20 -69.2 -35.8 76.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -45.03 133.79 6.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -126.24 121.13 23.78 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.866 ' HD3' HG21 ' A' ' 121' ' ' THR . 49.3 Cg_endo -69.96 149.85 66.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.717 2.278 . . . . 0.0 111.743 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.7 m-20 -92.16 155.31 18.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -50.42 -38.33 42.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.24 -48.54 81.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.33 -42.08 90.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.944 HD13 ' CE2' ' A' ' 5' ' ' PHE . 74.3 mt -60.15 -34.52 73.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.46 -46.47 82.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.259 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.5 m -57.4 -36.97 71.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.13 -47.36 91.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 140' ' ' ASP . 11.0 mtmm -57.09 -36.6 70.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -1.146 . . . . 0.0 109.391 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -58.23 -33.49 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 89' ' ' ALA . 69.5 tttt -74.34 -43.14 57.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -69.76 -49.06 56.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 7.5 p30 -68.43 -22.56 64.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -56.86 -48.69 77.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.7 tp -56.39 -35.52 67.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -74.33 -53.23 10.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 109.14 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -52.73 -37.92 59.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 -49.56 56.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.922 HG23 HG21 ' A' ' 29' ' ' VAL . 51.7 mt -63.07 -55.33 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.55 -50.31 13.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.18 -37.82 72.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 41.1 t80 -68.44 -38.13 80.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 18' ' ' LEU . 45.8 mt -59.16 -38.31 79.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mt -75.04 -27.68 60.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.61 61.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -128.5 91.88 42.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.27 -18.06 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.737 2.291 . . . . 0.0 111.747 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -77.26 -17.69 58.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.816 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.8 t80 -67.77 120.09 13.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.541 ' CB ' HG23 ' A' ' 17' ' ' THR . 6.2 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 119' ' ' TYR . 60.0 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -132.07 122.54 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.624 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 117' ' ' VAL . 79.2 m -110.67 144.24 39.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 89.4 m-85 -132.7 132.62 42.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.0 mt-10 -106.14 133.74 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -137.15 164.98 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.385 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.87 157.61 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.4 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.424 HD11 ' OG ' ' A' ' 101' ' ' SER . 14.6 mt -125.65 134.42 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 109.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 97.9 m-20 -140.68 132.87 28.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' OE2' ' A' ' 147' ' ' GLU . 27.3 m -152.78 138.63 11.81 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.52 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.26 -0.45 7.34 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.602 2.201 . . . . 0.0 111.714 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.87 ' HB ' HD11 ' A' ' 18' ' ' LEU . 98.1 t -94.73 153.49 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.6 139.31 97.59 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 46.7 Cg_endo -68.01 -25.77 37.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.734 2.289 . . . . 0.0 111.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.36 -37.6 60.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 157' ' ' ASN . 60.3 m -75.01 -39.39 61.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 13' ' ' VAL . 20.0 mt -68.69 -39.11 80.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 78.0 t80 -64.54 -50.03 68.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.585 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 24' ' ' THR . 8.5 tptm -63.4 -46.43 86.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -73.18 -24.51 60.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 18.4 tp -75.37 -48.83 21.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.686 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.75 -49.89 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.886 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -65.82 -48.83 70.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.957 . . . . 0.0 110.145 -179.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 6.3 t70 -91.01 14.67 13.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.723 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -56.09 -52.16 65.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.263 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 22.1 t70 -66.1 -25.89 67.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.946 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.0 m120 -90.92 -26.06 19.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.601 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' ALA . 8.0 p -83.87 -39.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 109.575 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.7 mt -52.88 -45.46 97.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.63 -21.84 45.04 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.394 2.063 . . . . 0.0 112.242 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' ALA . 41.8 mttm -108.98 -51.77 2.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 109.585 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . -42.28 -33.19 0.59 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.978 HD21 ' HB2' ' A' ' 57' ' ' PHE . 44.8 tp -92.52 112.62 24.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.067 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.4 -47.16 82.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.526 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.9 m -88.38 29.36 0.98 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.915 -1.116 . . . . 0.0 110.173 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 67.2 t80 -61.89 130.54 46.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.505 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' CD ' HD23 ' A' ' 58' ' ' LEU . 3.6 mtpm? -102.42 -48.58 4.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.639 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 37' ' ' PHE . 54.8 p -172.51 164.89 5.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 3.9 p -143.3 141.81 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 109.326 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -144.08 148.36 35.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.61 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -80.64 132.07 35.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 19.0 t -79.99 -42.12 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 51' ' ' THR . 71.2 mt-10 -161.74 149.33 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.72 -168.85 36.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -132.12 35.08 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.742 ' H ' HG21 ' A' ' 51' ' ' THR . . . 91.55 -1.92 76.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 51' ' ' THR . . . -76.73 -168.31 28.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.74 139.88 41.4 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.691 2.261 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 77.14 2.96 80.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 44' ' ' GLU . 85.9 m -69.23 150.44 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.58 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 25.1 mm -114.62 123.44 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -118.06 143.83 46.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.856 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . 86.8 tttt -116.35 128.25 55.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 109.081 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.666 ' HB ' HG22 ' A' ' 66' ' ' VAL . 58.7 mt -114.28 140.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.1 m -119.42 120.74 37.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.216 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.978 ' HB2' HD21 ' A' ' 34' ' ' LEU . 40.5 p90 -131.5 176.02 8.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -116.98 131.2 57.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -137.12 130.96 31.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 55.14 20.83 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.92 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.32 20.55 64.28 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.8 mt-10 -118.28 141.61 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.6 m -80.9 111.79 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 70.7 mttt -121.89 163.06 19.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 36.0 p90 -144.27 158.11 43.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.385 -0.822 . . . . 0.0 109.226 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' HE1' ' A' ' 57' ' ' PHE . 34.1 m -133.55 142.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 109.705 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.86 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.7 mt -111.23 130.55 55.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 109.003 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -126.23 139.83 53.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.146 -0.971 . . . . 0.0 109.71 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -122.52 150.81 42.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.238 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.7 mt -111.46 133.05 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.554 ' OE2' HG21 ' A' ' 98' ' ' THR . 94.0 mt-10 -89.42 -33.57 16.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.243 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -172.82 155.39 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.54 131.86 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.327 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.56 81.51 2.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 78.3 mt-10 -59.18 -36.84 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.29 -41.31 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.634 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 6.4 m-20 -101.1 14.01 33.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.546 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.75 25.98 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.318 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.24 150.73 17.79 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.89 169.16 22.95 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -1.208 . . . . 0.0 109.166 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 61.0 m -130.96 139.01 49.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.98 . . . . 0.0 109.375 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.618 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 14.1 p90 -151.87 154.79 36.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 79.9 p -144.41 155.8 43.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.355 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.1 p -95.8 131.16 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.244 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -124.14 2.04 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.605 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.86 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -163.77 153.38 23.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 117.07 172.13 16.03 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.21 -13.05 62.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -1.099 . . . . 0.0 109.46 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.04 59.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 4.8 tt -100.2 107.22 46.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.991 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.9 Cg_endo -69.43 149.86 69.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.68 2.253 . . . . 0.0 111.912 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 83.6 m-20 -76.76 -28.71 55.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -79.86 6.6 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.7 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.991 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -133.7 142.52 48.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.596 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 122' ' ' LYS . 77.4 mt-10 -69.14 -54.6 14.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -175.64 159.71 2.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.347 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 83' ' ' SER . 55.4 mt -118.18 136.2 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.554 HG21 ' OE2' ' A' ' 71' ' ' GLU . 7.9 m -112.12 117.85 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.126 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.915 ' CD1' HG23 ' A' ' 117' ' ' VAL . 89.0 m-85 -96.28 125.41 40.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.826 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 116' ' ' THR . 89.9 m-20 -117.74 129.3 55.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 109.206 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.8 t -146.63 136.81 23.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 103' ' ' LEU . 28.3 tttt -117.2 159.1 23.17 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 102' ' ' LYS . 33.6 mt -133.42 123.77 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.877 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.66 142.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.24 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.35 57.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.46 166.93 23.25 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.5 -0.05 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.646 2.231 . . . . 0.0 111.821 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -69.37 -28.34 66.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.11 26.78 8.14 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -156.14 -127.16 1.01 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 99.5 p -121.77 142.8 49.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -1.134 . . . . 0.0 109.746 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.57 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 162.95 168.64 25.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -105.29 147.66 27.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.137 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 100' ' ' ASP . 49.6 tp -115.01 136.56 52.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 100' ' ' ASP . 24.6 m -138.78 119.31 13.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.043 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.915 HG23 ' CD1' ' A' ' 99' ' ' PHE . 2.7 p -112.33 138.68 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 110.142 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 31.9 tttt -114.29 120.08 39.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 2' ' ' VAL . 37.4 t80 -102.72 126.82 49.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -111.41 126.65 55.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.353 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 34.2 p -99.91 165.91 11.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 20.4 mmtp -71.01 -36.34 72.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.19 -100.0 0.16 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -65.08 -28.57 69.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.92 137.07 58.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -147.18 112.51 4.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.44 141.33 42.2 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.715 2.277 . . . . 0.0 111.7 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -69.78 168.65 14.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.89 . . . . 0.0 109.55 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HA ' HD12 ' A' ' 132' ' ' LEU . 46.6 tt0 -60.34 -39.64 87.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.882 . . . . 0.0 109.444 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.85 -43.86 97.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.27 -39.34 82.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 25.0 mt -64.65 -36.82 85.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.63 -49.5 76.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 85.5 m -57.45 -32.45 66.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.89 -47.98 86.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . 27.9 ttpp -65.27 -38.32 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -1.133 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -54.41 -28.4 43.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -76.21 -38.18 56.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.453 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.13 -55.08 8.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 3.9 p30 -63.43 -25.05 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -61.22 -53.44 56.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 109.319 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 142' ' ' LEU . 19.0 mt -59.53 -35.21 73.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.15 -52.69 62.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -53.12 -38.42 62.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.39 -39.63 80.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.361 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 mm -62.73 -43.62 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.391 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.463 ' OE2' ' OG ' ' A' ' 11' ' ' SER . 90.6 mt-10 -64.28 -37.27 86.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.53 81.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.401 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 33.9 t80 -70.53 -52.5 21.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 18' ' ' LEU . 9.3 mp -63.77 -36.52 84.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.7 tp -76.1 -36.44 58.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.21 -20.43 61.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -134.38 98.58 13.76 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -11.42 30.22 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 111.788 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.72 -26.66 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.957 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 62.5 t80 -64.43 138.79 58.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' THR . 2.3 p-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.509 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 88.4 m-85 -80.83 120.57 24.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 19.8 m -109.94 117.09 32.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 97.0 m-85 -114.61 142.11 46.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 81.4 tt0 -109.3 133.34 53.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.265 -0.897 . . . . 0.0 109.63 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -130.01 164.41 24.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.58 153.59 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 54.1 mt -119.23 144.2 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 22.7 m120 -142.45 128.88 20.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.64 138.23 11.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.503 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.39 -12.82 32.36 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.702 2.268 . . . . 0.0 111.785 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 HG11 HD12 ' A' ' 150' ' ' LEU . 1.6 p -81.49 152.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 141.69 95.88 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.92 -28.51 35.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.735 2.29 . . . . 0.0 111.747 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.96 -41.39 59.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.3 m -76.21 -37.43 57.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.347 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.719 ' CD1' HD11 ' A' ' 150' ' ' LEU . 11.9 tp -69.15 -39.93 78.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 79.5 t80 -64.89 -44.81 88.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HE2' HG21 ' A' ' 24' ' ' THR . 12.8 tptm -65.18 -46.72 79.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.733 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -73.1 -17.77 61.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.967 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 19.5 tp -79.18 -48.25 14.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.91 -52.22 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.77 HG21 ' HE2' ' A' ' 20' ' ' LYS . 4.3 m -63.39 -49.37 74.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.943 . . . . 0.0 110.208 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m-20 -95.34 8.08 44.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.967 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.61 -53.22 11.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 109.292 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.792 ' HA ' HD12 ' A' ' 30' ' ' ILE . 56.7 t0 -65.07 -24.89 67.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 95.3 m-20 -87.16 -26.81 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 146' ' ' ILE . 98.2 t -82.66 -35.53 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 27' ' ' ASP . 7.0 mt -50.98 -47.84 86.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 110.327 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.8 Cg_endo -67.53 -28.08 38.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.44 2.093 . . . . 0.0 112.183 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -90.73 -45.41 8.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.559 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.4 mp -76.04 102.22 5.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -54.89 -46.25 74.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.871 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 88.4 p -91.51 30.1 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -57.23 122.56 12.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.07 -53.56 4.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.675 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 34.9 p -174.9 167.89 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.752 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.828 HG22 HG23 ' A' ' 55' ' ' ILE . 99.6 t -143.92 143.91 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.148 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.8 mt-10 -155.0 158.4 39.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 73.2 m-20 -96.65 124.9 40.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 6.8 m -82.01 -27.9 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 56.9 mm-40 -161.33 151.26 17.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.87 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.749 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 105.09 168.61 24.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -121.68 27.43 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -1.197 . . . . 0.0 109.62 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.97 -19.05 56.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.38 -169.18 28.72 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.95 140.97 43.26 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 111.71 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 88.64 5.64 74.44 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.749 HG23 ' HA3' ' A' ' 45' ' ' GLY . 59.6 m -75.12 150.78 38.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -1.153 . . . . 0.0 109.759 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 17.2 mm -112.5 123.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 108.994 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.4 mttm -119.76 144.67 47.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.853 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.705 ' HG3' HD11 ' A' ' 67' ' ' LEU . 2.2 ttmt -120.41 133.78 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.133 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.828 HG23 HG22 ' A' ' 40' ' ' VAL . 74.8 mt -123.91 143.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 36.0 m -124.63 122.26 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 43.1 p90 -127.24 165.84 18.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 1.2 mp -100.23 143.29 30.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.4 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -156.19 131.81 9.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 56.41 28.39 13.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.69 0.49 63.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 49.2 tp10 -107.24 138.95 42.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -1.186 . . . . 0.0 109.537 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.4 m -86.03 124.94 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 34.0 mttp -128.63 172.47 11.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.798 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.5 p90 -147.31 161.32 41.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.516 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.605 ' O ' HD12 ' A' ' 67' ' ' LEU . 32.6 m -135.53 145.05 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.43 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.798 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.4 mp -114.49 133.02 56.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.923 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -132.04 145.32 51.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 16.1 tttm -124.5 146.55 48.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 7.0 mm -101.58 131.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.3 pt-20 -103.5 -32.68 9.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.995 . . . . 0.0 109.828 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 35.9 t -165.78 138.43 4.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.909 -1.119 . . . . 0.0 109.955 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.35 136.25 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 91.4 m-20 -130.69 83.18 2.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.43 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.4 mt-10 -63.67 -34.58 78.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.05 67.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.286 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -87.26 12.59 11.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 8.7 mt 48.02 37.25 7.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.474 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -132.64 151.96 20.13 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -151.63 166.44 31.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.065 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 71' ' ' GLU . 29.0 t -137.37 143.17 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.2 p90 -153.05 160.62 42.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.339 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 t -139.12 153.8 48.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 67' ' ' LEU . 14.4 p -85.1 133.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 10.0 t -109.97 -4.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.49 43.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.05 164.27 15.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.59 -14.25 12.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -1.126 . . . . 0.0 109.452 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 138' ' ' LYS . . . -81.89 -12.08 58.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.64 115.34 60.23 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.978 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.08 147.56 61.11 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.677 2.252 . . . . 0.0 111.829 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.48 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 90.6 m-20 -79.57 -31.93 41.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.615 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 p -83.79 3.74 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.715 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.43 143.23 49.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 109.624 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' OE2' ' HG2' ' A' ' 122' ' ' LYS . 62.6 mm-40 -69.27 -51.57 36.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.421 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -171.28 163.09 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.548 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.4 mt -120.56 137.21 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -108.21 126.8 53.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.2 m-85 -108.3 125.81 52.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 115' ' ' LEU . 25.6 t0 -120.11 102.81 8.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.188 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 9' ' ' ILE . 34.1 t -111.95 142.15 44.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.842 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.3 tttm -127.1 146.71 50.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 108.896 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.842 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.5 mm? -125.69 129.75 50.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.855 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 112' ' ' ALA . 1.2 m -143.91 167.31 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 109.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.585 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -74.92 133.94 41.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.22 163.21 16.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.75 -3.96 13.06 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.628 2.219 . . . . 0.0 111.689 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.15 -23.84 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.87 24.98 10.07 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.71 -138.44 2.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -99.13 145.14 27.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.686 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.79 140.62 24.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.113 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -175.84 -170.58 38.8 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.422 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mttt -127.11 139.36 53.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -1.119 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.87 HD23 ' N ' ' A' ' 116' ' ' THR . 3.0 tt -114.31 137.73 51.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.87 ' N ' HD23 ' A' ' 115' ' ' LEU . 13.9 m -114.3 133.4 55.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 4' ' ' THR . 96.2 t -109.26 127.72 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.55 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 97' ' ' ILE . 37.5 tttp -115.09 122.24 45.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 42.8 t80 -117.59 115.32 24.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 95.7 mt-10 -103.61 140.36 37.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 17.5 p -106.49 165.77 11.03 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.612 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 75.1 mttt -73.85 -34.01 64.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.48 -145.91 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.14 -13.04 61.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.197 . . . . 0.0 109.468 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.69 130.16 24.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.07 131.49 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.7 Cg_endo -70.06 157.5 59.59 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.771 2.314 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.476 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 1.5 m-20 -86.94 175.15 8.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -71.13 -41.51 70.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -57.63 -47.13 83.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 69.4 mm-40 -58.03 -41.07 82.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' A' ' 5' ' ' PHE . 89.7 mt -62.55 -44.95 95.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -61.27 -46.41 90.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.335 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -58.99 -40.75 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.01 97.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -66.92 -39.84 87.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.338 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.85 80.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 109.284 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 39.8 mttm -60.78 -52.89 63.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.37 -56.07 6.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 52.0 t0 -50.04 -26.73 4.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.652 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.64 75.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 146' ' ' ILE . 1.3 tp -59.0 -45.53 90.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.199 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.474 ' HE1' HD21 ' A' ' 18' ' ' LEU . 68.7 t80 -68.6 -34.82 76.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.38 -0.825 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 85.6 mttt -64.04 -44.85 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.16 68.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.917 . . . . 0.0 109.312 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 29' ' ' VAL . 71.0 mt -58.6 -54.32 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -46.07 -53.74 9.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.85 69.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.877 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -65.7 -32.77 74.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.306 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 18' ' ' LEU . 17.1 mt -70.28 -44.33 68.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.372 -0.83 . . . . 0.0 109.529 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.11 -34.5 78.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.62 61.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -130.1 83.23 63.94 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.48 -19.34 37.58 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.682 2.255 . . . . 0.0 111.726 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -93.92 16.36 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.425 ' HE2' ' HB2' ' A' ' 21' ' ' ALA . 61.7 t80 -60.75 135.61 57.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.551 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.0 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.268 0.556 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.42 135.77 51.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.9 m -116.89 130.49 56.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 132' ' ' LEU . 83.7 m-85 -128.78 158.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -133.15 139.76 47.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.461 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -142.33 165.71 26.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -108.29 150.15 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 52.9 mt -115.02 142.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.399 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 40.5 m-20 -134.69 129.43 34.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 m -151.9 129.16 5.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.68 0.15 6.78 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.753 2.302 . . . . 0.0 111.693 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.09 152.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.643 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 134.42 91.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.19 -29.57 32.58 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.74 2.293 . . . . 0.0 111.935 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.11 -37.24 61.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 HD22 ' A' ' 157' ' ' ASN . 39.7 m -80.13 -40.4 27.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 150' ' ' LEU . 3.8 tp -68.38 -38.29 81.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 84.4 t80 -71.2 -36.61 71.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.923 . . . . 0.0 109.773 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 24' ' ' THR . 48.6 tptt -68.92 -47.24 66.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.842 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -75.9 -37.19 59.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.485 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 22.7 tp -52.87 -47.18 68.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.7 t -97.48 -53.34 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 110.077 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.544 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -63.64 -47.17 82.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.162 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.781 ' HB3' HG23 ' A' ' 29' ' ' VAL . 15.2 m-20 -95.62 17.64 14.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.004 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -66.34 -47.27 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.2 t0 -69.27 -29.08 66.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.94 . . . . 0.0 109.936 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -91.08 -31.61 16.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.963 . . . . 0.0 109.705 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' ASP . 77.6 t -80.4 -42.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 26' ' ' ALA . 42.0 mt -49.49 -51.86 54.91 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.381 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.7 Cg_endo -68.83 -46.69 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.532 2.154 . . . . 0.0 112.638 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -79.92 -44.68 19.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.0 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -48.13 -36.03 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 36' ' ' SER . 14.5 tp -142.65 133.55 25.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.74 -26.73 50.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.145 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.897 ' HB3' HD21 ' A' ' 34' ' ' LEU . 3.0 t -54.01 -36.82 63.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.661 ' HE1' HG23 ' A' ' 55' ' ' ILE . 62.8 t80 -52.74 135.74 34.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.428 -0.795 . . . . 0.0 109.124 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HE2' HD21 ' A' ' 58' ' ' LEU . 9.9 mttm -90.17 -54.82 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.487 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 1.7 t -178.9 172.34 1.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.972 HG23 ' CD1' ' A' ' 55' ' ' ILE . 10.9 p -139.07 134.75 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.776 . . . . 0.0 109.268 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -142.45 148.31 37.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 81.7 m-20 -92.18 119.39 31.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.6 m -80.13 -31.18 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.924 . . . . 0.0 109.456 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' THR . 79.4 tt0 -157.09 143.71 18.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.436 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.77 164.79 32.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -100.57 6.51 44.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 109.71 -8.67 32.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.25 -158.79 14.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 129.92 18.03 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.618 2.212 . . . . 0.0 111.718 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.36 3.66 69.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.862 ' O ' HD13 ' A' ' 52' ' ' ILE . 8.3 m -80.04 158.16 26.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -1.135 . . . . 0.0 109.697 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 51' ' ' THR . 13.9 mm -124.12 133.32 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 45.4 mtmt -129.02 153.96 47.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 78.9 tttt -111.89 121.92 46.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.281 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.972 ' CD1' HG23 ' A' ' 40' ' ' VAL . 5.5 mm -106.35 138.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 43.2 m -131.65 120.25 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -134.23 175.01 9.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' HE2' ' A' ' 38' ' ' LYS . 1.8 mm? -103.15 139.23 38.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 83.1 tt0 -148.94 130.63 15.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 52.8 37.45 24.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.26 8.84 52.59 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.08 126.03 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' ' HE3' ' A' ' 38' ' ' LYS . 79.1 m -72.34 119.21 16.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' A' ' 59' ' ' GLU . 64.7 mttm -119.6 167.29 12.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 23.1 p90 -144.68 156.63 44.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.368 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.651 HG13 ' HB ' ' A' ' 55' ' ' ILE . 3.1 p -143.43 152.01 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.781 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG22 ' A' ' 85' ' ' VAL . 12.3 mt -110.72 127.62 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -114.64 131.04 56.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.784 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 20.4 tttt -113.13 134.02 54.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 108.983 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' GLY . 46.5 mt -97.94 127.73 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 93.5 mt-10 -89.63 -33.25 16.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.224 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 81' ' ' SER . 65.3 p -174.86 154.75 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.88 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.68 84.34 2.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.333 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.39 -40.2 81.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.55 60.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.51 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 93.1 m-20 -94.39 14.63 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.9 mt 44.35 27.62 0.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.68 157.98 18.19 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 31.7 p90 -150.84 170.07 20.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 109.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 72' ' ' SER . 3.0 p -120.3 137.63 54.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 99' ' ' PHE . 19.7 p90 -152.91 156.67 39.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 77.3 p -148.02 158.19 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.605 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 90' ' ' LEU . 39.7 t -91.95 130.1 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.2 m -118.92 -0.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.148 -0.97 . . . . 0.0 110.0 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.02 163.1 34.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.48 169.4 14.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.4 62.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -1.128 . . . . 0.0 109.305 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.14 -14.67 58.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 84' ' ' VAL . 6.5 tt -84.2 114.45 54.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.371 -0.83 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.025 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.0 Cg_endo -69.8 143.56 51.03 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.657 2.238 . . . . 0.0 111.757 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 73.9 m-20 -74.88 -28.47 60.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.554 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 19.5 p -79.87 2.62 22.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.961 . . . . 0.0 109.689 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.025 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.27 132.94 50.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 109.548 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.68 -43.97 87.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -176.28 159.0 1.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.2 mt -122.97 133.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 59.0 m -102.07 145.89 28.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD1' HG22 ' A' ' 117' ' ' VAL . 96.3 m-85 -127.49 119.34 25.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.47 106.83 13.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 0.0 109.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.455 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 6.3 m -120.85 137.73 54.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 103' ' ' LEU . 33.6 tttt -116.04 159.83 21.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.083 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 102' ' ' LYS . 24.1 mt -135.67 122.43 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 109.641 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.7 m -140.27 143.96 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.15 150.26 46.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.81 175.19 21.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.07 -0.24 6.88 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.673 2.248 . . . . 0.0 111.842 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -74.34 -24.74 59.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.99 17.44 35.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.08 -132.88 2.62 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 t -117.28 140.55 49.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -144.75 148.3 33.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.388 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.33 -167.24 35.36 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -122.36 145.21 48.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -1.119 . . . . 0.0 109.463 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 116' ' ' THR . 2.0 tt -120.31 125.72 48.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.392 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.855 ' N ' HD23 ' A' ' 115' ' ' LEU . 19.2 m -121.42 129.88 53.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.672 HG22 ' HD1' ' A' ' 99' ' ' PHE . 81.6 t -121.2 121.39 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 97' ' ' ILE . 35.9 ttpt -99.23 130.43 45.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.579 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 15.3 t80 -112.4 120.0 40.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.8 138.01 40.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.323 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 29.6 p -120.02 150.48 40.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.518 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.8 mttm -52.55 -36.26 55.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.15 -93.16 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.43 -36.67 78.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 109.422 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -52.66 134.91 35.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.553 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -134.58 111.11 11.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.8 Cg_endo -70.09 126.47 13.13 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.751 2.301 . . . . 0.0 111.781 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -72.14 161.12 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.329 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.91 -34.18 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -56.44 -31.44 63.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.127 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.1 -35.9 48.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.0 108.758 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -58.63 -35.17 72.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -71.19 -38.83 72.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.235 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 138' ' ' LYS . 98.2 m -59.39 -42.26 91.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.15 -37.64 91.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -68.44 -40.36 81.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.247 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.51 66.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.832 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 134' ' ' THR . 31.1 mttp -62.54 -47.44 83.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.29 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.45 -46.34 90.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.14 -32.45 55.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.878 . . . . 0.0 109.466 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.47 86.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.8 mm? -78.59 -36.01 44.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -59.21 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -57.11 -37.1 71.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 -50.35 72.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.304 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 146' ' ' ILE . 4.6 mm -54.31 -46.13 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -66.05 -53.05 43.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.625 ' HD1' HD23 ' A' ' 150' ' ' LEU . 43.3 t80 -70.84 -45.55 64.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.625 HD23 ' HD1' ' A' ' 149' ' ' TYR . 5.2 mt -55.09 -38.6 68.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.2 -28.31 48.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.29 66.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -135.44 93.95 15.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -12.04 31.52 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.697 2.264 . . . . 0.0 111.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -79.03 -16.18 57.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 51.1 t80 -74.6 107.53 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.611 HD22 HG23 ' A' ' 17' ' ' THR . 71.0 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.73 HG12 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 94.3 m-85 -80.66 119.17 22.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 25.2 m -110.72 116.45 31.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.854 ' CE2' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -109.68 165.3 11.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 60.8 mt-10 -131.15 135.59 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.96 165.86 26.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 0.0 109.519 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -110.01 148.95 30.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.49 147.55 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -148.01 133.72 18.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.55 138.28 11.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -12.14 31.5 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.646 2.231 . . . . 0.0 111.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.974 ' HB ' HD11 ' A' ' 18' ' ' LEU . 88.0 t -86.05 153.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.91 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -57.27 137.82 80.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' CA ' ' HB2' ' A' ' 111' ' ' SER . 45.8 Cg_endo -67.86 -30.2 33.76 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.926 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.61 -33.23 62.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -77.09 -36.94 55.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 13' ' ' VAL . 1.8 mt -71.07 -40.43 71.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 69.0 t80 -65.46 -44.04 88.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.852 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.4 tptm -68.99 -46.22 68.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.13 -32.46 63.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.968 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 47.3 tp -63.29 -46.03 88.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.688 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.47 -57.08 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.985 . . . . 0.0 110.163 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -57.24 -44.5 83.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.907 . . . . 0.0 110.175 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.7 m-20 -99.05 4.68 47.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.615 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.968 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.05 -51.48 13.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.857 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -69.29 -22.72 63.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.123 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -93.36 -26.58 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HG23 ' A' ' 146' ' ' ILE . 97.7 t -82.34 -35.02 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 26' ' ' ALA . 17.8 mt -60.15 -51.45 80.3 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.2 Cg_endo -67.9 -19.41 46.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.554 2.169 . . . . 0.0 112.541 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -108.79 -48.86 3.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.035 -1.041 . . . . 0.0 109.78 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -61.82 -12.94 19.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 36' ' ' SER . 0.5 OUTLIER -156.23 112.2 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.058 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.57 -18.65 58.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.039 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.546 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.3 -36.14 60.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -51.23 133.14 28.72 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.32 -0.863 . . . . 0.0 109.346 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HD3' HG21 ' A' ' 56' ' ' THR . 36.5 tttp -87.13 -54.05 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 36.5 m -165.31 158.51 16.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.833 HG23 ' CE2' ' A' ' 37' ' ' PHE . 83.0 t -142.88 142.9 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.833 . . . . 0.0 109.208 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 71.1 mt-10 -153.73 150.68 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 0.0 109.631 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t-20 -84.68 133.63 34.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.287 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 7.9 m -104.93 -28.2 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 51' ' ' THR . 71.5 tt0 -159.71 147.16 16.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 109.504 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 96.45 158.71 31.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -119.62 35.23 4.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -1.113 . . . . 0.0 109.523 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.39 -17.03 60.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.08 36.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.94 137.32 34.66 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.737 2.292 . . . . 0.0 111.742 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.8 4.79 67.07 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.727 ' C ' HD13 ' A' ' 52' ' ' ILE . 53.0 m -73.37 148.4 43.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -1.15 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.727 HD13 ' C ' ' A' ' 51' ' ' THR . 4.1 mm -115.69 126.98 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.249 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 70.8 mttt -124.93 149.97 47.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 67' ' ' LEU . 22.6 mttm -117.22 131.23 56.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.02 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.701 HG23 ' CG2' ' A' ' 40' ' ' VAL . 23.0 mt -124.9 121.17 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 109.884 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 42.1 m -95.95 127.86 42.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.317 -0.864 . . . . 0.0 109.211 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.801 ' CE1' HG13 ' A' ' 66' ' ' VAL . 33.7 p90 -130.34 168.24 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.732 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -102.0 149.94 23.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -0.855 . . . . 0.0 109.286 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.77 ' H ' HD13 ' A' ' 58' ' ' LEU . 73.0 tt0 -164.41 123.07 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 55.77 39.19 30.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.47 16.14 54.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 83.5 tt0 -115.81 134.14 55.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -1.148 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.4 m -81.83 122.18 27.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.441 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HE2' ' CD ' ' A' ' 62' ' ' GLU . 75.9 mttt -131.28 170.25 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.4 p90 -141.06 156.2 46.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.801 HG13 ' CE1' ' A' ' 57' ' ' PHE . 27.9 m -130.63 141.8 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 65' ' ' PHE . 7.2 mp -112.47 129.25 56.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.454 ' HD2' HG22 ' A' ' 84' ' ' VAL . 40.6 m170 -121.43 137.72 54.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 81.2 tttt -117.36 151.93 35.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.368 -0.833 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.3 mt -111.06 129.1 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 75.2 mt-10 -97.73 -24.42 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.322 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.3 t 179.4 145.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.333 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.04 141.67 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -130.89 87.18 2.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.09 -37.57 87.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.95 83.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 17.8 m-20 -92.47 11.53 25.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 2.0 mt 47.69 34.86 3.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.25 152.72 19.57 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 25.1 p90 -150.19 169.11 22.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -1.168 . . . . 0.0 109.085 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 71' ' ' GLU . 77.4 p -128.64 140.88 51.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 22.1 p90 -155.34 161.27 41.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 35.5 p -146.54 157.38 43.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 HD12 ' A' ' 90' ' ' LEU . 37.3 t -90.83 126.93 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.271 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG13 ' HE3' ' A' ' 96' ' ' LYS . 3.1 t -108.47 0.55 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 90' ' ' LEU . . . 175.28 175.87 43.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 120.09 161.32 11.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -21.18 66.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.439 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.792 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . . . -79.93 -7.1 58.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.956 HD12 HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -79.81 116.97 64.87 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.515 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.075 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.02 148.03 68.93 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.762 2.308 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -79.79 -29.92 40.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.696 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.486 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 24.1 p -79.7 -8.7 59.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.075 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -116.68 127.62 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 82.8 mt-10 -65.63 -47.06 76.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 1.5 mtpm? -158.88 169.65 23.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 118' ' ' LYS . 51.0 mt -136.59 127.54 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.413 -0.805 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 3.9 m -109.03 124.08 50.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.393 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.814 ' CE1' HG13 ' A' ' 117' ' ' VAL . 69.9 m-85 -110.22 124.03 50.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 47.6 t0 -115.87 108.22 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.174 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 t -116.3 136.33 53.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.154 -0.966 . . . . 0.0 109.834 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.672 ' O ' HD23 ' A' ' 103' ' ' LEU . 65.4 tttt -119.23 153.01 35.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 108.931 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 102' ' ' LYS . 38.2 mt -131.23 123.76 29.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.007 -1.058 . . . . 0.0 109.738 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.5 m -138.96 143.17 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.382 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.09 147.7 53.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.87 170.0 23.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.47 -1.47 8.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.674 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -75.74 -23.84 56.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.63 7.51 56.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.26 -141.64 4.85 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB2' ' CA ' ' A' ' 15' ' ' PRO . 2.1 t -109.31 142.93 39.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.576 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -147.14 146.14 29.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.26 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.64 -166.09 32.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 12.9 tttp -124.38 143.38 50.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -1.142 . . . . 0.0 109.419 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -120.89 124.11 44.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.94 . . . . 0.0 109.602 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.728 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.6 m -108.26 135.21 49.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.814 HG13 ' CE1' ' A' ' 99' ' ' PHE . 24.0 t -110.91 127.84 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.561 ' CG ' HG21 ' A' ' 2' ' ' VAL . 71.6 tttt -110.99 118.61 36.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 0.0 108.849 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.904 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 32.5 t80 -122.65 109.0 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.951 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.73 ' HG3' HG12 ' A' ' 2' ' ' VAL . 62.1 tt0 -96.7 145.86 25.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.124 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.6 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.3 p -115.26 179.14 4.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.998 . . . . 0.0 109.587 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 93' ' ' THR . 57.6 mttt -62.03 -36.13 80.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.0 -94.0 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.39 -21.14 53.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 137.65 57.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 3' ' ' PHE . 61.9 tt0 -127.74 126.85 24.01 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.6 ' HD3' HG21 ' A' ' 121' ' ' THR . 50.0 Cg_endo -70.15 147.05 59.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.765 2.31 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.8 m-20 -72.69 169.23 17.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.47 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.4 -41.94 97.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.5 -43.76 93.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.854 HD13 ' CE2' ' A' ' 5' ' ' PHE . 61.2 mt -60.29 -37.46 80.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.372 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -69.41 -41.23 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.0 m -59.59 -41.22 89.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.67 89.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -68.97 -40.2 79.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.05 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.517 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.792 ' HE3' ' HB2' ' A' ' 89' ' ' ALA . 22.9 tttm -62.45 -45.82 91.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 109.425 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.47 70.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -53.26 -39.54 63.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.93 52.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.367 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 62.8 tp -64.37 -41.05 96.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -55.26 -53.02 61.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.923 . . . . 0.0 109.322 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -53.54 -35.07 60.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.193 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -57.55 -50.05 74.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.242 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.707 HG23 HG11 ' A' ' 29' ' ' VAL . 6.0 mm -55.73 -41.68 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.289 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 83.5 tt0 -62.82 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 -37.59 14.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.182 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.584 ' HD1' HD23 ' A' ' 150' ' ' LEU . 31.8 t80 -66.74 -43.41 84.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.645 HD13 HG11 ' A' ' 13' ' ' VAL . 6.7 mt -56.13 -33.33 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.74 48.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.52 -19.43 57.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -127.38 83.81 65.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.82 -20.22 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.683 2.255 . . . . 0.0 111.774 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 14.2 p-10 -83.6 -2.6 56.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.56 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -69.02 132.16 46.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.494 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.44 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.391 0.615 . . . . 0.0 109.764 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -124.26 145.77 49.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.284 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.6 m -118.26 146.93 43.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 132' ' ' LEU . 72.0 m-85 -139.12 162.19 35.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.04 132.87 45.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -131.88 164.56 25.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.13 149.3 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.7 mt -123.92 129.8 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -140.65 131.32 25.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -144.6 140.61 16.71 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.12 -10.65 28.76 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.698 2.265 . . . . 0.0 111.714 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -83.34 151.12 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.25 137.56 94.38 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.342 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.9 -28.64 35.74 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.682 2.255 . . . . 0.0 111.75 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.14 -41.72 57.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.851 HG23 ' OXT' ' A' ' 157' ' ' ASN . 55.2 m -77.47 -41.01 41.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 150' ' ' LEU . 41.9 tp -67.11 -38.34 85.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -67.55 -41.83 83.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.687 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' THR . 7.8 tptt -66.17 -46.84 75.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.896 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.47 -27.76 61.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.957 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -66.07 -48.1 72.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.652 HG23 HD23 ' A' ' 22' ' ' LEU . 72.7 t -97.39 -50.81 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.535 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.3 m -64.7 -48.77 73.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 109.988 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' VAL . 3.7 m-20 -92.31 3.94 54.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.622 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.007 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.25 -52.8 11.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.312 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.7 m-20 -66.14 -25.13 66.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 93.8 m-20 -88.89 -27.64 20.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.947 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.957 HG21 HG23 ' A' ' 146' ' ' ILE . 9.1 p -83.57 -38.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 109.637 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.007 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.6 mt -52.31 -46.45 94.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.141 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.4 Cg_endo -68.47 -17.47 43.73 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.8 mttp -108.1 -29.35 9.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.93 81.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 57' ' ' PHE . 22.7 tp -91.58 111.81 23.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.98 -44.4 87.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -89.74 29.96 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.048 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.772 ' CE1' HG22 ' A' ' 30' ' ' ILE . 47.5 t80 -63.44 132.75 52.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 39' ' ' SER . 49.7 tttp -96.08 -47.68 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.189 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.496 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 34.9 p -179.95 174.16 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.006 -1.059 . . . . 0.0 110.03 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.1 p -136.25 130.33 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 109.343 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -129.86 144.78 51.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.629 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.69 126.51 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.363 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 36.7 t -80.05 -41.58 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.625 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 51' ' ' THR . 50.8 tp10 -166.96 156.75 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 98.77 170.23 31.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -119.06 31.79 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -1.189 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.76 -11.62 66.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 -170.97 33.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.58 148.76 60.48 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.669 2.246 . . . . 0.0 111.745 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 80.04 3.32 89.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' GLU . 87.9 m -69.71 149.87 47.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.617 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 29.9 mm -114.96 124.97 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -119.68 144.15 47.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 109.557 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.775 ' HG3' HD11 ' A' ' 67' ' ' LEU . 17.2 tttt -114.48 127.62 55.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.58 ' HB ' HG13 ' A' ' 66' ' ' VAL . 64.3 mt -115.49 145.01 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m -128.72 112.11 13.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.915 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.4 p90 -115.64 173.02 6.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.98 142.57 47.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -143.54 131.3 21.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 53.18 21.88 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.94 71.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.86 155.44 18.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -1.105 . . . . 0.0 109.482 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.3 27.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 52.1 mttm -120.68 162.57 19.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.737 ' CE1' HD13 ' A' ' 67' ' ' LEU . 3.2 p90 -145.74 158.91 43.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.675 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -138.79 147.81 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.5 mp -116.26 136.12 53.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 0.0 108.918 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -129.5 142.45 50.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.743 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 81.7 tttt -124.03 149.31 46.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 24.4 mm -107.68 132.66 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.624 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.8 mt-10 -89.3 -39.24 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.346 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -173.62 140.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.68 136.03 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -128.66 78.57 1.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -58.91 -39.33 81.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.55 -52.09 42.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 74.8 m-20 -92.22 14.37 16.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 6.0 mt 45.49 42.21 7.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.66 21.7 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -151.6 169.6 21.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -1.155 . . . . 0.0 109.195 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 19.5 m -128.56 138.75 52.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.599 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.2 p90 -154.26 158.67 40.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 96.6 p -146.84 156.6 43.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 89' ' ' ALA . 9.6 p -94.4 135.5 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.213 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 67' ' ' LEU . 3.8 m -118.79 3.61 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.73 164.64 35.55 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.71 178.22 28.25 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.05 45.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.845 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.04 -8.69 59.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -103.72 104.21 41.1 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.503 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.5 Cg_endo -69.66 153.82 68.92 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.692 2.261 . . . . 0.0 111.699 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 65.2 m-20 -80.06 -35.9 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -80.01 8.38 7.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.048 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -136.88 130.66 32.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.555 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -56.65 -56.48 20.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 20.1 pttm -169.09 160.65 9.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 83' ' ' SER . 59.8 mt -117.17 136.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 8.4 m -106.54 141.21 38.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 73.8 m-85 -119.83 120.57 36.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.968 . . . . 0.0 109.955 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -119.57 101.73 8.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 108.976 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -115.07 141.18 48.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.905 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.8 tttm -127.3 145.37 50.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.436 -0.79 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.905 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.9 mm? -126.45 126.75 44.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.4 m -137.22 142.65 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.28 145.72 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.49 172.87 22.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.0 0.5 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.43 -25.7 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.25 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.39 -134.59 2.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.6 m -116.9 142.08 47.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -1.122 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.13 30.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.34 -159.73 22.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.94 142.43 49.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -1.135 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 116' ' ' THR . 2.3 tt -116.86 135.66 53.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.878 ' N ' HD23 ' A' ' 115' ' ' LEU . 38.8 m -127.32 125.88 41.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.841 . . . . 0.0 109.266 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 136' ' ' LYS . 50.8 t -109.69 134.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 63.5 tttt -113.88 120.95 42.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.003 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.571 ' CD2' ' HG3' ' A' ' 127' ' ' PRO . 14.9 t80 -102.58 125.33 49.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.975 . . . . 0.0 109.743 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 86.1 mt-10 -107.66 135.33 49.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.683 HG21 ' CD ' ' A' ' 127' ' ' PRO . 26.9 p -116.48 166.15 12.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 24.4 mttm -62.82 -35.66 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.4 -86.5 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -62.4 -27.98 69.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.15 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.71 136.04 52.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -132.32 106.91 13.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.683 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -70.57 122.42 8.88 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.698 2.266 . . . . 0.0 111.867 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -60.64 154.52 21.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -58.23 -36.15 72.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.52 -32.37 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.9 -32.6 51.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.0 -38.41 88.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.396 -0.815 . . . . 0.0 109.093 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -64.75 -45.44 86.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.0 m -57.2 -37.65 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.272 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.75 -46.52 93.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.42 ' HG2' HG21 ' A' ' 117' ' ' VAL . 65.0 mttp -53.44 -36.45 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -1.092 . . . . 0.0 109.246 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.79 -35.05 68.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.173 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.29 -47.01 78.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -67.36 -52.48 39.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -57.3 -33.41 67.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.21 81.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.22 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 142' ' ' LEU . 22.2 tp -73.12 -47.58 43.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 75.6 t80 -56.53 -55.35 34.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.066 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -50.76 -39.13 51.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -0.918 . . . . 0.0 109.358 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.957 HG23 HG21 ' A' ' 29' ' ' VAL . 47.7 mt -69.06 -55.1 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.307 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -48.63 -57.82 5.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.918 . . . . 0.0 109.156 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.62 -38.56 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 108.847 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.13 -41.67 85.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 18' ' ' LEU . 28.5 mt -57.35 -36.16 70.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.02 -28.41 63.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.59 -16.25 62.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -134.13 88.04 32.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.21 -14.83 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.719 2.279 . . . . 0.0 111.806 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -85.69 5.64 31.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.896 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.3 t80 -80.01 142.02 35.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.851 ' OXT' HG23 ' A' ' 17' ' ' THR . 81.6 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.356 0.598 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.402 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 77.9 m-85 -81.37 117.45 21.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -109.83 116.82 32.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 92.7 m-85 -109.84 157.9 18.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -125.79 127.97 46.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.257 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.73 164.9 17.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.618 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -97.53 149.78 21.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 115' ' ' LEU . 64.0 mt -118.23 134.72 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 109.517 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.16 109.7 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -131.92 131.84 22.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.1 -2.74 10.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.745 2.297 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 150' ' ' LEU . 41.3 t -92.81 151.49 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.22 75.84 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.23 -34.23 22.29 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.801 2.334 . . . . 0.0 111.908 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.639 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.26 -38.3 60.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.669 HG23 ' C ' ' A' ' 157' ' ' ASN . 94.9 m -76.9 -37.5 55.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -69.64 -39.44 77.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.518 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 86.1 t80 -66.23 -46.25 77.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.803 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HE3' HG21 ' A' ' 24' ' ' THR . 19.1 tptt -61.29 -46.74 89.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.9 -20.19 61.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.009 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.1 tp -80.19 -48.83 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.912 . . . . 0.0 109.835 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.3 t -97.99 -53.03 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.306 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 ' HE3' ' A' ' 20' ' ' LYS . 4.0 m -64.36 -50.41 67.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 110.449 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.4 t70 -90.32 2.57 55.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.013 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.009 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.67 -53.16 12.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.011 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 88.9 m-20 -63.57 -25.1 68.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 63.4 m-20 -90.35 -24.15 20.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 25' ' ' ASP . 37.9 t -81.93 -39.16 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.7 mt -50.61 -48.58 82.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.867 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.5 Cg_endo -67.67 -18.34 48.1 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.407 2.071 . . . . 0.0 111.814 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 21.2 mttt -103.66 -54.62 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.314 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.43 -50.82 66.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.051 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.941 HD21 ' CB ' ' A' ' 57' ' ' PHE . 29.9 tp -71.77 102.0 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 0.0 108.938 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.42 -41.22 76.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 110.352 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -97.05 29.26 3.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.881 -1.137 . . . . 0.0 110.174 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -56.19 123.01 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.088 -1.008 . . . . 0.0 109.218 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -87.17 -54.04 4.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 0.0 109.848 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.613 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 24.5 p -174.21 167.61 4.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.094 -1.003 . . . . 0.0 110.035 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.841 HG23 ' HE2' ' A' ' 37' ' ' PHE . 94.2 t -142.43 141.62 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.157 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 76.5 mt-10 -149.88 163.08 39.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ILE . 7.7 t-20 -101.02 127.48 47.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 20.0 m -93.62 -29.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.877 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 63.1 mm-40 -159.14 147.49 17.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 95.9 156.57 31.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.77 34.13 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.62 65.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.42 -166.97 27.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.5 143.99 48.84 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 111.801 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.19 1.67 90.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.564 ' C ' HD13 ' A' ' 52' ' ' ILE . 98.3 m -67.62 147.95 52.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -1.153 . . . . 0.0 109.733 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.564 HD13 ' C ' ' A' ' 51' ' ' THR . 11.1 mm -114.19 123.77 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -118.11 143.25 46.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.646 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 64.1 tttt -118.94 132.48 56.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 40' ' ' VAL . 46.3 mt -125.38 145.85 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 0.0 109.659 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 20.4 m -124.69 124.79 42.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.377 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CB ' HD21 ' A' ' 34' ' ' LEU . 49.5 p90 -127.24 156.78 41.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.412 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.26 136.9 37.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -151.68 135.97 16.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.04 38.88 21.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.34 21.92 60.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -124.37 134.12 53.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.319 -1.107 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.5 m -79.97 118.58 21.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.491 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 88.9 mttt -121.08 160.42 23.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.0 p90 -141.61 154.67 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.52 ' C ' HD23 ' A' ' 67' ' ' LEU . 24.3 m -134.52 144.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -110.92 126.09 54.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.198 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -116.32 134.4 54.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 16.2 tttt -119.54 149.51 41.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 48.8 mt -112.32 133.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.646 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.66 -32.57 12.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.8 p -171.47 146.18 2.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.01 138.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -133.66 76.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.292 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.7 mt-10 -59.66 -37.15 77.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.68 70.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.557 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.87 12.9 26.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 16' ' ' ALA . 3.8 mt 47.38 38.04 6.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.129 -0.982 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.34 20.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 21.3 p90 -149.88 169.56 20.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -1.171 . . . . 0.0 109.19 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -128.88 139.95 51.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 109.486 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 25.5 p90 -154.0 160.02 41.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.6 p -145.2 156.18 43.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.499 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.072 HG11 ' HB3' ' A' ' 89' ' ' ALA . 82.0 t -93.05 130.16 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.643 ' O ' HD22 ' A' ' 90' ' ' LEU . 4.5 m -121.89 -0.61 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.706 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -162.02 152.48 22.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 109.03 176.9 21.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.51 -14.16 18.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.434 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.072 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -80.09 -5.1 55.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD22 ' O ' ' A' ' 85' ' ' VAL . 9.1 tp -95.57 100.57 6.3 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.04 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 49.4 Cg_endo -69.08 150.1 72.0 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.774 2.316 . . . . 0.0 111.872 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.72 -32.26 41.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.619 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 122' ' ' LYS . 7.6 t -88.58 -15.72 34.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.655 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.04 ' HB3' ' CG ' ' A' ' 91' ' ' PRO . . . -111.08 114.82 28.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -45.78 -48.51 15.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -176.63 166.7 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.669 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 118' ' ' LYS . 64.0 mt -124.89 134.49 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 118' ' ' LYS . 33.1 m -106.32 128.39 53.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 95.4 m-85 -106.43 125.14 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.04 104.05 9.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.194 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.5 t -116.17 141.09 48.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.959 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttpm? -128.91 145.09 51.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 83.4 mt -127.53 131.98 49.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.0 110.081 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -142.99 168.96 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.629 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.79 136.84 38.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 160.69 15.6 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.52 1.27 5.11 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.657 2.238 . . . . 0.0 111.888 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -80.73 -20.99 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.426 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.75 19.07 11.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.52 -142.01 3.61 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.3 t -104.91 148.03 27.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.63 151.66 37.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.265 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.02 -156.55 17.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -139.89 142.74 36.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -1.117 . . . . 0.0 109.379 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 116' ' ' THR . 2.2 tt -118.59 131.87 56.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 115' ' ' LEU . 34.0 m -119.32 130.2 55.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.522 HG21 ' HD3' ' A' ' 136' ' ' LYS . 85.0 t -108.18 130.69 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.722 ' O ' HG23 ' A' ' 97' ' ' ILE . 32.1 ttpt -112.3 123.6 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 38.2 t80 -116.55 115.23 25.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.686 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -99.06 143.41 29.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.017 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.817 HG21 ' HD3' ' A' ' 127' ' ' PRO . 68.3 p -121.99 162.68 20.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 93' ' ' THR . 21.7 mttp -49.72 -39.79 38.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.65 -95.2 0.11 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -71.7 -28.39 63.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.46 133.92 40.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -124.58 125.44 25.55 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.817 ' HD3' HG21 ' A' ' 121' ' ' THR . 51.4 Cg_endo -70.77 142.71 44.13 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.727 2.284 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.4 m-20 -81.75 165.57 20.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -66.47 -40.58 89.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -59.76 -49.04 79.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.3 -42.41 98.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.02 -43.44 98.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.22 -50.16 74.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.5 m -58.25 -37.39 74.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.335 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.14 -42.38 99.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 117' ' ' VAL . 8.8 tptt -68.2 -39.91 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.28 28.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.951 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 14.3 tttp -67.67 -41.7 83.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.4 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.52 -55.49 10.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -52.19 -32.12 34.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.27 -39.5 75.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.849 ' O ' HD13 ' A' ' 142' ' ' LEU . 1.3 tm? -69.37 -40.63 77.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.344 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -70.57 -54.31 12.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.137 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -50.78 -31.19 16.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.43 64.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 142' ' ' LEU . 50.8 mt -65.15 -54.13 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.416 ' O ' HD12 ' A' ' 151' ' ' LEU . 76.6 tt0 -44.7 -51.45 9.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.237 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.84 71.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.441 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 37.3 t80 -68.1 -37.14 80.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 0.0 109.468 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 40.7 mt -60.39 -38.43 83.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 109.401 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 147' ' ' GLU . 1.3 mt -73.41 -28.39 61.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' A' ' 153' ' ' HIS . . . -69.29 -18.52 63.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.508 ' HD2' ' HB3' ' A' ' 152' ' ' ALA . 17.1 m-70 -133.37 93.8 21.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.386 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.83 -13.94 32.35 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.683 2.255 . . . . 0.0 111.907 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -86.73 -18.24 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.727 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 55.7 t80 -68.11 109.97 3.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.669 ' C ' HG23 ' A' ' 17' ' ' THR . 7.3 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.93 146.63 49.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.486 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -127.59 124.26 37.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.596 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.709 ' CE1' HD12 ' A' ' 132' ' ' LEU . 95.8 m-85 -118.74 137.38 53.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.406 ' CD ' ' HD3' ' A' ' 114' ' ' LYS . 60.7 tt0 -105.42 133.56 49.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 33.5 t0 -138.56 152.97 48.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mt-10 -92.24 160.45 15.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 64.8 mt -117.71 145.13 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 78.4 m-20 -136.56 127.0 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 1.5 m -151.88 125.86 4.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.502 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.36 -2.9 11.36 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.583 2.188 . . . . 0.0 111.761 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.861 HG11 HD23 ' A' ' 150' ' ' LEU . 90.4 t -89.17 151.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 134.79 83.57 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 47.1 Cg_endo -68.64 -27.18 32.66 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.747 2.298 . . . . 0.0 111.793 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.13 -43.91 49.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.599 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.454 HG23 ' OXT' ' A' ' 157' ' ' ASN . 95.0 m -77.38 -40.35 44.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.59 -39.81 77.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.586 ' HD1' HD23 ' A' ' 103' ' ' LEU . 75.8 t80 -67.08 -37.11 83.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.523 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.846 ' HE2' HG21 ' A' ' 24' ' ' THR . 18.5 tptm -69.86 -46.5 65.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.65 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -75.23 -20.86 59.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.966 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.93 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.4 tp -72.08 -49.49 35.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.1 t -97.42 -50.15 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 109.844 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.846 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -62.23 -48.54 79.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.92 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 29' ' ' VAL . 21.7 m-20 -95.46 5.95 50.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.753 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.29 -52.8 11.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.581 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 40' ' ' VAL . 38.3 t0 -67.44 -22.18 65.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.907 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 84.5 m-20 -91.72 -26.76 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 146' ' ' ILE . 7.7 p -81.61 -35.56 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.8 mt -57.78 -47.87 98.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.81 -38.19 14.14 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 57.7 mttp -85.39 -29.91 24.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 109.181 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -66.94 -30.51 70.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 108.849 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 15.6 tp -95.78 113.06 24.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 108.819 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.99 -34.7 76.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.533 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 p -98.03 27.15 4.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.845 -1.159 . . . . 0.0 109.991 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 58.4 t80 -60.33 137.1 58.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 55.1 tttm -98.01 -48.42 5.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.55 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -178.74 171.76 1.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.895 -1.128 . . . . 0.0 110.019 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 27' ' ' ASP . 4.0 p -137.83 133.05 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -141.58 130.72 23.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.0 m-20 -84.31 136.47 33.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.45 -79.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.11 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 51' ' ' THR . 90.5 mt-10 -115.57 164.16 14.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.4 157.84 29.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.63 13.61 31.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.338 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.4 42.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.93 -160.03 23.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 72' ' ' SER . 50.7 Cg_endo -70.31 130.8 19.25 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.764 2.31 . . . . 0.0 111.85 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.92 0.98 82.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 44' ' ' GLU . 43.5 m -71.98 151.71 43.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -1.177 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.61 128.15 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 33.2 mttt -125.67 149.68 48.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.929 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.754 ' HG3' HD11 ' A' ' 67' ' ' LEU . 19.0 tttt -116.29 127.57 54.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 30' ' ' ILE . 62.8 mt -113.03 137.1 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 48.0 m -128.81 128.07 43.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.467 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.564 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 28.8 p90 -137.68 176.51 8.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -103.35 145.33 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.578 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -147.74 126.21 12.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 52.43 23.43 2.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.77 11.85 73.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -112.0 159.71 18.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.6 m -99.8 111.52 23.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -119.33 162.51 18.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 67' ' ' LEU . 4.1 p90 -146.72 159.2 43.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 30.9 m -137.29 146.07 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.596 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.754 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.6 mp -116.17 137.3 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.045 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -134.14 145.69 49.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.045 -1.034 . . . . 0.0 109.835 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HE2' ' HA2' ' A' ' 50' ' ' GLY . 32.9 tttt -120.32 147.43 45.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.9 mt -108.89 132.77 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 26.1 mt-10 -86.41 -44.27 12.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 23.3 t -177.14 134.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -100.45 139.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -132.55 73.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.79 -29.33 59.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.61 73.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . 91.0 m-20 -90.16 14.12 13.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 20.9 mt 46.81 46.2 15.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 109.6 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.51 154.68 26.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -150.72 169.35 21.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -1.211 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 67.1 m -134.38 140.6 46.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.88 158.76 41.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.7 p -145.51 156.13 43.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.03 133.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' C ' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -119.81 1.26 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.894 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.39 36.95 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.13 176.59 19.1 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.52 -13.37 62.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -1.117 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.98 -9.12 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -90.59 110.3 40.29 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.022 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.6 Cg_endo -70.58 148.61 60.11 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.641 2.227 . . . . 0.0 111.7 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.432 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 61.6 m-20 -79.09 -32.54 44.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -79.85 5.83 12.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.022 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.98 134.71 45.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.057 -1.027 . . . . 0.0 109.63 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 88.0 mt-10 -63.38 -46.51 86.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 3.8 pttm 179.64 159.62 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.2 mt -116.73 136.32 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.3 m -111.84 124.83 53.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.865 . . . . 0.0 109.216 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 89.6 m-85 -108.7 124.27 50.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.97 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 16.6 t70 -119.18 107.04 12.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.065 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB3' HD13 ' A' ' 115' ' ' LEU . 76.8 p -121.11 140.61 51.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.977 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.2 tttm -121.03 154.42 36.08 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.977 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -131.17 127.2 37.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.003 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 105' ' ' ALA . 1.3 m -144.97 167.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 108.982 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.577 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -77.06 134.39 38.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.533 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.16 159.31 15.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.75 24.39 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.669 2.246 . . . . 0.0 111.867 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -70.1 -22.83 62.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.47 23.53 10.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.82 3.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.5 t -98.67 149.19 23.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -1.123 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -145.91 159.12 43.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.15 -174.54 43.62 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HD3' ' CD ' ' A' ' 6' ' ' GLU . 10.2 ttmt -117.02 141.13 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -1.121 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 101' ' ' SER . 34.9 tp -116.15 136.45 53.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.453 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 21.6 m -128.16 126.85 41.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.3 t -108.66 134.19 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.508 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 21.0 tttm -121.63 114.3 20.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.781 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.2 t80 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE2' ' NZ ' ' A' ' 118' ' ' LYS . 93.8 mt-10 -106.66 138.04 43.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.638 HG21 ' CD ' ' A' ' 127' ' ' PRO . 21.8 p -117.07 157.09 26.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 52.8 mttt -49.62 -44.94 47.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.04 -71.12 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 27.8 p30 -78.72 -17.04 56.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.097 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.52 132.49 41.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.9 107.5 25.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.878 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.638 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -69.65 119.62 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.95 158.92 26.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.54 -37.16 75.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.09 -31.67 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -78.64 -33.57 47.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 108.951 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.73 -43.2 99.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -59.25 -48.7 80.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.205 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.5 m -61.23 -40.1 92.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.36 -49.95 72.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -62.81 -37.89 88.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -1.18 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.42 -28.71 45.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -61.13 -46.74 89.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.272 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.27 -52.59 53.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -50.53 -39.07 47.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.03 86.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.87 -30.62 50.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.03 -52.09 67.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.145 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -52.1 -37.68 54.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.48 -48.02 78.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.072 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 29' ' ' VAL . 8.4 mm -57.62 -42.53 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.307 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 151' ' ' LEU . 93.5 mt-10 -73.59 -43.37 59.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.91 67.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 153' ' ' HIS . 38.8 t80 -68.23 -44.05 76.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.861 HD23 HG11 ' A' ' 13' ' ' VAL . 4.8 mp -57.62 -35.46 70.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 147' ' ' GLU . 0.7 OUTLIER -79.14 -31.64 44.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.558 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.89 -21.82 60.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 149' ' ' TYR . 74.9 m-70 -129.81 87.38 52.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.84 -17.8 37.01 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.695 2.263 . . . . 0.0 111.79 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.39 -0.78 23.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 74.6 t80 -75.69 136.48 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.454 ' OXT' HG23 ' A' ' 17' ' ' THR . 7.9 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.7 t . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.2 m-85 -123.27 149.66 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -127.19 135.0 50.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.305 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.807 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -127.0 157.76 38.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.116 -0.99 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -126.43 132.67 51.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 3.1 t70 -131.88 164.81 25.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.552 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 94.4 mt-10 -103.15 149.95 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.53 129.38 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -139.58 122.13 16.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -144.9 136.66 12.89 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.2 -1.13 8.32 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.597 2.198 . . . . 0.0 111.731 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.797 HG11 ' OE1' ' A' ' 147' ' ' GLU . 1.8 p -92.21 152.28 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.61 137.2 86.26 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.58 ' CA ' ' HB3' ' A' ' 111' ' ' SER . 46.1 Cg_endo -68.19 -30.4 31.25 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.749 2.299 . . . . 0.0 111.8 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.58 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 157' ' ' ASN . 61.6 m -80.16 -35.84 35.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 150' ' ' LEU . 7.6 tp -70.04 -39.44 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 85.4 t80 -70.12 -40.29 74.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.744 ' HE3' HG21 ' A' ' 24' ' ' THR . 52.0 tptt -66.0 -47.17 75.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.814 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.37 -47.89 53.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.055 -1.028 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.993 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.5 tp -47.5 -43.52 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.4 t -98.44 -56.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.744 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -64.02 -48.39 76.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.065 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HB2' ' CA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -90.64 2.81 55.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.756 -179.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.36 -50.9 15.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 0.0 109.497 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.3 m-20 -66.11 -28.88 69.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.031 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -87.9 -29.33 20.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.045 ' CG1' HG23 ' A' ' 146' ' ' ILE . 92.3 t -83.4 -38.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.1 mt -49.22 -48.26 74.27 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.795 . . . . 0.0 110.002 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.4 Cg_endo -68.93 -19.45 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.408 2.072 . . . . 0.0 111.899 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 53.1 mttm -99.21 -34.1 10.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -64.07 -34.51 78.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.25 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 10.3 tp -92.54 109.74 21.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 108.965 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.83 -26.52 65.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 p -109.04 26.98 9.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.0 110.203 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.066 ' CE1' HG23 ' A' ' 40' ' ' VAL . 4.9 t80 -59.17 137.54 57.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.44 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HE2' HD23 ' A' ' 58' ' ' LEU . 13.3 mttm -101.06 -49.52 4.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.942 . . . . 0.0 110.259 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.5 p -175.07 167.13 3.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.957 -1.089 . . . . 0.0 110.21 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.066 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.8 t -135.2 128.14 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.549 -0.719 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -138.65 151.46 47.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 27.1 p-10 -98.44 140.85 32.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.48 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -97.98 -29.9 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.526 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 51' ' ' THR . 77.6 mt-10 -157.93 145.59 18.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.56 159.74 30.92 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -97.37 5.58 49.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.56 -10.51 30.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.44 -158.13 9.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.06 138.09 36.09 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.744 2.296 . . . . 0.0 111.859 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.53 7.14 88.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' GLU . 15.1 m -79.55 157.29 27.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -1.159 . . . . 0.0 109.661 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 16.1 mm -117.85 126.7 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.2 mttm -119.13 144.14 46.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.865 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 23.4 tttt -115.41 127.36 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.062 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' CZ ' ' A' ' 37' ' ' PHE . 35.7 mt -121.22 145.3 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 0.0 110.032 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 57.7 m -131.9 127.31 36.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -0.769 . . . . 0.0 109.244 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 23.8 p90 -134.76 170.72 15.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 62' ' ' GLU . 1.9 mm? -107.84 133.53 52.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.366 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -141.41 140.01 33.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 48.46 22.2 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 109.62 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.83 29.34 39.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.759 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.0 mt-10 -132.62 145.16 50.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -85.03 109.25 18.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -113.17 156.86 22.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 12.2 p90 -141.24 153.05 45.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.553 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.4 p -138.88 147.52 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -115.11 134.48 55.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.226 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -124.51 138.0 54.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.514 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 51.9 tttt -118.4 144.1 46.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 52.5 mt -105.39 129.46 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 97.0 mt-10 -87.75 -40.73 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.28 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.1 p -171.74 151.77 2.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.84 133.85 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -128.14 82.12 2.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.85 -35.2 75.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -0.991 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.61 -52.35 62.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-20 -89.7 15.0 10.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.538 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 44.11 46.39 7.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.15 156.47 25.6 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.6 p90 -151.64 169.7 21.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.188 . . . . 0.0 109.071 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 21.2 m -126.73 138.46 53.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.579 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.8 p90 -154.42 158.62 40.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.852 . . . . 0.0 109.582 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 71.9 p -148.54 156.91 43.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 109.325 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.088 HG21 ' HB3' ' A' ' 89' ' ' ALA . 10.0 p -97.85 132.82 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.959 . . . . 0.0 109.199 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 90' ' ' LEU . 3.7 m -123.44 5.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.009 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.65 153.28 23.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.32 -176.22 23.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.47 -13.58 62.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 0.0 109.389 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.088 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.92 -8.61 59.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 85' ' ' VAL . 2.2 tp -105.72 101.8 34.81 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.055 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 50.1 Cg_endo -69.7 152.7 69.69 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.755 2.303 . . . . 0.0 111.601 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 63.0 m-20 -79.55 -34.92 40.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.628 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -79.96 7.75 8.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.913 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.055 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -138.02 127.53 24.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -52.02 -58.67 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 42.6 pttt -167.46 164.44 14.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 83' ' ' SER . 60.1 mt -118.26 135.41 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.403 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 7.7 m -107.01 145.91 31.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.631 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.9 m-85 -123.96 120.07 31.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.124 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -118.37 101.64 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.065 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.437 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 29.1 t -117.32 139.62 50.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.296 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 1.014 ' C ' HD22 ' A' ' 103' ' ' LEU . 35.7 ttpt -120.81 155.76 33.36 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.014 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -133.07 123.97 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.008 -1.058 . . . . 0.0 110.042 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.15 142.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.087 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.01 145.88 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.764 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 169.65 23.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.69 1.76 4.73 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.723 2.282 . . . . 0.0 111.844 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.25 -28.53 64.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.51 21.82 10.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.466 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.99 -131.41 1.63 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.58 ' HB3' ' CA ' ' A' ' 15' ' ' PRO . 1.1 p -120.18 142.78 48.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -1.134 . . . . 0.0 109.586 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.76 160.5 38.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.402 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.4 168.21 31.05 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -111.49 147.32 35.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.127 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -117.23 131.39 56.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.487 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.658 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.7 m -125.23 126.18 44.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.174 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.429 HG22 ' CD1' ' A' ' 99' ' ' PHE . 57.9 t -111.54 134.22 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.691 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 38.0 ttpt -106.91 126.33 52.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.662 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 36.8 t80 -106.94 121.07 43.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 91.3 mt-10 -104.83 138.96 40.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.624 HG22 ' HE1' ' A' ' 119' ' ' TYR . 26.2 p -119.31 161.86 19.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.5 mttt -63.31 -32.1 73.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.17 -108.52 0.31 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' O ' ' OE1' ' A' ' 126' ' ' GLU . 81.4 m-20 -63.43 -34.29 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.142 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.89 127.49 28.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -143.23 127.65 9.59 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.8 Cg_endo -70.46 163.85 37.36 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.7 2.267 . . . . 0.0 111.795 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -93.22 163.66 13.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -52.08 -40.39 61.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -61.35 -46.49 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -57.61 -44.77 85.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.44 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.807 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 78.9 mt -60.65 -39.07 86.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 109.424 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.08 -43.95 85.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.8 m -58.51 -40.22 82.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.314 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.08 92.88 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ASP . 42.8 mttt -69.36 -40.25 77.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.62 73.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -75.26 -44.82 43.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 142' ' ' LEU . . . -79.65 -26.42 41.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 136' ' ' LYS . 12.9 t0 -60.68 -40.11 90.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.89 68.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 142' ' ' LEU . 21.2 mt -54.78 -51.75 64.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.201 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -60.74 -53.91 51.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.16 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -56.36 -37.25 69.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.04 -54.38 45.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.186 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 ' CG1' ' A' ' 29' ' ' VAL . 6.6 mt -67.8 -53.39 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.885 . . . . 0.0 109.192 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.797 ' OE1' HG11 ' A' ' 13' ' ' VAL . 15.2 tp10 -52.97 -47.48 68.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.63 69.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.2 t80 -68.9 -31.15 69.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.287 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 18' ' ' LEU . 15.3 mt -69.84 -46.03 66.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.08 -30.01 70.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.94 -16.5 60.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -124.28 94.6 44.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.64 -21.36 29.49 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.734 2.289 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.3 -20.49 60.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.814 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 69.2 t80 -77.45 131.07 37.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.664 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.445 ' C ' HG23 ' A' ' 17' ' ' THR . 72.2 m-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 95.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HE2' HG21 ' A' ' 121' ' ' THR . 83.5 m-85 -130.98 120.92 24.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 109.538 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 117' ' ' VAL . 51.5 m -109.02 144.16 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.456 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.833 ' CE1' HD12 ' A' ' 132' ' ' LEU . 86.4 m-85 -135.17 135.79 41.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.4 mt-10 -106.12 131.34 53.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.917 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.662 ' HB3' HD23 ' A' ' 115' ' ' LEU . 21.1 t0 -130.08 164.41 24.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -101.8 160.01 14.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 10.5 mt -133.2 132.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -133.69 131.43 39.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 47.8 m -152.55 137.01 10.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 0.0 109.353 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.5 Cg_endo -70.13 -31.55 18.66 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.676 2.25 . . . . 0.0 111.815 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' H ' HG12 ' A' ' 13' ' ' VAL . 1.5 p -60.29 152.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 142.26 97.9 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' N ' ' HB3' ' A' ' 111' ' ' SER . 46.9 Cg_endo -68.19 -37.42 14.34 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.735 2.29 . . . . 0.0 111.775 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.05 82.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 157' ' ' ASN . 52.6 m -78.77 -36.88 42.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.702 HD12 HD11 ' A' ' 150' ' ' LEU . 11.6 tp -69.9 -39.53 76.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 86.7 t80 -68.06 -42.37 80.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.828 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HE3' HG21 ' A' ' 24' ' ' THR . 20.5 tptt -63.81 -46.63 84.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.933 . . . . 0.0 109.728 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.15 -25.64 60.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.905 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 2.8 tm? -69.63 -46.89 65.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.37 -53.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.593 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.7 m -62.81 -48.57 78.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 109.956 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -94.85 8.79 41.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 109.617 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.905 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -47.06 -53.42 12.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.602 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 p-10 -69.37 -27.04 64.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.1 m-20 -83.34 -28.21 29.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.063 HG11 HG23 ' A' ' 146' ' ' ILE . 88.0 t -81.53 -36.76 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.5 mt -49.64 -49.37 72.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.102 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.8 Cg_endo -67.4 -20.1 48.68 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.503 2.135 . . . . 0.0 111.921 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 72.9 mttt -97.64 -54.11 3.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.188 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.9 65.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.064 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 9.8 mp -78.2 99.57 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.2 -29.32 60.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.9 p -110.27 27.16 9.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.746 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.57 123.97 12.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -89.6 -55.77 3.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.7 p -171.95 164.22 6.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.956 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.746 HG23 ' HE2' ' A' ' 37' ' ' PHE . 74.7 t -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.805 . . . . 0.0 109.123 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 61.4 mt-10 -152.46 160.77 43.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.129 -0.982 . . . . 0.0 109.765 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 80.0 m-20 -98.97 131.05 45.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.7 m -90.69 -29.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.676 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.84 144.74 17.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.37 168.21 32.82 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.8 6.25 33.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -1.101 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.22 -9.56 31.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.91 -157.57 8.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.29 137.07 33.09 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.651 2.234 . . . . 0.0 111.862 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.07 7.5 88.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.488 HG23 ' HA3' ' A' ' 45' ' ' GLY . 100.0 m -76.65 153.81 34.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.192 . . . . 0.0 109.625 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.503 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 24.3 mm -114.18 123.28 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 109.239 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 29.8 mtmt -119.82 145.42 46.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.917 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.606 ' HG3' HD21 ' A' ' 67' ' ' LEU . 20.4 tttm -114.98 126.71 55.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.709 HG23 HG22 ' A' ' 40' ' ' VAL . 20.7 mt -116.4 143.82 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 65.1 m -127.04 128.0 45.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 64' ' ' LYS . 52.7 p90 -133.51 156.06 48.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 140.63 31.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -150.34 134.13 16.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 52.04 32.47 10.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.99 74.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -112.02 139.57 47.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -88.0 119.44 28.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 86.3 mttt -120.35 165.86 14.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 27.8 p90 -145.03 157.78 44.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.537 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.3 p -138.69 146.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.773 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 HD21 ' HG3' ' A' ' 54' ' ' LYS . 40.1 mt -113.65 133.26 55.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.871 . . . . 0.0 108.95 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.438 ' NE2' HG21 ' A' ' 66' ' ' VAL . 33.2 m170 -126.17 139.5 53.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 24.1 tttt -117.52 144.41 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.052 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 mt -102.71 127.44 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 94.9 mt-10 -89.16 -36.63 15.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 32.0 t 178.08 132.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -103.9 137.27 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.314 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -126.57 82.42 2.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.6 mt-10 -58.28 -34.57 70.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 109.284 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.12 65.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.433 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 77.6 m-20 -87.79 15.52 6.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.908 . . . . 0.0 109.189 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 14.8 mt 43.25 46.02 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.425 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -145.23 159.71 27.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 82' ' ' TYR . 19.9 p90 -152.17 169.78 21.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -1.202 . . . . 0.0 109.291 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 41.3 t -125.38 137.81 54.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 99' ' ' PHE . 14.2 p90 -151.36 153.97 35.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 98' ' ' THR . 10.9 t -142.44 155.19 45.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.071 HG21 ' HB3' ' A' ' 89' ' ' ALA . 12.2 p -96.43 132.52 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.122 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 p -127.63 2.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.912 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.591 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -157.95 148.04 16.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.09 -174.9 19.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.06 -12.37 61.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -1.074 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.071 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.87 8.78 6.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 85' ' ' VAL . 10.2 tt -121.22 101.08 44.69 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.308 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 1.017 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.1 Cg_endo -69.21 154.59 69.7 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.72 2.28 . . . . 0.0 112.003 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 61.4 m-20 -79.92 -31.7 40.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.483 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 26.2 p -79.76 2.12 24.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.722 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.017 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -134.11 137.26 44.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -65.51 -56.01 14.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' OE1' ' A' ' 120' ' ' GLU . 43.9 pttt -169.0 159.05 9.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 109.461 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 119' ' ' TYR . 29.1 mt -118.96 137.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 24.2 m -113.12 120.77 42.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 117' ' ' VAL . 91.8 m-85 -96.0 126.04 40.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.753 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' THR . 17.2 t70 -119.33 113.95 21.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.329 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.502 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 22.5 t -135.81 140.68 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.47 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.82 ' C ' HD22 ' A' ' 103' ' ' LEU . 29.9 tttt -119.26 160.74 21.64 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -124.15 126.77 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.881 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 112' ' ' ALA . 29.8 m -137.35 142.93 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.92 146.12 49.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.718 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.25 165.3 21.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -2.16 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.662 2.242 . . . . 0.0 111.894 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.51 18.14 31.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -140.91 3.8 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 13.6 p -119.66 145.56 46.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -1.151 . . . . 0.0 109.606 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.43 147.7 31.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 109.146 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -161.9 170.04 37.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -99.31 146.51 26.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 7' ' ' ASP . 30.4 tp -112.21 137.37 50.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 53.8 m -140.44 113.68 8.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.816 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -110.11 139.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 110.354 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.8 tttp -111.79 119.0 37.14 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 127' ' ' PRO . 12.7 t80 -102.54 123.48 46.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.099 -1.001 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 92.0 mt-10 -106.34 137.98 43.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 3' ' ' PHE . 56.5 p -117.6 159.38 23.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.562 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 59.2 mttt -62.32 -40.95 98.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.31 -83.03 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.39 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -1.211 . . . . 0.0 109.517 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -61.99 134.66 56.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -136.79 107.03 8.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.597 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 48.7 Cg_endo -69.77 131.73 21.84 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 111.885 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.21 149.53 35.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.366 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -52.75 -36.0 57.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -57.11 -31.61 65.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.98 -36.18 59.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.157 -0.964 . . . . 0.0 108.574 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.833 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -58.25 -40.93 83.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -52.65 -54.26 35.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.42 -0.8 . . . . 0.0 109.177 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.5 m -58.71 -37.93 77.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.09 97.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 140' ' ' ASP . 24.7 mttt -63.78 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -1.119 . . . . 0.0 109.214 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.31 76.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.66 -46.37 46.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.56 -27.13 51.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.153 -0.967 . . . . 0.0 109.18 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 136' ' ' LYS . 86.1 m-20 -80.15 -21.88 42.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.282 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.4 78.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.28 -45.88 87.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -59.28 -55.21 37.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.802 . . . . 0.0 109.25 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -49.75 -41.12 43.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.64 78.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 108.945 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.063 HG23 HG11 ' A' ' 29' ' ' VAL . 21.3 mt -72.89 -54.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.7 -49.52 47.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.234 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.003 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.43 -37.56 83.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.23 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 18' ' ' LEU . 14.1 mt -65.41 -43.16 91.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.376 -0.828 . . . . 0.0 109.396 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.47 HD21 ' HG2' ' A' ' 12' ' ' PRO . 73.8 mt -69.42 -31.7 70.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.595 ' HB3' ' HD2' ' A' ' 153' ' ' HIS . . . -73.89 -19.08 60.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.595 ' HD2' ' HB3' ' A' ' 152' ' ' ALA . 7.4 m-70 -127.13 89.35 52.06 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.87 -19.32 35.78 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.71 2.273 . . . . 0.0 111.805 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.82 -11.7 60.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.748 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 71.2 t80 -77.48 133.7 38.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.588 ' C ' HG23 ' A' ' 17' ' ' THR . 48.0 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.47 HG11 ' HD2' ' A' ' 118' ' ' LYS . 48.3 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 126' ' ' GLU . 97.2 m-85 -126.27 141.65 51.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 37.4 m -121.37 130.38 53.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 132' ' ' LEU . 87.6 m-85 -123.11 136.73 54.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -110.08 132.18 54.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -133.81 165.8 24.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.525 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -99.6 145.35 27.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.335 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.755 HG21 HD11 ' A' ' 103' ' ' LEU . 70.8 mt -106.55 142.34 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -154.92 128.89 8.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -152.97 140.92 13.6 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.479 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.13 -1.43 8.76 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.674 2.25 . . . . 0.0 111.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.723 HG21 ' HG3' ' A' ' 147' ' ' GLU . 64.5 t -97.49 149.47 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.52 95.63 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.4 -31.07 28.71 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.729 2.286 . . . . 0.0 111.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 -41.9 53.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.696 HG23 ' CB ' ' A' ' 157' ' ' ASN . 93.1 m -75.27 -43.74 49.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' CZ ' ' A' ' 143' ' ' PHE . 68.1 tp -67.48 -37.29 82.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.6 t80 -66.75 -41.24 88.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.607 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HE2' HG21 ' A' ' 24' ' ' THR . 17.1 tptm -67.12 -46.49 73.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.631 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -74.78 -17.3 60.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.001 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 26.1 tp -74.23 -51.37 15.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.53 -44.72 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.971 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.863 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.25 -47.97 74.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.949 . . . . 0.0 110.103 -179.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 29' ' ' VAL . 53.6 m-20 -98.51 11.28 38.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.035 . . . . 0.0 109.833 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.001 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -53.88 -51.57 63.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 20.2 t70 -70.57 -21.37 62.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 110.141 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.16 -27.2 16.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -80.95 -33.85 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.81 . . . . 0.0 109.67 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 26' ' ' ALA . 5.8 mt -61.91 -49.55 85.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.15 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 48.5 Cg_endo -68.92 -22.78 35.56 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.513 2.142 . . . . 0.0 112.445 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 33' ' ' ALA . 22.4 mttt -106.14 -35.72 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.004 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -43.23 -38.67 2.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.004 HD23 ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -155.44 144.0 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.442 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.8 -18.71 50.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' HD13 ' A' ' 58' ' ' LEU . 68.0 m -55.14 -38.12 67.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.398 -0.814 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 55' ' ' ILE . 1.3 t80 -49.93 135.52 19.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.087 -1.008 . . . . 0.0 109.294 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 40.2 tttp -81.07 -57.28 3.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 110.295 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -162.46 155.57 20.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.02 -1.05 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 55' ' ' ILE . 92.3 t -134.67 133.55 54.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.458 -0.776 . . . . 0.0 109.065 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 84.3 mt-10 -159.34 168.1 27.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.95 . . . . 0.0 109.634 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 65.9 m-20 -97.03 152.6 18.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 2.5 t -96.1 -33.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.558 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.803 ' O ' HG23 ' A' ' 51' ' ' THR . 45.3 tp10 -166.79 156.44 11.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 88.96 -172.97 40.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -120.99 17.35 11.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 51' ' ' THR . . . 99.93 -1.43 56.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.14 -164.01 23.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.95 126.41 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.623 2.215 . . . . 0.0 111.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 92.77 4.13 65.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 44' ' ' GLU . 86.1 m -75.34 150.4 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -1.121 . . . . 0.0 109.58 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' C ' ' A' ' 51' ' ' THR . 9.4 mm -111.56 122.25 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 21.8 tttt -116.98 142.1 47.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 110.108 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 43' ' ' VAL . 17.9 tttm -117.25 130.24 56.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.024 HG22 HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -130.46 138.25 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.981 -1.075 . . . . 0.0 110.004 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.1 m -120.52 114.67 22.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.386 -0.821 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 50.8 p90 -114.96 171.05 7.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -111.14 151.32 28.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' GLU . 60.5 tt0 -154.28 138.58 16.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.311 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 2.8 p-10 44.13 26.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . 81.58 24.29 56.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' GLU . 72.7 mt-10 -121.74 140.88 51.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.445 ' CG2' ' HD2' ' A' ' 38' ' ' LYS . 16.2 m -91.07 110.28 21.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -116.18 162.04 18.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 14.2 p90 -141.85 153.79 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 5.6 p -140.6 148.82 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.712 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -110.81 128.78 55.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.914 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -122.52 138.55 54.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 22.1 tttm -119.57 146.94 45.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.5 mt -104.93 130.52 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 72' ' ' SER . 48.4 mm-40 -93.56 -27.79 16.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.292 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.2 t 178.27 144.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.44 138.15 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.373 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 94.0 m-20 -130.79 81.97 2.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.32 -37.01 81.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.54 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.53 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 22.0 m-20 -97.58 12.11 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt 47.88 29.31 1.6 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -121.24 150.86 17.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.3 p90 -151.24 169.76 21.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -1.225 . . . . 0.0 109.123 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 47.4 t -128.56 138.88 52.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -153.97 158.91 41.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 80.7 p -145.23 157.07 44.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.643 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.049 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.0 p -96.48 129.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 67' ' ' LEU . 3.6 m -116.57 4.86 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.432 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -169.18 159.51 32.53 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 105.02 -171.54 18.99 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.88 61.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -1.079 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.049 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.91 -4.02 50.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 90' ' ' LEU . 7.4 tt -121.86 86.35 45.82 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.756 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -69.54 165.91 29.12 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.505 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 38.9 m-20 -70.44 -27.82 64.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.9 p -79.77 -23.94 41.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.601 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -106.32 121.58 44.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.972 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 92.8 mt-10 -64.97 -49.12 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 71.8 mttt -161.2 158.42 27.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CD1' ' CE2' ' A' ' 119' ' ' TYR . 62.7 mt -123.61 133.68 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.84 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.2 m -108.91 131.29 55.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 99.8 m-85 -115.11 122.39 45.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.47 ' O ' HD23 ' A' ' 115' ' ' LEU . 42.5 t0 -116.11 119.9 37.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.888 . . . . 0.0 109.188 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.506 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 9.9 t -138.48 134.93 34.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.797 ' O ' HD12 ' A' ' 103' ' ' LEU . 20.0 tttm -125.77 149.09 48.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.2 mp -130.1 128.88 42.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 109.954 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 112' ' ' ALA . 32.6 m -138.96 143.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 109.164 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.04 139.65 22.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.28 168.16 21.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.16 -16.36 35.87 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.73 2.287 . . . . 0.0 111.729 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -64.86 -22.56 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.03 42.78 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.76 -140.42 4.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 m -101.93 141.36 34.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -148.02 139.5 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.4 13.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -129.82 141.68 50.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.299 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 101' ' ' SER . 3.1 tt -124.52 119.8 30.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 110.005 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.478 ' N ' HD23 ' A' ' 115' ' ' LEU . 71.2 m -116.65 128.32 55.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 108.788 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -117.03 131.97 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 110.062 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 37.1 ttpt -111.08 115.61 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 15.7 t80 -99.45 128.92 45.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.234 -0.916 . . . . 0.0 109.647 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -102.9 144.43 31.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.312 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 70.1 p -123.72 152.84 41.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 12.5 mttm -55.15 -29.21 57.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.0 -108.11 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.65 -27.27 58.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.04 135.83 57.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -141.33 119.59 7.91 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.5 146.66 56.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.844 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -87.55 177.25 7.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.94 -36.15 80.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.26 -41.92 94.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.458 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -66.96 -42.77 84.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.555 HD13 ' CE2' ' A' ' 5' ' ' PHE . 79.7 mt -63.39 -42.1 98.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -63.13 -47.39 82.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 109.411 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.7 m -58.2 -37.88 75.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.407 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.82 95.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -67.45 -39.66 85.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.62 63.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.55 -49.38 76.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.61 86.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.32 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -57.41 -38.53 74.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . -57.79 -49.07 77.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.728 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.2 mm? -75.9 -37.24 59.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.309 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.604 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 51.2 t80 -58.35 -51.81 68.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -62.87 -32.17 73.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.411 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.94 70.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 109.319 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.722 HG23 HG21 ' A' ' 29' ' ' VAL . 29.4 mt -62.91 -45.13 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.723 ' HG3' HG21 ' A' ' 13' ' ' VAL . 82.7 tt0 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.267 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.4 -37.26 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.149 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.605 ' CE2' ' CE1' ' A' ' 153' ' ' HIS . 49.1 t80 -67.92 -41.25 82.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 12.9 mt -55.44 -34.9 64.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.427 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.2 mt -78.58 -28.25 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -20.79 59.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.455 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.605 ' CE1' ' CE2' ' A' ' 149' ' ' TYR . 74.9 m80 -130.32 90.3 41.97 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.46 -16.12 34.55 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.779 2.319 . . . . 0.0 111.815 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.37 -17.49 60.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.605 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 79.3 t80 -75.1 121.45 22.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.696 ' CB ' HG23 ' A' ' 17' ' ' THR . 5.8 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.463 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 119' ' ' TYR . 91.5 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -129.39 130.98 46.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' VAL . 98.4 m -113.35 145.01 41.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 91.3 m-85 -136.37 128.63 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.978 . . . . 0.0 109.676 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 77.0 tt0 -96.43 131.3 43.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 136' ' ' LYS . 6.5 m-20 -128.0 164.93 21.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -100.9 151.56 21.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.97 128.57 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.14 125.4 37.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.58 129.67 5.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.35 -0.03 6.8 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.661 2.241 . . . . 0.0 111.865 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -87.59 151.36 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.675 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.23 142.92 97.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 109.503 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.9 Cg_endo -68.55 -35.78 16.5 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.769 2.312 . . . . 0.0 111.814 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.32 80.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 157' ' ' ASN . 56.2 m -79.23 -40.93 29.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 HD11 ' A' ' 150' ' ' LEU . 22.3 tp -67.41 -38.8 85.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.606 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.648 ' CG ' HD22 ' A' ' 78' ' ' LEU . 68.1 t80 -69.55 -40.43 76.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 38.1 tptt -65.64 -46.93 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -75.03 -30.35 61.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.906 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.4 mt -58.71 -49.24 78.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.783 . . . . 0.0 109.722 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.51 -46.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.889 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -71.81 -50.87 25.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 62.5 t0 -85.15 7.56 21.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.012 . . . . 0.0 109.727 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -59.21 -49.7 76.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.937 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.7 m-20 -66.32 -31.27 71.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.819 . . . . 0.0 109.986 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 24.4 m-20 -87.3 -28.39 22.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.686 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 HG23 ' A' ' 146' ' ' ILE . 7.6 p -81.24 -36.75 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.655 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -53.24 -48.31 92.81 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.984 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -67.94 -34.55 23.16 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 111.943 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 18.2 mttp -83.23 -40.59 19.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.163 -0.961 . . . . 0.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -58.42 -61.7 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.938 HD21 ' HB2' ' A' ' 57' ' ' PHE . 47.5 tp -64.55 108.8 1.77 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 108.927 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.44 -35.41 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -96.81 27.18 4.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.941 -1.099 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.853 ' HA ' HD23 ' A' ' 34' ' ' LEU . 50.9 t80 -59.33 136.29 57.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 39' ' ' SER . 55.0 tttt -97.87 -49.77 4.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 110.051 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.51 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 83.1 p -178.69 171.87 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.986 . . . . 0.0 109.753 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.4 p -134.25 122.56 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.4 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 42' ' ' ASN . 18.0 tt0 -126.13 158.25 35.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' N ' ' CG ' ' A' ' 41' ' ' GLU . 45.4 m-20 -105.7 154.39 20.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.2 m -117.53 -34.92 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 85.1 mt-10 -158.3 145.78 18.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 98.43 162.0 30.34 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.78 2.86 49.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -1.113 . . . . 0.0 109.566 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 112.6 -10.32 25.9 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.24 -153.37 10.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.29 139.5 38.54 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 C-N-CA 122.714 2.276 . . . . 0.0 111.798 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.59 -1.18 86.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.639 ' O ' HD13 ' A' ' 52' ' ' ILE . 90.8 m -71.91 153.5 41.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -1.21 . . . . 0.0 109.63 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 51' ' ' THR . 14.6 mm -117.91 127.83 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -123.78 148.37 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 109.786 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 27.1 tttm -115.32 126.16 54.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 66' ' ' VAL . 84.9 mt -113.73 143.22 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.568 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 40.7 m -129.74 128.69 42.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.938 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.5 p90 -134.5 169.03 17.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 142.9 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.419 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.5 128.91 15.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 49.74 24.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 28.25 41.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -122.36 154.4 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.6 m -98.49 107.13 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.334 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 36.0 mttt -116.09 160.08 20.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -144.93 157.03 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.627 ' C ' HD23 ' A' ' 67' ' ' LEU . 17.1 m -137.25 145.82 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.707 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.775 HD12 ' HA3' ' A' ' 86' ' ' GLY . 8.5 mt -114.18 133.89 55.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.878 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -126.1 139.32 53.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 38.3 tttm -121.11 144.78 48.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.285 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 10.6 mm -102.79 125.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.443 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 92.0 mt-10 -82.97 -54.2 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.865 . . . . 0.0 109.33 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.6 t -162.39 136.97 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 70' ' ' ILE . 58.1 mt -113.41 134.76 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.403 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -129.83 79.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -50.96 -34.99 31.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.25 -49.43 64.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.674 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.497 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 59.9 m-20 -100.52 14.57 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.648 HD22 ' CG ' ' A' ' 19' ' ' TYR . 40.1 mt 42.43 41.21 2.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.84 106.42 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -109.79 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.691 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 p -136.07 142.83 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.4 p90 -152.85 157.6 40.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 109.656 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 12.4 p -142.2 153.91 44.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.4 p -103.37 128.31 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.577 HG12 ' CD ' ' A' ' 96' ' ' LYS . 2.3 m -122.3 6.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.775 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.89 147.88 16.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.89 179.66 16.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.22 -13.81 59.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' ' NZ ' ' A' ' 138' ' ' LYS . . . -79.99 -8.94 59.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 85' ' ' VAL . 4.5 tp -100.0 102.73 18.72 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.874 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -68.65 152.29 74.55 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.724 2.282 . . . . 0.0 111.836 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.96 -29.32 60.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.867 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.7 p -79.57 3.75 17.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.078 -1.014 . . . . 0.0 109.818 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.874 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.37 128.92 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 5.7 tt0 -63.82 -55.0 26.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' HG12 ' A' ' 85' ' ' VAL . 89.5 mttt -161.51 160.94 29.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 83' ' ' SER . 17.0 mt -126.15 132.78 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 34.6 m -118.55 115.89 25.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.842 ' CD1' HG23 ' A' ' 117' ' ' VAL . 69.5 m-85 -94.41 128.53 41.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 109.67 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 116' ' ' THR . 13.8 t0 -116.84 116.52 27.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.254 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 12.2 t -133.06 136.34 45.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.919 ' C ' HD22 ' A' ' 103' ' ' LEU . 28.9 tttt -122.74 144.81 48.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.919 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.4 mm? -128.36 124.04 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -133.75 162.55 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 109.059 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -60.87 125.33 23.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.057 -1.027 . . . . 0.0 109.514 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.79 150.28 19.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.58 2.33 4.1 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.647 2.231 . . . . 0.0 111.971 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.24 5.7 50.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.605 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.73 22.14 51.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -138.67 3.49 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -120.46 142.59 49.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -1.187 . . . . 0.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.55 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.28 147.37 30.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -166.26 -151.94 7.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -133.44 142.73 48.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -1.128 . . . . 0.0 109.261 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 116' ' ' THR . 4.8 tt -120.61 126.53 50.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.784 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.677 ' N ' HD23 ' A' ' 115' ' ' LEU . 68.0 m -125.72 124.85 41.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 108.849 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 99' ' ' PHE . 1.1 p -108.08 142.47 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.061 -1.025 . . . . 0.0 110.128 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 69.2 tttt -119.93 116.61 26.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 108.964 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.656 ' O ' HG13 ' A' ' 2' ' ' VAL . 15.3 t80 -102.68 130.51 49.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.137 -0.977 . . . . 0.0 109.667 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 2' ' ' VAL . 79.2 mt-10 -111.75 127.22 55.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 32.8 p -110.94 157.52 19.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.543 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -58.36 -39.23 78.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 -93.21 0.1 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -67.41 -31.65 72.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.13 115.19 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.89 108.48 28.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 117.95 5.4 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.783 2.322 . . . . 0.0 111.844 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -59.87 157.06 13.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -56.35 -38.57 71.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.82 -31.34 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.252 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 131' ' ' GLU . 63.2 mm-40 -74.38 -36.85 63.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 108.7 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.98 -35.8 69.6 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -60.63 -48.03 83.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.18 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.2 m -58.33 -39.02 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.44 99.35 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 7' ' ' ASP . 29.5 tttt -73.06 -41.78 63.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -1.111 . . . . 0.0 109.362 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.05 -34.96 70.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.642 ' NZ ' ' HB2' ' A' ' 89' ' ' ALA . 41.2 tttm -71.25 -44.76 64.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.252 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.93 89.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.837 . . . . 0.0 109.353 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.534 ' HB3' ' HE3' ' A' ' 144' ' ' LYS . 89.5 m-20 -50.95 -47.54 61.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.291 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.33 57.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.464 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 142' ' ' LEU . 3.1 tm? -70.62 -53.36 16.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.93 -53.63 54.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 108.948 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.534 ' HE3' ' HB3' ' A' ' 140' ' ' ASP . 49.4 mttt -51.93 -37.85 54.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.45 -45.83 80.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.28 -0.887 . . . . 0.0 108.989 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 29' ' ' VAL . 16.7 mt -69.07 -54.72 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.225 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -59.64 -52.65 64.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.341 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . -48.83 -39.19 24.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.062 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.535 ' OH ' ' CD2' ' A' ' 153' ' ' HIS . 35.1 t80 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.211 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 24.6 mt -58.82 -41.09 86.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.27 -29.64 67.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.918 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.0 -17.66 56.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CD2' ' OH ' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -125.74 85.77 58.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.575 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.44 -20.54 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.682 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -79.38 -1.45 37.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 157' ' ' ASN . 59.6 t80 -68.81 143.56 54.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 17' ' ' THR . 7.2 m120 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' N ' ' OE2' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 120' ' ' GLU . 70.0 t -138.15 137.43 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -1.145 . . . . 0.0 109.501 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.707 ' HE2' HG21 ' A' ' 121' ' ' THR . 89.0 m-85 -125.06 143.04 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.0 m -126.13 125.29 42.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.832 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.9 m-85 -121.72 139.1 54.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -112.9 133.56 54.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD2' ' CE ' ' A' ' 136' ' ' LYS . 49.1 t0 -132.3 165.0 25.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 87.2 mt-10 -101.84 157.9 16.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 27.2 mt -124.28 135.93 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 23.6 m120 -142.14 130.93 22.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.23 135.17 9.18 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.912 . . . . 0.0 109.481 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.49 -6.27 18.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.653 2.236 . . . . 0.0 111.794 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.935 HG21 HD23 ' A' ' 150' ' ' LEU . 2.7 p -87.16 150.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.33 136.84 60.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.07 -32.32 28.16 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.19 64.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -75.37 -38.63 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD22 ' A' ' 150' ' ' LEU . 39.6 tp -69.49 -39.65 77.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.9 t80 -64.68 -46.89 80.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HE2' HG21 ' A' ' 24' ' ' THR . 5.7 tptm -63.29 -46.16 88.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 156' ' ' TYR . . . -72.12 -17.91 61.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.949 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.6 tp -80.05 -50.17 10.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.815 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 -45.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.535 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -71.09 -50.46 33.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.3 t70 -95.03 17.09 14.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -54.55 -52.84 60.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' OD1' HG11 ' A' ' 40' ' ' VAL . 44.8 t0 -66.32 -26.07 67.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 59.0 m-20 -88.04 -26.61 22.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 109.449 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.077 HG11 HG23 ' A' ' 146' ' ' ILE . 75.3 t -82.27 -40.15 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.939 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.8 mt -49.47 -48.68 74.86 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.31 -34.61 20.77 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.355 2.036 . . . . 0.0 111.839 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 48.4 mttt -79.96 -40.43 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.063 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.96 88.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.268 -0.895 . . . . 0.0 108.878 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.849 HD21 ' HB2' ' A' ' 57' ' ' PHE . 40.5 tp -83.54 102.54 12.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 108.967 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.41 -35.6 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.3 p -97.73 29.5 3.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.982 . . . . 0.0 109.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.763 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.2 t80 -54.69 119.83 5.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -84.89 -55.66 3.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.618 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.602 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 60.6 p -175.1 168.23 3.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.63 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.576 HG11 ' OD1' ' A' ' 27' ' ' ASP . 7.2 p -144.08 142.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.386 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 40' ' ' VAL . 65.2 mt-10 -149.89 155.64 40.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 85.4 m-20 -96.57 121.97 38.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.4 m -79.97 -27.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' THR . 26.0 mt-10 -163.17 152.02 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 90.4 157.69 33.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.97 9.44 43.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.566 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 51' ' ' THR . . . 107.62 -6.93 36.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.36 -160.46 22.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.0 129.04 16.67 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.691 2.261 . . . . 0.0 111.714 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 89.88 2.31 75.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.491 ' C ' HD13 ' A' ' 52' ' ' ILE . 14.3 m -75.05 152.46 38.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -1.148 . . . . 0.0 109.604 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 8.3 mm -114.05 124.03 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.072 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 96.8 mttt -118.78 143.65 46.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 15.6 tttp -115.95 128.49 55.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 30' ' ' ILE . 49.2 mt -117.95 143.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 28.2 m -120.54 133.22 55.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.36 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.849 ' HB2' HD21 ' A' ' 34' ' ' LEU . 33.5 p90 -134.47 154.26 51.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -96.97 123.46 40.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.301 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -136.63 126.85 26.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.616 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 56.89 35.53 26.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.68 9.98 53.29 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -109.04 133.88 52.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -79.2 119.4 22.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 57' ' ' PHE . 24.3 mttt -123.64 165.6 16.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 32.7 p90 -146.01 159.87 42.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.637 ' C ' HD23 ' A' ' 67' ' ' LEU . 35.7 m -134.82 143.37 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 109.728 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.637 HD23 ' C ' ' A' ' 66' ' ' VAL . 8.5 mt -112.42 131.86 55.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 0.0 109.105 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -127.79 141.25 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.611 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 28.3 tttt -121.32 150.94 40.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.267 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 37.9 mt -112.59 133.95 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 94.2 mt-10 -92.02 -32.69 15.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.6 p -176.97 147.2 0.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.85 138.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -133.36 76.12 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.45 -37.72 84.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.17 -47.31 68.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -95.57 11.96 31.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 48.45 51.21 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.56 148.72 20.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 19.4 p90 -151.05 167.76 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 109.215 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 37.4 m -126.88 138.57 53.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.454 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 15.5 p90 -152.53 155.43 37.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.0 p -146.83 156.16 42.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 89' ' ' ALA . 6.7 p -93.04 133.37 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG13 ' CE ' ' A' ' 96' ' ' LYS . 2.9 t -123.77 0.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.018 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -167.34 157.18 29.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.35 173.52 21.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.94 -13.01 29.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -82.89 16.84 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 1.2 tt -120.97 103.82 42.35 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.13 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.2 Cg_endo -68.38 151.19 76.25 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.739 2.293 . . . . 0.0 111.866 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 47.7 m-20 -79.36 -32.55 43.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.6 p -79.6 -0.97 35.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.756 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.13 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.38 126.85 43.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.379 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 46.4 mt-10 -58.85 -54.11 50.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 85.9 mttt -160.82 163.63 31.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 mt -122.99 132.98 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 2.2 m -108.87 144.53 36.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.642 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.606 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.2 m-85 -126.52 120.86 30.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 0.0 109.8 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 59.2 t0 -119.9 102.4 8.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.15 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.522 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.9 t -119.06 140.58 49.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.128 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 1.039 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.6 tttt -119.36 163.72 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 109.122 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.039 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -133.45 123.46 25.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.63 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.67 143.03 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 109.315 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.37 58.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.528 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -126.6 162.65 20.72 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.82 -13.38 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.694 2.263 . . . . 0.0 111.776 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.57 -23.29 65.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.563 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.88 18.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.02 -140.06 3.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 87.0 p -110.08 145.92 36.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.6 41.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.453 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.83 171.19 35.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -105.53 142.45 35.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -1.189 . . . . 0.0 109.377 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 101' ' ' SER . 60.9 tp -115.55 136.89 52.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.585 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 30.4 m -127.8 125.57 40.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.35 131.95 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.52 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -113.39 122.16 46.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.957 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.1 t80 -110.76 119.99 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.553 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' HG3' HG22 ' A' ' 2' ' ' VAL . 77.1 tt0 -103.45 145.33 30.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.707 HG21 ' HE2' ' A' ' 3' ' ' PHE . 26.2 p -120.62 151.69 39.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 28.0 mttt -49.78 -43.42 48.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 177.24 -111.64 0.34 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.45 -44.13 89.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.74 134.47 36.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.574 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 98.9 mt-10 -149.6 132.1 7.97 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.603 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.58 139.52 37.55 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.679 2.253 . . . . 0.0 111.783 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -64.15 177.48 0.81 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.315 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.02 -42.29 89.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.62 -47.11 86.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.6 -40.41 79.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.832 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 79.7 mt -61.92 -37.33 84.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -59.97 -49.48 77.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.265 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.3 m -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.02 -41.87 98.42 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' CE ' ' OD2' ' A' ' 7' ' ' ASP . 49.6 tttp -70.28 -40.39 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -1.109 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.19 64.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.424 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -65.25 -46.21 81.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.78 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 70.5 m-20 -50.81 -29.77 12.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.77 76.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.872 . . . . 0.0 109.239 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 142' ' ' LEU . 20.2 mt -76.01 -43.86 42.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 18' ' ' LEU . 75.2 t80 -56.03 -54.68 41.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 77.4 mttt -50.46 -40.49 50.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.71 -48.81 80.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.237 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.077 HG23 HG11 ' A' ' 29' ' ' VAL . 34.0 mt -68.81 -44.48 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -62.34 -45.06 94.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.325 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.08 70.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 39.5 t80 -67.14 -46.0 75.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.935 HD23 HG21 ' A' ' 13' ' ' VAL . 9.5 mp -61.22 -43.49 98.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.6 mt -69.38 -36.17 76.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.26 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -127.07 84.05 64.46 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.68 -19.24 36.77 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.645 2.23 . . . . 0.0 111.725 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -72.79 -12.26 60.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 41.7 t80 -77.52 125.87 30.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.569 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 7.3 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.635 HG11 ' NZ ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -129.92 147.64 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.164 . . . . 0.0 109.348 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.456 ' CE1' ' HD2' ' A' ' 127' ' ' PRO . 97.1 m-85 -80.05 118.73 22.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 28.8 m -111.17 116.53 31.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.704 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.3 m-85 -108.91 163.67 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.688 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 46.0 mt-10 -130.34 132.47 45.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.253 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -132.91 166.23 22.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.27 140.99 36.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HG ' ' A' ' 115' ' ' LEU . 74.6 mt -114.15 136.69 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.307 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -151.76 138.99 19.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' HB3' ' OE1' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -153.07 144.7 16.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HG2' HD11 ' A' ' 151' ' ' LEU . 49.4 Cg_endo -70.25 -5.02 15.54 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 122.699 2.266 . . . . 0.0 111.794 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.94 HG21 HD23 ' A' ' 150' ' ' LEU . 7.1 p -92.88 151.62 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.14 79.19 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.3 Cg_endo -68.07 -30.61 31.73 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.71 2.273 . . . . 0.0 111.85 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.24 -36.0 61.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 157' ' ' ASN . 58.6 m -76.7 -38.89 53.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.495 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 150' ' ' LEU . 33.3 tp -68.13 -39.36 82.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 85.2 t80 -66.04 -44.59 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 0.0 109.785 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.872 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.1 tptt -63.83 -46.76 83.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 109.681 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -72.56 -17.67 61.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.544 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.948 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 51.1 tp -79.52 -49.05 12.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.39 -48.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.872 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.9 m -64.99 -49.43 70.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.9 m-20 -97.27 12.19 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -48.66 -53.56 18.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.338 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.798 ' HA ' HD12 ' A' ' 30' ' ' ILE . 73.7 m-20 -66.92 -23.56 65.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.927 . . . . 0.0 109.543 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 92.0 m-20 -87.23 -26.76 23.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD12 ' A' ' 146' ' ' ILE . 85.7 t -81.55 -35.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.4 mt -53.68 -48.59 92.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.25 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.9 Cg_endo -67.23 -19.73 50.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.524 2.149 . . . . 0.0 112.251 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 35.4 mttm -104.12 -45.82 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 109.347 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -59.89 -45.8 91.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 57' ' ' PHE . 55.0 tp -79.63 107.13 12.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 108.878 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.46 -44.73 85.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -92.14 29.75 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.828 -1.17 . . . . 0.0 110.344 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 54.4 t80 -58.38 123.75 17.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.02 -1.05 . . . . 0.0 109.363 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.36 -52.4 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -177.49 170.37 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.493 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.73 135.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -135.18 134.97 40.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.13 137.8 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.1 m -99.96 -36.83 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.433 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 43' ' ' VAL . 55.9 mt-10 -158.7 146.25 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.65 155.18 20.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -109.38 29.72 7.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -1.142 . . . . 0.0 109.583 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.78 -21.98 38.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.48 -162.42 5.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.4 160.55 49.14 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.66 2.24 . . . . 0.0 111.749 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 63.16 12.12 42.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -76.36 153.69 35.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.0 109.521 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 9.4 mm -117.39 126.94 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -119.88 144.51 47.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.706 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.7 tttt -115.29 128.97 56.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 66' ' ' VAL . 67.8 mt -117.41 145.64 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.3 m -124.43 125.15 43.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 109.298 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.893 ' HB2' HD21 ' A' ' 34' ' ' LEU . 48.0 p90 -133.66 158.21 43.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -99.22 150.14 22.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' OE1' ' CE ' ' A' ' 64' ' ' LYS . 57.7 tt0 -152.97 129.81 10.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.566 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 48.13 23.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.38 29.4 36.73 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' GLU . 96.9 mt-10 -123.71 155.39 37.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.8 m -97.86 112.26 24.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 62.3 mttt -124.67 158.63 32.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 30.0 p90 -142.76 157.6 44.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 55' ' ' ILE . 33.3 m -132.76 142.8 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.131 -0.98 . . . . 0.0 109.608 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.599 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.5 mt -110.29 125.42 53.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -116.01 133.86 55.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 64.0 tttt -120.59 146.06 46.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.195 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 66.1 mt -113.31 138.28 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.551 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.1 -42.61 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -161.58 142.75 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 109.499 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -109.88 140.71 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.48 77.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.398 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.488 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.6 mt-10 -57.29 -38.17 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.443 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.05 -47.73 64.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -95.01 12.67 27.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.1 mt 47.72 31.54 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.408 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.94 152.79 19.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.511 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.5 p90 -150.24 169.65 20.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -1.124 . . . . 0.0 109.26 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -125.97 139.28 53.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 25.9 p90 -154.29 160.76 41.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 51.7 p -146.19 156.48 43.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -86.36 132.15 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG13 ' HE2' ' A' ' 96' ' ' LYS . 4.1 t -117.67 -5.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.781 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -171.96 162.71 34.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 122.54 160.43 10.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.05 -15.16 20.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -1.079 . . . . 0.0 109.296 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.93 -6.03 56.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.338 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tt -79.98 110.19 15.13 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 109.356 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.027 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.21 146.42 63.52 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.747 2.298 . . . . 0.0 111.695 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 62.5 m-20 -78.89 -32.65 45.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.9 p -79.86 -5.44 55.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.727 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -122.75 136.92 55.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.058 -1.026 . . . . 0.0 109.624 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 81.1 mt-10 -70.63 -51.31 28.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' HG13 ' A' ' 85' ' ' VAL . 31.7 mttt -161.21 163.55 31.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 118' ' ' LYS . 60.3 mt -124.01 133.1 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.87 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 6.1 m -109.52 125.52 52.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.0 m-85 -108.79 122.87 48.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 56.7 t0 -120.42 102.63 8.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.933 . . . . 0.0 109.252 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 17.1 m -119.44 139.57 51.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.909 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HD23 ' A' ' 103' ' ' LEU . 31.6 ttpt -120.58 156.87 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.415 -0.803 . . . . 0.0 108.964 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 62.3 mt -129.54 127.5 40.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.5 m -139.61 142.97 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.33 54.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.25 170.63 22.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.13 -8.94 24.84 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.684 2.256 . . . . 0.0 111.853 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -67.9 -24.94 65.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.32 44.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.98 -143.32 4.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 85.3 p -106.1 144.74 32.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.12 30.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.41 -165.52 32.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.11 145.14 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -117.69 132.37 56.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.569 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 115' ' ' LEU . 20.1 m -122.11 128.69 51.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.269 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 4' ' ' THR . 49.2 t -107.7 131.35 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 31.8 tttm -112.66 121.41 44.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.84 . . . . 0.0 109.225 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.657 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t80 -116.48 114.32 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.544 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -101.12 138.05 38.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.092 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.9 p -116.42 164.32 14.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 41.3 mttt -55.22 -43.05 74.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.47 -106.88 0.21 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 125' ' ' ALA . 86.1 m-20 -63.32 -42.84 99.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 109.449 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -44.63 130.47 6.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 4.9 mt-10 -134.91 133.17 20.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.4 Cg_endo -70.44 158.13 56.99 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.613 2.209 . . . . 0.0 111.742 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.7 OUTLIER -90.93 164.99 13.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.95 -40.66 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.41 -46.63 89.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 64.7 mm-40 -58.11 -45.61 86.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.704 HD13 ' CE2' ' A' ' 5' ' ' PHE . 58.4 mt -59.55 -38.31 80.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -61.27 -48.55 80.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.35 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.4 m -58.83 -38.54 78.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.324 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -46.0 95.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.466 ' CD ' HG21 ' A' ' 117' ' ' VAL . 4.8 mtmt -64.94 -38.82 92.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.0 62.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.49 -45.99 84.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.359 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.3 -55.35 10.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -54.06 -35.72 62.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.39 -46.96 82.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.992 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.8 tm? -71.19 -33.57 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.202 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -56.07 -52.75 63.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.953 . . . . 0.0 109.125 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -51.76 -39.84 59.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.156 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.461 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.03 -38.71 73.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.305 -0.872 . . . . 0.0 109.053 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 142' ' ' LEU . 7.6 mm -71.68 -44.35 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.234 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.501 ' OE1' HG12 ' A' ' 13' ' ' VAL . 30.6 tp10 -67.69 -41.63 83.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.86 -34.28 74.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.95 -46.68 64.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.94 HD23 HG21 ' A' ' 13' ' ' VAL . 6.7 mp -63.26 -43.77 97.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 12' ' ' PRO . 82.0 mt -68.05 -33.48 74.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.71 -17.82 61.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -129.56 95.07 30.72 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.6 -16.58 34.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.699 2.266 . . . . 0.0 111.72 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -73.43 -20.73 60.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 70.8 t80 -79.89 129.92 34.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG22 ' HG3' ' A' ' 120' ' ' GLU . 87.0 t -138.26 137.67 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.571 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.4 m-85 -124.28 146.5 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.6 m -128.31 135.0 49.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 71.5 m-85 -126.39 160.0 31.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' CD ' ' HE2' ' A' ' 114' ' ' LYS . 71.7 mt-10 -135.93 129.26 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -133.26 165.13 25.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 8' ' ' GLU . 68.5 mm-40 -104.68 151.83 23.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 115' ' ' LEU . 47.4 mt -121.53 134.91 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 25.7 m120 -144.72 131.34 19.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.549 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 2.0 p -148.02 144.54 19.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.787 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.0 Cg_endo -71.48 1.38 5.63 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.415 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CG1' ' OG ' ' A' ' 11' ' ' SER . 2.4 p -97.89 152.78 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.55 137.9 61.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 111' ' ' SER . 47.1 Cg_endo -67.98 -35.16 21.2 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.744 2.296 . . . . 0.0 111.826 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.89 68.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.29 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 157' ' ' ASN . 68.1 m -78.55 -35.25 46.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 150' ' ' LEU . 14.5 tp -70.62 -40.59 73.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.368 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.771 ' HB2' HD12 ' A' ' 103' ' ' LEU . 91.3 t80 -65.51 -49.78 67.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.682 ' CE ' HG21 ' A' ' 24' ' ' THR . 7.3 tptm -59.77 -46.26 89.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -70.54 -18.63 62.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.04 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 13.4 mt -80.13 -46.16 16.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 109.749 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.52 -45.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.17 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.682 HG21 ' CE ' ' A' ' 20' ' ' LYS . 16.4 m -74.78 -50.05 18.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.334 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.6 t70 -92.12 9.18 34.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.047 -1.033 . . . . 0.0 109.819 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.04 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -51.05 -52.45 43.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 93.8 m-20 -65.19 -29.48 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.379 -0.826 . . . . 0.0 109.748 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.504 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 85.7 m-20 -84.41 -26.36 28.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 146' ' ' ILE . 45.0 t -80.77 -37.14 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -50.04 -49.48 74.76 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -68.37 -25.23 36.2 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.357 2.038 . . . . 0.0 111.97 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 59.6 mmtt -91.94 -33.31 14.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.149 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.65 -43.05 60.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -0.868 . . . . 0.0 109.046 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.61 106.6 18.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.016 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.26 -33.26 69.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.944 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 9.7 m -98.2 29.55 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 0.0 109.882 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 39' ' ' SER . 56.3 t80 -58.35 126.48 27.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -92.08 -52.04 4.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.62 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 54.3 p -177.66 170.85 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 109.722 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.6 p -142.33 140.32 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.308 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -145.93 153.79 41.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 7.1 m-20 -87.23 140.67 29.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 2.7 t -91.17 -39.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.644 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 51' ' ' THR . 87.9 mt-10 -161.03 149.21 15.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.448 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 96.16 167.36 34.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -98.14 8.14 45.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.91 -6.37 35.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.79 17.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.69 130.7 19.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.658 2.239 . . . . 0.0 111.758 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.5 3.49 69.04 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.7 m -77.76 155.19 31.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -1.178 . . . . 0.0 109.571 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 43' ' ' VAL . 21.1 mm -118.79 128.31 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.942 . . . . 0.0 109.308 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.7 mttp -122.52 147.72 46.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.614 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.3 tttm -116.98 129.3 55.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 40' ' ' VAL . 14.8 mm -116.28 146.21 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.528 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 23.5 m -130.71 121.59 25.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.903 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 47.6 p90 -129.1 160.8 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.2 mm? -96.25 148.56 22.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -150.37 127.74 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 52.36 22.71 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.45 10.86 72.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -108.35 159.12 16.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -1.11 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.6 m -104.93 115.47 30.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -121.22 164.68 16.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.49 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 45.6 p90 -143.75 156.47 44.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.844 ' C ' HD23 ' A' ' 67' ' ' LEU . 27.1 m -135.85 144.7 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.557 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.844 HD23 ' C ' ' A' ' 66' ' ' VAL . 2.5 mt -109.87 126.79 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.219 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -118.5 134.84 54.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 17.8 tttm -116.05 147.21 41.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' GLY . 12.2 mm -106.83 126.54 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.4 mt-10 -87.32 -42.88 12.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 p -168.04 148.46 4.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.01 135.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -133.12 75.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.352 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.25 -36.67 78.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -48.74 72.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.463 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 49.3 m-20 -90.63 13.01 17.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.7 mt 47.53 49.27 16.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.472 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -148.73 153.9 25.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.3 p90 -150.38 169.47 21.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -1.124 . . . . 0.0 109.133 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 62.7 m -131.09 140.75 50.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 24.1 p90 -155.76 162.6 40.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.578 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 51.9 p -146.36 156.53 43.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.51 133.32 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.541 ' C ' HD13 ' A' ' 90' ' ' LEU . 19.4 t -106.87 -7.93 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.478 ' C ' ' HG ' ' A' ' 67' ' ' LEU . . . 171.27 -179.06 43.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.75 166.02 27.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.84 -20.75 2.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -1.116 . . . . 0.0 109.379 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -79.92 -15.73 56.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -90.65 106.96 17.15 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.307 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.033 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.5 Cg_endo -69.58 146.26 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.728 2.285 . . . . 0.0 111.901 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.45 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 79.3 m-20 -77.47 -30.97 53.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 p -79.95 1.18 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.849 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.56 126.32 41.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' OE1' ' OE2' ' A' ' 120' ' ' GLU . 92.8 mt-10 -58.15 -42.4 85.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -178.54 157.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.359 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 118' ' ' LYS . 63.8 mt -119.67 135.56 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.532 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 34.6 m -109.62 128.2 55.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.752 ' CE1' HG13 ' A' ' 117' ' ' VAL . 94.2 m-85 -111.27 124.65 52.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.508 ' O ' HD12 ' A' ' 115' ' ' LEU . 57.2 t0 -120.09 105.0 10.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.647 ' CB ' HD13 ' A' ' 115' ' ' LEU . 8.5 t -114.5 141.0 48.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 103' ' ' LEU . 74.1 tttt -127.7 146.86 50.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.86 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 19' ' ' TYR . 46.5 mt -122.68 127.6 49.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.799 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.8 m -138.86 143.43 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -62.65 139.77 58.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.52 165.3 22.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.01 22.51 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.647 2.231 . . . . 0.0 111.831 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.16 -28.14 69.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.79 10.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.35 -134.44 2.08 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 100.0 p -108.42 143.16 37.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -1.129 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.94 141.97 27.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.57 -168.54 35.45 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HE2' ' CD ' ' A' ' 6' ' ' GLU . 69.2 tttt -125.83 140.72 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -1.121 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 101' ' ' SER . 25.0 tp -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.1 m -126.83 127.1 44.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' CE1' ' A' ' 99' ' ' PHE . 58.6 t -111.81 132.7 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 97' ' ' ILE . 33.8 ttpt -111.72 125.31 53.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 55.6 t80 -113.0 118.75 35.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 2' ' ' VAL . 87.0 tt0 -103.44 146.78 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.399 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 11.8 p -119.77 157.19 29.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.397 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.2 mttt -45.9 -37.71 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.66 -96.4 0.16 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.18 -32.15 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -1.148 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.51 137.77 57.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -145.59 110.44 4.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 47.9 Cg_endo -69.77 144.48 54.1 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.728 2.285 . . . . 0.0 111.772 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 131' ' ' GLU . 48.4 p30 -70.49 172.87 7.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.71 -35.1 78.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.579 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.47 -44.3 89.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.405 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 94.4 mt-10 -66.84 -39.99 87.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 95.7 mt -63.77 -42.93 97.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.46 -44.72 90.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.268 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.3 m -57.53 -38.66 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.04 97.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -62.98 -38.61 91.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -51.71 -32.04 28.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.444 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -75.86 -36.65 59.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.22 -55.29 8.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.877 . . . . 0.0 109.569 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 4.2 p30 -62.11 -26.03 68.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.499 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 140' ' ' ASP . . . -58.76 -50.98 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.895 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 6.4 tp -58.24 -38.16 76.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.883 . . . . 0.0 109.292 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.02 -54.95 38.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.128 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -51.54 -33.74 33.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -60.85 -53.72 53.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.247 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.919 HG23 HG11 ' A' ' 29' ' ' VAL . 45.0 mt -67.37 -53.55 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -50.48 -51.0 51.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.46 70.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 35.9 t80 -66.5 -39.72 88.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.394 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 18' ' ' LEU . 13.0 mt -61.21 -43.12 99.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 ' HG2' ' A' ' 12' ' ' PRO . 83.3 mt -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.37 61.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.595 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 93.85 46.59 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.81 -21.46 33.2 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.683 2.255 . . . . 0.0 111.759 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -75.42 -17.88 60.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 57.5 t80 -78.74 118.67 21.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.47 ' HA ' HG21 ' A' ' 17' ' ' THR . 75.6 m-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.609 HG11 ' HE3' ' A' ' 118' ' ' LYS . 88.5 t -132.87 137.12 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.513 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.42 146.88 49.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -130.62 130.46 44.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.888 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 132' ' ' LEU . 88.0 m-85 -129.28 160.92 31.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -127.9 130.11 47.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -126.22 164.71 20.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -94.51 160.47 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 61.4 mt -128.12 142.38 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.36 132.11 42.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -152.42 112.67 2.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.25 -2.22 10.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.581 2.187 . . . . 0.0 111.726 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.061 ' HB ' HD11 ' A' ' 18' ' ' LEU . 68.0 t -95.2 154.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 132.39 26.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.0 Cg_endo -67.93 -29.64 34.15 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.745 2.296 . . . . 0.0 111.939 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.88 -34.05 62.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 157' ' ' ASN . 90.2 m -77.31 -37.4 52.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.061 HD11 ' HB ' ' A' ' 13' ' ' VAL . 9.0 mt -69.24 -40.25 78.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.54 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 68.6 t80 -65.88 -45.54 81.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.3 OUTLIER -64.48 -47.6 78.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -70.34 -20.84 62.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.333 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.2 tt -80.13 -45.49 18.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -98.36 -54.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 20' ' ' LYS . 20.7 m -63.69 -49.5 72.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.577 ' OD2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 m-20 -95.61 13.59 25.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.074 -1.017 . . . . 0.0 109.938 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.01 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -53.3 -52.87 57.71 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.193 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 63.9 t0 -67.61 -23.02 65.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.97 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 7.6 m120 -90.94 -27.42 18.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 25' ' ' ASP . 8.9 p -83.51 -35.07 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.01 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -56.63 -46.47 99.83 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.4 Cg_endo -66.72 -22.18 50.42 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.456 2.104 . . . . 0.0 112.42 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -108.47 -26.0 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.115 -0.991 . . . . 0.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -63.49 -28.61 70.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.969 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 57' ' ' PHE . 42.2 tp -101.02 117.52 35.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.032 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.77 -44.07 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.532 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 57.9 m -93.02 28.17 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.891 -1.131 . . . . 0.0 110.072 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CE1' HG22 ' A' ' 30' ' ' ILE . 46.6 t80 -58.83 131.61 51.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.0 tttp -93.03 -51.08 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.933 . . . . 0.0 110.103 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.464 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 67.0 p -179.91 173.77 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 109.938 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 9.7 p -135.69 128.35 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.205 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 70.0 mm-40 -130.0 144.03 51.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.27 125.64 30.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 50.0 t -82.69 -44.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.562 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 51' ' ' THR . 81.7 tt0 -158.49 145.59 17.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.4 168.21 28.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.84 5.68 50.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -1.152 . . . . 0.0 109.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.28 -8.45 28.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -156.76 12.35 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.02 135.68 30.44 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.701 2.267 . . . . 0.0 111.774 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.25 1.5 84.06 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 44' ' ' GLU . 91.5 m -80.02 127.68 32.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 109.481 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 20.6 mm -93.29 134.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -125.77 150.75 47.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.742 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.5 tttt -115.33 126.45 54.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.644 ' HB ' HG22 ' A' ' 66' ' ' VAL . 56.4 mt -111.77 141.01 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -125.39 123.41 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.894 ' HB2' HD21 ' A' ' 34' ' ' LEU . 41.1 p90 -128.71 166.84 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.27 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -99.35 151.39 21.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.501 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -154.13 119.0 4.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.927 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.12 31.78 7.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.26 -7.09 65.15 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' OE2' ' HE2' ' A' ' 64' ' ' LYS . 72.8 tt0 -91.25 144.51 25.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -1.145 . . . . 0.0 109.419 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.7 m -95.79 120.15 35.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 12.7 mmtt -125.69 169.81 12.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 67' ' ' LEU . 5.0 p90 -147.93 161.39 41.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.668 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.8 m -137.94 147.18 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.742 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.9 mp -115.3 134.3 55.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.489 ' HD2' HG22 ' A' ' 84' ' ' VAL . 39.9 m170 -128.67 141.99 51.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 66.4 tttt -120.82 147.68 45.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 109.356 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.7 mt -108.61 132.2 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 92.9 mt-10 -87.6 -38.8 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.425 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 p -176.78 150.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.03 137.16 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -131.46 79.43 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -61.86 -37.76 85.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.55 63.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.455 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 56.5 m-20 -90.58 13.32 16.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 9.8 mt 47.31 47.63 16.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.89 152.95 24.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 17.3 p90 -151.12 169.35 22.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 0.0 109.14 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 22.7 t -137.76 142.03 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.9 p90 -154.64 160.7 41.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.349 -0.845 . . . . 0.0 109.533 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.4 p -145.55 156.49 43.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 90' ' ' LEU . 73.4 t -89.67 133.09 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.359 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -115.04 -1.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.863 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.52 168.09 39.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.32 166.28 18.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.0 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -1.148 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -81.35 -10.54 59.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -88.27 107.78 18.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.08 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.3 Cg_endo -69.43 148.29 66.88 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.647 2.231 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -79.37 -33.41 42.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -81.31 0.26 37.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.08 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -130.43 139.45 50.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HG3' ' HD3' ' A' ' 122' ' ' LYS . 89.7 mt-10 -67.03 -54.73 18.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 109.508 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 51.2 pttt -171.91 163.54 6.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 118' ' ' LYS . 56.2 mt -118.98 135.75 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.5 m -110.15 122.6 48.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.221 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.629 ' CE1' HG13 ' A' ' 117' ' ' VAL . 92.4 m-85 -104.04 125.17 50.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.841 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 48.7 t0 -120.34 102.22 8.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.33 -0.856 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.466 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 27.0 m -115.13 141.43 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.0 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.62 ' O ' HD23 ' A' ' 103' ' ' LEU . 50.3 tttt -123.24 153.8 39.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 108.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 102' ' ' LYS . 40.4 mt -129.88 126.45 37.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.94 143.26 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -70.4 148.3 48.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.48 168.07 24.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 -6.0 17.52 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.71 2.273 . . . . 0.0 111.701 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -63.81 -27.3 69.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.7 18.32 25.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.51 -139.09 3.42 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 31.0 t -117.0 145.99 43.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.682 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.11 166.13 25.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.885 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 169.2 169.43 32.55 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -109.51 144.93 37.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -1.164 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 116' ' ' THR . 1.2 tt -114.98 136.19 53.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.575 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.3 m -127.16 126.13 42.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 99' ' ' PHE . 48.0 t -111.24 130.5 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.651 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 97' ' ' ILE . 63.9 tttt -112.6 122.08 46.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 109.152 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.575 ' CD1' ' HG3' ' A' ' 127' ' ' PRO . 22.8 t80 -112.1 118.41 35.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 109.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.463 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 88.8 mt-10 -101.24 145.52 28.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.208 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 15.7 p -124.09 171.28 9.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.494 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HD3' ' HG3' ' A' ' 95' ' ' GLU . 41.9 mmtt -79.8 1.52 26.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.28 -88.46 0.46 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -57.79 -37.45 73.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.89 137.66 58.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 110.69 3.78 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.432 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' ' CD1' ' A' ' 119' ' ' TYR . 50.4 Cg_endo -70.28 147.22 59.04 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.732 2.288 . . . . 0.0 111.835 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.8 OUTLIER -84.61 163.51 19.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.448 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.61 -40.12 78.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.66 -45.56 91.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -59.36 -42.88 92.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.62 HD13 ' CE2' ' A' ' 5' ' ' PHE . 90.9 mt -58.16 -35.32 71.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -65.39 -44.12 88.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.6 m -57.79 -39.6 77.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.29 98.8 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -63.3 -39.2 93.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -1.155 . . . . 0.0 109.448 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.16 -33.1 38.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.95 -43.24 93.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.99 -50.66 67.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.336 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 84.4 m-20 -51.57 -33.67 33.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.36 97.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.269 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.947 ' O ' HD13 ' A' ' 142' ' ' LEU . 2.9 tm? -79.18 -36.45 40.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.12 -51.84 68.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 80.6 mttt -51.78 -39.87 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 0.0 109.212 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.655 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -57.28 -42.32 81.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.856 . . . . 0.0 109.143 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.09 -45.06 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.372 -0.83 . . . . 0.0 109.191 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.437 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 94.2 mt-10 -71.19 -37.82 72.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.83 79.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.162 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -71.33 -52.33 19.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.595 HD22 HD23 ' A' ' 18' ' ' LEU . 8.1 mp -60.97 -36.69 80.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.52 -31.69 68.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.46 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.71 -2.1 51.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -127.94 75.42 78.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.71 -14.17 35.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.673 2.249 . . . . 0.0 111.782 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -76.23 -26.1 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.659 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 81.6 t80 -79.88 125.58 29.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 8.5 m120 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG11 ' CE ' ' A' ' 118' ' ' LYS . 97.1 t -115.65 136.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' OE1' ' A' ' 126' ' ' GLU . 97.6 m-85 -124.61 147.13 48.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.49 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -127.6 120.69 28.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.797 ' CE2' HD13 ' A' ' 132' ' ' LEU . 91.8 m-85 -123.16 133.66 54.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -101.9 132.69 47.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 53.3 t0 -127.74 160.58 31.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 90.4 mt-10 -92.09 160.2 15.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 77.0 mt -117.67 143.8 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -138.03 112.26 8.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 51.1 m -149.33 126.78 5.58 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.68 -35.96 9.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -55.21 149.77 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.525 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 134.33 93.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.599 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' SER . 47.6 Cg_endo -68.67 -24.23 35.42 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.785 2.323 . . . . 0.0 111.826 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -44.16 49.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.667 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.8 m -76.27 -42.83 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.157 -0.965 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 HD22 ' A' ' 150' ' ' LEU . 16.1 tp -65.12 -38.35 90.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.908 . . . . 0.0 109.639 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 83.7 t80 -66.17 -43.86 85.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 24' ' ' THR . 18.7 tptt -64.51 -46.74 81.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.689 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.26 -16.84 60.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.0 tp -77.02 -51.03 11.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.5 -48.25 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -61.59 -48.77 79.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 109.778 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' VAL . 65.3 m-20 -101.54 15.26 29.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.32 -52.68 12.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -67.45 -23.16 65.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.541 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 m120 -88.53 -27.75 21.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.87 . . . . 0.0 109.317 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.058 HG21 HG23 ' A' ' 146' ' ' ILE . 8.0 p -82.76 -37.2 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.05 HD12 ' O ' ' A' ' 26' ' ' ALA . 1.4 mt -49.74 -48.9 76.02 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.869 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.2 Cg_endo -68.48 -33.45 22.8 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.396 2.064 . . . . 0.0 111.87 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.0 mttt -82.33 -52.91 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.136 -0.978 . . . . 0.0 109.133 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -53.06 -38.07 62.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 108.974 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.053 HD21 ' HB2' ' A' ' 57' ' ' PHE . 26.8 tp -84.39 105.42 15.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.77 -39.33 77.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.079 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.6 p -95.61 28.28 3.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 109.862 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -56.44 125.7 23.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB2' HD12 ' A' ' 58' ' ' LEU . 51.7 tptt -92.83 -52.69 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 m -170.34 162.92 8.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.717 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.092 HG22 HG23 ' A' ' 55' ' ' ILE . 96.3 t -143.03 142.42 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 86.1 mt-10 -150.97 161.86 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 109.54 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -88.51 135.4 33.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 109.446 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 28.5 t -83.27 -42.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.776 ' O ' HG23 ' A' ' 51' ' ' THR . 55.6 mm-40 -159.57 147.25 17.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.72 -154.09 21.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -140.66 13.21 2.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' H ' HG21 ' A' ' 51' ' ' THR . . . 109.36 -2.13 31.04 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.87 -162.66 25.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.71 134.94 27.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.731 2.287 . . . . 0.0 111.866 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.98 0.25 90.19 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 44' ' ' GLU . 89.5 m -70.2 151.57 45.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.63 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 37.8 mm -115.65 124.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -117.91 143.39 46.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.002 . . . . 0.0 109.763 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 65' ' ' PHE . 12.6 tttm -123.5 136.3 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.223 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.092 HG23 HG22 ' A' ' 40' ' ' VAL . 71.9 mt -128.92 146.22 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.804 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 30.3 m -120.14 121.99 40.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.279 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 1.053 ' HB2' HD21 ' A' ' 34' ' ' LEU . 51.4 p90 -122.32 162.27 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.546 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -101.07 149.98 23.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.27 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -164.89 131.29 2.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 53.85 28.81 8.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.05 67.5 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -107.74 129.0 55.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -1.207 . . . . 0.0 109.401 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -80.12 124.44 28.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 73.9 mttt -124.21 169.91 11.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.551 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 37.7 p90 -142.5 154.58 44.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.505 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 29.7 m -130.53 139.19 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.885 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -108.67 126.96 53.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -125.89 140.4 52.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.588 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 36.4 tttm -121.39 148.95 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.32 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 50' ' ' GLY . 57.7 mt -108.6 132.09 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 97.2 mt-10 -88.29 -36.43 16.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 109.355 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -175.16 150.27 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.73 136.38 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 109.361 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -132.81 78.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 45.9 mt-10 -57.23 -39.41 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.5 -46.99 57.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.925 . . . . 0.0 109.421 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.494 ' HB3' ' NZ ' ' A' ' 102' ' ' LYS . 47.2 m-20 -93.77 13.68 21.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.281 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 7.6 mt 47.03 35.87 3.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.98 154.22 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.9 p90 -150.71 169.72 20.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 109.068 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 72.5 m -129.72 139.51 51.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.674 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.612 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.9 p90 -153.27 158.7 42.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 91.1 p -148.04 157.71 43.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.6 p -97.08 125.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.285 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.48 2.47 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.655 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.885 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -164.59 154.33 25.09 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 113.9 159.14 13.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.77 -13.42 32.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.115 . . . . 0.0 109.406 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.45 9.33 7.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.596 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.59 122.41 42.0 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.371 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.0 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 51.1 Cg_endo -70.5 145.2 52.22 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.691 2.261 . . . . 0.0 111.826 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -79.76 -32.28 40.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -80.18 -2.77 46.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.0 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.0 117.98 25.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.967 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -49.94 -43.64 50.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 14.3 pttt -176.85 161.46 2.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.6 mt -122.65 134.04 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 50.8 m -107.89 129.81 55.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.612 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 90.8 m-85 -113.78 123.6 50.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.9 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -123.0 101.57 7.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.017 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.446 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 4.3 m -113.31 145.89 40.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 110.035 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.778 ' O ' HD23 ' A' ' 103' ' ' LEU . 19.4 tttt -123.27 158.39 31.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.778 HD23 ' O ' ' A' ' 102' ' ' LYS . 77.0 mt -138.93 129.91 26.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.006 . . . . 0.0 110.139 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -142.83 169.68 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 0.0 108.979 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.639 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.32 137.47 39.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 109.516 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.89 161.09 19.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.62 -0.45 6.82 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.689 2.26 . . . . 0.0 111.74 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -79.93 -23.43 41.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.31 12.52 33.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.96 -146.43 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.45 145.89 24.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.661 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.78 143.13 28.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.363 -0.835 . . . . 0.0 109.197 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.16 -161.12 26.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 116' ' ' THR . 2.1 tt -116.73 136.78 52.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.7 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.801 ' N ' HD23 ' A' ' 115' ' ' LEU . 25.0 m -123.27 127.72 48.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.28 129.06 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 97' ' ' ILE . 87.3 tttt -114.45 120.77 41.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.323 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.839 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.4 t80 -112.45 119.24 37.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.9 mt-10 -99.77 146.47 26.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 127' ' ' PRO . 66.2 p -123.8 160.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -52.74 -43.55 65.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.17 -82.14 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 18.1 p30 -76.78 -15.38 59.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.6 138.04 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' OE1' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -134.92 111.25 11.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 50.3 Cg_endo -70.89 140.35 38.24 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.729 2.286 . . . . 0.0 111.795 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -76.92 156.6 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -53.37 -34.78 58.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -59.05 -45.99 89.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 68.8 mm-40 -60.32 -41.5 93.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.797 HD13 ' CE2' ' A' ' 5' ' ' PHE . 54.2 mt -60.88 -38.64 86.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.377 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -71.44 -37.53 71.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 58.8 m -58.72 -42.16 88.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.303 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.26 -32.03 71.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -68.99 -40.44 78.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.327 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.17 -37.02 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -66.65 -42.95 85.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.306 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.79 -50.2 67.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.839 . . . . 0.0 109.285 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' PHE . 86.7 m-20 -56.37 -33.25 65.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.339 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.25 -54.46 40.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.34 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.7 mm? -76.34 -32.3 58.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.177 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' ASP . 86.6 t80 -63.15 -50.79 69.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.381 -0.825 . . . . 0.0 109.259 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -62.4 -34.5 76.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.92 -44.38 82.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.058 HG23 HG21 ' A' ' 29' ' ' VAL . 26.6 mt -67.59 -46.59 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.341 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 38.3 mt-10 -64.65 -40.38 95.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.855 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.38 71.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 18.6 t80 -69.29 -43.24 74.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.887 . . . . 0.0 109.351 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 HD12 ' A' ' 18' ' ' LEU . 8.1 mp -70.56 -35.81 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.92 -37.28 64.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.616 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.63 -15.21 61.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -131.49 91.06 35.63 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -16.42 33.95 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.719 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -78.29 -9.63 59.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.72 142.09 15.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.737 HG22 ' HG3' ' A' ' 120' ' ' GLU . 91.5 t -112.91 144.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -1.147 . . . . 0.0 109.293 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 59.9 m-85 -79.85 126.63 31.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.719 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.3 m -123.16 116.45 23.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 132' ' ' LEU . 90.9 m-85 -103.8 167.09 10.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -140.81 130.92 24.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -139.87 165.37 27.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.31 140.92 37.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 70.3 mt -106.62 141.54 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.559 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -142.9 128.88 19.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 14.8 m -152.77 134.63 8.64 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 -0.78 7.76 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.661 2.241 . . . . 0.0 111.679 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.4 p -92.51 149.79 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.494 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' GLY . . . -61.73 133.79 93.71 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.685 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 47.0 Cg_endo -68.34 -26.84 34.84 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.759 2.306 . . . . 0.0 111.695 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.67 -39.28 57.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.695 HG23 ' OXT' ' A' ' 157' ' ' ASN . 15.6 m -75.52 -43.49 48.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 150' ' ' LEU . 3.8 tp -70.81 -39.81 72.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.1 t80 -66.83 -41.69 87.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HE3' HG21 ' A' ' 24' ' ' THR . 30.7 tptt -66.34 -46.3 77.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.8 -24.49 59.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.203 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.916 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 16.3 tp -66.44 -49.62 66.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.19 -46.21 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.763 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -67.66 -48.35 66.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 109.651 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.4 m-20 -94.2 6.36 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.95 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -45.89 -52.57 11.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 19.6 t70 -67.06 -26.27 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.747 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.3 m-20 -87.12 -27.04 23.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.125 -0.985 . . . . 0.0 109.73 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG21 HG23 ' A' ' 146' ' ' ILE . 8.3 p -81.94 -35.54 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.619 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.95 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.1 mt -52.58 -47.49 93.69 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.324 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.2 Cg_endo -67.07 -17.39 50.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.352 2.035 . . . . 0.0 112.057 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 19.5 mttm -107.5 -35.78 6.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.471 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.44 -41.74 88.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 109.175 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 57' ' ' PHE . 45.7 tp -86.69 109.05 18.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -57.51 -43.45 84.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.29 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -91.23 29.52 1.41 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.804 ' HA ' HD23 ' A' ' 34' ' ' LEU . 66.1 t80 -60.73 127.18 30.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.117 -0.99 . . . . 0.0 109.502 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.734 ' HD3' HD23 ' A' ' 58' ' ' LEU . 41.3 mtmt -96.38 -49.85 5.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 109.551 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 59.8 p -178.15 170.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -138.81 141.81 38.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 34.4 t30 -77.63 129.67 35.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.445 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -79.85 -41.3 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 45' ' ' GLY . 81.8 tt0 -167.46 157.53 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.498 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.42 173.31 33.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.09 3.9 22.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -1.164 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.04 -9.13 25.15 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.62 -160.77 26.44 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.15 125.41 11.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.616 2.211 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 100.29 0.06 55.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.543 HG23 ' HA3' ' A' ' 45' ' ' GLY . 62.6 m -75.67 152.54 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 51' ' ' THR . 27.3 mm -115.78 125.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.854 . . . . 0.0 109.186 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 87.4 mttt -118.7 143.92 46.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.897 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HG3' HD11 ' A' ' 67' ' ' LEU . 22.2 tttt -115.54 128.48 56.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 66' ' ' VAL . 66.2 mt -115.03 133.37 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -112.78 124.97 53.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.842 ' HB2' HD21 ' A' ' 34' ' ' LEU . 53.2 p90 -134.38 161.19 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.734 HD23 ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -101.73 135.94 42.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.368 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -137.51 128.43 27.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.586 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 50.77 22.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.546 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.02 59.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 58' ' ' LEU . 85.0 mt-10 -117.06 140.67 49.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -1.089 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.703 HG23 ' NZ ' ' A' ' 38' ' ' LYS . 86.6 m -81.22 111.69 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -128.03 164.65 21.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE1' HD13 ' A' ' 67' ' ' LEU . 10.8 p90 -149.66 165.6 31.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 67' ' ' LEU . 25.8 m -137.13 146.28 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.695 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.5 mp -115.32 134.57 55.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -131.19 144.32 51.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 31.9 tttt -125.42 150.21 47.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' GLY . 63.1 mt -106.48 133.07 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 81' ' ' SER . 3.8 pt-20 -107.53 -29.83 8.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.788 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 22.7 t -158.96 139.79 12.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.052 -1.03 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 70' ' ' ILE . 65.4 mt -128.39 131.57 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.078 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -131.99 81.73 1.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.284 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.1 -34.78 75.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.49 81.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -89.59 12.12 17.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.8 mt 50.03 28.96 3.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.42 149.31 17.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 20.7 p90 -150.98 169.06 22.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.133 . . . . 0.0 109.04 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.505 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 42.3 m -135.84 141.4 44.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 26.6 p90 -154.28 160.47 41.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.341 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -142.46 155.59 45.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 67' ' ' LEU . 6.1 p -90.9 132.87 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 109.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' HD13 ' A' ' 90' ' ' LEU . 6.0 m -113.46 0.47 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 90' ' ' LEU . . . 179.26 171.3 42.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.66 171.35 24.59 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.72 -17.03 31.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.21 59.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' C ' ' A' ' 85' ' ' VAL . 1.1 tp -94.93 106.0 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.12 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.26 148.35 61.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.706 2.271 . . . . 0.0 111.781 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 80.6 m-20 -79.36 -32.95 43.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.82 . . . . 0.0 109.561 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.4 p -80.27 3.77 19.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.717 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.12 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.21 131.94 44.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.072 -1.018 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 89.6 mt-10 -59.73 -43.64 94.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 95' ' ' GLU . 12.3 pttp -179.11 163.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.0 mt -122.68 133.39 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 28.7 m -105.88 136.8 44.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.299 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 78.5 m-85 -116.49 122.12 43.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 20.9 t70 -118.79 102.25 8.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.077 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -116.04 138.4 51.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.784 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.749 ' C ' HD22 ' A' ' 103' ' ' LEU . 54.5 tttm -131.49 141.02 49.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.119 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.0 mm? -123.67 129.13 50.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 0.0 109.608 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 112' ' ' ALA . 1.6 m -89.06 146.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 15' ' ' PRO . . . -78.4 103.71 8.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.634 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.67 137.47 19.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.47 -16.84 34.63 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.728 2.285 . . . . 0.0 111.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.5 -2.97 50.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . 104.26 -29.93 11.1 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.38 171.42 8.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 53.0 p -126.4 137.48 53.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.07 139.56 26.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -168.78 -157.09 11.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -131.69 144.54 51.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 116' ' ' THR . 1.3 tt -119.13 128.19 54.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 115' ' ' LEU . 24.6 m -116.73 129.97 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.349 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 136' ' ' LYS . 58.3 t -112.26 128.12 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.55 ' CG ' HG11 ' A' ' 2' ' ' VAL . 18.5 tttt -115.81 119.62 36.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 40.4 t80 -110.0 118.67 37.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.141 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.737 ' HG3' HG22 ' A' ' 2' ' ' VAL . 78.4 tt0 -102.14 146.32 28.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.1 p -117.78 167.15 11.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 40.7 mttt -55.41 -32.63 62.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.67 -102.15 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -59.34 -19.82 49.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.44 132.71 48.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -133.49 107.89 12.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.2 146.91 58.83 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.655 2.237 . . . . 0.0 111.776 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -60.3 161.23 7.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.579 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -65.83 -36.45 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.45 -42.5 98.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.21 -40.0 80.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 85.8 mt -64.86 -39.28 93.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -68.13 -46.28 71.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.42 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 87.6 m -57.82 -36.51 72.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.08 99.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HG3' HG21 ' A' ' 117' ' ' VAL . 21.5 tttm -64.63 -37.81 88.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.515 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.64 -28.19 53.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -63.59 -45.62 89.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.06 90.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 80.8 m-20 -53.98 -33.74 57.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.71 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 142' ' ' LEU . 3.3 tm? -77.79 -45.15 25.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -55.01 -53.14 59.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 45.3 mttm -54.85 -37.87 66.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.37 -53.51 56.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 22' ' ' LEU . 29.7 mt -68.02 -42.97 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -61.32 -44.64 96.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.98 71.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 26.7 t80 -68.44 -42.5 78.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 18' ' ' LEU . 6.9 mp -67.33 -41.85 84.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.65 -35.0 79.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.419 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.74 -13.41 59.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.84 86.8 57.03 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.12 -20.17 33.47 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 111.788 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -75.85 -15.82 60.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.756 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 66.0 t80 -59.04 141.65 53.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.695 ' OXT' HG23 ' A' ' 17' ' ' THR . 98.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.537 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG11 ' HE3' ' A' ' 118' ' ' LYS . 92.7 t -135.25 136.22 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -1.138 . . . . 0.0 109.354 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.18 145.03 48.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -125.2 131.74 53.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.867 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.716 ' CE2' HD12 ' A' ' 132' ' ' LEU . 75.6 m-85 -126.71 156.18 41.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -128.01 132.62 49.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.23 165.13 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -99.56 152.06 20.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.0 mt -120.05 136.78 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 96.0 m-20 -139.13 134.25 32.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.5 126.44 4.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HD2' ' OE2' ' A' ' 147' ' ' GLU . 49.6 Cg_endo -70.22 -5.02 15.52 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.728 2.285 . . . . 0.0 111.81 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.81 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.398 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 126.37 65.83 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.4 Cg_endo -68.23 -24.06 38.33 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.762 2.308 . . . . 0.0 111.834 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.46 64.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.625 HG23 ' C ' ' A' ' 157' ' ' ASN . 89.7 m -76.91 -36.22 56.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' CE1' ' A' ' 143' ' ' PHE . 18.5 tp -70.24 -39.6 74.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.519 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -65.49 -44.22 87.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.874 ' HE2' HG21 ' A' ' 24' ' ' THR . 22.4 tptm -66.15 -46.33 77.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.02 -20.59 60.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.375 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.927 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 42.3 tp -73.56 -49.1 28.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.655 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.96 -47.47 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.748 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.874 HG21 ' HE2' ' A' ' 20' ' ' LYS . 1.4 m -65.78 -46.94 76.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' VAL . 7.6 m-20 -98.51 9.35 43.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.822 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.31 -53.23 11.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.414 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' OD1' HG11 ' A' ' 40' ' ' VAL . 54.5 t0 -68.41 -24.78 64.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.717 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.9 m120 -87.23 -26.78 23.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.59 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 146' ' ' ILE . 9.0 p -82.66 -36.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.5 mt -51.29 -47.99 86.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.3 Cg_endo -68.43 -21.63 40.3 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.352 2.035 . . . . 0.0 111.923 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 40.6 mttm -96.27 -35.15 11.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.293 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.38 -39.47 74.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 57' ' ' PHE . 15.9 tp -88.73 106.66 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 108.867 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.32 -29.8 66.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -104.54 27.93 7.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 109.95 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CZ ' ' HA ' ' A' ' 39' ' ' SER . 20.2 t80 -56.74 127.84 33.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.153 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -92.31 -52.37 4.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -178.28 171.3 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 0.0 109.838 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.93 HG23 ' CD1' ' A' ' 55' ' ' ILE . 5.9 p -142.62 140.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 109.227 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 85.2 mt-10 -151.33 143.74 24.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 70.0 m-20 -84.09 127.38 33.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -83.82 -29.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 94.9 mt-10 -156.72 142.43 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 104.33 162.59 24.49 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -102.9 3.29 36.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 109.53 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.42 -14.9 13.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.7 -161.11 6.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.75 148.42 58.61 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.653 2.235 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 9.39 84.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 52' ' ' ILE . 25.0 m -79.98 157.24 26.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 109.545 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 15.6 mm -116.94 124.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.5 mttm -116.78 143.02 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.687 ' HG3' HD11 ' A' ' 67' ' ' LEU . 20.3 tttm -117.42 129.29 55.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.316 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.93 ' CD1' HG23 ' A' ' 40' ' ' VAL . 11.9 mm -115.12 144.52 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 m -126.22 126.03 43.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.592 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.743 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.8 p90 -129.78 175.22 9.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 57' ' ' PHE . 4.3 mm? -110.04 147.42 33.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 109.543 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -156.58 123.03 5.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 54.34 33.01 17.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.06 4.72 63.68 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -102.37 138.17 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.389 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.5 m -86.38 119.99 27.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -125.44 167.92 14.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.726 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.3 p90 -147.71 161.73 40.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.619 HG13 ' HE1' ' A' ' 57' ' ' PHE . 28.7 m -134.64 143.78 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.321 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 65' ' ' PHE . 5.4 mp -112.57 131.57 55.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -126.27 139.66 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 tttt -118.03 146.72 43.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -108.72 130.33 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.9 mt-10 -88.94 -33.33 17.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -177.49 157.65 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.16 132.99 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -129.48 78.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.2 mt-10 -64.84 -30.08 71.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -48.98 79.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.377 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 54.5 m-20 -89.86 14.25 12.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 16.2 mt 47.18 52.58 11.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.486 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -153.75 156.56 26.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.4 p90 -150.9 169.85 20.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.0 109.018 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 70.1 m -130.11 139.33 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.89 158.42 40.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 94.8 p -146.35 156.48 43.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG12 HD23 ' A' ' 90' ' ' LEU . 93.0 t -86.11 132.87 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.954 . . . . 0.0 109.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 4.8 t -109.48 -2.73 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.8 42.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.9 175.56 24.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.06 65.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -1.182 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.13 -11.92 59.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.721 HD23 HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -99.68 108.73 52.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.343 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.987 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.8 Cg_endo -69.88 152.91 68.86 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.69 2.26 . . . . 0.0 111.935 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 83.7 m-20 -79.43 -30.12 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.437 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 15.8 p -79.99 7.1 9.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.15 131.29 42.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.489 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 91.9 mt-10 -61.08 -44.05 97.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HA ' HD21 ' A' ' 90' ' ' LEU . 3.8 pttm 179.74 159.21 0.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.942 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' SER . 70.3 mt -118.38 135.7 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.676 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.9 m -107.41 138.76 43.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 76.6 m-85 -119.76 120.25 35.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.564 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -116.25 113.95 23.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.093 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.512 ' OG ' ' CD1' ' A' ' 115' ' ' LEU . 2.6 m -128.13 136.38 51.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.562 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 47.6 tttt -132.78 124.5 28.19 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 53.2 mt -108.57 132.9 53.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.062 -1.023 . . . . 0.0 110.266 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.8 143.05 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.06 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.34 141.17 51.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.47 166.03 22.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.4 -4.94 15.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.622 2.215 . . . . 0.0 111.792 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.98 -27.36 66.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.82 23.42 11.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -149.96 -131.1 1.87 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.511 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 68.9 m -118.73 143.98 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.3 166.06 25.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.274 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 164.86 -177.6 40.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 28.2 ttpt -123.24 143.25 50.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -1.089 . . . . 0.0 109.396 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HB2' HD11 ' A' ' 9' ' ' ILE . 30.2 tp -116.5 135.3 53.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -124.25 125.93 45.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.94 132.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.598 ' HE3' HG11 ' A' ' 2' ' ' VAL . 23.6 tttt -116.43 116.04 26.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.676 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 33.3 t80 -105.9 122.09 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 90.9 mt-10 -105.63 141.44 37.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.658 HG21 ' CD ' ' A' ' 127' ' ' PRO . 16.6 p -118.29 164.61 14.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -0.978 . . . . 0.0 109.552 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 92.7 mttt -56.99 -40.06 75.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.45 -92.22 0.11 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -37.2 83.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -1.175 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.43 135.58 39.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.29 109.83 15.09 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.658 ' CD ' HG21 ' A' ' 121' ' ' THR . 51.3 Cg_endo -70.24 124.29 10.75 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.675 2.25 . . . . 0.0 111.875 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -60.04 161.05 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.42 -36.15 80.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -56.03 -31.43 63.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.03 -34.95 61.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.271 -0.893 . . . . 0.0 108.729 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.716 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.53 -39.29 90.51 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -60.22 -48.31 82.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.5 m -57.22 -36.75 71.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.3 99.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -60.37 -37.1 79.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -1.091 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.72 -30.43 61.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.252 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -66.0 -44.86 83.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.21 -55.41 10.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.9 -34.92 63.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.97 75.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.276 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 146' ' ' ILE . 29.8 mt -74.94 -44.0 50.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.91 ' CE1' HD21 ' A' ' 18' ' ' LEU . 73.9 t80 -61.62 -55.78 26.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.166 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -49.49 -46.73 48.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.303 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.94 77.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.153 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 29' ' ' VAL . 34.3 mt -67.11 -44.11 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.251 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 12' ' ' PRO . 80.0 tt0 -60.46 -44.91 95.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -31.11 70.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.21 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 21.6 t80 -66.79 -38.88 87.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.85 . . . . 0.0 109.303 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.512 HD22 ' CD1' ' A' ' 18' ' ' LEU . 7.5 mp -72.86 -40.85 65.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.18 -37.78 78.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.51 -15.84 60.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.382 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -126.7 90.25 50.17 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.1 -18.91 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.61 2.207 . . . . 0.0 111.793 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -74.12 -12.68 60.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 63.8 t80 -80.01 125.48 29.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.625 ' C ' HG23 ' A' ' 17' ' ' THR . 8.5 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.412 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.45 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 118' ' ' LYS . 89.4 t -141.44 137.93 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.61 149.53 42.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.7 m -129.81 128.84 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 0.0 109.428 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.734 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 97.4 m-85 -119.81 163.34 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -135.59 133.81 38.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.411 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.29 166.09 25.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -101.15 151.17 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.508 HG21 HD11 ' A' ' 103' ' ' LEU . 65.1 mt -114.36 128.22 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -128.95 127.61 42.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 13' ' ' VAL . 75.7 m -153.43 132.92 7.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -19.0 35.13 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.677 2.251 . . . . 0.0 111.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 18' ' ' LEU . 2.2 p -70.39 153.1 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.545 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 139.77 97.73 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.22 -26.78 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.81 2.34 . . . . 0.0 111.91 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.52 -39.24 53.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -79.76 -41.85 25.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.77 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.757 HD13 HG11 ' A' ' 13' ' ' VAL . 3.9 tp -67.15 -38.5 85.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.401 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 79.0 t80 -70.63 -36.4 73.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HE3' HG21 ' A' ' 24' ' ' THR . 43.9 tptt -67.17 -47.21 71.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 109.781 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -72.27 -40.13 67.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.836 ' CD1' HD13 ' A' ' 146' ' ' ILE . 64.5 tp -53.33 -45.66 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -97.3 -53.63 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.974 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.575 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.1 m -66.38 -50.09 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.694 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -92.44 19.66 6.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -60.46 -51.61 68.71 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.155 -0.966 . . . . 0.0 109.143 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.87 ' HA ' HD12 ' A' ' 30' ' ' ILE . 86.6 m-20 -66.69 -31.24 71.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.648 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 75.2 m-20 -83.23 -29.57 28.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 25' ' ' ASP . 77.4 t -78.64 -34.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 27' ' ' ASP . 12.0 mt -51.33 -51.71 66.17 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.929 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.9 Cg_endo -68.39 -34.87 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.552 2.168 . . . . 0.0 111.888 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 50.9 mttm -79.95 -40.75 27.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.089 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -65.88 -38.08 87.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.302 -0.874 . . . . 0.0 108.909 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 57' ' ' PHE . 41.0 tp -87.16 106.0 17.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 108.968 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.11 -28.18 67.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -105.38 27.49 8.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.966 -1.084 . . . . 0.0 109.879 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.807 ' HA ' HD23 ' A' ' 34' ' ' LEU . 44.6 t80 -53.24 125.43 17.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -90.9 -56.22 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.806 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 28.8 p -174.27 166.56 4.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.681 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.69 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 2.9 p -144.79 143.48 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.9 mt-10 -147.17 152.1 37.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.559 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -79.55 131.08 35.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 52' ' ' ILE . 13.8 t -83.65 -44.38 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.315 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 51' ' ' THR . 80.8 mt-10 -159.38 146.87 17.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 95.59 -175.68 33.11 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -110.73 6.17 21.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' HG21 ' A' ' 51' ' ' THR . . . 109.74 -3.7 30.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.63 -156.35 13.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.24 138.76 37.03 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.741 2.294 . . . . 0.0 111.811 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.46 -4.04 75.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 44' ' ' GLU . 26.1 m -69.18 155.01 41.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 109.566 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 20.4 mm -119.33 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.19 147.35 46.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.846 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.662 ' HG3' HD21 ' A' ' 67' ' ' LEU . 22.4 tttt -116.89 127.35 54.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.22 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 63.7 mt -115.25 145.35 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -0.999 . . . . 0.0 109.848 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 24.0 m -128.1 123.0 33.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.201 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.883 ' HB2' HD21 ' A' ' 34' ' ' LEU . 23.8 p90 -125.53 174.27 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 109.637 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 57' ' ' PHE . 3.2 mm? -112.63 138.25 49.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE1' ' HE3' ' A' ' 64' ' ' LYS . 75.8 tt0 -148.49 127.76 12.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 53.12 34.62 17.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.77 66.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -107.3 134.14 50.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 m -82.73 116.16 21.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 23.0 mttm -116.74 164.21 14.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' ' HE3' ' A' ' 54' ' ' LYS . 18.5 p90 -145.87 157.75 43.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.422 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.7 p -141.2 149.68 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.898 . . . . 0.0 109.618 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 54' ' ' LYS . 48.2 mt -112.6 130.98 55.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.241 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -122.55 136.88 55.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 42.3 tttm -119.08 145.18 46.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.5 mt -105.87 127.05 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 93.6 mt-10 -82.46 -53.45 5.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -162.73 137.59 6.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.8 mt -102.78 133.73 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.91 . . . . 0.0 109.338 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -129.18 76.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 86.8 mt-10 -54.61 -37.61 65.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.19 57.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 78' ' ' LEU . 64.6 m-20 -90.67 17.0 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.377 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 11.6 mt 43.57 46.24 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.576 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.49 158.9 27.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.5 p90 -152.02 170.04 20.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -1.217 . . . . 0.0 109.131 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 4.7 m -126.3 138.84 53.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -156.06 160.67 40.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 54.8 p -150.41 158.22 43.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.483 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 89' ' ' ALA . 14.5 p -97.41 135.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 109.086 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.1 m -130.16 3.87 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' A' ' 67' ' ' LEU . . . -156.19 146.26 13.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 111.01 -174.29 16.79 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.17 62.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 0.0 109.497 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.85 1.49 30.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -112.9 83.52 6.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.328 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -68.9 163.43 37.48 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.897 2.398 . . . . 0.0 111.998 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.483 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 70.1 m-20 -80.12 -32.71 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.912 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 33.9 p -79.55 -11.99 59.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 110.026 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -119.95 127.75 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -62.51 -50.79 70.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -177.33 156.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.42 137.55 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 1.4 m -107.42 138.2 44.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.848 . . . . 0.0 109.135 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.2 m-85 -118.56 120.58 37.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.881 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -117.2 106.39 13.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -115.59 136.13 53.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.773 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.618 ' C ' HD22 ' A' ' 103' ' ' LEU . 20.3 tttt -132.96 131.26 40.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.833 . . . . 0.0 109.123 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 103' ' ' LEU . 1.7 mm? -118.18 127.44 53.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.364 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -120.48 172.58 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -80.25 127.14 32.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.206 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.99 155.54 17.93 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 -1.95 8.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.578 2.185 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -74.11 -15.55 61.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.41 7.15 63.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.56 -138.08 4.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 103' ' ' LEU . 2.7 t -122.25 140.65 52.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -1.113 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.698 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.42 147.81 31.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.207 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -174.08 -143.63 4.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.05 138.95 32.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.353 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 116' ' ' THR . 3.9 tt -115.31 136.4 53.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.969 ' N ' HD23 ' A' ' 115' ' ' LEU . 14.5 m -125.5 126.89 45.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.35 136.16 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.331 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 2' ' ' VAL . 26.6 tttt -116.07 121.02 40.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.732 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 30.3 t80 -103.58 126.56 50.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HA ' HG22 ' A' ' 2' ' ' VAL . 82.9 mt-10 -109.73 130.94 55.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 19.5 p -107.4 156.73 18.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 73.5 mmtt -60.13 -37.0 78.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.82 -103.84 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.35 -35.52 72.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -1.187 . . . . 0.0 109.468 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.9 136.98 33.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.41 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -149.34 107.66 3.36 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.2 Cg_endo -70.04 151.55 67.52 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.734 2.289 . . . . 0.0 111.699 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -83.22 178.73 7.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 132' ' ' LEU . 92.9 mt-30 -67.89 -35.35 78.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.59 -48.53 80.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -61.14 -39.14 88.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.38 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.734 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 67.0 mt -63.64 -35.79 81.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 26.2 mttt -64.22 -48.53 75.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.604 HG22 ' HE2' ' A' ' 138' ' ' LYS . 86.8 m -56.22 -33.24 65.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.343 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.22 -43.13 99.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 140' ' ' ASP . 23.9 tttp -67.14 -39.58 86.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -1.149 . . . . 0.0 109.497 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -31.22 64.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.29 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HE2' HG22 ' A' ' 134' ' ' THR . 46.3 mttm -77.3 -40.7 43.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.05 -26.41 53.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.825 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 96.9 m-20 -60.78 -41.64 95.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -44.95 82.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 142' ' ' LEU . 23.0 mt -54.71 -46.19 74.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -61.61 -50.26 73.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 148' ' ' ALA . 88.6 mttt -63.22 -33.56 75.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.897 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.7 -52.46 64.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.836 HD13 ' CD1' ' A' ' 22' ' ' LEU . 11.7 mt -68.47 -51.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.21 -45.22 91.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.697 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 144' ' ' LYS . . . -59.63 -31.39 69.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.519 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.4 t80 -69.3 -41.14 77.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.64 HD22 HD12 ' A' ' 18' ' ' LEU . 7.8 mp -66.43 -46.3 76.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.636 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.39 -33.79 74.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.96 -11.9 57.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.515 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.566 ' CE1' ' CZ ' ' A' ' 149' ' ' TYR . 74.4 m80 -122.06 90.16 48.72 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.26 -21.57 30.95 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.673 2.249 . . . . 0.0 111.767 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -70.87 -17.88 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 42.3 t80 -67.31 158.8 30.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.571 ' O ' HG21 ' A' ' 17' ' ' THR . 74.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.639 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -130.37 149.4 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 0.0 109.472 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.566 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 97.6 m-85 -81.51 126.87 32.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 117.88 27.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.309 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.944 ' CE2' HD13 ' A' ' 132' ' ' LEU . 97.8 m-85 -110.25 164.23 12.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.624 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 88.2 mt-10 -134.05 134.24 42.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -137.09 165.0 27.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -104.13 158.59 16.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 42.3 mt -129.14 137.37 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.71 137.0 34.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.9 OUTLIER -152.58 138.68 11.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.09 0.74 6.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.665 2.243 . . . . 0.0 111.96 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.867 ' CG1' HD11 ' A' ' 18' ' ' LEU . 69.4 t -98.17 155.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.829 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -64.21 127.64 92.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.511 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 44.4 Cg_endo -66.84 -25.51 45.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.801 2.334 . . . . 0.0 111.904 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.928 . . . . 0.0 109.036 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 157' ' ' ASN . 76.5 m -72.7 -38.86 67.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.182 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.867 HD11 ' CG1' ' A' ' 13' ' ' VAL . 2.4 mp -70.29 -38.63 75.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 72.5 t80 -63.92 -50.27 69.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE3' HG21 ' A' ' 24' ' ' THR . 12.2 tptt -65.05 -46.38 81.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.749 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.63 -28.33 63.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.964 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 44.4 tp -67.01 -47.36 71.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.857 . . . . 0.0 109.67 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -97.96 -51.7 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.576 HG21 ' HE3' ' A' ' 20' ' ' LYS . 2.1 m -62.62 -45.64 91.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.7 m-20 -98.44 6.14 47.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.08 -1.012 . . . . 0.0 109.767 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.964 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -45.96 -53.27 10.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.6 m-20 -67.54 -23.3 65.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.772 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 90.9 m-20 -89.84 -25.79 20.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.493 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -83.39 -35.98 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 109.545 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.952 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.3 mt -55.36 -47.07 99.44 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 110.211 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.6 Cg_endo -68.08 -35.97 18.46 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.307 2.004 . . . . 0.0 112.193 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 32.3 mttm -87.91 -29.28 20.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.421 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -69.42 -34.77 74.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.257 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 57' ' ' PHE . 54.5 tp -96.18 113.31 24.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.32 -40.92 92.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.663 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.0 p -93.71 26.8 2.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.811 -1.181 . . . . 0.0 110.117 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 30' ' ' ILE . 57.2 t80 -59.91 134.11 56.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.124 -0.985 . . . . 0.0 109.409 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' SER . 33.6 tttm -95.28 -49.12 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 110.312 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 68.9 p -178.59 172.13 1.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 40' ' ' VAL . 6.0 p -135.91 129.97 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.274 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -135.53 145.47 47.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 109.613 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.97 128.08 34.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 13.9 t -85.17 -41.0 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.673 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 51' ' ' THR . 96.5 mt-10 -158.58 145.44 17.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.601 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 159.04 30.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -94.59 5.36 52.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.93 -9.28 23.28 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.03 -158.66 13.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.05 131.16 20.26 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.644 2.23 . . . . 0.0 111.687 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 93.23 0.44 67.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 44' ' ' GLU . 90.3 m -76.01 154.78 35.5 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.307 -1.114 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 69' ' ' LYS . 71.2 mt -129.89 138.32 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 109.349 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -126.67 152.39 46.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 36.6 tttm -112.87 125.74 54.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.425 -0.797 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 66' ' ' VAL . 83.9 mt -113.88 142.95 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.2 m -131.36 119.54 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.962 ' HB2' HD21 ' A' ' 34' ' ' LEU . 39.0 p90 -124.5 171.55 9.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.348 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 145.85 31.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.364 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 62' ' ' GLU . 84.9 tt0 -141.84 123.74 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 49.66 27.73 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.78 12.66 71.38 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' GLU . 99.6 mt-10 -106.47 157.58 17.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -1.085 . . . . 0.0 109.421 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.2 m -104.94 112.55 25.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.413 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -120.35 162.95 18.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -145.66 158.96 43.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 55' ' ' ILE . 22.4 m -138.31 147.05 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 86' ' ' GLY . 12.8 mt -116.63 137.82 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.065 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.72 141.82 50.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.752 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' HG12 ' A' ' 52' ' ' ILE . 19.4 tttm -117.77 146.41 43.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.87 . . . . 0.0 109.121 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.0 mt -104.75 126.57 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -88.18 -40.19 13.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 t -173.74 150.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.58 132.67 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -127.03 85.51 2.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' OH ' ' A' ' 19' ' ' TYR . 97.0 mt-10 -64.24 -31.69 72.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.85 84.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -89.3 14.86 10.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.539 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 19.4 mt 47.52 51.86 13.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.27 27.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 28.7 p90 -150.96 168.4 24.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 108.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -126.67 138.64 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 19.4 p90 -152.49 155.82 38.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.382 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 t -144.85 156.06 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.624 HG22 HD12 ' A' ' 90' ' ' LEU . 10.0 p -98.52 128.35 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HE2' ' A' ' 96' ' ' LYS . 1.5 t -127.49 4.16 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.729 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.46 148.48 17.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 128.0 152.29 7.8 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.38 47.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.275 -1.132 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 138' ' ' LYS . . . -79.89 -7.92 59.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -79.81 116.28 59.89 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.11 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.3 Cg_endo -68.48 146.6 68.7 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.767 2.311 . . . . 0.0 111.911 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 66.2 m-20 -78.84 -29.57 44.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.632 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 29.4 p -79.82 -7.49 58.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.11 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -118.27 123.57 45.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.339 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 86.3 mt-10 -62.28 -52.18 64.73 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 0.0 109.703 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' A' ' 85' ' ' VAL . 7.4 mtpm? -159.1 161.65 36.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 109.721 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.4 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CE ' ' A' ' 118' ' ' LYS . 8.9 m -109.83 137.58 47.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.95 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 78.8 m-85 -120.23 121.29 38.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 58.5 t0 -117.02 110.51 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.204 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -123.25 136.64 54.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.559 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 75.8 tttt -130.72 127.43 38.78 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 103' ' ' LEU . 2.6 mm? -107.62 130.19 54.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.057 -1.027 . . . . 0.0 110.152 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -138.03 143.02 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.03 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 139.52 57.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.104 -0.998 . . . . 0.0 109.718 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.43 22.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.78 -9.71 26.76 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.774 2.316 . . . . 0.0 111.825 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.49 -31.95 68.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.84 27.93 6.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -157.94 -125.16 0.82 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 73.9 m -118.54 144.91 45.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 9' ' ' ILE . . . -143.58 162.49 35.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.763 . . . . 0.0 108.991 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 171.63 176.15 40.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -112.08 141.22 46.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.439 -1.036 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 29.0 tp -116.33 131.62 56.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.519 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 26.0 m -130.0 122.11 27.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -0.926 . . . . 0.0 109.144 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.67 135.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.639 ' CG ' HG21 ' A' ' 2' ' ' VAL . 7.0 ttpt -115.0 116.71 28.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.15 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 36.6 t80 -107.73 120.92 43.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.672 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 98.2 mt-10 -106.32 133.52 50.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.866 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.4 p -109.92 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 84.4 mttt -54.85 -42.31 71.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.56 -92.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ALA . 82.1 m-20 -69.2 -35.8 76.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' ASP . . . -45.03 133.79 6.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -126.24 121.13 23.78 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.866 ' HD3' HG21 ' A' ' 121' ' ' THR . 49.3 Cg_endo -69.96 149.85 66.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.717 2.278 . . . . 0.0 111.743 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.7 m-20 -92.16 155.31 18.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -50.42 -38.33 42.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.24 -48.54 81.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.33 -42.08 90.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.944 HD13 ' CE2' ' A' ' 5' ' ' PHE . 74.3 mt -60.15 -34.52 73.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.46 -46.47 82.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.259 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 86.5 m -57.4 -36.97 71.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.13 -47.36 91.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 140' ' ' ASP . 11.0 mtmm -57.09 -36.6 70.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -1.146 . . . . 0.0 109.391 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -58.23 -33.49 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 89' ' ' ALA . 69.5 tttt -74.34 -43.14 57.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -69.76 -49.06 56.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 7.5 p30 -68.43 -22.56 64.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -56.86 -48.69 77.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.7 tp -56.39 -35.52 67.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -74.33 -53.23 10.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 109.14 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -52.73 -37.92 59.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 -49.56 56.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.922 HG23 HG21 ' A' ' 29' ' ' VAL . 51.7 mt -63.07 -55.33 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.55 -50.31 13.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.18 -37.82 72.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 41.1 t80 -68.44 -38.13 80.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 18' ' ' LEU . 45.8 mt -59.16 -38.31 79.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mt -75.04 -27.68 60.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.41 -21.61 61.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -128.5 91.88 42.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.27 -18.06 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.737 2.291 . . . . 0.0 111.747 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -77.26 -17.69 58.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.816 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.8 t80 -67.77 120.09 13.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.541 ' CB ' HG23 ' A' ' 17' ' ' THR . 6.2 m120 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.711 ' O ' HG23 ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 119' ' ' TYR . 60.0 t -128.84 138.85 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -1.174 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -132.07 122.54 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.624 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 117' ' ' VAL . 79.2 m -110.67 144.24 39.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 89.4 m-85 -132.7 132.62 42.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.0 mt-10 -106.14 133.74 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -137.15 164.98 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.385 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.87 157.61 16.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.4 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.424 HD11 ' OG ' ' A' ' 101' ' ' SER . 14.6 mt -125.65 134.42 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 109.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 97.9 m-20 -140.68 132.87 28.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' OE2' ' A' ' 147' ' ' GLU . 27.3 m -152.78 138.63 11.81 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.52 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.26 -0.45 7.34 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.602 2.201 . . . . 0.0 111.714 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.87 ' HB ' HD11 ' A' ' 18' ' ' LEU . 98.1 t -94.73 153.49 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.6 139.31 97.59 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 46.7 Cg_endo -68.01 -25.77 37.88 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.734 2.289 . . . . 0.0 111.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.36 -37.6 60.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 157' ' ' ASN . 60.3 m -75.01 -39.39 61.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 13' ' ' VAL . 20.0 mt -68.69 -39.11 80.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 78.0 t80 -64.54 -50.03 68.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.585 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 24' ' ' THR . 8.5 tptm -63.4 -46.43 86.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -73.18 -24.51 60.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 18.4 tp -75.37 -48.83 21.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.686 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.75 -49.89 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.886 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -65.82 -48.83 70.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.957 . . . . 0.0 110.145 -179.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 6.3 t70 -91.01 14.67 13.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.723 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.942 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -56.09 -52.16 65.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.263 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 22.1 t70 -66.1 -25.89 67.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.946 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 27.0 m120 -90.92 -26.06 19.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.601 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' ALA . 8.0 p -83.87 -39.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 109.575 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.7 mt -52.88 -45.46 97.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.63 -21.84 45.04 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.394 2.063 . . . . 0.0 112.242 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' ALA . 41.8 mttm -108.98 -51.77 2.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 109.585 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . -42.28 -33.19 0.59 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.978 HD21 ' HB2' ' A' ' 57' ' ' PHE . 44.8 tp -92.52 112.62 24.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.067 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.4 -47.16 82.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.526 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.9 m -88.38 29.36 0.98 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.915 -1.116 . . . . 0.0 110.173 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 67.2 t80 -61.89 130.54 46.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.505 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' CD ' HD23 ' A' ' 58' ' ' LEU . 3.6 mtpm? -102.42 -48.58 4.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.639 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 37' ' ' PHE . 54.8 p -172.51 164.89 5.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG12 ' HZ ' ' A' ' 37' ' ' PHE . 3.9 p -143.3 141.81 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 109.326 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -144.08 148.36 35.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.61 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -80.64 132.07 35.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 19.0 t -79.99 -42.12 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 51' ' ' THR . 71.2 mt-10 -161.74 149.33 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.72 -168.85 36.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -132.12 35.08 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.742 ' H ' HG21 ' A' ' 51' ' ' THR . . . 91.55 -1.92 76.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 51' ' ' THR . . . -76.73 -168.31 28.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.74 139.88 41.4 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.691 2.261 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 77.14 2.96 80.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 44' ' ' GLU . 85.9 m -69.23 150.44 47.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.58 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 25.1 mm -114.62 123.44 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -118.06 143.83 46.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.856 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . 86.8 tttt -116.35 128.25 55.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 109.081 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.666 ' HB ' HG22 ' A' ' 66' ' ' VAL . 58.7 mt -114.28 140.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.1 m -119.42 120.74 37.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.216 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.978 ' HB2' HD21 ' A' ' 34' ' ' LEU . 40.5 p90 -131.5 176.02 8.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -116.98 131.2 57.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -137.12 130.96 31.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 55.14 20.83 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.92 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.32 20.55 64.28 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.8 mt-10 -118.28 141.61 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.6 m -80.9 111.79 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 70.7 mttt -121.89 163.06 19.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 36.0 p90 -144.27 158.11 43.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.385 -0.822 . . . . 0.0 109.226 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' HE1' ' A' ' 57' ' ' PHE . 34.1 m -133.55 142.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 109.705 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.86 HD12 ' HA3' ' A' ' 86' ' ' GLY . 10.7 mt -111.23 130.55 55.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 109.003 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -126.23 139.83 53.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.146 -0.971 . . . . 0.0 109.71 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -122.52 150.81 42.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.238 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.7 mt -111.46 133.05 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.554 ' OE2' HG21 ' A' ' 98' ' ' THR . 94.0 mt-10 -89.42 -33.57 16.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.243 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -172.82 155.39 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.54 131.86 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.327 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.56 81.51 2.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 78.3 mt-10 -59.18 -36.84 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.29 -41.31 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.634 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 6.4 m-20 -101.1 14.01 33.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.546 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 47.75 25.98 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.318 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.24 150.73 17.79 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.89 169.16 22.95 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -1.208 . . . . 0.0 109.166 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 61.0 m -130.96 139.01 49.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.98 . . . . 0.0 109.375 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.618 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 14.1 p90 -151.87 154.79 36.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 79.9 p -144.41 155.8 43.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.355 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.1 p -95.8 131.16 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.244 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -124.14 2.04 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.605 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.86 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -163.77 153.38 23.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 117.07 172.13 16.03 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.21 -13.05 62.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -1.099 . . . . 0.0 109.46 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.04 59.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 85' ' ' VAL . 4.8 tt -100.2 107.22 46.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.991 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 47.9 Cg_endo -69.43 149.86 69.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.68 2.253 . . . . 0.0 111.912 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 83.6 m-20 -76.76 -28.71 55.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -79.86 6.6 10.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.7 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.991 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -133.7 142.52 48.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.596 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 122' ' ' LYS . 77.4 mt-10 -69.14 -54.6 14.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -175.64 159.71 2.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.347 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 83' ' ' SER . 55.4 mt -118.18 136.2 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.554 HG21 ' OE2' ' A' ' 71' ' ' GLU . 7.9 m -112.12 117.85 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.126 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.915 ' CD1' HG23 ' A' ' 117' ' ' VAL . 89.0 m-85 -96.28 125.41 40.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.826 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 116' ' ' THR . 89.9 m-20 -117.74 129.3 55.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 109.206 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 21.8 t -146.63 136.81 23.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 103' ' ' LEU . 28.3 tttt -117.2 159.1 23.17 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 102' ' ' LYS . 33.6 mt -133.42 123.77 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.877 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.66 142.67 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.24 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.35 57.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.46 166.93 23.25 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.5 -0.05 6.15 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.646 2.231 . . . . 0.0 111.821 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -69.37 -28.34 66.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.11 26.78 8.14 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -156.14 -127.16 1.01 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 99.5 p -121.77 142.8 49.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -1.134 . . . . 0.0 109.746 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.57 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . 162.95 168.64 25.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -105.29 147.66 27.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.137 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 100' ' ' ASP . 49.6 tp -115.01 136.56 52.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 100' ' ' ASP . 24.6 m -138.78 119.31 13.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.043 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.915 HG23 ' CD1' ' A' ' 99' ' ' PHE . 2.7 p -112.33 138.68 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 110.142 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 31.9 tttt -114.29 120.08 39.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 2' ' ' VAL . 37.4 t80 -102.72 126.82 49.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -111.41 126.65 55.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.353 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 1' ' ' GLY . 34.2 p -99.91 165.91 11.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 20.4 mmtp -71.01 -36.34 72.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.19 -100.0 0.16 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -65.08 -28.57 69.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.92 137.07 58.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -147.18 112.51 4.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.7 Cg_endo -70.44 141.33 42.2 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.715 2.277 . . . . 0.0 111.7 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.9 OUTLIER -69.78 168.65 14.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.89 . . . . 0.0 109.55 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HA ' HD12 ' A' ' 132' ' ' LEU . 46.6 tt0 -60.34 -39.64 87.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.882 . . . . 0.0 109.444 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.85 -43.86 97.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.27 -39.34 82.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 25.0 mt -64.65 -36.82 85.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.63 -49.5 76.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 85.5 m -57.45 -32.45 66.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.89 -47.98 86.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . 27.9 ttpp -65.27 -38.32 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -1.133 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 141' ' ' ALA . . . -54.41 -28.4 43.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -76.21 -38.18 56.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.453 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.13 -55.08 8.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 141' ' ' ALA . 3.9 p30 -63.43 -25.05 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 137' ' ' ALA . . . -61.22 -53.44 56.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 109.319 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 142' ' ' LEU . 19.0 mt -59.53 -35.21 73.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.15 -52.69 62.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -53.12 -38.42 62.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.39 -39.63 80.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.361 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 mm -62.73 -43.62 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.391 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.463 ' OE2' ' OG ' ' A' ' 11' ' ' SER . 90.6 mt-10 -64.28 -37.27 86.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.53 81.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.401 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 33.9 t80 -70.53 -52.5 21.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 18' ' ' LEU . 9.3 mp -63.77 -36.52 84.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.7 tp -76.1 -36.44 58.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.21 -20.43 61.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -134.38 98.58 13.76 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -11.42 30.22 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 111.788 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.72 -26.66 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.957 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 62.5 t80 -64.43 138.79 58.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' THR . 2.3 p-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -134.83 148.49 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -1.061 . . . . 0.0 109.31 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 88.4 m-85 -80.83 120.57 24.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 19.8 m -109.94 117.09 32.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 97.0 m-85 -114.61 142.11 46.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 114' ' ' LYS . 81.4 tt0 -109.3 133.34 53.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.265 -0.897 . . . . 0.0 109.63 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -130.01 164.41 24.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.58 153.59 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 54.1 mt -119.23 144.2 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 9' ' ' ILE . 22.7 m120 -142.45 128.88 20.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.64 138.23 11.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.503 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.39 -12.82 32.36 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.702 2.268 . . . . 0.0 111.785 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 HG11 HD12 ' A' ' 150' ' ' LEU . 1.6 p -81.49 152.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 141.69 95.88 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.92 -28.51 35.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.735 2.29 . . . . 0.0 111.747 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.96 -41.39 59.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.3 m -76.21 -37.43 57.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.347 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.719 ' CD1' HD11 ' A' ' 150' ' ' LEU . 11.9 tp -69.15 -39.93 78.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 79.5 t80 -64.89 -44.81 88.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HE2' HG21 ' A' ' 24' ' ' THR . 12.8 tptm -65.18 -46.72 79.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.733 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -73.1 -17.77 61.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.967 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 19.5 tp -79.18 -48.25 14.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.91 -52.22 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.77 HG21 ' HE2' ' A' ' 20' ' ' LYS . 4.3 m -63.39 -49.37 74.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.943 . . . . 0.0 110.208 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m-20 -95.34 8.08 44.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.967 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.61 -53.22 11.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 109.292 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.792 ' HA ' HD12 ' A' ' 30' ' ' ILE . 56.7 t0 -65.07 -24.89 67.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 95.3 m-20 -87.16 -26.81 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 146' ' ' ILE . 98.2 t -82.66 -35.53 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 27' ' ' ASP . 7.0 mt -50.98 -47.84 86.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 110.327 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.8 Cg_endo -67.53 -28.08 38.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.44 2.093 . . . . 0.0 112.183 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -90.73 -45.41 8.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.559 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.4 mp -76.04 102.22 5.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -54.89 -46.25 74.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.871 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 88.4 p -91.51 30.1 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -57.23 122.56 12.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.07 -53.56 4.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.675 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 34.9 p -174.9 167.89 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.752 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.828 HG22 HG23 ' A' ' 55' ' ' ILE . 99.6 t -143.92 143.91 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.148 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 73.8 mt-10 -155.0 158.4 39.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 73.2 m-20 -96.65 124.9 40.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.244 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 6.8 m -82.01 -27.9 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 56.9 mm-40 -161.33 151.26 17.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.87 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.749 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 105.09 168.61 24.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -121.68 27.43 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -1.197 . . . . 0.0 109.62 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.97 -19.05 56.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.38 -169.18 28.72 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.95 140.97 43.26 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 111.71 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 88.64 5.64 74.44 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.749 HG23 ' HA3' ' A' ' 45' ' ' GLY . 59.6 m -75.12 150.78 38.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -1.153 . . . . 0.0 109.759 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 17.2 mm -112.5 123.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 108.994 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.4 mttm -119.76 144.67 47.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.853 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.705 ' HG3' HD11 ' A' ' 67' ' ' LEU . 2.2 ttmt -120.41 133.78 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.133 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.828 HG23 HG22 ' A' ' 40' ' ' VAL . 74.8 mt -123.91 143.33 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 36.0 m -124.63 122.26 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 43.1 p90 -127.24 165.84 18.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 1.2 mp -100.23 143.29 30.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.4 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -156.19 131.81 9.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 56.41 28.39 13.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.69 0.49 63.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 64' ' ' LYS . 49.2 tp10 -107.24 138.95 42.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -1.186 . . . . 0.0 109.537 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.4 m -86.03 124.94 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 34.0 mttp -128.63 172.47 11.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.798 ' CE1' HD13 ' A' ' 67' ' ' LEU . 6.5 p90 -147.31 161.32 41.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.516 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.605 ' O ' HD12 ' A' ' 67' ' ' LEU . 32.6 m -135.53 145.05 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.43 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.798 HD13 ' CE1' ' A' ' 65' ' ' PHE . 4.4 mp -114.49 133.02 56.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.923 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -132.04 145.32 51.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.526 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 16.1 tttm -124.5 146.55 48.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 7.0 mm -101.58 131.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 72' ' ' SER . 3.3 pt-20 -103.5 -32.68 9.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.995 . . . . 0.0 109.828 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 35.9 t -165.78 138.43 4.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.909 -1.119 . . . . 0.0 109.955 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.35 136.25 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 91.4 m-20 -130.69 83.18 2.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.43 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 97.4 mt-10 -63.67 -34.58 78.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.05 67.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.286 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -87.26 12.59 11.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 8.7 mt 48.02 37.25 7.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.474 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -132.64 151.96 20.13 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -151.63 166.44 31.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.065 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 71' ' ' GLU . 29.0 t -137.37 143.17 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 27.2 p90 -153.05 160.62 42.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.339 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 t -139.12 153.8 48.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 67' ' ' LEU . 14.4 p -85.1 133.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 69' ' ' LYS . 10.0 t -109.97 -4.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.49 43.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.05 164.27 15.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.59 -14.25 12.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -1.126 . . . . 0.0 109.452 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 138' ' ' LYS . . . -81.89 -12.08 58.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.64 115.34 60.23 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.978 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.032 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.9 Cg_endo -70.08 147.56 61.11 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.677 2.252 . . . . 0.0 111.829 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.48 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 90.6 m-20 -79.57 -31.93 41.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.615 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 p -83.79 3.74 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.715 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -132.43 143.23 49.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 109.624 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' OE2' ' HG2' ' A' ' 122' ' ' LYS . 62.6 mm-40 -69.27 -51.57 36.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.421 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -171.28 163.09 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.548 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 118' ' ' LYS . 69.4 mt -120.56 137.21 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -108.21 126.8 53.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.2 m-85 -108.3 125.81 52.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 115' ' ' LEU . 25.6 t0 -120.11 102.81 8.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.188 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 9' ' ' ILE . 34.1 t -111.95 142.15 44.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.842 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.3 tttm -127.1 146.71 50.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 108.896 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.842 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.5 mm? -125.69 129.75 50.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.855 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 112' ' ' ALA . 1.2 m -143.91 167.31 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 109.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.585 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -74.92 133.94 41.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.22 163.21 16.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.75 -3.96 13.06 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.628 2.219 . . . . 0.0 111.689 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.15 -23.84 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.87 24.98 10.07 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.71 -138.44 2.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -99.13 145.14 27.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.686 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.79 140.62 24.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.113 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -175.84 -170.58 38.8 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 96.3 mttt -127.11 139.36 53.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -1.119 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.87 HD23 ' N ' ' A' ' 116' ' ' THR . 3.0 tt -114.31 137.73 51.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.87 ' N ' HD23 ' A' ' 115' ' ' LEU . 13.9 m -114.3 133.4 55.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 4' ' ' THR . 96.2 t -109.26 127.72 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.55 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 97' ' ' ILE . 37.5 tttp -115.09 122.24 45.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 42.8 t80 -117.59 115.32 24.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 95.7 mt-10 -103.61 140.36 37.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 17.5 p -106.49 165.77 11.03 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.612 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 75.1 mttt -73.85 -34.01 64.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.48 -145.91 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.14 -13.04 61.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.197 . . . . 0.0 109.468 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.69 130.16 24.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.07 131.49 22.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.7 Cg_endo -70.06 157.5 59.59 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.771 2.314 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.476 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 1.5 m-20 -86.94 175.15 8.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -71.13 -41.51 70.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -57.63 -47.13 83.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 69.4 mm-40 -58.03 -41.07 82.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' A' ' 5' ' ' PHE . 89.7 mt -62.55 -44.95 95.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -61.27 -46.41 90.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.335 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -58.99 -40.75 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.01 97.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -66.92 -39.84 87.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.338 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.85 80.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 109.284 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 39.8 mttm -60.78 -52.89 63.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.37 -56.07 6.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 144' ' ' LYS . 52.0 t0 -50.04 -26.73 4.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.652 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.64 75.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 146' ' ' ILE . 1.3 tp -59.0 -45.53 90.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.199 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.474 ' HE1' HD21 ' A' ' 18' ' ' LEU . 68.7 t80 -68.6 -34.82 76.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.38 -0.825 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 140' ' ' ASP . 85.6 mttt -64.04 -44.85 91.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.16 68.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.917 . . . . 0.0 109.312 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 29' ' ' VAL . 71.0 mt -58.6 -54.32 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -46.07 -53.74 9.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.85 69.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.877 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -65.7 -32.77 74.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.306 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 18' ' ' LEU . 17.1 mt -70.28 -44.33 68.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.372 -0.83 . . . . 0.0 109.529 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.11 -34.5 78.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.0 -15.62 61.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -130.1 83.23 63.94 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.48 -19.34 37.58 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.682 2.255 . . . . 0.0 111.726 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -93.92 16.36 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' HE2' ' HB2' ' A' ' 21' ' ' ALA . 61.7 t80 -60.75 135.61 57.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.551 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.0 t -125.63 140.16 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.42 135.77 51.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.9 m -116.89 130.49 56.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 132' ' ' LEU . 83.7 m-85 -128.78 158.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -133.15 139.76 47.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.461 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -142.33 165.71 26.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -108.29 150.15 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 52.9 mt -115.02 142.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.399 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 40.5 m-20 -134.69 129.43 34.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 m -151.9 129.16 5.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.68 0.15 6.78 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.753 2.302 . . . . 0.0 111.693 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.09 152.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.643 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 134.42 91.11 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.353 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.19 -29.57 32.58 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.74 2.293 . . . . 0.0 111.935 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.11 -37.24 61.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.611 HG23 HD22 ' A' ' 157' ' ' ASN . 39.7 m -80.13 -40.4 27.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 150' ' ' LEU . 3.8 tp -68.38 -38.29 81.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 78' ' ' LEU . 84.4 t80 -71.2 -36.61 71.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.923 . . . . 0.0 109.773 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 24' ' ' THR . 48.6 tptt -68.92 -47.24 66.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.842 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -75.9 -37.19 59.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.485 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 22.7 tp -52.87 -47.18 68.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.7 t -97.48 -53.34 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 110.077 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.544 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -63.64 -47.17 82.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.162 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.781 ' HB3' HG23 ' A' ' 29' ' ' VAL . 15.2 m-20 -95.62 17.64 14.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.004 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -66.34 -47.27 74.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.2 t0 -69.27 -29.08 66.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.94 . . . . 0.0 109.936 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -91.08 -31.61 16.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.963 . . . . 0.0 109.705 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' ASP . 77.6 t -80.4 -42.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 26' ' ' ALA . 42.0 mt -49.49 -51.86 54.91 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.381 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.7 Cg_endo -68.83 -46.69 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.532 2.154 . . . . 0.0 112.638 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -79.92 -44.68 19.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.0 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 29' ' ' VAL . . . -48.13 -36.03 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 36' ' ' SER . 14.5 tp -142.65 133.55 25.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.74 -26.73 50.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.145 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.897 ' HB3' HD21 ' A' ' 34' ' ' LEU . 3.0 t -54.01 -36.82 63.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.661 ' HE1' HG23 ' A' ' 55' ' ' ILE . 62.8 t80 -52.74 135.74 34.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.428 -0.795 . . . . 0.0 109.124 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HE2' HD21 ' A' ' 58' ' ' LEU . 9.9 mttm -90.17 -54.82 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.487 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 1.7 t -178.9 172.34 1.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.125 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.972 HG23 ' CD1' ' A' ' 55' ' ' ILE . 10.9 p -139.07 134.75 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.458 -0.776 . . . . 0.0 109.268 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -142.45 148.31 37.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 81.7 m-20 -92.18 119.39 31.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 10.6 m -80.13 -31.18 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.924 . . . . 0.0 109.456 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' THR . 79.4 tt0 -157.09 143.71 18.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.436 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.77 164.79 32.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -100.57 6.51 44.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 109.71 -8.67 32.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.25 -158.79 14.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.12 129.92 18.03 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.618 2.212 . . . . 0.0 111.718 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.36 3.66 69.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.862 ' O ' HD13 ' A' ' 52' ' ' ILE . 8.3 m -80.04 158.16 26.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -1.135 . . . . 0.0 109.697 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 51' ' ' THR . 13.9 mm -124.12 133.32 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.272 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 45.4 mtmt -129.02 153.96 47.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 78.9 tttt -111.89 121.92 46.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.281 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.972 ' CD1' HG23 ' A' ' 40' ' ' VAL . 5.5 mm -106.35 138.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 43.2 m -131.65 120.25 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -134.23 175.01 9.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' HE2' ' A' ' 38' ' ' LYS . 1.8 mm? -103.15 139.23 38.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 83.1 tt0 -148.94 130.63 15.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 52.8 37.45 24.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.26 8.84 52.59 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.08 126.03 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' ' HE3' ' A' ' 38' ' ' LYS . 79.1 m -72.34 119.21 16.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HD2' ' OE1' ' A' ' 59' ' ' GLU . 64.7 mttm -119.6 167.29 12.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 23.1 p90 -144.68 156.63 44.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.368 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.651 HG13 ' HB ' ' A' ' 55' ' ' ILE . 3.1 p -143.43 152.01 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.781 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG22 ' A' ' 85' ' ' VAL . 12.3 mt -110.72 127.62 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -114.64 131.04 56.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.784 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 20.4 tttt -113.13 134.02 54.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 108.983 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' GLY . 46.5 mt -97.94 127.73 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 93.5 mt-10 -89.63 -33.25 16.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.224 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 81' ' ' SER . 65.3 p -174.86 154.75 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.88 135.13 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.68 84.34 2.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.333 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.39 -40.2 81.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.55 60.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.51 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 93.1 m-20 -94.39 14.63 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 3.9 mt 44.35 27.62 0.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.68 157.98 18.19 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 31.7 p90 -150.84 170.07 20.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 109.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 72' ' ' SER . 3.0 p -120.3 137.63 54.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.424 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 99' ' ' PHE . 19.7 p90 -152.91 156.67 39.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 77.3 p -148.02 158.19 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.605 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 90' ' ' LEU . 39.7 t -91.95 130.1 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.2 m -118.92 -0.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.148 -0.97 . . . . 0.0 110.0 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.02 163.1 34.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.48 169.4 14.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.4 62.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -1.128 . . . . 0.0 109.305 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.14 -14.67 58.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 84' ' ' VAL . 6.5 tt -84.2 114.45 54.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.371 -0.83 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.025 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.0 Cg_endo -69.8 143.56 51.03 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.657 2.238 . . . . 0.0 111.757 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 73.9 m-20 -74.88 -28.47 60.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.578 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.554 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 19.5 p -79.87 2.62 22.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.961 . . . . 0.0 109.689 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.025 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -127.27 132.94 50.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 109.548 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.68 -43.97 87.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -176.28 159.0 1.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.2 mt -122.97 133.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 59.0 m -102.07 145.89 28.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD1' HG22 ' A' ' 117' ' ' VAL . 96.3 m-85 -127.49 119.34 25.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.47 106.83 13.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 0.0 109.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.455 ' OG ' ' HG ' ' A' ' 115' ' ' LEU . 6.3 m -120.85 137.73 54.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 103' ' ' LEU . 33.6 tttt -116.04 159.83 21.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.083 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 102' ' ' LYS . 24.1 mt -135.67 122.43 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 109.641 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.7 m -140.27 143.96 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.15 150.26 46.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.81 175.19 21.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.07 -0.24 6.88 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.673 2.248 . . . . 0.0 111.842 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -74.34 -24.74 59.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.99 17.44 35.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.08 -132.88 2.62 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 t -117.28 140.55 49.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -144.75 148.3 33.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.388 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.33 -167.24 35.36 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -122.36 145.21 48.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -1.119 . . . . 0.0 109.463 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 116' ' ' THR . 2.0 tt -120.31 125.72 48.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.392 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.855 ' N ' HD23 ' A' ' 115' ' ' LEU . 19.2 m -121.42 129.88 53.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.672 HG22 ' HD1' ' A' ' 99' ' ' PHE . 81.6 t -121.2 121.39 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 97' ' ' ILE . 35.9 ttpt -99.23 130.43 45.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.579 ' CE1' ' HG3' ' A' ' 127' ' ' PRO . 15.3 t80 -112.4 120.0 40.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.8 138.01 40.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.323 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 1' ' ' GLY . 29.6 p -120.02 150.48 40.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.518 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.8 mttm -52.55 -36.26 55.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.15 -93.16 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.43 -36.67 78.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 109.422 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -52.66 134.91 35.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.553 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -134.58 111.11 11.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 49.8 Cg_endo -70.09 126.47 13.13 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.751 2.301 . . . . 0.0 111.781 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -72.14 161.12 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.329 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.91 -34.18 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -56.44 -31.44 63.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.127 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.1 -35.9 48.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.0 108.758 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -58.63 -35.17 72.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -71.19 -38.83 72.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.235 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 138' ' ' LYS . 98.2 m -59.39 -42.26 91.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.15 -37.64 91.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -68.44 -40.36 81.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.247 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.51 66.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.832 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 134' ' ' THR . 31.1 mttp -62.54 -47.44 83.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.29 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.45 -46.34 90.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.14 -32.45 55.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.878 . . . . 0.0 109.466 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.47 86.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.8 mm? -78.59 -36.01 44.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -59.21 -50.06 75.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -57.11 -37.1 71.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 -50.35 72.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.304 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 146' ' ' ILE . 4.6 mm -54.31 -46.13 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -66.05 -53.05 43.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.625 ' HD1' HD23 ' A' ' 150' ' ' LEU . 43.3 t80 -70.84 -45.55 64.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.625 HD23 ' HD1' ' A' ' 149' ' ' TYR . 5.2 mt -55.09 -38.6 68.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.2 -28.31 48.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.29 66.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -135.44 93.95 15.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.09 -12.04 31.52 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.697 2.264 . . . . 0.0 111.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -79.03 -16.18 57.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 51.1 t80 -74.6 107.53 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.611 HD22 HG23 ' A' ' 17' ' ' THR . 71.0 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.73 HG12 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -134.09 148.96 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -1.145 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 94.3 m-85 -80.66 119.17 22.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 25.2 m -110.72 116.45 31.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.854 ' CE2' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -109.68 165.3 11.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 60.8 mt-10 -131.15 135.59 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.96 165.86 26.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 0.0 109.519 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -110.01 148.95 30.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.49 147.55 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -148.01 133.72 18.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.55 138.28 11.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -12.14 31.5 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.646 2.231 . . . . 0.0 111.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.974 ' HB ' HD11 ' A' ' 18' ' ' LEU . 88.0 t -86.05 153.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.91 ' O ' HD12 ' A' ' 18' ' ' LEU . . . -57.27 137.82 80.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' CA ' ' HB2' ' A' ' 111' ' ' SER . 45.8 Cg_endo -67.86 -30.2 33.76 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.926 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.61 -33.23 62.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.341 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.0 m -77.09 -36.94 55.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 13' ' ' VAL . 1.8 mt -71.07 -40.43 71.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 69.0 t80 -65.46 -44.04 88.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.852 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' THR . 8.4 tptm -68.99 -46.22 68.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -74.13 -32.46 63.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.968 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 47.3 tp -63.29 -46.03 88.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.688 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.47 -57.08 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.985 . . . . 0.0 110.163 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m -57.24 -44.5 83.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.907 . . . . 0.0 110.175 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 29' ' ' VAL . 4.7 m-20 -99.05 4.68 47.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.615 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.968 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.05 -51.48 13.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.857 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 86.3 m-20 -69.29 -22.72 63.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.123 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -93.36 -26.58 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HG23 ' A' ' 146' ' ' ILE . 97.7 t -82.34 -35.02 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 26' ' ' ALA . 17.8 mt -60.15 -51.45 80.3 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.2 Cg_endo -67.9 -19.41 46.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.554 2.169 . . . . 0.0 112.541 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -108.79 -48.86 3.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.035 -1.041 . . . . 0.0 109.78 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 29' ' ' VAL . . . -61.82 -12.94 19.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 36' ' ' SER . 0.5 OUTLIER -156.23 112.2 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.058 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.57 -18.65 58.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.039 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.546 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.3 -36.14 60.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -51.23 133.14 28.72 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.32 -0.863 . . . . 0.0 109.346 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HD3' HG21 ' A' ' 56' ' ' THR . 36.5 tttp -87.13 -54.05 4.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 36.5 m -165.31 158.51 16.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.833 HG23 ' CE2' ' A' ' 37' ' ' PHE . 83.0 t -142.88 142.9 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.833 . . . . 0.0 109.208 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 71.1 mt-10 -153.73 150.68 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 0.0 109.631 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t-20 -84.68 133.63 34.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.287 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 7.9 m -104.93 -28.2 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 51' ' ' THR . 71.5 tt0 -159.71 147.16 16.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 109.504 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 96.45 158.71 31.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -119.62 35.23 4.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -1.113 . . . . 0.0 109.523 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.39 -17.03 60.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.08 36.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.94 137.32 34.66 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.737 2.292 . . . . 0.0 111.742 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 91.8 4.79 67.07 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.727 ' C ' HD13 ' A' ' 52' ' ' ILE . 53.0 m -73.37 148.4 43.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -1.15 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.727 HD13 ' C ' ' A' ' 51' ' ' THR . 4.1 mm -115.69 126.98 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.249 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 42' ' ' ASN . 70.8 mttt -124.93 149.97 47.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 67' ' ' LEU . 22.6 mttm -117.22 131.23 56.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.02 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.701 HG23 ' CG2' ' A' ' 40' ' ' VAL . 23.0 mt -124.9 121.17 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 109.884 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 42.1 m -95.95 127.86 42.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.317 -0.864 . . . . 0.0 109.211 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.801 ' CE1' HG13 ' A' ' 66' ' ' VAL . 33.7 p90 -130.34 168.24 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.732 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -102.0 149.94 23.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -0.855 . . . . 0.0 109.286 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.77 ' H ' HD13 ' A' ' 58' ' ' LEU . 73.0 tt0 -164.41 123.07 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 55.77 39.19 30.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.47 16.14 54.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 83.5 tt0 -115.81 134.14 55.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -1.148 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.4 m -81.83 122.18 27.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.441 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HE2' ' CD ' ' A' ' 62' ' ' GLU . 75.9 mttt -131.28 170.25 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.4 p90 -141.06 156.2 46.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.801 HG13 ' CE1' ' A' ' 57' ' ' PHE . 27.9 m -130.63 141.8 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 65' ' ' PHE . 7.2 mp -112.47 129.25 56.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.454 ' HD2' HG22 ' A' ' 84' ' ' VAL . 40.6 m170 -121.43 137.72 54.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 81.2 tttt -117.36 151.93 35.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.368 -0.833 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.3 mt -111.06 129.1 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 75.2 mt-10 -97.73 -24.42 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.322 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.3 t 179.4 145.4 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.333 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.04 141.67 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -130.89 87.18 2.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.09 -37.57 87.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.95 83.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 17.8 m-20 -92.47 11.53 25.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 2.0 mt 47.69 34.86 3.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.25 152.72 19.57 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 25.1 p90 -150.19 169.11 22.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -1.168 . . . . 0.0 109.085 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 71' ' ' GLU . 77.4 p -128.64 140.88 51.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 22.1 p90 -155.34 161.27 41.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 35.5 p -146.54 157.38 43.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.474 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 HD12 ' A' ' 90' ' ' LEU . 37.3 t -90.83 126.93 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.271 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG13 ' HE3' ' A' ' 96' ' ' LYS . 3.1 t -108.47 0.55 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 90' ' ' LEU . . . 175.28 175.87 43.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 120.09 161.32 11.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.71 -21.18 66.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.439 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.792 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . . . -79.93 -7.1 58.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.956 HD12 HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -79.81 116.97 64.87 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.515 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.075 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.2 Cg_endo -69.02 148.03 68.93 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.762 2.308 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -79.79 -29.92 40.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.696 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.486 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 24.1 p -79.7 -8.7 59.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.075 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -116.68 127.62 54.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 82.8 mt-10 -65.63 -47.06 76.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 1.5 mtpm? -158.88 169.65 23.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 118' ' ' LYS . 51.0 mt -136.59 127.54 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.413 -0.805 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 3.9 m -109.03 124.08 50.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.393 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.814 ' CE1' HG13 ' A' ' 117' ' ' VAL . 69.9 m-85 -110.22 124.03 50.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 47.6 t0 -115.87 108.22 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.174 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 t -116.3 136.33 53.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.154 -0.966 . . . . 0.0 109.834 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.672 ' O ' HD23 ' A' ' 103' ' ' LEU . 65.4 tttt -119.23 153.01 35.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 108.931 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 102' ' ' LYS . 38.2 mt -131.23 123.76 29.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.007 -1.058 . . . . 0.0 109.738 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 112' ' ' ALA . 35.5 m -138.96 143.17 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.382 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.09 147.7 53.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.87 170.0 23.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.47 -1.47 8.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.674 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -75.74 -23.84 56.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.63 7.51 56.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.26 -141.64 4.85 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB2' ' CA ' ' A' ' 15' ' ' PRO . 2.1 t -109.31 142.93 39.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.576 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -147.14 146.14 29.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.26 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.64 -166.09 32.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 12.9 tttp -124.38 143.38 50.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -1.142 . . . . 0.0 109.419 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -120.89 124.11 44.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.94 . . . . 0.0 109.602 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.728 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.6 m -108.26 135.21 49.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.359 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.814 HG13 ' CE1' ' A' ' 99' ' ' PHE . 24.0 t -110.91 127.84 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.561 ' CG ' HG21 ' A' ' 2' ' ' VAL . 71.6 tttt -110.99 118.61 36.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 0.0 108.849 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.904 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 32.5 t80 -122.65 109.0 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.951 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.73 ' HG3' HG12 ' A' ' 2' ' ' VAL . 62.1 tt0 -96.7 145.86 25.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.124 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.6 HG21 ' HD3' ' A' ' 127' ' ' PRO . 17.3 p -115.26 179.14 4.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.998 . . . . 0.0 109.587 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 93' ' ' THR . 57.6 mttt -62.03 -36.13 80.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.0 -94.0 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.39 -21.14 53.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.66 137.65 57.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 3' ' ' PHE . 61.9 tt0 -127.74 126.85 24.01 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.6 ' HD3' HG21 ' A' ' 121' ' ' THR . 50.0 Cg_endo -70.15 147.05 59.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.765 2.31 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.8 m-20 -72.69 169.23 17.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.47 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.4 -41.94 97.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.5 -43.76 93.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.854 HD13 ' CE2' ' A' ' 5' ' ' PHE . 61.2 mt -60.29 -37.46 80.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.372 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -69.41 -41.23 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.0 m -59.59 -41.22 89.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.67 89.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -68.97 -40.2 79.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.05 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.517 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.792 ' HE3' ' HB2' ' A' ' 89' ' ' ALA . 22.9 tttm -62.45 -45.82 91.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 109.425 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.47 70.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -53.26 -39.54 63.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.93 52.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.367 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 62.8 tp -64.37 -41.05 96.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -55.26 -53.02 61.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.224 -0.923 . . . . 0.0 109.322 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -53.54 -35.07 60.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.193 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 142' ' ' LEU . . . -57.55 -50.05 74.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.242 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.707 HG23 HG11 ' A' ' 29' ' ' VAL . 6.0 mm -55.73 -41.68 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.289 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 83.5 tt0 -62.82 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 -37.59 14.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.182 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.584 ' HD1' HD23 ' A' ' 150' ' ' LEU . 31.8 t80 -66.74 -43.41 84.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.645 HD13 HG11 ' A' ' 13' ' ' VAL . 6.7 mt -56.13 -33.33 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 109.492 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.74 48.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.52 -19.43 57.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -127.38 83.81 65.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.82 -20.22 34.85 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.683 2.255 . . . . 0.0 111.774 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 14.2 p-10 -83.6 -2.6 56.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.56 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -69.02 132.16 46.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.494 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.44 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -152.38 143.65 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -1.141 . . . . 0.0 109.764 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -124.26 145.77 49.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.284 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.6 m -118.26 146.93 43.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 132' ' ' LEU . 72.0 m-85 -139.12 162.19 35.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.04 132.87 45.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -131.88 164.56 25.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.13 149.3 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 115' ' ' LEU . 69.7 mt -123.92 129.8 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -140.65 131.32 25.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -144.6 140.61 16.71 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.12 -10.65 28.76 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.698 2.265 . . . . 0.0 111.714 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -83.34 151.12 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.25 137.56 94.38 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.342 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.9 -28.64 35.74 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.682 2.255 . . . . 0.0 111.75 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.14 -41.72 57.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.851 HG23 ' OXT' ' A' ' 157' ' ' ASN . 55.2 m -77.47 -41.01 41.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 150' ' ' LEU . 41.9 tp -67.11 -38.34 85.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 91.3 t80 -67.55 -41.83 83.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.687 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' THR . 7.8 tptt -66.17 -46.84 75.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.896 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.47 -27.76 61.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.957 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -66.07 -48.1 72.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.652 HG23 HD23 ' A' ' 22' ' ' LEU . 72.7 t -97.39 -50.81 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.535 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.3 m -64.7 -48.77 73.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 109.988 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' VAL . 3.7 m-20 -92.31 3.94 54.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 109.622 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.007 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -46.25 -52.8 11.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.312 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 91.7 m-20 -66.14 -25.13 66.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 93.8 m-20 -88.89 -27.64 20.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.947 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.957 HG21 HG23 ' A' ' 146' ' ' ILE . 9.1 p -83.57 -38.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 109.637 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.007 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.6 mt -52.31 -46.45 94.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.141 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 47.4 Cg_endo -68.47 -17.47 43.73 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 23.8 mttp -108.1 -29.35 9.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.93 81.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.915 HD21 ' HB2' ' A' ' 57' ' ' PHE . 22.7 tp -91.58 111.81 23.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.98 -44.4 87.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -89.74 29.96 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.048 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.772 ' CE1' HG22 ' A' ' 30' ' ' ILE . 47.5 t80 -63.44 132.75 52.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 39' ' ' SER . 49.7 tttp -96.08 -47.68 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.189 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.496 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 34.9 p -179.95 174.16 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.006 -1.059 . . . . 0.0 110.03 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.1 p -136.25 130.33 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 109.343 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -129.86 144.78 51.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.629 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.69 126.51 33.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.363 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 36.7 t -80.05 -41.58 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.625 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 51' ' ' THR . 50.8 tp10 -166.96 156.75 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 98.77 170.23 31.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -119.06 31.79 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -1.189 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.76 -11.62 66.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 -170.97 33.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.58 148.76 60.48 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.669 2.246 . . . . 0.0 111.745 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 80.04 3.32 89.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 44' ' ' GLU . 87.9 m -69.71 149.87 47.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.617 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 29.9 mm -114.96 124.97 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -119.68 144.15 47.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 109.557 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.775 ' HG3' HD11 ' A' ' 67' ' ' LEU . 17.2 tttt -114.48 127.62 55.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.58 ' HB ' HG13 ' A' ' 66' ' ' VAL . 64.3 mt -115.49 145.01 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m -128.72 112.11 13.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.915 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.4 p90 -115.64 173.02 6.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.98 142.57 47.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -143.54 131.3 21.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 53.18 21.88 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.94 71.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.86 155.44 18.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -1.105 . . . . 0.0 109.482 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.3 27.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 52.1 mttm -120.68 162.57 19.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.737 ' CE1' HD13 ' A' ' 67' ' ' LEU . 3.2 p90 -145.74 158.91 43.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.675 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -138.79 147.81 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.5 mp -116.26 136.12 53.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 0.0 108.918 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -129.5 142.45 50.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.743 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 81.7 tttt -124.03 149.31 46.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 24.4 mm -107.68 132.66 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.624 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 95.8 mt-10 -89.3 -39.24 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.346 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -173.62 140.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.68 136.03 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -128.66 78.57 1.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.2 mt-10 -58.91 -39.33 81.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.55 -52.09 42.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 74.8 m-20 -92.22 14.37 16.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 6.0 mt 45.49 42.21 7.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.66 21.7 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -151.6 169.6 21.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -1.155 . . . . 0.0 109.195 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 19.5 m -128.56 138.75 52.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.599 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.2 p90 -154.26 158.67 40.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 96.6 p -146.84 156.6 43.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 89' ' ' ALA . 9.6 p -94.4 135.5 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.213 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 67' ' ' LEU . 3.8 m -118.79 3.61 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.73 164.64 35.55 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.839 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 101.71 178.22 28.25 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.05 45.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.845 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -80.04 -8.69 59.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -103.72 104.21 41.1 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.503 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.048 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.5 Cg_endo -69.66 153.82 68.92 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.692 2.261 . . . . 0.0 111.699 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.497 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 65.2 m-20 -80.06 -35.9 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -80.01 8.38 7.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.048 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -136.88 130.66 32.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.555 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -56.65 -56.48 20.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 20.1 pttm -169.09 160.65 9.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 83' ' ' SER . 59.8 mt -117.17 136.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 8.4 m -106.54 141.21 38.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 73.8 m-85 -119.83 120.57 36.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.968 . . . . 0.0 109.955 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -119.57 101.73 8.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 108.976 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -115.07 141.18 48.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.905 ' C ' HD22 ' A' ' 103' ' ' LEU . 19.8 tttm -127.3 145.37 50.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.436 -0.79 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.905 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.9 mm? -126.45 126.75 44.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 112' ' ' ALA . 27.4 m -137.22 142.65 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.28 145.72 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.49 172.87 22.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.0 0.5 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.43 -25.7 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.25 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.39 -134.59 2.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.6 m -116.9 142.08 47.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -1.122 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.47 147.13 30.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -176.34 -159.73 22.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.94 142.43 49.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -1.135 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 116' ' ' THR . 2.3 tt -116.86 135.66 53.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.878 ' N ' HD23 ' A' ' 115' ' ' LEU . 38.8 m -127.32 125.88 41.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.841 . . . . 0.0 109.266 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 136' ' ' LYS . 50.8 t -109.69 134.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 63.5 tttt -113.88 120.95 42.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.003 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.571 ' CD2' ' HG3' ' A' ' 127' ' ' PRO . 14.9 t80 -102.58 125.33 49.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.975 . . . . 0.0 109.743 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 86.1 mt-10 -107.66 135.33 49.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.683 HG21 ' CD ' ' A' ' 127' ' ' PRO . 26.9 p -116.48 166.15 12.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 92' ' ' ASP . 24.4 mttm -62.82 -35.66 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.4 -86.5 0.14 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -62.4 -27.98 69.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.15 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.71 136.04 52.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -132.32 106.91 13.38 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.683 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -70.57 122.42 8.88 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.698 2.266 . . . . 0.0 111.867 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -60.64 154.52 21.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -58.23 -36.15 72.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.415 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.52 -32.37 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.9 -32.6 51.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.0 -38.41 88.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.396 -0.815 . . . . 0.0 109.093 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -64.75 -45.44 86.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.0 m -57.2 -37.65 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.272 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.75 -46.52 93.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' HG2' HG21 ' A' ' 117' ' ' VAL . 65.0 mttp -53.44 -36.45 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -1.092 . . . . 0.0 109.246 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.79 -35.05 68.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.173 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.29 -47.01 78.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -67.36 -52.48 39.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -57.3 -33.41 67.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.21 81.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.22 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 142' ' ' LEU . 22.2 tp -73.12 -47.58 43.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 75.6 t80 -56.53 -55.35 34.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.066 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -50.76 -39.13 51.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -0.918 . . . . 0.0 109.358 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.957 HG23 HG21 ' A' ' 29' ' ' VAL . 47.7 mt -69.06 -55.1 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.307 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -48.63 -57.82 5.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.918 . . . . 0.0 109.156 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.62 -38.56 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 108.847 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.13 -41.67 85.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 18' ' ' LEU . 28.5 mt -57.35 -36.16 70.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.321 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.02 -28.41 63.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.59 -16.25 62.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -134.13 88.04 32.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.21 -14.83 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.719 2.279 . . . . 0.0 111.806 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -85.69 5.64 31.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.896 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 76.3 t80 -80.01 142.02 35.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.851 ' OXT' HG23 ' A' ' 17' ' ' THR . 81.6 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' CG ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -131.99 148.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -1.181 . . . . 0.0 109.449 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.402 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 77.9 m-85 -81.37 117.45 21.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -109.83 116.82 32.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 92.7 m-85 -109.84 157.9 18.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -125.79 127.97 46.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 109.257 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.73 164.9 17.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.618 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -97.53 149.78 21.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 115' ' ' LEU . 64.0 mt -118.23 134.72 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 109.517 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.16 109.7 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -131.92 131.84 22.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.1 -2.74 10.92 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.745 2.297 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 150' ' ' LEU . 41.3 t -92.81 151.49 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.77 146.22 75.84 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.23 -34.23 22.29 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.801 2.334 . . . . 0.0 111.908 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.639 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -75.26 -38.3 60.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.669 HG23 ' C ' ' A' ' 157' ' ' ASN . 94.9 m -76.9 -37.5 55.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -69.64 -39.44 77.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.518 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 75' ' ' GLU . 86.1 t80 -66.23 -46.25 77.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.803 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HE3' HG21 ' A' ' 24' ' ' THR . 19.1 tptt -61.29 -46.74 89.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.9 -20.19 61.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.009 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.1 tp -80.19 -48.83 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.912 . . . . 0.0 109.835 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.3 t -97.99 -53.03 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.306 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 ' HE3' ' A' ' 20' ' ' LYS . 4.0 m -64.36 -50.41 67.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 110.449 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.4 t70 -90.32 2.57 55.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.013 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.009 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.67 -53.16 12.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.011 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 88.9 m-20 -63.57 -25.1 68.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 63.4 m-20 -90.35 -24.15 20.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 25' ' ' ASP . 37.9 t -81.93 -39.16 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.7 mt -50.61 -48.58 82.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.867 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.5 Cg_endo -67.67 -18.34 48.1 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.407 2.071 . . . . 0.0 111.814 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 21.2 mttt -103.66 -54.62 2.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.314 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.43 -50.82 66.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.051 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.941 HD21 ' CB ' ' A' ' 57' ' ' PHE . 29.9 tp -71.77 102.0 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.912 . . . . 0.0 108.938 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.42 -41.22 76.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 110.352 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.8 p -97.05 29.26 3.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.881 -1.137 . . . . 0.0 110.174 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -56.19 123.01 13.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.088 -1.008 . . . . 0.0 109.218 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -87.17 -54.04 4.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 0.0 109.848 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.613 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 24.5 p -174.21 167.61 4.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.094 -1.003 . . . . 0.0 110.035 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.841 HG23 ' HE2' ' A' ' 37' ' ' PHE . 94.2 t -142.43 141.62 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.157 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 76.5 mt-10 -149.88 163.08 39.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ILE . 7.7 t-20 -101.02 127.48 47.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 20.0 m -93.62 -29.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.877 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 63.1 mm-40 -159.14 147.49 17.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' THR . . . 95.9 156.57 31.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.77 34.13 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.62 65.0 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.42 -166.97 27.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.5 143.99 48.84 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 111.801 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 82.19 1.67 90.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.564 ' C ' HD13 ' A' ' 52' ' ' ILE . 98.3 m -67.62 147.95 52.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -1.153 . . . . 0.0 109.733 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.564 HD13 ' C ' ' A' ' 51' ' ' THR . 11.1 mm -114.19 123.77 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -118.11 143.25 46.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.646 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 64.1 tttt -118.94 132.48 56.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 40' ' ' VAL . 46.3 mt -125.38 145.85 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 0.0 109.659 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 20.4 m -124.69 124.79 42.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.377 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CB ' HD21 ' A' ' 34' ' ' LEU . 49.5 p90 -127.24 156.78 41.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.412 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.26 136.9 37.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -151.68 135.97 16.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.04 38.88 21.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.34 21.92 60.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -124.37 134.12 53.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.319 -1.107 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.5 m -79.97 118.58 21.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.491 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 88.9 mttt -121.08 160.42 23.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.0 p90 -141.61 154.67 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.52 ' C ' HD23 ' A' ' 67' ' ' LEU . 24.3 m -134.52 144.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 86' ' ' GLY . 11.0 mt -110.92 126.09 54.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.198 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -116.32 134.4 54.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 16.2 tttt -119.54 149.51 41.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 48.8 mt -112.32 133.01 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.646 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.66 -32.57 12.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.8 p -171.47 146.18 2.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.417 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.01 138.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -133.66 76.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.292 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.7 mt-10 -59.66 -37.15 77.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.68 70.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.557 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -94.87 12.9 26.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 16' ' ' ALA . 3.8 mt 47.38 38.04 6.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.129 -0.982 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.34 20.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 21.3 p90 -149.88 169.56 20.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -1.171 . . . . 0.0 109.19 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 m -128.88 139.95 51.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 109.486 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 25.5 p90 -154.0 160.02 41.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.6 p -145.2 156.18 43.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.499 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.072 HG11 ' HB3' ' A' ' 89' ' ' ALA . 82.0 t -93.05 130.16 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.643 ' O ' HD22 ' A' ' 90' ' ' LEU . 4.5 m -121.89 -0.61 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.706 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -162.02 152.48 22.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 109.03 176.9 21.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.51 -14.16 18.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.434 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.072 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -80.09 -5.1 55.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD22 ' O ' ' A' ' 85' ' ' VAL . 9.1 tp -95.57 100.57 6.3 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.04 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 49.4 Cg_endo -69.08 150.1 72.0 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.774 2.316 . . . . 0.0 111.872 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.72 -32.26 41.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.619 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 122' ' ' LYS . 7.6 t -88.58 -15.72 34.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.655 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.04 ' HB3' ' CG ' ' A' ' 91' ' ' PRO . . . -111.08 114.82 28.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -45.78 -48.51 15.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -176.63 166.7 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.669 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 118' ' ' LYS . 64.0 mt -124.89 134.49 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 118' ' ' LYS . 33.1 m -106.32 128.39 53.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 95.4 m-85 -106.43 125.14 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.04 104.05 9.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.194 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.5 t -116.17 141.09 48.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.959 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttpm? -128.91 145.09 51.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 83.4 mt -127.53 131.98 49.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.0 110.081 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -142.99 168.96 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.629 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -76.79 136.84 38.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 160.69 15.6 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.52 1.27 5.11 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.657 2.238 . . . . 0.0 111.888 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -80.73 -20.99 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.426 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.75 19.07 11.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.52 -142.01 3.61 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.3 t -104.91 148.03 27.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -146.63 151.66 37.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.265 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.02 -156.55 17.57 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -139.89 142.74 36.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -1.117 . . . . 0.0 109.379 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 116' ' ' THR . 2.2 tt -118.59 131.87 56.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 115' ' ' LEU . 34.0 m -119.32 130.2 55.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.522 HG21 ' HD3' ' A' ' 136' ' ' LYS . 85.0 t -108.18 130.69 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.722 ' O ' HG23 ' A' ' 97' ' ' ILE . 32.1 ttpt -112.3 123.6 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.776 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 38.2 t80 -116.55 115.23 25.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.686 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -99.06 143.41 29.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.017 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.817 HG21 ' HD3' ' A' ' 127' ' ' PRO . 68.3 p -121.99 162.68 20.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.054 -1.029 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 93' ' ' THR . 21.7 mttp -49.72 -39.79 38.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.65 -95.2 0.11 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -71.7 -28.39 63.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 109.411 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.46 133.92 40.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -124.58 125.44 25.55 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.817 ' HD3' HG21 ' A' ' 121' ' ' THR . 51.4 Cg_endo -70.77 142.71 44.13 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.727 2.284 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 1.4 m-20 -81.75 165.57 20.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -66.47 -40.58 89.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -59.76 -49.04 79.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.3 -42.41 98.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.02 -43.44 98.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.22 -50.16 74.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.5 m -58.25 -37.39 74.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.335 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.14 -42.38 99.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 117' ' ' VAL . 8.8 tptt -68.2 -39.91 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.28 28.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.951 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 14.3 tttp -67.67 -41.7 83.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.4 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.52 -55.49 10.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -52.19 -32.12 34.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.27 -39.5 75.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.849 ' O ' HD13 ' A' ' 142' ' ' LEU . 1.3 tm? -69.37 -40.63 77.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.344 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -70.57 -54.31 12.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.137 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -50.78 -31.19 16.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.43 64.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.264 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 142' ' ' LEU . 50.8 mt -65.15 -54.13 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.416 ' O ' HD12 ' A' ' 151' ' ' LEU . 76.6 tt0 -44.7 -51.45 9.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.237 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.79 -37.84 71.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.441 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 37.3 t80 -68.1 -37.14 80.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 0.0 109.468 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 40.7 mt -60.39 -38.43 83.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 109.401 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 147' ' ' GLU . 1.3 mt -73.41 -28.39 61.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' A' ' 153' ' ' HIS . . . -69.29 -18.52 63.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.508 ' HD2' ' HB3' ' A' ' 152' ' ' ALA . 17.1 m-70 -133.37 93.8 21.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.386 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.83 -13.94 32.35 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.683 2.255 . . . . 0.0 111.907 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -86.73 -18.24 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.727 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 55.7 t80 -68.11 109.97 3.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.669 ' C ' HG23 ' A' ' 17' ' ' THR . 7.3 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.6 t -150.99 137.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.461 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.93 146.63 49.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.486 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.5 m -127.59 124.26 37.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.596 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.709 ' CE1' HD12 ' A' ' 132' ' ' LEU . 95.8 m-85 -118.74 137.38 53.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' CD ' ' HD3' ' A' ' 114' ' ' LYS . 60.7 tt0 -105.42 133.56 49.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 8' ' ' GLU . 33.5 t0 -138.56 152.97 48.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mt-10 -92.24 160.45 15.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 115' ' ' LEU . 64.8 mt -117.71 145.13 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 9' ' ' ILE . 78.4 m-20 -136.56 127.0 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 1.5 m -151.88 125.86 4.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.502 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.36 -2.9 11.36 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.583 2.188 . . . . 0.0 111.761 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.861 HG11 HD23 ' A' ' 150' ' ' LEU . 90.4 t -89.17 151.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 134.79 83.57 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 47.1 Cg_endo -68.64 -27.18 32.66 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.747 2.298 . . . . 0.0 111.793 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.13 -43.91 49.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.599 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 HG23 ' OXT' ' A' ' 157' ' ' ASN . 95.0 m -77.38 -40.35 44.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.59 -39.81 77.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.569 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.586 ' HD1' HD23 ' A' ' 103' ' ' LEU . 75.8 t80 -67.08 -37.11 83.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.523 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.846 ' HE2' HG21 ' A' ' 24' ' ' THR . 18.5 tptm -69.86 -46.5 65.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.65 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -75.23 -20.86 59.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.966 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.93 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 23.4 tp -72.08 -49.49 35.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.1 t -97.42 -50.15 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 109.844 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.846 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -62.23 -48.54 79.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.92 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 29' ' ' VAL . 21.7 m-20 -95.46 5.95 50.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.753 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.29 -52.8 11.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.581 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 40' ' ' VAL . 38.3 t0 -67.44 -22.18 65.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.907 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 84.5 m-20 -91.72 -26.76 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 146' ' ' ILE . 7.7 p -81.61 -35.56 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.8 mt -57.78 -47.87 98.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.3 Cg_endo -67.81 -38.19 14.14 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 57.7 mttp -85.39 -29.91 24.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.946 . . . . 0.0 109.181 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -66.94 -30.51 70.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 108.849 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 57' ' ' PHE . 15.6 tp -95.78 113.06 24.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 108.819 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.99 -34.7 76.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.533 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 p -98.03 27.15 4.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.845 -1.159 . . . . 0.0 109.991 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PRO . 58.4 t80 -60.33 137.1 58.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 55.1 tttm -98.01 -48.42 5.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.55 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -178.74 171.76 1.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.895 -1.128 . . . . 0.0 110.019 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 27' ' ' ASP . 4.0 p -137.83 133.05 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -141.58 130.72 23.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.0 m-20 -84.31 136.47 33.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.45 -79.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.11 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 51' ' ' THR . 90.5 mt-10 -115.57 164.16 14.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.4 157.84 29.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.63 13.61 31.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.338 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.4 42.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.93 -160.03 23.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 72' ' ' SER . 50.7 Cg_endo -70.31 130.8 19.25 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.764 2.31 . . . . 0.0 111.85 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 87.92 0.98 82.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 44' ' ' GLU . 43.5 m -71.98 151.71 43.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -1.177 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.61 128.15 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 33.2 mttt -125.67 149.68 48.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.929 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.754 ' HG3' HD11 ' A' ' 67' ' ' LEU . 19.0 tttt -116.29 127.57 54.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 30' ' ' ILE . 62.8 mt -113.03 137.1 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 48.0 m -128.81 128.07 43.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.467 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' HB2' ' CD2' ' A' ' 34' ' ' LEU . 28.8 p90 -137.68 176.51 8.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.0 mm? -103.35 145.33 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.578 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -147.74 126.21 12.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 52.43 23.43 2.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 109.644 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.77 11.85 73.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -112.0 159.71 18.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.6 m -99.8 111.52 23.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -119.33 162.51 18.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 67' ' ' LEU . 4.1 p90 -146.72 159.2 43.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 30.9 m -137.29 146.07 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.596 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.754 HD11 ' HG3' ' A' ' 54' ' ' LYS . 3.6 mp -116.17 137.3 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.045 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -134.14 145.69 49.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.045 -1.034 . . . . 0.0 109.835 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HE2' ' HA2' ' A' ' 50' ' ' GLY . 32.9 tttt -120.32 147.43 45.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 50' ' ' GLY . 49.9 mt -108.89 132.77 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 26.1 mt-10 -86.41 -44.27 12.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 23.3 t -177.14 134.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -100.45 139.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -132.55 73.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.79 -29.33 59.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.61 73.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . 91.0 m-20 -90.16 14.12 13.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 20.9 mt 46.81 46.2 15.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 109.6 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.51 154.68 26.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 82' ' ' TYR . 18.3 p90 -150.72 169.35 21.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -1.211 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 71' ' ' GLU . 67.1 m -134.38 140.6 46.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.5 p90 -153.88 158.76 41.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.581 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.7 p -145.51 156.13 43.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.03 133.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' C ' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -119.81 1.26 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.894 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.39 36.95 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 114.13 176.59 19.1 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.52 -13.37 62.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -1.117 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.98 -9.12 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -90.59 110.3 40.29 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.022 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 49.6 Cg_endo -70.58 148.61 60.11 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.641 2.227 . . . . 0.0 111.7 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.432 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 61.6 m-20 -79.09 -32.54 44.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.1 p -79.85 5.83 12.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.929 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.022 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -131.98 134.71 45.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.057 -1.027 . . . . 0.0 109.63 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 88.0 mt-10 -63.38 -46.51 86.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 3.8 pttm 179.64 159.62 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.2 mt -116.73 136.32 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 21.3 m -111.84 124.83 53.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.865 . . . . 0.0 109.216 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 89.6 m-85 -108.7 124.27 50.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.97 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 16.6 t70 -119.18 107.04 12.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.065 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB3' HD13 ' A' ' 115' ' ' LEU . 76.8 p -121.11 140.61 51.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.977 ' C ' HD22 ' A' ' 103' ' ' LEU . 61.2 tttm -121.03 154.42 36.08 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.977 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -131.17 127.2 37.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.003 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 105' ' ' ALA . 1.3 m -144.97 167.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 108.982 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.577 ' N ' HG23 ' A' ' 104' ' ' VAL . . . -77.06 134.39 38.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.533 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.16 159.31 15.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.8 -8.75 24.39 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.669 2.246 . . . . 0.0 111.867 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -70.1 -22.83 62.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.44 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.47 23.53 10.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.82 3.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.5 t -98.67 149.19 23.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -1.123 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' VAL . . . -145.91 159.12 43.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.15 -174.54 43.62 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HD3' ' CD ' ' A' ' 6' ' ' GLU . 10.2 ttmt -117.02 141.13 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -1.121 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 101' ' ' SER . 34.9 tp -116.15 136.45 53.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.453 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 21.6 m -128.16 126.85 41.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.3 t -108.66 134.19 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 21.0 tttm -121.63 114.3 20.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.781 ' CZ ' ' HB2' ' A' ' 94' ' ' ALA . 39.2 t80 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE2' ' NZ ' ' A' ' 118' ' ' LYS . 93.8 mt-10 -106.66 138.04 43.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.638 HG21 ' CD ' ' A' ' 127' ' ' PRO . 21.8 p -117.07 157.09 26.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 92' ' ' ASP . 52.8 mttt -49.62 -44.94 47.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.04 -71.12 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 27.8 p30 -78.72 -17.04 56.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.097 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.52 132.49 41.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.9 107.5 25.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.878 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.638 ' CD ' HG21 ' A' ' 121' ' ' THR . 49.6 Cg_endo -69.65 119.62 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.708 2.272 . . . . 0.0 111.833 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.95 158.92 26.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.54 -37.16 75.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.09 -31.67 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -78.64 -33.57 47.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 108.951 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -61.73 -43.2 99.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -59.25 -48.7 80.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.205 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.5 m -61.23 -40.1 92.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.36 -49.95 72.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -62.81 -37.89 88.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -1.18 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.42 -28.71 45.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -61.13 -46.74 89.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.272 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.27 -52.59 53.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -50.53 -39.07 47.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.03 86.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.87 -30.62 50.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.03 -52.09 67.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.145 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -52.1 -37.68 54.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.766 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.48 -48.02 78.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.072 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 29' ' ' VAL . 8.4 mm -57.62 -42.53 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.307 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.761 ' O ' HD12 ' A' ' 151' ' ' LEU . 93.5 mt-10 -73.59 -43.37 59.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.91 67.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 153' ' ' HIS . 38.8 t80 -68.23 -44.05 76.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.861 HD23 HG11 ' A' ' 13' ' ' VAL . 4.8 mp -57.62 -35.46 70.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 147' ' ' GLU . 0.7 OUTLIER -79.14 -31.64 44.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.558 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.89 -21.82 60.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 149' ' ' TYR . 74.9 m-70 -129.81 87.38 52.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.84 -17.8 37.01 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.695 2.263 . . . . 0.0 111.79 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.39 -0.78 23.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 74.6 t80 -75.69 136.48 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.454 ' OXT' HG23 ' A' ' 17' ' ' THR . 7.9 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 58.7 t -134.91 137.42 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -1.113 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' TYR . 97.2 m-85 -123.27 149.66 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -127.19 135.0 50.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.305 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.807 ' CZ ' HD13 ' A' ' 132' ' ' LEU . 98.0 m-85 -127.0 157.76 38.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.116 -0.99 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -126.43 132.67 51.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 3.1 t70 -131.88 164.81 25.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.552 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 94.4 mt-10 -103.15 149.95 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.53 129.38 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -139.58 122.13 16.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -144.9 136.66 12.89 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.2 -1.13 8.32 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.597 2.198 . . . . 0.0 111.731 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.797 HG11 ' OE1' ' A' ' 147' ' ' GLU . 1.8 p -92.21 152.28 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.61 137.2 86.26 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' CA ' ' HB3' ' A' ' 111' ' ' SER . 46.1 Cg_endo -68.19 -30.4 31.25 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.749 2.299 . . . . 0.0 111.8 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 -36.58 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 157' ' ' ASN . 61.6 m -80.16 -35.84 35.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 150' ' ' LEU . 7.6 tp -70.04 -39.44 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 85.4 t80 -70.12 -40.29 74.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.744 ' HE3' HG21 ' A' ' 24' ' ' THR . 52.0 tptt -66.0 -47.17 75.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 109.808 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.814 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -71.37 -47.89 53.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.055 -1.028 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.993 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 61.5 tp -47.5 -43.52 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.622 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.4 t -98.44 -56.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.744 HG21 ' HE3' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -64.02 -48.39 76.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.065 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HB2' ' CA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -90.64 2.81 55.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.756 -179.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -46.36 -50.9 15.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 0.0 109.497 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.3 m-20 -66.11 -28.88 69.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.031 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -87.9 -29.33 20.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.045 ' CG1' HG23 ' A' ' 146' ' ' ILE . 92.3 t -83.4 -38.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.439 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.1 mt -49.22 -48.26 74.27 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.795 . . . . 0.0 110.002 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 46.4 Cg_endo -68.93 -19.45 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.408 2.072 . . . . 0.0 111.899 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 53.1 mttm -99.21 -34.1 10.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -64.07 -34.51 78.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.25 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 57' ' ' PHE . 10.3 tp -92.54 109.74 21.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 108.965 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.83 -26.52 65.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 p -109.04 26.98 9.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.0 110.203 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.066 ' CE1' HG23 ' A' ' 40' ' ' VAL . 4.9 t80 -59.17 137.54 57.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.44 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HE2' HD23 ' A' ' 58' ' ' LEU . 13.3 mttm -101.06 -49.52 4.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.942 . . . . 0.0 110.259 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.5 p -175.07 167.13 3.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.957 -1.089 . . . . 0.0 110.21 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.066 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.8 t -135.2 128.14 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.549 -0.719 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -138.65 151.46 47.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 27.1 p-10 -98.44 140.85 32.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.48 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 5.0 m -97.98 -29.9 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.526 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 51' ' ' THR . 77.6 mt-10 -157.93 145.59 18.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.56 159.74 30.92 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -97.37 5.58 49.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.56 -10.51 30.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.44 -158.13 9.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.06 138.09 36.09 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.744 2.296 . . . . 0.0 111.859 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.53 7.14 88.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' GLU . 15.1 m -79.55 157.29 27.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -1.159 . . . . 0.0 109.661 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 16.1 mm -117.85 126.7 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 24.2 mttm -119.13 144.14 46.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.865 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 23.4 tttt -115.41 127.36 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.062 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' CZ ' ' A' ' 37' ' ' PHE . 35.7 mt -121.22 145.3 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 0.0 110.032 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 57.7 m -131.9 127.31 36.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -0.769 . . . . 0.0 109.244 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CB ' ' CD2' ' A' ' 34' ' ' LEU . 23.8 p90 -134.76 170.72 15.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 62' ' ' GLU . 1.9 mm? -107.84 133.53 52.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.366 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -141.41 140.01 33.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 48.46 22.2 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 109.62 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.83 29.34 39.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.759 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.0 mt-10 -132.62 145.16 50.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -85.03 109.25 18.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -113.17 156.86 22.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 12.2 p90 -141.24 153.05 45.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.553 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 1.4 p -138.88 147.52 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -115.11 134.48 55.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.226 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -124.51 138.0 54.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.514 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 51.9 tttt -118.4 144.1 46.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 50' ' ' GLY . 52.5 mt -105.39 129.46 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 81' ' ' SER . 97.0 mt-10 -87.75 -40.73 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.28 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.1 p -171.74 151.77 2.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.84 133.85 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -128.14 82.12 2.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.85 -35.2 75.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -0.991 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.61 -52.35 62.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-20 -89.7 15.0 10.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.538 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 3.8 mt 44.11 46.39 7.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.15 156.47 25.6 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 20.6 p90 -151.64 169.7 21.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.188 . . . . 0.0 109.071 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 21.2 m -126.73 138.46 53.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 0.0 109.579 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 22.8 p90 -154.42 158.62 40.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.852 . . . . 0.0 109.582 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 71.9 p -148.54 156.91 43.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 109.325 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.088 HG21 ' HB3' ' A' ' 89' ' ' ALA . 10.0 p -97.85 132.82 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.959 . . . . 0.0 109.199 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 90' ' ' LEU . 3.7 m -123.44 5.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.009 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.65 153.28 23.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 104.32 -176.22 23.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.47 -13.58 62.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 0.0 109.389 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.088 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.92 -8.61 59.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 85' ' ' VAL . 2.2 tp -105.72 101.8 34.81 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.055 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 50.1 Cg_endo -69.7 152.7 69.69 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.755 2.303 . . . . 0.0 111.601 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.512 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 63.0 m-20 -79.55 -34.92 40.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.628 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -79.96 7.75 8.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.913 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.055 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -138.02 127.53 24.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -52.02 -58.67 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG2' ' OE1' ' A' ' 120' ' ' GLU . 42.6 pttt -167.46 164.44 14.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 83' ' ' SER . 60.1 mt -118.26 135.41 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.403 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 7.7 m -107.01 145.91 31.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.631 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 81.9 m-85 -123.96 120.07 31.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.124 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -118.37 101.64 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.065 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.437 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 29.1 t -117.32 139.62 50.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 110.296 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 1.014 ' C ' HD22 ' A' ' 103' ' ' LEU . 35.7 ttpt -120.81 155.76 33.36 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.014 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.1 mm? -133.07 123.97 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.008 -1.058 . . . . 0.0 110.042 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.15 142.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 109.087 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.01 145.88 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.764 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 169.65 23.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.69 1.76 4.73 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.723 2.282 . . . . 0.0 111.844 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.25 -28.53 64.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.51 21.82 10.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -152.99 -131.41 1.63 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.58 ' HB3' ' CA ' ' A' ' 15' ' ' PRO . 1.1 p -120.18 142.78 48.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -1.134 . . . . 0.0 109.586 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.76 160.5 38.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.402 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.4 168.21 31.05 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -111.49 147.32 35.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.127 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -117.23 131.39 56.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.487 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.658 ' N ' HD23 ' A' ' 115' ' ' LEU . 27.7 m -125.23 126.18 44.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.174 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.429 HG22 ' CD1' ' A' ' 99' ' ' PHE . 57.9 t -111.54 134.22 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.691 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 38.0 ttpt -106.91 126.33 52.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.662 ' OH ' ' HB2' ' A' ' 94' ' ' ALA . 36.8 t80 -106.94 121.07 43.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 96' ' ' LYS . 91.3 mt-10 -104.83 138.96 40.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.624 HG22 ' HE1' ' A' ' 119' ' ' TYR . 26.2 p -119.31 161.86 19.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 24.5 mttt -63.31 -32.1 73.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.17 -108.52 0.31 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' O ' ' OE1' ' A' ' 126' ' ' GLU . 81.4 m-20 -63.43 -34.29 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.142 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.89 127.49 28.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -143.23 127.65 9.59 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.584 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 50.8 Cg_endo -70.46 163.85 37.36 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.7 2.267 . . . . 0.0 111.795 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -93.22 163.66 13.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -52.08 -40.39 61.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -61.35 -46.49 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -57.61 -44.77 85.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.44 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.807 HD13 ' CZ ' ' A' ' 5' ' ' PHE . 78.9 mt -60.65 -39.07 86.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 109.424 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.08 -43.95 85.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 88.8 m -58.51 -40.22 82.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.314 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.08 92.88 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ASP . 42.8 mttt -69.36 -40.25 77.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.62 73.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -75.26 -44.82 43.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 142' ' ' LEU . . . -79.65 -26.42 41.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 136' ' ' LYS . 12.9 t0 -60.68 -40.11 90.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.89 68.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 142' ' ' LEU . 21.2 mt -54.78 -51.75 64.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.201 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -60.74 -53.91 51.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.16 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -56.36 -37.25 69.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.04 -54.38 45.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.186 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.045 HG23 ' CG1' ' A' ' 29' ' ' VAL . 6.6 mt -67.8 -53.39 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.885 . . . . 0.0 109.192 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.797 ' OE1' HG11 ' A' ' 13' ' ' VAL . 15.2 tp10 -52.97 -47.48 68.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.63 69.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 32' ' ' LYS . 34.2 t80 -68.9 -31.15 69.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.287 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 18' ' ' LEU . 15.3 mt -69.84 -46.03 66.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.08 -30.01 70.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.94 -16.5 60.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -124.28 94.6 44.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.64 -21.36 29.49 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.734 2.289 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.3 -20.49 60.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.814 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 69.2 t80 -77.45 131.07 37.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.664 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.445 ' C ' HG23 ' A' ' 17' ' ' THR . 72.2 m-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' CA ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 95.2 t -138.32 137.74 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.534 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HE2' HG21 ' A' ' 121' ' ' THR . 83.5 m-85 -130.98 120.92 24.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 109.538 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 117' ' ' VAL . 51.5 m -109.02 144.16 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.456 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.833 ' CE1' HD12 ' A' ' 132' ' ' LEU . 86.4 m-85 -135.17 135.79 41.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 87.4 mt-10 -106.12 131.34 53.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.917 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.662 ' HB3' HD23 ' A' ' 115' ' ' LEU . 21.1 t0 -130.08 164.41 24.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -101.8 160.01 14.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CD1' ' OG ' ' A' ' 101' ' ' SER . 10.5 mt -133.2 132.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -133.69 131.43 39.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OG ' ' A' ' 111' ' ' SER . 47.8 m -152.55 137.01 10.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 0.0 109.353 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HG2' HD21 ' A' ' 151' ' ' LEU . 51.5 Cg_endo -70.13 -31.55 18.66 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.676 2.25 . . . . 0.0 111.815 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' H ' HG12 ' A' ' 13' ' ' VAL . 1.5 p -60.29 152.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 142.26 97.9 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' N ' ' HB3' ' A' ' 111' ' ' SER . 46.9 Cg_endo -68.19 -37.42 14.34 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.735 2.29 . . . . 0.0 111.775 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.05 82.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 157' ' ' ASN . 52.6 m -78.77 -36.88 42.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.702 HD12 HD11 ' A' ' 150' ' ' LEU . 11.6 tp -69.9 -39.53 76.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 86.7 t80 -68.06 -42.37 80.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.828 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HE3' HG21 ' A' ' 24' ' ' THR . 20.5 tptt -63.81 -46.63 84.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.933 . . . . 0.0 109.728 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . . . -73.15 -25.64 60.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.905 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 2.8 tm? -69.63 -46.89 65.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.37 -53.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.593 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.7 m -62.81 -48.57 78.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 109.956 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -94.85 8.79 41.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 109.617 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.905 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -47.06 -53.42 12.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.602 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 p-10 -69.37 -27.04 64.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 86.1 m-20 -83.34 -28.21 29.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.063 HG11 HG23 ' A' ' 146' ' ' ILE . 88.0 t -81.53 -36.76 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 26' ' ' ALA . 4.5 mt -49.64 -49.37 72.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.102 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 44.8 Cg_endo -67.4 -20.1 48.68 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.503 2.135 . . . . 0.0 111.921 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 149' ' ' TYR . 72.9 mttt -97.64 -54.11 3.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.188 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.08 -41.9 65.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.064 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 9.8 mp -78.2 99.57 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.2 -29.32 60.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.9 p -110.27 27.16 9.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.522 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.746 ' HE2' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.57 123.97 12.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -89.6 -55.77 3.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.7 p -171.95 164.22 6.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.956 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.746 HG23 ' HE2' ' A' ' 37' ' ' PHE . 74.7 t -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.805 . . . . 0.0 109.123 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 40' ' ' VAL . 61.4 mt-10 -152.46 160.77 43.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.129 -0.982 . . . . 0.0 109.765 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 80.0 m-20 -98.97 131.05 45.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.7 m -90.69 -29.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.676 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.84 144.74 17.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 97.37 168.21 32.82 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.8 6.25 33.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -1.101 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 110.22 -9.56 31.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.91 -157.57 8.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.29 137.07 33.09 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.651 2.234 . . . . 0.0 111.862 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.07 7.5 88.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.488 HG23 ' HA3' ' A' ' 45' ' ' GLY . 100.0 m -76.65 153.81 34.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.192 . . . . 0.0 109.625 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.503 ' HB ' ' CG2' ' A' ' 43' ' ' VAL . 24.3 mm -114.18 123.28 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 109.239 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 29.8 mtmt -119.82 145.42 46.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.917 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.606 ' HG3' HD21 ' A' ' 67' ' ' LEU . 20.4 tttm -114.98 126.71 55.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.709 HG23 HG22 ' A' ' 40' ' ' VAL . 20.7 mt -116.4 143.82 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 65.1 m -127.04 128.0 45.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 64' ' ' LYS . 52.7 p90 -133.51 156.06 48.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 140.63 31.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -150.34 134.13 16.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 52.04 32.47 10.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.99 74.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -112.02 139.57 47.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -88.0 119.44 28.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 86.3 mttt -120.35 165.86 14.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 27.8 p90 -145.03 157.78 44.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.537 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 2.3 p -138.69 146.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.773 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 HD21 ' HG3' ' A' ' 54' ' ' LYS . 40.1 mt -113.65 133.26 55.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.871 . . . . 0.0 108.95 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.438 ' NE2' HG21 ' A' ' 66' ' ' VAL . 33.2 m170 -126.17 139.5 53.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.928 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 24.1 tttt -117.52 144.41 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.052 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 mt -102.71 127.44 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 94.9 mt-10 -89.16 -36.63 15.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 32.0 t 178.08 132.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -103.9 137.27 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.314 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -126.57 82.42 2.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 96.6 mt-10 -58.28 -34.57 70.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 109.284 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.12 65.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.433 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 77.6 m-20 -87.79 15.52 6.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.908 . . . . 0.0 109.189 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 19' ' ' TYR . 14.8 mt 43.25 46.02 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' N ' ' CE1' ' A' ' 19' ' ' TYR . . . -145.23 159.71 27.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 82' ' ' TYR . 19.9 p90 -152.17 169.78 21.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -1.202 . . . . 0.0 109.291 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 41.3 t -125.38 137.81 54.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 99' ' ' PHE . 14.2 p90 -151.36 153.97 35.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 98' ' ' THR . 10.9 t -142.44 155.19 45.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.071 HG21 ' HB3' ' A' ' 89' ' ' ALA . 12.2 p -96.43 132.52 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.122 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 p -127.63 2.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.912 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.591 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -157.95 148.04 16.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 108.09 -174.9 19.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.06 -12.37 61.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -1.074 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.071 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.87 8.78 6.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 85' ' ' VAL . 10.2 tt -121.22 101.08 44.69 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.308 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.017 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.1 Cg_endo -69.21 154.59 69.7 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.72 2.28 . . . . 0.0 112.003 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' NZ ' ' A' ' 122' ' ' LYS . 61.4 m-20 -79.92 -31.7 40.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.483 ' HB ' ' HB1' ' A' ' 125' ' ' ALA . 26.2 p -79.76 2.12 24.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.722 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.017 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -134.11 137.26 44.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -65.51 -56.01 14.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.685 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' OE1' ' A' ' 120' ' ' GLU . 43.9 pttt -169.0 159.05 9.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 109.461 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 119' ' ' TYR . 29.1 mt -118.96 137.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.661 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 24.2 m -113.12 120.77 42.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 117' ' ' VAL . 91.8 m-85 -96.0 126.04 40.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.753 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' THR . 17.2 t70 -119.33 113.95 21.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.329 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.502 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . 22.5 t -135.81 140.68 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.47 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.82 ' C ' HD22 ' A' ' 103' ' ' LEU . 29.9 tttt -119.26 160.74 21.64 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 102' ' ' LYS . 3.6 mm? -124.15 126.77 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.881 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 112' ' ' ALA . 29.8 m -137.35 142.93 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.92 146.12 49.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.718 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.25 165.3 21.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.21 -2.16 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.662 2.242 . . . . 0.0 111.894 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.51 18.14 31.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -140.91 3.8 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 13.6 p -119.66 145.56 46.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -1.151 . . . . 0.0 109.606 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -146.43 147.7 31.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 109.146 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 102' ' ' LYS . . . -161.9 170.04 37.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -99.31 146.51 26.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 109.415 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 7' ' ' ASP . 30.4 tp -112.21 137.37 50.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 53.8 m -140.44 113.68 8.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.816 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -110.11 139.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 110.354 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.8 tttp -111.79 119.0 37.14 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 127' ' ' PRO . 12.7 t80 -102.54 123.48 46.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.099 -1.001 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 92.0 mt-10 -106.34 137.98 43.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 3' ' ' PHE . 56.5 p -117.6 159.38 23.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.562 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 92' ' ' ASP . 59.2 mttt -62.32 -40.95 98.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.31 -83.03 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.39 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -1.211 . . . . 0.0 109.517 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -61.99 134.66 56.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -136.79 107.03 8.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.597 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 48.7 Cg_endo -69.77 131.73 21.84 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 111.885 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.21 149.53 35.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.366 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -52.75 -36.0 57.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -57.11 -31.61 65.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.98 -36.18 59.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.157 -0.964 . . . . 0.0 108.574 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.833 HD12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -58.25 -40.93 83.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -52.65 -54.26 35.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.42 -0.8 . . . . 0.0 109.177 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.5 m -58.71 -37.93 77.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.09 97.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 140' ' ' ASP . 24.7 mttt -63.78 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -1.119 . . . . 0.0 109.214 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.35 -34.31 76.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.66 -46.37 46.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.56 -27.13 51.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.153 -0.967 . . . . 0.0 109.18 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 136' ' ' LYS . 86.1 m-20 -80.15 -21.88 42.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.282 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.4 78.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.28 -45.88 87.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -59.28 -55.21 37.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.802 . . . . 0.0 109.25 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -49.75 -41.12 43.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.64 78.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 108.945 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.063 HG23 HG11 ' A' ' 29' ' ' VAL . 21.3 mt -72.89 -54.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.7 -49.52 47.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.234 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.003 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 32' ' ' LYS . 36.0 t80 -67.43 -37.56 83.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.23 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 18' ' ' LEU . 14.1 mt -65.41 -43.16 91.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.376 -0.828 . . . . 0.0 109.396 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.47 HD21 ' HG2' ' A' ' 12' ' ' PRO . 73.8 mt -69.42 -31.7 70.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.595 ' HB3' ' HD2' ' A' ' 153' ' ' HIS . . . -73.89 -19.08 60.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.595 ' HD2' ' HB3' ' A' ' 152' ' ' ALA . 7.4 m-70 -127.13 89.35 52.06 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.87 -19.32 35.78 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.71 2.273 . . . . 0.0 111.805 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.82 -11.7 60.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.748 ' OH ' ' HB2' ' A' ' 21' ' ' ALA . 71.2 t80 -77.48 133.7 38.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.588 ' C ' HG23 ' A' ' 17' ' ' THR . 48.0 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' THR . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG11 ' HD2' ' A' ' 118' ' ' LYS . 48.3 t -127.69 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -1.164 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 126' ' ' GLU . 97.2 m-85 -126.27 141.65 51.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 37.4 m -121.37 130.38 53.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 132' ' ' LEU . 87.6 m-85 -123.11 136.73 54.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -110.08 132.18 54.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -133.81 165.8 24.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.525 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -99.6 145.35 27.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.335 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.755 HG21 HD11 ' A' ' 103' ' ' LEU . 70.8 mt -106.55 142.34 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -154.92 128.89 8.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -152.97 140.92 13.6 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.479 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.13 -1.43 8.76 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.674 2.25 . . . . 0.0 111.778 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.723 HG21 ' HG3' ' A' ' 147' ' ' GLU . 64.5 t -97.49 149.47 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.52 95.63 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.4 -31.07 28.71 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.729 2.286 . . . . 0.0 111.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 -41.9 53.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.696 HG23 ' CB ' ' A' ' 157' ' ' ASN . 93.1 m -75.27 -43.74 49.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' CZ ' ' A' ' 143' ' ' PHE . 68.1 tp -67.48 -37.29 82.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' C ' ' A' ' 78' ' ' LEU . 73.6 t80 -66.75 -41.24 88.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.607 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HE2' HG21 ' A' ' 24' ' ' THR . 17.1 tptm -67.12 -46.49 73.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.631 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 156' ' ' TYR . . . -74.78 -17.3 60.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.001 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 26.1 tp -74.23 -51.37 15.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.53 -44.72 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.971 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.863 HG21 ' HE2' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.25 -47.97 74.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.949 . . . . 0.0 110.103 -179.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 29' ' ' VAL . 53.6 m-20 -98.51 11.28 38.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.035 . . . . 0.0 109.833 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.001 ' HB2' ' O ' ' A' ' 22' ' ' LEU . . . -53.88 -51.57 63.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 20.2 t70 -70.57 -21.37 62.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 110.141 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.16 -27.2 16.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 HG23 ' A' ' 146' ' ' ILE . 7.9 p -80.95 -33.85 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.81 . . . . 0.0 109.67 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 26' ' ' ALA . 5.8 mt -61.91 -49.55 85.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.15 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 48.5 Cg_endo -68.92 -22.78 35.56 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.513 2.142 . . . . 0.0 112.445 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 33' ' ' ALA . 22.4 mttt -106.14 -35.72 7.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.004 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -43.23 -38.67 2.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.004 HD23 ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -155.44 144.0 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.442 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.8 -18.71 50.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' HD13 ' A' ' 58' ' ' LEU . 68.0 m -55.14 -38.12 67.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.398 -0.814 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 55' ' ' ILE . 1.3 t80 -49.93 135.52 19.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.087 -1.008 . . . . 0.0 109.294 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 40.2 tttp -81.07 -57.28 3.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 110.295 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -162.46 155.57 20.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.02 -1.05 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 55' ' ' ILE . 92.3 t -134.67 133.55 54.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.458 -0.776 . . . . 0.0 109.065 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 84.3 mt-10 -159.34 168.1 27.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.95 . . . . 0.0 109.634 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 65.9 m-20 -97.03 152.6 18.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 2.5 t -96.1 -33.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.558 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.803 ' O ' HG23 ' A' ' 51' ' ' THR . 45.3 tp10 -166.79 156.44 11.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 44' ' ' GLU . . . 88.96 -172.97 40.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -120.99 17.35 11.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 51' ' ' THR . . . 99.93 -1.43 56.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.14 -164.01 23.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.95 126.41 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.623 2.215 . . . . 0.0 111.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 92.77 4.13 65.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 44' ' ' GLU . 86.1 m -75.34 150.4 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -1.121 . . . . 0.0 109.58 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' C ' ' A' ' 51' ' ' THR . 9.4 mm -111.56 122.25 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' ASN . 21.8 tttt -116.98 142.1 47.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 110.108 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 43' ' ' VAL . 17.9 tttm -117.25 130.24 56.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.024 HG22 HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -130.46 138.25 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.981 -1.075 . . . . 0.0 110.004 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 91.1 m -120.52 114.67 22.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.386 -0.821 . . . . 0.0 109.343 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 50.8 p90 -114.96 171.05 7.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -111.14 151.32 28.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' GLU . 60.5 tt0 -154.28 138.58 16.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.311 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 2.8 p-10 44.13 26.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 59' ' ' GLU . . . 81.58 24.29 56.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' GLU . 72.7 mt-10 -121.74 140.88 51.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.445 ' CG2' ' HD2' ' A' ' 38' ' ' LYS . 16.2 m -91.07 110.28 21.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -116.18 162.04 18.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 14.2 p90 -141.85 153.79 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 5.6 p -140.6 148.82 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.712 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 12.0 mt -110.81 128.78 55.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.914 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -122.52 138.55 54.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 22.1 tttm -119.57 146.94 45.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.5 mt -104.93 130.52 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 72' ' ' SER . 48.4 mm-40 -93.56 -27.79 16.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.292 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 23.2 t 178.27 144.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.44 138.15 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.373 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 94.0 m-20 -130.79 81.97 2.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.32 -37.01 81.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.54 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.53 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 22.0 m-20 -97.58 12.11 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt 47.88 29.31 1.6 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ASP . . . -121.24 150.86 17.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 82' ' ' TYR . 22.3 p90 -151.24 169.76 21.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -1.225 . . . . 0.0 109.123 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 47.4 t -128.56 138.88 52.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 99' ' ' PHE . 19.9 p90 -153.97 158.91 41.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.493 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 80.7 p -145.23 157.07 44.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.643 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.049 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.0 p -96.48 129.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 67' ' ' LEU . 3.6 m -116.57 4.86 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -169.18 159.51 32.53 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 105.02 -171.54 18.99 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.88 61.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -1.079 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.049 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -79.91 -4.02 50.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 90' ' ' LEU . 7.4 tt -121.86 86.35 45.82 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.756 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 48.3 Cg_endo -69.54 165.91 29.12 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.505 ' O ' ' CE ' ' A' ' 122' ' ' LYS . 38.9 m-20 -70.44 -27.82 64.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.9 p -79.77 -23.94 41.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.601 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -106.32 121.58 44.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.972 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 92.8 mt-10 -64.97 -49.12 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 71.8 mttt -161.2 158.42 27.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.574 ' CD1' ' CE2' ' A' ' 119' ' ' TYR . 62.7 mt -123.61 133.68 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.84 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 118' ' ' LYS . 5.2 m -108.91 131.29 55.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CD1' ' CG2' ' A' ' 117' ' ' VAL . 99.8 m-85 -115.11 122.39 45.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.47 ' O ' HD23 ' A' ' 115' ' ' LEU . 42.5 t0 -116.11 119.9 37.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.888 . . . . 0.0 109.188 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.506 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 9.9 t -138.48 134.93 34.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.187 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.797 ' O ' HD12 ' A' ' 103' ' ' LEU . 20.0 tttm -125.77 149.09 48.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.2 mp -130.1 128.88 42.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 109.954 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 112' ' ' ALA . 32.6 m -138.96 143.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 109.164 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.04 139.65 22.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -129.28 168.16 21.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.16 -16.36 35.87 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.73 2.287 . . . . 0.0 111.729 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -64.86 -22.56 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.03 42.78 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.76 -140.42 4.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 m -101.93 141.36 34.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 104' ' ' VAL . . . -148.02 139.5 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.89 -156.4 13.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -129.82 141.68 50.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.299 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 101' ' ' SER . 3.1 tt -124.52 119.8 30.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 110.005 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.478 ' N ' HD23 ' A' ' 115' ' ' LEU . 71.2 m -116.65 128.32 55.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 108.788 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -117.03 131.97 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 110.062 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 37.1 ttpt -111.08 115.61 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CE1' ' HB2' ' A' ' 94' ' ' ALA . 15.7 t80 -99.45 128.92 45.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.234 -0.916 . . . . 0.0 109.647 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -102.9 144.43 31.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.312 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 70.1 p -123.72 152.84 41.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 92' ' ' ASP . 12.5 mttm -55.15 -29.21 57.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.0 -108.11 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.65 -27.27 58.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.04 135.83 57.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -141.33 119.59 7.91 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.5 146.66 56.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.844 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -87.55 177.25 7.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.94 -36.15 80.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.26 -41.92 94.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.458 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -66.96 -42.77 84.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.404 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.555 HD13 ' CE2' ' A' ' 5' ' ' PHE . 79.7 mt -63.39 -42.1 98.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -63.13 -47.39 82.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 109.411 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.7 m -58.2 -37.88 75.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.407 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.82 95.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -67.45 -39.66 85.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.62 63.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.55 -49.38 76.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.61 86.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.32 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -57.41 -38.53 74.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . -57.79 -49.07 77.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.728 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.2 mm? -75.9 -37.24 59.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.309 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.604 ' CZ ' HD21 ' A' ' 18' ' ' LEU . 51.2 t80 -58.35 -51.81 68.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -62.87 -32.17 73.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.411 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.94 70.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 109.319 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.722 HG23 HG21 ' A' ' 29' ' ' VAL . 29.4 mt -62.91 -45.13 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.723 ' HG3' HG21 ' A' ' 13' ' ' VAL . 82.7 tt0 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.267 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.4 -37.26 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.149 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.605 ' CE2' ' CE1' ' A' ' 153' ' ' HIS . 49.1 t80 -67.92 -41.25 82.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 12.9 mt -55.44 -34.9 64.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.427 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.2 mt -78.58 -28.25 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -20.79 59.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.455 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.605 ' CE1' ' CE2' ' A' ' 149' ' ' TYR . 74.9 m80 -130.32 90.3 41.97 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.46 -16.12 34.55 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.779 2.319 . . . . 0.0 111.815 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.37 -17.49 60.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.605 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 79.3 t80 -75.1 121.45 22.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.696 ' CB ' HG23 ' A' ' 17' ' ' THR . 5.8 m120 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.463 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 119' ' ' TYR . 91.5 t -133.2 138.02 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -1.121 . . . . 0.0 109.487 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -129.39 130.98 46.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' VAL . 98.4 m -113.35 145.01 41.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 91.3 m-85 -136.37 128.63 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.978 . . . . 0.0 109.676 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 77.0 tt0 -96.43 131.3 43.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 136' ' ' LYS . 6.5 m-20 -128.0 164.93 21.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -100.9 151.56 21.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.97 128.57 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.14 125.4 37.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.58 129.67 5.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.35 -0.03 6.8 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.661 2.241 . . . . 0.0 111.865 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -87.59 151.36 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.675 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.23 142.92 97.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 109.503 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 105' ' ' ALA . 46.9 Cg_endo -68.55 -35.78 16.5 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.769 2.312 . . . . 0.0 111.814 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.32 80.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 157' ' ' ASN . 56.2 m -79.23 -40.93 29.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 HD11 ' A' ' 150' ' ' LEU . 22.3 tp -67.41 -38.8 85.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.606 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.648 ' CG ' HD22 ' A' ' 78' ' ' LEU . 68.1 t80 -69.55 -40.43 76.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' THR . 38.1 tptt -65.64 -46.93 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -75.03 -30.35 61.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.906 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.4 mt -58.71 -49.24 78.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.448 -0.783 . . . . 0.0 109.722 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.51 -46.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.889 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 1.7 m -71.81 -50.87 25.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.56 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 62.5 t0 -85.15 7.56 21.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.012 . . . . 0.0 109.727 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 30' ' ' ILE . . . -59.21 -49.7 76.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.937 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 90.7 m-20 -66.32 -31.27 71.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.819 . . . . 0.0 109.986 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 24.4 m-20 -87.3 -28.39 22.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.686 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.731 HG21 HG23 ' A' ' 146' ' ' ILE . 7.6 p -81.24 -36.75 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.655 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 26' ' ' ALA . 2.7 mt -53.24 -48.31 92.81 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.984 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 45.9 Cg_endo -67.94 -34.55 23.16 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 111.943 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 149' ' ' TYR . 18.2 mttp -83.23 -40.59 19.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.163 -0.961 . . . . 0.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -58.42 -61.7 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.938 HD21 ' HB2' ' A' ' 57' ' ' PHE . 47.5 tp -64.55 108.8 1.77 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 108.927 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.44 -35.41 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -96.81 27.18 4.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.941 -1.099 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.853 ' HA ' HD23 ' A' ' 34' ' ' LEU . 50.9 t80 -59.33 136.29 57.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 39' ' ' SER . 55.0 tttt -97.87 -49.77 4.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 110.051 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.51 ' C ' ' CE2' ' A' ' 37' ' ' PHE . 83.1 p -178.69 171.87 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.122 -0.986 . . . . 0.0 109.753 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.4 p -134.25 122.56 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.4 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 42' ' ' ASN . 18.0 tt0 -126.13 158.25 35.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' N ' ' CG ' ' A' ' 41' ' ' GLU . 45.4 m-20 -105.7 154.39 20.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 52' ' ' ILE . 4.2 m -117.53 -34.92 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 85.1 mt-10 -158.3 145.78 18.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.567 ' HA3' HG23 ' A' ' 51' ' ' THR . . . 98.43 162.0 30.34 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.78 2.86 49.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -1.113 . . . . 0.0 109.566 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 51' ' ' THR . . . 112.6 -10.32 25.9 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.24 -153.37 10.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.29 139.5 38.54 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 C-N-CA 122.714 2.276 . . . . 0.0 111.798 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 70' ' ' ILE . . . 81.59 -1.18 86.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.639 ' O ' HD13 ' A' ' 52' ' ' ILE . 90.8 m -71.91 153.5 41.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -1.21 . . . . 0.0 109.63 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 51' ' ' THR . 14.6 mm -117.91 127.83 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -123.78 148.37 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 109.786 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' CD2' ' A' ' 67' ' ' LEU . 27.1 tttm -115.32 126.16 54.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 66' ' ' VAL . 84.9 mt -113.73 143.22 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.568 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 40.7 m -129.74 128.69 42.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.938 ' HB2' HD21 ' A' ' 34' ' ' LEU . 30.5 p90 -134.5 169.03 17.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -106.25 142.9 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.419 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.5 128.91 15.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.513 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 49.74 24.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 28.25 41.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -122.36 154.4 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.6 m -98.49 107.13 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.334 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 57' ' ' PHE . 36.0 mttt -116.09 160.08 20.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 24.8 p90 -144.93 157.03 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.627 ' C ' HD23 ' A' ' 67' ' ' LEU . 17.1 m -137.25 145.82 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.707 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.775 HD12 ' HA3' ' A' ' 86' ' ' GLY . 8.5 mt -114.18 133.89 55.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.878 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -126.1 139.32 53.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 38.3 tttm -121.11 144.78 48.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.285 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 10.6 mm -102.79 125.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.443 ' OE2' ' CG2' ' A' ' 98' ' ' THR . 92.0 mt-10 -82.97 -54.2 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.865 . . . . 0.0 109.33 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.6 t -162.39 136.97 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 70' ' ' ILE . 58.1 mt -113.41 134.76 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.403 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -129.83 79.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -50.96 -34.99 31.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.25 -49.43 64.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.674 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.497 ' O ' ' HE3' ' A' ' 102' ' ' LYS . 59.9 m-20 -100.52 14.57 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.648 HD22 ' CG ' ' A' ' 19' ' ' TYR . 40.1 mt 42.43 41.21 2.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.84 106.42 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -109.79 170.38 8.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.691 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 p -136.07 142.83 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 99' ' ' PHE . 21.4 p90 -152.85 157.6 40.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 109.656 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 12.4 p -142.2 153.91 44.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 67' ' ' LEU . 9.4 p -103.37 128.31 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.577 HG12 ' CD ' ' A' ' 96' ' ' LYS . 2.3 m -122.3 6.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.775 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . -158.89 147.88 16.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 66' ' ' VAL . . . 119.89 179.66 16.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.22 -13.81 59.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' ' NZ ' ' A' ' 138' ' ' LYS . . . -79.99 -8.94 59.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 85' ' ' VAL . 4.5 tp -100.0 102.73 18.72 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.874 ' HG2' ' HB3' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -68.65 152.29 74.55 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.724 2.282 . . . . 0.0 111.836 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.96 -29.32 60.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.867 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.7 p -79.57 3.75 17.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.078 -1.014 . . . . 0.0 109.818 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.874 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . . . -125.37 128.92 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 5.7 tt0 -63.82 -55.0 26.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' HG12 ' A' ' 85' ' ' VAL . 89.5 mttt -161.51 160.94 29.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 83' ' ' SER . 17.0 mt -126.15 132.78 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 34.6 m -118.55 115.89 25.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.842 ' CD1' HG23 ' A' ' 117' ' ' VAL . 69.5 m-85 -94.41 128.53 41.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 109.67 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 116' ' ' THR . 13.8 t0 -116.84 116.52 27.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.254 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 115' ' ' LEU . 12.2 t -133.06 136.34 45.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.919 ' C ' HD22 ' A' ' 103' ' ' LEU . 28.9 tttt -122.74 144.81 48.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.919 HD22 ' C ' ' A' ' 102' ' ' LYS . 2.4 mm? -128.36 124.04 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 112' ' ' ALA . 2.0 m -133.75 162.55 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 109.059 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . . . -60.87 125.33 23.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.057 -1.027 . . . . 0.0 109.514 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.79 150.28 19.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.58 2.33 4.1 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.647 2.231 . . . . 0.0 111.971 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.24 5.7 50.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.605 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.73 22.14 51.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.56 -138.67 3.49 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -120.46 142.59 49.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -1.187 . . . . 0.0 109.51 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.55 ' O ' HG13 ' A' ' 104' ' ' VAL . . . -147.28 147.37 30.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -166.26 -151.94 7.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -133.44 142.73 48.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -1.128 . . . . 0.0 109.261 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 116' ' ' THR . 4.8 tt -120.61 126.53 50.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.784 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.677 ' N ' HD23 ' A' ' 115' ' ' LEU . 68.0 m -125.72 124.85 41.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 108.849 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 99' ' ' PHE . 1.1 p -108.08 142.47 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.061 -1.025 . . . . 0.0 110.128 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 69.2 tttt -119.93 116.61 26.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 108.964 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.656 ' O ' HG13 ' A' ' 2' ' ' VAL . 15.3 t80 -102.68 130.51 49.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.137 -0.977 . . . . 0.0 109.667 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 2' ' ' VAL . 79.2 mt-10 -111.75 127.22 55.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.37 -0.831 . . . . 0.0 109.313 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 32.8 p -110.94 157.52 19.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.543 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -58.36 -39.23 78.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 -93.21 0.1 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -67.41 -31.65 72.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.13 115.19 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.89 108.48 28.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 117.95 5.4 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.783 2.322 . . . . 0.0 111.844 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -59.87 157.06 13.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -56.35 -38.57 71.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.82 -31.34 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.252 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 131' ' ' GLU . 63.2 mm-40 -74.38 -36.85 63.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 108.7 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.98 -35.8 69.6 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -60.63 -48.03 83.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.18 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.2 m -58.33 -39.02 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.44 99.35 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 7' ' ' ASP . 29.5 tttt -73.06 -41.78 63.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -1.111 . . . . 0.0 109.362 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.05 -34.96 70.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.642 ' NZ ' ' HB2' ' A' ' 89' ' ' ALA . 41.2 tttm -71.25 -44.76 64.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.252 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.93 89.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.837 . . . . 0.0 109.353 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.534 ' HB3' ' HE3' ' A' ' 144' ' ' LYS . 89.5 m-20 -50.95 -47.54 61.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.291 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.33 57.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.464 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 142' ' ' LEU . 3.1 tm? -70.62 -53.36 16.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -60.93 -53.63 54.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 108.948 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.534 ' HE3' ' HB3' ' A' ' 140' ' ' ASP . 49.4 mttt -51.93 -37.85 54.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.849 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -56.45 -45.83 80.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.28 -0.887 . . . . 0.0 108.989 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 29' ' ' VAL . 16.7 mt -69.07 -54.72 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.362 -0.836 . . . . 0.0 109.225 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -59.64 -52.65 64.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.341 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . -48.83 -39.19 24.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.062 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.535 ' OH ' ' CD2' ' A' ' 153' ' ' HIS . 35.1 t80 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.211 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 24.6 mt -58.82 -41.09 86.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.27 -29.64 67.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.918 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.0 -17.66 56.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CD2' ' OH ' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -125.74 85.77 58.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.575 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.44 -20.54 31.52 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.682 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -79.38 -1.45 37.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 157' ' ' ASN . 59.6 t80 -68.81 143.56 54.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 17' ' ' THR . 7.2 m120 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 stop_ save_